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Director's
Report
The recombinant DNA age is now 15 years old. During this brief period the doing
of biological research has changed beyond recognition, and the ability to
manipulate DNA has industrial and agricultural consequences that modern nations
can ignore only at the expense of their long-term futures. Even more important,
DNA research is beginning to have medical and ethical consequences that will
affect how we lead our daily lives and plan for the future of our children and they
for their children's future.
We thus have to assume that the number of scientists who work with DNA will
steadily increase, soon to exceed 100,000. In contrast, when, in 1953, Francis
Crick and I found the structure of DNA to be the double helix, those of us who
focused exclusively on DNA numbered at most only several hundred. This
massive increase in our numbers naturally has had many consequences both
scientific and human, some of which are obviously good and others not so
wanted. To understand where we now stand, we must realize that we are living in
the midst of a virtual biological gold rush, searching in areas where no one has
ever before tread and where the rules for decent behavior in more civilized territo-
ries are not easily transferable to the new frontiers.
That DNA is today's gold first became apparent when the double helix began
to have real consequences on experimental science and the possibility of working
out the genetic code gripped our imagination. Francis Crick epitomized this
calculated bravado and proclaimed as The Central Dogma' the transfer of genetic
information from DNA to RNA to protein. At the same time, he called his newly
expanded Cambridge row house "The Golden Helix" and hung on its exterior wall
a helically shaped strip of copper to inform his guests that they were at the right
door. What seemed to Francis like common sense, however, could only annoy his
more conservative peers, who shuddered at the possibility that they might have to
follow his lead along the double helix or disappear into oblivion.
Initially, prospecting for DNA was a civilized affair, and the pace of our daily
lives did not measurably change through the remainder of the 1950s and even
into the mid-1960s. Important discoveries occurred frequently enough to keep our
minds alert, but not so often that long summer vacations in the mountains or on
the beaches would fall victim to fears that new discoveries would blow our labs out
of the water. For the most part, each major lab worked on its own unique
problems, and when, by chance, direct competition existed, the winning or losing
of a particular race never was a life or death matter. In this way, the genetic code
became established, and the culminating event, the 1966 CSH Symposium on
"The Genetic Code:' displayed a DNA world that knew and liked each other
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enough to take pleasure in each other's successes. Helping make possible this
camaraderie was the then high level of financial support. Capable scientists
virtually never had a grant turned down, and since the DNA world was then still
relatively small, supporting it was not a significant drain on any federal treasury.
Scientific success, particularly on the part of younger scientists, could always be
rewarded through obtaining the larger grants needed to exploit real breakthrough
discoveries.
By the late 1960s, however, this semi-idyllic world almost began to come apart.
The Vietnam War was now on, and federal monies for health-related research were
no longer ever-increasing. Moreover, the constant influx of new scientific blood,
coupled with the fact that few DNA scientists were old enough to retire, meant that
the number of individuals applying for the same pot of money had to increase. For
the first time since the end of World War II, we could not assume that our next
grant application would be routinely successful. So our morale would have badly
deteriorated had it not been for the "War on Cancer" that was decalred by
Congress in 1972. Though initiated over the opposition of most pure molecular
biologists, who thought this war promised too much, it was only through the
availability of copious cancer funds that the DNA world of the 1970s remained one
that outsiders could envy for its ability to do what it wanted.
Until the 1973 advent of recombinant DNA, only the general facts of how DNA
functions could be established, and there had never been enough obviously
solvable, important objectives for a gold rush to develop. But with the recombinant
DNA procedures for gene cloning and the equally spectacular new methods for
sequencing DNA, the exact details of virtually any genetic message were up for
grabs. At long last, the genetic nature of cancer was a solvable problem and so
might be the mysteries of embryological development and the nature of the
immune response. Moreover, methods soon developed to introduce functional
DNA into a variety of key biological species, opening up the possibilities of using
such genetic manipulations for industrial and agricultural ends.
The rush for all this potential gold, however, did not start off with a bang due to
worries that a genetically modified organism might upset the current balance of
nature, conceivably even annihilating the human race through new forms of
cancer-causing human pathogens. So an effective worldwide moratorium on all
recombinant DNA work came into effect in mid-1974. The inherent implausibility of
these doomsday scenarios, however, led eventually to general disbelief, and in
1977 an NIH-sponsored committee gave permission for the first experiments with
genetically manipulated E. coli cells to begin. By 1979, further permissions were
on hand to do experiments on the genetic determinants that give rise to cancer,
and within two years the first human oncogenes were cloned.
To begin to train the vast numbers of scientists who now wanted to work with
recombinant DNA, a formal course on gene cloning was initiated here in the
summer of 1980, and today we hold seven advanced techniques courses that deal
with recombinant DNA procedures. Equally important has been our publishing of
a massive gene cloning laboratory manual, written by Tom Maniatis, Ed Fritsch,
and Joe Sambrook. Molecular Cloning has already sold over 60,000 copies,
becoming in effect the bible of the recombinant DNA world. Most of its sales
appear to be to individual scientists, not to students taking prescribed university
courses, and the number sold may be a good measure of the number of scientists
who now work with DNA.
The DNA world thus is no longer a collection of friends who have grown up
with each other and know each other's strengths and weaknesses. Instead, none
of us can personally know more than a small fraction of our peers. All we can now
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do is to try to maintain real contacts with that subset of the recombinant DNA
world that focuses on a common research objective (e.g., nuclear oncogenes). At
the same time, it is becoming impossible to read thoroughly all the new journal
articles that common sense tells us we should be conversant with. So, increas-
ingly, we have to rely on the writings of others, say, in Nature, Science, or TIBS,
to tell us what is happening in areas outside our immediate research focus. And
because of the much faster rate at which the new discoveries occur, it is more
important than ever to attend specialized meetings where you can meet your true
peers. So, we are steadily increasing the number of such meetings held here.
During 1988, we will host 25 high-level gatherings, in contrast to the two
gatherings (the Symposium and the phage meeting) held the year I became the
director. Within five years, I can easily see this number rising to at least 35, and it
takes little imagination to predict that by the year 2000 we will have to host some
50 meetings if we are to continue as the premier meeting place in the world for
biology.
In so expanding, the DNA world is not getting duller. The new facts being
reported are every bit as important as those found, say, 25 years ago and very
often reflect deeper insights into the nature and functioning of living organisms.
Many fields that totally bored me 25 years ago (embryology and the functioning of
the human brain) now begin to excite me. So it is hard to imagine that our rate of
growth will soon level off. Who will pay for this seemingly never-ending expansion,
however, is far from clear, particularly in the United States where our borrowing
from abroad cannot go on forever in Ponzi-like fashion. With the NIH budget now
effectively capped at $6 billion, we have reached the point where more and more
highly meritorious grant applications are arbitrarily being turned down. The
dangerous situation has arrived where real scientific success is no longer
necessarily being rewarded.
The running of even our best research institutions in a first-class manner thus
cannot be taken for granted. No matter how hard we work, one or more of our
staff may be intellectually strangled by a peer-review group that has too many
hungry mouths to feed. For now, a complete lack of faith in the peer-review system
is only held back by the recent arrival on the scene of the vastly expanded
Howard Hughes Medical Research Institute. It is yearly adding $300 million to the
funding of basic biological research. Those several hundred key scientists whom
they now support will be able to do science to the best of their ability, as will
many of those individuals who work under the umbrella of program project
support from the National Cancer Institute. But for the vast majority who are not
so fortunate, the future must look increasingly troubled.
Increasingly we hear the assertion that American science is a zero sum game,
with every winner happy only at the expense of a loser's gloom. This must not be
accepted! To go this route is to accept the inevitability of the decline of the United
States as the major intellectual force in the world. If we do not rise to the occasion
and do the science that can be done today, then other nations, particularly those
in the Orient, will fill the vacuum. The head start that the NIH has given American
scientists to find the gold of DNA could easily be dissipated within a decade. The
aspirations of the youth of Singapore, for example, will not be limited to the
assembly of Apple computers, and serious DNA research is bound to commence
there soon. So, to keep our lead, we must be able to follow up our latest
successes with the resources needed for their exploitation. To do this, the NIH
budget must be approximately doubled in real terms by the year 2000.
This new money cannot realistically come from the already poor, the aged, or
any of our middle-class entitlement programs. Nor are our nation's better-off
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farmers going to lose their political clout. Instead, the monies should and can
come from our bloated military-industrial complex, which increasingly is producing
weapons that either do not work as promised or have costs totally incomparable
with any addition they may give to true national security. There is no way we can
continue to make albatrosses like the B1 bomber without further hastening our
relative industrial decline. Admittedly, it will take courage for our national leaders to
admit that our overpreoccupation with national security is destroying our fabric for
future greatness. Unless, however, we act soon, we shall be economically
dominated by an Orient that has the good sense not to spend money for exotic
weapons incapable of rational use. Planning for military engagements in which
computers must of necessity replace the human brain is inherently a losing game
in which we should not gamble our future.
Fortunately, this may be the time in history when we can reverse our aberrant
course. The realization by the current Soviet leadership that their economy is in a
shambles and that their fancy weapons lead them even deeper into bankruptcy
creates the possibility that our two nations can work together to reduce our
military-industrial complexes to levels commensurate with those of our true
industrial rivals in Asia and Western Europe. Were this to happen, more than
sufficient monies would be released here in the United States to support the
increases in our science budgets needed to retain our scientific leadership. At the
same time, there would be the money needed by our industries to constantly
modernize themselves. Our highest political priority as scientists must be to work
toward arms reduction efforts that lower the true costs of our military establish-
ment. So arguing may help our science much more than directly lobbying for
more grant funds. Last year's disaster for NSF funding showed how hard it is to
get monies that must be stolen from other good causes.
In so arguing, we must take care that we are not outflanked by a growing belief
that just as the military-industrial complex is loaded with sleaze, today's DNA world
in its search for its own form of gold has lost not only its civility, but its soul. Are
we in our bidding for federal monies all too often deceiving our public benefactors
through both overstating our achievements and covering up all too frequent cases
of hasty, sloppy, if not fraudulent, research?
Admittedly, there have been some real crooks among us over the last few
years, and conceivably their relative numbers are increasing. A dishonest
undergraduate worked in the lab next to mine while I was at Harvard, and here at
Cold Spring Harbor, we had a postdoctoral fellow whom we should not have
trusted. The oncogene field, moreover, was temporarily excited by a blatantly
crooked graduate student who temporarily rose to great heights at Cornell. But the
consequences of these charlatans' deceptions have seldom spread seriously
beyond the labs in which they worked, and as a profession, we have not been
effectively harmed. More often, we are faced with situations where we cannot
distinguish between deliberate deceit and wishful thinking, but here again the
scientific truth usually soon sorts itself out, with the individuals concerned having a
lingering reputation for often claiming more than they should. So at least in the
DNA world that I personally know, there have been no major misuses of federal
money that in any sense are comparable with the major Pentagon scandals of the
recent past. In those latter cases, it has been virtually impossible to abort quickly
the ineffective weapon systems on whose continued production depend the jobs
of thousands of innocent workers.
In stating that fraud is not a serious factor in our profession, we should not,
however, argue that science must remain essentially a private club that can correct
itself without outside help. The thought that a shoplifter might go to jail while a
4
dishonest scientist is just locked out of our laboratories is bound to bother many
decent outsiders. Why should only blue-collar crooks go to jail, with the so-called
victimless crimes being treated so much more leniently? Moreover, there are
often real victims of scientific fraud who, because of the dishonesty of their
associates, have months of lost experiments and may lose not only their research
grants, but even the opportunity of staying in science.
I therefore find it hard to defend the notion that the perpetuators of scientific
fraud should not be penalized beyond expulsion from the scientific fraternity. To be
sure, there will often be difficulties in establishing definitive guilt, and the offenses
in many cases will be too trivial to warrant formal legal action. But this is also the
case with many other forms of criminal activities, and yet firm penalties are
enforced when the circumstances warrant. Stealing a case of soda may only
deserve a warning, but a truckload is another matter.
There is, of course, the response that the perpetrators of scientific fraud must
invariably be mentally unstable and should be helped back into society rather
than incarcerated with common criminals. With no real gold to bank away, they
cannot skip off to Brazil and live the good life when their scientific claims fall
apart. But if they are to be judged mentally incompetent, this should be left for the
courts to decide, not their embarrassed colleagues who don't want it known that
they might have been asleep at the helm.
I realize that many of my friends strongly disagree with me, believing that the
prospect of jailing our deliberate deceivers will cause more harm than it will ever
prevent. Legalizing the right to demand evidence for scientific assertions could
easily provide open field days for the malcontents and nonachievers who have
nothing better to do. But if we really have the goods to prove our assertions, it
costs little to make Xerox copies, and then the shoe is on the other foot. Of
course, it is annoying to be attacked by flies, but we virtually never hear of anyone
seriously harmed by their bites.
The question must also be faced as to what we should do when we discover
that a scientific claim that we honestly believed correct and so published later
turns out to be invalid. The obvious response of a decent stranger to science
would be to withdraw publicly the claim as soon as possible. Such clear
expulsions of mistruths, however, do not always occur, and, in fact, straightforward
retractions of misleading claims now are the exception rather than the rule. Yet, as
scientists, we always like it to be known that we are offended by other than
straightforward pursuit of the truth.
There are many reasons for our apparent hypocrisy in seeming indifferent to
setting straight the record of our discoveries. In the simplest cases, the facts that
have disappeared were not crucial to the main claims and calling attention to
minor errors will serve no valid end and only make our journals even heavier to
carry about. In other cases, we will argue that scientific claims that are not
followed up by further details tend to be forgotten. If no one cares about an
already forgotten and by now irrelevant observation, no harm will come by failure
to make a public retraction. But then there are the cases where we don't retract for
reasons of embarrassment or semihumiliation. Who wants one's peers to know that
we may have been too hasty in doing the right controls, possibly having been
driven by the greed to be the first to strike a claim for a particularly pure form of
gold? Publicly being perceived as hasty is bound to upset members of the peer-
review groups who will judge your next grant, your promotion to tenure, or even
your right for a trip to Stockholm.
Being nimble in covering up ends mistakes often may seem as important for
one's future as finally getting the right answer. The basest perpetrators of such
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false infallibility generally are well known, and there is much talk behind their
backs. Occasionally, it bursts into the open when an outraged peer who has
gotten the answer without false claims is made to share credit with a fellow
scientist whom he thinks he has reason to despise.
We would be making a mistake, however, to neatly divide ourselves into the
good and bad guys, for we as scientists are also human beings. True gods exist
only in our imagination, and we will seldom find a peer who when faced with even
temporary loss of respect does not feel threatened and behaves inappropriately.
That we are all imperfect, however, does not mean that we should not try to better
ourselves and the society in which we live. Not retracting a false claim is not
always a victimless act. Many individuals can be hurt badly by following up
supposedly firm observations which by then are known to be false by the original
claimant. Making the excuse that all interested parties already know the truth by
the grapevine, say, from New York to Cambridge to San Francisco, then on to
Berkeley, does not gel well with those working in less-watered areas.
So although it is easy to sneer at the Wall Street Ivan Boeskys and the
Pentagon Melvin Paisleys, we must take care that we as scientists do not become
the newest victims of the corruption that comes from gold. There are already too
many fallen idols in our country, and if we do not fight to keep our standards for
honesty and decency above reproach, we will not command the respect we so
need.
Neuroscience Center
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HIGHLIGHTS OF THE YEAR
Major Grant from Howard Hughes Medical Institute to
Increase Our Teaching Activities
In the fall of 1987, we received the largest foundation grant in our 98-year history.
Seven million dollars was pledged by the Howard Hughes Medical Institute toward
development of an expanded Neuroscience Education Program. The three-year
grant will allow us to establish a year-round training program in advanced areas of
neurobiology and to maintain a permanent research program emphasizing
molecular approaches to neural development. The grant provides $5 million
toward the construction of and equipment for the Neuroscience Education and
Research Facility. An additional $2 million is slated for faculty development and
ongoing support of the teaching program, to be named the Howard Hughes
Education Program.
We are proud to have received the largest award among the first group of
recipients of grants under the Hughes Institute's new research resource grant
program. Officials at the Institute stated that the grant was in recognition of the
Laboratory's role as "the schoolhouse for modern biology"
Greatly Expanded Plans for the Upper Campus
The plan for development of the upper campus presented in last years Annual
Report included three separate components: a 24,000-square-foot neuroscience
research facility, a 60-bed lodge, and a complex of 6 visitor cabins. However,
receipt of the Hughes grant prompted a major rethinking by ourselves and our
architects (Centerbrook, Essex, Connecticut) of both the scope and style of the
upper campus project.
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First, the research-teaching tacility and 60-room visitor lodge were reconcep-
tualized as a coordinated unit-the Neuroscience Center-linked by a common
courtyard. Second, the square footage of the research-teaching facility was nearly
doubled to 45,000 square feet. This was cleverly accomplished by resiting large
mechanical and storage rooms, formerly on the lower level of the research facility,
underneath the central courtyard. This freed up an entire floor of usable research
space in which will be situated all of the campus facilities for structural analysis of
biologically important molecules.
As redesigned, the facility will contain ten research laboratories housing some
60 scientists and three specialized teaching laboratories for up to 45 course
participants. In keeping with Cold Spring Harbor Laboratory tradition, the teaching
components of the facility will be located within a strong research environment
that provides course participants with a constant flow of state-of-the-art methods
and ideas.
Both the size and the style of the upper campus were reconceived. The
original plan called for rustic buildings styled in the manner of the great
Adirondack camps of the early 1900s. This fit well with our traditional role as a
summer camp for science. However, as it became increasingly clear that the
Neuroscience Center would be the hub of the Laboratory's future year-round
development, it was felt that its architecture should reflect a greater sense of
permanence, as already exemplified here by the highly successful eclectic features
of our Grace Auditorium.
In October, we presented plans for the Neuroscience Center, and other
potential construction projects, to representatives from the Village of Laurel Hollow.
Bill Grover, the principal Centerbrook architect, explained how the structure had
been styled to give the impression (when viewed from the other side of the
harbor) of a large estate rather than of an institutional building. He conveyed well
our concern for maintaining the beauty of our Long Island community. We were
especially pleased when the Zoning Board of Appeals formally approved our
construction plans in June 1988.
The Beckman Name to Grace Our Neurobiology Building
The new plans were enthusiastically endorsed at the annual meeting of the Board
of Trustees in November, to which we invited Dr. Arnold Beckman, the celebrated
founder of the Beckman Instrument Company and noted philanthropist. Happily,
he liked our proposal to him for major help in the construction of the Neurosci-
ence Center. In the spring, we were awarded a $4 million grant from the Arnold
and Mabel Beckman Foundation toward construction of the neuroscience
education and research facility, which will be named for the Beckmans. We
thought the grant especially appropriate in light of the fact that Mrs. Beckman was
raised in the Bayside region of Queens.
Further major support for this project has come through $1 million grants from
the Esther A. and Joseph Klingenstein Fund and from the James S. McDonnell
Foundation. We also have received a $200,000 grant from the Samuel S. Freeman
Charitable Trust to expedite the preparation of the architectural drawings.
Neurobiology Course Program Expanded
A new course offered in summer of 1987, "Molecular Cloning of Neural Genes:'
was an indication of the future expansion of our programs in neuroscience
education. The organizers, Jim Eberwine of Stanford University and Marian
Evinger of Cornell University, saw a need among neuroscience researchers for the
recombinant DNA tools that have so revolutionized cancer research.
Reverse genetics-where one first finds the gene, then the protein, and finally a
biochemical function within the cell-should provide keys to unraveling the
function of the human brain. The new course was made possible through a
generous core grant from the Esther A. and Joseph Klingenstein Fund, which has
been largely responsible for the expansion of the Neurobiology Teaching Program
to its present size of eight courses.
Alumni Fund Helps Build First Cabin Complex
In the fall, we broke ground on construction of six heated visitor cabins to replace
dilapidated ones erected here in the 1950s. Each of the new log structures
contains four double bedrooms, two baths, and a common living area; multiple
gables and planed, clapboard-like siding give them an architectural flair.
Completion of the cabins in fall 1988 will make the first phase of development of
the upper campus site. Over the next several years, we hope to get village
approval to construct an additional four cabins.
Major gifts from Herb Boyer and Mark Ptashne provided the impetus to begin
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construction of the cabin complex. But just as heartening were gifts from 80
scientists worldwide, to date totaling $60,000, toward an "Alumni Cabin:' This cabin
will honor all the remarkable biologists who have enriched the legacy of Cold
Spring Harbor Laboratory-as staff members and as meeting and course
participants.
Advanced Teaching Program to Become a Year-round Effort
Since most of our on-site accommodations lack heating, our advanced-training
workshops have always been confined to the summer months. With completion of
the first six cabins in fall 1988, we will be able to institute our first spring and fall
teaching sessions. Supported by our Hughes grant will be four courses: Cloning
and Analysis of Large DNA Molecules, Macromolecular Crystallography, Protein
Chemistry, and Molecular Biology of the Yeast, Schizosaccharomyces pombe.
Page Laboratory Is Dedicated
The dedication of the Arthur W. and Walter H. Page Laboratory this October
marked the culmination of our three-year capital program in plant genetics. More
than 350 people gathered in Grace Auditorium to honor the remarkable contribu-
tions of a father-son team whose commitment to the Laboratory has stretched
unbroken for more than 60 years. Among the day's speakers was Barbara
McClintock, whose seminal work on transposable elements in maize (corn) forms
the intellectual basis of research carried out in the Page Laboratory. The
dedication was followed by a special dinner in Bush Lecture Hall for friends of the
Page family.
Arthur Page was a key player in founding the Long Island Biological Associa-
tion (LIBA), which assumed administrative responsibility for the Laboratory when
the Brooklyn Institute of Arts and Sciences withdrew its support in 1924. Including
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Renovated Delbruck teaching lab
13 years as president, Arthur Page served continuously on the LIBA Board until
1958, when his son Walter Page became president, serving until 1973. Walter
Page, whose tribute appeared in last year's Annual Report, was instrumental in
effecting the merger of the Biological Laboratory with the Carnegie operation to
establish, in 1962, what we now know as Cold Spring Harbor Laboratory. Walter
was a founding member of our Board of Trustees, serving as our Chairman from
1980 to 1986, at which time he became an Honorary Trustee.
The 6500-square-foot Page facility was designed by Centerbrook of Essex,
Connecticut. On the ground level are three laboratories occupied by the corn
genetics group led by Steven Briggs, Vankatesan Sundaresan, and Tom Peterson.
The main level includes scientists offices and the laboratory of yeast molecular
biologist Kim Arndt.
In addition to the new construction, the adjoining original section of Delbruck
Laboratory (1929) was completely remodeled. A new glassware kitchen and
darkroom were installed on the lower level, and the teaching laboratory on the
upper floor was updated. The focal point on the main floor, the Robert L.
Cummings Seminar Room, honors Bob's near decade of service on the
Laboratory's Board of Trustees, including seven years as treasurer.
Cancer Center Grant Gets Fourth Renewal
Mr. and Mrs.
Robert L. Cummings
Our five-year DNA Tumor Virus Program Project grant from the National Cancer
Institute was renewed for the fourth time since its inception here in 1972. This time,
Mike Mathews oversaw preparation of the massive grant proposal and now serves
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as the program director. This grant was the initial basis of our long-term investiga-
tion of the molecular basis of cancer and has enabled us to nurture the careers of
numerous young scientists. Equally important was the awarding to us by the
National Cancer Institute of a large core grant for our activities as a specialized
cancer center. Here, Rich Roberts played the vital role in coordinating the
successful grant proposal. Combined, these two grants now provide some $6
million of support to our cancer research efforts.
Uniting Oncogenes and Anti-oncogenes
Since the early 1970s, Cold Spring Harbor has been a leader in understanding
the action of oncogenes that play critical roles in oncogenesis. Important work on
viral oncogenes, such as E1A and T antigen, was done here, and Mike Wigler's
group helped launch the study of human oncogenes with the discovery of ras in
1981.
Initially, all oncogenes isolated from both viral and mammalian cells were found
to be dominant-acting; i.e., the presence of the gene is a prerequisite for cancer
formation. Oncogene proteins play crucial roles in relaying signals that tell a cell
when to divide. The alteration or deregulation of the oncoprotein causes cancer
cells to replicate inappropriately.
More recently, a fundamentally different type of oncogene was found involved
in the rare childhood cancer, retinoblastoma. This malignancy results from the
absence of a functional copy of the Rb (retinoblastoma) gene. Rb is considered an
anti-oncogene, because its presence inhibits cancer formation. Presumably, the
Rb protein in some way tells cells when not to divide. Thus, there was great
excitement when, early this year, Senior Staff Investigator Ed Harlow and his group
discovered the first physical connection between an oncogene and an anti-
oncogene. Working in collaboration with scientists from the Whitehead Institute for
Biomedical Research in Cambridge, they found that a protein produced by the
viral oncogene E1A binds to the Rb protein. This result suggests that the proteins
of dominant-acting oncogenes may bring about malignancy by deactivating anti-
oncogene proteins that are needed to suppress cell proliferation.
This most important conceptual breakthrough relied on monoclonal antibodies
generated in the specialized facilities that became available with the opening of
Sambrook Laboratory in 1984. Long before we even started its construction, we
argued that monoclonal antibodies would be powerful tools for understanding
cancer, but we never dared to believe that they soon would prove to be so
decisive.
DNA Learning Center Opens
Our effort to bring biotechnological literacy to the nation has culminated in the
development of a new facility, the DNA Learning Center. In the fall, we assumed a
long-term lease (with option to buy) on the former grade school building at the
foot of Goose Hill Road in Cold Spring Harbor Village. By spring 1988, we had
completed Phase I renovations, which included preparation of office space for a
full-time staff of four and the installation of a teaching laboratory where high-school
students have the opportunity to perform experiments with DNA.
We also reached agreement with the National Museum of American History, a
branch of the renowned Smithsonian Institution of Washington, to display its
12
DNA Learning Center
exhibit-The Search for Life: Genetic Technology in the Twentieth Century-at the
Learning Center from September 1988 to September 1989. Acceptance of the
exhibit required us to accelerate our renovation schedule and to entirely revamp
the building's antiquated heating and air-conditioning systems. The opening of the
exhibit will firmly establish the DNA Learning Center as a leader in its field and
also serve as the kickoff for our centennial celebration.
The DNA Literacy Program was founded in 1985 by David Mick los as a
community relations project. For several years, Dave administered the program in
conjunction with his duties as Director of Public Affairs and Development.
However, with receipt of major grant support from the National Science
Foundation and the Josiah Macy, Jr, Foundation in 1987, and the subsequent
decision to open the Learning Center, it became clear that DNA education had
become for Dave more than a full-time job. So, early in 1988, he was named
Director of the DNA Learning Center, and Susan Gensel Cooper assumed the title
of Director of Public Affairs (while continuing also as Director of Libraries). At the
same time, Konrad Matthaei was recruited as the new Director of Development.
Fifty-second Symposium Explores the Origin of Life
Coming on the heels of last year's Symposium on "The Molecular Biology of
Homo sapiens: the 52nd Symposium tackled an equally fundamental and intrigu-
ing topic, "The Evolution of Catalytic Function:' It is fitting that a science that has
come so close to fully understanding the biochemical basis of life should also
attempt to find the origin of the molecules that carry the genetic description of life.
Topics ranged from how self-replicating molecules arose in the "primordial soup" of
the primitive earth to how protein structure relates to chemical activity. This made
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for an extremely intense schedule that included Dr. Ernst Mayr's Dorcas
Cummings Lecture, "What Is Evolution All About?' It was a great personal pleasure
to welcome back Ernst and his wife Gretal, whom I first met when they spent their
summers here living in Hooper House, in the years following World War II. Ernst
was then a member of the staff of the American Museum of Natural History,
moving in 1953 to the Museum of Comparative Zoology of Harvard University.
Scientists and LIBA members alike packed Grace Auditorium for the talk, which
was followed by some 15 dinner parties held at the homes of LIBA members.
Undergraduate Research
Our Undergraduate Research Program has, since 1959, been a stepping stone in
the careers of many excellent scientists. Under the commendable direction of
Winship Herr, the program flourished in 1987, growing to 19 students compared to
15 in 1986. This was accomplished with major support from the National Science
Foundation, four-year core support from the Alfred P. Sloan Foundation, and grants
from the Burroughs Wellcome Fund, American Cyanamid Company, Pfizer, Inc.,
and the Samuel Freeman Charitable Trust. One student was supported by the
Olney Memorial Fund of the Long Island Biological Association.
A Remarkable Presentation on Brain Research at Banbury
We were honored to collaborate with Shearson Lehman Brothers in October to
present an informational weekend for senior corporate executives on "The Human
Brainy The purpose was to offer leaders of the nation's pharmaceutical and health-
Max Cowan leads seminar on "The Human Brain"
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care industry a view of the frontiers of research on the human nervous system.
The meeting opened with Max Cowan's entertaining "field guide" to the human
brain, followed by dissection of a real one during a lab session on the second
day. One highlight was Terry Sejnowski's description of his success in building a
computer that had learned to speak (but not understand) English. The meeting
closed with Patricia Smith Church land's talk on the relationship between philoso-
phy and neuroscience.
Molecular Cloning, Second Edition
When the first edition of the laboratory manual Molecular Cloning was published
in 1982, the size of its success came as a welcome surprise; sales reached an
unprecedented 60,000 volumes. So in 1986, authors Joe Sambrook, Ed Fritsch,
and Tom Maniatis began the large task of producing an expanded and updated
second edition. The editorial task proved greater than anticipated-the seven
existing chapters were completely revised and ten new chapters are being written.
As a result, the second edition will be issued in two volumes and is due out in
spring of 1989. Despite its large size, this edition will remain moderately priced so
that it can continue to be the standard reference on the lab bench of every
recombinant DNA scientist.
New Director For Banbury Center
We were very fortunate in October to attract Jan Witkowski as the new director of
our Banbury Center. Jan brings to Banbury an intimate view of the sociological
aspects of molecular biology, as well as hands-on experience in laboratory work
and administration. Before coming to the Laboratory, Jan was the director of the
Kleberg DNA Diagnostic Laboratory at Baylor College of Medicine, one of the first
labs in the world to use DNA techniques to diagnose Duchenne muscular
dystrophy and other genetic diseases. His talents have been made evident by the
recent successful meetings held at Banbury, including one on gene expression in
Jan Witkowski, John Inglis
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Staff Investigator
N. Hernandez
the AIDS virus. Jan's organizational flair is matched by his ability and eagerness to
speak to nonscientific audiences on the social impact of DNA science.
New Executive Director of Publications
We were also pleased to welcome, in the fall, John Inglis as the new Executive
Director of Cold Spring Harbor Laboratory Publications. John is no stranger either
to science or to publishing. After receiving his Ph.D. in immunology from the
University of Edinburgh, he chose scientific publishing as a career and soon
moved to Elsevier Publications, Cambridge, England. While there, he was the
managing editor of several successful journals, including Immunology Today and
Trends in Biotechnology. He has also published numerous scientific articles and
edited two books. Presently, he is working on a proposal for a scientific journal
dealing with current cancer research.
Robertson Research Fund Provides Key Support
Although young scientists are the core of our research program, they often find it
difficult to obtain the initial grant needed to establish themselves as independent
scientists. For several years, income from the Robertson Research Fund, the
Laboratory's largest endowment, has helped many scientists take this first step, by
supplementing salaries and helping with travel and relocation expenses.
The Robertson Research Fund supports entirely two Cold Spring Harbor
Laboratory Fellows. Selected during their final year of graduate work, the CSHL
Fellows, in effect, skip the postdoctoral period during which most young scientists
work under the direction of a senior scientist. Cold Spring Harbor Fellows are
instead given the status of independent junior investigators and are free to work
entirely on projects of their own choosing. Each receives a full stipend, as well as
funds for supplies and a full-time technician. Adrian Krainer, who joined the
Laboratory in 1986 from Harvard, works on factors necessary for nuclear pre-
mRNA splicing in mammalian cells. Arriving in January 1988, from Berkeley, Carol
Greider studies the RNA-containing enzyme telomerase, which synthesizes
telomere sequences found on the ends of all chromosomes.
The Robertson Research Fund also provided full stipend suport for seven
postdoctoral fellows and several graduate students. Start-up funds were given to
Bruce Futcher, David Frendewey, and Noun's Hernandez to help them establish
their labs and hire personnel needed prior to receipt of federal support.
Equipment and support funds supplemented the plant genetics program, which
receives primary support through a joint agreement with Pioneer Hi-Bred Interna-
tional, Inc. Honoraria and travel expenses were provided for visiting scientists
presenting talks at the Laboratory's in-house seminars and winter symposium.
LIBA Initiates New Start-up Funds
This past year, under the adept chairmanship of George W. Cutting, Jr, LIBA
continued to provide the key community relations and support that are so vital to
the Laboratory's well-being. At the LIBA annual meeting in January, George
reported on the creation of a new fund to help answer the needs of young
scientists for laboratory equipment. The New Investigator Start-up Fund this year
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provided much needed supplies and equipment for Nouria Hernandez and David
Spector. LIBA also continued to support four $25,000 LIBA Fellowships to help the
Laboratory attract the finest new Ph.D. scientists. Both of these programs, and
partial support of our meetings program, were funded through the annual
contributions of the almost 600 LIBA members. I was pleased to hear George also
report that for the first four months of fiscal 1988, contributions had already
exceeded the total for the entire previous year.
Changes in Our Scientific Staff
Senior Staff Investigator Fevzi Daldal, who came to the Laboratory under the joint
research agreement with Exxon Research and Engineering Company, accepted a
position as Associate Professor in the Biology Department of the University of
Pennsylvania, Philadelphia. Fevzi joined the Laboratory in 1983 after receiving his
Ph.D. from the Louis Pasteur Institute in Strasbourg, France and doing his
postdoctoral work at Harvard Medical School, where he also taught microbiology.
A prokaryotic geneticist, Fevzi was interested in the molecular genetics of
cytochrome bc, complex of photosynthetic bacteria.
Staff Investigators Andrew Hiatt and Takashi Toda moved on to new positions.
Andy accepted a position as an assistant member at the Scripps Research
Institute in La Jolla. He came to the Laboratory in 1983 as a postdoctoral fellow in
Delbruck Laboratory and worked on the molecular genetics of polyamine
regulation. Takashi, who worked here with Michael Wig ler since 1984, assumed an
assistant professorship in the Department of Biophysics at Kyoto University, to
resume his studies on genetic control of mitosis in the fission yeast Schizosac-
charomyces pombe.
New Staff Members
Joining the Laboratory this year was Senior Staff Investigator Tom Peterson, who is
doing research on the role of transposable elements in maize gene expression. A
native of California, he received his Ph.D. in yeast genetics from the University of
California, Santa Barbara in 1984. During his postdoctoral period with the
Commonwealth Scientific and Industrial Research Organization (CSIRO) Division of
Plant Industry in Canberra, Australia, he switched to the field of maize genetics.
Bruce Futcher also joined the laboratory as Senior Staff Investigator. Bruce is a
citizen of Canada and held the position of Assistant Professor of Biochemistry at
McMaster University in Hamilton, Ontario, Canada prior to coming to Cold Spring
Harbor Laboratory.
Visiting scientists arriving in 1987 were Barbara Knowles, Davor Solter, Stephen
Munroe, Janos Posfai, and Paul Young. Both members of the Wistar Institute in
Philadelphia, Barbara Knowles and Davor Solter are collaborating with Doug
Hanahan. Janos Posfai, from the Institute of Biophysics at the Hungarian Academy
of Science, is working with Rich Roberts on sequence analysis and structure
prediction. Stephen Munroe, on sabbatical leave from the Biology Department of
Marquette University, is working with Rich Roberts on mRNA splicing and RNA-
protein interactions. Paul Young, associate professor in the Biology Department at
Queen's University, Kingston, Ontario, is working with David Beach on cell-cycle
control in Schizosaccharomyces pombe.
Several visiting scientists completed their studies at Cold Spring Harbor
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Laboratory and went on to new positions: Arie Admon to the Department of
Biochemistry at the University of California, Berkeley; Esa Kuismanen to the
Robert Wood Johnson Laboratory, Department of Medicine, University of New
Jersey, Piscataway, New Jersey; and Junichi Nikawa returned to Gunma University
School of Medicine, Japan.
Winship Herr Promoted to Senior Scientist
In recognition of his important research on the fine-structure analysis of the SV40
enhancer region, Winship Herr has been promoted to the position of Senior Staff
Scientist. Winship, who works in James Laboratory, received his Ph.D. from
Harvard in the spring of 1982 and did his postdoctoral work here under Joe
Sambrook.
The Senior Scientist rank carries with it a "Rolling-5" year appointment, which
specifies funding for a minimum of five years, continuously rolling forward with
time.
Staff Promotions
Robert Franza and Andrew Rice both accepted positions as Senior Staff Investiga-
tors. Bob works in McClintock Laboratory, where he is interested in the analysis of
oncogenic proteins. He completed his M.D. at Georgetown University, Washington,
D.C., did his graduate work at the National Institutes of Health, and completed his
medical residency program at Dartmouth Medical School. Bob came to the
Laboratory as a postdoctoral fellow with Jim Garrels in July 1982 and shortly after
became Staff Investigator.
Andrew completed his Ph.D. at Harvard in 1981 and did his postdoctoral work
at the University of Cambridge, England. He came to the Laboratory from the
Imperial Cancer Research Fund and since has focused on the regulation of
human immunodeficiency virus (HIV) gene expression. He works in Demerec
Laboratory.
Jeffrey Field and Dalian Young, formerly postdoctoral fellows, accepted
positions as staff associates in the laboratory of Michael Wig ler. This newly created
position is intended to provide a transition between the postdoctoral period and
an independent staff position. The appointment to staff associate is made only in
cases where a postdoctoral fellow has demonstrated potential for technical
proficiency, scientific creativity, interaction with others, and independent thought.
Jeffrey, who came to the Laboratory in 1985, studies ras oncogene function in
yeast. Dalian, who arrived in 1984, is working on the effector pathway of the mas
oncogene.
Visiting scientists Steven Briggs and Loren Field were appointed to Senior Staff
Investigator and Staff Investigator, respectively. Steven, who shares a joint appoint-
ment with Pioneer Hi-Bred International, Inc., works in the area of molecular plant
pathology. Loren, previously with Roswell Park Memorial Institute in Buffalo, is
developing transgenic mouse models of hyper- and hypotension.
Postdoctoral Fellows
Leaving the Laboratory after completion of postdoctoral terms were Edgar
Davidson to the Institute of Structural and Functional Studies (Philadelphia, PA);
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Anne Fernandez-Solt to the Centre Nationale de la Recherche Scientifique (Nice,
France); Wendy Heiger to the Department of Applied Biological Sciences at
Massachusetts Institute of Technology (Cambridge, MA); Mathew Kostura to
Merck Sharpe & Dohme Laboratories (Rahway, NJ); and Eugenia Lamas to the
Institut National de la Sante et de la Recherche Medicale (INSERM) (Paris,
France).
Also leaving were Jeremy (Ned) Lamb to the C.R.B.M. (Centre de Recherche
en Biologie Marine), Centre Nationale de la Recherche Scientifique (Montpellier,
France); Michael Lambert to the Research Foundation of Scripps Clinic (La Jolla,
CA); George Livi to Smith Kline & French Laboratories, Department of Molecular
Genetics (Philadelphia, PA); Beat Mollet to Nestle Research Centre (Switzerland);
Philip Sass to Leder le Laboratories (Pearl River, NY); Neil Sullivan to the Imperial
Cancer Research Fund (London, England); and Frances Purves to the University
of Chicago.
Margaret Kelly and Robert O'Malley, both graduate students who received their
Ph.Ds. in 1987, left to pursue careers elsewhere. Margaret moved to Charleston,
South Carolina, where she accepted a position in the Department of Pharmacol-
ogy at the Medical University of South Carolina. Robert moved to the Department
of Molecular Cardiology at the Children's Hospital in Boston. Another graduate
student, Mary Chapman, returned to the University of California, Berkeley, after
receiving her M.S. at Stony Brook.
Changes in Our Board of Trustees
At the November Board meeting, we welcomed as new trustees David B. Pall of
Roslyn Estates and Mrs. George (Elinor) Montgomery of New York City. David is
the founder and chairman of Pall Corporation of Glen Cove, New York. He is
generally acknowledged to be the world authority on filtration and has been
granted 100 patents.
Elinor joined us following 15 years of active service on the Board of Trustees of
Memorial Sloan-Kettering Cancer Center and experience as a teacher at the
Brearly School in New York City. Her presence on our board brings back
memories of her wonderful mother Mrs. Alex (Posie) White, who served for many
years both as a Laboratory Trustee and as a LIBA Director.
Preparing for Our Second Century
I was most pleased when David Luke accepted the chairmanship of a high-level
trustee committee with primary responsibility for coordinating the fund-raising
effort that will prepare the Laboratory for its second century of scientific
excellence. One of his first tasks was to lead the search for a full-time development
director.
We were lucky to find Konrad Matthaei, who joined the Laboratory in April
1988. Before then, Konrad was associated with the fund-raising efforts of the New
York State Republican Committee. Earlier, he served as director of the
Shakespeare Festival in Stratford, Connecticut. He and his staff took up new
quarters renovated in the lower level of Wawepex.
The public affairs group of David Mick los, Susan Zehl, and Ellen Skaggs (aided
by science writer Dan Schechter and Librarian/Archivist Susan Cooper) designed
and produced a most attractive package of development materials. "The First
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Hundred Years" gives a fascinating history of the Laboratory, while "The Second
Hundred Years" describes development objectives that will launch a new era of
productivity. A third major piece describes the Neuroscience Center and begins
with a thought-provoking analogy that compares the challenge of neurobiological
research to the puzzle of the mythical Gordian knot.
Our Board Is among the Best
At the time of this report, $13.2 million has been pledged toward the total $20
million cost to construct and equip the Neuroscience Center. Major proposals for
the remaining sums are currently being reviewed by several leading foundations,
and we have reason to be hopeful that the funding for the Center will be in place
by the beginning of 1989.
Our extraordinary good fortune in finding funding for this and other centennial
projects would not have been possible without the strong leadership and partici-
pation of our board. Personal contributions totaling more than $6 million in the last
several years have gone a long way in convincing others that our goals are
realistic and our management sound. In terms of both willingness to give and
personal expertise, we have a board that compares favorably with that of any
major university.
We Desperately Need Better Accommodations for Our Visitors
Attendance at Cold Spring Harbor and Banbury meetings registered a 14% rise,
from 3600 scientists in 1986 to 4100 in 1987. Two factors contribute to the continued
growth in our meetings program. First, in Grace Auditorium, we have perhaps the
nation's most beautiful meeting facility. Second, the annual support of our Corporate
Sponsors, which now number 30, has given us the flexibility to schedule meetings
whose critical importance may not be apparent to federal funding agencies.
Unfortunately, our arrangements for the housing and feeding of visitors suffer
greatly in comparison to the quality of our meetings and meeting facilities. Far too
many meeting participants, housed in the plastic surroundings of the Jericho strip
motels, must commute to and from meeting sessions. They miss the opportunity
for a late-night walk down Bungtown Road and informal camaraderie of those who
are housed on grounds. Yet, even those housed on the Laboratory campus must
endure accommodations that really go several steps beyond rustic. Off-grounds
housing has another detrimental impact: at $60.00 per night, motel accommoda-
tions cost the Laboratory nearly twice as much as on-site rooms.
A more subtle problem is the great inadequacy of our food service facilities in
Blackford Hall, which is mitigated only by the good food and good-natured staff
orchestrated by our chef Jim Hope. During large meetings, his staff serves some
1500 meals per day out of a kitchen and service area designed for a third that
volume. Enduring long lines and cramped seating (in a non-air-conditioned
environment) can make cranky even those newly inspired by the report of
important research results.
Our centennial fund-raising agenda includes three projects that will help
alleviate these problems: construction of 10 eight-bed cabins, construction of a 60-
bed visitor lodge, and complete renovation of Blackford Hall. However, most
foundations and private individuals view these projects as secondary to hard
research. Therefore, one of my major goals for the upcoming year is to find
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benefactors who realize, as trustee Mary Jean Harris wisely put it: "I don't see how
anyone can find a cure for cancer if he hasn't had a good night's sleep':
My Twentieth Anniversary as the Director
This summer marks my twentieth year as the Director, having formally takenover
the reins in the early winter of 1968. Soon afterward, I married Elizabeth Lewis,
then a student at Radcliffe. When the Harvard term ended, we came down for the
summer, living briefly in Cole Cottage and then in a rented much larger home on
Shore Road, where we could look after my then very ill father. Our permanent
home in Cold Spring Harbor was to be a much repaired and expanded Osterhout
Cottage, dating from the late 18th century and in which Alfred Hershey earlier had
lived. When construction was to start, the contractor told us that Osterhout had
decayed beyond redemption. We were soon relieved when we learned that a
brand new house could be built for the same price and with ceilings more
appropriate for my height and with air-conditioning thrown in for nothing. This was
a very good turn of fate, and we found the new Osterhout a perfect home for our
then growing family. In 1974, upon the closing down of our Cambridge house, we
moved into a totally renovated Airs lie, the product of the extraordinary imagination
of Charles Moore, then on the faculty of the Yale School of Architecture. At first,
the grand size and spaces of Airs lie overwhelmed us, making us wonder whether
we deserved it. By now, however, it seems very much the perfect family country
house.
In coming here, I never asked myself whether we could continue to do inspired
science in the past manner of Barbara McClintock and Alfred Hershey. Then, my
thoughts focused primarily on the Lab's survival, as opposed to whether we would
do science competitive with that I had experienced personally before at
Cambridge, Caltech, and Harvard. So, the fact that we have operated at a world-
class level for virtually all of the last 20 years gives me pleasure that I never
anticipated and so never initially worried about. Now it is natural to ask whether
our current period of real glory is coming to an end. Need it be the inevitable
consequence of so many institutions of much greater resources also deciding to
take DNA seriously? This moment of time, however, is one of our most scientifically
productive periods. We continue to reveal ourselves to be an extraordinarily fertile
site for young investigators to do their first world-class science. As a consequence,
we are all too often subject to raids by prestigous universities who need new
young stars on their faculties. Virtually every year I must accept the loss of one to
several colleagues that I have depended on for friendship as well as for intellectual
stimulation.
At all times since our arriving here, I have strived to strengthen the Lab
physically while somehow keeping it very much a village for science. Ever since
the summer of 1948, when I first came here as a graduate student of Salvador
Luria, I have loved this institution both for its intrinsic beauty and for the unpreten-
tious way it does innovative science, and encourages others to take the same
quiet path. No eager mind is too young to be thought important and, correspond-
ingly, no senior scientist is too old to be a student in one of our advanced
courses, as long as he or she lives for science and does not demand respect on
the basis of age alone. So, I worry each time we undertake a new building project
whether we shall lose our past sense of intimacy and the feeling that grand ideas
can be at home in simple surroundings. In particular, I was concerned whether
the Grace Auditorium might make us an alien place to our real old-timers. Already,
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however, the verdict is in. Absolutely no one bemoans the disappearance of the
hard cramped seats of Bush or the TV screens for those unable to push
themselves in. We cannot imagine functioning without the listening ease made
possible by the extraordinary design of Grace Auditorium.
Now, I am not unduly worried by what we will be like upon the completion of
the Neuroscience Center, which is bound for the first time to give us the feeling of
an academic institution. That is what we already are and if we are to continue to
attract the cream of the world's advanced students, we must have the facilities
equal to our role. These new buildings must be compatible with our architectural
heritage or we could quickly look overblown among our neighbors wooden
homes. But both the new Residence Hall and the Neuroscience Center have been
designed with care, and I'm sure they will further enhance the beauty of our inner
harbor scene. We must also take great care in the finding of the right scientists to
go into these new labs. As long, however, as we continue to have the assistance of
our many friends whose careers we have helped shape, we are bound to make
the right choices.
We thus have every reason to believe that we will continue to be an Institution
that not only our nation, but also the world can both admire and cherish.
July 27, 1988 James D. Watson
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ADMINISTRATION
CSHL operations during 1987 resulted in an excess of revenues over expenses,
but not in sufficient amount to fully fund depreciation, which has come to exceed
$1 million per year.
These financial results were better than expected considering that a major five-
year research support agreement with Exxon Corporation ended on December 31,
1986. In addition, there was an unexpected delay in the publication of the second
edition of the Molecular Cloning Manual, the Laboratory's heretofore best-selling
publication, which is now scheduled for early 1989. The last few months of the
year were positively affected by the August start of a three-year NIH Cancer
Center Core Facility Grant, which will now be a major help in funding the increas-
ing cost of scientific support services.
It is clear, however, that we must continue to seek additional sources of
funding, both from government and from among our many friends in the private
sector, while emphasizing programs to control the cost of operating the
Laboratory. Increasingly, we find that it is more difficult to obtain money for
construction of facilities than for program support. Limited laboratory space for
research and teaching activities is a serious concern and lends urgency to the
need to fully fund depreciation. This is a real expense and absolutely vital to the
proper maintenance and replacement of the extraordinary facilities here.
It is also important that overall operations result in a surplus each year. This
strengthens the confidence of those we will be asking to fund the expensive new
facilities needed for our soon to begin "Second Century" and makes it possible to
maintain and build endowment.
Although Cold Spring Harbor seems far removed from Wall Street, October 19th
did not pass entirely unnoticed here. The Laboratory's endowment, consisting of
the Robertson Research and Maintenance Funds and the Cold Spring Harbor
Fund, had risen nicely with the market early in the year; but following October
19th, it ended the year essentially unchanged from the close of 1986, with a total
value of $31,608,778. Over the past five years, the endowment has appreciated
substantially and has outperformed the popular indices, even though it has been
invested conservatively. The conservative investment posture helped to avoid any
serious damage from the October collapse of the stock and bond market.
During 1987, it was decided to establish a full-time development office. In past
years, Dave Mick los did an outstanding job of obtaining foundation grants and
creating the very successful Corporate Sponsor Program, all while attending to his
many other responsibilities at CSHL. Now Dave will be heading full time the Lab's
new DNA Learning Center. In April of 1988, we were most fortunate to have
Konrad Matthaei join us as Director of Development. Konrad has been Executive
Finance Director for the New York State Republican Committee and was
previously President and Chief Executive Officer of the American Shakespeare
Theater in Stratford, Connecticut. He is a graduate of Yale University and received
his MBA from the University of Michigan. Konrad is experienced in all aspects of
development and is a most welcome addition to the Laboratory. In June, the
Development Department moved into new offices in the recently renovated ground
floor of Wawepex, from where they and their many community volunteers will have
one of the Laboratory's very best views of the harbor.
Our Director of the Library, Susan Cooper, has taken on the additional
responsibilities and title of Director of Public Affairs. Susan will also be orchestrat-
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ing the many programs and events now in the planning stage, leading up to the
Laboratory's 100th Centennial birthday in 1990. She will continue to be responsible
for special Laboratory events, such as the Page Laboratory Dedication and the
"Nothing But Steel" Exhibit, which she has handled so well.
Since the close of 1987, several good friends and valued associates have left
the Laboratory for personal reasons or for other pursuits. We shall miss particularly
Bill Putnam and Jacquie Maidel. Bill supervised the Personnel Department and a
myriad of other activities, including Meetings, the telephone system, the parking
problem, and the many social events that make the Laboratory a civilized and
enjoyable place for all. Jacquie was Bill's right hand in Personnel and brightened
the Lab with her good nature and grace. Together they made the Lab a caring
institution.
In February, Peter Rice departed abruptly, but he left as his legacy a first-class
Purchasing Department. His staff, temporarily led by John Maroney and Sande
Chmelev, managed with great competence and professionalism in the difficult
days following Peter's leaving, and we owe them a debt of gratitude. We are now
fortunate indeed to have as our new Director of Purchasing, Chuck Haibel, who
comes to CSHL from Rochester, New York, with extensive experience in procure-
ment management, buying of scientific equipment, and contract management in
the construction industry. Chuck exhibits a remarkable combination of leadership,
overall competence, and good humor and already it is difficult-to think of him as a
relative newcomer.
Recently, we received the good news that Tony Napoli will be joining us shortly
as director of Personnel. Tony lives in East Norwich, New York, with his wife and
four children. He is coming to CSHL from Gulf & Western Industries with extensive
experience in the personnel field.
Much time was spent last year in planning the Laboratory's expansion, particu-
larly the new Neuroscience Center, on which it is hoped construction can begin
this coming Fall and be completed by the end of the 1990 centennial year. A five-
year pro-forma operating projection was prepared, including the new guest house
complex. The overall project is at least three times larger than any previously
undertaken here and will increase the Lab's overall operating budget by more than
one-third once it is fully in operation. CSHLs administrative departments are led by
highly motivated and professional managers; but now each will be challenged to
plan the additional personnel, space, and methods required to properly support
this major expansion.
G. Morgan Browne
BUILDINGS AND GROUNDS
In 1987, the Buildings and Grounds Department continued in the fast lane with an
ever-growing workload as well as an ever-growing staff to do all the jobs that need
to be done. Our Maintenance Department has improved immeasurably under the
guidance of Peter Stahl. Thanks to a very competent mechanical, electrical, and
plumbing crew and their preventive maintenance programs, air-conditioning and
heating problems have been reduced considerably. Stubborn problems, such as
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poor temperature control, inadequate wiring, and boiler shutdowns, were solved
with both patience and persistence.
Both the custodial and housekeeping crews have also increased their
workloads. With the addition of Uplands Farm and the new Page Laboratory to
their list, the custodians have taken on an ever-increasing burden of maintenance
as well as the collection and disposal of all of the laboratories waste. The
housekeepers silently go about their tasks of linen changing and cleaning as
hundreds of meeting participants come and go. Maintaining all of the residences,
both permanent and temporary, takes all of their time and effort.
While all this is going on inside the buildings, the grounds crew continually
grooms the grounds. However, the job is made even more difficult as they also
must do all the new landscaping and are constantly on call to move heavy lab
equipment from location to location. Keeping the Laboratory operating efficiently is
an enormous job that ALL of our crews have a hand in. This year, again, they
have done a fine job.
The Firehouse
In 1986, the Firehouse was moved to its new location and set on its foundation.
This year, we continued to work on the interior of the building. The existing
apartments were renovated and a new basement apartment was completed. We
also furnished the apartments and helped the tenants, who were very patient, to
move in. On the exterior, brick and cement staircases were installed, and a histori-
cally acceptable entrance porch was constructed. We regraded the north side,
putting in a drainage system for a future pond and constructed massive retaining
walls. Landscaping was completed after all the concrete work was finished. The
Firehouse was then painted red as it was years ago, when it housed the Cold
Spring Harbor Fire Department.
Page Laboratory
With remarkable energy, the Buildings and Grounds crew worked hard and long
to complete the Page Laboratory in time for the dedication held on Sunday,
October 25, 1987. With the dedication only hours away, painters, carpenters,
floormen, housekeepers, and custodians were literally backing out of just-
completed rooms in order to exit the building while people were coming in the
front door for the dedication.
On the lower level of Page, we completed the remaining labs, and on the
upper level, we installed two new offices and completed the post-doc offices.
Planters were also installed in the hallway. In Delbruck, the first and second floors
were also totally renovated, including installation of a new kitchen on the lower
level and a brand new darkroom. On the second floor, we ripped out everything
and put in an Early American oak Seminar Room, with projection screens, room-
sized chalkboards, and a conference table for 20 people. We also installed new
tiled bathrooms. The whole area around Page/Delbruck was graded and
landscaped and sod was put down.
The building of Page also included the construction of the Delbruck icehouse
and a generator shed. The icehouse, which is 300 feet from the lab, houses the
air-conditioning chillers for Delbruck/Page buildings. The generator shed is an
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Barbara McClintock, Owen Stewart,
Louise Chow
addition to the Treatment Plant and houses the emergency generator for
Delbrilick/Page Labs.
Other Alterations and Renovations
Hershey: Many changes were made at the Hershey X-ray Crystallography Lab.
The second floor was completely transformed from an apartment into office space.
The first floor saw changes as well-the space that had been Equipment Service
was reworked and made into a computer office for the crystallographers. All of the
new offices also had air conditioning installed in them.
Doubleday House: During the summer, the Lab assumed ownership of the
Doubleday House. A total cleanup was needed, including interior painting
throughout and furnishing all the rooms. This was a trick to accomplish because
our hassled custodial and housekeeping departments are extremely busy during
the summer meetings.
Yellow House: The renovation of the Yellow House was finished during the past
year. We replaced the old boiler with a more efficient one and updated two
bathrooms, including new fixtures in one of them. The windows were repaired, the
interior and exterior were painted, and all the floors were refinished. It all turned
out beautifully-just in time for our new Director of Publications and his family to
move in.
Blackford Pathway: We completed the pathway that connects Blackford/Bush
patio to the Grace patio. A stairway, with seating areas between the two buildings,
leads up to Bungtown Road, and a new masonry stair in the rear of Blackford
leads to the Blackford lawn.
DNA Learning Center: Although starting late in the year, we managed to remove
the asbestos from the boiler and piping and to install new electrical services in the
west room Teaching Lab and the three offices. Carpentry was also begun in the
same area as well as interior painting and window replacements. This work will
continue into the new year.
Uplands Field Station: The second floor was converted into offices and the new
Farm Manager's apartment was completed, plus four air-conditioning units were
installed. Much landscaping was also done, including the construction of a
retaining wall.
We All Miss Owen
We all regret the loss of Owen Stewart. Owen was our electrician for many years
and we respected him for his skill and for what he could accomplish on his own.
We will miss him sorely. We will also miss all his ghastly jokes, which he so often
repeated, and his stories about old Huntington.
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Jack Richards
PUBLIC AFFAIRS AND DEVELOPMENT
Since the first Symposium on Quantitative Biology in 1933, scientists have come to
Cold Spring Harbor to exchange information on the latest advances in research.
However, not until 50 years later did the Laboratory establish a Public Affairs
Department to explain science to the nonscientific public. Today, the major goal of
the Public Affairs staff is to share the unique resources of the Laboratory with
many audiences requiring accurate, up-to-the-minute information about DNA
science.
The DNA Literacy Program, founded in 1985 (and explained in greater detail in
the education section of this report), is the embodiment of the Laboratory's
commitment to public education. The Literacy Program staff, traveling in two
Vector Mobile DNA Laboratories, have presented week-long workshops on
recombinant DNA techniques to more than 700 high school teachers from New
York to California and from Wisconsin to Alabama. Bolstered by receipt of long-
term core grants from the National Science Foundation and from the Josiah Macy,
Jr Foundation, the Laboratory began development of a DNA Learning Center in
nearby Cold Spring Harbor Village. The nation's first "museum" devoted to explain-
ing biotechnology, the Learning Center is a unique educational resource for Long
Island, the New York metropolitan area, and the nation. Dedication of the facility in
fall 1988, coordinate with the opening of a major exhibit, "The Search for Lifer on
loan from the Smithsonian Institution National Museum of American History, will
provide tangible evidence of the Laboratory's leadership in stimulating public
understanding of genetic biology.
During 1987, two conferences were arranged to bring together scientists and
business leaders. In September, at a conference
Hi-Bred International, Inc., Wall Street financial analysts heard research briefings
on plant genetics from Cold Spring Harbor scientists; they also toured the main
Laboratory campus and the Uplands Farm Agricultural Experiment Station. A
weekend workshop entitled The Human Brain, cosponsored with Shearson
Lehman Brothers, Inc., included scientists from leading research institutions
throughout the United States and corporate executives from health care and
investment companies.
Local high school students and teachers received an in-depth view of
molecular biology from practicing researchers in the continuing Great Moments in
Science lecture series. The highlight of the series was a talk by Dr. Charles Cantor
of Columbia University College of Physicians & Surgeons on Determining the
Structure of the Human Genome. Other topics were Techniques of Gene Splicing,
Restriction Enzymes and RNA Splicing, Molecular Regulation of Glucose
Transport, Microscopic Localization of Oncoproteins, Molecular Diagnosis of
Genetic Diseases, Tracking Down the Huntington's Gene, and Genetic Screening
for Duchenne Muscular Dystrophy.
A three-part public forum on Gene Manipulation: Personal and Social Implica-
tions was cosponsored in April with Hutton House Lectures of Long Island
University. Following an introductory session, Newsday science writers Robert
Cooke and B.D. Co len moderated panel discussions on Human Gene Therapy
and Release of Genetically Altered Plants.
Cold Spring Harbor Laboratory Associates participated in two hands-on
workshops designed to help them to better understand recombinant DNA
techniques that are central to biomedical research. The basis of gene splicing was
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shown in the Cutting DNA with Enzymes workshop, where Associates manipulated
DNA and separated the resulting fragments using electrophoresis. The Inserting
DNA into Cells workshop showed participants how new DNA molecules are
introduced into living bacterial cells. Associates also were given an historical
walking tour of the Laboratory campus and a research briefing, in which Senior
Staff Scientist Dr. James Feramisco demonstrated microinjection techniques used
to inject cancer-causing proteins directly into living cells.
To increase awareness of the Laboratory's centennial anniversary in 1990, the
Cold Spring Harbor logo was redesigned, and centennial colors of maroon and
grey were chosen. The maroon color matches the covers of volumes of proceed-
ings of Cold Spring Harbor Symposia and was originally selected by Reginald
Harris, who organized the first Symposium. The logo has been used on a variety
of products and publications, including stationery, full-color notecards depicting
scenes of the Laboratory, the Harbor Transcript newsletter, and announcements of
LIBAs new Associates Program. Posters announcing Cold Spring Harbor courses
on neurobiology and on molecular genetics were redesigned in centennial colors,
and, for the first time, posters were printed to publicize Cold Spring Harbor
meetings and to announce the 53rd Cold Spring Harbor Symposium on Quantita-
tive Biology.
Of special importance was the design and printing of an articulated set of
literature to explain the significance of the Laboratory's centennial. The First
Hundred Years uses events that occurred at Cold Spring Harbor as an allegory of
the development of modern American science. It explains how the quest to
understand the nature of heredity, beginning with the work of Charles Darwin, has
led biologists to the brink of understanding the molecular basis of life. The Second
Hundred Years sets forth development objectives necessary to ensure a second
century of scientifc excellence at Cold Spring Harbor. A third major piece
describes plans for development of the Neuroscience Center, which will be a focal
point of research and education in the Laboratory's second century.
The dedication of the Arthur and Walter Page Laboratory in October marked
the successful completion of the Plant Genetics Capital Program initiated in 1983.
The Department coordinated efforts that resulted in a total of $3 million in capital
funds for the development of the Uplands Farm Agricultural Experiment Station, as
well as construction of the Page Laboratory. It also helped to negotiate a joint
research agreement with Pioneer Hi-Bred International, Inc. and other grants that
resulted in an additional $1.75 million in program support.
The Corporate Sponsor Program, initiated by the Department in 1984,
continues to provide core support for the Laboratory's professional meetings and
has helped to boost industrial attendance by 73%. Membership grew from 20
companies in 1986 to 29 companies in 1987. Donations from sponsoring
companies totaling more than $1.2 million since 1984 have stimulated significant
expansion in the number of scientific meetings and overall attendance.
David Mick los
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LIBRARY SERVICES
Library Director Celebrates 15 Years at Laboratory
Celebrating 15 years in one organization is certainly a personal milestone;
celebrating it at Cold Spring Harbor Laboratory is to have witnessed an extraordi-
nary contribution to scientific research and education, and growth in all manner
of things.
1972 1987 Increase
Laboratory staff 94 339 260%
Library staff 3 6 100%
Annual Report pages 52 366 604%
CSHL titles in print 7 87 1,143%
Buildings* 21 31 48%
Sites 1 3 200%
Nobel Prize winners 2 3 50%
Courses 9 13 44%
Meetings 6 13 117%
*Does not include renovations
To say that the Laboratory has flourished is an understatement. Typewriters without
correcting ribbons have been replaced with microcomputers, word processers,
and laser printers. Scientific searches, then gleaned from 4-inch encyclopedic
volumes, are now done by accessing massive computerized databases. Parking
lots have gone from dirt to blue stone. Wild foliage has given way to a plush
landscape. The adaptive reuse of our victorian era architecture, along with the
addition of several new buildings, has retained the eclectic atmosphere while
completely modernizing the facility.
Growth in Permanent Collection
In 1972, the book collection numbered 14,200 and the bound journal volumes
equalled 10,800. In contrast, in 1987, the book collection numbers only 8,546 and
bound journals have more than doubled to 23,201. This pattern is indicative of the
need for rapid exchange of scientific information, as contrasted with the more
sedentary nature of the book.
Reference Services Expanded
Our interlibrary loan service has been automated to achieve a rapid response to
requests for articles and books for our scientists. Steps have been taken to
improve access to clinical and research journals not held in our collection. The
library is now a reciprocal member of the Basic Health Sciences Library network,
consisting of over 250 medical and health science libraries in the Northeast. This
network is also part of Docline, the automated interlibrary loan system of the
National Library of Medicine. We have received grants to test several electronic
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loan request systems. New document delivery systems are being used, including
telefacsimile.
The use of our computerized scientific databases has increased by 42% over
the last year, and photocopying by the library staff for patrons has increased by
46%.
In December 1986, the library began an experiment to distribute journal
content pages to our senior scientific staff; this is now a regularly established
library service. Photocopies of the contents of 53 journals are sent on a daily basis
to 28 senior scientists. The program has been very well received.
Continued Use of Storage Facility
Our retrieval of older materials from our storage facility continues to work very well.
However, the number of volumes requested has decreased from 287 volumes in
1986 to 158 in 1987, a decline of 45%. This indicates that as time goes on, fewer
of these materials will be required, and eventually we will be able to withdraw the
unused titles from our collection.
Banbury Center Library
The new director of the Banbury Center, Jan Witkowski, arrived in October and
participated in the reorganization of the Banbury Library. Several journal titles were
cancelled and others were ordered, changing the emphasis from strictly risk
assessment to include more in molecular biology. The book collection has also
been weeded, and new titles were ordered.
Special Projects
The Library Director and the staff have been involved in organizing several special
events this year, among them the ongoing sculpture exhibit "Nothing But Steel"
and the dedication of the Arthur W. and Walter H. Page building.
New Plans for Library Building
To accommodate increased staffing in the Publications Department housed in the
Library, plans were completed for the renovation of the second floor and attic of
the library building in 1988. The results of this renovation will locate the journal
offices, the office of the Director, and the Marketing Department on the second
floor. By moving the book and reference collections to the basement, more quiet
study space will be available.
Susan Cooper
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PUBLICATIONS
A Year of Major Upheavals
1987 was a year of major upheavals within the Publications Department. By far
the most disturbing of these was the loss in February of Steve Prentis, who had
been the Executive Director of Publications and Director of the Banbury Center.
Steve's death in an auto accident, besides being a personal loss for his colleagues
here, greatly disrupted the publishing projects he was in the process of initiating.
Although we were able to devote the utmost attention to the more developed
projects, such as the journal Genes & Development, others were put on hold as
we began the search for Steve's successor.
Meanwhile, it had been decided to reorganize in such a way that would require
the hiring of two new people, one for the Publications position and another to
head the Banbury Center, the Laboratory's facility in nearby Lloyd Harbor. In
October, the role of Executive Director of Publications was filled by Dr. John Inglis,
who came to us from Cambridge, U.K., where he had been Managing Editor of
several Elsevier journals, including Immunology Today, Parasitology Today, Trends
in Pharmacological Sciences, and Trends in Biotechnology. Also in October, Dr.
Jan Witkowski came to direct the Banbury Center's meetings and publishing
programs. Selected meetings that are held at the Banbury Center are published
either as Banbury Reports or in the series Current Communications in Molecular
Biology.
Banbury Center Publishing Program Moves to Urey Cottage
Soon after the arrival of Dr. Witkowski, it was decided to incorporate the editorial
and production tasks for the Banbury Reports into the program run out of Urey
Cottage, on the grounds of the Laboratory in Cold Spring Harbor. Unfortunately, it
was at this same time that Judith Blum, who had handled the editing and
production of the Banbury Reports for more than three years, left to take a
supervisory position elsewhere. The editorial assistant from Banbury, Inez Sialiano,
was moved into the Urey offices, where she quickly adapted to the needs of the
general publishing program, working in crowded office conditions that demand
super powers of concentration from all the staff. Editing of the Banbury Reports
was given out to freelancers until March, when Ralph Battey was hired as Editor.
Banbury Reports published in 1987 included Antibiotic Resistance Genes.'
Ecology, Transfer, and Expression; Nongenotoxic Mechanisms in Carcinogene-
sis; and Developmental Toxicology.' Mechanisms and Risk.
Still More Staff Changes
The position of Technical Editor left vacant by Doug Owen's departure in
December for Massachusetts was filled in March with the hiring of Patricia Barker.
In April, Dorothy Brown was promoted to Senior Technical Editor, book division,
and Judith Cuddihy was promoted to the new position of Journals Editor and later
to Managing Editor of Genes & Development.
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Genes & Development, Our First Journal
Cold Spring Harbor Laboratory stepped into the journal publishing arena in March
with the premiere issue of Genes & Development. Published monthly in coopera-
tion with the Genetical Society of Great Britain, the Journal's aims are to explore
the relationship between gene expression and phenotype. Almost immediately,
Genes & Development attracted high-quality research papers, and it quickly
became required reading for molecular and developmental biologists. The
enthusiastic response of the scientific community, both as authors and as
reviewers, enabled us to publish 10 issues in 1987 comprising 1351 pages
(including a 312-page issue in December). Genes & Development was successful
on the subscription and advertising fronts as well, reaching its forecast goals well
before years end.
That this could be accomplished in the aftermath of Stevds death was due to
the tireless efforts of the journal staff and the unselfish outpouring of assistance we
received from the Editorial Board and the scientific community at large. Our
sincere gratitude goes to Mike Mathews, who without a moment's hesitation, so
effectively took up the task of Executive Editor of the Journal.
Mention must also be made of the marketing efforts of Susan Cooper and her
staff and the efforts of the Fulfillment Department, headed by Charlaine Apsel.
With the advent of the Journal came a whole host of new enterprises for these
departments, not the least of which were the selling of space advertising and the
handling of subscription lists. That it all came off without a hitch is due to the
dedication, at times ingenuity, of both of these departments.
Changes in Our Computer System
A Lab-wide decision to eliminate the PDP44 main frame and convert to IBM PCs
called for more major adjustments in our procedures. In April, the new computers
arrived and both staff and freelancers began training while continuing to use the
old equipment to complete work in progress. This dual operation and conversion
of existing files to the new software continued through December. Staff worked
extra hours for months to minimize any negative impact that an unavoidable
learning curve would have upon production.
The new system also required the reworking of all of our typesetting codes,
new tests being conducted with our typesetting suppliers, and new suppliers
solicited now that we would be transmitting manuscripts on floppy disks instead of
by modem. These changes required that we get revised estimates on all of our
series, now including Banbury books.
Desktop Publishing Initiated
With the arrival in September of our Postscript laser printer, we began to generate
camera copy in-house. Programming was done both for the marketing newsletter
and for all titles in the Current Communications in Molecular Biology series. For
setting tables and for more complex work, a page-makeup software package will
be essential, and we began the process of testing several packages.
Inquiries were begun with manufacturers of OCR scanners. This technology will
greatly relieve the amount of keying that needs to be done and allow us to
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increase the number of pages produced without the need to recruit, train, and
supply computers and software to additional freelance typists.
Two Major Laboratory Manuals in Production
The manuscript for the second edition of Molecular Cloning, by Sambrook,
Fritsch, and Maniatis, grew in size and complexity to a point where it became
clear that the book would have to be published in a two-volume set, totaling about
1200 pages. Publication is expected early in 1989.
Antibodies: A Laboratory Manual, by Ed Harlow and David Lane, began
production and will appear in Fall 1988. This will be our first two-color text.
Symposium and Other Book Series
The 1987 Symposium brought together a diverse collection of pure chemists,
biochemists, molecular biologists, and evolutionary biologists. Their enlightening
discussions of the evolutionary events that may have given rise to living organisms
that now exist on earth are contained in Volume 52 of our Symposium series.
Other publications in our regular series included the fifth volume of Cancer
Cells: Papillomaviruses; Vaccines 88; four titles in Current Communications in
Molecular Biology: Nuclear Oncogenes, Inositol Lipids in Cellular Signaling,
Angiogenesis, and Gene Transfer Vectors for Mammalian Cells; and the
Methods in Yeast Genetics Course Manual.
The Newest Volume of a Standard Reference Work
Composed of more than 750 pages, Genetic Maps 1987, the newest volume of
this now standard reference work, contains over 100 maps and covers more than
80 organisms. With the rapidly increasing amount of mapping data available, we
recognize that an innovative approach to the presentation of this material will be
required to preserve the usefulness of this series a few years hence when faced
with the next volume, which is sure to pass the 1000-page mark. Alternatives are
already being discussed.
Books Dedicated to Max De 1bl-tick and Ahmad Bukhari
Dedicated to Max Delbruck, Phycomyces is the only comprehensive review of this
field since that written by Max in 1969. Although current work is emphasized, the
lasting values of older research are preserved in this 1987 publication.
Also published in 1987 was Phage Mu, which details how work using this
bacteriophage has contributed to our understanding of transposition, site-specific
recombination, and DNA modification and its use as a genetic tool in gene
manipulation experiments. This book is fittingly dedicated to Ahmad Bukhari,
whose contribution to the study of genetic recombination using bacteriophage Mu
as the model system helped inaugurate the field of DNA transposition.
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When the Dust Settled .
It is gratifying to look back and review that, despite the trials and challenges of
1987, we managed to publish 14 new titles, 7 reprints, 13 abstracts, the Annual
Report, and a new journal. As the year ended, we had some 22 new titles in
contract or in production, and looked to 1988 to be a happier, albeit even more
hectic, year.
Nancy Ford
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TUMOR VIRUSES
In this section are the reports of the eight laboratories comprising the Tumor Virus
group. These laboratories are studying a wide spectrum of biological processes,
ranging from cellular transformation and DNA replication to protein modification
and RNA structure. The common thread that joins together these diverse
endeavors is the use of the DNA tumor viruses, adenovirus and SV40, as the chief
objects of study. Their imitation of and interplay with cellular mechanisms provide
an unexcelled window onto the ways in which the processes of growth and repli-
cation occur in the mammalian cell. The oncogenes carried by these viruses are
capable of inducing the profound changes in cellular metabolism that characterize
malignant transformation, and one of the recurrent themes in this year's report is
the means by which these genes exert their proliferative effects. A particularly ex-
citing development in this area is the discovery by E. Harlow and his group of the
interaction between proteins encoded by an adenovirus oncogene and by a cellu-
lar oncogene, the retinoblastoma gene. Variations on this theme of gene regulation
and growth control will be evident in the pages that follow.
ADENOVIRUS GENETICS
T. Grodzicker L. Arrigoni
R. Chisum
R. Cone
M. Goodwin E. Lamas
P. Hinton M. Quinlan
M. Jaramillo
The adenovirus oncogene E1A (early region 1A) is
a multifunctional protein that affects many aspects
of cellular function, such as transcription and in-
duction of cellular DNA synthesis and proliferation.
Expression of E1A can lead to immortalization or
transformation of different cell types. Several E1A
proteins are expressed due to alternative splicing of
the primary transcripts, and different proteins may
express some but not all of the E1A functions. We
have been interested in several aspects of E1A func-
tion. First, we have been analyzing the growth fac-
tors induced in primary epithelial cells by E1A pro-
teins. Second, we have been using ElA mutants to
define the role of growth factors in E1A-induced cell
proliferation. We have also continued work using vi-
ral vectors that express E1A and SV40 T antigen to
immortalize a variety of primary cell types.
Role of the Adenovirus E1A 12S Gene
Product in Stimulation of Epithelial
Cell Proliferation, Immortalization,
and Growth-factor Production
M. Quinlan, E. Lamas, P Hinton, T. Grodzicker
The 12S genes of the E1A region of adenovirus in-
duces primary baby rat kidney (BRK) epithelial cells
to synthesize DNA and proliferate in the presence
or absence of serum and immortalizes them. In-
creased cellular DNA synthesis is first detectable be-
tween 8 and 12 hours after infection and is main-
tained at a level at least tenfold higher than in
adenovirus-5 d/312 or mock-infected cells. The 12S-
infected and 12S-immortalized cell lines retain many
of their original epithelial cell characteristics and are
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not transformed. This is in contrast to changes in-
duced by the large T antigen of SV40. The early ef-
fects of the protein are similar to those of the 12S
protein. However, the cells lose many normal char-
acteristics and become fully transformed (Quinlan
and Grodzicker, J. Virol. 61: 673 [1987]).
We have shown that a growth factor that stimu-
lates primary epithelial cell proliferation is produced
by BRK cells infected with the 12S virus. Increased
epithelial cell DNA synthesis and proliferation is de-
tectable between 24 and 36 hours after adding con-
ditioned medium from 12S-virus-infected cells to pri-
mary cultures. This mitogenic factor is effective in
the absence of serum and can override the inhibi-
tory effect(s) of serum on primary epithelial cells.
There is a requirement for the continued presence
of the growth factor(s) to maintain the epithelial cells
in a proliferative mode, which it can do for at least
8 weeks. The stimulatory activity is complexed with
high-molecular-weight molecules, from which it can
be released by high salt (Quinlan et al., Proc. Natl.
Acad. Sci. 84: 3283 [1987]). To identify this growth
factor(s), we are pursuing several channels. We are
testing the ability of other growth factors to stimu-
late quiescent primary BRK cells to proliferate. We
are also trying to purify the growth factor(s) from
conditioned medium generated in the absence of se-
rum (in collaboration with D. Marshak, Protein
Chemistry).
In our pursuit of the identification of the 12S-
induced growth factor, we have been testing the abil-
ity of known growth factors to stimulate quiescent
primary BRK cells to proliferate. These cells do not
respond to TBFI3, PDGF, EGF, bradykinin, or
bombesin. TGFI3 also does not inhibit the prolifera-
tive response of the primary epithelial cells to the
12S-conditioned medium. However, the BRK cells
do proliferate in the presence of bFGF or TBFa .
Since we know that our growth factor(s) does not
bind to the EGF receptor, we have eliminated the pos-
sibility that TGFa is present in the conditioned
medium. In addition, 12S-conditioned medium in-
duces a morphological alteration of NIH-3T3 cells
that resembles that which is produced by the condi-
tioned medium from cells transformed by the Kaposi
sarcoma oncogene, a member of the FGF family
(provided by C. Basilico, NYU School of Medicine).
In collaboration with E. Lamas, we have found
that the adenovirus 12S-induced growth factor ena-
bles the maintenance of primary rat hepatocytes in
culture for extended time periods, in a proliferative
mode. The hepatocytes do not proliferate as rapidly
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as the epithelial cells. However, the hepatocytes con-
tinue to express adult hepatocyte markers, such as
albumin and aldolase B, and do not express fetal
markers such as a-fetoprotein.
To map the regions of the 12S gene required for
the induction of growth factors and to compare these
regions with those required for other 12S functions,
we undertook a mutational analysis, in collabora-
tion with P. Whyte (Protein Immunochemistry). We
have found that the first exon of the 12S gene in-
volves a function(s) that stimulates quiescent primary
BRK epithelial cells to synthesize DNA and prolifer-
ate. However, it is unable to maintain the cells in a
proliferative mode and immortalize them or to in-
duce growth-factor production. The entire first exon
is not required for the induction of DNA synthesis
and proliferation of BRK cells; rather, about 12
amino acids at both ends of the first exon peptide
are dispensable. The carboxy-terminal boundary of
first exon sequences required for stimulation of
quiescent epithelial cells coincides with the bound-
ary required for E1A cooperation with Ha-ras to
transform primary cells, as determined by P. Whyte
et al. (Protein Immunochemistry) and B. Moran et
al. (Protein Synthesis). In contrast, the cooperation
with Ha-ras and immortalization of primary cells
both require a wild-type amino terminus of the E1A
12S protein, whereas induction of DNA synthesis
and proliferation does not. Together, these data in-
dicate that an additional function(s) necessary for
both immortalization and cotransformation is en-
coded within the first 13 amino acids of the ElA pro-
tein. This demonstrates a new region important for
E1A function.
To immortalize primary BRK cells, expression of
a 52-amino-acid region encoded near the 3' end of
the second exon is required. Activation of quiescent
primary epithelial cells into the cell cycle is a prereq-
uisite in order for second exon sequences to effect
extended growth and immortalization.
The induction of the epithelial-cell-growth factor
also requires the expression of the 52-amino-acid re-
gion near the carboxyl terminus of the 12S protein.
This same region also enables primary epithelial cells
to be replated, an early function of the 12S gene.
Thus, maintenance of primary epithelial cells in a
proliferative mode, immortalization, ability to be
replated, and growth factor production are cosegre-
gating properties that require expression of the car-
boxyl terminus of the 12S protein. No function has
previously been ascribed to the second exon of E1A.
Further analysis of this region is being pursued to
determine whether the sequences for any of these
functions are separable.
The subcellular localization of mutant polypep-
tides has led to the identification of additional
regions required for the localization and/or reten-
tion of the 12S protein into the nucleus. The five
carboxy-terminal amino acids have previously been
identified as a nuclear localization signal for E1A
(Lyons et al., Mol. Cell. Biol. 7: 2451 [1987]). How-
ever, E1A polypeptides missing this sequence are not
excluded from the nucleus but are localized in both
the nucleus and the cytoplasm. Furthermore, the
presence of these five amino acids does not ensure
complete E1A nuclear localization. The presence of
the first 36 amino acids encoded by the second exon
may enhance nuclear localization. A sequence resem-
bling the SV40 large T antigen nuclear localization
signal is located in this region and may serve as an
additional nuclear localization signal. A signal in-
volved in nuclear localization and/or retention seems
to be located toward the amino terminus of the pro-
tein. 12S or 13S E1A polypeptides missing amino
acids encoded between amino acids 29 and 86 are
completely excluded from the nucleus. Further anal-
ysis of this region is in progress. Thus, multiple sig-
nals seem to be operating in the efficient localiza-
tion and retention of E1A polypeptides in the
nucleus.
Establishment of Murine Bone Marrow
Stromal Cell Lines That Support
CFU-S Cell Proliferation
R. Cone [in collaboration with David Williams,
Children's Hospital, Boston]
During this past year, we have continued to exam-
ine the use of oncogene-containing retrovirus vec-
tors for the establishment of differentiated cell lines.
T.M. Dexter showed some time ago that long-term
bone marrow cultures provide an in vitro environ-
ment capable of supporting proliferation of hema-
topoietic stem cells, analogous to the role of bone
marrow in vivo. These cultures are very complex,
containing a variety of adherent stromal cells and
nonadherent hematopoietic cells that are dependent
on the stromal cells for continued growth in culture.
To simplify the study of stromal cell-hematopoietic
cell interactions, we have established a number of
murine bone marrow stromal cell lines from long-
term Dexter-type cultures by infection of the adher-
ent layer with retroviruses encoding E1A or SV40
T antigen. Three of five lines immortalized with
SV40 T antigen were able to support proliferation
of the most primitive murine hematopoietic cell
known, the CFU-S cell (colony forming unit-spleen),
whereas none of the E1A-immortalized lines were
able to do so. Assays were performed by cocultivat-
ing fresh nonadherent bone marrow cells with feeder
layers of immortalized stromal cell lines and quan-
titating the number of CFU-S cells per culture at 1-
week intervals for up to 5 weeks. CFU-S cells are
quantitated by virtue of their ability to home to the
spleen and form macroscopic hematopoietic colo-
nies there after intravenous injection into irradiated
recipient mice.
One clone, U2, supported CFU-S proliferation at
levels comparable to those of primary murine ad-
herent cells (200 per flask for up to 5 weeks). Evi-
dence from a number of laboratories suggests that
proteins on the surface of stromal cells may be in-
volved in the homing and proliferation of CFU-S
cells. Future efforts will be directed toward identify-
ing proteins on the surface of U2 cells that may be
involved in these processes.
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DNA SYNTHESIS
B. Stillman E. White
J. Diffley
M. Fairman
W. Heiger
N. Heintz S. Smith
T. Tsurimoto C. Bauer
G. Prelich R. Cipriani
The DNA tumor viruses continue to be valuable
probes for understanding the molecular biology of
mammalian cells. Consequently, the DNA Synthe-
sis Section remains committed to studying these in-
teresting viruses, but we have strayed far from the
field of virology. Our purpose continues toward an
understanding of DNA replication and its control
in eukaryotic cells, as well as solving some functions
of the adenovirus E1B-encoded tumor antigens that
effect cellular growth properties.
During the past year, we have (1) studied the func-
tions of cellular proteins that replicate SV40 DNA
in vitro, (2) continued to characterize factors required
for assembly of DNA into chromatin, (3) analyzed
cellular proteins that bind to chromosomal origins
of DNA replication in the yeast, Saccharomyces
cerevisiae, and (4) determined the function of the
adenovirus EIB-encoded 19,000-dalton tumor anti-
gen in regulation of viral gene expression. Highlights
of this research include the continued characteriza-
tion of the proliferating cell nuclear antigen and its
role in coordinating leading- and lagging-strand syn-
thesis at a replication fork. In addition, several cel-
lular proteins have been isolated and characterized
that are required for initiation or elongation of SV40
DNA replication or for the assembly of the repli-
cating DNA into chromatin. Two site-specific DNA-
binding proteins that interact with yeast origins of
DNA replication have been characterized biochem-
ically, and we are now in a position to continue this
characterization to include a genetic approach of the
function of these two proteins in yeast. Finally, it
has now become clear from our cumulative work on
the function of the E1B 19K tumor antigen over the
last few years that this protein plays an important
role in controlling viral gene expression during the
productive infection of human cells with adenovi-
rus. The 19K protein negatively regulates the activ-
ity or amount of the virus-encoded E1A protein,
which itself is a transcriptional activator of gene ex-
pression and an oncogene.
In addition to these ongoing projects, we were for-
tunate to have as a visitor Dr. Nicholas Heintz from
the University of Vermont on a sabbatical leave for
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part of this year. During his stay at Cold Spring Har-
bor, Nick studied the replication of DNA from an
origin of DNA replication located adjacent to the
dihydrofolate reductase gene, establishing a poten-
tially valuable cell-free system to investigate the
mechanism of elongation of chromosomal DNA
replication from specific chromosomal sites.
SV40 DNA Replication
M. Fairman, W. Heiger, G. Prelich, T. Tsurimoto,
S. Longionetti, B. Stillman
The development of a cell-free system for the repli-
cation of SV40 DNA in vitro in 1984 by Li and Kelly
of Johns Hopkins University allowed a detailed anal-
ysis of eukaryotic DNA replication to begin. SV40
contains a small double-stranded, circular genome
with a single origin of DNA replication. Only one
virus-encoded protein, the SV40 large tumor anti-
gen (TAg) is required for SV40 DNA replication, and
although this protein plays a critical role in DNA
synthesis, the virus relies heavily upon the cellular
DNA replication machinery. During the past 3 years,
we have focused on the function of TAg and cellu-
lar proteins in SV40 DNA replication. More recently,
we have concentrated on identifying the cellular pro-
teins that function during SV40 DNA replication,
with the ultimate goal of deciphering their regula-
tion and linking this important cell-cycle event to cel-
lular growth regulatory pathways.
IDENTIFICATION OF MULTIPLE CELLULAR REPLICATION
COMPONENTS
To identify cellular replication proteins, in the ab-
sence of suitable genetic techniques, we have resorted
to a direct biochemical fractionation of the cellular
replication extract and purification of individual
components from these separate fractions. We de-
scribed in last year's Annual Report the purification
of the first replication factor and demonstrated its
identity with three previously recognized proteins.
These were the human autoantigen called the
proliferating cell nuclear antigen (PCNA), a growth-
and cell-cycle-regulated protein called cyclin, and an
auxiliary protein for the DNA polymerase 8 enzyme,
which we demonstrated, in collaboration with K.
Downey and A. So (University of Miami Medical
School), could greatly increase the processivity of
this little known DNA polymerase.
FUNCTION OF PCNA
The role of PCNA in the replication of DNA from
the SV40 origin was investigated by comparing the
replication products synthesized in the presence or
absence of this protein. In the completely recon-
stituted replication system that contains PCNA,
DNA synthesis initiates at the origin and proceeds
bidirectionally on both the leading and lagging
strands around the template DNA to yield duplex,
circular daughter molecules. In contrast, in the ab-
sence of PCNA, early replicative intermediates ac-
polymerase oC
cumulate. Replication forks continue bidirectionally
from the origin, but only lagging-strand products
are synthesized, and these products remain the size
of Okazaki fragments. Thus, two stages of DNA
replication have been identified. The first is the ini-
tiation of DNA replication at the origin and the for-
mation of the first nascent strands, a PCNA-
independent stage. During the second stage, PCNA
is required for leading-strand DNA synthesis and for
coordinating replication fork progression on both
the leading and lagging strands. Since PCNA func-
tions as a processivity factor for the DNA polymer-
ase 8 enzyme, we suggested that this polymerase
functions as the leading-strand DNA polymerase.
Carrying the speculation a little further, we propose
that DNA polymerase a, once thought to be the only
replicative polymerase, is involved in producing the
first nascent strands at the replication origin and sub-
sequently the Okazaki fragments during the elon-
gation stage of DNA replication. A hypothetical
scheme showing our current view of a eukaryotic
replication fork is shown in Figure 1.
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FIGURE 1 A hypothetical view of the eukaryotic replication fork showing two different DNA polymerases that
may synthesize leading and lagging strands in a coordinated manner. This diagram highlights the function of
PCNA in the synthesis of leading strands at a replication fork.
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A MAMMALIAN SINGLE-STRANDED DNA-BINDING
PROTEIN
Another cellular protein, purified on the basis that
it is absolutely required for SV40 DNA replication
in vitro is a multisubunit factor containing polypep-
tides of 70,000, 34,000, and 11,000 daltons in approx-
imate 1:1:1 stoichiometry. This replication factor,
called RF-A, binds to single-stranded DNA cellulose
with 30-50-fold higher affinity than to double-
stranded DNA and may function as a mammalian
cell single-stranded DNA-binding protein (SSB),
analogous to the Escherichia colt SSB. The three
polypeptides are tightly associated in a complex that
is resistant to denaturation with urea and thus prob-
ably functions in the cell as such. We are currently
determining the role that this protein plays in ini-
tiation of DNA replication and if it has any regula-
tory role throughout the cell cycle.
PRESYNTHESIS COMPLEX PROTEIN
A third cellular protein, tentatively labeled SSI, that
is essential for the initiation of SV40 DNA replica-
tion in vitro has been isolated, although not yet pu-
rified. However, this replication factor is of consid-
erable interest because it is the only cellular factor
that is required to form a presynthesis complex at
the replication origin with SV40 TAg. This factor,
together with TAg and the plasmid DNA, when in-
cubated for 15 minutes at 37°C, will allow DNA
replication to proceed immediately upon addition
of the complete complement of replication factors.
In contrast, if this presynthesis factor is not prein-
cubated with TAg and the template DNA, but is
added with the other cellular components, then repli-
cation is delayed for 15 minutes at 37°C. This
presynthesis step, which defines an additional stage
in SV40 DNA replication, requires ATP and an in-
cubation temperature of 37°C, since 30°C will not
suffice. Since it is possible that this interesting fac-
tor is required for a similar stage prior to initiation
of chromosomal DNA replication, we are well un-
der way to characterize this protein fully.
OTHER CELLULAR FACTORS
Further fraction of the replication extracts has en-
abled us to confirm the role of topoisomerases I and
II during the elongation stage of SV40 DNA repli-
cation. Another cellular protein, which has been ex-
tensively purified, is required for the elongation of
DNA replication and, as for PCNA, may also be re-
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quired preferentially for leading-strand, but not
lagging-strand, replication.
This analysis, although not complete, has already
allowed us to define multiple stages of SV40 DNA
replication in vitro (Fig. 2). Some of these steps may
be analogous to the multiple stages expected for cell
chromosomal DNA replication. It is likely that some
of these stages of replication, and the components
involved, will be targets for regulatory pathways that
control events such as the temporal control of DNA
replication throughout the cell cycle, the regulation
of initiation and prevention of reinitiation of repli-
cation at the origin, and perhaps also elongation
from initiated replication complexes at different
times in S phase. Finally, we must ultimately under-
stand how these replication proteins are controlled
following stimulation of quiescent, nongrowing cells
to proliferate.
Replication-dependent Chromatin
Assembly
S. Smith, B. Stillman
In addition to our studies on SV40 DNA replication,
we have previously described a cell-free system that
is capable of assembling the replicating plasmid
DNA into a chromatin structure that resembles the
structure of mammalian cell chromosomes. The
chromatin assembly occurs concomitantly with
DNA replication and requires the addition of a nu-
clear extract obtained from human cells to the DNA
replication reactions. A single chromatin assembly
factor (CAF) has been fractionated from the nuclear
extract, and it appears that this factor can replace
the nuclear extract and permit the synthesis of chro-
matin to occur preferentially on replicating DNA.
The focus of current efforts is to identify this interest-
ing cellular protein and determine its function in as-
sembly of chromatin, as well as to characterize fully
the structure of the replication products for their his-
tone content and presence of DNase-I-hypersensitive
sites.
DNA-Protein Interactions at Cellular
Origins of DNA Replication
J. Diffley, B. Stillman
Cell-free systems that faithfully replicate viral DNA
have been extremely useful in yielding a deeper un-
TAg, SSI
Multiple Stages of
SV40 DNA Replication
in vitro
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FIGURE 2 A summary of the multiple stages of SV40 DNA replication and the require-
ment for various cellular replication proteins.
derstanding of the enzymology and mechanism of
eukaryotic DNA replication. In comparing viral and
chromosomal DNA replication, however, one must
ultimately consider the critical role played by virus-
encoded proteins, especially in the initiation reac-
tions. The identity of cellular proteins with functions
and biochemical activities analogous to the virus-
encoded initiator proteins can at present only be in-
ferred.
The identification of autonomously replicating se-
quences (ARSs) as origins of DNA replication in the
yeast Saccharomyces cerevisiae allows us to approach
the mechanism of initiation of chromosomal DNA
replication more directly. That ARSs are, in fact, ori-
gins of DNA replication is based on many different
lines of evidence. ARSs allow any colinear DNA to
be maintained episomally, replicating once per cell
cycle under control of the same genes required for
chromosomal DNA synthesis. The number of ARSs
is approximately equal to the number of origins of
replication. Mutations within ARS1 that reduce ARS
function increase the frequency of aberrant 1:0 (and
not 2:0) segregation events, which is consistent with
a defect in replication rather than in segregation of
daughters after replication. Finally, replication has
been directly shown to initiate at or near ARS se-
quences in vivo.
Two important generalizations have emerged from
analysis of several ARSs concerning the sequences
required for efficient ARS function. First, all known
ARSs contain and apparently require the ARS core
consensus sequence (./TTTTATPuTTTA/T). Sec-
ond, this sequence alone is not capable of efficient
ARS function. Sequences flanking the ARS core
consensus sequence, which apparently exhibit little
homology and can range from as little as 14 by on
only one side of the consensus sequence in the case
of the HO ARS to several hundred base pairs, in-
cluding sequences on both sides of the consensus se-
quences in the case of ARS1, are important for ARS
function.
Not much is known about the molecular mecha-
nisms governing eukaryotic DNA replication, but it
is likely that control of cell growth and DNA repli-
cation are effected on multiple levels prior to S phase.
In yeast, for example, S phase is dependent on the
execution of a number of genetically defined events
during G1. Moreover, a number of proteins appar-
ently required for DNA replication are expressed in
a cell-cycle-dependent fashion just prior to S phase.
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The complexity of eukaryotic DNA replication with
respect to the number of origins and the temporal
regulation of origin function during S phase makes
it unlikely that replication is controlled solely by con-
trolling the level of some initiator protein. Thus, al-
though each eukaryotic origin of replication may
have complex and subtle roles during S phase, the
sequences required for origin function may be sim-
pler sequences than their prokaryotic counterparts
and may not serve as central loci for the control of
S phase and, consequently, cell growth. This notion
is supported experimentally by the fact that any se-
quence can be replicated in a controlled fashion when
injected into a Xenopus oocyte. Additionally, there
is some evidence that the yeast ARS core consensus
sequence, which is, in fact, a very simple sequence
expected to arise randomly once every 10,000 by in
the yeast genome, is capable of functioning alone
as an ARS, albeit very weakly. The sequences that
normally flank the core and increase mitotic stabil-
ity may function to make origins more efficient and
may not actually be mechanistically required for ori-
gin function. It is within this context that the roles
of ARS-binding factors I and II (ABFI and ABFII),
two proteins which we have purified and character-
ized, in ARS function must be considered, since both
proteins appear to interact specifically with se-
quences that flank the ARS core consensus sequence,
and neither protein appears to interact specifically
with the essential core consensus.
We have purified ABFI as a 135-kD sequence-
specific DNA-binding protein that binds to a single
site at both ARS1 and the HMR E region (HRME)
but does not bind to all ARSs. Deletion of this bind-
ing site at both ARS1 and HMRE reduces the mi-
totic stability of these plasmids but does not affect
the ability of these ARSs to transform yeast at high
frequency. Deletion of these binding sites therefore
does not inactivate either ARS, although it does re-
duce the apparent efficiency of these sequences to
serve as replication origins. HMRE, in addition to
being an ARS, also functions in cis to repress com-
pletely transcription of the mating-type information
contained within HMRE in a position- and orien-
tation-independent manner (Brand et al., Cell 51: 709
[1987]). HMRE contains three functional elements
designated A, E, and B that are required for repres-
sion. Element A is the ARS core consensus sequence,
element E is a binding site for the cellular protein
SBF-E, and element B is a binding site for ABFI.
These three elements exhibit some functional redun-
dancy, since any one can be deleted without drasti-
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cally reducing silencer function. Deletion of any two
elements, however, completely inactivates the si-
lencer. Since one of these three elements is an ABFI-
binding site, ABFI can apparently function in tran-
scriptional repression. Characterization of the gene
encoding the ABFI polypeptide and mutations there-
in will allow an analysis of these possibilities and
yield an understanding of the in vivo role of ABFI.
The availability of the purified ABFI protein pro-
vides approaches that will allow the identification
of this gene.
A role for ABFII in ARS function is more diffi-
cult to assign on the basis of biochemistry and se-
quence analysis due primarily to the fact that this
21-kD protein can bind any DNA with roughly equal
affinity, although its binding to ARS-containing
DNA is qualitatively different from its binding to
nonspecific pBR322 DNA. As shown by DNase I
footprinting, ABFII binding to pBR322 DNA ap-
pears to occur randomly across the entire fragment,
whereas binding to ARS1 and the histone 1-14 ARS
occurs at multiple discrete sites within sequence ele-
ments that flank the ARS core consensus sequence
and are required for full ARS function. A summary
of the ABFI- and ABFII-binding sites at ARSI is
shown in Figure 3. ABFII, furthermore, can alter the
conformation of at least one ARS, ARSI, apparently
by DNA bending. It is interesting that both of these
biochemical characteristics -the ABFII ARS-bind-
ing pattern and the ABFII-induced ARS bending -
are reminiscent of initiator protein binding at many
origins of DNA replication. dnaA binds at the
E. coli oriC both to specific sequences and nonspe-
cifically in a cooperative fashion until 20-40 dnaA
monomers are bound at oriC. A number of episome-
and bacteriophage-encoded initiator proteins also
bind at multiple contiguous sites within their respec-
tive origins of replication, and some of these pro-
teins have been shown to bend origin DNA upon
binding. Finally, the SV40-encoded large T antigen
exhibits both specific and nonspecific DNA-binding
activity and binds at multiple sites within the SV40
origin of DNA replication and, upon binding, alters
the structure of the origin DNA. The pattern of
ABFII binding at both ARS1 and the histone H4
ARS is such that the ARS core consensus sequence
is at least partially exposed to DNase I digestion,
which is interesting since both the dnaA-binding sites
at oriC and the TAg-binding sites at the SV40 on
lie adjacent to conserved sequences required for
DNA replication. dnaA binds adjacent to the 13-mer
sequences that are required to interact with the dnaB
ABFI
/ I' A
A
FIGURE 3 Protein binding sites at the ARS1 origin of replication. The positions of ABFII
(hatched ovals)- and ABFI (bracket)-binding sites were derived from DNase I footprinting
data. Arrows indicate DNase-l-hypersensitive sites induced by the binding of ABFII. Lo-
cations of the essential domains (A,B) that constitute the ARS1 origin are shown.
helicase, and TAg binds adjacent to an essential 17-
bp A +T-rich sequence.
Function of the Adenovirus E1B
19K Tumor Antigen
E. White, A. Denton, R. Cipriani, B. Stillman
Adenovirus early region 1 (El) is primarily respon-
sible for regulating transcription of adenovirus early
genes during productive infection as well as convey-
ing the ability of adenovirus to transform cells in
culture. El consists of two transcription units, desig-
nated E1A and E1B. Although E1A is known to
trans-activate transcription of viral and cellular genes
and cause immortalization of primary cells in cul-
ture, proper regulation and manifestation of these
processes require expression of the E1B oncogene.
The nature of the function of one E1B gene prod-
uct, the 19K tumor antigen, has been largely un-
known, save its requirement for gene regulation and
transformation. We have adopted two strategies for
delineating the function of this important protein.
The first approach was genetic, where we have ex-
amined the effect of mutations in the gene encod-
ing the E1B 19K protein on adenovirus gene expres-
sion and transformation. The second approach
involved the construction of expression vectors to
express the 19K protein and specifically define its
effects on gene expression and to assess whether the
19K protein possesses any intrinsic biological activity.
Characterization of adenovirus mutants contain-
ing point and deletion mutations in the E1B 19K gene
yielded a wealth of information regarding the func-
tion of the 19K protein in the life cycle of the virus.
The mutations induced a number of interesting
pleiotropic phenotypes during infection; enhanced
and abnormal cytopathic effect (cyt phenotype),
degradation of the host-cell DNA (deg phenotype),
formation of large plaques (lp phenotype), acceler-
ated growth in quiescent human cells (host range,
hr phenotype), and defective transformation (tra
phenotype). The wide scope of these phenotypes sug-
gested that the 19K protein affects fundamental
aspects of viral morphogenesis. The two critical find-
ings from this work are (1) that the 19K protein was
acting as a negative regulator of adenovirus early
gene expression, accounting for the accelerated
growth of mutant viruses, and (2) that induction of
the mutant phenotypes was dependent on expression
of the E1A proteins. Two main points remaining to
be elucidated are (1) the mechanism by which the
19K protein repressed gene expression and (2) the
involvement of the E1A proteins in inducing the E1B
19K gene mutant phenotypes.
E1A-DEPENDENT REPRESSION OF ADENOVIRUS
EARLY GENE EXPRESSION BY THE 19K
PROTEIN DURING VIRAL INFECTION
Introducing mutations into the E1B 19K gene-coding
region resulted in accelerated growth of the mutant
viruses, compared with the wild-type virus in growth-
restricted human cells (WI38). Similar results were
obtained in HeLa cells, but most dramatically with
viruses that expressed an E1A 12S cDNA gene in
place of genomic E1A sequences. In the case of the
12S virus, introducing E1B 19K gene mutations
caused increased early gene transcription, viral DNA
replication, early and late viral protein synthesis, and
virus production. Elevated viral gene expression in
ElB 19K mutant-infected cells was independent of
viral DNA synthesis, since it still occurred under con-
ditions where viral DNA synthesis was inhibited. The
basis for the effect of ElB mutations appears to be
elevated expression of the E1A proteins, which leads
to further increased transcription.
The obvious complicated nature of unraveling the
mechanism of gene regulation by the 19K protein
has led us to restrict our investigation to a single,
well characterized gene promoter (SV40 enhancer
and early promoter) driving expression of a marker
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gene encoding bacterial chdoramphenicol acetyltrans-
ferase (CAT), constructed by M. Quinlan (Adeno-
virus Genetics Lab) and E. Harlow (Protein Immu-
nochemistry Lab). This SV40-CAT indicator gene
was placed in an adenovirus chromosome in place
of El sequences. Effects of the E1A and the E1B 19K
proteins on expression of the SV40 promoter/en-
hancer could be determined simply by coinfection
of the SV40-CAT with viruses that expressed the E1A
12S gene product, with or without an intact E1B 19K
gene, and measuring CAT activity. The result from
this experiment was, as expected, that E1B 19K mu-
tations caused elevated expression of the SV40 en-
hancer. Demonstrating an effect of E1B on E1A and
this specific promoter/enhancer should enable us to
ask if interactions of cellular factors with this pro-
moter are effected by the E1B 19K protein.
E1A-INDEPENDENT STIMULATION OF VIRAL
REPLICATION BY THE E1B 19K PROTEIN
To examine the effects of E1B 19K gene mutations
on adenovirus gene expression and replication in the
absence of the E1A proteins, we constructed a virus
(9S.R2) that contained an E1B 19K gene point mu-
tation and was capable of expressing only a nonfunc-
tional E1A 9S cDNA gene. Viral gene expression,
DNA replication, and virus production were exam-
ined and compared to that of a 9S virus capable of
synthesizing wild-type E1B proteins. Surprisingly,
E1B 19K mutations had the opposite effect in the
absence of E1A, as they did when E1A was expressed;
i.e., instead of causing increased viral gene expres-
sion, an E1B 19K mutation in an E1A 9S cDNA
background resulted in diminution of viral gene ex-
pression, viral DNA synthesis, and viral replication,
albeit at low levels. This effect of 19K gene muta-
tions was manifest primarily at the level of viral DNA
synthesis, since inhibiting viral DNA synthesis sub-
stantially eliminated any effect of the E1B mutations
on gene expression. This indicated that in the ab-
sence of E1A, the primary effect of the E1B 19K pro-
tein may be to stimulate viral DNA replication, and
thereby increase gene expression indirectly.
CONSTRUCTION AND USE OF PLASMID VECTORS
AND CELL LINES THAT EXPRESS THE
E1B 19K PROTEIN
From the work with adenovirus mutants, it was clear
that the E1B 19K protein effected viral gene expres-
sion in both a positive (in the absence of E1A) and
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a negative (in the presence of E1A) fashion. Because
examining gene expression during viral infection is
complicated by the interaction of many viral and cel-
lular proteins, and indirect effects resulting from
replication of viral DNA templates, we decided to
examine the role of the E1B 19K protein in regulat-
ing gene expression in a more simplified system. Ex-
pression vectors were constructed to produce the E1B
19K protein under the control of heterologous
promoters for use in transient expression assays. The
two promoters that were chosen were the mouse
metallothionein promoter, because its expression is
inducible, and the cytomegalovirus enhancer and
promoter, because it is an extremely strong promoter
and is capable of expressing large amounts of the
19K protein, comparable to those found in infected
cells. These plasmid expression vectors, MT19K and
CMV19K (Fig. 4A), were also used to construct cell
lines that express the E1B 19K protein. Once these
vectors were constructed and demonstrated to express
the E1B 19K protein (Fig. 4B), they were used in
transfection experiments with marker genes contain-
ing various promoters driving expression of the cat
gene.
EXPRESSION OF THE E1B 19K PROTEIN RESULTS
IN STIMULATED EXPRESSION OF
TRANSFECTED GENES
He La cells were cotransfected with the plasmid ex-
pression vectors MT19K or CMV19K, and the effects
of the 19K protein expression on a number of other
promoter-CAT constructs were determined (E3CAT,
ElACAT, RSVCAT, SV,CAT). In all cases, cotrans-
fection with either the MT19K or CMV19K vectors
with the CAT plasmids resulted in increased CAT
activity over transfection of the CAT plasmids alone.
Stimulation of gene expression by cotransfection of
the MT19K expression vector was small (2-fold),
compared with the CMV19K vector (3-5-fold), which
produces considerably more 19K protein. Similar
stimulation of gene expression (2-25-fold) was ob-
served when cell lines that express the E1B 19K pro-
tein were transfected with promoter-CAT plasmids,
compared with cell lines that did not express the 19K
protein.
POSSIBLE MECHANISMS BY WHICH THE E1B 19K
PROTEIN REGULATES GENE EXPRESSION
From studies with adenovirus mutants that carry mu-
tations in the E1B 19K gene, it is clear that the 19K
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FIGURE 4 E1B 19K expression vectors. (A,8) Schematic representation of E1B plasmid expression vec-
tors; (A) MT19K; (8) CMV19K. (C,D) Expression of the El B 19K protein in HeLa cells. Cells were transfected
with the CMV19K vector and examined by indirect immunofluorescence with an E1B 19K-specific monoclonal
antibody (C) or by phase-contrast microscopy (EA
protein negatively regulates E1A-dependent viral
gene expression. The absence of this negative regu-
lation leads to an accelerated infection and over-
production of early and late viral gene products and
most likely accounts for the enhanced cytopathic ef-
fect, large-plaque formation, and the host-range
phenotype observed in mutant-infected cells. This
negative effect of the 19K protein is an important
aspect of viral gene regulation during infection, since
without it, premature death of the host cell occurs,
resulting in compromised virus yield. Furthermore,
since the negative regulation of viral gene expression
is E1A-dependent, it follows tnat the E1B 19K pro-
tein either directly or indirectly modifies the activ-
ity of the E1A proteins during infection.
How the E1B 19K protein stimulates expression
of transfected genes may be related to the ability of
the 19K protein to prevent degradation of DNA (deg
phenotype). Since transfected DNAs are inherently
unstable and eventually become degraded after trans-
fection, extending the half-life of the transfected
DNA template should greatly increase gene expres-
sion. Increased DNA stability might similarly ac-
count for increased 9S virus replication compared
to the 9S virus, which does not express a functional
E1B 19K gene product. Evaluation of the role of the
19K protein in stabilizing transfected DNA is being
carried out using the CMV19K plasmid expression
vector in transient expression assays (in collabora-
tion with C. Gorman, Genentech, Inc.).
These studies have demonstrated that the E1B 19K
protein can modify gene expression possibly by two
(not necessarily independent) mechanisms: (1) by af-
fecting the activity of the E1A proteins and (2) by
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possibly affecting the stability of DNA in the nu-
cleus. Eventually, demonstration of E1B 19K pro-
tein function will be carried out with purified pro-
teins in in vitro systems. As a first step toward this
goal, we have expressed the 19K protein in E. coli
using the T7 expression system, which should serve
as a source of protein for these experiments.
Role of the E1A Proteins in Inducing
the deg Phenotype in E1B 19K
Mutant-infected Cells
E. White, A. Denton
The E1A proteins are central to the induction of the
E1B 19K gene mutant phenotypes. For example, the
deg phenotype occurs in cells infected with an E1B
19K mutant virus, but the same 19K gene mutation
does not cause DNA degradation if the E1A gene
is also deleted. How the E1A proteins induce DNA
degradation in the absence of E1B is not known, and
since the E1A proteins are multifunctional, serving
to regulate transcription, stimulate DNA synthesis,
and otherwise modify basic cellular functions, the
possibilities are numerous. By comparing amino acid
homologies between different adenovirus serotypes
in conjunction with mutational studies of the E1A
gene, the E1A-coding region has been divided into
discrete functional domains. We have set out to de-
termine which domains and their associated func-
tions within the E1A-coding region are required for
the induction of the deg phenotype.
Mapping the functional domains of E1A required
for inducing DNA degradation was accomplished
by the construction of E1A -E1B 19K double-mutant
viruses. Specifically, viruses were constructed that
carried deletion or point mutations within each of
the three E1A conserved domains, in addition to an
E1B 19K gene deletion. These E1A -E1B double-
mutant viruses were then assayed for the induction
of DNA degradation with the anticipation that
eliminating the E1A function required for inducing
DNA degradation would result in extragenic suppres-
sion of the deg phenotype. This was exactly the re-
sult that was obtained when E1A domain one was
deleted. Domain one has been demonstrated to func-
tion in the stimulation of cellular DNA synthesis.
Therefore, it appears likely that the means by which
the E1A proteins induce DNA degradation in E1B
19K mutant-infected cells may be related to the abil-
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ity of E1A to stimulate cellular DNA synthesis and
alter growth properties of infected cells. This is in-
teresting in light of our previously reported result
that the deg phenotype does not occur in E1B 19K
mutant-infected human WI38 cells, which are strictly
growth-controlled. It is conceivable that the E1A pro-
teins alter cell-growth physiology by modulating the
expression of cellular genes or by producing changes
in chromatin structure that might otherwise require
E1B expression to maintain the integrity of the host-
cell chromosomal DNA during productive infection.
Differential Localization of the
Adenovirus E1A Proteins and
Association of E1A with the
Cellular Heat-shock Protein 70
in Infected Cells
E. White [in collaboration with D. Spector and W. Welch,
Cold Spring Harbor Laboratory]
We originally set out simply to examine the local-
ization of the adenovirus E1A proteins by indirect
immunofluorescence and immunoelectron micros-
copy in adenovirus-infected cells. Much to our sur-
prise, the distribution of E1A was heterogeneous with
not one, but five distinct localization patterns being
observed in the nucleus of infected He La cells. We
have designated these E1A localization patterns dif-
fuse, reticular, nucleolar, punctate, and peripheral
nuclear staining on the basis of their appearance (Fig.
5). The heterogeneity of E1A localization during in-
fection was quite unexpected, but interestingly, this
variable distribution of E1A correlated with both the
time postinfection and the cell-cycle stage of the host
cell at the time of infection.
To distinguish which localization patterns of E1A
were associated with the early versus the late stage
of infection, El A localization was examined in time
course experiments. The distribution of E1A was also
determined during infection in the presence of
hydroxyurea in order to inhibit viral DNA replica-
tion and block passage to the late phase of infec-
tion. We have found that all E1A distributions, ex-
cept the peripheral E1A-staining pattern, were
associated with the early phase of infection and were
therefore not a consequence of the gross changes in
nuclear structure accompanying the late phase.
To examine the effect of the host cell cycle on the
localization of the E1A proteins, we compared the
FIGURE 5 Localization of the E1A proteins in infected cells at the electron microscopy level. He La
cells were infected with Ad2, and 24 hr later, the cells were prepared for immunoelectron microscopy
using an E1A monoclonal antibody. Shown are representative examples of the diffuse (a), reticular (b),
speckled (c), nucleolar (d), and peripheral (e,f ) staining patterns of E1A. The nucleolar distribution of
E1A is limited to the granular region (G) of the nucleolus (d). The nucleolar fibrillar regions (F) are devoid
of immunoreactivity (d). Numerous nuclear pore (NP) profiles can be observed in the regions of periph-
eral immunoreactivity (e, f ).
distribution of E1A after infection of normal popu-
lations of asynchronized cells to that of cells that
had been accumulated in the late G, and S cell-cycle
stages prior to infection due to inhibition of cellular
DNA synthesis. When cells accumulated in G, and
S were infected, there was a more homogeneous dis-
tribution of E1A staining with a predominance of
the diffuse nucleus-staining pattern. This is in sharp
contrast to the heterogeneous staining observed af-
ter infection of asynchronized cells, suggesting that
the cell-cycle stage at the time of infection may ef-
fect the distribution of E1A within the nucleus.
We have also observed that the localization of the
E1A proteins resembles that of the 70-kD cellular
heat-shock protein (hsp70) after heat shock of unin-
fected cells. This is interesting in light of the fact that
ElA is known to stimulate transcription of hsp70.
Therefore, we investigated whether E1A expression
could alter the intracellular localization of hsp70,
as well as stimulate hsp70 expression. Examination
of the distribution of hsp70 before and after adeno-
virus infection revealed that hsp70, which is normally
predominantly cytoplasmic, was rapidly translocated
to the nucleus after infection. hsp70 accumulated in
nucleoli, and also showed reticular, diffuse, and
punctate nuclear distributions. This translocation of
hsp70 to the nucleus upon infection was an E1A-
dependent process, since the localization of hsp70
was unaltered by infection with an E1A 9S cDNA
virus, which does not synthesize a functional ElA
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FIGURE 6 E1A and hsp70 colocalize in Ad2-infected He La cells.
and 24 hr later, the cells were fixed and simultaneously analyzed for
immunofluorescence. Detection of the rabbit anti-E1A antibody and
bation with rhodamine-conjugated goat anti-rabbit antibodies and
Shown are selected fields of cells which displayed colocalization
experiment). Note that the same cells are shown in each vertical
gene product. The localization of hsp70 after infec-
tion was remarkably similar to the distribution of
E1A proteins in infected cells. Double-label indirect
immunofluorescence of E1A and hsp70 in infected
cells demonstrated colocalization of these proteins
within the nucleus (Fig. 6). The discrete nuclear lo-
calization patterns of E1A, and the colocalization
of E1A with hsp70, were a consequence of adenovi-
rus infection, since only the diffuse nuclear E1A-
staining pattern was observed in adenovirus-trans-
formed 293 cells that constitutively express the E1A
and E1B proteins.
Demonstration of hsp70 and E1A in the same in-
tracellular locale raised the possibility that the two
proteins may be physically associated in vivo. In im-
munoprecipitation experiments, we have been able
to coimmunoprecipitate hsp70 with monoclonal an-
tibody directed against the E1A proteins. These data
suggested that the adenovirus E1A proteins may as-
sociate with, and possibly form, a physical complex
with cellular hsp70 in infected cells. Functional rele-
vance of this association of E1A with hsp70 is not
yet known. hsp70 has, however, been found to com-
plex with other oncoproteins and potentially modu-
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He La cells, growing on glass coverslips, were infected with Ad2,
the distribution of both hsp70 and E1A using double-label indirect
of the mouse anti-hsp70 antibody was done by subsequent incu-
fluorescein-conjugated goat anti-mouse antibodies, respectively.
of E1A and hsp70 (roughly 10-25% of the total population in this
column.
late their activity. High levels of cellular hsp70 have
been correlated with increased permissivity for
adenovirus infection, suggesting that an E1A-hsp70
association may be functionally relevant.
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MOLECULAR BIOLOGY OF SV40
Y. Gluzman D. McVey M. Pizzolato
I. Mohr
Current work in this laboratory is aimed at under-
standing the role the multifunctional large T antigen
plays in the replication of SV40 DNA. In our con-
tinuing efforts to correlate various structural regions
of large T antigen with a biochemical function, we
have assessed the effect of a series of replication-
defective point mutations on the DNA helicase ac-
tivity of large T antigen. This has permitted us to
examine the relationship between this newly discov-
ered activity and previously described biochemical
activities. Single-amino-acid substitutions that de-
stroyed origin-specific DNA binding had little or no
effect on the DNA helicase activity of T antigen.
However, a mutation at residue 522, which ablates
the ATPase activity of the protein, eliminated the
DNA helicase activity of the protein. This mutation
also dramatically reduced the ability of large T an-
tigen to bind to single-stranded DNA, whereas it had
little or no effect on the ability of the protein to bind
specifically to the origin of replication. Other mu-
tants, which failed to bind specifically to origin
DNA, displayed wild-type levels of single-stranded
DNA-binding activity. Thus, these studies have also
permitted us to separate origin-specific DNA bind-
ing from single-stranded DNA-binding genetically.
To identify the minimal protein domain that is re-
quired for T antigen to bind specifically to the SV40
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origin replication, we have constructed a series of
T-antigen mutants coding for amino-terminal frag-
ments of different lengths. Mutant DNAs were used
to produce truncated T-antigen proteins in Esche-
richia coli using the T7 expression system of Studier
and Moffatt (J. Mol. Biol. 189: 133 [1986]). The
origin-binding properties of truncated T antigens
were screened in soluble Escherichia coli extracts, and
several proteins chosen for further analysis were puri-
fied. Whereas full-length T antigen (708 amino acids)
produced in E. coli binds to fragments containing ei-
ther the wild-type origin or site I, truncated T-antigen
proteins containing the amino-terminal 272 or 266
amino acids bind only to the wild-type fragment with
very low efficiency. Shorter proteins, however, dis-
played a resurgence in specific DNA-binding activ-
ity beginning with amino-terminal fragments of 259
amino acids and culminating with a protein contain-
ing the amino-terminal 246 amino acids. This 246
-
amino -acid protein, along with a 249-amino-acid
amino-terminal fragment, bound efficiently to DNA
fragments containing either the wild-type origin, site
I, or site II. When an equimolar mixture of these
three DNA fragments was used to evaluate DNA
binding, T antigen bound to the wild-type fragment
first, followed by the site I fragment, and finally the
site H fragment. The 246-amino-acid protein was the
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most efficient of all the truncated proteins in the spe-
cific DNA-binding assay. Although a 242-amino-
acid amino-terminal fragment bound DNA at lev-
els slightly above background, all proteins 240 amino
acids in length and shorter failed to demonstrate any
specific DNA binding. This allows us to place the
carboxy-terminal boundary of the specific DNA-
binding domain at amino acid 246. The amino-
terminal boundary of the origin-binding domain lies
at amino acid 132, and a protein containing only
amino acids 132-246 binds efficiently to all sites in
the origin of replication. Current work is geared to-
ward purifying this small protein domain for bio-
chemical and structural analysis.
We have continued our interest in crystallizing T
antigen for structural analysis (in collaboration with
J. Anderson; see Structure Section). Our primary fo-
cus has been to purify large amounts of the 259- and
246-amino-acid truncated proteins using the E. coli-
based expression system. We are currently capable
of obtaining 2-5 mg of the truncated T antigens per
500-m1 culture. However, degradation products con-
taining an intact amino terminus copurify with the
truncated proteins on the immunoaffinity resin em-
ployed in the isolation. Most of these contaminants
can be removed using various ion-exchange columns.
To simplify the isolation of these truncated proteins
from their degradation products, we are working
with D. Lane (ICRF, London) to identify antibod-
ies that will recognize epitopes present only on the
NUCLEIC ACID CHEMISTRY
truncated proteins, but not on the degradation prod-
ucts.
In collaboration with R. Lanford (Southwest
Foundation for Biomedical Research, San Antonio),
full-length T antigen has been expressed using
baculovirus vectors. T antigen purified from infected
insect cells and T antigen produced in He La cells
(using adenovirus vectors) both function equivalently
in the SV40 in vitro DNA replication system. We are
currently modifying the baculovirus vector in order
to increase our yield of full-length T antigen. If the
production can be substantially increased, this ma-
terial may be valuable for structural studies on the
full-length protein.
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Characterization of Pre-mRNA
Splicing Factors
G.C. Conway
My research goal is the purification and character-
ization of splicing factors. I have used the technique
of sucrose gradient sedimentation to separate com-
ponents of nuclear splicing extracts according to their
sedimentation coefficients. Sedimentation analysis
of these extracts reveals the presence of slow-sedi-
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menting proteins and small nuclear ribonucleopro-
teins (snRNPs; <20S) as well as faster-sedimenting
RNP structures (?,20S). When the slow- or fast-sedi-
menting material is analyzed separately for splicing
activity, neither fraction is found to splice; however,
when the two fractions are combined, they are found
to complement each other. Interestingly, when the
nuclear extract is preincubated with ATP before
sedimentation, the top fractions (i.e., <20S) now pos-
sess splicing activity. It appears that a splicing fac-
tor(s) is released from large endogenous RNP com-
plexes in the presence of ATP and, once freed, is
capable of participating in the splicing process. Ini-
tial characterization of the released activity suggests
that it consists of multiple components. One or more
of the factors is micrococcal-nuclease-sensitive, in-
dicating that it is an snRNP or associated with
snRNPs.
Another of the factors is SF2, a previously charac-
terized nonmicrococcal-nuclease-sensitive factor.
RNA analysis of top and bottom fractions from ATP
preincubated extracts and nonpreincubated extracts
reveals no difference in the abundance of Ul, U2,
U4, U5, and U6 snRNAs when comparing tops to
tops and bottoms to bottoms. Interestingly, these
snRNAs are equally abundant in both top and bot-
tom fractions whether preincubated or not. Protein
analysis of top and bottom fractions reveals major
differences in composition; for example, heteroge-
neous nuclear ribonucleoproteins (hnRNPs) are
more abundant in the faster-sedimenting fractions.
A comparison of the proteins in bottom fractions
from extracts preincubated and not preincubated re-
veals only slight differences. Only seven bands, on
one-dimensional gels, are missing in the preincubated
bottom fractions when compared to the nonin-
cubated bottoms, and as expected, these bands now
appear in the ATP preincubated top fractions. It is
possible that the ATP released splicing factors are
among these proteins. Further characterization of
these released proteins and splicing factors is in
progress.
Alternative Splicing of
Adenovirus Genes
J. Harper, S. Miceli
The use of alternative splicing to generate multiple
mRNAs from a single gene is a common strategy
among viral genes and in certain classes of cellular
genes. Frequently, splicing is regulated to give
differential expression of alternatively spliced
mRNAs in a tissue-specific or temporal fashion. We
have been trying to identify factors that regulate al-
ternative splicing using the adenovirus lytic cycle as
a model system. Most adenovirus transcription units
make multiple mRNAs by alternative RNA process-
ing, and many of these show differential expression
of mRNAs between early and late phases of infec-
tion. We have examined the products of in vitro splic-
ing of two of these.
SPLICING OF E1A PRE-mRNA
Most of our work has focused on alternative splic-
ing of the E1A transcription unit. E1A pre-mRNA
has three 5' splice sites and two 3' splice sites that
are used to generate at least five different mRNAs
in adenovirus-infected cells. Of these mRNAs, two
(12S and 13S) are expressed throughout infection,
and three (9S, 10S, and 11S) are expressed only at
late times after infection. The common feature of
the three late specific mRNAs is that all of them use
the 9S 5' splice site, suggesting that differential ac-
tivity of this splice site is responsible for regulation
of E1A RNA expression. Our past work has shown
that 9S 5' splice-site activity does not require an
adenovirus-encoded factor, because splicing extracts
prepared from uninfected cells can produce all of
the E1A mRNAs during in vitro reactions. In addi-
tion, we found no dramatic differences in the activi-
ties of extracts prepared from uninfected cells or
adenovirus-infected cells. This year, we have concen-
trated on examining the effects of variations in ex-
tract preparations on the products of the splicing
reactions. In general, we find that the splicing pat-
tern is quite sensitive to variations in the method of
extract preparation. However, none of the changes
we see reflect the changes produced during the course
of adenovirus infection. Changing the cell growth
conditions also changes the splicing activity of the
extracts obtained, although most of these changes
are also unrelated to those seen during infection. One
potentially relevant result in these experiments is that
serum deprivation of adenovirus-infected cells
produces extracts that make relatively higher
amounts of late specific RNAs than those from cells
grown in serum-rich medium. Overall, our results
indicate that regulation of E1A splicing is not
preserved during in vitro splicing reactions. This may
be due to our inability to extract regulatory factors
under the conditions used or may indicate that E1A
splicing is regulated in vivo by alteration of the sub-
strate pre-mRNA, rather than solely by changes in
trans-acting factors.
SPLICING OF L-I PRE-mRNA
This work was carried out in collaboration with
C. Delsert and D. Klessig (Rutgers University). The
LI region of the adenovirus major late transcription
unit produces three mRNAs (Lla, Llb, and Lie) that
share the same 5' and 3' ends, but differ in the 3' splice
site used to join the third late leader to the body of
the RNA. All three are expressed at late times after
infection, whereas only Llb RNA (the 52,55K
mRNA) is expressed at early times. We have recently
begun experiments to look at LI splicing in vitro.
We have used deleted templates to transcribe pre-
mRNA substrates that allow us to compare Llb
(52,55K) splicing with Lie (Ma) splicing. In a sur-
vey of more than 40 splicing extracts, most produce
only 52,55K RNA; however, we have found 4 extracts
(2 nuclear extracts and 2 whole-cell extracts) that
contain Ilia splicing activity. These extracts stimu-
late Illa splicing in reactions that make only 52,55K
RNA, even when the Ilia extract represents only 2%
of the total. This indicates that Ma-splicing activ-
ity is due to a positive factor that could be purified
relatively simply using a complementation assay. Our
major problem is that there is no obvious reason why
the four positive extracts should contain this activ-
ity while other similar extracts do not. Active extracts
were obtained from both uninfected and adenovirus-
infected cells and by two different extraction pro-
tocols; therefore, we believe that the differences are
due to the condition of the cells used. We are cur-
rently examining different cell lines and cell-growth
conditions to determine optimal conditions for Ilia
RNA expression in adenovirus-infected cells so that
extracts containing Ilia activity can be obtained rou-
tinely.
Purification of Factors Involved in
Mammalian Nuclear Pre-mRNA splicing
A.R. Krainer, D. Kozak
We are interested in purifying the components of the
general nuclear pre-mRNA splicing apparatus. The
long-term goal of these experiments is to identify
and characterize all the general splicing factors from
mammalian cells. By studying splicing with purified
components, we hope to elucidate presently un-
known aspects of the pre-mRNA splicing reaction.
These include the nature of the catalytic active sites
(protein and/or RNA), the molecular basis of the
specificity of splice-site selection, the role of ATP,
and the evolution of the splicing machinery.
To purify one whole class of factors that are neces-
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sary for pre-mRNA splicing, i.e., snRNPs, we have
taken advantage of the fact that their RNA con-
stituents possess a unique trimethylated 5' cap struc-
ture. With the help of C. Bautista and E. Harlow
(Protein Immunochemistry Section), we have gener-
ated mouse monoclonal antibodies against N2,N2,7-
trimethylguanosine (m3G)- keyhole limpet hemo-
cyanin nucleoside-protein conjugates. Hybridomas
were screened in pools by immunoprecipitation of
labeled Ul snRNA in order to obtain high-affinity
antibodies. Two monoclonal antibodies were ob-
tained that are capable of immunoprecipitating
deproteinized snRNAs or labeled snRNPs. These
antibodies are useful for analyzing the polypep-
tide composition of snRNPs from a wide variety of
species, including Schizosaccharomyces pombe (A.
Krainer and D. Frendewey, unpubl.).
We have employed these monoclonal antibodies
for preparative immunoaffinity chromatography of
HeLa cell snRNPs from active splicing extracts. The
bound snRNPs are recovered by competition with
free nucleoside, under gentle ionic conditions. The
m3G-eluted snRNPs do not catalyze any cleavage-
ligation reactions when incubated with pre-mRNA
under splicing conditions. However, they can fully
complement a micrococcal-nuclease-treated nuclear
extract for splicing activity. Therefore, all of the
nuclease-sensitive RNPs that are necessary for pre-
mRNA splicing can be purified by anti-m3G im-
munoaffinity chromatography. These snRNPs have
a very high degree of purity based on the RNA and
polypeptide composition. They lack SF2 and SF3,
two activities that were previously shown to be neces-
sary for 5' splice-site cleavage and lariat formation.
The snRNPs do not appear to contain the intron-
binding protein that was previously shown by other
investigators to be associated with U5 snRNP un-
der some conditions. We are currently characteriz-
ing these splicing-competent snRNPs with respect
to their physical properties, as well as RNA-binding
properties and putative enzymatic activities. Elec-
tron microscopy studies of the purified snRNPs, in
collaboration with D. Spector (Cell Biology Section),
are in progress. We are also attempting to separate
the m3G-snRNPs from each other while preserving
their splicing activity. The resulting fractions will be
employed to study the biochemical and physical
properties of individual snRNPs and for reconsti-
tution studies, as well as to attempt to identify mi-
nor snRNPs that may be necessary for splicing.
In addition to the snRNPs, we are attempting to
identify and purify the remaining protein factors that
are necessary for the reaction. With this aim, we are
developing a rapid quantitative assay for pre-mRNA
splicing, which should facilitate the ongoing purifi-
cation of splicing factors by complementation. Fi-
nally, in collaboration with S. Munroe and G. Con-
way, we are exploring affinity and immunochemical
methods to identify and characterize the stable com-
ponents of the spliceosome.
Antisense RNA as a Probe for
Pre-mRNA Splicing
S. Munroe
Although large pre-mRNA transcripts typically con-
tain many sequences that closely resemble functional
splice sites, splicing occurs only at a small number
of authentic splice sites. Accumulating evidence sug-
gests that sequences some distance from the splice
site are important for splice-site selection. Antisense
RNAs complementary to adenovirus and globin pre-
mRNA sequences were used as probes to assess se-
quence requirements for pre-mRNA splicing. These
antisense RNAs were found to inhibit splicing effi-
ciently in vitro. Several features of this inhibition are
of particular interest for understanding the mecha-
nism of splice-site selection and factors that inter-
act with pre-mRNA molecules under conditions of
splicing in vitro and in vivo.
First, splicing is strongly inhibited by antisense
RNA that anneals to sequences more than 80 nucleo-
tides downstream from 3' splice sites. This inhibi-
tion provides strong evidence that exon sequences
affect splice-site function at a distance. The level of
inhibition depends on the length, position, and con-
centration of antisense RNA relative to pre-mRNA.
Antisense RNAs that anneal directly across splice
sites also inhibit pre-mRNA splicing, although the
efficiency of inhibition is no greater than that ob-
served with a number of antisense RNAs hybridiz-
ing to downstream exons only.
Second, the effects of antisense RNA appear to
be relatively localized to the nearest upstream splice
site. Experiments with substrates containing dupli-
cated splice sites suggest that antisense RNAs do not
inactivate more distant sites and inhibition at one
site does not activate splicing at a more distant site.
This result contrasts with the effect of many splice-
site mutations that activate splicing at cryptic sites
when blocking splicing at a proximal site.
Third, inhibition of splicing is mediated in vitro
by proteins that catalyze RNA/RNA annealing.
When antisense RNA is added with the substrate
directly to the splicing reaction, a factor(s) catalyzes
the rapid annealing of complementary RNAs in a
manner that closely parallels inhibition of splicing.
This activity closely resembles that of several well-
characterized single-stranded nucleic-acid-binding
proteins, such as T4 gene-32 protein and Escherichia
coli ssb protein, which both facilitate annealing of
complementary nucleic acids. Since many of the pro-
teins that associate with pre-mRNAs in vivo bind
specifically to single-stranded molecules, antisense
RNAs should provide useful probes for studying the
functional role of these protein-RNA interactions
in RNA splicing. Finally, there is a specific temporal
requirement for inhibition with antisense RNA.
When antisense RNA is added to the splicing reac-
tion after the substrate, the efficiency of inhibition
is greatly reduced. This suggests that additional fac-
tors block RNA duplex formation shortly after splic-
ing is initiated. Thus, antisense RNA appears to
block splicing at an early step in the assembly of an
active splicing complex.
The inhibition of splicing by antisense RNA an-
nealing to exon sequences might be explained by a
number of different models including (1) disruption
of RNA secondary structure, (2) blocking of specific
binding sites, (3) interference with scanning of 3'
exons, and (4) disruption of RNP assembly. Present
results favor the latter of these possibilities. Further
work is in progress to characterize the assembly of
spliceosomes and hnRNP complexes in the presence
of antisense RNA inhibitors in order to determine
the mechanism of this inhibition and to use antisense
RNA as a tool for dissecting the assembly of func-
tionally important ribonucleoprotein structure on
the pre-mRNA substrate.
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PROTEIN CHEMISTRY
D.R. Marshak A. Admon D. Carroll R. Tonner
G. Binns N. Santoro
The members of the Protein Chemistry Laboratory
conduct research on the structure and function of
proteins that are involved in normal and abnormal
cell growth. The biochemical analysis of proteins in-
cludes their purification, primary structure determi-
nation, and analysis of modifications. We employ
advanced technology for automated chemical anal-
yses and structural studies. Understanding the rela-
tionship between structure and function in proteins
is fundamental to developing an understanding of
the mechanisms of cellular growth in normal and
cancer cells.
Our research projects are oriented around four ma-
jor areas: (1) modifications of the oncogene prod-
ucts, including adenovirus ElA, myc, fos, and SV40
T antigen; (2) purification and characterization of
the mitogenic factor associated with the adenovirus
E1A 12S gene product; (3) the role of protein kinases
in cell proliferation and transformation; and (4) de-
velopment of new methods for protein structural
analysis and peptide synthesis. Our investigations are
designed to use quantitative biochemical procedures
to uncover the structure and function relationships
in proteins. These approaches complement the
genetic and cell biological strategies to unraveling
mechanisms of cell growth.
Modification of Oncogene Products
D. Carroll, N. Santoro, A. Admon, D. Marshak
[in collaboration with E. Harlow and Y. Gluzman,
Cold Spring Harbor-Laboratory]
We have used peptide-mapping procedures on high-
performance liquid chromatography (HPLC) and
developed several techniques in order to identify the
sites of phosphorylation on adenovirus E1A proteins
and SV40 T antigen. Amino acid analysis of phos-
phorylated amino acids has been developed using
enzymatic hydrolysis, derivatization of the products
with phenylisothiocyanate, and separation of the de-
rivatives by reversed-phase HPLC. In this protocol,
phosphoserine, phosphothreonine, and phospho-
tyrosine are separated from the corresponding un-
phosphorylated amino acids completely. Amounts
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of the amino acids can be quantitated to 1-5 pmoles.
Enzymatic hydrolysis is limited, however, by two
parameters. First, using sequential digestion with
aminopeptidase M and carboxypeptidase Y, com-
plete digestion is not always achieved. Second, there
appears to be residual phosphohydrolase activity in
commercial preparations of these enzymes, leading
to some dephosphorylation during treatment. The
method is useful when phosphorylation sites are at
either end of a short peptide. We are currently try-
ing to improve the method with more highly puri-
fied sources of enzymes for digestion. To sequence
phosphorylation sites on the peptides, we have used
[3-elimination of phosphoserine with hydroxide, fol-
lowed by reaction of the product, dehydroalanine,
with ethanethiol. This results in the stoichiometric
conversion of phosphoserine to ethylcysteine. Dur-
ing automated sequence analysis, ethylcysteine is sta-
ble, and the phenylthiohydantoin derivative elutes
near diphenylthiourea in standard HPLC separa-
tions. Thus, the kinetics and extent of phosphoryla-
tion of serine can be quantitated accurately.
SV40 T antigen (TAg) was expressed in HeLa cells
using an adenovirus construct developed by Y. Gluz-
man (Molecular Biology of SV40) and was purified
from [32P]PO4-labeled HeLa cell extracts by im-
munoaffinity chromatography on immobilized anti-
body 419. Mapping of phosphorylation sites was ac-
complished by tryptic digestion of the protein and
separation of the fragments by reversed-phase HPLC
on a Vydac C. column (300 A pore size) using 0.1%
trifluoroacetic acid and increasing proportions of
acetonitrile. Two major peptides account for >90%
of all the radioactivity incorporated. The carboxy-
terminal peptide contained 30% of the radioactiv-
ity and was resistant to hydrolysis by alkaline phos-
phatase from calf intestine. This result (as well as
amino acid analysis and sequence analysis) suggests
that Thr-701 is the phosphorylated residue in this
region. The second peptide nearer the amino termi-
nus contained 50-70% of the radioactivity, and vari-
able amounts of radioactivity was labile to alkaline
phosphatase. Preliminary experiments have been
conducted to subdigest this tryptic peptide with V8
protease and to analyze the smaller fragments by se-
quence and amino acid analysis. The majority of the
phosphate appears to be on serine, although some
phosphorylation probably occurs at Thr-121 and/or
Thr-123 as well.
Adenovirus E1A (13S) has been overexpressed in
Escherichia coli by E. Harlow (Protein Immunochem-
istry) using a T7 expression system. We have purified
this protein from the E. coli lysate-soluble fraction.
The protocol consists of (1) DEAE-Sephadex chroma-
tography, (2) phenyl-Sepharose chromatography, and
(3) Sephadex G-75 chromatography. The resulting
protein is >90% homogeneous as analyzed by gel
electrophoresis. We are using this protein as substrate
for various protein kinases in vitro. We are currently
establishing peptide maps of the unlabeled protein
and the phosphorylated protein. Corresponding
maps of E1A labeled in vivo will then be evaluated
by comparison to these standard maps. As described
below, it will be essential to obtain in vivo maps at
various time points after infection, since the phos-
phorylation patterns are likely to change, based on
observations with various protein kinases.
Adenovirus E1A (12S)-induced
Mitogenic Activity
D. Marshak, R. Tonner [in collaboration with M. Quinlan
and T. Grodzicker, Cold Spring Harbor Laboratory]
Purification of the mitogenic activity from cells in-
fected with adenovirus 5 (Ad5)-12S depends on the
scaling up of production of conditioned media from
infected cells. M. Quinlan has established a line of
baby rat kidney epithelial cells, BRK 12-1, that can
be infected with Ad5-12S and produces active con-
ditioned media as described previously for primary
BRK cells. We have increased production of this con-
ditioned media to 2400 ml per week. The media is
centrifuged at low speed, filtered to remove cell de-
bris, and then concentrated using a Minitan tangen-
tial flow apparatus and a 100,000-molecular-weight
cutoff filter. The activity is retained by the filter in
a volume of 30 ml. Using this concentrated media,
we have established a time course of dose-response
curves for the activity by monitoring [3H]thymidine
incorporation into DNA for a 24-hour pulse. The
activity is optimal at 72-96 hours incubation with
the conditoned media concentrate. Half-maximal re-
sponse of the activity occurs at approximately 0.6-1.5
hg/ml of protein. Thus, the amount of growth fac-
tor is roughly 1 hg/liter of conditioned media. Our
current experiments are using concentrated condi-
tioned media for column chromatography on ion ex-
change, hydrophobic interaction, and gel filtration.
Preliminary data indicate that hydrophobic interac-
tion chromatography on phenyl-Sepharose and
affinity-based adsorption chromatography on im-
mobilized dyes produce up to a 100-fold purifica-
tion of the activity.
Protein Kinases in Cell
Proliferation and Transformation
D. Carroll, N. Santoro [in collaboration with E. Moran,
Cold Spring Harbor Laboratory]
We have examined the protein kinase activities from
bovine liver using synthetic peptide that are specific
substrates for different kinases. In parallel, we have
monitored the phosphorylation of a peptide from
E1A and the corresponding homologous site on TAg.
The activity that phosphorylates the E1A and
T-antigen peptides copurifies with the enzyme casein
kinase II (CK-II) throughout the purification. The
sites on TAg and E1A are serines residues, followed
by several acidic amino acids, which is similar to that
found for substrates for CK-II. We searched a pro-
tein sequence database for oncogene products and
found that a concensus sequence for the phosphory-
lation site appears in the nuclear oncoproteins
TAg, myc, myb, fos, and p53, but not in the cyto-
plasmic oncoproteins. To pursue this observation,
we synthesized peptides corresponding to each of the
sites on the nuclear oncoproteins and used them as
substrates for purified CK-II. Most of these peptides
are good substrates for CK-II and are not phos-
phorylated by cAMP-dependent protein kinase,
phosphorylase kinase, myosin light-chain kinase,
protein kinase C, and Ca"/calmodulin-dependent
protein kinase. Detailed kinetics have been done for
all the peptides. We have also attempted to construct
peptide analogs that might act as inhibitors of the
enzyme.
To determine CK-II peptide kinetics rapidly, we
have developed an assay using reversed-phase thin-
layer chromatography (RP-TLC). The assay mixtures
are applied to the RP-TLC plates and initially eluted
with 0.1% phosphoric acid, 0.25% trifluoroacetic
acid, and 10% acetonitrile to elute the nucleotides.
The second elution is in the same solvent contain-
ing 50% acetonitrile to move the peptide away from
the origin. This assay is rapid, simple, and boosts
the signal/noise ratio considerably. Our current
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studies are aimed at identifying the phosphorylated
and unphosphorylated CK-II substrates in vivo. To
this end, we are preparing monoclonal and poly-
clonal antibodies to phosphorylated and un-
phosphorylated peptides to use as reagents in cell
biological experiments.
The identification of CK-II as a potential regula-
tory modifier of E1A and TAg led us to study its
role in signal transduction during the process of
adenovirus infection, changes in cell cycle, and trans-
formation of cells. Wild-type Ad5 was infected in
7-day-old BRK cells, and the levels of CK-II and
cAMP-dependent protein kinase were measured at
various time points for 48 hours. Similar experiments
were performed with Ad5 d1312, a virus whose E1A
region is deleted. Both wild-type and d1312 viruses
cause a biphasic increase in CK-II activity; the first
phase is a 10-fold activation occurring at 15 minutes
after application of the virus to the cells, and the
second phase is a further 10-fold activation (20-fold
total) appearing at 2 hours. In contrast, the cAMP-
dependent protein kinase levels fall approximately
20-fold from basal levels in the first 15-minute
period. The initial phase of CK-II induction is not
blocked by cycloheximide, a protein synthesis inhib-
itor. Experiments to determine if the second phase
requires protein synthesis are in progress. These
results suggest that there are two modes for activa-
tion of CK-II, possibly from different intracellular
pools or by different transduction mechanisms. We
plan to study this by subcellular fractionation of cells
during the same time course of CK-II induction by
adenovirus infection. Overall, we believe that these
results indicate that CK-II induction is rapid, does
not require E1A expression, does not require pro-
tein synthesis, and is complementary to a decrease
in cAMP-dependent protein kinase. Preliminary
studies indicate that the initial phase of CK-II in-
duction is stimulated by the adenovirus coat protein
interacting with a host-cell receptor protein.
Experiments were conducted to study CK-II in-
duction during the cell cycle. WI38 cells, a human
lung fibroblast cell line, were serum-starved to syn-
chronize in Go. After serum stimulation, CK-II lev-
els and cAMP-dependent protein kinase activities
were measured over a 48-hour time course. The
results were similar to those obtained for adenovi-
rus infection of BRK cells. CK-II was induced by 15
minutes with a corresponding decrease in cAMP-
dependent protein kinase activity. At 16 hours, when
thymidine incorporation into DNA began, cAMP-
dependent protein kinase levels recovered to near
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basal levels, whereas CK-II showed a recovery fol-
lowed by a second phase of induction. In other pre-
liminary experiments, phorbol esters stimulated
CK-II levels, presumably through a protein-kinase-
C-mediated event. Our current investigations in this
area are to test whether CK-II induction is a general
phenomenon that parallels stimulation of prolifer-
ation in cells. We will test growth factors and other
stimuli and measure their effects on the kinetics and
the level of CK-II stimulation.
Structural Analysis and Synthesis of
Proteins
G. Binns, D. Marshak, N. Santoro
We provide protein chemistry support to all of the
laboratories at Cold Spring Harbor. During the past
year, we have synthesized, purified, and character-
ized 12 peptides that have been used as substrates
or inhibitors of protein kinases. We obtained a
preparative HPLC that permits purification of sev-
eral hundred milligrams of peptide in one run, at flow
rates of up to 75 ml/min. This greatly facilitates pep-
tide purification. We have prepared over 30 peptide
maps using a microbore HPLC with diode array de-
tector for on-line monitoring of absorption spectra.
In sequence analysis, we have made preliminary se-
quencer determinations on various proteins from
other laboratories at Cold Spring Harbor, includ-
ing transcription factors, protein kinases, and cell-
cycle-related proteins.
In the past few months, we have optimized a new
method for electroblotting proteins from polyacryl-
amide gels on to polyvinylidene difluoride mem-
branes (PVDF). These membranes can be stained
with Coomassie blue, and they are stable to sequenc-
ing chemistry. Thus, the spots appearing on these
blots can be placed directly in the sequencer for anal-
ysis. This method has been applied to high-resolution
two-dimensional gels prepared in the Quest Labo-
ratory under the direction of J. Garrels. Successful
sequencing of spots identified on these gels allows
us to assign chemical structures to previously uniden-
tified proteins.
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M. Falkowski C. Stephens
S. Koehler-Peck P. Whyte
A. Le le N. Williamson
M. Raybuck
Work in the Protein Immunochemistry Laboratory
has continued to focus on understanding the mode
of action of nuclear oncogenes. Our research over
the last year has concentrated on the adenovirus E1A
proteins and in particular on two subjects: (1) the
function of the protein/protein complexes formed
between the E1A proteins and various host-cell poly-
peptides and (2) on the origin and function of the
multiple E1A protein species. Our work has identi-
fied three cellular proteins with relative molecular
weights of 300K, 107K, and 105K as potential tar-
gets for E1A-mediated transformation. One of these
proteins, the 105K, has recently been identified as
the product of the retinoblastoma gene. The iden-
tity of the 107K and 300K proteins has not been de-
termined. The heterogeneity of the E1A proteins was
first demonstrated by immunoprecipitation of these
proteins and analysis on two-dimensional gels. These
studies have shown that the heterogeneity arises from
the production of at least four mRNAs by differen-
tial splicing and by extensive posttranslational
modification of the primary translation products.
We are currently trying to determine which of these
modifications contribute to the function of the E1A
proteins.
In addition to the research work in the Protein Im-
munochemistry Laboratory, a separate group pre-
pares monoclonal antibodies for the Cold Spring
Harbor Laboratory staff. The monoclonal antibody
facility is run by Carmelita Bautista and is staffed
by Margaret Falkowski, Susan Koehler-Peck, and
Michael Delannoy.
Cellular Targets for Transformation
by the Adenovirus E1A Proteins
F Whyte, N. Williamson, E. Harlow
In cells infected or transformed by adenovirus, the
viral proteins encoded by the early region IA (E1A)
form stable protein/protein complexes with a series
of host-cell polypeptides. These proteins are known
by their relative molecular weights of 28K, 40K, 50K,
60K, 80K, 90K, 105K, 107K, 130K, and 300K. The
three most abundant of these proteins are the 105K,
107K, and 300K polypeptides, and physical and
genetic studies have shown that all three of these pro-
teins bind directly to E1A. As an initial strategy to
determine the possible functions of these complexes,
we compared the regions of E1A required for bind-
ing to the cellular proteins with the regions neces-
sary for various E1A activities. A series of E1A de-
letion mutants were constructed and screened for
their ability to induce foci in primary baby rat kid-
ney cells when cotransfected with an activated Ha-
ras gene. Two regions of the E1A proteins, amino
acids 1-76 and 120-127, were shown to be required
for cooperation with ras. Amino acids outside these
sequences could be deleted without destroying the
transforming ability of E1A. Any mutation that
resulted in a deletion within one of two regions of
the E1A proteins destroyed the focus-forming activ-
ity. Therefore, these mutations have defined the min-
imal regions of the E1A proteins essential for trans-
formation.
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The mutant E1A proteins were next screened for
their ability to bind the cellular proteins. By infecting
He La cells with recombinant adenoviruses contain-
ing the deletion mutations and then immunoprecip-
itating the E1A products and any bound cellular pro-
teins, we have mapped the binding sites of the 105K,
107K, and 300K proteins. The binding sites of the
300K and 107K proteins are amino acids 1-76 and
120-127, respectively, whereas the 105K protein re-
quires the regions between amino acids 30-60 and
120-127. Interestingly, the boundaries of these bind-
ing sites coincided precisely with the boundaries of
the transforming regions. Every E1A mutant that
failed to bind one of these proteins also failed to
transform cells efficiently, and, conversely, every mu-
tant capable of binding all three of these proteins
was transformation-competent. This result led us to
hypothesize that these three proteins are cellular tar-
gets for E1A-mediated transformation.
Monoclonal Antibodies Specific
for the Cellular Proteins That Bind to
the Adenovirus E1A Polypeptides
P Whyte
To study the cellular proteins that bind to the
adenovirus E1A proteins directly, we have prepared
a series of monoclonal antibodies against these poly-
peptides. The M73 monoclonal antibody, which is
specific for an epitope near the carboxyl terminus
of the E1A proteins, was purified and coupled to
agarose beads using cyanogen bromide. Protein ly-
sates from 293 cells that constitutively express the
adenovirus E1A and El B proteins were added to the
M73 beads. After the E1A proteins and their as-
sociated proteins were bound to the antibody beads,
the extraneous proteins were removed by washing,
and the bound proteins were eluted by treating with
acetic acid. The purified proteins were used to im-
munize mice and prepare monoclonal antibodies.
The hybridomas were screened by immunoprecipi-
tation against lysates from radiolabeled 293 cells.
Twenty hybridomas were identified that secreted an-
tibodies specific for 293 proteins. Among these
monoclonal antibodies were several that specifically
bound to the E1A-associated proteins. The best
characterized of these antibodies are the C36 anti-
body, which is specific for the 105K protein, and
C160, which is specific for the 60K protein. The re-
maining antibodies are currently being characterized.
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The Adenovirus E1A Proteins
Bind to the Retinoblastoma
Gene Product
K. Buchkovich, P Whyte, M. Raybuck, E. Harlow
[in collaboration with J.M. Horowitz, S.H. Friend, and
R.A. Weinberg, Whitehead Institute, Boston, Massachusetts]
Among the cellular polypeptides that bind to the
adenovirus E1A gene products is a nuclear phos-
phoprotein of 105K. The 105K E1A-associated pro-
tein took on increasing interest when it became ap-
parent that it shared several characteristics with the
polypeptide product of the retinoblastoma (Rb) gene,
a gene first identified as a locus responsible for a
predisposition to retinal tumors. The Rb gene prod-
uct was first identified by Lee and his colleagues (Na-
ture 329: 642 [1987]) as an approximately 110K nu-
clear phosphoprotein. In addition to having similar
molecular weights and similar subcellular distribu-
tions, both the 105K and Rb proteins are absent from
several Rb tumor cell lines.
To determine if these two proteins were identical,
we first confirmed that their molecular weights were
the same. The protein immunoprecipitated with a
monoclonal antibody specific for the E1A-bound
105K protein, and the protein immunoprecipitated
with rabbit antisera raised against synthetic peptides
deduced from the Rb cDNA sequence comigrated
on SDS-polyacrylamide gels. Next, we compared
these immunoprecipitated proteins by subjecting
them to partial proteolysis with either Staphylococ-
cus aureus V8 protease or N-chlorosuccinimide
(NCS). V8 protease enzymatically cleaves proteins
after acidic residues (aspartic acid or glutamic acid),
whereas NCS chemically cleaves after tryptophan
residues. Each reagent yielded an identical proteo-
lysis pattern for both proteins, demonstrating that
the positions of accessible aspartic acid, glutamic
acid, and tryptophan residues are identical in the two
polypeptides.
Finally, we performed two types of experiments
to prove that these proteins were recognized directly
by the anti-105K and anti-Rb antibodies and were
not simply spurious cross-reacting proteins or pro-
teins immunoprecipitated via another antigen. In one
set of experiments, the monoclonal antibody spe-
cific for 105K was shown to immunoprecipitate poly-
peptides produced by in vitro translations of cRNA
transcribed directly from the cloned Rb cDNA. In
complementary immunoblotting experiments, the
E1A-associated 105K was recognized by two antipep-
tide antibodies raised against different regions of the
Rb proteins. By proving that 105K is recognized
directly by more than one anti-Rb antibody, this last
experiment demonstrated that 105K shares at least
two epitopes with the Rb proteins. These data dem-
onstrate that the E1A-associated 105K and the Rb
proteins are products of the same gene.
The disruption of both copies of the Rb gene has
been linked to the appearance of retinoblastomas
and other genetically related tumors, suggesting that
the Rb gene product may be a component of a
regulatory pathway responsible for inhibiting cell
proliferation. Since the inactivation of genes such
as Rb leads to tumor growth, these proteins have been
described as tumor suppressors or anti-oncogenes.
The demonstration of the E1A /105K -Rb complex is
the first example of an association between an on-
cogene and an anti-oncogene. The existence of this
oncogene/anti-oncogene complex unifies two fields
of research that were thought to be unrelated.
What is the role of the complex? One model sug-
gests that anti-oncogene proteins like 105K are ele-
ments of a pathway that allows cells to respond to
environmental signals. These signals might be
differentiation inducers, cell-cycle regulators, or
other factors that carry an inhibitory cue to the cell.
The loss of the Rb gene and subsequent loss of the
Rb protein would remove or block the signal. As a
consequence, the cell would lose its ability to respond
normally to the inhibitory signal while retaining its
proliferative ability. In this model, by interacting with
105K, the E1A proteins may block the passage of
the inhibitory signal and serve as an indirect stimu-
lator of cell proliferation.
Monoclonal Antibodies Specific
for the Adenovirus Type-3
and Type-12 E1A Proteins
A. Le le, E. Harlow
To study the possible role of the E1A/host-cell pro-
tein complexes isolated from cells that are infected
or transformed with adenovirus serotypes other than
our standard laboratory strains of adenovirus type
2 or 5, we have begun the preparation of antibodies
specific for the E1A proteins isolated from these sero-
types. cDNA clones for the 13S mRNA from types
3 and 12 were inserted into a derivative of the T7
expression system developed by W. Studier (Brook-
haven National Laboratory). E1A proteins were iso-
lated from Escherichia coli and used to prepare
monoclonal antibodies. A series of monoclonal an-
tibodies specific for the E1A proteins from adenovi-
rus type 3 have been prepared. These antibodies are
currently being characterized.
The Heterogeneity of the
Adenovirus E1A Proteins
C. Stephens
The adenovirus E1A proteins migrate on SDS-
polyacrylamide gels as a heterogeneous group of
polypeptides. This heterogeneity is due to the exis-
tence of multiple E1A mRNAs that arise from
differential splicing of the primary E1A transcript
and to posttranslational modification of the multi-
ple E1A polypeptides. Our interests are to understand
the roles of the multiple E1A polypeptides.
The primary E1A transcript is differentially spliced
to yield five mRNAs that have been designated the
13S, 12S, 11S, 10S, and 9S mRNAs. The 13S and 12S
mRNAs are synthesized at both early and late times
during the viral lytic cycle, whereas the 11S, 10S, and
9S mRNAs are produced at late times in infection.
Two of these late mRNAs, the 10S and 11S species,
were recently identified and cloned in both our lab-
oratory and that of G. Akusjarvi. Functional ana-
lyses of the E1A proteins have shown that 13S pro-
tein product is essential for viral growth because of
its role in the activation of the other adenovirus early
genes. The 12S protein product is necessary for lytic
infection of quiescent, serum-starved cells. An anal-
ysis of what function the "late" E1A mRNAs might
have for viral growth was initiated by construction
of mutant viruses that could only synthesize the 10S
or 11S mRNA. These viruses were found to be defec-
tive, suggesting that the sequences removed in the
generation of these mRNAs were essential for viral
growth.
Another virus, designated 5-1, was constructed
that removed the splice donor for all three late
mRNAs (11S, 105, and 9S) and therefore could not
synthesize the late proteins. The 5-1 mutant virus was
first tested for its ability to grow on He La cells and
was found to grow to wild-type levels. The only
phenotype that could be attributed to this virus was
a slight cytopathic phenotype that caused the in-
fected cells to round up and come up off the plate
at earlier times in infection than wild-type virus-
infected cells. Since this is a characteristic of E1B
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19K mutants, the splicing mutant virus was further
analyzed to determine whether it shared any of the
other properties attributed to the E1B 19K mutants.
These included accelerated growth in quiescent,
serum-starved cells and the degradation phenotype,
which results from nuclease activity on cellular
DNA. When tested, the 5-1 virus was found to pos-
sess neither of these properties, but rather to behave
similarly to the wild-type control virus.
Since the consensus splice donor and acceptor se-
quences used to form the late E1A mRNAs have been
conserved between the different adenovirus sero-
types, it appears that there must be a selective growth
advantage in producing these late mRNAs, but we
have been unable to determined what this advantage
might be. It is possible that experiments done in tis-
sue culture are sufficiently different from the nor-
mal growth environment of the virus that we will be
unable to answer this question.
In addition to differential splicing, the heteroge-
neity of the E1A proteins is also generated by exten-
sive posttranslational modification. Pulse-chase ex-
periments have shown that modified polypeptides
migrate more slowly and at more acidic pI values
than unmodified forms. Phosphatase treatment re-
moves most, if not all, of the modifications found
on the E1A proteins, indicating that phosphoryla-
tion accounts for the majority of modification. To
determine what residues in E1A are modified and
whether these modifications are important for E1A
function, all of the serine and threonine residues in
the region encoded by the first exon of the 12S
mRNA were mutated to alanine. Although these
residues do not account for all of the serine and
threonine residues found in the entire E1A, we chose
to concentrate on mutations in the first exon for a
number of reasons. First, these sequences contain
two regions that are conserved between different
adenovirus serotypes, and mutations in either of
these two regions result in ElA proteins with altered
biological properties. Second, deletion mutants in
64
these regions eliminate many of the slower-migrating
forms of the E1A proteins that are observed on SDS-
polyacrylamide gels.
The serine and threonine mutants have been con-
structed by site-directed mutagenesis, and these mu-
tant DNAs are being used to construct recombinant
adenoviruses. Once viruses are constructed, the E1A
polypeptides will be analyzed on two-dimensional
gels, and the viruses will be tested for their ability
to grow in He La cells. The mutated E1A proteins will
also be tested for their ability to function in cotrans-
formation assays with the ras oncogene.
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PROTEIN SYNTHESIS
M.B. Mathews A.P. Rice A. Maran M. Corrigan
E. Moran G.F. Morris H. Goodrich
M. Kostura C. Herrmann A. Kamenick
M. Laspia K. Mellits
Gene expression in higher cells is regulated at several
levels, and viruses employ a diverse array of strate-
gies in coopting cellular processes to their own ends.
During 1987, we continued to exploit adenovirus as
a means to study several of these regulatory events,
with the dual purpose of understanding the normal
processes and the means by which they are subverted.
Taking advantage of the extensive knowledge of
adenovirus molecular biology accumulated over the
years in many laboratories, we have also begun to
explore the functioning of tat, one of the regulatory
genes of the AIDS virus, HIV-1.
VA RNA, DAI, and Translational
Control
M. Kostura, A. Maran, K. Mellits, L. Manche,
P.A. Wendel, M.B. Mathews
Adenovirus encodes two small RNAs, the virus-
associated (VA) RNAs, transcribed by RNA poly-
merase III. These RNAs are approximately 160
nucleotides long and accumulate to high concentra-
tions in the cytoplasm of adenovirus-infected cells.
In the absence of VA RNA,, protein synthesis in
adenovirus-infected He La cells fails because of
defective polypeptide chain initiation. The defect
results from phosphorylation of the initiation fac-
tor eIF-2 on its a-subunit. Earlier work showed that
the protein kinase responsible is DAI, the double-
stranded RNA (dsRNA)-activated inhibitor of pro-
tein synthesis. This enzyme, which is present at a
basal level in uninfected cells and at elevated levels
in cells treated with interferon, is activated during
the late phase of infection with the VA RNA, -
lacking mutant virus, Ad 5d1331. During the year, we
have worked on the nature of the enzyme activator,
the relationship between the structure of VA RNA,
and its function, and the purification and proper-
ties of DAI.
L. Manche
R. Packer
PA. Wendel
DAI ACTIVATOR
We showed previously that an activator of DAI is
present in cytoplasmic RNA from d/331-infected cells
and suspected from the characteristic bell-shaped ac-
tivation curve (low concentrations activate, higher
concentrations do not) that the activator might be
dsRNA. To identify the activator more definitively,
we fractionated the deproteinized RNA prepared
from cytoplasmic extracts of d1331-infected cells ac-
cording to its secondary structure, using a Franklin
column (a cellulose column that provides a method
to separate various nucleic acids with graded con-
centrations of ethanol). Several lines of evidence in-
dicate that the activator is RNA, and dsRNA in par-
ticular. First, the activator has chromatographic
properties similar to that of dsRNA. Second, it is
destroyed by a dsRNA-specific nuclease, RNase III,
and it is at least partly resistant to RNases A and
T, which are specific for single-stranded RNA.
Third, the activator is heat-sensitive and regains its
activity upon reannealing. Fourth, a bell-shaped ac-
tivation curve similar to that observed with authen-
tic dsRNA is obtained with the activator.
Previous work had shown that DAI is only acti-
vated in cells that have progressed into the late phase
of infection, and we have now found that the dsRNA
from d/331-infected cells contains viral sequences
that hybridize to an extensive region in the center
of the adenovirus genome. Thus, it seems that the
activator of DAI present in d1331-infected cells in-
cludes viral dsRNA originating from symmetrical
transcription of the viral genome. Its site of origin
on the viral genome and shortness (only 100-200
nucleotide pairs, based on gel electrophoresis and
gel filtration analyses) hint that it may represent frag-
ments of discarded intron sequences. Further work
demonstrated the presence of dsRNA in wild-type
adenovirus-infected cells, as expected from the pro-
posal that VA RNA is required to counter the effects
of dsRNA generated during viral infection. Less ex-
pected was the detection of dsRNA in uninfected cell
extracts. This observation raises several questions.
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It is not clear whether dsRNA acts as an activator
of DAI in uninfected cells. If it does, it may be that
its effect is antagonized by small RNAs or by other
factors present in uninfected cells. To date, we have
not detected any RNA in the cytoplasm of uninfected
cells that blocks DAI activation, but an inhibitory
activity capable of this function has been found in
the ribosomal salt-wash (as described below).
VA RNA STRUCTURE AND FUNCTION
The exact mechanism of VA RNA, action is un-
known, but it has long been thought that its second-
ary structure is important because VA RNA, has ex-
tensive duplex regions and it is known that the kinase
interacts with dsRNA. To test this idea, we con-
structed mutant VA RNA, genes that would change
proposed stem or loop regions. These alterations in-
clude a series of nested deletions and a series of linker
scanning mutations. In a transient expression assay,
12 of 14 mutants exhibited drastically decreased VA
RNA, function. The remaining two mutants re-
tained wild-type function. Many of the mutant
RNAs also exhibited dramatically altered elec-
trophoretic mobilities. We have therefore begun to
examine the secondary structures of wild-type and
four mutant VA RNAs in solution, using the
nuclease-sensitivity method. We derived a structure
for wild-type VA RNA, that approximates models
generated in other laboratories but differs from them
in significant ways. As shown in Figure 1A, it in-
cludes regions of short, perfectly duplexed RNA and
longer, imperfectly duplexed RNA, both of which
are known to be able to inhibit DAI. Broadly speak-
ing, results from the transient expression assay corre-
late with structural data: Mutant RNAs that behave
as wild type in the transient assay preserve the same
basic conformation as wild-type VA RNA', whereas
mutant RNAs with decreased function have struc-
tures in which some or most of the duplexed regions
of the molecule are destroyed (see Fig. 1B). The dis-
ruption often affects structures at a considerable dis-
tance from the mutation, suggesting that the con-
formation of the molecule is probably quite intricate.
Its functionality is surprisingly sensitive to changes
that alter its secondary structure, but not all modifi-
cations in regions of secondary structure destroy its
function. Our current hypothesis is that certain stem-
loop structures are more critical than extended
duplex regions. Current plans include the generation
of point mutations to allow more sensitive probing
of VA RNA, structure and function and the appli-
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cation of additional techniques to the determination
of the higher-order structure of the molecule.
PURIFICATION AND PROPERTIES OF DAI
DAI activity is associated with the phosphorylation
of an n-,70-kD protein as well as of the a-subunit
of the protein synthesis initiation factor eIF-2. Be-
cause of its ability to phosphorylate eIF-2, DAI could
potentially exert a pronounced effect on the trans-
lation of both cellular and viral mRNAs. Further-
more, the induction of DAI synthesis probably plays
a role in the antiproliferative effects of interferon.
Adenovirus and other viruses that generate dsRNA
during their life cycles have developed mechanisms
to thwart the activity of this enzyme. To character-
ize its physical and enzymatic properties, we under-
took the task of purifying the enzyme. Through a
series of chromatographic columns, we have now
obtained nearly homogeneous preparations of the
kinase from human 293 cells. Final purification is
accomplished by sedimentation through a glycerol
gradient. Our data indicate that the ,-,70K protein
is indeed DAI, as previously suggested by other
investigators, and that no other polypeptides are
required for its activities. This is evidenced by the
copurification of the -s-,70K protein with protein
kinase (autophosphorylation) activity, with eIF-2
kinase activity, with the ability to bind dsRNA (based
on nitrocellulose filtration assays using dsRNA syn-
thesized in vitro), and with the ability to bind VA
RNA. Interestingly, VA RNA is able to block the
binding of dsRNA, suggesting a rather simple mech-
anism for its inhibitory action.
During the course of the purification, we discov-
ered a potent inhibitor of the kinase in the ribosomal
salt wash of interferon-treated cells. This inhibitor
is not a phosphatase and does not function to in-
hibit the ability of the activated enzyme to phos-
phorylate eIF-2. Indeed, it appears to function much
like VA RNA', in that it can prevent the activation
of the enzyme in the presence of dsRNA. The na-
ture of this inhibitory factor and its possible rela-
tionship to the dsRNA found in uninfected cells are
being explored.
Present work with the purified kinase is directed
toward defining its interactions with activating
dsRNA, on the one hand, and with VA RNA,, on
the other. Preliminary data suggest that the interac-
tions may not, in fact, be simple ones. We have asked
whether the activation reaction is intramolecular or
intermolecular in nature. Dilution of the enzyme at
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FIGURE 1 Secondary structure of adenovirus VA RNA,. (A) A likely structural model for
adenovirus-2 VA RNA, based on probing end-labeled molecules with nucleases specific
for paired or unpaired nucleotides. Closed arrowheads denote sites sensitive to nucleases
specific for single-stranded regions; open arrowheads denote sites sensitive to a nuclease
specific for duplex regions and stacked bases. The large arrowheads mark the most preferred
cleavage sites. (8) An example of the nuclease-sensitivity data derived from a wild-type adenovi-
rus 5 molecule (left) and a mutant adenovirus 2 molecule (right). (Reproduced from Mellits
and Mathews 1988.)
constant dsRNA levels revealed that the rate of DAI
autophosphorylation is second order with respect to
protein concentration, implying that autophosphory-
lation of DAI proceeds through an intermolecular
phosphate transfer. Additional experiments that in-
volved mixing of preactivated enzyme with latent
DAI in the presence of VA RNA indicated that the
substrate of the active enzyme is eIF-2 and that the
activated enzyme cannot phosphorylate the latent
form of the kinase. These results suggest that acti-
vation (autophosphorylation) of DAI occurs when
two molecules of the latent kinase form a complex
on dsRNA, resulting in the phosphorylation of one
or both of the kinase proteins. The data also imply
that there are two separable kinase activities con-
tained in DAI, since the phosphorylated kinase mol-
ecule no longer uses latent kinase as substrate but
instead phosphorylates eIF-2 quite readily. This lat-
ter event is not inhibitable by VA RNA and provides
a useful method for discriminating between the two
kinase activities intrinsic to DAI.
Activation of Human Immunodeficiency
(AIDS) Virus Gene Expression
A.P. Rice, M. Laspia, H. Goodrich, M.B. Mathews
Transcription of human immunodeficiency virus
type 1 (HIV-1), the causative agent of acquired im-
munodeficiency syndrome (AIDS), is directed by its
long terminal repeat (LTR) sequences. The HIV-1
LTR is composed of several distinct regulatory ele-
ments: a negative regulatory element (NRE, located
between nucleotides - 340 and -185, upstream of
the cap site), a core enhancer (-105 to - 80), three
binding sites for the transcription factor SP1 ( -76
to - 48), a TATA box (- 26 to - 22), and an element
termed TAR (trans-activation response element). The
TAR element confers responsitivity to the HIV -1-
encoded trans-activator known as tat and appears
to represent a novel type of genetic regulatory ele-
ment. The TAR sequences encompass 17 nucleotides
upstream and some 44 nucleotides downstream from
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the site of transcription initiation. Unlike an en-
hancer, TAR function is orientation- and position-
dependent: When inserted between a heterologous
promoter and a reporter gene, the TAR element does
not respond to trans-activation by tat in the reversed
orientation or when removed to a location far up-
stream or downstream from the site of transcription
initiation.
The mechanism by which tat trans-activates HIV-1
LTR-directed gene expression is unclear and con-
troversial. Some studies suggested that an increase
in mRNA accumulation directed by the HIV-1 LTR
can fully explain the action of tat. Other studies
presented contradictory evidence, indicating that
mRNA levels increase little, if at all, and that the
increase in mRNA accumulation can only partially
explain trans-activation by tat. Consequently, it has
been suggested that posttranscriptional mechanisms,
perhaps translational control, are also involved. To
analyze trans-activation of the HIV-1 LTR, we have
developed an adenovirus vector system that offers
some advantages over the plasmid DNA transfec-
tion techniques used previously by other investiga-
tors. It allows the highly efficient introduction of
the HIV-1 LTR into a variety of cell types of rodent,
simian, and human origin and allows experiments
to be scaled to preparative levels for biochemical
analysis.
We inserted the HIV-1 LTR, fused to the chlor-
amphenicol acetyltransferase (cat) gene as a reporter,
into adenovirus in place of the El region. As a con-
trol, a similar recombinant adenovirus, containing
the Rous sarcoma virus (RSV) LTR fused to cat, was
also constructed (Fig. 2). The HIV-1 LTR expressed
from this adenovirus responds to tat trans-activation
in a He La cell line constitutively expressing the tat
protein. The RSV-LTR is not sensitive to tat. The
mechanism of trans-activation in this system involves
an increase in the transcription rate of the HIV-LTR
and dramatically increased accumulation of mRNA
encoding cat. On the other hand, the translational
efficiency of the cat mRNA in the cell is unaffected
by the presence of tat in this adenovirus system. At
least in this system, it is evident that tat regulation
operates on transcriptional processes but not trans-
lational processes.
We are continuing to use this adenovirus vector
to analyze the transcriptional regulation of the HIV-1
LTR by tat. The two recombinant adenoviruses,
HIV-1CAT-ad and RSVCAT-ad, lack most of the
adenovirus El region and do not produce any of the
multiple protein products of the E1A and E1B genes,
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including the 13S E1A protein, which itself is a
powerful transcriptional activator. Consequently, ex-
pression of the adenovirus genes is extremely ineffi-
cient in HIV-1CAT-ad and RSVCAT-ad infections.
To explore possible interactions between adenovirus
gene product(s) and the HIV-1 LTR, we performed
coinfection experiments with HIV-1CAT-ad and wild-
type adenovirus. We found that wild-type adenovi-
rus greatly increased cat expression in HeLa cells with
HIV-1CAT-ad. This trans-activation of the HIV-1
LTR does not require DNA replication, as it occurs
in coinfections when DNA synthesis is blocked by
the drug cytosine arabinoside, indicating that an
early adenovirus gene product is involved in activa-
tion of the HIV-1 LTR. Coinfections were also car-
ried out with adenovirus mutants capable of express-
ing only one of the individual E1A products, 13S,
12S, and 9S. In HeLa cells, expression of the 13S pro-
tein is required for trans-activation of the HIV-1 LTR
contained in adenovirus; neither the 12S nor the 9S
protein is competent for trans-activation. Similarly,
in experiments involving co-transfection of plasmid
DNAs, we observed that the 13S protein, but not the
12S protein, is able to activate the HIV-1 LTR in
HeLa cells, indicating that no other adenovirus prod-
ucts are required for this response. The 13S effect
also increases expression from RSV-cat. This obser-
vation, together with the finding that the 13S E1A
and tat proteins are able to work synergistically to
"super-trans-activate" the HIV -1 LTR, suggests that
tat and the 13S E1A protein act by different mecha-
nisms, both largely, if not entirely, at the transcrip-
tional level. We have constructed a number of addi-
tional recombinant adenoviruses containing various
deletions of the HIV-1 LTR fused to the cat gene and
will use these viruses, as well as adenoviruses with
mutations within the 13S E1A protein, to investigate
the interaction of the 13S E1A and tat proteins in
regulating transcription of the HIV-1 LTR.
Structure-Function Relationships
in the Adenovirus E1A Gene
E. Moran, M. Corrigan
We are continuing to study how the structural fea-
tures of the adenovirus E1A gene products determine
their biological activities, particularly with reference
to the ability of these products to induce prolifera-
tion of quiescent cells. By last year, we had shown
that the E1A gene is an exceptionally interesting
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FIGURE 2 Structure of recombinant adenoviruses. Shown are HIVCAT-adenovirus (HIVCAT-ad) and RSVCAT-
adenovirus (RSVCAT-ad). These recombinant adenoviruses contain a deletion of adenovirus sequences
from 1.4 to 9.1 map units of wild-type adenovirus 5, comprising all of the coding region for the E1A genes
and all but the last 60 amino acids of the E1B genes. The site of initiation and direction of transcription
from the HIV and RSV LTRs are indicated by arrows. Also shown are the RSV and HIV LTRs (open box),
cat reporter gene coding sequence (hatched box), and SV40 polyadenylation sequences (closed box).
(Reproduced from Rice and Mathews 1988b.)
model for studying structure-function relationships
in a eukaryotic cell-cycle control protein because its
polypeptide products contain readily distinguishable
functional domains (conserved domains 1, 2, and
3) that have been highly conserved in the evolution
of various adenovirus serotypes (for review, see
Moran and Mathews, Cell 48:177 [1987]).
Recently, a mammalian homolog of the Schizosac-
charomyces pombe cdcr gene and its 34-kD pro-
tein product have been described (see Cell-cycle Con-
trol in Yeast and Vertebrates in the Genetics Section).
This yeast gene is of particular interest because its
activity is required for progression through both the
G, and G2 phases of the cell cycle, and a variety of
evidence suggest that it acts as a regulator of the
G, /S and G2/M transitions. To gain more informa-
tion about the pathways by which the E1A products
affect the cell cycle, in collaboration with G. Draetta
and D. Beach (Genetics Section), we have investigated
the expression of the p34 product during adenovirus-
induced proliferation of baby rat kidney (BRK) cells.
Adenovirus-mediated activation of BRK cell growth
caused rapid induction of p34 synthesis. Induction
was dependent on the E1A gene, did not require the
presence of the E1B gene, and, like proliferating cell
nuclear antigen (PCNA) induction, did not require
13S-specific activity. Neither p34 nor PCNA induc-
tion was affected by inhibition of cellular DNA syn-
thesis with hydroxyurea. Increased synthesis of both
products was due, at least in part, to an increased
abundance of translatable mRNA. Preliminary
results suggest that p34 induction in BRK cells, like
induction of PCNA, is also relatively unaffected by
the functional absence of E1A domain 2, consistent
with previous observations that regions outside con-
served domain 1 are not essential for induction of
G, and progression to S phase in E1A-activated
BRK cells (although domain 2 is required for progres-
sion beyond S phase). The similarity between PCNA
and p34 induction supports the suggestion that E1A-
mediated activation of the cell-growth cycle involves
activation of a set of host products responding to
a different regulatory function of ElA than that car-
ried by the 13S product.
To explore the possibility that regions of similar
sequence in other cell-growth-controlling proteins
may be functionally analogous to E1A domains, we
substituted a small region from SV40 large T anti-
gen for domain 2 of E1A and found that this chi-
mera has much of the biological activity of the
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authentic E1A product. In particular, it is able to
induce DNA synthesis and cell proliferation in quies-
cent BRK cells, to establish them, and to cooperate
with the ras oncogene in transforming them. These
results suggest that a functional substitution can in-
deed be made between a region of large T antigen
and E1A domain 2, even though the two regions
share less than 50% amino acid identity (Fig. 3). In
contrast, an E1A derivative (pm928) containing a
single amino acid substitution in one of the residues
conserved in both adenoviruses and papovaviruses
(Cys-124-.Gly in Ad5 E1A) is nearly as defective as
a mutant in which domain 2 is deleted entirely.
A molecular assay of the function of the chimeric
protein involves the ability of the E1A proteins to
bind to cellular products. In addition to the E1A pro-
teins themselves, monoclonal antibodies specific for
these polypeptides precipitate a series of cellular pro-
teins from adenovirus-infected He La cells (see Pro-
tein Immunochemistry section). Coprecipitation of
two of the most prominent of these, the 105K and
107K proteins, depends on the presence of domain-
2 sequences in the E1A polypeptides. The pattern
of coprecipitating bands seen upon immunoprecipi-
tation of the E1A /SV40 chimeric products appears
identical to that seen after immunoprecipitation of
the 12S wild-type ElA products. With the recent
identification of the 105K cellular protein with the
product of the retinoblastoma oncogene by E.
Harlow and his colleagues, it seems highly likely that
these interactions are significant for the cell-cycle-
regulating functions of the ElA products. Our evi-
dence that a similar functional unit exists in the
E1A Ad2/5
E1A Ad4
E1A Ad7
ESA Ad12
E1A SA7
LT SV40
LT BK
LT LPV
LT Py
121 139
DLTCHEAGFPP--SDDEDEEG
DLACYEECLPP--SDDEDEQA
DLACYEEGFPP--SDDEDGET
DLLCYEDGFPCSDSEDEQD
DLFCYEDGFPPSDSEEGEH
101 118
ENLFCSEEM-PS--SDDEATA
DLFCHEDMFA---SDEEATA
DLFCSETMSSS--SDEDTP
DLFCYEE--PLLSPNPSSPT
FIGURE 3 Alignment of sequences from several adenovirus
E1A proteins and papovavirus large T antigens. Domain-2 se-
quences from human adenovirus serotypes 2/5, 4, 7, and 12 and
simian adenovirus SA7 are aligned with homologous papovavi-
rus sequences from SV40, BK, lymphotropic papovavirus (LPV),
and mouse polyomavirus (Py). Gaps have been introduced to
maximize the homology. The position numbers of the first and
last amino acids of the Ad2/5 E1A and SV40 large T antigen se-
quences are indicated above the amino acid symbols.
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transforming proteins of both SV40 and adenovi-
rus suggests that the SV40 T antigen may exert its
cell-growth-regulating effects through a similar
mechanism.
At the biochemical level, domain 2 also exhibits
features related to a cellular protein kinase, casein
kinase II (CK-II). The carboxy-terminal half of do-
main 2 consists of a serine residue followed by several
acidic amino acid residues (Fig. 3), a motif that con-
stitutes a recognition site for CK-II. A similar se-
quence occurs in several viral and cellular nuclear
oncogenes, including SV40 large T antigen. Experi-
ments conducted with D. Carroll and D. Marshak
(Protein Chemistry section) showed that peptides
containing the E1A or SV40 T antigen CK-II motifs
are excellent in vitro substrates for CK-II phosphory-
lation. Using these peptides as substrates, we assayed
the activity of CK-II during adenovirus infection of
BRK cells. Primary BRK cells are quiescent even in
the presence of serum, but when infected with
adenovirus, they are induced to proliferate. Unin-
fected BRK cells have a low basal level of CK-II
activity, but within 15 minutes after infection, the
activity of this enzyme increases severalfold. Simul-
taneously, the activity of cAMP-dependent kinase
drops sharply and then rises, in a manner similar to
the response that has been observed for this activity
following serum stimulation of established serum-
dependent cell lines. Interestingly, these responses
do not appear to require expression of the E1A prod-
ucts. They occur well before E1A expression can be
detected and are induced even after infection with
a mutant virus from which E1A is deleted entirely.
In fact, exposure of the cells to the purified adenovi-
rus capsid protein, fiber, which mediates viral attach-
ment to the cell membrane, is sufficient to induce
at least the CK-II response. These effects suggest that
viral attachment to the cell membrane may be able
to stimulate initial membrane signal transduction
events in a manner analogous to stimulation by se-
rum growth factors.
To investigate these effects further in a system in
which the responses to virus infection and serum
stimulation can be compared directly, we are study-
ing the activity of these enzymes during cell-cycle
induction of quiescent WI38 cells, which can be
stimulated to reenter the growth cycle by either se-
rum addition or virus infection. Like primary BRK
cells, WI38 cells have a low basal level of CK-II ac-
tivity. Within the first 24-30 hours after serum stim-
ulation of WI38 cells (the approximate length of a
single cell cycle), CK-II activity exhibits three dis-
tinct peaks. Cellular DNA synthesis becomes detect-
able following the second peak of CK-II activity.
These distinct peaks of CK-II activity are in clear
contrast to the pattern of cAMP-dependent kinase
activity, which stays constant after an initial early
fall and rise. The finding that a kinase activity related
to functional domains in transforming proteins ex-
hibits specific peaks of activity during cell-cycle
progression should provide a means for defining spe-
cific steps in this process and help distinguish the
pathways by which extracellular events signal growth
changes within the cell. We are now comparing cell-
cycle progression induced by adenovirus infection
with that induced by serum growth factors and ex-
ploring the role played by the E1A products in this
process.
Regulation of Gene Expression by E1B
C. Herrmann, M.B. Mathews
The E1B 19K tumor antigen is the smaller of the two
major proteins encoded by the E1B gene and is re-
quired in cooperation with the E1A gene for the com-
plete transformation of primary rodent cells. As we
reported last year, the E1B protein, like ElA proteins,
can regulate expression of viral genes. Using a He La
cell transient expression system in which the activ-
ity of the various adenovirus promoters was moni-
tored by an enzymatic assay for the reporter gene
cat, we have shown that all the adenovirus early
promoters are stimulated by the E1B 19K protein.
These promoters, which also respond to trans-
activation by a product of the E1A gene, are stimu-
lated to a higher degree by the combination of ElA
and E1B genes than by either the E1A or E1B gene
alone, suggesting that products of the E1A and El B
genes can cooperate in regulating viral gene expres-
sion. The activity of the promoters expressed at late
times during virus infection is not detectably affected
by either the E1A or the E1B gene when present
alone, but the E1A and E1B genes together are clearly
capable of increasing expression from the major late
promoter. In addition to regulating expression of the
adenovirus genes, the E1B 19K protein also stimu-
lates expression from the SV40 early promoter linked
to its enhancer, as well as the promoter for the cellu-
lar 70K heat-shock protein.
Our interest is to learn about the mechanism of
action of the 19K tumor antigen in stimulating viral
and cellular gene expression. One approach we have
taken has been to construct an adenovirus vector that
contains the E1A-cat chimeric gene in place of the
E1A and E1B genes. By coinfecting the recombinant
E1A-cat virus with the 9S virus (which contains a
wild-type E1B gene but an inert E1A 9S cDNA in
place of the genomic E1A gene) or the 9S.R2 virus
(which is the same as the 9S virus except that it con-
tains a point mutation within the coding region of
the 19K protein), we can study the effect of the 19K
protein in the absence of E1A products which can
regulate viral gene transcription both positively and
negatively. E. White (DNA Synthesis section) has
reported that in the presence of E1A, the 19K pro-
tein exerts a negative effect on viral gene expression.
We have shown that in the absence of E1A, the 19K
protein has a positive effect during virus infection,
consistent with our transfection results. We found
higher steady-state levels of E1A-directed cat mRNA
in cells coinfected with E1A -cat and the 9S virus than
in cells coinfected with E1A-cat and the 19K mutant
9S.R2 virus. Nuclear run-on transcription assays re-
vealed an increased rate of transcription from the
E1A promoter, as well as from several other early
and late promoters, in the presence of a wild-type
19K protein, suggesting that the 19K protein acts at
the transcriptional level.
A second approach that we are taking to study the
action of the 19K protein is to construct He La cell
lines capable of expressing the E1B 19K protein. We
have obtained several positive clones and, using the
technique of immunofluorescence, we have detected
the 19K protein in the nuclear envelope of the 19K-
transformed cell lines, consistent with its location
during lytic infection. Preliminary results indicate
that these cell lines complement the cyt and deg
phenotypes exhibited by 19K mutant viruses. When
transfected with the E1A-cat plasmid, the 19K cell
lines produced much higher levels of cat activity than
control cell lines. However, we believe that at least
some of the increased expression is due to a higher
level of DNA template, which we have observed in
cells expressing the 19K protein. We are currently
conducting experiments to determine whether the
E1B 19K protein acts by stabilizing the DNA tem-
plate or by enhancing the rate of transcription, or
by both mechanisms.
Regulation of PCNA
G.F. Morris, M.B. Mathews
PCNA, also known as cyclin and the auxiliary pro-
tein for DNA polymerase 8, is required for replica-
71
tion of the leading strand of SV40 DNA in vitro and
it presumably performs an analogous function in the
replication of cellular DNA in vivo (see DNA Syn-
thesis section). The direct involvement of PCNA in
cellular DNA replication, coupled with its detection
by immunofluorescence only during S phase, led us
to investigate the expression of PCNA during the
cell cycle. Toward that end, we fractionated randomly
growing He La cells into populations representing the
various stages of the cell cycle. This was accom-
plished by a procedure known as centrifugal elutri-
ation. Surprisingly, and in contrast with the results
obtained with immunofluorescence, the amount of
PCNA did not fluctuate by more than twofold
through the cell cycle when assayed by Western blots
of protein prepared from these synchronous cell
populations.
While this work was in progress, a resolution of
this paradox was provided by an observation made
by Bravo and MacDonald-Bravo (J. Cell Biol.
105: 1549 [1987]). They reported that the pattern of
PCNA detected by immunofluorescence depends on
the fixation method used. The commonly employed
methanol fixation method reveals only a population
of PCNA that is tightly associated with the nucleus:
This population is subject to cell-cycle regulation,
in concert with DNA synthesis. An alternative
method involving fixation with formaldehyde reveals
diffuse nucleoplasmic staining of PCNA through-
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out the cell cycle. We have examined nuclei from syn-
chronous cell populations for the presence of a
tightly bound population of PCNA. The PCNA
tightly associated with the nucleus increases dramat-
ically as the cells enter S phase and remains at high
levels until DNA synthesis discontinues, whereupon
it declines dramatically. Presumably, the loosely
bound population, which is a large fraction of the
total PCNA population, provides a reservoir from
which PCNA is recruited when DNA synthesis com-
mences. Unless only a small increment in PCNA con-
centration can tip the balance, this picture implies
that the availability of PCNA is unlikely to trigger
replication. The situation may be different, however,
when quiescent cells are stimulated by mitogens (se-
rum, E1A, etc.) to re-enter the cell cycle. Such non-
growing cells have significantly reduced levels of
PCNA and rates of PCNA synthesis, and it is rea-
sonable to suppose that PCNA synthesis is a pre-
requisite for replication under these circumstances.
These findings notwithstanding, the rate of PCNA
synthesis does vary during the cell cycle, as shown
by pulse-labeling synchronous populations of HeLa
cells. It seems that the alterations in the rate of syn-
thesis of the protein during the cell cycle can be ac-
counted for by changes in the level of PCNA mRNA.
We are currently determining the mechanisms in-
volved in the changes of PCNA mRNA levels dur-
ing the cell cycle. Since PCNA is a relatively stable
5' end
FIGURE 4 Localization of the autoreactive epitope on human tRNA,Ala. The antibody-binding site (stippled box) and anti-
body protected region (entire box) are superimposed on the tRNAiAla cloverleaf structure (left) and a model representing
the tRNA tertiary structure (right). (Reproduced from Bunn and Mathews 1987a.)
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protein, the fluctuation of PCNA synthesis does not
correlate with a constant level of the protein through-
out the cell cycle. We are also examining the possi-
bility that PCNA stability is regulated in a cell-cycle-
dependent fashion.
Autoimmunity
A. Maran, L. Manche, M.B. Mathews
Autoantibodies directed against cellular antigens are
frequently found in the connective tissue diseases.
Three antibody systems that involve transfer RNA
occur in patients with myositis, an inflammatory
muscle disease. In two of these systems, Jo-1 and
PL-7, the antigenic components are protein mole-
cules, the aminoacyl-tRNA synthetases specific for
histidine (Jo-1) and threonine (PL-7). In the third
system, PL-12, patients' sera contain antibody recog-
nizing alanyl-tRNA synthetase, together with anti-
body that directly recognizes alanine tRNA. As re-
ported last year and shown in Figure 4, the antigenic
site on the tRNA molecule is the anticodon loop.
We have now set about the more difficult task of
determining the antigenic sites recognized on the syn-
thetases. Presently, attention is focused on the Jo-1
antigen. E Tsui (Toronto Western Hospital) has iso-
lated a full-length cDNA clone for human histidyl-
tRNA synthetase and constructed mutants carrying
insertions and deletions at various sites in the cod-
ing region. In collaboration with Dr. Tsui, we are cur-
rently using the mutant proteins, produced in a tran-
sient expression system, to map the epitopes reacting
with various Jo-1 antisera. The information obtained
in this way should shed light on the origin of the au-
toantibodies and, we hope, of the disease.
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TRANSCRIPTIONAL CONTROL
W. Herr R. Aurora L. Gloss R. Sturm
T Baumruker E. Mathews M. Tanaka
J. Clarke B. Ondek
Eukaryotic transcriptional regulation is manifested
by a complex combination of positive and negative
signals. The DNA sequences responsible for regula-
tion of transcriptional initiation (i.e., the promoter)
are a patchwork of cis-acting elements that combine
with a multitude of trans-acting factors. To dissect
these complex promoter structures, we have used the
small DNA tumor virus SV40 as a probe. This rela-
tively simple virus can be used to perform genetic
selections in which deleterious promoter mutations
are overcome by selection for viral revertants that
have restored growth potential. Our studies have been
focused on the structure and function of the SV40
enhancer region. Enhancers are promoter elements
that can activate transcription over large distances
from either downstream or upstream of the tran-
scriptional start site. We have shown in previous years
that the SV40 enhancer contains three 15- to 20-bp-
long enhancer elements, called A, B, and C, which
can compensate for loss of function in the remain-
ing two elements by duplication. Studies with syn-
thetic multimerized enhancer elements showed that
these three elements possess different patterns of cell-
specific enhancer activity. Experiments during the
past year indicate that these elements are themselves
bipartite, being composed of subunits we call enhan-
sons. Enhansons combine in pairs to form enhancer
elements. This creates a two-tiered enhancer sub-
structure that allows for a much more complex pat-
tern of combinatorial regulation.
To study the factors that regulate SV40 enhancer
function, we have been purifying He La cell proteins
that bind to the SV40 enhancer. These experiments
have led to the purification of a 100-kD nuclear pro-
tein that binds to the octamer sequence ATGCAAAT.
This sequence motif is found to be associated with
a number of enhancers and promoters. To our sur-
prise, we found that the purified protein can bind
to two adjacent sites within the SV40 enhancer, one
of which is a poor match to the octamer concensus.
It is not evident, however, whether this 100-kD
octamer-binding protein, which we call OBP100, is
involved in SV40 enhancer function or whether it
is involved in SV40 DNA replication or late tran-
scription.
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SV40 as a Vector to Identify
Elements in Heterologous Enhancers
W. Herr, J. Clarke
Last year, we described the construction of an SV40
enhancer replacement vector in which the SV40 en-
hancer region had been deleted and could be replaced
by heterologous enhancers. When the SV40 enhancer
was replaced by two separate regions (called A and
B) from the polyomavirus enhancer, we were able
to obtain revertant viruses from the A, but not the
B, enhancer replacement virus. The A enhancer
revertants contained duplications that all spanned
a 28-bp element within the polyoma A enhancer. To
extend the studies of the polyoma B enhancer region,
we have replaced the SV40 enhancer with the poly-
oma B enhancer host-range mutant F9.1.
Polyomavirus does not normally replicate in un-
differentiated murine embryonal carcinoma (EC)
cells, but polyomavirus host-range mutants capable
of replication in EC cells can be isolated after
repeated passage in these cells. When host-range mu-
tants have been isolated in the embryonal carcinoma
cell line F9, they frequently contain a specific A-,G
point mutation within the polyoma B enhancer
(called F9.1), and this mutation improves enhancer
function in a variety of cell lines (Herbomel et al.,
Cell 39: 653 [1984]). When the SV40 enhancer was
replaced by the F9.1 point mutation polyoma B en-
hancer, we were able to isolate viable virus in CV-1
cells. This result is consistent with the F9.1 point mu-
tation creating a generally active enhancer element.
Analysis of the enhancer region from the viable
viruses gave a surprising result. As expected, the re-
gion carrying the F9.1 point mutation was duplicated
in all but two out of ten revertants. Surprisingly, how-
ever, the polyoma B enhancer/SV40 recombinants
also carry variably sized deletions or, in one case,
point mutations within a specific region of the B en-
hancer sequences. The pattern suggests that a nega-
tive element is being inactivated to allow growth in
CV-1 cells. We are currently testing the deletions to
determine whether they inactivate a negative element
with enhancer-like properties (i.e., a silencer). This
is the first time we have observed such a consistent
deletion pattern and suggests that the SV40 genetic
selections can be used to identify both positive and
negative elements.
Cell-type-specific SV40
Enhancer Elements
M. Tanaka, E. Mathews, W. Herr
We have taken two approaches to investigate the cell-
specific activity of individual SV40 enhancer ele-
ments. First, we have extended to new cell lines the
analysis of the activity of synthetic enhancers con-
taining multimerized SV40 enhancer elements, and
second, we have constructed an "enhancer replace-
ment" polyomavirus vector that allows genetic se-
lection of SV40 enhancer rearrangements in murine
cell lines. This latter approach allows revertant analy-
sis of the SV40 enhancer in cells other than African
green monkey kidney cells. The analyses of cell-type-
specific enhancer activities using synthetic enhancers
have focused on the B element in the murine lym-
phoid cell line NS-1 and on the C element in differen-
tiated and undifferentiated embryonal carcinoma F9
cells.
The location and sequence of the SV40 enhancer
A, B, and C elements are shown in Figure 1. The 22-
bp B element contains an imperfect direct 9-bp re-
peat AAGc/TATGCA, which has been referred to
as the sph motifs. The junction formed by these two
repeats creates a sequence similar to the octamer mo-
tif (ATGCAAAT; see Fig. 1) found in a variety of
upstream promoter and enhancer regions including
the immunoglobulin enhancer. We have shown pre-
viously (Ondek et al., EMBO J. 6: 1017 [1987]) that
multimers of a 17-bp fragment (6 x B17), which when
multimerized create the 18-bp sph motif repeat, are
active as an enhancer. In these previous studies, the
same construct containing the two mutations (Fig.
1) was inactive in all cell lines tested including lym-
phocytes. These results indicate that the SV40
octamer-like sequence is insufficient for enhancer
activity. We have extended these studies by analyz-
ing mutations within the octamer-related sequence.
Two mutations dpm7 (AT TTAAAG) and dpm8
(AAGGAAAG) have been introduced into the B17
constructs and assayed for enhancer activity. The
dpm8 mutant is inactive in all cell lines tested (CV-1,
HeLa, and NS-1, a lymphocyte cell line) but the dpm7
mutation only has an effect in the lymphoid cell line
NS-1. These results suggest that there are two func-
tionally distinguishable overlapping elements within
the SV40 enhancer B element. We are currently map-
ping the sequences responsible for the lymphoid-
specific activity.
Another example of overlapping elements is
emerging from the experiments using F9 cells. The
embryonal carcinoma cell line F9 can be induced to
differentiate in vitro by treatments with retinoic acid.
We have tested the activity of the A, B, and C syn-
thetic oligomer enhancers in both undifferentiated
and differentiated F9 cells. The A and B enhancer
constructs are active in both undifferentiated and
differentiated cells, whereas the C enhancer showed
little or no activity in undifferentiated F9 cells but
became the most active among the the three elements
upon differentiation. The inactivity of the C element
in undifferentiated cells was surprising because, of
the three sets of point mutations dpml, dpm2, and
dpm6, the dpm6 mutations within the C element (see
Fig. 1) have the most detrimental effect on SV40 en-
hancer function in undifferentiated F9 cells. These
results can be explained if there is another overlap-
ping SV40 enhancer element that functions in un-
differentiated F9 cells and is sensitive to the dpm6
mutation. To define this putative overlapping ele-
ment, we isolated growth revertants in undifferen-
tiated F9 cells of SV40 enhancer/polyomaviruses car-
rying either the wild-type SV40 enhancer or the
dpm12 mutant in which the A and B elements are
inactive. In general, these growth revertants contain
simple duplications of the SV40 enhancer sequences,
but the duplication pattern differs from that seen
when dpm12 revertants are isolated in CV-I cells, be-
cause the C element is not consistently duplicated.
This pattern further establishes the inactivity of the
C element in undifferentiated F9 cells. We are cur-
rently using synthetic oligomer constructs to iden-
tify the enhancer element that is active in undifferen-
tiated F9 cells and overlaps the C element.
The SV40 Enhancer Contains Two
Distinct Levels of Organization:
Enhancer Elements and Enhansons
B. Ondek, L. Gloss, W. Herr
The SV40 enhancer is characteristic of many en-
hancers in that it contains multiple short (8-10-bp)
sequence motifs. Many of these are shown in Figure
1 and include the coreA and coreC motifs within the
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FIGURE 1 SV40 early promoter showing the location of enhancer elements and sequence motifs. The diagram of the SV40 early
promoter shows, from right to left, the early transcriptional start sites, origin of replication, AT-rich TATA-like element, one imperfect
(dashed box) and two perfect 21-bp repeats, and a single copy of the wild-type 72-bp repeat. The A, B, and C enhancer elements
(stippled boxes) are shown below their corresponding position within the early promoter. The nucleotide sequence of the enhancer
region (nucleotides 179-284) is shown below with sequence motifs bracketed above the sequence, and the dpml, dpm2, and dpm6
point mutations are identified below the sequence along with the location of the A, B, and C elements. (Reprinted, with permission,
from Ondek et al. 1988.)
A and C elements and the sphl and sphII motifs in
the B element. Studies by Chambon and colleagues
have shown that these motifs are important for en-
hancer function and interact with distinct factors
(Zenke et al., EMBO J. 5: 387 [1986]).
Nevertheless, our studies with wild-type and mu-
tant A, B, and C element synthetic enhancers indi-
cate that these motifs are insufficient for enhancer
function because inactive mutant elements can still
contain wild-type motifs. During the past year, we
discovered that the A and B enhancer elements are
bipartite, containing subunits that correlate with the
core and sph sequence motifs. These subunits are
called enhansons because they appear to be the ba-
sic units of enhancer structure. Enhansons can be
duplicated or combined with a heterologous enhan-
son to create new enhancer elements, but unlike en-
hancer elements, they are very sensitive to changes
in spacing. These results lead to a picture of the SV40
enhancer as a composite of many subunits that are
organized in a hierarchical structure, first creating
enhancer elements and subsequently an enhancer.
This two-tiered enhancer substructure became ap-
parent because of the complex revertant double-
duplication patterns that arose when all three of the
SV40 A, B, and C elements were inactivated by point
mutation. For example, a small 9-bp duplication of
the coreA motif (Fig. 1) arose in three independent
revertants of the triple A, B, and C mutants, and this
short duplication was subsequently duplicated itself.
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The double-duplication pattern suggested that the
initial coreA motif duplication was creating a new
enhancer element. To test this hypothesis, we made
a synthetic enhancer with multiple copies of the 18-
bp coreA repeat. This construct is exceptionally ac-
tive as an enhancer, but point mutations in either
coreA repeat inactivate the enhancer, showing that
both coreA motifs are required for activity. Similar
analyses of the 9-bp sph motifs in the B element
showed that the sphI and sphII motifs, which differ
at a single position, are not equivalent (the sphI motif
is much "weaker" than the sphII motif), but they can
be inverted with respect to one another and still func-
tion as an enhancer element. Furthermore, a com-
bination of the sphII and coreA motifs or enhan-
sons was active, which showed that enhansons from
separate elements can be combined to create new en-
hancer elements. The activities of enhansons and en-
hancer elements are differentiated by their sensitiv-
ity to spacing. Enhansons must be positioned near
one another to form an enhancer element, whereas
enhancer elements can be separated by up to about
100 by and still cooperate with one another to en-
hance transcription.
The bipartite structure of enhancer elements sug-
gests that two trans-acting factors bind to adjacent
enhansons to form a complex that can enhance tran-
scription in combination with another enhancer ele-
ment complex. Figure 2A shows a hypothetical se-
ries of productive (la, lb, and 4) and nonproductive
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FIGURE 2 Enhancer, enhancer element, and enhanson organization. (A) Putative functional
and nonfunctional complexes between trans-acting factors and enhansons. Enhansons of different
sequences are shown as differently shaded boxes along a DNA molecule (line). trans-Acting
factors are shown above with (1) shaded portions indicating DNA-binding domains that correspond
to a specific enhanson sequence, and (2) blackened A shape, indicating a half-activation do-
main. (B) Illustration of two functional enhancer element-factor complexes interacting with a proximal
factor complex bound to proximal promoter elements. (C) Three levels of binary organization
within a regulatory region can be functionally distinguished by their differential response to spacing.
See text for details. (Reprinted, with permission, from Ondek of al. 1988.)
(2 and 3) complexes between enhancer factors and
enhansons. In the productive complexes, juxtaposed
factors are shown creating identical activation do-
mains (AA) because enhancer elements (and thus
factors) can functionally compensate for one an-
other. Complexes 2 and 3 represent solitary, non-
productive interactions between enhansons and en-
hancer factors. Complex 2 is inactive because the
transcription factor specific for the unoccupied en-
hanson is absent, and complex 3 simply represents
a solitary enhanson. These hypothetical nonproduc-
tive complexes show how enhancer motifs could
serve as binding sites for trans-acting factors but not
display activity in vivo.
The relatively strict spacing requirements between
paired enhansons can be explained by a need for
close protein-protein contacts to form a functional
enhancer element complex. It is not clear, however,
how enhancer elements display less-strict spacing
constraints. As shown in Figure 2B, we have sug-
gested that enhancer elements do not interact directly
with one another but instead associate with factors
bound to proximal elements. If these interactions are
broken and reformed during transcription, the long-
range enhancer/promoter interaction can be main-
tained by breakage and reassociation of the sepa-
rate enhancer element complexes at different times.
This enhancer substructure emphasizes multiple
levels of binary organization, in which each level is
differentiated from the other by the flexibility in
spacing between its component pairs of subunits. In
Figure 2C, we show a regulatory region divided into
three levels of binary organization, with each level
exhibiting increased sensitivity to spacing between
its components. At the first level, a regulatory re-
gion is divided into enhancers and proximal pro-
moter elements (e.g., CCAAT and TATA boxes);
these two control elements are capable of activating
transcription when separated by distances as large
as 10 kb. The enhancer is, in turn, composed of ele-
ments that can enhance transcription when separated
by roughly up to 100 bp, whereas a pair of enhan-
sons must be in close proximity to create a functional
enhancer element. An enhancer structure such as this
with multiple levels of binary organization permits
a greater degree of transcriptional regulation with
a limited number of transcription factors.
The increased complexity generated by two levels
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of binary organizations may also serve to buffer
regulatory regions from the spontaneous appearance
of new enhancers during evolution. Unlike proximal
elements, enhancers can activate transcription over
very large distances from the transcriptional start site.
This high degree of positional freedom creates a
much larger target size within which mutations can
create new enhancers. Thus, if enhancers were struc-
turally simple, they might evolve frequently, creat-
ing chaotic patterns of gene expression.
Replacement of the Wild-type SV40
Enhancer with Multimerized
Synthetic Enhancers Creates
Stable Viable Viruses
B. Ondek
Previous experiments showed that multiple (six) syn-
thetic copies of the three SV40 enhancer elements,
A, B, and C, possess intrinsic enhancer activity when
assayed in the SV40 host cell line CV-1. To determine
whether these synthetic enhancer constructions are
capable of supporting SV40 growth and replication
in the absence of the wild-type viral enhancer, the
wild-type enhancer region was replaced by each of
the A, B, and C synthetic enhancers. These recom-
binant viruses are viable when tested by plaque as-
say, although the viability is decreased 100-1000-fold
compared to wild-type SV40. As expected, viruses
containing inactive mutant enhancer elements are
defective for viral growth. When virus stocks were
passaged and then tested for rearrangements within
the enhancer region, the recombinant viruses were
stable. This contrasts with the rapid appearance of
rearrangements after passage of the enhancer point
mutants (e.g., dpm12). These results indicate that the
active synthetic enhancer constructions can substi-
tute for the wild-type SV40 enhancer and that there
is no distinct activity within the enhancer region,
other than enhancer activity, that is required for
growth and replication of a stable virus.
Determination of Late Start Sites
in SV40 Containing Synthetic
Enhancer Elements
R. Aurora
The SV40 early and late promoters overlap one an-
other but are oppositely oriented. The late promoter
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initiation sites are scattered throughout the regula-
tory region, and there are no obvious TATA boxes
to position the initiation sites. It is not understood
how initiation sites are selected in the absence of a
TATA element. The frequency of initiation site us-
age could be determined by sequences immediately
adjacent to the start site or by a global effect of dis-
tant sequences. To address this question, the pattern
of initiation sites in SV40 carrying multiple tandem
copies of the individual A, B, or C enhancer elements
was analyzed. These recombinant viruses are viable
and replicate stably (see above). Because these viruses
contain six reiterated copies of the enhancer element
sequence, it is possible to distinguish local from
global sequence effects on late start-site selection.
If local sequences dominate the selection, then six-
fold reiteration of an initiation site should create six
reiterated start sites. But, if global sequences are
responsible for determining start sites, then an even
reiteration of start sites would not likely occur.
Late initiation sites in the different multimerized
enhancer recombinant viruses were mapped by
primer extension and nuclease protection of total
RNA isolated from CV-1 cells after infection. The
results indicate that start sites are reiterated with each
synthetic repeat and that, when present, the nucleo-
tides used to initiate in each repeat are approximately
the same as in the wild-type virus. Nevertheless, ini-
tiation occurs more frequently at the repeats prox-
imal to the 21-bp repeats. This gradient of start-site
usage is observed regardless of the synthetic element
or its orientation. These results indicate that the se-
lection of initiation sites by RNA polymerase II in
the SV40 late promoter is determined by local se-
quences, whereas the frequency of use is determined
by global elements.
A 100-kD HeLa Cell Octamer-binding
Protein (OBP100) Interacts Differently
with Two Separate Octamer-related
Sequences within the SV40 Enhancer
R. Sturm, T Baumruker, W. Herr [in collaboration with
B.R. Franza, Jr, Cold Spring Harbor Laboratory]
Numerous eukaryotic upstream promoter and en-
hancer regions contain a functional octamer se-
quence ATGCAAAT. We have purified a 100-kD
HeLa cell octamer-binding protein, called OBP100,
and studied its interactions with the SV40 enhancer.
We were surprised to find that, although only one
octamer-related sequence (ATGCAAAG, see Fig. 1)
had been identified by sequence comparison,
OBP100 binds to two adjacent sites within the SV40
enhancer. Before purifying OBP100, we character-
ized its binding sites using a gel-retardation assay in
combination with mutagenesis of the binding sites
and chemical interference.
Figure 3A shows the nucleotide sequence of the
SV40 enhancer containing the OBP100-binding sites.
This region contains two sets of repeated sequences.
The B element (labeled B17) contains the imperfect
9-bp direct repeats called sphl and sphll (see Fig.
1). The junction formed by the sph motifs creates
the octamer-related sequence ATGCAAAG, which
we refer to as Octal. A second octamer-related se-
quence ATGCATCT is called Octa2. Figure 3B shows
a gel-retardation assay in which radiolabeled wild-
type or mutant SV40 enhancer fragments were al-
lowed to bind to a partially purified preparation of
OBP100 and separated by electrophoresis on non-
denaturing polyacrylamide gels. Complex formation
between DNA and protein(s) results in a retarded mo-
bility of the labeled fragment during electrophore-
sis. Two complexes (CI and CII) form when the wild-
type SV40 enhancer is used as probe. The dpm2 mu-
tations within the sphl motif, which inactivate the
B element, reduce the amount of CII complex, but
not the amount of the CI complex. Likewise, muta-
tions called dpm8 in the sphll motif also have a large
effect on CII formation. The combination of these
two sets of point mutations in dpm28 eliminates not
only CII formation, but also CI formation, indicat-
ing that the dpm2 and dpm8 mutations affect differ-
ent interactions.
To characterize these interactions, we assayed the
effects of chemical modification of the wild-type and
mutant sites on complex formation. In general,
modification of bases that are important contact
points for protein binding will disrupt complex for-
mation, and thus these modifications will be under-
represented in the complexed probe DNA. We have
used both dimethylsulfate (DMS) and diethyl-
pyrocarbonate (DEPC) as modifying agents. Results
of this analysis revealed that chemical modifications
over a 10-bp sequence spanning the Octal site af-
fect binding, whereas modifications over a 13-bp se-
quence spanning the Octa2 site prevent binding.
These results indicated to us that the two octamer-
related sequences and not the sph motifs are respon-
sible for formation of complexes CI and CII and thus
are the result of interaction with an octamer-binding
protein. This conclusion was confirmed by showing
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FIGURE 3 Gel retardation with mutated SV40 enhancer frag-
ments and a partially purified HeLa cell nuclear extract. (A) Nucleo-
tide sequence of the region surrounding the SV40 enhancer B
element is shown with point mutations (dpm2 and dpm8) and
sequence motifs described in the text shown above and below
the sequence, respectively. The Xs in the brackets identifying the
Octal and Octa2 sequences identify the bases that differ from
the octamer consensus ATGCAAAT. (B) Wild-type (lane 1), dpm2
(lane 2), dpm8 (lane 3), and dpm28 (lane 4) SV40 enhancer frag-
ments and a nonspecific fragment (lane 5) were assayed by gel
retardation using a HeLa cell nuclear extract that had been puri-
fied by heparin-agarose column chromatography. (Reprinted, with
permission, from Sturm et al. 1987)
that the same activity binds to the consensus octamer
sequence in the immunoglobulin heavy-chain (IgH)
enhancer.
This octamer-binding activity was extensively pu-
rified in a three-step purification procedure from a
HeLa cell nuclear extract. The activity was first frac-
tionated by heparin-agarose chromatography and
then greatly purified by DNA affinity-precipitation
(Franza et al., Nature 330: 391 [1987]). In the DNA
affinity precipitation procedure, fractions enriched
for the octamer-binding protein were incubated with
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FIGURE 4 Purification of OBP100. OBP100 was purified by DNA-
affinity precipitation as described in the text. The figure shows
a silver-stained 8% SDS-polyacrylamide gel. (Lane 1) Bio-Rad
high-molecular-weight markers; (lane 2) 1/250 of the starting ma-
terial used in the OBP100 purification; (lanes 3 and 4) protein
specifically precipitated by the negative control HIV enhancer
fragment or the Octal- containing 14x B17 fragment, respectively
(Reprinted, with permission, from Sturm et al. 1987.)
a biotinylated DNA fragment containing 14 copies
of the B17 sequence (see Fig. 3A), which contains
the Octal sequence but not the Octa2 sequence. The
proteins able to interact specifically with this se-
quence were purified by subsequent binding of the
DNA to streptavidin agarose beads, which can be
easily removed from the mixture by centrifugation.
After several washes, the bound protein was eluted
and identified on an SDS-polyacrylamide gel as
shown in Figure 4. This assay identified OBP100, a
100-kD octamer-binding-protein. OBP100 was shown
80
to be responsible for the formation of the SV40 en-
hancer CI and CII complexes by elution of the pro-
tein from the SDS gel and renaturation of the DNA-
binding activity. The renatured protein interacts with
the Octal and Octa2 sites and the IgH enhancer se-
quence, showing that OBP100, which was purified
to the Octal sequence, can bind to dissimilar se-
quences.
Although OBP100 interacts with the SV40 en-
hancer B element and the dpm2 and dpm8 muta-
tions that affect its binding also inactivate the B ele-
ment (see above), the protein may not be responsible
for the enhancer activity of the B element. This is
because the 6 x B17 synthetic enhancer, which con-
tains multiple copies of the Octal site but not the
Octa2 site, is inactivated by the dpm2 mutations that
have no discernible effect on OBP100 binding to the
Octal site. We are presently testing whether the
Octal- and Octa2-binding sites in combination can
function to enhance transcription. These OBP100-
binding sites may instead be involved in some other
process, including DNA replication or late transcrip-
tion, because the SV40 enhancer is within a com-
plex regulatory region that includes the bidirectional
early and late promoters and the origin of repli-
cation.
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MOLECULAR GENETICS OF EUKARYOTIC CELLS
This section encompasses laboratories studying the mechanism of the control of
gene expression and the ways that alterations in gene expression lead to altera-
tions in cellular proliferation. The laboratory of M. Wig ler focuses on the genes
that control cell proliferation. Mammalian oncogenes were identified by methods of
gene transfer, and these oncogenes are studied in great detail. Studies of the ras
oncogene have led to studies of growth regulation in yeast. The ros oncogene
encodes a transmembrane tyrosine kinase. The mas oncogene encodes a novel
member of a class of transforming proteins, with structural homology with the
family of receptors that contain multiple membrane spanning regions. The labora-
tory of M. Gilman focuses on the c-fos oncogene. Activation of the expression of
this oncogene is perhaps the earliest event in the response of cells to a large
number of external signals. Dr. Gilman and co-workers have identified serum re-
sponse and cAMP cis-response elements and have shown that these are distinct.
They are in the process of purifying and characterizing the protein factors that
bind to these elements. The laboratory of N. Hernandez studies the expression of
the small nuclear RNA (snRNA) genes, which are involved in a variety of RNA
processing events. Molecular analysis reveals that the transcription units of three
of these genes, Ul, U2, and U6, combine features of classic RNA polymerase II
and Ill transcription units. The laboratories of D. Hanahan and L. Field employ the
transfer of genes into the germ line of laboratory mice to explore a wide variety of
biological problems: tumor formation induced by various tumor virus genes, sec-
ondary events associated with tumor progression, essential hypertension and au-
toimmune disease, and, finally, the embryological origin of endocrine cells.
GENETICS OF CELL PROLIFERATION
M. Wig ler C. Birchmeier J. Field H. Ping
D. Broek T Michalei L. Rodgers
S. Powers J. Nikawa K. O'Neill
T. Toda P Sass M. Riggs
R. Ballester S. Sharma R. Elsin
G. Bolger D. Young B. Shenko
J. Colicelli I. Wieland
K. Ferguson S. Cameron
During the past year, our laboratory has continued
its investigations into oncogenes and growth control.
The central focus of the laboratory has been on the
RAS genes, which may play a critical role in a large
portion of human cancers. We mainly have been
studying the function of theRAS genes of the model
eukaryotic organism, Saccharomyces cerevisiae. As
a consequence, we also have been examining growth
control in this organism. In addition to these studies,
we have been studying two new human oncogenes,
the MAS and ROS oncogenes.
Function of the RAS Oncogenes
S. Powers, D. Broek, T Toda, J. Field, J. Nikawa,
S. Cameron, P Sass, T Michaeli, J. Colicelli,
R. Ballester, B. Shenko
Three basic questions about the RASgene products
remain unanswered: What controls their activity?
What biochemical activities do they control? How
does activation of the RAS-controlled pathways lead
to tumorigenicity? We have explored these questions
by using as a model system the S. cerevisiae RAS
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genes, which encode proteins that regulate yeast ad-
enylate cyclase. This is to date the only RAS-coupled
effector system known. Although RAS proteins
probably do not control adenylate cyclase in ver-
tebrates, this yeast system can be used to yield in-
sights into RAS function.
Four points of significance have emerged from our
yeast RAS studies during the past year. First, we dis-
covered that the product of the CDC25 gene appears
to regulate the yeast RAS1 and RAS2 proteins, which
was the first evidence that RAS activity is controlled
by other proteins (Broek et al., Cell 48: 789 [1987]).
RAS proteins in cells lacking the CDC25 gene act
as though they are not in an active state: They fail
to stimulate adenylate cyclase, although they can be
induced to do so by incubation with GTP. Cells con-
taining a RAS2va" gene, a mutant form of RAS2
that is "activated," are virtually oblivious to the ab-
sence of CDC25, which suggests that CDC25 may
be involved in maintaining RAS proteins in the GTP-
bound state. We do not yet know the mechanism of
this control, nor whether an analogous mechanism
exists in mammals. The normal Ha-ras protein when
expressed in yeast does not require the CDC25 gene
product to function, but we do have preliminary
genetic evidence that the CDC25 gene product can
interact with the mammalian Ha-ras protein. A mu-
tant form of RAS2 can block CDC25 function, and
the analogous Ha-ras mutation appears able to do
likewise. These results may indicate a direct interac-
tion between the protein products of these genes.
Second, we have developed a novel genetic/bio-
chemical method for purifying the yeast adenylate
cyclase complex from cells (Field et al., MoL
Biol. [1988] in press). The method entails the con-
struction and expression of the desired gene prod-
uct as an epitope fusion protein which is then puri-
fied by immunoaffinity chromatography and eluted
with a synthetic peptide epitope. This method yields
a several hundredfold purification of adenylate cy-
clase from yeast. The purified adenylate complex is
about 600 kD and probably contains two molecules
of the 210-kD adenylate cyclase and some number
of a 70-kD component. The complex is fully respon-
sive to RAS proteins and requires the continued pres-
ence of RAS proteins to remain active. Analysis of
the responsiveness of the purified complex demon-
strates that RAS proteins have an almost absolute
requirement for GTP in order to activate their ef-
fector. We are currently investigating the role of the
70-kD component of the complex in RAS respon-
siveness.
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Third, we have evidence from genetic experiments
that there must be a second RAS effector system in
yeast (Toda et al., in Oncogenes and cancer, Japan
Scientific Societies Press, Tokyo, Japan [1987]; Toda
et al., Ce1150: 277 [1987]). Two observations support
this idea. First, although the major effects of RAS
in yeast are mediated through its effects on adenyl-
ate cyclase, deletion of the adenylate cyclase gene is
not uniformly lethal in haploid spores, whereas de-
letion of both RAS1 and RAS2 genes is. Second, the
slow growth phenotype of adenylate cyclase deletion
mutants is fully suppressed by high-copy plasmids
expressing a variety of protein kinases, although
these same plasmids suppress deletion mutants in
RAS poorly and in a temperature-sensitive manner.
We have demonstrated that the alternate function
of RAS is also dependent on CDC25 function. We
are currently testing whether human Ha-ras can sup-
ply this function in yeast and are trying by genetic
means to isolate genes encoding components of the
alternate RAS pathway. These results raise impor-
tant new questions. Do RAS proteins have more than
one function in mammalian cells? If so, which are
important in malignant transformation?
Fourth, we have discovered "interfering" mutants
of the RAS genes. These are mutants that either
block normal RAS function or block "activated" or
"oncogenic" RAS in a dominant way. We first dis-
covered these mutants during suppressor studies of
yeast. A dominant temperature-sensitive RAS2 mu-
tant was isolated that blocks the function of CDC25.
A similar mutation in Ha-ras also appears to block
CDC25 function, and we are currently testing the
ability of this Ha-ras mutant to block Ha-ras func-
tion in mammalian cells. Upon realizing the poten-
tial value of such dominant interfering mutants, we
deliberately sought mutants of Ha-ras in mutage-
nized pools of Ha-ras genes that could block acti-
vated RAS2va" function. These were indeed found,
and they may be useful tools for exploring RAS func-
tion, particularly in mammalian cells. Preliminary
analysis indicates that these mutants compete for at
least one of the RAS effectors.
Growth Regulation in S. cerevisiae
T. Toda, S. Cameron, J. Nikawa, S. Powers, P. Sass,
K. Ferguson, J. Colicelli, K. O'Neill, M. Riggs
Our attempts to understand RAS function in yeast
have led us to explore in great detail the cAMP-
signaling system and its role in growth regulation.
First, we isolated BCYI, the gene encoding the
regulatory subunit of the CAMP kinases (Toda et al.,
MoL Cell. Biol. 7 1371 [1987]). We also isolated three
genes, TPK1, TPK2, and TPK3, that encode the cata-
lytic subunits (Toda et al., Cell 50: 277 [1987]). Cells
lacking BCY1 display a cluster of phenotypes, in-
cluding a failure to sporulate, accumulate glycogen,
resist starvation, or become heat-shock-resistant.
These are the responses of a normal cell to nutrient
limitation and can be thought of as the yeast equiva-
lent of entering the Go state of the cell cycle. These
defective phenotypes appear to be mediated by the
unbridled action of the catalytic subunits of the
CAMP- dependent protein kinases, since mutant, at-
tenuated TPK genes can reverse these phenotypes.
These results suggest that the only function of the
regulatory subunit is to control the activity of the
CAMP- dependent protein kinases. Moreover, cells
lacking BCY1 but containing attenuated TPK genes
can dynamically regulate responses to nutritional
limitation in an apparently normal manner, enter-
ing and leaving the Go state appropriately (Came-
ron et al., Cell [1988] in press). In such cells, it is even
possible to delete the entire ensemble of genes en-
coding the CAMP- generating and -regulatory ma-
chinery (CDC25, RAS, and CYR1) and still retain
normal growth regulation. These results support the
idea that, although the CAMP signaling system may
regulate entry and exit from the Go state, there must
be cAMP-independent mechanisms for regulating
this growth pathway. The "simple" eukaryote, S. cere-
visiae, may resemble mammalian cells in the com-
plexity of its overlapping signaling pathways.
In the course of our work, we also isolated the
CAMP phosphodiesterase genes of yeast. There are
two, PDE1 and PDE2, that encode proteins of low
and high affinities for cAMP, respectively (Nikawa
et al., MoL Cell. BioL 7: 3629 [1987]). Deletion of
these genes only modestly elevates cAMP levels in
yeast, a surprising result that suggested the existence
of feedback control of cAMP levels in that organ-
ism. This idea received dramatic confirmation when
we measured cAMP levels in yeast strains lacking
PDE genes but containing the RAS2va119 mutation
(Nikawa et al., Genes Dev. 1: 931 [1987]). Such cells
had cAMP levels that were nearly a thousandfold
elevated when compared to normal cells. Cells con-
taining RAS2va" but possessing PDE genes have
only modestly elevated cAMP levels. These results
indicate that there is feedback control of cAMP lev-
els, that normal RAS proteins are part of that feed-
back pathway, and that the mutant form of RAS is
not responsive to that feedback. The source of the
feedback is almost certainly the activity of the cAMP
kinase itself. Cells lacking the regulatory subunit
have almost unmeasurable levels of CAMP, whereas
cells with attenuated catalytic subunits have dramat-
ically elevated levels of cAMP. Mammalian cells also
have feedback systems that modulate cAMP levels,
and in this regard, they may resemble yeast cells.
However, in neither organism are the pathways of
feedback understood, and the extent of the similar-
ity of mechanism cannot presently be assessed.
During our effort to clone the CDC25 gene by
complementation analysis, we isolated a number of
yeast genes all possessing the ability to suppress the
temperature-sensitive defects of a CDC25 mutant.
Among these were the TPK genes and a gene we
called SCH9. Sequence analysis of SCH9 revealed
that it encodes a protein with a carboxy-terminal do-
main strikingly similar to that of the catalytic
subunits of the cAMP-dependent kinases (Toda et
al., Genes Dev. [1988] in press). SCH9 also encodes
an amino-terminal domain similar in size to the
regulatory domains of protein kinases C and the
cGMP-dependent kinases, but without sequence ho-
mology. The suppression of CDC25 by SCH9 sug-
gested that SCH9 might have functions that are
redundant with the CAMP- dependent protein kinase.
Further genetic analysis bears out this conclusion.
High-copy plasmids containing the SCH9 gene can
suppress the effects of loss of RAS, CYR1, and TPK
genes. Conversely, although loss of the SCH9 gene
is not lethal, it does lead to a slow-growth pheno-
type, which can, in turn, be suppressed by activat-
ing the CAMP pathway. These results indicate that
SCH9 might encode a protein that is a component
of a cAMP-independent signaling pathway in yeast
controlling growth regulation.
Mammalian Oncogenes
C. Birchmeier, D. Young, S. Sharma, K. Ferguson,
L. Rodgers, K. O'Neill, M. Riggs
We have been studying two human oncogenes, MAS
and ROS, which we first isolated using a cotransfer
and tumorigenicity assay (Birchmeier et al., Cold
Spring Harbor Symp. Quant. BioL 51: 993 [1987]).
In both cases, the activation of these genes required
_a rearrangement occurring during gene transfer.
Nevertheless, both genes are of considerable inter-
est. We find that the ROS gene is expressed almost
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exclusively in tumors of glial origin, but not in nor-
mal brain or in tumors of other origins (Birchmeier
et al., Proc. Natl. Acad. Sci. 84: 9270 [1987]). We are
in the midst of cloning and sequencing a full-length
copy of ROS cDNA and have raised antibodies to
its product, which is a membrane spanning tyrosine
protein kinase. Sequence analysis indicates a signifi-
cant homology with the Drosophila sevenless gene
product, both in the external and internal domains.
The gene product is large, perhaps 270,000 daltons,
and we estimate the mRNA length to be 9 kb, of
which 7 kb may be coding. The full-length product
appears to be expressed in many glial tumor cells,
with the exception of one glioblastoma cell line in
which the ROS gene appears to have suffered a rear-
rangement and now produces a truncated product
that has lost its transmembrane domain but still re-
tains tyrosine kinase activity. Our studies suggest a
possible role for ROS in the etiology of glial tumors,
and we wish to test this possibility in an experimen-
tal model system. Our findings may provide a use-
ful diagnostic marker for glial tumors.
The MAS gene represents a new class of oncogene.
Its sequence indicates that it encodes a protein in
the same class as the multiple membrane-spanning
hormone receptors that activate G proteins (Birch-
meier et al., Cold Spring Harbor Symp. Quant Biol.
51: 993 [1987]). It is normally expressed at high lev-
els in the cerebral cortex and especially in the hip-
pocampus (D. Young et al., Submitted). Thus, it is
likely that MAS encodes a neurotransmitter recep-
tor. We do not find it expressed in other tissues or
in over 40 different human tumor cell lines we have
examined. Activation of the gene during DNA trans-
fer appears to have resulted from rearrangement of
the promoter sequences, since merely forcing expres-
sion of a normal MAS product in NIH-3T3 cells is
sufficient to transform these cells. The phenotype
produced in NIH-3T3 cells by MAS is rather unusual
(D. Young et al., Submitted). Such cells are highly
tumorigenic and grow to high cell density in culture,
but they appear to be morphologically normal and
do not grow in agar suspension. MAS has an even
more limited effect on other rodent cell lines. Our
interest in MAS, as it relates to oncogenesis, is the
biochemical pathway that it activates.
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NUCLEAR ONCOGENES AND SIGNAL TRANSDUCTION
M. Gilman L. Berkowitz W. Ryan
R. Graham
Our goal is to understand how extracellular signals
are communicated to the nucleus. Our efforts are
focused on the c-fos proto-oncogene, which appears
to represent a critical junction in the pathways
through which growth signals are relayed to nuclear
targets. Transcription of the c-fos gene is induced
rapidly and dramatically within minutes of exposure
to a broad collection of growth factors. Induction
is a direct consequence of intracellular signals trig-
gered by growth factors and does not require the syn-
thesis of new cellular proteins. Our experiments are
primarily aimed at identifying and following the sev-
eral intracellular routes through which these signals
travel from the cell surface to the c-fos gene. Our
strategy is to identify the cis-acting DNA sequences
in the c-fos gene required for response to signals and
to use these DNA sequences to identify cellular pro-
teins that bind to these DNA elements. Our assump-
tion is that such proteins constitute important in-
termediates in these signaling pathways. We hope
that these proteins will lead us further back along
each signaling pathway so that we may eventually
reach a complete molecular description of how sig-
naling information from outside the cell reaches the
genome and influences the pattern of gene ex-
pression.
c-fos Sequences Required for
Growth Factor Induction
M. Gilman, R. Graham
To identify cellular signaling pathways through
which growth factor signals travel to the c-fos gene
and the c-fos sequences through which they act, our
strategy is to use site-directed mutagenesis to inacti-
vate c-fos regulatory elements and return these mu-
tant genes to cells. The mutants are tested for their
ability to respond to a variety of signals. A critical
element for the response of c-fos to growth factors
is the serum response element (SRE), located 300 by
upstream of the gene. This 20-bp element is neces-
sary and sufficient for the response of c-fos to whole
serum, which is a complex mixture of growth fac-
tors. Because the growth factors in serum activate
several characterized and uncharacterized intracel-
lular signaling pathways, it is not known which sig-
nals act on c-fos through the SRE and which use
other sequences. Therefore, we have mutated the SRE
and asked to what signals the mutant c-fos genes can
still respond. As expected, these mutations reduce
induction of the c-fos gene by serum as well as by
a number of purified growth factors. In addition,
the mutations abolish the response to phorbol esters,
pharmacological agents that activate a critical in-
tracellular signaling intermediate, protein kinase C.
This observation shows that the protein kinase C
pathway communicates with c-fos via the SRE.
Growth factors also trigger signals that do not in-
volve protein kinase C. To determine whether the
SRE is required for these protein-kinase-C-indepen-
dent pathways, we have transfected c-fos genes into
cells made temporarily deficient in protein kinase
C. Under these conditions, the transfected wild-type
gene still responds to serum and to purified growth
factors, suggesting that the gene carries sequences
responsive to protein-kinase-C-independent path-
ways. Transfected genes carrying mutations in the
SRE no longer respond under these conditions, sug-
gesting that the SRE is also required for this response.
Our results therefore show that the SRE is the tar-
get for at least two distinct intracellular signaling
pathways.
In contrast, the SRE is not required for response
to agents that elevate the intracellular concentration
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of cAMP, another important signaling molecule in
the cell. c-fos genes carrying mutations in the SRE
that abolish reponse to serum still respond fully to
cAMP. Thus, cAMP constitutes a third signal that
reaches the c-fos gene, and, in contrast to the others,
this signal does not operate through the SRE.
There may be still more signals that act through
distinct c-fos regulatory sequences. We find, for ex-
ample, that certain SRE mutations that abolish c-
fos induction by serum and phorbol esters do not
fully ablate response to platelet-derived growth fac-
tor (PDGF). c-fos response to PDGF is not fully in-
dependent of the SRE, however, because more ex-
tensive SRE mutations do prevent PDGF induction.
Experiments are currently under way to clarify the
role of the SRE and other c-fos sequences in the re-
sponse to PDGF.
Induction of c-fos by cAMP
L. Berkowitz, M. Gilman
Our studies with c-fos SRE mutants indicate that
the SRE is not required for c-fos induction by CAMP.
We are therefore trying to identify the c-fos sequences
required for this response. Simple 5'-deletion analy-
sis suggests that an element located approximately
60 by upstream of the transcriptional start site of
the c-fos gene is required for induction of the gene
by cAMP in fibroblasts. However, deletion of this
element almost completely abolishes c-fos promoter
function. Therefore, it is difficult to prove that this
element is indeed cAMP-regulated and not simply
the last constitutive element in the promoter, which,
when deleted, prevents any cAMP induction from
being detected. To address this problem, we have
placed several other regulatory elements immediately
upstream of the - 60-bp site in either a wild-type
or mutant configuration. Our goal is to increase the
activity of the promoter in the absence of the - 60-
bp element so that we can determine clearly whether
mutation of this element leaves a promoter detect-
ably active but no longer regulated by cAMP. Pre-
liminary results suggest that when multiple copies
of the SRE are inserted upstream of position -71,
the resulting gene responds to both serum and CAMP,
but when mutations are introduced into the - 60 ele-
ment, response to cAMP but not serum is lost. There-
fore, we believe that this element is indeed cAMP-
responsive.
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When the same point mutations are introduced
into a c-fos promoter carrying sequences through
position - 356, cAMP responsiveness is not lost.
Therefore, in addition to the element at - 60, other
cAMP-responsive sequences lie between positions
-356 and -71. Again, the SRE does not appear to
be cAMP-responsive because a double mutant with
an inactive SRE and an inactive -60 element be-
haves similarly to a mutant in which only the -60
mutant is inactive. By comparing a set of promoter
mutants carrying the -60 mutations and various
amounts of upstream sequence, we believe that we
have mapped an additional cAMP-responsive ele-
ment to the sequence between positions -110 and
-71. There are probably still others farther up-
stream.
Cellular Proteins That Bind to c-fos
Regulatory Sequences
W. Ryan, G. Graham, M. Gilman [in collaboration with
B.R. Franza, Jr, Cold Spring Harbor Laboratory]
Cellular proteins that bind to the c-fos SRE and
other regulatory elements are potential intermedi-
ates in the pathways through which signals travel to
the c-fos gene. We are therefore identifying cellular
proteins that interact specifically with these sites.
Using the mobility-shift DNA-binding assay, we and
other investigators detect what appears to be a sin-
gle DNA-binding activity in nuclear and whole-cell
extracts of a variety of cell types. Fractionation of
extracts by heparin-agarose chromatography results
in approximately tenfold purification of this activ-
ity but also yields a DNA-protein complex with faster
mobility in polyacrylamide gels. Mixing these active
DNA-binding fractions with fractions that flow
through the heparin-agarose column and contain no
detectable SRE-binding activity reconstitutes the
complex with the mobility seen in crude fractions.
Therefore, we believe that the protein-DNA complex
that forms on the SRE in vitro is at least tripartite,
consisting of DNA, the primary DNA-binding pro-
tein, and an unidentified third protein (or complex
of proteins). We are currently further purifying this
heparin-agarose flow-through activity to learn more
about it.
Although only a single SRE-binding activity is de-
tectable using the mobility-shift assay, the presence
of this activity does not appear to be sufficient to
account for the transcriptional state of the c-fos gene,
because many cells that do not express c-fos con-
tain this activity and some cells expressing c-fos at
high levels lack the activity. Therefore, we have used
a different assay to determine if there are additional
SRE-binding proteins in the cell that are not detected
using the mobility-shift assay. Using a microscale
DNA-affinity assay to recover cellular proteins that
bind to the SRE, we find several proteins that are
specifically recovered with a wild-type SRE oligo-
nucleotide and not with a mutant. These are new can-
didate SRE-binding proteins. Our current efforts are
focused on determining which of these proteins
corresponds to the mobility-shift activity we detect
in the same extracts and to examine these proteins
in extracts of mitogen-stimulated cells by high-
resolution, two-dimensional gel electrophoresis.
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EXPRESSION OF SMALL NUCLEAR RNA GENES
N. Hernandez S. Lobo P Reinagel
R. Lucito
Small nuclear RNA (snRNA) genes encode the
snRNAs Ul to U7. These RNAs are complexed with
a set of proteins to form small nuclear ribonucleo-
protein particles (snRNPs). The functions of several
snRNPs have been elucidated recently. The snRNPs
Ul, U2, U4, U5, and U6 are involved in pre-mRNA
splicing, whereas U7 is involved in processing of the
3' end of histone mRNAs. The role of U3, which is
localized in the nucleolus, is unknown.
We are studying the mechanisms that govern the
synthesis of the human snRNAs Ul, U2, and U6.
The human U6 gene is transcribed by RNA poly-
merase III, whereas the human Ul and U2 snRNA
genes are transcribed by RNA polymerase II. These
transcription units, however, differ in several respects
from the majority of polymerase III and polymer-
ase II genes. Thus, the U6 gene is characterized by
a promoter located entirely in the 5'-flanking se-
quence of the coding region, in contrast to most poly-
merase III promoters described to date that are at
least in part located within the RNA-coding region.
The U6 promoter contains several sequence motifs
also found in polymerase II promoters: (1) an oc-
tamer motif centered around position -215, (2) a
motif also found in the proximal element of the Ul
and U2 genes and located between positions -66
and -49, and (3) a TATA box centered around po-
sition -27. Deletion analyses have shown that the
distal part of the promoter, which contains the oc-
tamer motif, serves to enhance the efficiency of tran-
scription. Upon deletion to position -43, promoter
activity is lost.
The Ul and U2 promoters are bipartite, consist-
ing of a distal element and a proximal element. The
distal element contains an Spl-binding site adjacent
to an octamer motif and has some of the functional
characteristics of an enhancer. The proximal element
is located between the cap site and position -62.
In this region, a sequence motif is conserved between
the Ul and U2 genes; as mentioned above, this se-
quence motif is also found in the U6 promoter re-
gion and in two additional polymerase III promoters,
the 7SK and myc polymerase III promoters.
The Ul and U2 snRNAs are not polyadenylated,
and their 3' ends are formed by a unique process.
The longest Ul and U2 precursors that can be de-
tected in the nucleus are five to ten nucleotides longer
at the 3' end than the mature RNAs. Within minutes
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after synthesis, these precursors are exported into the
cytoplasm. There, the RNAs are packaged into
snRNPs and shortened to the mature size, probably
by an exonuclease. The snRNPs are then translocated
back into the nucleus. The reaction that forms the
3' ends of the Ul and U2 precursors is dependent
on a signal, the 3' box, located 10-19 nucleotides
downstream from the mature 3' end of the RNAs.
Surprisingly, the reaction also requires promoter ele-
ments. Thus, if the Ul or U2 promoters are replaced
by other polymerase II promoters derived from
mRNA-encoding transcription units, 3'-end forma-
tion at the 3' box is abolished and the RNAs become
polyadenylated at a polyadenylation site inserted
downstream. This observation demonstrates that 3'-
end formation of Ul and U2 is coupled to transcrip-
tion and therefore differs fundamentally from the
processing reactions that form the 3' ends of poly-
adenylated and nonpolyadenylated mRNAs. The 3'
ends of Ul and U2 could be formed by termination
of transcription or by a processing reaction coupled
with transcription.
U2 Promoter Sequences Involved in
Initiation of Transcription and
3'-end Formation
N. Hernandez, R. Lucito
The promoter region of the U2 snRNA gene is re-
quired for correct 3'-end formation at the 3' box. To
define precisely the sequences involved in initiation
of transcription and U2 3'-end formation, we have
extensively mutated the U2 promoter region. The
different constructs were transiently transfected into
He La cells, and the RNA was analyzed by RNase
T1 mapping. The first series of mutations, 5'-3' de-
letions, are shown in Figure 1A. Promoter sequences
can be deleted in a 5'-3' direction up to position - 240
upstream of the cap site without effect on initia-
tion of transcription. Thus, the SP1-binding site
located just downstream from position -270 is dis-
pensable. Upon deletion to position -198, the effi-
ciency of transcription drops by 80%, confirming
that the Spl and adjacent octamer motifs serve to
enhance transcription from the U2 cap site. Dele-
tion to position -62 reduces transcription another
10%. In the Minipr and Minipr +4 constructs, the
Spl and octamer motifs were placed just upstream
of position -62, with an insertion of 4 by in
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Minipr + 4. These "minipromoters" are quite active,
although the efficiency of transcription varies with
the spacing and/or sequence separating the proximal
region of the promoter and U2 enhancer.
The proximal region of the promoter was analyzed
by linker-scanning mutations, as shown in Figure 1B.
The two substitutions (LS - 51/- 60 and LS
- 44/- 53) that modify the motif conserved in the
Ul, U2, and U6 genes (and thereafter referred to as
the proximal element) reduce transcription to barely
detectable levels. Interestingly, the next two substi-
tutions (LS - 33/- 42 and LS - 28/- 37), which fall
outside of the conserved motif, also reduce transcrip-
tion drastically and therefore define another pro-
moter element. The other substitutions had little ef-
fect on transcription.
In the last series of mutations (Fig. 1C), the
U2 enhancer was replaced by artificial enhancers
(6 x B17, 6 x A21, and 6 x C17; obtained by B. Ondek
and W. Herr [Tumor Viruses Section]), which con-
sist of six tandem copies of the A, B, or C element
of the SV40 enhancer (Ondek et al., EMBO 1017
[1987]). The B element of the SV40 enhancer con-
sists of two Sph repeats (indicated by arrows under
the sequence in Fig. 1C), the junction of which forms
an octamer motif (boxed) similar to the octamer mo-
tif found in the natural U2 enhancer. The double
point mutation dpm2 affects the second Sph repeat
and destroys the enhancer activity of the element
when tested downstream from the 13-globin promoter
(Ondek et al., EMBO J. 6 1017 [1987]), whereas
dpm7 destroys the octamer motif and has no effect
on enhancer activity on the 13-globin promoter (see
1986 CSH Annual Report, p.75). Interestingly, the
situation is reversed when these artificial enhancers
are tested upstream of the U2 proximal element;
6 x B17/dpm2 is as active as 6 x B17 or the U2 natu-
ral enhancer, whereas 6 x B17 /dpm7 is inactive. The
octamer motif in the B element therefore seems to
be essential for activation of transcription from the
U2 promoter, but not from the P-globin promoter.
Similarly, 6 x A21 and 6 x C17, but very active en-
hancers when tested downstream from the 13-globin
gene (Ondek et al., EMBO J. 6 1017 [1987]), are com-
pletely inactive upstream of the U2 promoter. These
results suggest that the factors that bind to the
6 x B17 /dpm7, 6 x A21, and 6 x C17 enhancers can-
not cooperate with the U2 proximal element to en-
hance transcription. The U2 enhancer is thus a pro-
moter-specific enhancer, which can only be replaced
by enhancers such as 6 x B17/dpm2, which presum-
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FIGURE 1 (A) Deletions in the U2 promoter region. Boxes indicate the proximal element
(PE), the octamer sequence (octa), and sequences similar to S1-binding sites (SP1). The start
site of transcription is labeled +1. (B) Linker-scanning mutations in the U2 promoter region.
The upper two lines indicate the structures of the U2 promoter region in the "Minipr" con-
struct and in the parent construct. The linker-scanning mutations indicated below the wild-
type sequence were introduced into both of these constructs, except for the linker-scanning
mutation LS -59/-68, which was introduced only in the parent construct, since it replaced
a sequence absent in the Minipr construct. (C) Enhancer replacements in the U2 promoter.
The region upstream of position -198 was replaced by different synthetic enhancers: 6 x B17
containing the double point mutation dpm7, 6 x B17 containing the double point mutation dpm2,
6 xA21 and 6 x C17.
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ably bind the same factors as the wild-type U2 en-
hancer.
The deletions, linker-scanning mutations, and en-
hancer replacements were also analyzed for their ef-
fect on 3'-end formation. None of the deletions or
linker-scanning mutations inhibited 3'-end forma-
tion. Replacement of the U2 enhancer by the SV40-
derived artificial enhancers, however, had interest-
ing effects. 6 x B17/dpm2, which enhanced transcrip-
tion from the U2 promoter, had no effect on the
efficiency of correct 3'-end formation. In contrast,
correct 3'-end formation was reduced five- to ten-
fold when the U2 enhancer was replaced by the
6 x B17 /dmp7 and 6 x A21 enhancers. 6 x C17 had a
very weak inhibitory effect. These results suggest that
the introduction of foreign transcriptional elements
in the U2 promoter, and hence presumably foreign
transcription factors in the U2 transcription com-
plex, is incompatible with 3'-end formation. The
Ul and U2 promoters must, then, direct the forma-
tion of a specialized transcription complex differ-
ent from the transcription complexes that form on
promoters of mRNA-encoding genes and compati-
ble with 3'-end formation at the 3' box. We will learn
more about this transcription complex as we iden-
tify its constituent proteins.
Biochemical and Functional
Characterization of a Protein
That Interacts with the U2
and U6 Proximal Elements
S. Lobo, N. Hernandez
The promoter regions of the U2 and the U6 genes
share at least two sequence motifs: the octamer and
U2 proximal element. These motifs may bind fac-
tors that participate in polymerase II and polymer-
ase III transcription. Using the gel-mobility shift as-
say, we detected a protein that interacts specifically
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with the U2 and the U6 proximal elements. The pre-
cise binding sites on U2 and U6 were determined by
diethyl pyrocarbonate interference and were very
similar. We are mutating the DNA-protein contact
points defined by the chemical interference analysis
to correlate loss-of-factor binding in vitro and loss-
of-promoter activity in vivo. We are also purifying
the protein for in vitro transcription studies.
Factors Binding to the 3' Box
of the Human U1 and U2 Genes
Reinagel, N. Hernandez
The 3' box of the Ul and U2 snRNA genes may con-
stitute a binding site for a 3'-end formation factor.
Because the mechanism of 3'-end formation at the
3' box is completely unknown, it is unclear whether
the 3' box is recognized as a DNA signal or an RNA
signal. It could even be recognized as a single-
stranded DNA signal, if the reaction forming the 3'
end occurred concomitantly with the passage of the
RNA polymerase. We have screened extracts and pro-
tein fractions for factors that form a complex with
a double-stranded or single-stranded DNA fragment
containing the 3' box, but not with a DNA fragment
in which the 3' box was replaced by a Sall linker. For-
mation of complexes was monitored by the gel-
mobility shift assay and by DNase I footprinting.
We have detected a factor that binds to single-
stranded DNA and footprints over the 3' box. This
factor recognizes only the RNA strand of the DNA.
We are now examining whether it also recognizes the
3' box at the RNA level.
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TRANSGENIC MICE
D. Hanahan J. Alexander V. Bautch J. Hager J. Skowronski
L. Field A. Almeida S. Efrat N. Labelle M. Steinhelper
S. Alpert S. Grant J. Moyse E. Wetzel
Research using gene transfer into the mouse germ
line to produce stable lines or families of "transgenic"
mice has continued to expand in scope both at Cold
Spring Harbor Laboratory and in the scientific com-
munity at large. The current work of the mouse
molecular genetics group described below illustrates
the breath of possible applications of this powerful
technique. Transgenic mice are being used to inves-
tigate mechanisms of tumorigenesis and of immuno-
logical tolerance, the requirements for tissue-specific
gene regulation, and the physiological consequences
of altering synthesis of hormones involved in main-
taining blood pressure and, finally, to expand cells
selectively from rare cell types and establish them
in culture.
Characterization of Skin Tumors
Induced by Bovine Papillomavirus
in Transgenic Mice
E. Wetzel, J. Skowronski, D. Hanahan [in collaboration
with M. SippolaThiele, V. Lindgren, and P. Howley,
National Cancer Institute, Bethesda, Maryland]
Bovine papillomavirus type 1 (BPV-1) is a DNA tu-
mor virus with a circular, double-stranded genome
of 8 kb. In cattle, BPV-1 infects cutaneous tissue and
induces benign fibropapillomas composed of prolif-
erative epidermal cells and dermal fibroblasts. The
viral genome replicates as an autonomous plasmid
to a high copy number in tumors. Experimental in-
troduction of viral DNA induces fibroblastic tumors
in a variety of heterologous hosts, including ham-
sters, mice, and horses. The ability of BPV-1 to repli-
cate and to morphologically transform murine cells
in vitro has allowed molecular and genetic analysis
of the viral genome, including the characterization
of regions that are involved in cellular transforma-
tion. A subgenomic fragment comprising 69% of
the genome is sufficient to induce in vitro transfor-
mation of selected murine cell lines and to maintain
viral DNA as a free plasmid. Eight open reading
frames (ORFs), designated El through E8, have been
identified within the 69% subgenomic transform-
ing segment. Two of these ORFs, called E5 and E6,
have been shown to encode proteins with oncogenic
activity.
To study papillomavirus-induced tumorigenesis,
we have constructed a transgenic mouse lineage that
harbors the BPV-I genome integrated in the mouse
germ line. The transgene, BPV-1.69, consists of a par-
tial tandem duplication of the complete viral ge-
nome. This design provides an uninterrupted copy
of the complete genome to allow transcription from
all ORFs and to facilitate possible excision and ex-
trachromosomal replication. About five copies of
the BPV-1.69 plasmid are integrated in a head-to-tail
tandem array on chromosome 15.
Transgenic mice harboring the BPV-1 genome de-
velop skin tumors that have characteristics similar
to those that arise after natural infection in cattle.
Tumors induced by BPV-1 in this transgenic lineage
do not appear until 8-9 months of age. Two classes
of pathology arise: abnormal skin and protuberant
tumors. Areas of abnormal skin, which appear first,
are characterized by balding, thickening, and harden-
ing of the skin. Histologically, these skin lesions are
characterized by hyperplasia of the dermal fibro-
blasts. The protuberant tumors, which arise approx-
imately 2 months later, are defined as fibrosarcomas,
with densely packed fibroblasts. The skin tumors are
locally invasive, as they do not have a capsule typical
of benign tumors, but apparently are not metastatic.
Abundant extrachromosomal viral DNA and
BPV-1-specific transcripts are found in abnormal skin
and protuberant tumors. In contrast, neither BPV-1
episomes nor BPV-1-specific transcripts can be
demonstrated in other tissues, including areas of nor-
mal skin. Thus, there is a complete correlation be-
tween the presence of viral episomes and transcrip-
tional activity of BPV-1 in the two types of
pathologies. The two clearly distinct pathologic
phenotypes (abnormal skin and protuberant tumors)
are indistinguishable in terms of BPV-1 extrachromo-
somal copy number and level of viral gene expres-
sion. Thus, although BPV-1 provides the animals
with a predisposition to develop skin cancer, expres-
sion of BPV-1 information does not seem to be suffi-
cient for tumor formation. Thus, cellular events are
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likely to be required for the full neoplastic transfor-
mation. To study the molecular and genetic events
occurring during the progression of the BPV-1-
induced pathology, we have established cell cultures
from the different skin lesions. Fibroblasts isolated
from the three different conditions show stable
differences in their in vitro phenotypes, which might
be representative of the stage of tumor development
from which they were removed. Fibroblasts isolated
from normal skin are flat, grow slowly, and are
contact-inhibited. Additionally, they do not form
colonies in soft agar nor do they induce tumors in
athymic or syngeneic mice. The BPV-1 genome is ap-
parently latent with respect to both expression and
extrachromosomal replication. Fibroblasts derived
from abnormal skin and fibrosarcomas are spindel-
shaped, grow rapidly, and form spontaneous, dome-
shaped foci. They also exhibit anchorage-indepen-
dent growth in soft agar and induce tumors in
athymic or syngeneic mice. Expression of the BPV-1
genome is activated in these cells in that extrachro
mosomal BPV-1 DNA and BPV-1-specific transcripts
are detectable in tissue biopsies and in all cell cul-
tures derived from abnormal pathologies.
The chromosomes of cells isolated from mice of
this lineage have been characterized in order to ex-
amine whether specific chromosomal abnormalities
are associated with tumor formation. In general, the
karyotypes of tumors and tumor cell lines are more
complex than those of abnormal skin, which are es-
sentially diploid. When the various tumor karyotypes
are compared, it is apparent that two nonrandom
changes correlate with the fibrosarcomas; namely,
abnormalities of chromosomes 8 and 14 are charac-
teristically associated with tumor formation. Chro-
mosome 8, or a portion of it, is frequently dupli-
cated (70%). Chromosome 14 is lost with similar
frequency (60%). All fibrosarcomas have one or both
of these chromosomal changes. The BPV-1 transgene
is integrated on chromosome 15; thus, the commonly
observed rearrangements of chromosomes 8 and 14
are not likely to result from rearrangements of viral
DNA.
Several known genes that are implicated in neo-
plastic transformation are located on chromosomes
8 and 14 and therefore might be important for
tumorigenesis in this model system. We are currently
investigating two of them. One candidate that maps
to chromosome 8 is the tissue plasminogen activa-
tor (tPA) gene. tPA is thought to play an important
role in cell migration, tissue remodeling, and
metastasis. However, preliminary results do not sug-
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gest any consistent correlation between tPA activity
and specific stages of tumorigenesis. The retino-
blastoma (Rb) gene, which is located on chromosome
14, is another cellular gene that might be involved
in tumor progression in this transgenic lineage. Rb
is a recessive oncogene that is thought to have anti-
oncogenic effects, such that the loss of the Rb gene
results in tumorigenicity. We are currently analyz-
ing the transcriptional activity of the Rb gene and
the levels of Rb gene product in the three different
types of fibroblastic cultures. In addition, we are be-
ginning to study expression of proto-oncogenes,
growth factors, and receptors in tissues and in cell
lines isolated from either normal skin or skin lesions.
It is our expectation that these types of approaches
will increase our understanding of the nature of tu-
mor progression and the types of molecular changes
that accompany the development of fibrosarcomas.
Proliferation, Senescence, and
Neoplastic Progression of [I Cells
in Hyperplastic Pancreatic Islets
S. Alpert, D. Hanahan [in collaboration with G. Teitelman,
Cornell University Medical College]
Tissue hyperplasia can result from the generalized
proliferation of most cells in the population (or of
a special subclass of those cells), and the hyperpla-
sia can be either preneoplastic or not. We have
characterized three different conditions of pancreatic
13-cell hyperplasia in mice. Two of these, the transient
increase in 13-cell number during pregnancy and the
localized proliferation in some islets of the mutant
ob/ob mouse, do not lead to tumor formation. The
third case, that of 0 cells expressing the SV40 large
T oncoprotein, does result in progression to neo-
plasia.
The latter condition is achieved in transgenic mice,
called RIP1-Tag2, which carry a hybrid gene com-
posed of the 5' regulatory sequences of the rat insu-
lin II gene linked to the protein-coding information
for the oncogene, SV40 large T antigen (Tag). The
islets are normal in neonatal mice and become hyper-
plastic in young adult mice, and a fraction progress
into highly vascularized 0-cell tumors in adult mice.
The contrasting cases, of transient 13-cell hyperpla-
sia and regression in pregnant mice (Green et al., J.
Endocrinol. 88: 219 [1981]) and of localized hyper-
plasia of some but not all of the islets in the ob/ob
mouse (Herberg and Coleman, Metabolism 26: 59
[1977]), appear to involve normal 13 cells responding
to external stimuli.
Our initial observations demonstrated that hyper-
plastic islets of transgenic mice contain a large num-
ber of p cells that coexpress insulin and tyrosine
hydroxylase (TH). In contrast, normal islets of adult
mice contain only a few TH-insulin cells (Teitelman
and Lee, Dev. Biol. 121: 454 [1987]). These findings
suggested that the TH-insulin cells could be islet cell
precursors that proliferate and increase in number,
thereby effecting islet growth. Alternatively, islet
hyperplasia could result from the proliferation of an-
other subclass of 13 cells, and the appearance of large
numbers of TH-insulin cells in islets might only be
a consequence of the general increase in 13 cells.
Pregnant and ob/ob mutant mice were examined
for the expression of TH by immunocytochemistry.
In both models, hyperplasia was accompanied by an
increase in the number of TH-containing cells. Vir-
tually all of the TH cells in normal and hyperplastic
islets express insulin and none of the other pancreatic
hormones. Thus, the increase in the number of TH
cells in these two systems results from an increase
in the number of (3 cells that coexpress insulin and
TH and is not due to the appearance of TH in an-
other cell type.
To determine if the rare TH-insulin cell present
in nonhyperplastic islets divides to give rise to the
larger number of these cells present in the hyperplas-
tic islets, pancreata of ob/ob and pregnant mice were
examined to determine which populations of endo-
crine cells were proliferating. Cells that contain in-
sulin did proliferate, whereas TH-containing cells did
not. Thus, although "insulin-only" cells can divide,
cells containing TH-insulin have withdrawn from the
cell cycle. Experiments conducted to determine the
fate of the TH-insulin cells revealed that these cells
disappear from the islets. Either these cells lose TH
and re-enter the cell cycle or they may be postmi-
totic cells destined to die. The possibility that the
TH-insulin cells are on a pathway toward elimina-
tion is supported by the observation that in normal
pregnancy, the number of fl cells doubles, but then
subsequently returns to the original level, which must
involve the elimination of 13 cells.
A distinct condition of 13-cell proliferation is that
of tumorigenesis under the direct influence of an on-
cogene(s) expressed in the 13 cells. One might predict
that such transformed cells would not undergo nor-
mal senescence. Since TH apparently marks 13 cells
in a pathway toward senescence and elimination, its
expression has been examined during the heritable
oncogenesis of pancreatic p cells, which occurs in
the RIP-Tag2 line of transgenic mice (Hanahan, Na-
ture 325: 155 [1985]). In agreement with previous
findings (Hanahan, Nature 325: 155 [1985]), it was
observed that the increase in islet size was due to an
increase in the number of insulin-containing cells.
The proportion of TH cells in pancreatic islets of
young transgenic mice was significantly higher than
that in controls, and it continued to increase during
postnatal development. Certain islets in young adult
mice contained a majority of cells that expressed the
enzyme. However, the pancreas of adult transgenic
mice contained many large islets that completely lack
TH cells. When sections of pancreas were processed
for immunocytochemical localization of two anti-
gens, it was found that TH cells always coexpressed
insulin. Therefore, the increase in the proportion of
TH cells during tumor progression reflects an in-
crease in the proportion of TH-insulin cells. When
experiments were conducted to determine which
populations of [3 cells were dividing, it was found
that, in contrast to normal and mutant ob/ob mice,
the TH-insulin cells and insulin-only cells do prolifer-
ate in RIP1-Tag 2 mice.
The observation that both insulin-only cells and
TH-insulin cells proliferate in islets in transgenic mice
raises the possibility that different stages of tumor
progression could be marked by the populations of
p cells that comprise the islets. Thus, pancreata from
RIP-Tag2 mice at several stages of postnatal life were
sectioned and processed to determine the mitotic rate
and the number of 13 cells that contained TH. Several
classes of islets were detected, and a change in the
distribution of islet types was noted during postna-
tal life. It is possible that as an islet becomes a tu-
mor, it undergoes a gradual progression through the
various classes until it becomes a rapidly dividing
tumor. As not all islets become tumors, the progres-
sion in islet cell types is likely to be accompanied
by an additional, relatively infrequent event, such
as the induction of angiogenesis, which converts a
rapidly proliferating islet into a tumor. Thus, TH,
an enzyme involved in catecholamine biosynthesis,
has been shown to mark a particular class of pan-
creatic f3 cells. TH is expressed in nonmitotic p cells
following periods of proliferation in what appears
to be a terminal differentiation pathway to cellular
senescence and is also expressed during transforma-
tion of [3 cells into tumor cells. The implications of
these findings are severalfold. First, TH can serve
as a marker to study the life cycle of pancreatic p
cells in vivo. Second, the possibility arises that the
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TH-insulin cells may be distinct and perhaps phys-
iologically deficient. The development of disease
states could be related, in part, to the appearance
of large numbers of this class of 13 cells. Third, in
p cells containing an oncogene, the patterns of TH
expression identify states in the preneoplastic period,
where critical secondary events may occur. Although
TH is not active in the catecholamine biosynthetic
pathway in pancreatic 13 cells, it is possible that TH
is performing some other function; perhaps, it is ac-
tively participating in the senescence pathway. Al-
ternatively, its expression may relate to the regula-
tory pattern and cellular history of the cells,
therefore providing a marker for conditions of 11 cells
that have heretofore been indistinguishable.
Hybrid Insulin Genes Reveal a
Developmental Lineage for
Pancreatic Endocrine Cells
S. Alpert, D. Hanahan [in collaboration with G. Teitelman,
Cornell University Medical College]
The mouse pancreas develops as an outpocketing
from the embryonic gut beginning on day 10 of gesta-
tion (e10) (Wessel ls and Evans, Dev. Biol. 17: 413
[1968]; Pictet and Rutter, Handb. Physiol. 7: 25
[1972]). Cells lining this evagination differentiate and
segregate into exocrine and endocrine tissues. The
endocrine cells initially appear adjacent to the na-
scent pancreatic duct and then are displaced from
the duct as the islets of Langerhans are formed (Pic-
tet and Rutter, Handb. Physiol. 7: 25 [1972]). The
hormones produced by the endocrine pancreas ap-
pear sequentially during development: Glucagon (a
cells) appears first, followed by insulin 03 cells), so-
matostatin (8 cells), and finally pancreatic poly-
peptide (PP cells) (Pictet and Rutter, Handb. Phys-
iol. 7: 25 [1972]).
We have analyzed pancreatic development in two
lines of mice, each harboring a distinct transgene
consisting of the regulatory information flanking the
rat insulin II gene linked to the sequences encoding
the SV40 large T antigen (Hanahan, Nature 325: 155
[1985]). T antigen is a nonsecreted nuclear antigen
and therefore identifies the cells where it is being syn-
thesized. During the pancreatic development of mice
harboring the insulin/T antigen hybrid gene, many
cells express the transgene product. T antigen can
be found in cells expressing any of the pancreatic
hormones at the time of onset of expression. Initially,
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T antigen is present in 100% of the cells that con-
tain insulin, TH, and glucagon. At the onset of so-
matostatin and PP expression, a significant sub-
population of the cells (36% for somatostatin and
25% for PP) contain the transgene product. As de-
velopment proceeds, the proportion of glucagon,
somatostatin, and PP cells immunoreactive for T an-
tigen decreases, whereas the number of insulin-con-
taining cells that also produce T antigen remains at
100%. T antigen is never present in cells immuno-
reactive for amylase. Thus, the information con-
tained in the transgene specifies transient expression
of T antigen in all four endocrine cell types during
prenatal development of the pancreas.
The observation that the hybrid insulin/T anti-
gen gene is coexpressed with other islet hormones
during embryogenesis motivated a similar evalua-
tion of possible coexpression of the endogenous in-
sulin genes with the other pancreatic markers in non-
transgenic mice. When sections of CD-1 mouse
pancreas were processed for the dual localization of
insulin and glucagon, cells containing both hor-
mones could be detected at all stages of embryonic
development. The number of cells that produced
both hormones decreased dramatically during post-
natal life. These results suggest that throughout nor-
mal development, insulin can be coexpressed with
glucagon. These results argue that the coexpression
of the insulin/T antigen genes with glucagon in the
same cells in transgenic mice is neither unprecedented
nor artifactual. To determine if insulin colocalizes
with other pancreatic hormones in the same cells,
e17 pancreatic sections were processed for the local-
ization of somatostatin and insulin, and pl pan-
creatic sections were processed for the localization
of insulin and PP. In both cases, significant num-
bers of cells could be found that contained both hor-
mones. Thus, during development, both T antigen
and insulin can be detected in a subpopulation of
all of the other endocrine cell types.
Classically, lineage relationships have been ana-
lyzed through the removal of cell populations by ab-
lation or microdissection, as well as by visualizing
either endogenous markers (Le Douarin, in Molecu-
lar Basis of Neural Development, John Wiley and
Sons, New York [1985]) or histological labels (see
Jacobson, Ann. Rev. Neurosci. 8: 71 [1986]). More
recent approaches have utilized retroviral integration
(see, e.g., Price et al., Proc. Nat!. Acad. Sci. 84: 156
[1987]) or cell-specific ablation using targeted expres-
sion of a toxin gene (Palmiter et al., Cell 50 435
[1987]). The experiments described here demonstrate
that cell lineages can be specifically marked by hy-
brid gene expression in transgenic mice so as to pro-
vide insight into progenitor populations and to evalu-
ate the regulation of genes during development.
Tolerance and Autoimmunity in
Transgenic Mice
S. Alpert, J. Skowronski, D. Hanahan
Transgenic mice carry a new genetic element that has
been experimentally transferred into the germ line.
Different transgenes have been found to be expressed
at different times during development, depending
both on the regulatory sequences contained in the
construct used to generate the mice and on the site
of integration of the injected gene (Palmiter and
Brinster, Ann. Rev. Genet. 20: 465 [1986]). In prin-
ciple, transgenic mice can provide a new approach
to the study of immunological tolerance and autoim-
munity, as novel transgene products can be presented
in a physiological manner, since they are part of the
genetic makeup of the animals. Recently, the ability
of mice to respond to transgenic products has been
studied at a humoral level in several lines of mice
a hybrid insulin/T antigen transgene (Hana-
han, Nature 325: 155 [1985]).
Immunohistochemical characterization of adult
animals from four lineages of transgenic mice har-
boring hybrid insulin/T antigen genes show that T
antigen is expressed in a tissue-specific manner in
the p cells of the islets of Langerhans. However, more
detailed analyses of the ontogeny of T-antigen ex-
pression has revealed that both timing of the onset
and levels of T-antigen expression vary between
different insulin/T antigen lineages. Individual mice
in a given lineage show a consistent temporal pat-
tern of expression of the transgene.
We identified two transgenic lineages with an early
onset of expression of the transgene: the RIP1-Tag2
lineage, where T antigen is easily detected in all cells
immunoreactive for insulin from embryonic day 10
(e10) of development through postnatal life, and the
RIR-Tag2 lineage, where T antigen can first be de-
tected at e10 and is present in most, if not all, p cells
from el 8 onward (Alpert et al., Cell 53: 295 [1988]).
In two other lineages, RIP1-Tag3 and RIP1-Tag4, the
onset of expression was considerably delayed when
compared to that of the endogenous insulin gene.
In these lines, immunoreactive T antigen was not de-
tectable in the fl cells prenatally, nor through the first
2-3 months of postnatal development. Rather, be-
ginning at 9-12 weeks of age, a subset of the insulin-
producing cells begin to express T antigen.
The availability of lines of transgenic mice that
reproducibly show either prenatal or delayed onset
of expression of a unique II-cell antigen presents an
opportunity to examine the relationship between this
expression and the establishment of tolerance
(Adams et al., Nature 325: 223 [1987]). When RIP1-
Tag2 (early onset of expression), RIP1-Tag3, and
RIP1-Tag4 (late onset of expression) mice were im-
munized with exogenous large T antigen protein and
analyzed for the production of a humoral response
to T antigen, it was found that the transgenic line-
ages with delayed onset of expression could mount
a readily detectable antibody response to T antigen.
RIP1-Tag2 mice exhibited a very weak response; thus,
the ability to respond to the transgenic protein is im-
paired in these mice. Quantitative assays on control,
RIP1-Tag2, and RIRITag2 mice revealed that the titer
of antibodies following immunization was two- or
threefold lower than that of controls.
It thus appears that prenatal expression of T an-
tigen has a tolerogenic effect. Second, the tolerizing
effect of the prenatal expression of the transgene is
quantitative in nature and leads to reduced, rather
than abolished, responses upon exposure to the same
antigen in adult life. The degree to which the response
is affected correlates positively with levels and du-
ration of expression of the transgenic antigen
through the prenatal period of life.
Delayed onset of expression of T antigen does not
affect the ability of RIP1-Tag3 and RIP1-Tag4 mice
to respond to large T antigen. In addition, a system-
atic survey of sera revealed that antibodies against
T antigen arise spontaneously at a high frequency.
The frequency of this autoimmune response appears
to be characteristic of the lineage. In addition to the
humoral response noted in the lineages with delayed
onset of expression, a cellular response was also
noted. The islets of Langerhans of RIP1-Tag3 and
RIP1-Tag4 mice frequently exhibited infiltration with
lymphocytes (insulinitis) and physical disruption in
the islet structure. This insulinitis is not focused on
the tumors; rather, it appears to be present in the
islets.
The observation that some but not all of the mice
with delayed onset of transgene expression develop
an autoimmune response to T antigen indicates that
the delayed presentation of the antigen is necessary,
but not sufficient, to elicit the response. The trans-
genic lineages generated with the insulin/large T an-
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tigen hybrid gene were constructed in F2 hybrids de-
rived from crossing two inbred strains of mice
(C57BL/6J and DBA/2J) and maintained by back-
crossing to C57BL/67 or by intercrossing. Thus, in-
dividual mice of the delayed-onset lineages have
different contributions of genetic information
originating from either of the parental inbred strains.
It was therefore possible that there was a genetic con-
tribution to the immune response.
When RIP1-Tag3 progeny were generated by cross-
ing transgenic males to DBA/2J or C57BL/6J fe-
males, distinct differences in the frequency and dy-
namics of the humoral response were noted in the
offspring. All of the progeny generated from the
DBA crosses developed a humoral response in the
first 6 months of life, whereas only 20% of the mice
derived from the C57BL/6J crosses responded to T
antigen during the first 8 months of life. Although
this analysis does not unambiguously define the
number and mode of action of loci responsible for
the autoimmune reaction, since the transgenic par-
ent is a mixture of DBA/2J and C57BL/6J, the pat-
tern is not inconsistent with the idea that a single
locus in the DBA/2J backround acts dominantly to
promote the autoimmune response. The actual num-
ber and identity of the immunoregulary loci that con-
trol the response to T antigen are unknown.
Transgenic mice can thus provide a new approach
to address the question as to how specific antigens
of rare cell types interact with the immune system.
This raises the prospect that a variety of immuno-
logically or pharmacologically characterized proteins
can be directed to a cell type such as the 13 cell, and
the reaction of the immune system to this antigen
can be assessed. The mechanisms by which tolerance
is established for proteins specific for rare cells can
thus be studied from the perspective of using a well-
characterized antigen, with known temporal pattern
and level of expression.
Transgenic Mice Carrying Two Viral
Genes Show an Altered Tumor
Phenotype
V. Bautch, S. Grant, D. Hanahan [in collaboration with
I. Seidman, New York University Medical School, New York]
We are studying the cooperative effects of different
oncogenes in transgenic mice. The paradigm of this
concept is found in cultured primary cells that re-
quire an immortalization function found in one
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group of oncogenes and a transformation function
found in a second group of oncogenes to become
fully transformed in culture. The polyoma early re-
gion genes are well suited to this type of analysis be-
cause polyoma large T (PyLT) antigen is an immor-
talizing gene, whereas polyoma middle T (PyMT)
antigen is a transforming gene. Polyoma small T
(PyST) antigen has no well-defined role in transfor-
mation of cultured cells. The early region of the
DNA tumor virus SV40 has one gene with both im-
mortalizing and transforming functions (SV40 large
T antigen [SV40 LT]) and another gene with no well-
defined role in transformation (SV40 small T anti-
gen [SV40 ST]). To test for cooperation among these
viral genes in mouse tissues, we targeted their expres-
sion to the insulin-producing 13 cells in the pancreas
using transgenic mice.
We generated transgenic mice carrying each of the
polyoma early region genes (as cDNAs) linked to the
rat insulin promoter. Mice carrying insPyLT devel-
oped pancreatic 13-cell tumors, but with a latency of
1 year or more. Mice carrying insPyMT or insPyST
did not develop any tumors or other abnormalities,
although these genes could be expressed. These
mice were bred with each other to generate mice
carrying two different insulin-promoted transgenes.
These combination mice carried either insPyLT and
insPyMT or insPyLT and insPyST. None of these
combination animals appear to develop 13-cell or
other tumors with kinetics different from that of the
parental insPyLT. Thus, the paradigm of cooperating
oncogenes does not appear to be operative for the
polyoma genes in [3 cells.
We have also bred the insPy mice to mice carry-
ing an insulin-promoted SV40 early region. The
insSV40 mice have been described previously, and
they develop pancreatic (3 -cell tumors that are fatal
at 14-16 weeks of age. These mice on rare occasions
also develop tumors at extrapancreatic sites that in-
clude the intestine, mesentery, and liver. Combina-
tion mice carrying insSV40 and insPyST, however,
showed a much higher frequency of extrapancreatic
tumor formation. For example, in littermates 12
weeks of age or older, insSV40 mice have a 20% (4
of 19) incidence of intestinal tumors, whereas com-
bination mice (insSV40 and insPyST) have a 100%
(20 of 20) incidence of intestinal tumors. Both classes
of mice show the same kinetics of 13-cell tumor
development. Preliminary analysis indicates that
SV40 LT, SV40 ST, and PyST are all expressed in
tumors. These results suggest that the SV40 early
region and PyST can cooperate to accelerate the de-
velopment of extrapancreatic tumors in mice carry-
ing both gene regions linked to the insulin promoter.
Our current efforts include clarification of both
the biological and the molecular aspects of this
unpredicted cooperation between two transgenes.
Because tumors at all sites have been classified as
neuroendocrine, we are investigating whether the
extrapancreatic tumors arise de novo or metastasize
from other sites. We are attempting to reproduce this
effect with different lineages of each parent. Finally,
we will determine the relative contributions of SV40
LT and SV40 ST to this phenomenon.
Oncogenesis in Polyoma
Transgenic Mice
V Bautch, J. Moyse, K. Theiler, L. Gregorio,
D. Hanahan [in collaboration with J. Hassell,
McGill University, Montreal]
We are analyzing the effects of the early region of
polyomavirus in transgenic mice. Ultimately, we
would like to understand oncogenesis in vivo and,
specifically, to relate the relatively well-understood
process of transformation of cultured cells to the
poorly understood process of tumor formation. The
polyomavirus early region genes were chosen for this
analysis because both the virus and the early gene
products have been characterized. The permissive
host for polyomavirus is the mouse, and inoculation
of newborn mice with high titers of polyomavirus
leads to the development of tumors in a variety of
tissues starting at 3 months of age. Thus, polyoma-
virus can be tumorigenic in mice, and the tumor-
forming potential of the virus resides in the early re-
gion. Three proteins are encoded by the early region:
large T (100 kD), middle T (56 kD), and small T (22
kD) antigens. Polyoma large T (PyLT) antigen can
immortalize primary cells to continuous growth in
culture, and polyoma middle T (PyMT) antigen can
morphologically transform established cultured cells,
but not primary cells. These two proteins can cooper-
ate with each other and with other oncogenes to
transform primary cells. The function of polyoma
small T antigen (PyST) in cultured cells is not well
defined.
These analyses were initiated by creating trans-
genic mice carrying different polyoma early region
genes linked to the polyoma early region promoter.
Each mouse that scored positive for polyoma se-
quences was used to establish a lineage or family of
mice with the same gene integrated in the same chro-
mosomal position. Two lineages of mice carrying
PyLT were generated, and until recently, these
animals showed no overt phenotype. Recently, one
of the two lineages has developed pituitary tumors
with a latency of greater than 1 year. These results
were unexpected because polyomavirus-infected mice
do not develop pituitary tumors. Because only one
of the two PyLT lineages develops these tumors, the
phenotype is probably modulated by the position of
transgene integration. However, these results do sug-
gest that expression of an "immortalizing" gene can
increase the probability that certain cell types will
become tumorigenic, although expression is not suf-
ficient for tumor formation.
As described in previous reports, animals carry-
ing PyMT develop fatal hemangiomas, or tumors
of the endothelial cells that line the blood vessels.
This phenotype is an intrinsic property of the trans-
gene because it is found in multiple lineages. This
year, we have completed an extensive expression anal-
ysis of the transgene. We found that MT RNA and
protein are expressed in both tumors and testes of
these mice. The MT protein in both cases is found
complexed to a cellular tyrosine kinase. In cultured
cells, this complex is thought to be necessary but not
sufficient for PyMT-mediated transformation. In
mouse testes, expression of complexed MT protein
does not appear to result in any visible or functional
abnormalities, although expression correlates with
tumor formation in endothelial cells. These results
indicate that, despite the fact that PyMT can trans-
form different types of cell lines in culture, the
deleterious effects of this oncogene are cell-type-
restricted in vivo. As demonstrated in cell culture,
a complex between PyMT and a cellular tyrosine ki-
nase appears to be necessary but not sufficient for
tumorigenesis in mice.
This year, we have also developed three lineages
of mice that carry the intact early region of poly-
omavirus, capable of expressing all three early re-
gion proteins. These mice show an expanded tumor
spectrum relative to mice carrying PyMT alone. In
addition to endothelial cell tumors, these mice de-
velop bone abnormalities and rare spindle cell sar-
comas. We are undertaking an expression analysis
to determine why these mice show an expanded tu-
mor spectrum relative to PyMT mice. One hypothe-
sis is that coexpression of LT and/or ST with MT
is necessary for tumor formation in bone cells. Be-
cause preliminary evidence suggests that the poly-
oma genes are coexpressed in the testes of these poly-
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oma transgenic mice with no deleterious effect,
cooperation between different polyoma oncogenes
to form tumors may also be cell-type-specific.
To summarize, our studies to date indicate that
some oncogenes show a cell-type specificity for tu-
mor formation in mice that is not obvious in cul-
tured cells. The cooperative effects of different on-
cogenes may also be cell-type-restricted. Finally, the
requirements for a complex between PyMT and a
cellular kinase appear to be similar in both cultured
cells and in vivo.
Targeted Oncogenesis in the Cardiac
Atria of Transgenic Mice
N. Labelle, L. Field
We have generated transgenic mice that carry fusions
between the putative transcriptional regulatory se-
quences of the atrial natriuretic factor (ANF) gene
and those encoding the SV40 large T antigen. ANF
is a peptide hormone that is intimately involved in
the maintenance of blood pressure and electrolyte
levels. The hormone is made and stored in the atria
of the heart and is secreted in response to elevated
blood-pressure levels. Once in the circulation, ANF
modulates blood volume through both acute and
chronic mechanisms. The goals of these experiments
were threefold. First, we wanted to identify the ANF
promoter sequences in an in vivo system. The sec-
ond goal was to assess the capacity of the cardiac
atria to generate tumors and to determine the patho-
logical consequences of any tumors that may arise.
Finally, if any atrial tumors were obtained, we would
attempt to establish cell lines that retain ANF ex-
pression.
The fusion gene carried 500 by of 5'-flanking ANF
sequence and was constructed such that the ANF
promoter would drive synthesis of T antigen. Eight
independent transgenic mice have been generated
that carry this construct, four of which successfully
established lineages. Immunohistochemical analyses
were performed on animals from each of the line-
ages to assess the specificity of transgene expression
in cardiac tissue. T-antigen expression was observed
in both left and right atrial muscle cells, with virtu-
ally no expression in ventricle tissue. This pattern
of expression is identical to that observed for the en-
dogenous ANF gene and is seen in all four trans-
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genic lines. Western blot tissue surveys have shown
that oncogene expression is specific for the cardiac
atria. Thus, these experiments demonstrate that 500
by of 5'-flanking sequence are sufficient to direct
tissue-specific expression of the ANF gene in vivo.
Experiments were performed to assess the patho-
logical consequences of atrial T-antigen expression.
Fusion gene expression is observed in the first week
of life. However, at this stage, no pathology is dis-
cernible by histological analyses. At 20 weeks of age,
asymmetrical atrial hyperplasia is apparent; the right
atrium has increased in mass and the left atrium re-
mains relatively normal. At 25 weeks of age, the
asymmetry is gross; the right atrium is five- to ten-
fold larger than the left atrium. Interestingly, light
and electron microscopy analyses indicate that nu-
clear abnormalities are apparent in both left and
right atria at this stage of pathology. At 30 weeks
of age, the right atrium has grown to three to five
times the size of the normal heart, which corresponds
to a 50- to 100-fold increase in size compared to non-
transgenic atria. Remarkably, the hyperplasia is re-
stricted to the right atrium: Even animals with grossly
enlarged right atria have relatively normal-sized left
atria. Thus far, this pathology has been observed in
three of the four established lines.
The asymmetrical nature of the atrial hyperpla-
sia is intriguing. Both atria express T antigen at simi-
lar levels (although oncoprotein dose is slightly
higher on the right side). Moreover, similar nuclear
abnormalities are present in both atria, indicating
that the oncoprotein is biologically active on both
sides. However, only the right atrium exhibits a
hyperplastic response. Logic dictates that this
unilateral pathology is a consequence of (1) differen-
tial expression and/or activity of a requisite progres-
sion factor(s) in left versus right atria, (2) differences
in the physiological cues or signals presented to left
versus right atria, or (3) a combination of points 1
and 2. We are currently performing experiments
aimed at distinguishing between these possibilities.
Given the asymmetrical nature of the pathology, it
would seem that these animals provide a unique
model system in which to assess the steps required
for a cell to commit to the hyperplastic state.
We have also started physiological analysis of the
ANFrag mice to determine the consequences of right
atrial hyperplasia on the blood pressure and elec-
trolyte regulatory cascade, as well as the effect on
cardiac function per se. Initial studies suggest that
mice that carry the fusion gene show somewhat
higher levels of urine production, as well as elevated
levels of circulating ANF. This observation is in-
teresting as both protein and mRNA analyses indi-
cate that ANF expression is greatly attenuated in the
hyperplastic right atrium. Animals with gross hyper-
plasia exhibit normal blood-pressure levels, in the
vicinity of 85-95 mm Hg systolic.
Electrocardiograms (ECGs) were performed in an
effort to develop a noninvasive means with which
to monitor the progression of atrial hyperplasia. This
experiment was based on the assumption that the
depolarization waves observed in ECG traces would
increase proportionally with atrial mass. Our results
indicate that ECGs can be used to monitor atrial
hyperplasia in the transgenic animals. Moreover, the
study has also shown that cardiac arrhythmias ac-
company the hyperplasia. The frequency and severity
of these arrhythmias increase with atrial mass, sug-
gesting a causative association. We are currently try-
ing to establish the source of the arrhythmias, and
we will determine if these animals can be useful for
the screening of anti-arrhythmic pharmaceuticals.
Finally, we have been trying to establish cell lines de-
rived from the right hyperplastic atria. However, our
initial attempts have met with little success. Given
that fact that the hyperplastic material has signifi-
cantly down-regulated ANF expression, it is likely
that any lines derived from this material will be of
limited value for the analysis of ANF gene ex-
pression.
Transgenic Models of
Hypertension
M. Steinhelper, P Weinberg, L. Field
Transgenic mice have been used to develop animal
models of oncogenesis by many investigators. How-
ever, transgenic systems have not been used exten-
sively to study other complex biological systems. We
are interested in studying the molecular events as-
sociated with cardiovascular homeostasis. A poten-
tially useful experimental tact involves generating
animals that aberrantly express gene products which
influence this complex regulatory system. To this
end, we are producing transgenic mice that will over-
express proteins involved in blood pressure and elec-
trolyte homeostasis. Since the transgenic lineages are
being generated and maintained in inbred back-
grounds, the only genetic difference between ex-
perimental and control mice will be the presence of
the transgene.
Overexpression of vasoactive peptide hormones
is being targeted to the peripheral circulation. The
initial studies will once again utilize the ANF gene.
Fusion genes have been constructed between the
mouse albumin (ALB) transcriptional regulatory se-
quences and those encoding the mouse ANF gene.
Orientation is such that transcripts which arise from
the fusion gene will encode ANF. Studies performed
by other investigators have shown that transgenic
mice that carry ALB growth hormone fusion genes
express and secrete the hormone from the liver. By
analogy, expression of the ALB-ANF fusion gene
should result in secretion of pro-ANF. Moreover, re-
cent studies suggest that the ALB and ANF convert-
ing enzymes are identical; if so, then the secreted
product may in fact be ANF (if not, sufficient con-
verting enzyme exists in the circulation to process
the pro-hormone). These mice should thus provide
an animal system that exhibits chronicly elevated lev-
els of ANF in the peripheral circulation. We have
recently obtained our first ALB-ANF transgenic
animals and will soon initiate the physiological
analyses.
Many of the hormones that regulate blood pres-
sure and electrolyte levels are found both in the pe-
ripheral circulation and in the cerebral spinal fluid
(CSF). However, numerous studies suggest that these
proteins do not readily cross the blood brain bar-
rier, suggesting that synthesis must occur both
peripherally and centrally. As such, it would be of
interest to discriminate between the effects of cen-
tral versus peripheral overexpression. Accordingly,
we are constructing fusion genes between the trans-
thyretin (TTR) promoter and the ANF structural
gene. TTR is expressed at high levels in the choroid
plexus and to a lesser extent in the liver and kidney.
We have recently cloned the mouse TTR gene and
will soon have the fusion gene completed and in-
jected into mice. Expression of the fusion gene in
the choroid plexus should result in secretion of ANF
into the CSF, whereas expression in the kidney and
liver will result in peripheral secretion. These animals
will be compared to ALB-ANF mice which exhibit
similar levels of peripheral ANF; any phenotypic
differences will most likely be due to central expres-
sion. Should an interesting phenotype emerge, con-
structs that express exclusively in the central nervous
system will be generated. A potential promoter for
such constructs is that from the serotonin receptor
gene.
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Insulinoma Cell Lines Derived
from Insulin/T Antigen
Transgenic Mice
S. Efrat, D. Spector, M. Delannoy, S. Grant, D. Hanahan
[in collaboration with S. Baekkeskov, S. Linde, and H. Kofod,
Hagedorn Research Laboratory, Gentofte, Denmark)
The ability to target expression of oncogenes to par-
ticular cells in transgenic mice, using cell-specific
regulatory elements, offers, in principle, a method
for immortalization of rare cell types. We have
reported that transgenic mice harboring insu-
lin/SV40 T antigen hybrid genes heritably develop
tumors in 13 cells of the endocrine pancreas. Normal
13 cells are difficult to isolate, since they comprise
only 1% of the pancreas and are dispersed in the pan-
creatic exocrine tissue, and they do not grow well in
culture. In recent years, several cell lines of trans-
formed p cells have been generated, such as RIN cells
from X-ray-induced rat insulinoma, and HIT cells,
developed by infecting hamster islets with SV40 vi-
rus. Although they have some properties of 13 cells,
these cells show various abnormalities in expression
of insulin and in regulation of insulin secretion. A
more authentic 13-cell line may be useful for studies
on regulation of the insulin genes and on 13-cell phys-
iology, as well as for isolation of molecules that regu-
late insulin gene expression and those involved in the
autoimmune response against 13 cells in diabetes.
We have established a 13-cell line from an insuli-
noma derived from an insulin/T antigen transgenic
mouse. The prci ((3 tumor cell) line maintains the
features of differentiated 13 cells after more than 60
passages in culture. The cells produce both proinsu-
lin I and II and efficiently process each into mature
insulin, in a manner comparable to that of normal
13 cells in isolated islets. Electron microscopy reveals
typical 13-type secretory granules in which insulin is
stored, as is shown in Figure 1. The levels of insulin
mRNA are much higher in 13TC 1 cells compared to
that of the HIT and RIN cell lines.
Unlike the situation with other insulinoma cell
lines, the availability of lineages of transgenic mice
that heritably develop 13-cell tumors allows for
repeated derivation of cell lines from the original tu-
mor material as necessary. So far, we have derived
13TC lines from four different tumor-bearing mice.
These results demonstrate that the use of cell-
specific control regions not only may provide unique
access to dispersed, rare cells, but may as well pres-
ent a selection for the maintenance of the differen-
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tiated phenotype of those cells in culture, given that
the hybrid oncogene providing the proliferative sig-
nal requires the differentiated condition to be ex-
pressed.
Glucagon/T Antigen
Transgenic Mice
S. Efrat, D. Hanahan [in collaboration with G. Teitelman,
M. Anwar, and D. Ruggiero, Cornell University
Medical School]
The preproglucagon gene is expressed in three cell
types: a cells of the endocrine pancreas, located in
the outer rim of the islets of Langerhans; L cells of
the intestinal mucosa; and some neurons in the brain,
particularly in a region of the brain stem. The prepro-
hormone contains, in addition to glucagon, two
glucagon-like peptides, GLP-I, and GLP-II. The pro-
teolytic processing of the preprohormone gives rise
in the pancreas primarily to glucagon and GLP-I,
both involved in maintaining serum glucose levels
and regulating carbohydrate metabolism, whereas in
the intestine, the major products are glycentin, a
larger form of glucagon, GLP-I and GLP-II. In the
brain, the processing resembles the intestinal pattern.
The regulatory region of the rat glucagon gene was
employed to direct expression of SV40 T antigen to
these cell types and to compare the effects of the on-
cogene product on different cells in the same mouse.
In the islets, this region is sufficient to direct correct
onset of expression during development and cell-
specific transformation of a cells. Immunohistochem-
ical analysis of pancreas sections with antibodies
against T antigen, glucagon, and GLP-I reveals spe-
cific expression of the transgene in a cells of mice
from four independent lineages. T antigen can be
first detected at day 10 of development, a time at
which glucagon cells normally appear. In young
transgenic mice, the pancreatic a cells are distributed
in normal numbers around the periphery of the islets.
Hyperplasia of a cells develops at about 5 months
of age. This is manifested in a broad ring of cells
coexpressing T antigen and glucagon, which are ini-
tially localized in the periphery of each islet, and later
invade the core of the islets. By 9 months of age, a
few islets (out of several hundred) have progressed
into highly vascularized, solid tumors, which are
composed of cells that continue to express glucagon,
GLP-I, and T antigen, and contain very few of the
other endocrine cells normally found in the islets.
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FIGURE 1 Electron microscopy analysis of 13TC1 cells. (A) Negative staining; (N) nucleus. Arrows indicate insulin secre-
tory granules. Magnification, 10,600 x . (8) Immunoelectron microscopy with anti-insulin serum and protein A-gold parti-
cles. Specific signal is observed over insulin granules (arrowheads). One insulin granule appears to have secreted its
content (arrow). Magnification, 80,000 x .
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A cell line has been derived from one of the glucago-
nomas, and preliminary characterization has re-
vealed qualities consistent with its identification as
immortalized a cells. The development of tumors
is followed by premature death. These stages of
progression are remarkably similar to those observed
in insulin/T antigen transgenic mice and suggest
a requirement for other events, in addition to ex-
pression of the oncogene, for the development of
neoplasia.
The enteroendocrine cells of the intestinal mucosa
that stain for GLP-I do not seem to express T anti-
gen in the transgenic mice, nor do tumors arise in
the intestine. It may be that the hybrid gene lacks
a regulatory element necessary for expression in the
intestine, a possibility that will require additional
transgenic experiments.
In contrast to the transformation of pancreatic a
cells, expression of T antigen in the central nervous
system does not induce any abnormality. T antigen
is first detected in the hindbrain at day 12 of devel-
opment, in proliferating cells of the germinal layer.
Despite continuous expression of the oncogene
through adult life, these cells follow their fate and
withdraw from the cell cycle and remain postmitotic
throughout life. [31-1]Thymidine labeling reveals that
they are also
strates that the cessation of cell division prevails over
the proliferative effects of T antigen, which has been
shown to transform almost all other cell types of
transgenic mice in which it has been expressed.
Studies on the Insulin Gene
Regulatory Region in
Transgenic Mice
S. Efrat, D. Hanahan
Hybrid genes composed of the 5'-flanking region of
the rat insulin II gene linked to the early region of
SV40 direct expression of large T antigen to the
insulin-producing 13 cells of the endocrine pancreas.
A fragment of the insulin gene extending 450 by up-
stream of the cap site, and including promoter and
enhancer elements, is sufficient to elicit cell-specific
expression in transgenic mice. A promoter element,
located 255 by upstream of the cap site on the op-
posite strand, can also direct specific expression of
large T antigen to the 13 cells, by activating transcrip-
tion in the opposite direction from the insulin-coding
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region. Bidirectional transcription is apparently an
intrinsic quality of the insulin gene regulatory region.
Deletion analyses indicate that elements of the en-
hancer region, but not the insulin promoter, are
necessary for reverse promoter activity in transgenic
mice. Expression of Tantigen in mice harboring two
of these deletions, although remaining cell-specific,
is markedly reduced, as determined by immuno-
histochemical analysis of pancreas sections with an-
tibodies directed against large T antigen. The levels
of the cellular protein p53, which is associated with
large T antigen in cells transformed by SV40, are also
reduced proportionally. The islets of Langerhans in
adult mice harboring these constructs show hyper-
plasia of 13 cells, but no tumors have been observed
in mice over 20 months of age. A possible interpre-
tation of these results is that certain minimal levels
of T antigen or p53 in the cells are necessary for the
progression of some islets into solid tumors and that
these mice express amounts that are below the thresh-
old for transformation.
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GENETICS
The Genetics group at Cold Spring Harbor Laboratory a year ago experienced a
large turnover where many of our colleagues moved to other reputed institutions.
Although it took some doing to hire new investigators, we are very happy with the
scientists who have since joined. The major exciting area is that of plant molecular
genetics. Three colleagues, V. Sundaresan, S. Briggs, and T. Peterson, all
specializing in understanding the behavior of movable genetic elements in corn,
are on board. We have also continued our studies and made major advances in
the field of cell-cycle and cell-type determination of both Saccharomyces
cerevisiae and of Schizosaccharomyces pombe yeasts. An account of some of
the work carried out by these subgroups follows.
YEAST GENETICS
A.J.S. Klar R. Cafferkey V Sharma
M. Kelly J. Wood
During the past year, we have continued our studies
on defining the molecular basis of cell-lineage de-
termination and the DNA sequences required for
switching of both Schizosaccharomyces pombe and
Saccharomyces cerevisiae. Both yeasts switch their
mating types in a nonrandom fashion. In S. cere-
visiae, the older "mother" cell produces a pair of
switched cells (designated a and a), whereas in
S. pombe, only one in four grandchildren of a cell
is switched between minus (M) and plus (P) types
(Fig. 1). In last year's Annual Report, we presented
evidence suggesting that the one-in-four rule of
S. pombe is a consequence of DNA-strand-specific
imprinting at the matl locus of the grandparent cell.
The main argument presented was that cells contain-
ing inverted duplications of the matl locus cleave
each cassette at one or the other cassette, but never
at both. DNA cleavage is required for the recombi-
nation event. From this analysis, it is predicted that
in strains containing inverted tandem duplication,
one member of each pair of granddaughter cells
should switch, i.e., two in four granddaughters
should switch. We wanted to test this genetic predic-
tion by phenotypically assaying the cell type in cell-
lineage studies. Unfortunately, this was impossible
because if we test the mating type of a cell by mat-
ing to another cell of known mating type, we essen-
tially lose that cell to zygote formation. Thus, it is
not possible to determine the phenotype of a cell in
consecutive generations.
Diploid Pedigrees Allow Test
of Both mail Loci
A.J.S. Klar, J. Wood
Diploid strains that contain both matl-P- and mall-
M-expressed cassettes are competent to undergo mei-
osis and sporulation. Thus, we can test the matl con-
tents of a cell by assaying for its capability to sporu-
late. An exciting result is that a diploid strain
containing the constitution matl/h-L allows us to
test the pattern of switching of the single chromo-
some containing the matl locus. The h-r- allele is a
fusion between matl and mat3; it provides stable ex-
pressed M information and it does not switch. By
following the ability of such cells to sporulate in a
cell-lineage study, we find that the matl allele can
switch from matl-M to matl-P again in one in four
cells (Fig. 2a). In addition, once a cell has become
competent to switch, it can produce one switched
cell and the other cell, which can again switch con-
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FIGURE 1 Comparison of the patterns of switching of budding and fission yeasts.
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FIGURE 2 Pattern and efficiency of switching of matl in
matllh-L diploid cells in a cell lineage. The switch from matl-
M to matl-P results in a cell that can sporulate (P). Mu is a cell
that is unswitchable and produces a switchable (Ms) cell and
an unswitchable (Mu) cell. Ms mostly produces a switched cell
and another Ms cell.
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tinuously in subsequent generations (Fig. 2b). As
many as eight consecutive switches were found.
Therefore, this procedure of assaying the contents
of the matl allele by assaying sporulation of the cells
will be useful for testing strains with matl dupli-
cation.
Sequence Determination of
swi3 and swil Genes and a
matl cis-Acting Mutation
R. Cafferkey, V. Sharma, A.J.S. Klar
We have previously defined the roles of the swil,
swi3, and swi7 genes, which are required for effi-
cient switching of mall. Mutants in these genes are
defective in switching because they are defective in
catalyzing a break at the matl locus. Clearly, these
gene functions are required for the above-mentioned
imprinting event and/or to form components of the
hypothesized endonuclease that cleaves the im-
printed substrate in vivo. To understand the details
of this process, we have molecularly isolated the swi3
gene. We are almost finished with the sequence de-
termination of this gene, and we have subcloned the
swil gene for sequence determination. Knowing the
sequence will allow us to make constructs for prepar-
ing large quantities of the coded protein for func-
tional analysis.
Efficient matl switching can also be reduced by
mutations present at the matl locus that act in a cis
manner to reduce the level of double-strand breaks
at matt. We have sequenced one such mutation (a
deletion of 27 bases) that deletes 7 by of the distal
homology box HI and a matl distal sequence (Fig.
3). Interestingly, the deletion affects the ability of
the chromosome to be cleaved at a site 50 by away
from the deletion.
Protection of Cut Ends In Vivo
A.J.S. Klar, R. Cafferkey, J. Wood
We found that 20 -25 We of the DNA is broken when
it is isolated from cells from any phase of the cell
cycle. These broken ends persist throughout the cell
cycle and are presumably healed in the next cell cycle,
resulting in a switch. We wondered whether the bro-
ken ends are protected from degradation in vivo and
subsequently found that both 5' ends generated are
protected from X-exonuclease digestion even in vitro
(Fig. 4). One of the 3' ends is protected and the other
is sensitive to 3'-end-specific exonuclease III diges-
tion. Even more interesting is the result that the
exonuclease-III-sensitive strand has an exonuclease
G -
A -
T -
C -
digestion block about 150-200 bases away from the
3' end. Whether the block constitutes the imprinted
event is the major question to address in the near
future.
The Mother-Daughter Mating-type
Switching Asymmetry of Budding Yeast
Is Not Conferred by the Segregation
of Parental HO Gene DNA Strands
A.J.S. Klar
The fundamental issue to address in developmental
biology is to determine why a given cell division
generates two developmentally unequivalent daugh-
ter cells. As shown in Figure 1 in S. cerevisiae, only
the mother cell switches, whereas the newly born bud
cell never does. It is known that the mother cell ex-
presses the HO gene (which encodes the site-specific
endonuclease) required for initiating recombination,
whereas in the daughter cell, it is transcriptionally
unexpressed. In light of the discussion on S. pombe,
we may imagine that the HO gene is expressed in
a mother cell because the DNA strand containing
the transcriptionally competent gene is segregated
ti
TTTGTTTTCTCTCGTTCGTGTCATTCATTCTCCC C13-P11
allele
TTCCATG'TTTCCAATTATGCTGTTCGT wild type
mol /
H2 + HI
FIGURE 3 C13-P11 is a 27-bp deletion mutation, ,',50 by away from the cut site.
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to the mother cell; the incompetent chromatid is
segregated to the daughter cell. A critical test of the
strand-segregation model is that the daughter cells
should switch in those strains containing an inverted
HO gene, whereas the mother cells should not. We
find that in such a strain, only mothers switch. There-
fore, this simple test rules out the strand-segregation
model for HO gene expression.
X Exo Exam
matt
d id 2d 3d 11d 5' 10' 20' 0' 5' e 20'
10.4 kb - ON OD elb qp 1p
5.4 kb -
5.0 kb -
Puc -
- 5.3kb
Smt breakHind III Hindi!'
5.4 >I<-50
Exolll block XExo block
200bp
5'
3.
67'..'XExo block
FIGURE 4 Protection of double-stranded DNA cut ends at matt in vitro to digestion
with X.-exonuclease and exonuclease Ill. The total yeast DNA is treated with the indi-
cated enzyme for varying lengths of time. Then, after the nucleolytic activity is removed,
the DNA is digested with HindIll, run on agarose gels, transferred to a nitrocellulose
filter, and probed with mall sequences. The 10.4-kb fragment results from an intact
mat/-containing fragment, whereas the 5.4-kb and 5.0-kb fragments result from a break
at the matt locus. P and M indicate whether the DNA is derived from the matt -P
or matt -M strain. Puc indicates HindlIl -cut pUC118 plasmid fragment added in each
reaction. The interpretation of the result is diagramed at the bottom.
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Isolates of Schizosaccharomyces
kompucha
A.J.S. Klar, J. Wood
kompucha is regarded as a "divine fungus" of
heavenly origin and has been used since its introduc-
tion by the Chinese emperors of the Tsin dynasty in
the 3rd century B.C. It is used to make a fermented
drink called "Tshe" from sugar and tea, which is
claimed to provide a remedy against aging, improved
health and strength, and revitalization of the whole
body. Mr. Joseph Licata, a curious neighbor of Cold
Spring Harbor Laboratory, brought this culture to
our attention when he inquired about its contents.
We noted that it is composed primarily of one kind
of rod-shaped bacteria and primarily one kind of
fungus. The fungus is fission yeast!
Among ten isolates tested, six are homothallic,
since they switch mating type, and the rest seem to
be heterothallic. At least one of the latter class is
capable of mating with the laboratory strains of
S. pombe. Comparison of the HindIII digestion pat-
tern of mDNA of the laboratory stock with that of
the kompucha yeast shows that four fragments are
of identical size and the other four differ (Fig. 5).
The similarity clearly shows that the new yeast is re-
lated to S. pombe. The restriction site polymorphism
has also been found at matl and mat2 but not at
mat3. The polymorphism should be useful for fu-
ture studies should this yeast successfully cross with
the laboratory stocks. Nevertheless, the existence of
fission yeast in the culture suggests that the wonder-
ful health-related effects of the Tshe drink could pos-
sibly be ascribed to alcohol.
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CELL-CYCLE CONTROL IN YEAST AND VERTEBRATES
D. Beach G. Draetta L. Brizuela M. Stein
M. McLeod L. Molz S. Dembski
R. Booher
Our research has continued to focus on the mecha-
nism of regulation of the eukaryotic cell cycle. As
in previous years, we have made use of the fission
yeast for genetic investigations, but we have now con-
siderably expanded our work on the molecular ba-
sis of cell-cycle control in mammalian cells. We have
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also initiated one entirely new research project, in
collaboration with the laboratory of Dr. John New-
port (University of California, San Diego), to test
the possibility that elements of the mitotic control
pathway in Schizosaccharomyces pombe might be
the so-called maturation promoting factor identified
in Xenopus. During the past year, we have been
joined by two visiting scientists, Dr. Jeremy Hyams
(University College, London) and Dr. Paul Young
(Queens University, Ontario).
Cell Cycle of Fission Yeast
G. Draetta, R. Booher, L. Brizuela,
L. Molz, D. Beach
The cdc2* gene product plays a unique role in the
regulation of the cell cycle of Schizosaccharomyces
pombe. This protein kinase is required for traverse
of both the G, /S and the G2/M boundaries. Our
major objective is to identify those genes and their
protein products that regulate cdc2* and that act as
the critical substrates of the protein kinase in G,
and 02.
During the past year, we have been able to iden-
tify a protein, the product of the sucP gene, that
forms a complex with the cdc2* gene product. sucl*
was initially identified as a plasmid-borne gene that
could rescue certain temperature-sensitive alleles of
cdc2. p13"" was expressed in Escherichia coli, and
antibodies raised against the protein purified from
this source recognized the yeast protein. We were able
to show that p13"" is not a substrate of the cdc2*
protein kinase either in vitro or in vivo, but neverthe-
less forms a stable complex with p34ea'. This com-
plex has cdc2 * -dependent protein kinase activity that
is lost as cells enter the stationary phase under ad-
verse nutritional conditions. At present, the precise
role of p13"" is unclear, but it is known to be es-
sential for cell-cycle progression and may act to al-
low the cdc2* protein kinase to interact with its sub-
strates.
Since cdc2* is required for the initiation of both
DNA replication and mitosis, there is considerable
interest in establishing whether the protein kinase
phosphorylates an identical set of substrates in 0,
and 02 or whether its GI and G2 roles can be
differentiated. At present, no physiologically rele-
vant substrates of the cdc2* protein kinase have been
biochemically identified. A genetic analysis of rever-
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tants of temperature-sensitive cdc2 mutants has given
us the first indication that the G, and 02 roles of
cdc2* can be discriminated. A cold-sensitive allele
of cdc2* was rescued by a compensating mutation
in cdc13 *, a gene that been had previously thought
not to interact with cdc2*. This result is of particu-
lar interest because cdc13* is required for the ini-
tiation of mitosis. cdc13 mutants arrest with con-
densed chromosomes analogous to the metaphase
state of higher eukaryotic cells. A variety of genetic
evidence leads us to believe that the cdc13* gene prod-
uct is a G2-specific substrate of the cdc2* protein ki-
nase. We have recently isolated the cdc13* gene, ex-
pressed its 55-kD product in E. coli, and are currently
testing by direct biochemical experiment whether this
protein is indeed a substrate of cdc2.
In addition to sucP and cdc13 *, we have identi-
fied other genes that interact with cdc2* in either GI
or 02. Use has been made of the observation that
a certain dominant allele of cdc2 (cdc2-3w) is lethal
in combination with a loss-of-function weel muta-
tion. This phenomenon is not well understood but
has been termed mitotic catastrophe. We have iso-
lated mutants that suppress the mitotic catastrophe
lethality. They define six new genes (mitotic catas-
trophe suppressor, mcs 1 through 6). Among these,
two appear to interact very closely with cdc2* and
might encode substrates. The others appear to in-
teract more closely with the weel* protein kinase.
These possibilities will be further elaborated by iso-
lation of the relevant mcs genes.
Mammalian Cell-cycle Control
G. Draetta, L. Brizuela, D. Beach
During the course of our studies with the cdc2* gene
product, we prepared both poly- and monospecific
antibodies against the protein. Two monoclonal anti-
bodies were obtained that recognized not only
p34cda, but also p36"c28 of Saccharomyces cerevis-
iae. These antibodies were also able to immunopre-
cipitate a 34-kD protein from He La cells. Peptide
mapping revealed a remarkable degree of evolution-
ary conservation between the yeast and human pro-
teins. Human p34 was also shown to be complexed
with a homolog of p13"". We have continued to
study mammalian p34. The tissue distribution of the
protein in rat organs was first determined. In general,
p34 was more abundant in tissues that contain a sub-
stantial fraction of proliferating cells, with the no-
table exception of the brain. Brain tissue has high
levels of p34. This leads us to suppose that mam-
malian p34 plays some role in nonproliferative cells.
One organ that contains very low levels of p34 is
the kidney. In collaboration with E. Moran (Tumor
Viruses Section), we tested whether kidney cells in-
duced to divide by infection with adenovirus ex-
pressed higher levels of p34 and found that this was
indeed the case. Adenovirus infection induced rapid
synthesis of p34, and the protein accumulated at a
higher level than in uninfected cells.
As a more direct test of the role of p34 in the cell
cycle, we have tested whether the activity of the pro-
tein kinase varies during the cell cycle. We found that
p34 phosphorylates a protein of 62 kD that is co-
immunoprecipitated with p34. In He La cells syn-
chronized at various cell-cycle phases by elutriation
centrifugation, p62 phosphorylation was barely de-
tectable in G, but rose dramatically during G2/M.
p34 also phosphorylated an artificial substrate
(casein) much more actively in G2 than in G,. We
further found that p34 itself was more highly phos-
phorylated at this stage of the cell cycle (Fig. 1). These
observations are provocative and suggest that the hu-
man p34 protein kinase may play a role in the regu-
lation of mitosis.
Relationship between p34 and MPF
L. Brizuela, D. Beach [in collaboration with W. Dunphy
and J. Newport, University of California, San Diego]
For many years, it has been known that the cytoplasm
of fertilized Xenopus eggs is able to induce meiotic
maturation upon injection in oocytes. The activity
responsible for this effect has been termed
maturation-promoting activity (MPF). It is now
known to be a mitosis-inducing factor. Many prop-
erties of MPF are known, but it has proved very dif-
ficult to purify the factor. We were interested in de-
termining whether p34 might be a component of
MPF.
Since p34'4'2 is complexed with p13" in yeast
and the same complex can be found human cells,
we assumed the same situation would prevail in
Xenopus. Since native p13 protein had previously
been purified from E. coli, we tested whether this
polypeptide might interfere with MPF activity. We
found that microinjection of p13 into oocytes, in con-
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FIGURE 1 Cell-cycle regulation of p34 protein kinase. (A) Flow-
cytometric profiles of HeLa cells separated by elutriation; (B) per-
centage of cells in G1 (circles), S phase (triangles), and G2
(squares) in each elutriated fraction; (C) immunoblot of each elutri-
ation fraction probed with anti-p34 serum; (D) incorporation of
32PO4 into p34; (E) association between p34 and p62 during the
cell cycle; (F) protein kinase activity of p34 with respect to p62
and casein substrates during the cell cycle.
junction with MPF, abolished the activity of the lat-
ter. This effect was also apparent in an in vitro assay
of MPF. Furthermore, it was discovered that a p13
affinity column totally retained MPF activity and
that p34 was one of the components of the initial
cellular extract that bound to the column. These ex-
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FIGURE 2 Inhibition of p52rani by p21'nei3. (A) Lysate of fission yeast was im-
munoprecipitated with anti-p52 serum. Prior to addition of ATP to the kinase reaction,
either no material (lane 1), 0.5 1.1g of bacterial lysate containing p21me13 (lane 2), or 0.5
1.1g of bacterial lysate without p21"l3 was added to the immunocomplexes. (8) Sedimen-
tation of purified p21"'°13 analyzed by SDS-PAGE (top) and p52tani protein kinase inhibi-
tory activity (bottom) through a glycerol gradient. The numbers marked by arrows indi-
cate the position of molecular-weight markers in the gradient.
periments do not prove that p34 is MPF, but they
indicate that the p34-p13 complex is probably at least
a component of the activity. These studies will be
pursued further, particularly making use of sub-
strates of p34 that are formally identified in
Schizosaccharomyces pombe.
Meiotic Control in Fission Yeast
M. McLeod, D. Beach
For the last 5 years, we have been using fission yeast
as a model system in which to investigate the molecu-
lar basis of the transition from mitosis to meiosis.
The last year has seen considerable progress with the
first biochemical studies of the rant* protein kinase.
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In S. pombe, meiosis is ultimately regulated by the
genes of the mating-type locus. Only kik- diploids
that express all four mating-type genes are meioti-
cally competent. The primary meiotic role of the mat
genes is to induce transcription of mei3 *. Expression
of this gene alone in a vegetative cell is sufficient
to cause the full transition from mitotic division to
meiosis. We have proposed previously that the role
of the mei3* gene product might be to inhibit rant *.
The rant* gene acts as a critical negative regulator
of meiosis. Temperature-sensitive rani mutants un-
dergo haploid meiosis and sporulation at the restric-
tive temperature.
We have isolated both the rant' and mei3+ genes
and have raised antibodies against their protein prod-
ucts. p52mn' was predicted by homology to be a pro-
tein kinase and this turns out to be the case. p52""'
displayed autophosphorylation activity in vitro.
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FIGURE 3 Model of meiotic control in fission yeast. (Mitotic cell) During vegetative growth of either haploid
or diploid cells, the mat-Pc and Mc genes are weakly expressed, but Pi and Mi are not. Consequently, mei3'
is not expressed. ranl` is expressed constitutively and encodes a 52-kD protein kinase. This is presumed to phos-
phorylate (heavy arrows) hypothetical substrates, S1, S2, and S3, which promote vegetative growth and inhibit
meiosis. (Meiotic cell) In an h' /h- diploid, under nitrogen starvation conditions, each mat gene is induced and
is presumed to be translated into proteins of the indicated molecular weights. The mat gene products induce
transcription of mei3t. The 21-kD mei3` gene product binds to the p52rani protein kinase and inactivates it. This
leads to dephosphorylation of S1, S2, and S3 and thus to meiotic initiation.
In vegetative cells, p21"''' is not expressed, but in
meiotic cells, this protein is expressed and was found
to be complexed with rani' protein kinase. The pro-
tein kinase was strongly inhibited in the complex,
suggesting that the role of p21"' might indeed be
to inactivate rant'. This was tested further by purify-
ing p21nned from E. coli and adding this material to
a rani' protein kinase assay. We were able to show
that p21'ne'' is a direct inhibitor of the rani"- protein
kinase (Fig. 2). These results led to the following
model for meiotic initiation (summarized in Fig. 3).
In an le h- diploid cell, nutritional starvation causes
transcriptional induction of each of the four genes.
These in turn induce transcription of the meir gene.
The product of meir acts to inhibit directly the ac-
tivity of the rant' protein kinase by direct protein-
protein binding. The major objective of future
studies will be to identify substrates of the rani' pro-
tein kinase and thus to understand how it acts as the
critical negative regulator of meiosis.
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PRE-mRNA SPLICING IN SCHIZOSACCHAROMYCES POMBE
D. Frendewey J. Potashkin R. Li
A. Serrano C. Leptac
This past year, we began our investigation of the
mechanism of splicing of messenger RNA precur-
sors (pre-mRNAs) in the fission yeast Schizosac-
charomyces pombe. In eukaryotes, many, if not
most, of the protein-coding genes are interrupted by
intervening sequences (introns). The removal of these
introns from the primary transcripts by the process
of splicing is therefore essential for the expression
of a large portion of the nuclear genome. This also
applies to the simple eukaryotes such as yeast.
The splicing of mRNA precursors occurs in the
nucleus by the concerted action of a number of small
nuclear ribonucleoprotein particles (snRNPs) and
other proteins that associate with the pre-mRNA in
a large complex known as the spliceosome. The nu-
cleic acid components of the snRNPs constitute a
family of distinctly sized small RNAs. The sizes of
these snRNAs in S. pombe are very similar to those
in the higher eukaryotes. This is not the case, for ex-
ample, in the budding yeast Saccharomyces cere-
visiae. As more genes are cloned and sequenced in
S. pombe, it is beginning to appear that the majority
of the protein-coding genes possess introns. S. pombe
shows no bias for the types of genes that contain in-
trons or the position of the introns within the genes,
and several examples of genes interrupted by mul-
tiple introns are known. This pattern is similar to
that observed in higher eukaryotic genomes. In
S. cerevisiae, on the other hand, introns are found
primarily in the genes for the ribosomal proteins and
are located near the extreme 5' ends of the pre-
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mRNAs. Only one example of multiple introns has
been described. These observations, as well as the
genetically well-characterized simple genome of
S. pombe, led us to choose this yeast as our experi-
mental system for the study of pre-mRNA splicing.
Isolation of Pre-mRNA Splicing
Mutants from S. Pombe
J. Potashkin, R. Li, D. Frendewey
One of the goals of our research is to identify genes
that are involved in pre-mRNA splicing. Historically,
this has been accomplished by isolating and charac-
terizing mutants that are defective in pre-mRNA
splicing. Our approach has been similar. First, we
have produced a collection of mutants that grow
poorly at an elevated temperature. We have then
screened these temperature-sensitive (ts) mutants for
defects in pre-mRNA splicing.
To create the initial ts bank, we exposed a wild-
type strain of S. pombe to the chemical mutagens
ethylmethanesulfonate and nitrosoguanidine. Sur-
vivors of the mutagenesis were grown at the permis-
sive temperature (23°C) and then replica-plated at
23°C and the nonpermissive temperature (37°C).
Those colonies that grew very poorly or not at all
at 37°C were picked from the 23°C plate. After con-
firmation of the ts phenotype, the mutants were in-
cluded in our ts bank. By using this procedure, we
have collected 350 mutants that exhibit growth defi-
ciencies at 37°C.
We have worked out a method that allows us to
screen the ts bank for mutants defective in pre-
mRNA splicing by a Northern blot assay. The pro-
cedure consists of preparing whole-cell RNA from
the ts mutants after a shift from growth at 23°C to
37°C, fractionating the RNA on formaldehyde
agarose gels, blotting the RNA onto nylon mem-
branes, and probing the blots with an oligodeoxy-
nucleotide (oligo) that is complementary to a par-
ticular intron. The rationale for the screen is based
on the assumption that a pre-mRNA splicing mu-
tant will accumulate precursors and that these can
be detected by the intron-specific probe. Thus, a posi-
tive signal on the Northern blot is indicative of a
splicing defect. For the screen to work optimally, two
conditions must be met: (1) an mRNA must be cho-
sen that is sufficiently abundant to be detectable and
(2) the steady-state level of pre-mRNA in a wild-type
culture at 37°C must be too low to be detectable.
As our target RNA, we chose the mRNA for the
S. pombe D-tubulin. This transcript is relatively
abundant, and the pre-mRNA has five small introns
whose combined length is approximately 300 nucleo-
tides. Since introns in S. pombe are rather small (usu-
ally <100 nucleotides), the difference between the
sizes of the pre-mRNA and mature mRNA for a
single-intron pre-mRNA would be difficult to resolve
on an agarose gel. The 300-nucleotide difference for
13-tubulin, however, is large enough to detect. Al-
though the ability to resolve the pre-mRNA and
mRNA is not essential to the screen, it confirms our
interpretation of the results. We designed two oligo
probes. One is complementary to a 30-nucleotide
stretch of intron 4 of D-tubulin and is specific for
the pre-mRNA. The other is complementary to 15
nucleotides of exon 4 and 15 nucleotides of exon 5
that are contiguous and span the splice junction be-
tween these two exons in the mRNA. This exon oligo
is specific for spliced mRNA under sufficiently strin-
gent hybridization conditions. In preliminary experi-
ments, we used the exon oligo to demonstrate that
we could detect ft-tubulin mRNA in total RNA from
wild-type cells. The intron oligo gave no hybridiza-
tion signal on the same RNA. Thus, the two condi-
tions stated above, which are necessary for the screen
to work, were satisfied.
The initial screen of the first 100 ts mutants with
the intron oligo probe identified three mutants that
accumulated pre-mRNA at the nonpermissive tem-
perature: ts32, ts46, and ts50. These three were sub-
sequently confirmed by repeated blotting and prob-
ing. In addition, the same blots were stripped of the
intron oligo and then reprobed with the exon oligo.
This probe produced a positive signal in all the ts
mutants except ts32, ts46, and ts50, indicating that
the accumulation of pre-mRNA in the three was due
to an essentially complete block in splicing. Repeated
analysis has indicated that ts46 is slightly leaky; a
small amount of mRNA is detected at 37°C.
To investigate the temperature sensitivity of the
pre-mRNA splicing defects, RNA was prepared from
these strains grown at the permissive temperature and
compared to RNA from cells that had been shifted
to 37°C for 1 and 2 hours. Use of both the exon and
intron probes revealed that normal levels of mRNA
were produced at 23°C and no pre-mRNA was de-
tected, whereas the loss of the mRNA signal was es-
sentially complete by 1 hour at 37°C and was ac-
companied by an accumulation of pre-mRNA. The
kinetics of pre-mRNA accumulation differed slightly
among the three splicing mutants. The results of the
Northern analysis reflect directly on the splicing of
only intron 4 of 11-tubulin. However, the size of the
pre-mRNA that is present at 37°C appears to be
identical in all three splicing mutants, and the differ-
ence between this size and that of the mRNA seen
at 23°C suggests that the splicing of all five introns
of 13-tubulin is blocked in ts32, ts46, and ts50.
To further characterize the molecular phenotype
of the splicing mutants, we showed that the pre-
mRNA produced by all three mutants at 37°C could
be selected on an oligo(dT)-cellulose column. This
result indicates that the block in splicing in the mu-
tants is not associated with or due to a lack of poly-
adenylation. Thus, in S. pombe, as in mammals,
polyadenylation can occur on an unspliced pre-
mRNA. We do not know from this experiment if
polyadenylation has occurred at the correct site. A
similar analysis with a probe for the alcohol de-
hydrogenase mRNA showed that neither the size of
the mRNA nor its ability to be selected on oligo(dT)-
cellulose was affected by a growth shift from 23°C
to 37°C in ts32, ts46, and ts50. To test whether the
splicing defect was specific for pre-mRNA, we
probed RNA from ts32, ts46, and ts50 grown at 37°C
with an oligo specific for the intron of a S. pombe
pre-tRNAser (a gift from I. Willis, Yale). An ac-
cumulation of tRNA precursors was not evident in
the pre-mRNA splicing mutants. Finally, since Ul
and U2 RNAs are required for pre-mRNA splicing,
we checked the mutants for decreased levels of these
snRNAs using probes derived from human se-
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quences but which hybridize to the S. pombe Ul and
U2 RNA homologs. The Ul and U2 RNA concen-
trations appeared to be normal in all three mutants
at the nonpermissive temperature.
In all of our molecular analyses, we have studied
the block in pre-mRNA splicing by following one
intron in the 13-tubulin pre-mRNA. An important
question that remained unresolved concerned the
generality of the splicing defect. Although it is highly
unlikely that all three splicing mutants are specific
for P-tubulin, we had not eliminated the possibility
that one was due to a mutation that affects the splic-
ing of only the 13-tubulin pre-mRNA or only intron
4 of I3-tubulin. To address this point, we have assayed
the splicing of another pre-mRNA, that for al-
tubulin, by an RNase protection procedure. These
experiments confirmed the Northern blot results.
The al-tubulin pre-mRNA accumulated at the non-
permissive temperature in all three splicing mutants,
and the patterns of inhibition were identical to those
observed for 13-tubulin.
To summarize the molecular analyses, ts32, ts46,
and ts50 possess temperature-sensitive lesions that
lead to a block in splicing at 37°C. The defects are
specific for the splicing of mRNA precursors and
are not caused by a loss of polyadenylation or re-
duced levels of Ul or U2 RNA.
The three pre-mRNA splicing mutants have also
been characterized genetically. Each mutant was
backcrossed to a wild-type strain at least two times.
The resultant diploids were sporulated, and tetrad
analysis showed that all three mutants exhibited 2:2
segregation of both the ts growth and the splicing-
defect phenotypes. Therefore, for each mutant, the
ts phenotype almost certainly results from a lesion
in a single gene, and this gene is required for pre-
mRNA splicing. Diploid progeny from crosses with
the wild-type strain were not temperature-sensitive
for growth at 37°C and did not exhibit accumula-
tion of pre-mRNA, demonstrating that the muta-
tions are recessive. The mutants were also crossed
with each other. The result of these crosses was that
each of the mutants could complement the others
for the ts growth phenotype. Thus, ts32, ts46, and
ts50 fall into three separate complementation groups.
We have designated the three pre-mRNA splicing
mutants ma 1, ma 2, and ma 3.
Further characterization of the pre-mRNA splic-
ing mutants is in progress. The ultimate genetic anal-
ysis of the mutants is to clone and sequence the af-
fected genes. We have already crossed the mutants
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into a genetic background that will allow us to trans-
form them with an S. pombe genomic library in an
attempt to clone the ma genes by functional com-
plementation of the ts phenotype.
A Possible U2 RNA Mutant
J. Potashkin, A. Serrano, R. Li, D. Frendewey
As mentioned in the previous section, part of the
analysis of the pre-mRNA splicing mutants consisted
of determining if they were defective in the synthe-
sis of U2 RNA. We did this by probing the blots con-
taining RNAs from the first 70 temperature-sensitive
mutants with an oligo complementary to U2 RNA.
Nearly all of the RNAs, including the three splicing
mutants ts32, ts46, and ts50, appeared to have nor-
mal levels of U2 RNA. The U2 signal for one of the
mutants, ts45, was quantitatively and qualitatively
different. The level of U2 RNA in ts45 appeared to
be reduced compared to the other samples, and a
new RNA of approximately 400 nucleotides in length
was detected. U2 RNA is 180 nucleotides in S. pombe.
To confirm that the U2 RNA pattern exhibited by
ts45 was abnormal, we fractionated equal amounts
of the same ts45 RNA and RNA from wild-type cells
grown at 30°C (the normal growth temperature) on
a polyacrylamide gel. These RNAs were then blot-
ted and probed with the U2-specific oligo. Again,
the amount of U2 RNA in ts45 was reduced com-
pared to that of the wild type, and the 400-nucleotide
signal was seen only in the ts45 sample.
The RNA used for the initial analyses was pre-
pared from the ts45 after a 2-hour shift to 37°C. To
investigate the temperature dependence of the
molecular phenotype in ts45, we prepared RNA from
the mutant grown to mid-log stage at 23°C and af-
ter a shift to 37°C for various times out to 7 hours.
After polyacrylamide gel electrophoresis and North-
ern blotting, the RNAs were probed with the U2
RNA oligo. This analysis showed that the U2 RNA
levels at 23°C and 37°C were identical and remained
unchanged out to 7 hours after shift-up to the non-
permissive temperature. On the other hand, the 400 -
nucleotide RNA was present only at 37°C, increas-
ing up to 3 hours and then leveling off. In addition,
a new RNA of approximately 110 nucleotides was
seen whose signal was faint at 23°C and increased
steadily during the 37°C incubation. A parallel ex-
periment was performed with wild-type cells. In this
case, neither the 400- nor the 110-nucleotide RNA
was observed regardless of the temperature. Com-
parison of the two experiments indicated a two- to
fivefold lower level of mature-size U2 RNA in ts45
versus the wild type. Subsequent analysis of the same
RNAs showed that Ul RNA and mRNA levels were
normal in ts45 even after extended incubation at
37°C, and there was no accumulation of pre-mRNA.
At this point, the molecular phenotype of ts45 can
be described as follows. The mutant exhibits a slight
decrease in the steady-state levels of U2 RNA that
is independent of a shift in growth temperature from
23°C to 37°C. This decrease in U2 RNA is insuffi-
cient to affect pre-mRNA splicing. At 37°C, two new
RNAs appear that are related to U2 RNA in that
they hybridize to a U2-specific probe. These RNAs
are approximately 400 and 110 nucleotides in length.
We are currently trying to determine the nature of
these RNAs. We have also initiated a genetic analy-
sis of ts45 to determine whether a single mutation
is responsible for the molecular phenotype and
whether the U2 RNA defect segregates with the weak
is growth phenotype exhibited by ts45.
Biochemical Characterization of
S. Pombe Pre-mRNA Splicing
Components
C. Leptac, A. Serrano, D. Frendewey [in collaboration
with A. Krainer, Cold Spring Harbor Laboratory]
Another aspect of our work has been an attempt to
characterize pre-mRNA splicing in S. pombe bi-
ochemically. The direct approach to this problem is,
of course, to study splicing in vitro. However, after
trying several different types of extracts and a vari-
ety of pre-mRNA substrates and conditions, we have
not been successful in obtaining in vitro splicing in
extracts derived from S. pombe. We will continue
to devote considerable efforts along these lines be-
cause of the significant value of an in vitro system.
In the meantime, we have taken an alternative in-
direct approach by investigating the relatedness be-
tween the S. pombe and the well-characterized HeLa
cell pre-mRNA splicing systems. We tested the abil-
ity of S. pombe introns to be spliced by a HeLa cell
in-vitro-splicing extract (a gift from A. Krainer).
Eight introns from four different S. pombe genes
were tested. None of the introns spliced correctly in
the HeLa extract. Only intron 5 of the13-tubulin gene
spliced at all, but aberrantly. Its 5' splice site was used,
but a cryptic 3' splice site and branchpoint down-
stream from the S. pombe sites were chosen.
The splicing of the S. pombef)-tubulin substrate
in the HeLa extract suggested an experiment. Could
we force the HeLa system to choose the S. pombe
3' splice site by supplying it with S. pombe compo-
nents and thereby identify an S. pombe factor in-
volved in 3' splice-site selection? The f3-tubulin pre-
mRNA is inefficiently spliced in the HeLa extract.
When reduced amounts of extract are used for the
splicing reaction, no splicing of the 13-tubulin sub-
strate is detected. Under these conditions, if the HeLa
extract is reconstituted with a S. pombe whole-cell
extract, splicing of the (3-tubulin pre-mRNA is re-
stored. The S. pombe extract does not splice the 13-
tubulin pre-mRNA on its own. The restored splic-
ing in the mixing experiment appears to be the same
as that in the complete HeLa reaction; i.e., the aber-
rant 3' splice site is chosen. Although this experiment
failed to identify an S. pombe 3' splice-site selection
factor, it suggests that such a reconstitution assay
may prove useful for investigating components in-
volved in pre-mRNA splicing in S. pombe.
We have also compared the S. pombe snRNPs with
their human counterparts. In collaboration with A.
Krainer, we have enriched the S. pombe snRNPs
from a whole-cell extract by immunoaffinity chro-
matography with an anti-M3G monoclonal anti-
body. This antibody recognizes the trimethylated
guanosine "caps" on the 5' ends of the snRNAs. The
purified S. pombe snRNPs contain four or five small
RNAs that are similar in size to the human snRNAs.
Analysis of the proteins in the purified snRNPs by
SDS-PAGE and silver staining revealed a simple pat-
tern of 12-15 polypeptides. Only one of these was
identical in size to a human snRNP protein, that be-
ing the D protein found in all human snRNPs. The
anti-M3G antibody should be very helpful in the
further characterization of the S. pombe snRNAs
and snRNPs.
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Molecular Genetics of Robertson's
Mutator
R. Morfeld, M. Papazian, J. Sorrentino, V. Sundaresan
Robertson's mutator is a transposable element sys-
tem in maize identified by D. Robertson in 1978
(Mutat. Res., 51: 21 [1978]). Mutator (Mu) lines of
maize generate new recessive mutations at high fre-
quencies; these mutations are caused by insertional
inactivation of genes by transposable elements
known as Mu transposons. The Mu transposons con-
sist of three types of elements, Mul, Mul.7, and Mu3;
they are characterized by common 200-bp-terminal
inverted repeats flanking a variable internal se-
quence. We have been studying the mechanism and
regulation of transposition of the Mu transposable
elements.
MECHANISM OF MU TRANSPOSITION
To understand the mechanism of Mu transposition,
we have been studying DNA molecules that might
correspond to intermediates or products of trans-
position. An extrachromosomal form of the Mu
transposons has been identified (Sundaresan and
Freeling, Proc. Natl. Acad. Sci. 84: 4924 [1987]). This
is a circular supercoiled DNA molecule that can be
isolated from Mu plants and that corresponds to a
circularized form of the transposon that is free from
the host DNA. The extrachromosomal Mu is not
abundant; it is present at less than 1 copy/cell and
its presence correlates with the timing of Mu activ-
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ity in the plant. We have cloned some of the extra-
chromosomal circular Mu elements in order to char-
acterize them in detail. In the process, we have found
that some of the clones (called MuC4, MuC6, MuC7,
and MuC8) are new additions to the Mu transposon
family. They have the same terminal inverted repeats
as Mul, but with internal sequences unrelated to Mul
and to each other. MuC4, MuC7, and MuC8 appear
to be homologous to elements identified in the ge-
nome by their Mu termini, but not previously shown
to be transposable (V. Chandler, University of
Oregon). It is likely that all elements of the Mu trans-
poson family generate extrachromosomal circles
(Fig. 1). The role of circles in Mu transposition (e.g.,
whether they are real or abortive transposition/repli-
cation intermediates) is yet to be elucidated.
THE PHENOMENON OF MU INACTIVATION
Spontaneous inactivation of Mu lines can occur dur-
ing propagation through either outcrossing or self-
ing. These inactive derivatives of Mu lines carry Mu
elements, but the elements no longer transpose, and
furthermore, the circular Mu disappears. This inac-
tive state of the Mu elements has been found to be
correlated with methylation of these elements at sites
within the inverted repeats (Chandler and Walbot,
Proc. Natl. Acad. Sci. 83: 1767 [1986]; Bennetzen,
Ma Gen. Genet. 208: 45 [1987]). We have asked the
question, Can a "dead" line be revived? We derived
inactive lines by following the instability of a Mu
insertion in the Bronze] (Bz1) gene. In an active line,
this insertion produces spotted bronze kernels,
M
fractions
FIGURE 1 Autoradiogram of uncut DNA fractions from a Robert-
son Mu line fractionated on a CsCl/EthBr gradient showing at
least four circular DNA molecules including Mul hybridizing to
a complete Mul probe. Arrow indicates concentrations of CsCI
from high to low, with linear fractions on the right. (M) Closed
circular DNA size markers.
whereas in an inactive derivative, the kernels are
stable bronze and the Mu elements are methylated.
Inactive lines were obtained by outcrossing active
lines to normal maize and identifying stable bronze
kernels (ON x NORMAL-. ON + few OFF). When
these inactive lines are crossed to normal maize lines,
the progeny are stable bronze, showing that, in
general, a dead line remains dead, i.e.. spontaneous
reactivation does not occur (OFF x NORMAL-.
OFF). However, if crossed to an active Mu line (with
a standard recessive bronze allele), we find complete
restoration of the spotted bronze phenotype (Fig. 2);
the restoration is the same regardless of which par-
ent is the female (OFF x ON-.0N). Furthermore,
the methylation of the Mu elements is reversed, i.e.,
all of the Mu elements in the progeny are un-
methylated (Fig. 3). This shows that the changes that
occur during inactivation are reversible and that the
Mu elements in an OFF line retain their ability to
transpose. B. McClintock has suggested that the ge-
nomes of higher eukaryotes carry many elements (in-
cluding transposons) capable of reorganizing the ge-
nome that are normally silent or unexpressed, but
that these can be activated or triggered by stress or
shock to the organism (McClintock, Stadler Symp.
FIGURE 2 A kernel from an ear of bzl-Mum9-inactive crossed
to bz 1 ; Mu-active pollen showing a large purple sector reflecting
an early reactivation event.
10: 25 [1978]). Because the inactive Mu elements re-
tain their ability to transpose, they may be capable
of spontaneous reactivation in response to stress. We
have begun experiments to test this possibility.
USE OF MU IN GENE TAGGING
Another area of interest is the use of Mu to study
genes important in plant growth and development
by gene tagging. The rate of new mutants generated
by Mu lines is exceptionally high, and 5-15 We of the
progeny in a Mu outcross carry new recessive muta-
tions. We have therefore been using Mu to generate
recessive mutations in different genes, with the idea
of studying them at the molecular level by cloning
the gene using a Mu transposon probe. In theory,
this can be done by identifying a Mu-hybridizing
band on a Southern blot that cosegregates with the
mutant phenotype. In practice, because of the large
number (20 or more copies) and the high transposi-
tion rates of the Mu elements, this is a difficult
proposition. To get around this problem, we are
utilizing a system in which the Mu insertion at Bzl
is used to obtain inactive progeny from the mutant
plants by identifying stable bronze kernels. The in-
active progeny have a stable number of Mu elements;
these are outcrossed to follow the segregation of Mu
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FIGURE 3 Autoradiogram of a Southern blot of Hinfl digests
of DNA isolated from progeny and parents of a cross of an inac-
tive Mu female to an active Mu male. Hinfl cuts Mu/ and Mul. 7
at the termini to generate 1.4-kb and 1.7-kb fragments, respec-
tively; if these sites are modified, larger fragments are seen. (Lanes
1-7) DNA from the progeny; (lane F) DNA from the female par-
ent (inactive Mu with modified Mu elements); (lane M) DNA from
the male parent (active Mu with no modified Mu elements). Lane
F was deliberately underloaded to contain 25./o as much DNA
as the other lanes to show that higher-molecular-weight bands
can be detected under our conditions with one-fourth the DNA
than in lanes 1-7.
elements with the mutant phenotype while reducing
the Mu copy number.
One set of genes that we are applying this tech-
nique to are the dwarf genes. These genes are in-
volved in the synthesis and response to gibberellin
(GA,), a plant growth regulator. The dwarf mutants
are characterized by greatly shortened internodes,
broad dark-green wrinkled leaves, and anthers in the
ear; the mature dwarf plant is one-fourth to one-
eighth the height of a normal plant. We have a Mu
insertion in the dl gene; this gene regulates the
amount of GA, in the plant by encoding the en-
zyme that synthesizes GA, from GAZO, the biologi-
cally inactive precursor. We have obtained stable de-
rivatives of this mutant using the Bzl marker, and
we are now in a position to begin the segregation
analysis. Other unmapped dwarf mutants have been
generated in our Mu stocks, and we have begun their
characterization. There is evidence from restriction-
fragment-length polymorphism analysis that the
variation in height in maize lines might be due to
differences in the alleles at one of the dwarf loci
(Helentjaris, Trends Genet. 3: 217 [1987]). Thus,
study of the dwarf genes might also help us to under-
stand the basis of quantitative trait variation in field
crops.
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A Change in the State of the
Ac-induced PIIV Allele Is
Associated with Inversion of Ac
T Peterson, S. Allan [in collaboration with W.J. Peacock
and E.S. Dennis, CSIRO-Division of Plant Industry,
Canberra, Australia]
The maize P locus controls pigmentation of certain
floral tissues, including the pericarp and glumes of
the cob. Since pericarp and cob pigmentation can
differ, P alleles are commonly given a two-letter
designation indicating the expression in each tissue.
Thus, the P-RR, P-RW, P-WR, and P-WW alleles
specify red pericarp/red cob, red pericarp/white cob,
white pericarp/red cob, and white pericarp/white
cob, respectively. The P-VV allele, which gives varie-
gated pericarp and cob, comprises the transposable
element Ac situated at the P locus. We have previ-
ously isolated a DNA clone from P-VV, and we are
now using P DNA sequences to study the structure
and expression of P. The long-term objective is to
determine how the P gene is expressed in specific flo-
ral tissues during development of the maize plant.
I have isolated an allele termed P-OVOV (orange
variegated pericarp and cob) derived from P-VV. The
P-OVOVallele was recovered from a sector of 40 ker-
nels, with orange variegated pericarp on an ear with
otherwise ordinary variegated pericarp, from a plant
of P-VV/P-WR genotype. P-VV specifies colorless
pericarp with red sectors, whereas P-OVOV speci-
fies orange pericarp with many dark-red sectors and
some colorless sectors (Fig. 4). Thus, FLOVOVrepre-
sents a change in state of the P-VV allele.
Two hypotheses have been proposed to explain the
molecular basis for changes in state. The composi-
tion hypothesis attributes changes in state to changes
within the transposable element, such as internal de-
letions or DNA modification. The position hypoth-
esis proposes that the element is unchanged but that
it has moved to a new position within the locus. The
P-OVOV allele was studied to determine the basis
of this change in state.
The genetic properties of the P-OVOV allele were
investigated in progeny of the cross P-OVOV/P-
WR x P-WW. For each progeny plant, ear pheno-
type was scored by inspection, and the presence or
absence of Ac was determined in tests crosses. The
results are shown in Table 1. Three points can be
drawn from these data. First, the number of P-WR
ears (126) is approximately equal to the combined
number of P-OVOV, P-RR, and variant ears (122).
FIGURE 4 Pericarp phenotypes specified by the progenitor
P-VV allele (top) and the new P-OVOV allele (bottom).
This shows that P-OVOV segregates as an allele of
P-WR. The P -OVOV phenotype does not depend on
unlinked modifying factors. Second, Ac activity is
tightly linked to P-OVOV; 109 plants producing P-
OVOV ears carried Ac. There were no examples of
plants producing P-OVOV ears that did not carry
Ac. Third, the P-OVOV allele is itself unstable, as
evidenced by the P-RR and "other" ears among the
progeny. These variants are presumed to arise from
mutation of P-OVOV because the P-WR allele used
in this cross is stable.
Has the Ac element at the P locus undergone a
compositional change in the mutation of P-VV to
P-OVOV? This possibility was tested by comparing
the abilities of the Ac elements associated with the
P-VV and P-OVOV alleles to trans-activate a Ds ele-
ment. No differences in the Ds response were seen,
suggesting that the trans-acting functions of Ac are
unchanged.
Southern analysis of DNA from the progenitor
TABLE 1 Segregation of Ac Activity with the P-OVOV
Allele
Cross: P-OVOV/P-WR x P-WW
Ear phenotype
WR OVOV RR other
Ac + 2 109 5 2
Ac - 124 , 0 5 1
i
Total 126
i-
122
P-VV allele and the P-OVOV allele shows that the
Ac element associated with P-OVOV has remained
within a 850-bp genomic DNA fragment at the P
locus. Interestingly, the Ac element is in an inverted
orientation in P-OVOV compared to P-VV. These
results suggest that the change in state of P-VV to
P-OVOV is due to inversion of Ac.
I propose the following explanation for the ori-
gin and behavior of the P-OVOV allele (Fig. 5). The
progenitor P -VV allele comprises the Ac element in-
serted in a particular orientation at the P locus. The
P -OVOV allele may have arisen by an event in which
Ac has inverted, or flipped, from its orientation in
P-VV to the opposite orientation. Inversion might
have occurred by (1) short-range transposition and
reinsertion in an inverted orientation, (2) a special-
ized inversion mechanism of Ac, or (3) inversion
mediated by sequences just outside Ac. In the in-
verted orientation, the Ac insertion may partially
suppress P expression, resulting in a lowered level
of P function, less pigment formation, and thereby
an orange pericarp color. Ac can excise from P-
OVOV to restore a P-RR gene, producing the red sec-
tors on P-OVOV kernels and P-RR germinal rever-
tants. The colorless sectors may result from other
mutagenic Ac activities, such as imprecise excision,
formation of deletions, and transposition of Ac to
a new site within the P locus, where it may partially
or completely suppress P expression. I have already
isolated a number of new alleles derived from P-
OVOV that specify novel patterns of P gene expres-
sion. Preliminary results show that some of these new
alleles have structural alterations at the P locus con-
sistent with local transpositions of Ac. We are cur-
rently using the P-OVOV allele to mutagenize the P
locus with Ac insertions efficiently, and we expect
to correlate the sites of Ac insertion with the mutant
phenotypes to produce a fine-structure map of the
P gene.
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FIGURE 5 Model for the origin and behavior of the P-OVOV allele (see text for details).
Function of the Hml Gene in
Disease Resistance
S. Briggs
Resistance to the maize pathogen Cochliobolus car-
bonum race 1 maps to two nuclear genes, Hml and
Hm2. Hml conditions immunity, even in the het-
erozygote, but Hm2 can provide only intermediate
resistance. Certain alleles at Hml can also confer in-
termediate resistance, in which case the action of
Hml and Hm2 is additive. A correspondence be-
tween disease resistance and 100-fold decreased sen-
sitivity to a C. carbonum race 1 metabolite (HC
toxin; Fig. 6) provides circumstantial evidence that
Hml is pleiomorphic, controlling both resistance to
the fungus and lack of sensitivity to the fungal
metabolite. Alternatively, two linked genes could be
determining these traits. Direct evidence for Hml
control of both traits was obtained by testing sus-
ceptible mutants from a transposon-mutagenesis
screen for sensitivity to HC toxin. In all cases exam-
ined, the loss of resistance to the fungus was accom-
panied by an acquired sensitivity to HC toxin. These
results suggest that the function of the Hml gene
is to block the action of HC toxin.
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Suppression of Disease Resistance
by HC Toxin
S. Briggs, B. Elliott [in collaboration with J. Duvick,
Pioneer Hi-Bred International]
C (Helminthosporium) carbonum, a filamentous as-
comycete, exists in nature as three races defined by
virulence and host range. Race 1 is the most virulent
and only infects genotypes of maize that are reces-
sive at Hml, race 2 is avirulent on maize, and race
3 is moderately virulent, and the interaction with
maize is under polygenic control. C. carbonum is in-
terfertile with Cochliobolus victoriae, a pathogen of
oats. Progeny from a cross between race 1 and C.
victoriae show segregation for two unlinked genes,
of which one permits pathogenicity on maize and
the other permits pathogenicity on oats. Strictly cor-
related with pathogenicity are the production of a
toxin that only affects susceptible maize (HC toxin)
and the production of a toxin that only affects sus-
ceptible oats (HV toxin). These results indicate that
both host range and pathogenicity of C carbonum
race 1 (and of C victoriae) are a consequence of host-
selective toxin production.
The mechanism by which HC toxin permits in-
Toxin Sequence
HC-I Pro-Ala-Ala-Aoe
HC-II Pro-Ala -Gly-Aoe
HC-III Hyp-Ala-Ala-Aoe
Chlarnydocin Pro-Phe-Aib-Aoe
Cyl -2 Pip-Ile-MetTyr-Aoe
FIGURE 6
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HO toxin and related toxins.
gress of C. carbonum is unknown. Studies of toxin
responses show that, in contrast to most fungal
toxins, HC toxin action is slow to manifest and is
first seen as a stimulated uptake of selected solutes
2-4 hours after exposure, followed several hours later
by leakage of electrolytes and cell death. Histologi-
cal studies show that penetration of susceptible cells
precedes cell death, suggesting that the toxin is not
simply killing cells in advance of saprophytic inva-
sion. At low doses, HC toxin actually stimulates
growth up to 25%. This effect is seen in other spe-
cies as well; both sorghum and tomato grow faster
at low doses of HC toxin but are killed at high doses.
Cultured mammalian cancer cells are even more sen-
sitive to HC toxin than is susceptible maize; the
ED50 for growth is 0.01 gx4 and 1.0 gm for mastocy-
toma cells and maize roots, respectively. The epox-
ide moiety of HC toxin is required for biological ac-
tivity, but certain amino acids can be substituted at
other positions in the molecule.
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To describe further the action of HC toxin, we
wish to compare two-dimensional gel profiles of
[35S]methionine- labeled proteins from tissue cul-
tures of resistant and susceptible plants. Conditions
for labeling, extracting, and electrophoresing maize
proteins have been determined. The acidic nature of
the proteins required the use of a pH 4-8 isoelectric
focusing range for optimal separation (Fig. 7). The
effects of HC toxin are now being studied.
Molecular Cloning of Hml
S. Briggs, S. Ismail
Thirty recessive mutations at Hml were recovered
from a cross between Mutator Hml Hml x hml
hml. The susceptible mutants were crossed with
testers. Progeny from these crosses were screened
with restriction-fragment-length polymorphism
(RFLP) probes that are linked to Hml to distinguish
those that carry the mutant allele from those that
received the standard recessive allele. Progeny that
carry the mutant allele were examined to determine
the copy number of Mu/-homologous fragments.
One plant was selected that appears to have 17 sepa-
rate inserts. A genomic library was constructed in
Stratagene's X-DASH vector. Approximately 1.3 x
106 plaques were screened, and 63 Mu-homologous
clones were recovered. The clones are being screened
by using the T7 and T3 promoters in the arms of
X-DASH to generate hybridization probes. Two
screening strategies are being used. The probes are
hybridized to genomic DNA of isogenic lines that
differ only near the Hml locus (they are derived from
backcross siblings); each DNA is cut with several en-
FIGURE 7 [35SiMethionine-labeled proteins from maize cell cultures (pH 4-8).
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zymes to identify RFLPs. Polymorphisms should
only be detected when using probes from clones that
come from the Hml region. The second strategy is
to hybridize the probes to genomic blots of DNA
from recombinant inbred families. This provides the
chromosomal map location for each clone. The ex-
pected pattern for the Hml gene has not been de-
tected in the clones that have been screened.
Transposon Mutagenesis
of the Rpl Gene
S. Briggs [in collaboration with D. Wilkinson and
R. Christiansen, Pioneer Hi-Bred International,
and S. Dellaporta, Yale University]
Resistance to the obligate maize rust pathogen, Puc-
cinia sorghi, maps to several nuclear loci. The Rpl
locus is known to have at least 14 different alleles,
each encoding resistance to a different subset of rust
races. Interest in the Rp genes stems from their diver-
sity, genetic instability, and agronomic value. There
is no information regarding the nature of the Rp gene
products nor the means by which they act.
The Rpl-d allele was recombined under homozy-
gous conditions with the heterozygous r-njml allele.
The r-nj:ml allele contains an active Ac element at
the R locus, on the same chromosome as Rpl. This
line was crossed with a homozygous rp tester that
carried resistance to pathogens other than rust. Ker-
nals in which a germinal transposition of Ac had oc-
curred were screened for mutations at Rpl-d.
Seventy-eight susceptible mutants were recovered.
Tests are under way to determine whether any of the
mutations were caused by insertion of Ac at Rpl.
Cloning Genes by Random
Transposon-Mutagenesis
S. Briggs, P.S. Chomet, B.A. Lowe [in collaboration with
S. Dellaporta and J. Chen, Yale University]
Maize kernal genetics were used to select progeny
in which the Ac element had transposed and re-
mained active (hence, clonable) at a new site. Ears
from the cross P-VV/P-WR r-g x P-WR r-m3 were
examined for revertant kernels or ear sectors in which
Ac had excised from the P locus. These kernels or
sectors were recognized by a uniform red pigmenta-
tion in the pericarp caused by restoration of the wild-
type P-RR allele from the Ac-containing P-VV al-
lele. Revertant kernals were also examined for spots
in the aleurone to detect the presence of a transposed
Ac. Since reversion occurs in only one homolog,
segregation at meiosis will cause the transposed Ac
to be transmitted to only half of the red kernals. Fur-
thermore, in approximately one third of all cases,
the revertant kernals or sectors receive no transposed
Ac due to an alternate pattern of transposition.
Therefore, selection based solely upon reversion of
P will give Ac-containing kernals only one sixth of
the time. In our case, transposed Ac was detected
by the somatic reversion of r-m3 (a Ds-containing
allele) to R-sc, causing spots (revertant sectors) in
the aleurone. Ac-containing mutant alleles are rela-
tively easy to clone because they are hypomethylated
in comparison to the many other Ac-homologous
genomic sequences. Methylation-sensitive enzymes
cut only the desired restriction fragment, vastly en-
riching genomic libraries for the clone of interest.
Families from selfs of the selected progeny were
screened for segregating mutations. Several new mu-
tations were observed, with the Ac element linked
to the mutant locus. Cloning of the active Ac ele-
ment from these mutants has provided probes for
genes involved in floral determination and chlo-
roplast biogenesis. This appears to be a general and
efficient method for cloning maize genes that are as-
sociated with a mutant phenotype.
Map Positions of Cryptic Ac Elements
S. Briggs [in collaboration with S. Dellaporta
and J. Chen, Yale University]
Southern blot analysis of all maize lines tested re-
vealed the presence of several Ac-homologous se-
quences, whether or not an active Ac element was
present. These cryptic elements have no known func-
tion but may be inactive or mutant elements. To gain
further insight into their distribution in the genome,
the cryptic elements from two different lines were
mapped by segregation analysis in recombinant
inbreds. Although the study is not yet complete, it
is clear that some of the cryptic elements in one line
are polymorphic alleles of cryptic elements in the
other line, suggesting an extensive period of quies-
cence. Elements appear to be clustered at certain
chromosome locations. There was no evidence that
the cryptic elements transpose in the presence of an
active Ac.
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Functional Analysis of Inhibitor-Diffuse
B.A. Lowe [in collaboration with Irwin Greenblatt,
University of Connecticut, Storrs]
Inhibitor-diffuse (Idf) is a dominant inhibitor of pig-
ment biosynthesis in maize. Genetic analysis has
mapped Idf to the long arm of chromosome 4. Al-
lelism tests with the C2 gene have shown no recom-
binants between C2 and Idf in a population of 20,000
kernels, indicating that Idf is allelic or closely linked
to C2. C2 is one of many genes required in the dom-
inant form for anthocyanin production in the plant
body as well as in the seed pericarp and aleurone.
C2 encodes chalcone synthase, the first flavonoid-
specific enzyme in the pathway. When homozygous,
Idf inhibits pigment formation even though all dom-
inant color genes are present (Fig. 8A). Idf/C2 het-
erozygotes have pale color in the aleurone but have
no detectable pigment in the plant or pericarp (Fig.
8B). In contrast, a C2 homozygote has full color (Fig.
8C). The dominant inhibitory effect of Idf is most
pronounced in the diploid pericarp and plant tissues,
where no pigment is detectable with a single dose
A B
of Idf. In contrast, a single dose of Idf in the aleu-
rone allows some pigment production. Because the
aleurone is a triploid tissue, two C2 alleles may be
able to overcome the inhibitory effect of Idf. Only
one other dominant inhibitor of anthocyanin syn-
thesis has been reported. I or C-I is an allele of the
C locus. Inhibition is thought to result from the over-
production of a competing homologous RNA prod-
uct rather than by suppression of mRNA levels. The
mechanism by which Idf inhibits anthocyanin bio-
synthesis is unknown.
To test whether the inhibitory effect of Idf is simi-
larly caused by an overproduction of a competing
homologous product, poly(A). RNAs from imma-
ture kernels (23 days after pollination) of Idf
homozygotes, C2 homozygotes, and C2/Idf hetero-
zygotes were hybridized with gene probes of C2 (Fig.
9A) and P (Fig. 9B). P is required for pigmentation
in the pericarp but not the aleurone. The waxy gene
probe was used to confirm that similar amounts of
RNA were loaded in each lane (Fig. 9C). Two RNA
species hybridizing to the C2 probe were detected in
the C2 homozygotes. The 1.5-kb band corresponds
to the spliced C2 transcript and the larger 2.8-kb
C
Idf Idf/C2 C2
FIGURE 8 Phenotypes of Idf (A), Idf/C2 heterozygote (B), and C2 (C) alleles.
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FIGURE 9 Poly(A)* RNA in kernel tissue homologous to the
C2, p, and Wx genes. Poly(A)* (10 pg) RNA isolated from ker-
nels homozygous for C2 (lane 1 in A and 8), heterozygous for
Idf/C2 (lane 2 in A and 8, lane 1 in C), and homozygous for ldf
(lane 3 in A and 8, lane 2 in C) was fractionated on a 1%
formaldehyde-agarose gel, transferred to nitrocellulose filters, and
hybridized with labeled probes for the C2 (A), P (B), and Wx (C)
genes.
band is thought to be the unspliced form represent-
ing the 1.5-kb coding region plus the 1.3-kb intron.
No RNA species were detected with the C2 probe
in the Idf homozygote. A faint 1.3-kb RNA was de-
tected in the C2/Idf heterozygote, indicating that the
C2 allele is functioning in the heterozygote. The ab-
sence of the larger 2.8-kb RNA species may indicate
that a splicing enzyme is limiting in the C2 homo-
zygote. The P probe detects a 1.5- and a 1.8-kb dou-
blet in the C2 homozygote, but no RNA hybridizes
in the C2/Idf heterozygote or Idf homozygote. These
results show that the C2 and P gene probes detect
the transcriptional activity that is reflected visually
when the ears are examined for pigment. No pigment
in the pericarp is visible in the C2/Idf heterozygote
and no P transcript is detected. In contrast, some
pigment is visible in the aleurone of the C2/Idf het-
erozygote and C2 transcript is detected. These results
indicate that Idf is somehow suppressing mRNA for
both C2 and P, concomitant with a suppression of
the phenotypes that are determined by each gene.
This is in marked contrast to the action of the C-I
inhibitor. Experiments are in progress to determine
the effect of Idf on the mRNA levels of other genes
in the pathway, such as Al, CI, Bzl, and R.
Attempts are being made to clone the Idf allele.
A C2-specific probe hybridizes to three fragments
of a HindIll digest in Idf and a single fragment in
C2 material (Fig. 10). The initial step is to identify
which of the three fragments in Idf plants are as-
sociated with the Idf phenotype. When a C2/Idf
plant is self-pollinated, the resulting ear shows ker-
nels that segregate 1 full color (C2/C2):2 pale
(C2/Idj):1 colorless (Idf /Idf). DNA was isolated
from kernels of the three phenotypes and compared
with the Idf progenitor by genomic blot analysis.
Only two of the three HindII1 fragments in the Idf
progenitor are detected in the Idf/Idf derived by
selecting for the Idf phenotype. Presumably, these
two fragments are the minimum required to have a
functional inhibitor. Genomic libraries are being
screened to obtain clones of Idf. The molecular struc-
ture of Idf may explain its inhibitory nature.
Idf was first observed as a mutable allele (Idf-m)
visible in the pericarp as colorless stripes on a colored
background (Fig. 11A). The Idf-m phenotype may
be caused by a transposon insertion into the Idf al-
lele. Transposition away from Idf could restore Idf
function, resulting in colorless stripes. Early mitotic
sectoring on the ear is common and the meiotic trans-
missability of Idf derived from Idf-m depends on
whether the mutation occurred in the L2 or Ll cell
lineages. If the mutation occurs in the LI, it is not
(c,
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FIGURE 10 DNA in kernels homologous to the C2 gene. DNA
(31.Q) isolated from kernels homozygous for C2 (lane 1), hetero-
zygous for Idf/C2 (lane 2), homozygous for Idf derived from self-
ing Idf/C2 (lane 3), and homozygous for the ldf progenitor (lane
4) was restricted with HindIII, fractionated on a 0.7% agarose
gel, transferred to nitrocellulose, and hybridized with labeled probe
for the C2 gene.
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FIGURE 11 Phenotypes of the ldf-mutable (A) and Idf- stable
(8) alleles.
heritable. If it occurs in the L2, from which the germ
line is derived, the mutation is heritable (Fig. 11B).
Attempts are being made to determine if the muta-
tion is mediated by a transposon. Comparison of C2-
hybridizing DNA fragments from mutable plants
and stable revertants may reveal a fragment as-
sociated with an insertion. If so, the fragment will
be cloned and characterized.
The Transposable Element Activator
P.S. Chomet, S.L. Dellaporta
Our research efforts continue to focus on the biol-
ogy and behavior of the transposable element Acti-
vator (Ac). Ac, the autonomous element, encodes
a mutator function that can generate a trans-acting
product (a transposase) capable of promoting trans-
position of itself and of Ds elements. The transpo-
sition of these elements is affected by the dosage of
active Ac elements in the genome and possibly by
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other signals in the cell (McClintock, Cold Spring
Harbor Symp. Quant. Biol. 15: 13 [1951]). We have
investigated three distinct changes that affect Ac: (1)
a metastable event that shifts Ac between active and
inactive phases, (2) an aberrant Ac element with an
altered pattern of transposition, and (3) a phenotypic
change to a variegation pattern at the waxy locus
under the control of an Ac element.
WXM7: CHANGES IN-PHASE
The Ac element, like the Spm and Dt elements of
maize, has the ability to undergo cyclical changes in
its activity (McClintock, Carnegie Inst. Wash. Year-
book 56: 393 [1957], Carnegie Inst. Wash. Yearbook
62: 486 [1963]; Doerschug, Theor. AppL Genet. 43:
182 [1973]). The initial studies of Ac "phase changes"
involved the Ac-induced waxy mutation, wx-m 7
(McClintock, Carnegie Inst. Wash. Yearbook 62: 486
[1963]). The waxy locus codes for a UDPG:glucosyl
transferase that is involved in the synthesis of amy-
lose in endosperm and pollen cells (Nelson and
Rines, Biochem. Biophys. Res. Commun. 9: 297
[1962]). When Ac at wx-m7 is inactive, the Ac ele-
ment can no longer transpose autonomously, trans-
activate a Ds element, or contribute to overall Ac
dosage effects (McClintock, Carnegie Inst. Wash.
Yearbook 63: 592 [1964]). When Ac activity is
regained, each of these functions is restored. The ac-
tive Ac at the wx-m7 allele has been cloned and se-
quenced (Behrens et al., Mol. Gen. Genet. 194: 346
[1984]; Muller-Neumann et al., Mol. Gen. Genet. 198:
19 [1985]) and shown to be structurally indistinguish-
able from other Ac elements at wx-m9 and bz-m2
(Fedoroff et al., Cell 35: 235 [1983]; Proc. Natl. Acad.
Sci. 81: 3825 [1984]).
In past reports, we have shown that when the ele-
ment is inactive, Ac DNA is methylated at all of the
PvuII, SstII, and EcoRII restriction endonuclease
sites (Chomet et al., EMBO J 6: 295 [1987]). The
SstII, EcoRII, and one of the PvuII sites are situ-
ated near the 5' end of the transcribed region of Ac
(Kunze et al., EMBO J. 6: 1555 [1987]). These sites
are hypomethylated when Ac is active.
We have cloned the inactive Ac element and shown
it to be structurally indistinguishable from the ac-
tive Ac7 element by detailed restriction analysis; it
is also in the same orientation and position in the
waxy gene. The methylation is specific for the Ac
DNA, since the flanking waxy DNA is hypomethyl-
ated whether Ac is active or inactive.
Inheritance studies of Ac at wx-m 7 show that Ac
can exist in at least three heritable states: active
(Ac:a), cycling (Ac:cyc), and inactive (Aci). In the
active line, Ac at wx-m 7 is maintained as an active
element through meiotic generations. In the inactive
line, Ac is maintained as an inactive element, al-
though Ac:a and Ac:i can change to a new state at
a low frequency. The stock derived from the origi-
nal waxy mutable kernel was an active line. From
this apparently normal Ac allele, a stock was derived
in which Ac underwent changes to its activity in sub-
sequent mitotic and meiotic generations (McClin-
tock, Carnegie Inst. Wash. Yearbook 62: 486 [1963]).
We have termed this the Accyc allele.
Inheritance of Ac:cyc. The Ac:cyc allele is defined
by the ability of Ac to undergo changes in its activ-
ity readily during endosperm development. In-
heritance of these endosperm phenotypes was tested
in the next plant generation by planting kernels that
phenotypically did or did not show Ac activity in
the endosperm and reciprocally crossing to wx/wx
al-m3(Ds) plants.
Kernels in which the Endosperm Showed Ac Ac-
tivity. Of 23 plants grown from these kernels and
crossed as a female, 22 bore ears that showed the
Ac:cyc phenotype; i.e., the endosperm of kernels on
these ears showed Ac active, cycling, and inactive
phenotypes.
Kernels in which Endosperm Showed No Ac Ac-
tivity. Of 57 plants grown from these kernels, 32
bore ears that exhibited the Ac:cyc phenotype when
crossed as a female; 25 of 57 plants grown from these
kernels bore ears, when crossed as a female, show-
ing the Ac inactive phenotype in all the kernels (the
Aci line). This phenotype is inherited through the
germ line as Ac:i. We have tested a number of in-
dependently derived Aci lines for at least one more
generation, and they continue to show the inactive
phenotype on the entire ear. A second generation
has been tested this summer. Three independently
derived Aci lines (derived by B. McClintock and B.
Burr) have been propagated in this laboratory for
three generations with no evidence of Ac activity
when backcrossed in similar genetic backgrounds.
These Aci alleles do have the ability to revert to
the Ac:cyc allele at a low frequency. This occurred
when the Ac:i alleles were backcrossed into a new
genetic background for two generations, although
it is unclear whether the new genetic background was
the cause of this reversion event. Experiments are
under way to answer this question.
Male Transmission of the Ac:cyc Allele. In every
reciprocal cross of the above-mentioned crosses,
there was a greater than 60% reduction in the activ-
ity of Ac when the Ac:cyc allele was transmitted
through the pollen rather than the embryo sac. Most
often, the Ac:cyc allele showed no Ac activity in the
endosperm of kernels on these test-crossed ears.
Further tests of plants grown from these pheno-
typically inactive kernels showed that Ac can regain
activity through the germ line (upon subsequent fe-
male transmission of the allele). Some ears of plants
grown from kernels showing no Ac activity (the male-
transmitted Accyc allele) showed the Ac:cyc pheno-
type, whereas 9 out of 24 ears showed the Ac:i allele
phenotype. These data are comparable to germ-line
expression of Ac:cyc when transmitted through the
female; i.e., male transmission of Accyc has a dras-
tic (reduction) effect on Ac activity in the immedi-
ate generation only. The mode of transmission has
little or no effect on the subsequent germ-line activ-
ity of the Ac:cyc allele. We are currently testing
whether this effect is actually due to the mode of
transmission or simply the dosage of the Ac:cyc al-
lele in the endosperm. If it is the mode of transmis-
sion that causes this phenomenon, then parallels can
be drawn between this type of behavior and the im-
printing phenomenon in maize.
Ac:i in the Presence of an Active Ac (bz-m2 Al-
lele). To understand whether inactivity of the Ac
element at wx-m 7 was a consequence of its position
in the genome, we performed crosses to isolate ger-
minal transpositions of the Ac:i and to study its be-
havior at new positions in the chromosome. It has
been reported that the Ac:i can respond to the trans-
posase of an active Ac (McClintock, Carnegie Inst.
Wash. Yearbook 63: 592 [1964]). We introduced the
active Ac at the bz-m2 allele with the wx-m7:i allele.
Many kernels on these ears showed a very late (de-
velopmentally) pattern of wx-m 7.1 response to the
active Ac, as would be expected with the two doses
of the active Ac in the endosperm. However, in ker-
nels showing the bz-m2 phenotype (2 dose) and car-
rying the wx-m 7:i allele, the inactive Ac did not al-
ways respond to the active Ac. This conclusion was
interpreted from kernels showing the bz-m2 spot-
ting pattern in the aleurone and the wx -m7 inactive
pattern in underlying endosperm cells.
A reciprocal cross of the above (and the cross sh
bz wx-m7:i/sh bz wx x Sh bz-m2 wx/sh bz wx) pro-
duced progeny in which the inactive Ac responded
to one dose of the active Ac (bz-m2). Many kernels
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were noted in which wx-m7:i responded (by express-
ing a clonal "excision" pattern of Ac at waxy) to bz-
m2 early in kernel development, as would be ex-
pected with one dose of an active Ac in the en-
dosperm. Furthermore, the bz-m2 spotting pattern
was unaltered by changes in the waxy phenotype.
These data suggest that inactive Ac at wx-m7 is re-
sponding to the transposase of the active Ac at bz-
m2, but the inactive Ac has not been activated, since
no increase in Ac dosage is reflected in the bz-m2
pattern.
Methylation of the Inactive Ac in the Presence of
an Active Ac. Since the inactive Ac could respond
to an active Ac but apparently was not activated, we
asked if the modification of the Ac:i was still main-
tained in the presence of the active Ac's transposase.
DNA from plants of the genotype Sh bz-m2 wx-
m7:i/sh bz wx (+ Ac activity) and Sh Bz wx-m7./sh
bz wx (-Ac activity) was isolated and cleaved with
SstI and SstII. This blot was probed with pWx0.4
(Sall-Smal fragment of Wx). No changes in the
modification of the SstII sites within Ac:i were seen
whether the active Ac at bz-m2 was present or ab-
sent. These data imply that the active Ac element
does not regulate the methylation at the 5' end of
the transposase gene in the Aci element. Further-
more, it is the expression of the transposase of Ac,
not the ability of Ac to transpose, that is correlated
with the methylation of Ac DNA (at SstII sites).
Ac-cyc in the Presence of an Active Ac (bz-m2). We
have also crossed an active Ac into the wx-m7cyc
stock to isolate transpositions of the Ac:cyc element.
In the progeny of the cross, Sh b3-m2 wx/Sh Bx wx-
m7:cyc x sh bz wx, some kernels showed changes
in the bz-m2 spotting pattern, from the two-dose to
a three- or four-dose Ac pattern. A few kernels of
this type also heterozygous for the wx-m7cyc allele
revealed that the Ac at wx-m7:cyc could undergo cy-
cling even in the presence of an active Ac. Under-
neath the two-dose Ac spotting pattern of bz-m2 in
the aleurone, the Ac:cyc element appeared inactive,
as assayed by the "nonclonal" expression of wx -m7
in the starchy endosperm. Underneath the higher-
dose Ac bz-m2 pattern was the excision pattern of
wx-m 7. This suggested that Ac at wx-m 7 cycled be-
tween the inactive and active state, as revealed by its
own excision pattern at waxy and by its contribu-
tion to Ac dosage in only a sector of the endosperm.
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Conclusions
1. Ac at wx-m 7 can exist in three heritable states:
active, cycling, and inactive.
2. Aca and Ac:i are relatively stable alleles, whereas
Accyc readily changes to Ac:i.
3. The Aci allele was associated with specific meth-
ylation of the Ac DNA, whereas the Ac:a allele was
hypomethylated.
4. Male transmission of the Accyc allele drastically
reduced Ac activity in the endosperm, whereas Ac
activity through the germ line (in subsequent gener-
ations) was not affected. This imprinting effect is
associated with the Accyc allele only.
5. The inactive Ac does not always respond to the
transposase of an active Ac, unlike Ds elements. This
may be due to a local chromatin structure change
associated with the methylation.
6. Ac at wx-m7 can undergo a change in its trans-
posase expression (change in-phase) even in the pres-
ence of an active Ac. This suggests that control of
the shift in Ac activity is not a general control over
the Ac-Ds system, but rather a local control over Ac
at waxy.
7. The inactive Ac DNA remains methylated in the
presence of an active Ac, again suggesting that the
control of activity and methylation of Ac is specific
for Ac at waxy.
AC-STABILIZED
An unstable allele caused by a controlling element
insertion can undergo heritable changes that affect
the pattern of somatic variegation. These changes
then give rise to new states of the locus that differ
from the parental state in the pattern of somatic mu-
tation (McClintock, Carnegie Inst. Wash. Yearbook
54: 245 [1955]). New states of the dSpm controlling
element have been characterized molecularly and
shown to be rearrangements within the responding
element (Schiefelbein et al., Proc. Natl. Acad. Sci.
82: 4783 [1985]).
A new state of the Ac element, termed Ac-
stabilized (Ac-st), is characterized by the late and in-
frequent action of its transposase (B. McClintock,
unpubl.). Unlike other Ac elements, this late response
occurs in the presence of one dose of the Ac-st ele-
ment in the genome. This element is not located
within a scorable gene; therefore, its effect is moni-
tored on Ds-suppressed alleles. Other heritable
changes that affect the activity of the autonomous
element have not been well characterized. Some in-
ternal deletions of Ac have been shown to destroy
the transposase function of the element (Fedoroff
et al., Cell 35: 235 [1983a]; Pohlman et al., Ce1137:
635 [1984]). Ac-st is unique in that a mutation has
altered the action of the transposase without the
complete loss of Ac activity.
The Late-acting Action of Ac-st Is Independent of
the Ds Allele on which It Acts. A stock carrying I
Ds (standard position) was crossed as a male onto
stock heterozygous for Ac-st. Similarly, a stock car-
rying bz-m2 (derivative I) was crossed as a male to
the Ac-st stock. Both chromosome breaks mediated
by Ds, and transpositions of Ds, occurred late in en-
dosperm development as compared to the action of
a normal Ac (B. McClintock, unpubl.). The r-m3 and
al-m3 Ds alleles also showed a developmentally late
and infrequent response to one Ac-st, as compared
to other Ac elements (wx-m7:a, P-VV).
Genetic Background Has No Effect on the Late Ac-
tion of Ac-st. Inbred W22 Ac-st/ + , r/r-m3 was
crossed into inbred W22, W23, Mo17, A632, and OH
43 lines for three generations. In the F, progeny, no
change in the behavior of Ac-st (as assayed by r-m3
response) was observed. This suggests that a trans-
acting factor is not necessary for the late action of
Ac-st.
Ac-st Has Little or No Effect of Dosage upon It-
self A plant of the genotype r-m3 /r, + /Ac-st was
crossed reciprocally to a homozygous r-m3 plant.
Among the progeny of the reciprocal crosses, the tim-
ing of the r-m3 response was indistinguishable when
Ac-st was present in one or two doses. This test of
dosage contribution has been repeated this summer
with plants of the genotype Ac-st/ + , al-m3. These
plants were reciprocally crossed to al-m3 plants as
well as selfed. This construction allows for the
monitoring of the effect of Ac-st dosage, whereas
the dosage of al-m3 does not vary.
Ac-st Makes Little or No Contribution to the Dos-
age of a Normal Ac in the Cell. Plants of the geno-
type wx-m7:active/wx, al-m3 were crossed by a plant
of the genotype Ac-st/+, Al/al-m3. Half of the
progeny kernels carrying the wx-m7 and al-m3 al-
leles should carry the Ac-st allele. No variation in
the variegation pattern at waxy and al was evident
among these kernels. This experiment was repeated
this summer using P-VVas the donor of an active Ac.
Ac-st Cloning. We have cloned a BamHI fragment
containing most of Ac-st and 3 kb of flanking DNA.
BamHI, Sstl, and BglII digests of genomic DNA
show that one of the nine Ac homologous bands is
present in Ac-st stocks [W22] but is absent in W22
lines lacking Ac-st. When genomic DNA is cleaved
with PvuII, this fragment is replaced by a 2.5-kb frag-
ment that represents the internal portion of an ac-
tive Ac. Restriction analysis of the Bamill clone
shows that the 4.3 kb of Ac-st is indistinguishable
from Ac7. The remaining 0.2 kb of Ac-st is yet to
be characterized. A flanking unique probe of Ac-st
has been isolated and will be used to clone a BglII
fragment containing the entire Ac-st element. Se-
quence analysis will be performed on this clone to
uncover any change to the Ac-st element.
Ac-st Maps to Position 26 on Chromosome 10L. We
have mapped the Ac-st flanking probe to its chro-
mosomal position using recombinant inbred lines of
maize (Burr et al., Genetics [1988] in press). This
method has replaced the element at approximately
position 26 on the long arm of chromosome 10.
Moreover, genetic linkage data of Ac-st with the R
locus have placed the element at approximately the
same position. The confirmation of the data with
these two independent methods assures the map po-
sition of Ac-st and shows that the Ac-st BamHI frag-
ment is the correct clone for Ac-st.
Conclusions
These data suggest that Ac-st is associated with a
reduction in transposase activity, since Ac-st action
is recessive to a standard Ac. An alternative expla-
nation of the phenotype of Ac-st would be an in-
crease in the suppression of transposase activity as-
sociated with the Ac dosage effect. Our studies rule
this out, since Ac-st action should display a domi-
nant effect over a standard Ac element if the dosage
contribution is increased. It is interesting to note that
timing and Ac dosage contribution associated with
this Ac are simultaneously affected, suggesting that
these functions may be both associated with the
transposase.
CHANGE IN STATE OF WX-M7:A
A new state of the wx-m7 allele has been derived that
shows a heritable change in the expression of waxy
(B. McClintock, unpubl.). The pattern of this allele
(designated wx-m404) no longer shows frequent wild-
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type revertant sectors of starchy endosperm as seen
with the wx-m7 progenitor. Most revertant sectors
contain low levels of amylose (as detected by IKI
staining), with wild-type sectors appearing infre-
quently in the endosperm. The wx-m404 allele is still
under the control of the Ac-Ds system. This allele
will be used to define the alteration associated with
the change in state of wx-m7.
One Ac Element Is Associated with the Waxy Locus
in wx-m404. A plant with the genotype wx-m404/wx,
a2-m4 was reciprocally crossed to a plant carrying
a2-m4, -Ac. All of the A2 mutable kernels (50%)
were also mutable for waxy, indicating that one Ac
was segregating and that it was associated with the
waxy locus. Ac also showed the expected dosage ef-
fect when crossed reciprocally.
Ac Is no Longer Present at the Original Location
of Ac in wx-m7. A 3.2-kb Sal C fragment of Wx was
present, indicating the loss of the entire Ac element
from this fragment as is seen in wx-m 7. An increase
of 4.5 kb is seen for the Sal D fragment, from 2.0
kb to 6.5 kb. This indicates that Ac is now present
in the Sal D fragment of the wx-m404 allele. This
insertion has been mapped to within 200 by of the
3' end of the Sal D fragment.
Ac Is in the Opposite Orientation in Relation to Wx
When Compared to the Original wx-m7 Position.
We have cloned the putative donor (location of Ac7)
and the receptor site of this transposition event. Both
sites have been recovered on an EcoRI clone span-
ning half of the Ac element into the 5' end of the
wx gene. This clone has been restriction mapped and
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is consistent with results from genomic Southern blot
data.
We have sequenced across the 5' junction region
of Ac and Wx. This sequence shows that the inser-
tion site of Ac in wx-m404 is in exon 9 of the waxy
gene. This location is 32 by 5' of the insertion site
of Ds1 in the wx -ml allele (Wessler et al., EMBO
J. 5: 2427 [1986]).
Conclusions
The wx-m404 allele is associated with a change in
position and orientation of the Ac element relative
to Wx. This change in location is from the 5' pro-
moter region of the waxy gene to a site in the coding
region of the gene. The phenotypic change associated
with the wx-m404 allele may be due to the new posi-
tion of Ac in exon sequence or a rearrangement in
the promoter of Wx (donor site) as a consequence
of transposition. These two possibilities may be dis-
tinguished when the donor site is sequenced.
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CELL BIOLOGY
The Cell Biology Section includes six laboratories using diverse approaches to
analyze various aspects of the cellular biology of eukaryotes. The control of cell
growth is the focus of the laboratory of J. Feramisco. Cellular oncogenes (e.g., the
ras and the fos oncogenes) that influence the proliferative capacity of cells are be-
ing studied with respect to their biological effects and biochemical functions. The
analysis of cellular trans-activators of gene expression is the focus of the labora-
tory of R. Franza. Cellular proteins that interact with specific, genetically defined
control elements for gene expression are being identified and characterized. The
laboratory of J. Garrels (The QUEST 2D Gel Facility) is continuing to build and to
analyze the REF52 rat cell database for the study of protein synthesis modification
and turnover in normal, transformed, and serum-stimulated cells. Similar database
studies (in collaboration with C. McLaughlin and J. Warner) are now under way in
yeast. The control of expression of the tropomyosins is the focus of the laboratory
of D. Helfman. The tissue-specific tropomyosin isoforms are expressed from a sin-
gle gene by alternative RNA splicing and polyadenylation. The molecular basis for
this tissue-specific expression is being studied. The laboratory of D. Spector is in-
vestigating the structural and functional organization of the cell nucleus. Nuclear
components that interact with the myc oncoprotein are being analyzed. The labo-
ratory of W. Welch continues to focus on the biology and biochemistry of the
stress proteins. Using monoclonal and polyclonal antibodies, the intracellular local-
ization and the biochemical properties of the stress proteins are being determined.
MOLECULAR MECHANISMS OF GROWTH CONTROL
J.R. Feramisco C. Arrigo J.C. Lamb S. Kaplan
D. Bar-Sagi K. Riabowol J. Suhan
Phospholipase A2 and Cell
Transformation
D. Bar-Sagi, S. Kaplan, J. Suhan, J.R. Feramisco
Phospholipase A2 (PLA2) is a calcium-requiring es-
terase catalyzing the hydrolysis of fatty acid ester
bonds specifically at the sn-2 position of glycero-
phospholipids. The activity of PLA2 has been pos-
tulated to play a regulatory role in several metabolic
pathways, including the biosynthesis of prostaglan-
dins, the turnover of membrane phospholipids, and
the generation of receptor-mediated mitogenic sig-
nals. Following our earlier observation that microin-
jection of the ras oncogene protein into fibroblasts
stimulates PLA2 activity, we have initiated studies
aimed at the characterization of the molecular and
biological properties of this enzyme. Our goal is to
understand the role of PLA2 in the regulation of
normal cell growth and in the transformation pro-
cess. We have been pursuing our research in three
main directions as described below.
GENERATION OF MONOCLONAL AND POLYCLONAL
ANTI-PLA, ANTIBODIES
We have been using homogeneous preparations of
porcine pancreatic PLA2 as immunogen for raising
antibodies in rabbits and mice. Within a 2-3-month
period following the first injection, we have obtained
high-titer serum as determined by the enzyme-linked
immunosorbent assay. The rabbit antisera were pu-
rified on PLA2 affinity columns, and the resulting
affinity-purified anti-PLA2 antibodies have been
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extensively utilized during the past year for the anal-
ysis of the intracellular localization of PLA2 in nor-
mal and ras-transformed cells. Immunofluorescence
microscopy indicated that PLA2 was diffusely dis-
tributed throughout the cell. Increased concentra-
tion of PLA2 was detected under membrane ruffles
in normal and ras-transformed cells (Fig. 1). Spe-
cific immunofluorescence staining was also detected
on the outer surface of the cells. Immunoelectron
microscopy demonstrated the increased accumula-
tion of PLA2 in membrane ruffles and also re-
vealed the presence of the enzyme in microvilli and
its association with intracellular vesicles. Ultrastruc-
tural localization of PLA2 and the ras oncogene
protein, using a double immunogold-labeling tech-
nique, indicated a spatial proximity between PLA2
and ras proteins in the ruffles of ras-transformed
cells. We plan to utilize further these antibodies for
microinjection studies as well as for the biochemi-
cal characterization of PLA2. In particular, we will
attempt to immunoprecipitate PLA2 polypeptide
from metabolically labeled cells in order to analyze
the biosynthesis and posttranslational modifications
of this enzyme.
CLONING OF cDNAs ENCODING CELLULAR PLA,
The calcium-dependent phospholipase A2 enzymes
occurring in mammalian tissues are classified into
two groups in terms of their localization. Extracel-
lular PLA2 is abundant in pancreatic tissue and has
been studied extensively with respect to its physical
and chemical characteristics. The intracellular
PLA2 has been characterized to a much lesser ex-
tent than the pancreatic enzyme because of its low
cellular content and low specific activity. To circum-
vent these limitations, we have been working toward
the isolation and characterization of PLA2 cDNAs.
In our studies to date, we have used a rat skeletal
muscle cDNA expression library prepared in plas-
mid (pUC8 or pUC9) vectors. This cDNA library
was screened with an oligonucleotide derived from
the published cDNA sequence of the rat pancreatic
PLA2. We chose the sequence Tyr-Gly-Cys-Tyr-Cys-
Gly-Leu-Gly for the synthesis of a 25-mer probe. This
sequence encodes a highly conserved region of secre-
tory phospholipase A2 enzymes from various spe-
cies. Thus far, we have obtained 12 independent
recombinants that hybridize to the oligonucleotide
probe. The plasmid DNAs from these clones were
isolated, and cDNA inserts were found to range from
500 to 3000 bp. We are currently sequencing and
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FIGURE 1 Localization of cellular PLA2 by immunofluores-
cence. NRK cells grown on glass coverslips were fixed in 3.7%
formaldehyde and permeabilized by brief extraction with 0.2%
Triton X-100. The cells were stained with monoclonal anti-PLA2
antibody (PLA29) followed by fluorescein-conjugated goat anti-
mouse IgG. Note the intense staining in membrane ruffles (arrow-
heads).
characterizing some of these clones. In addition, we
have recently obtained a rat brain and a rat pancreatic
2.gt11 cDNA library. We are using these libraries for
immunological screening with our specific anti -
PLA2 antibodies.
BIOCHEMICAL MECHANISMS OF PLA, ACTIVATION
Activation of PLA2 has been implicated in mito-
genic transmembrane signaling. The proliferative re-
sponse of Swiss-3T3 cells to platelet-derived growth
factor (PDGF) appears to be accompanied by
PLA, stimulation and prostaglandin production. In
addition, PLA2 seems to be an important compo-
nent of the mechanism by which mitogens activate
Na'/H+ exchange. This activation leads to cytoplas-
mic alkalinization, which has been shown to be re-
quired for the initiation of the mitogenic response.
We have found that addition of serum to quiescent
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FIGURE 2 Activation of PLA2 by serum and Ca" ionophore.
Confluent serum-deprived NRK cells were labeled with [3H]ar-
achidonic acid. Label was removed after 24 hr, and cells were
treated with DME alone (b), DME + Ca- ionophore (A23187,
2 5M) (c), DME + 5% serum (d), DME + serum (5%) + Ca"
ionophore (2 gm) (e). [3H]Arachidonic acid released to the
medium was extracted and analyzed by thin-layer chromatogra-
phy (TLC). The position of standard arachidonic acid (stained
with iodine) is shown in lane a. (Ori) Origin of TLC plate.
serum-deprived NRK cells results in a three- to five-
fold enhancement of PLA2 activity within 15 min-
utes of exposure to the serum (see Fig. 2b,d). The
release of [31-1]arachidonic acid was used in these
experiments as a measure of PLA2 activity. We have
begun to characterize the mechanisms underlying the
stimulatory effects of serum on PLA2 activity by
investigating the Ca" requirement for the activation
of arachidonic acid release by serum. All phospho-
lipase A2 enzymes that have been adequately
characterized are activated by Ca ** ions. Since the
action of several serum growth factors is accompa-
nied by enhancement of Ca+* influx, the resulting
increase in intracellular calcium level constitutes a
plausible mechanism for the activation of Ca**-
dependent PLA2. We have found that the Ca *'
ionophore A23187 (2 pm), when added to NRK cells
in the absence of serum, stimulates [31-1]arachidonic
acid release (Fig. 2c). The extent of stimulation is
lower than that obtained by serum treatment (Fig.
2d). Furthermore, we have found that the effects of
serum and Ca ** ionophore on [31-1]arachidonic acid
release are additive (Fig. 2e), an observation consis-
tent with two independently activatable release mech-
anisms. We will utilize similar approaches to ana-
lyze further the identity of the serum growth factors
that are responsible for the stimulation of PLA2 ac-
tivity and to investigate the mechanistic aspects of
this activation process.
Microinjection of fos-specific
Antibodies Blocks DNA Synthesis
in Fibroblast Cells
K. Riabowol, J.C. Lamb, J.R. Feramisco
[in collaboration with R. Vosatka and E. Ziff,
New York University Medical Center]
Transcription of the proto-oncogene c-fos is in-
creased more than tenfold within minutes of treat-
ing fibroblasts with serum or purified growth fac-
tors. Due to this rapid transcriptional induction and
accumulation of c-fos protein seen following mito-
gen stimulation of quiescent fibroblasts, the DNA-
binding properties of the protein, and the reported
ability of v-fos to trans-activate transcription from
heterologous promoter sequences, it has been sug-
gested that c-fos serves a role in coupling external
stimuli, such as mitogens, to long-term transcrip-
tional responses, leading to cell proliferation. Recent
experiments using mouse 3T3 cell lines containing
inducible fos antisense RNA constructs have shown
that induced fos antisense RNA transcripts cause
either a marked inhibition of growth in continuously
proliferating cells or a minimal effect, except dur-
ing the transition from a quiescent (Go) state into
the cell cycle. We have also isolated lines of rat fi-
broblast cells transfected with a glucocorticoid-
inducible fos antisense RNA construct, and we have
found that high levels of fos antisense RNA reduced
the level of c-fos protein seen upon addition of se-
rum to quiescent cells and that fewer cells were able
to incorporate [31-1]thymidine in the presence of
dexamethasone and serum compared to untrans-
fected cells. In some of our cell lines, however,
production of fos antisense RNA did not correlate
well with reduced levels of fos protein, nor with a
decreased rate of logarithmic growth. Since intra-
cellular production of large amounts of antisense
RNA does not completely block gene expression, we
used the technique of needle microinjection to in-
troduce polyclonal, affinity-purified antibodies
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FIGURE 3 M icroinjection of antibodies. At various times following injection of antibodies, cells were fixed,
incubated with biotinylated goat anti-rabbit IgG, washed with PBS, incubated with Strep-avidin-conjugated
HRP, and stained for the presence of antibodies. Stained fields of cells were photographed and processed
for emulsion autoradiography. (A-D) Two fields of cells fixed after injection with fos (A,B) or control (C,D)
antibodies 2 hr prior to addition of 15% FCS and 2 gCi/m1 of [31-I]thymidine for 24 hr. (A,C) HRP staining;
(B,D) the corresponding fields of cells following emulsion autoradiography. (E,F) Fields of cells microin-
jected with fos antibodies 8 and 12 hr, respectively, after addition of FCS and [3Fl]thymidine. These results
were obtained by injecting control and fos-specific antibodies at a concentration of 5 mg/ml. Injection of
fos antibodies 2 hr prior to addition of medium containing 15% FCS at concentrations of 2.5 mg/ml, 0.5
mg/ml, and 0.1 mg/ml inhibited synthesis 92%, 26%, and 2% as well, respectively, as when used at 5 mg/ml.
directed against the fos protein into both quiescent
(serum-deprived) cells and logarithmically growing
cells to determine if, and when during the cell cycle,
functional c-fos protein is required for cell prolifer-
ation. As shown in Figure 3, we find that microin-
jected fos antibodies efficiently block serum-
stimulated DNA synthesis when injected up to 6-8
hours following serum stimulation of quiescent
REF52 fibroblasts. To define further when the func-
tion of c-fos was required for cell growth, injection
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of antibodies was carried out at various times fol-
lowing serum stimulation. Figure 4 shows that by
12 hours following addition of serum, injection of
fos antibodies had no effect on the ability of cells
to synthesize DNA 6-8 hours later. Furthermore,
when fos antibodies were injected into asyn-
chronously growing cells, a consistently greater num-
ber of cells were prevented from synthesizing DNA
than when cells were injected with nonspecific im-
munoglobulins. Thus, although the activity of c-fos
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FIGURE 4 Time-course injections of anti-fos and control antibodies. Fibroblasts grown
for 24 hr in medium containing 0.1% FCS were injected before or after the addition of
15% FCS and 2 1.1Ci/mI[3H]thymidine as indicated on the abscissa. Fields of 25-40 cells
were injected for each time point in three separate experiments. Thus, each time point
represents data from 75-120 injected cells. Cells that received antibody were identified
by staining for Igs with HRP, and the percentage incorporating [3H]thymidine was deter-
mined following emulsion autoradiography. (Inset) A time course of [3FI]thymidine incor-
poration following addition of serum to quiescent REF52 cells under the conditions used
in these studies.
may be necessary for transition of fibroblasts from
Go to G, of the cell cycle, its function is also re-
quired during the early G, portion of the cell cycle
to allow subsequent DNA synthesis.
Although this approach has determined that func-
tional c-fos is required for transit of fibroblast cells
through the cell cycle, it does not address the ques-
tion of the role of fos protein in this process. It has
recently been reported that the c-fos protein binds
to an upstream regulatory element of the AP2 gene,
whose product, a fat-binding protein, is expressed
in 3T3-F44A cells only upon their differentiation into
adipocytes. We have obtained these cells, as well as
antisera to the AP2 protein, from B. Spigelman and
are presently investigating whether manipulation of
the intracellular levels of functional c-fos protein by
microinjection of fos antibodies has any effect on
the expression of AP2.
The Catalytic Subunit of
cAMP-dependent Protein
Kinase Is Sufficient to Induce
Expression of the c-fos Gene
and a Synthetic Gene That also
Contains a cAMP-responsive DNA
Sequence Element
K. Riabowol, J.R. Feramisco [in collaboration with
M. Gilman, Cold Spring Harbor Laboratory,
R. Goodman and S. Fink, Tufts University, and
D. Walsh, University of California at Davis]
Changes in the phosphorylation state of proteins by
protein kinases and phosphatases are a major pro-
cess for regulating cell function. The cAMP-
dependent protein kinase exists as an inactive
tetramer consisting of two molecules of catalytic (C)
subunit complexed with two molecules of regulatory
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FIGURE 5 Induction of c -fos expression by microinjection of ras and CAMP- dependent protein kinase.
Rat 208F cells were made quiescent by incubation in serum-poor medium (0.5% FCS) for 24 hr prior to
injection of the catalytic subunit of CAMP- dependent protein kinase (A,B,D) or bacterially produced ras
(T-24) protein. Cells were then fixed 1 hr (A) or 4 hr (B-D) after injection and incubated with affinity-purified
fos antibodies, followed by fluorescein-conjugated goat anti-rabbit IgG. Nuclear fluorescence indicating
the production of c-fos was evident within 1 hr of microinjection of C, and reached a maximum by 4 hr
following injection. Injection of ras protein also resulted in expression of c-fos, but was not evident until
2-3 hr following injection. (D) Cells injected with Rii subunit and stained with fos antibodies.
(R) subunit. It is believed that cAMP affects cellu-
lar processes by binding to the R subunit, which
results in the liberation of enzymatically active C
subunits. Since the expression of several genes has
been shown to be induced by the addition of cAMP
analogs to cells, we tested the idea of whether in-
troduction of purified C subunit (provided by
D. Walsh) could alter the expression of two differ-
ent test genes. Initially, a cell line containing a cAMP-
responsive DNA sequence linked to I3-galactosidase
(provided by R. Goodman) was injected with C
subunit alone and in the presence of the two forms
of R subunits. We found that microinjection of the
C subunit, in the absence of cyclic nucleotides, was
sufficient to induce production of p-galactosidase,
whereas injection of regulatory subunits RI and R,I
had no discernible effect on expression of this gene
construct. We next tested the effect of C-subunit in-
jection on the expression of c-fos. Using affinity-
purified fos antibodies to assess levels of c-fos ex-
pression, we found that the C subunit dramatically
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induced the expression of c-fos when injected into
cells made quiescent by incubation in serum-poor
medium (0.5% serum, 24 hr) or by contact inhibi-
tion in complete medium (10% serum). Figure 5
shows that injected cells display high levels of fos
staining both 1 hour (A) and 4 hours (B) after injec-
tion of the C subunit. For comparison, Figure 5C
shows the effect of ras (T-24, previously reported to
induce c-fos expression) on the level of c-fos stain-
ing 4 hours after injection, and Figure 5D shows a
field of cells injected with the R,I subunit and
stained with fos antibodies. These results demon-
strate that increasing the activity of cAMP-dependent
protein kinase within individual cells rapidly induces
the expression of genes containing DNA sequences,
termed cAMP-response elements (CREs), and that
this induction can occur in the absence of cyclic
nucleotides and the R subunits of cAMP-dependent
protein kinase. We are now attempting to determine
how the C subunit and ras affect expression of c-fos
and the CRE-P-galactosidase construct.
Expression of c-fos and Entry into
DNA Synthesis Is Prevented by
Microinjection of Serum Response
Element DNA Oligonucleotides
K. Riabowol, J.R. Feramisco [in collaboration with
M. Gilman, Cold Spring Harbor Laboratory]
The 5' region of the c-fos gene contains several pro-
moter regions, including an element with a region
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of dyad symmetry termed the serum response ele-
ment (SRE), previously shown to be necessary for
transcriptional induction of gene constructs by fac-
tors present in serum. The induction of gene expres-
sion seen upon serum stimulation of quiescent cells
is thought to occur by the activation and binding of
positively acting (or inactivation of negatively act-
ing) transcription factors within this DNA sequence.
To address this question, we designed experiments
EN
FIGURE 6 Expression of c-fos in cells injected with oligonucleotides. Serum-deprived (0.5% serum, 24
hr) rat 208F fibroblasts were fixed and processed for indirect immunofluorescence analysis before (8) or
after (A,C-F) stimulation with medium containing 10% serum. Oligonucleotides injected into cells were
as follows: (A,B) not injected; (C) 0.5 mg/ml SRE; (D) 0.1 mg/ml SRE; (E) 0.5 mg/ml SRE point mutant;
(F) 0.5 mg/ml SV40 control oligonucleotide. Staining was done by incubation of fixed cells with affinity-
purified rabbit anti-fos antibodies, followed by incubation with fluorescein-conjugated goat anti-rabbit IgG
antibodies.
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to determine if expression of the endogenous c-fos
gene could be altered by affecting the availability of
active transcription factors within serum-stimulated
fibroblast cells. Double-stranded DNA oligonucleo-
tides corresponding to (1) the wild-type SRE; (2) a
point mutant of the SRE known to bind protein fac-
tors much less avidly, as assayed by gel-shift assay;
and (3) two mutant sequences of the SV40 promoter
that display no enhancer activity (kindly supplied
by B. Ondek and W. Herr, Tumor Viruses Section)
were microinjected into quiescent, serum-deprived
cells. Cells were refed with medium containing 10%
serum, incubated 90 minutes, and fixed and pro-
cessed for indirect immunofluorescence analysis by
incubation with affinity-purified fos antibodies, fol-
lowed by fluorescein-conjugated goat anti-rabbit IgG
antibodies. We find that cells injected with buffer
or with mutant SV40 promoter oligonucleotides
show levels of nuclear fluorescence similar to those
in uninjected cells. In contrast, cells injected with
oligonucleotides corresponding to the wild-type SRE
show levels of nuclear fluorescence similar to those
in quiescent cells, whereas cells injected with the SRE
point mutant show intermediate levels of nuclear
fluorescence. Figure 6 shows the nuclear-staining pat-
tern obtained when quiescent, serum-deprived (Fig.
6B) or serum-stimulated 208F cells were injected with
SRE oligonucleotides (0.5 mg/ml, panel C; 0.1
mg/ml, panel D), SRE point mutant (0.5 mg/ml,
panel E), and SV40 control oligonucleotides (0.5
mg/ml, panel F) or were left uninjected (panel A).
Pictures were automatically exposed for the same
period of time to allow comparison of fluorescence
intensity between fields of cells. In addition to af-
fecting c-fos expression, microinjection of the SRE
oligonucleotides into serum-deprived 208F fibro-
blasts inhibited the incorporation of PHIthymidine
when cells were subsequently stimulated by the ad-
dition of medium containing 10% serum and in-
cubated for 24 hours prior to emulsion autoradiog-
raphy. This inhibition was not as complete as seen
when cells were injected with antibodies directed
against the fos protein, which may reflect the t1,2 of
140
the oligonucleotides, compared to antibody mole-
cules, when injected into fibroblast cells.
We are now in the process of determining if this
experimental approach can be used in conjunction
with other methods, to determine which cell-signal
pathways operate through DNA sequences known
to be important in the control of gene expression.
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MAMMALIAN HEAT-SHOCK (STRESS) RESPONSE
W.J. Welch A.-P. Arrigo K.T. Riabowol M. Mulcahy
L.A. Mizzen JP. Suhan L. Cipp
We have continued our efforts to understand how
mammalian cells recognize and confront adverse
changes in their local growth environment. Our sys-
tem of study, the so-called heat-shock or stress re-
sponse, is best characterized by the rapid and prefer-
ential transcription and translation of a set of genes
that lead to the synthesis and accumulation of a
group of proteins, the stress proteins. Collectively,
these proteins appear to serve a function in either
protecting the cell during the particular stress event
at hand or facilitating the return of normal cellular
functions when the cell is placed back into its nor-
mal environment. Consequently, most of our efforts
have centered around purifying and characterizing
the individual stress proteins with the ultimate ob-
jective, of course, of defining their exact biochemi-
cal function. Toward these ends, we have succeeded
in purifying most of the major stress proteins and
have prepared antibodies to each, and, as discussed
further below, we are quite involved in experiments
aimed at determining the function of these proteins
both in the normal cell and in cells under stress.
Within the past year or two, we have witnessed
a considerable increase in the number of laborato-
ries investigating the structure/function of the heat-
shock proteins. This new interest stems from recent
observations implicating a role for many of the stress
proteins in diverse areas of cell biology. These in-
clude a role for the 70-kD stress proteins in the ATP-
dependent uncoating of clathrin-coated vesicles and
recent reports of rather stable associations between
members of the 70-kD stress-protein family and var-
ious oncogene proteins, including the SV40 large
T antigen, the adenovirus E1A protein, polyoma
middle T antigen, and the cellular p53 protein. With
respect to the very abundant and highly phosphory-
lated 90-kD stress protein, we and other investiga-
tors have shown that the protein is a component of
(and perhaps regulator of) various steroid receptor
complexes and is involved in the intracellular trans-
port of various protein tyrosine kinases such as
pp6Os". In the case of the low-molecular-mass heat-
shock protein, 28 kD, recent studies are beginning
to implicate a role for the protein in proliferation
and/or differentiation. Finally, in the last year or so,
it has been shown by a number of laboratories that
members of the 70-kD stress-protein family are in-
volved in the translocation of proteins across the in-
tracellular membranes and trafficking through the
endoplasmic reticulum and Golgi complex. These
studies, in sum, both underlie the importance of the
stress proteins in normal cellular processes and pro-
vide us with a solid foundation by which to examine
their biochemical function further. Moreover, with
this influx of laboratories beginning to focus on the
stress proteins from so many different directions, I
am confident that the field will realize considerable
acceleration with respect to determining the struc-
ture/function of the stress proteins.
Defining the Thermotolerant Cell
L.A. Mizzen, W.J. Welch
Perhaps the most important clue we have concern-
ing the role of the heat-shock response and the pos-
sible function of the heat-shock proteins comes from
studies examining the ability of cells to survive mul-
tiple stress events. For example, if cells are presented
a mild heat-shock treatment and then allowed to re-
cover, they acquire a transient resistance to a subse-
quent and otherwise lethal heat-shock challenge.
This phenomenon, referred to as acquired ther-
motolerance, appears to be dependent on the prior
production of functional stress proteins during the
conditioning heat-shock treatment. To understand
more fully how cells become thermoresistant and to
determine the possible role of the stress proteins in
the acquisition of the thermotolerant state, we un-
dertook a study to define the major differences ex-
hibited by the tolerant cell, as compared to the non-
tolerant cell in response to a severe heat-shock
challenge.
As discussed in last year's Annual Report, one ma-
jor difference exhibited by the tolerant cell is the pro-
tection of translational activity following the second
and more severe heat-shock event. For example, if
cells are brought immediately to a rather high tem-
perature (45°C for 30 min), overall protein synthe-
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sis activity is severely impaired and does not recover
for as long as 5 hours following the return of the
cells back to 37°C. In contrast, cells first made ther-
motolerant (e.g., a 43°C, 1-hr heat shock and recov-
ery at 37°C for 8 hr) and then presented the 45°C,
30-minute shock exhibit a return of translational ac-
tivity by as soon as 1 hour. In a number of different
studies, we have observed a strict correlation between
the levels of the 70-kD stress proteins and the abil-
ity of the cells to acquire resistance to hyperthermic
treatment, as assayed by their ability to recover trans-
lational activity. Moreover, using this new assay, we
are trying to determine directly, via microinjection
studies of either the purified 70-kD stress proteins
or alternatively antibodies specific to 70-kD, whether
the 70-kD stress proteins are directly involved in pro-
tecting the translational machinery against inacti-
vation by high-temperature exposure of the cell (Miz-
zen and Welch, J. Cell Biol. 106 1105 [1988]).
Acquisition of the thermotolerant state is mani-
fested in a number of other events that are perturbed
in the cell following heat shock. For example, al-
though processing of heterogeneous nuclear RNA
(hnRNA) (i.e., splicing) is severely curtailed in cells
given a severe heat-shock treatment, such RNA pro-
cessing is significantly less inhibited if the cells are
first made thermotolerant. In this respect, we are in-
trigued by our preliminary observations showing that
a portion of the 70-kD stress proteins colocalize
within the nucleus with the so-called small nuclear
ribonucleoproteins (snRNPs), which are involved in
RNA-processing activities (W. Welch et al., unpubl.).
Finally, we have found that a number of other le-
sions that occur in cells as a consequence of heat-
shock treatment, including the collapse of the inter-
mediate filaments and the disruption of the nucleo-
lar integrity and function, either do not occur or are
repaired faster if the cells are first rendered ther-
motolerant (Welch and Mizzen, J. Cell BioL 106 1117
[1988]).
We think it likely that the stress proteins, particu-
larly the 70-kD proteins, serve a critical role in pro-
tecting various cellular machineries from heat-
induced damage and as such facilitate the acquisi-
tion of the thermotolerant state. Understanding the
mechanism of thermotolerance acquisition will prove
to be quite important with respect to a number of
areas in biology and medicine. For example, it has
been shown that developmental abnormalities aris-
ing from exposure to various teratogenic agents can
be prevented if the embryo is first made thermotoler-
ant. In addition, because new enthusiasm is resur-
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facing concerning the use of site-directed hyperther-
mia as a cancer treatment modality, understanding
how cells (and tumors) defend themselves (and be-
come thermotolerant) will prove critical to the suc-
cessful development of this new approach to cancer
treatment.
A Family of ATP-binding
Stress Proteins
L.A. Mizzen, W.J. Welch
If the 70-kD stress proteins are indeed involved in
protecting macromolecular proteinaceous complexes
from protein denaturation and/or repairing such
denaturation events, the obvious question arises as
to how this might occur mechanistically. A number
of recent observations are beginning to shed new light
on the possible biochemical functions of hsp70.
First, the simple fact that the cell contains such high
levels of hsp70 both before or after heat-shock treat-
ment is indicative of the proteins having some
general, mass-acting function in the cell, as opposed
to a very defined catalytic role. Second, the hsp70
proteins appear to be capable of binding and per-
haps hydrolyzing ATP. Finally, it has been shown
that a protein involved in the proper assembly of im-
munoglobulins within the endoplasmic reticulum is
in fact related to the hsp70 proteins. This protein,
referred to as BiP, was first observed to form tran-
sient interactions with immunoglobulin heavy chains
in pre-B cells, with the interaction dependent on ATP.
A number of experiments indicate that BiP func-
tions in the ordered assembly of the immunoglobu-
lin heavy chains (H) with the immunoglobulin light
chains (L), thereby allowing for the mature form of
the immunoglobulin, H2L2. Both cDNA sequence
analysis and immunological studies have shown that
BiP is identical for the glucose-regulated 80-kD stress
protein and exhibits approximately 50% homology
with the hsp70 proteins.
Using this model in which BiP transiently inter-
acts in an ATP-dependent manner with proteins
trafficking through the endoplasmic reticulum, we
think it possible that the 70-kD stress proteins simi-
larly might form transient interactions with dena-
tured proteins in the cell following stress. Using the
energy provided by ATP hydrolysis, the 70-kD pro-
teins might function to either promote refolding of
these partially denatured proteins or prevent such
a denaturation event from ever occurring. In this way,
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FIGURE 1 Identification of stress proteins present in the mitochondria. Mitochondria were purified from
rat liver, and the mitochondrial proteins were analyzed by two-dimensional gel electrophoresis and visual-
ized by silver staining of the gel (in collaboration with J. Garrels). In parallel, rat embryo fibroblasts, growing
at 37°C, were labeled with [35S]methionine, the radiolabeled proteins were analyzed by two-dimensional
gel electrophoresis, and the proteins were visualized by fluorography. (A) [35S]methionine- labeled proteins
of rat fibroblasts; (B) protein constituents of isolated rat liver mitochondria. The positions of the 75-kD and
56-kD mitochondrial stress proteins are indicated by the downward and upward pointing arrows, respectively.
one could imagine then how the 70-kD stress pro-
teins might function in providing a protective effect
of macromolecular complexes (e.g., translational ma-
chinery and RNA-processing machinery) known to
be affected by heat shock or other stress-inducing
agents (discussed above). Hence, using a number of
different approaches, we are examining the possibil-
ity that the 70-kD protein interacts with partially
denatured proteins and that such an interaction is
dependent on ATP.
We should also mention that we have found what
appears to be yet another member of the hsp70 pro-
tein family, what we refer to as the 75-kD protein.
We have found that the 75-kD protein appears to be
structurally related to hsp72, hsp73, and the glucose-
regulated 80-kD protein (BiP) as determined by both
comparative peptide mapping and immunological
cross-reactivity. This protein, like the other proteins
of the family, binds avidly to ATP covalently linked
to Sepharose, and this property of the protein has
facilitated our purification of the protein to appar-
ent homogeneity. In addition, in a collaborative ef-
fort with J. Garrels' laboratory, we have found that
the 75-kD protein is compartmentalized within the
mitochondria and, as such, is synthesized as a precur-
sor with an apparent mitochondrial signal leader se-
quence (Fig. 1). Presently, we are attempting to de-
termine the exact location of the 75-kD protein
within the mitochondria as well as other proteins
with which it might interact. Finally, we find it in-
triguing that the 75-kD protein, like the 80-kD (BiP)
protein, is both a compartmentalized form of hsp70
and is increased in cells as a result of either glucose
or calcium deprivation (L.A. Mizzen et al., in prep.).
Thus, we think it likely that the 75-kD protein may
function, like its related counterpart, the 80-kD
protein (BiP), in regulating protein-trafficking
events within the mitochondria in an ATP-dependent
manner.
Characterization of the
Low-molecular-mass 28-kD
Mammalian Stress Protein
A.-P Arrigo, J.P. Suhan, W.J. Welch
As discussed in last year's Annual Report, we have
finally succeeded in purifying, to apparent
homogeneity, the smaller 28,000-kD stress protein
from HeLa cells. This was a difficult endeavor ow-
ing to the fact that this protein, unlike the other stress
proteins, does not accumulate to high levels in cells
following heat-shock treatment. Nevertheless, using
a combination of ion-exchange and gel-filtration
chromatography, the protein has been isolated in
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FIGURE 2 The 28-kD mammalian stress protein exists as a defined structure and is localized
near the Golgi complex in monkey cells. The 28-kD stress protein was purified to homogeneity,
and the isolated protein was analyzed by high-voltage electron microscopy (8). Note the well-
defined 15-20-nm spherical structure and its structural homology with that of a-crystallin pro-
teins (A), which exhibit approximately 50% sequence homology with the low-molecular-weight
28-kD stress protein. Using the purified protein, a rabbit polyclonal antibody specific to 28-kD
was obtained and used to determine the intracellular locale of 28-kD in monkey cells (CV-1) be-
fore and after heat-shock treatment via indirect immunofluorescence. Panel C shows the distri-
bution of the protein in cells grown at 37°C and panel D shows the location of 28-kD following
heat shock. The perinuclear distribution of the protein in the 37°C cells corresponds to the distri-
bution of the Golgi complex as determined by double-label staining using anti-28kD and a lectin
specific for Golgi-associated components.
pure form (Arrigo and Welch, J. Biol. Chem.
262: 15359 [1987]). Interestingly, the purified protein
appears to be an oligomer with an approximate na-
tive mass of 300-500 kD. In the electron microscope,
the protein appears as a circular particle with an av-
erage diameter of m18 nm (Fig. 2).
Using the purified protein as antigen, we have suc-
ceeded in raising polyclonal antibodies specific for
the 28-kD protein. Using these antibodies, we have
examined the intracellular locale of the protein be-
fore and after heat-shock treatment via indirect im-
munofluorescence (Fig. 2). In cells grown at 37°C,
the 28-kD protein is observed to localize primarily
within the perinuclear region. Because the staining
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patterns appeared to be similar to that observed for
the Golgi compartment, we obtained a fluorescently
labeled lectin that recognizes a number of proteins
known to reside within the Golgi. Using double-label
fluorescence techniques, we have found that the
28-kD protein is closely aligned in and around the
Golgi stacks. After heat-shock treatment, this stain-
ing pattern appears to "break up," and there is a cor-
responding increased staining within the peripheral
regions of the nucleus. We have previously shown
that the Golgi complex itself similarly becomes frag-
mented and somewhat dispersed after heat-shock
treatment of the cells. We are currently investigat-
ing whether the 28-kD protein might actually be an
integral component of the Golgi or a more periph-
eral protein situated on the external side of the in-
dividual Golgi stacks/vesicles.
We have observed a number of interesting prop-
erties of the 28-kD protein that appear to differ de-
pending on the physiological state of the cell. First,
as mentioned above, the 28-kD protein is an oligo-
meric protein with an apparent mass of at least 300
kD in cells grown at their normal temperature. Af-
ter heat-shock treatment, however, the protein ap
pears to form large oligomers and exhibits a native
size between 500 kD and approximately 2 x 106 dal-
tons. With recovery from heat-shock treatment, the
protein slowly returns to its smaller size. A second
property of the protein is its different intracellular
distribution and solubility in the cell as a function
of stress. Although much of the protein is found in
the low-speed supernatant of detergent-extracted
cells incubated under normal conditions, most of the
protein redistributes within the detergent-insoluble,
low-speed pellet following heat-shock treatment.
However, rendering the cells thermotolerant (by ex-
posure to a prior mild heat-shock treatment and sub-
sequent recovery period at 37°C) results in the pro-
tein to now remain in the detergent-soluble phase
following a second and more severe heat-shock treat-
ment. As the cells slowly lose their thermotolerant
status, more of the protein is observed to fraction-
ate within the low-speed pellet following the heat-
shock treatment. Using this simple observation, i.e.,
the distribution within the low-speed supernatant
versus the pellet, we can now fairly well predict the
thermotolerant "status" of the cell (A.-P. Arrigo et
al., in prep.).
One direction we plan to pursue with respect to
the 28-kD protein involves the response of cells to
steroids and/or growth factors. Recently, we came
across reports from workers in the steroid field show-
ing that the addition of steroids to various target cells
results in an increased synthesis of a protein of ap-
proximately 27 kD and that has now been shown to
be the 28-kD heat-shock protein. This result, coupled
with our previous observation showing that the phos-
phorylation of the 28-kD protein increases in cells
following addition of mitogens or tumor promoters,
leads us to believe that the 28-kD heat-shock pro-
tein may play an essential role in proliferation, de-
velopment, and/or differentiation. Further support
for this idea follows from other observations that
the expression of the Drosophila melanogaster
equivalent of hsp28 appears to be regulated at differ-
ent times during embryonic development. Conse-
quently, we are beginning to examine the properties
of the 28-kD protein in both normal and transformed
cells and are setting up the appropriate tissue-culture
cell lines that will respond in a known fashion to
added steroids to facilitate our search for 28-kD
function.
Identification of the Prosome
Particle as a Large Multifunctional
Protease
A: P. Arrigo, J.P. Suhan, W.J. Welch [in collaboration
with A.L. Goldberg, Harvard Medical School]
For a number of years, there have been numerous
reports of a ring-shaped 19S-20S particle in both the
cytoplasm and nucleus of eukaryotic cells. Because
these particles were often found to copurify with in-
active mRNAs, they were assumed to function in the
regulation of translation of certain classes of mRNAs
and hence were named prosomes (for program-o-
some). Prosomes isolated from many different
sources exhibit the same polypeptide composition,
with approximately six to ten proteins ranging in size
between 25 kD and 35 kD. In fact, because of their
subunit composition and appearance as a defined
particle in the electron microscope, the prosome was
once thought to be composed of the low-molecular-
weight heat-shock proteins. However, this is not the
case; instead, the low-molecular-weight heat-shock
proteins, as detailed above, form their own 19S-20S
particle and as such, often copurify with the 19S-
20S prosome particle. In the course of examining the
prosome from HeLa cells, we noted that it was simi-
lar in many ways to a high-molecular-weight protease
complex purified in A.L. Goldberg's laboratory. This
70-kD enzyme complex, designated LAMP (for large
alkaline-sensitive multifunctional protease) contains
three endoproteolytic sites that function at neutral
or alkaline pH and are specific for the hydrolysis of
proteins, hydrophobic peptides, or basic peptides.
Using a number of criteria including electron mi-
croscopy, immunological cross-reactivity, and pep-
tide mapping, we have shown that the prosome is
in fact identical to this large protease, LAMP (Ar-
rigo et al., Nature 331: 192 [1988]). Currently, in con-
junction with A.L. Goldberg's laboratory, we are in-
vestigating whether LAMP may serve a role in
intracellular protein breakdown in cells subjected to
physiologic stress.
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Association of hsp70 with Different
Oncogene Proteins
W.J. Welch [in collaboration with J. Jenkins, Marie Curie
Cancer Research Foundation; G. Walter, University of
California at San Diego; E. White and D. Spector, Cold
Spring Harbor Laboratory]
During the past few years, it has become apparent
that the expression of at least one form of hsp70 ap-
pears to be cell-cycle-regulated and in some cases,
its levels are increased in highly proliferating cells.
Moreover, it has been demonstrated that hsp70 lev-
els increase in cells transfected with a number of so-
called cooperating oncogene products, including
SV40 large T antigen, polyomavirus T, c-myc,
adenovirus E1A, and the cellular p53 protein. In ad-
dition to promoting hsp70 expression, a number of
these oncogene proteins have been observed to form
an association with hsp70, and in some cases, these
associations appear to be ATP-dependent. In a col-
laborative effort with other investigators, we have
shown that mutated forms of both polyomavirus
medium T antigen and the cellular p53 protein form
a stable complex with hsp70 (Walter et al., J. ViroL
61: 405 [1987]; Sturzbecher et al., Oncogene 1: 201
[1987]). Very recently, in a collaborative effort with
E. White and D. Spector, we observed a similar coas-
sociation of hsp70 with the adenovirus E1A (12S and
13S) protein (E. White et al., submitted). At the pres-
ent time, the biological relevance of these associa-
tions of various oncogene proteins with hsp70 is not
clear. One interpretation is that the high-level expres-
sion of these oncogene proteins is recognized as del-
eterious to the cell, and therefore the association with
hsp70 reflects a housekeeping function of the pro-
tein perhaps similar to its role in the cell after stress.
Alternatively, these various associations of hsp70
may be important to the stability, regulation, and/or
function of these oncogene proteins and the main-
tenance of the transformed phenotype.
Heat Shock Is Lethal to Fibroblasts
Microinjected with Antibodies
Directed against hsp70
K.T. Riabowol, L.A. Mizzen, W.J. Welch
One approach we are using to dissect the function
of the individual stress proteins has employed the
technique of microinjection. Through finely drawn
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glass needles, we are able to introduce into the cell
either purified proteins, their corresponding antibod-
ies, mRNAs, or antisense RNA and then assess the
effects by morphological or biochemical criterion.
Using this approach, we have introduced a mixture
of affinity-purified monoclonal antibodies directed
against hsp70 and have examined the cells follow-
ing a subsequent heat-shock treatment. We have
found that the introduction of hsp70 antibodies into
the cytoplasm of the cell completely inhibits the heat-
dependent redistribution of hsp70 from the cyto-
plasm into the nucleus and nucleolus. Moreover, the
injected cells are unable to survive the heat-shock
treatment (KT. Riabowol et al., submitted). These
results then demonstrate that hsp70 is required for
the survival of cells exposed to thermal stress. This
result nicely complements previous genetic studies
demonstrating a similar requirement for hsp70 in the
ability of either yeast or E. coli to grow and accli-
mate to high temperatures.
Using this same approach, we are beginning to as-
sess the effects either of introducing antibodies spe-
cific for the other stress proteins or of modulating
the intracellular levels of the stress proteins directly
by injection of the purified stress proteins. In the lat-
ter case, we plan to examine whether the absolute
levels of the individual stress proteins serve in regulat-
ing their own synthesis and whether such regulation
is in fact dependent on the severity of the stress treat-
ment. Finally, because one or more of the stress
proteins may be involved in the acquisition of ther-
motolerance, we plan to determine whether introduc-
tion of specific antibodies against the individual
stress proteins might result in an inability of the cell
to acquire the thermotolerant state.
COLLABORATIVE EFFORTS
Numerous laboratories working in many different
areas of cell biology are beginning to converge in the
areas of the mammalian stress response and the func-
tion of the stress proteins. Owing to our having pu-
rified all but one of the stress proteins, as well as
raising the appropriate antibodies to each, we have
entered into a number of exciting collaborative ef-
forts including (1) the possible role of the heat-shock
proteins, and in particular hsp70, in the regulation
and/or function of intracellular protein break-
down in cells following heat-shock treatment (with
N. Spector, S. Fraser, and A.L. Goldberg, Harvard
Medical School); (2) the induction and accumula-
tion of hsp70 in rodent brains following transient
ischemia (with T. Nowak, National Institutes of
Health); (3) the possible participation of hsp70
in hnRNA processing (splicing) (with R. Mori-
moto, Northwestern University, and D. Spector and
A. Krainer, Cold Spring Harbor Laboratory); (4) the
role of the 90-kD heat-shock protein in regulating
the activity of the translation factor eIF-2a protein
kinase (with B. Hardesty, University of Texas, Aus-
tin); (5) the stimulation of heat-shock protein syn-
thesis in T lymphocytes treated with various T-cell
mitogens (with W. Farrar, National Cancer Institute);
and (6) the participation of both hsp70 and hsp90
in the regulation and activity of steroid receptors
(with D. Edwards, University of Colorado, and
D. Toft, Mayo Clinic).
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MOLECULAR BIOLOGY OF THE CYTOSKELETON
D.M. Helfman S. Cheley L. Goodwin L.A. Finn
S. Erster J.P. Lees-Miller W.M. Ricci
The emphasis of our research is directed toward un-
derstanding the molecular and cellular biology of
tropomyosins in normal and transformed cells.
Tropomyosins comprise a family of related actin-
binding proteins present in muscle (skeletal, cardiac,
and smooth) and nonmuscle cells. Although they are
present in all cells, different isoforms of the protein
are characteristic of specific cell types. During the
past year, we have concentrated our efforts on study-
ing the genes that encode tropomyosins and on de-
veloping experimental assays to study their expres-
sion in muscle and nonmuscle cells. Work from our
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laboratory and others has demonstrated that the
generation of tropomyosin isoform diversity involves
the expression of multiple genes, most of which code
for more than one isoform by the use of alternatively
spliced exons. Some of our efforts are aimed at
studying the molecular basis for the tissue-specific
RNA processing that is involved in the generation
of tropomyosin isoform diversity. In addition, we
have continued to investigate the mechanism and
functional significance of the alterations in tropo-
myosin expression in transformed cells. The follow-
ing is a brief description of these studies.
Studies of Alternative Splicing
Pathways of Tropomyosin
Pre-mRNAs In Vitro
D.M. Heitman, W.M. Rico
Work from our laboratory has previously demon-
strated that a single gene encodes both rat fibroblast
tropomyosin 1 (TM-1) and skeletal-muscle 13-tropo-
myosin by alternative RNA splicing (Helfman et al.,
MoL Cell. Biol. 6: 3582 [1986]). The gene contains
11 exons and spans approximately 10 kb (Fig. 1).
Exons 1 through 5 and exons 8 and 9 are constitu-
tive exons common to all mRNAs expressed from
this gene. Exons 6 and 11 are used in fibroblasts as
well as smooth-muscle cells, whereas exons 7 and 10
are used exclusively in skeletal muscle. The structural
features of this gene raises a number of questions
concerning the mechanisms involved in tissue-
specific RNA processing. The existence of a mecha-
nism(s) whereby the same gene can generate unique
isoforms in cells as different as skeletal muscle and
fibroblasts underlies the importance of regulatory
factors (both cis and trans) that must be implicated
CAP SITE
in alternative RNA processing. At present, the na-
ture of these cis- and trans-acting factors are not
known and constitutes a major focus of our research.
We have been studying alternative RNA splicing
of the rat TM-1 gene in vitro using nuclear extracts
derived from HeLa cells. We have used nuclear ex-
tracts derived from HeLa cells because human cells
contain the same isogene as the rat and HeLa cells
express the same isoform as rat fibroblasts. We find
that in vitro splicing of "P-labeled pre-mRNAs
composed of the internal alternatively spliced region
of the gene (exons 5 through 8) results in exon skip-
ping, wherein exon 5 is spliced efficiently to exon
8. The lack of splicing of exon 5 to exon 6 or 7 was
not due to a simple cis-competition for 3' splice sites
because truncated pre-mRNAs containing only
exons 5 and 6 or exons 5 through 7 did not splice
exon 5 to 6 or 7. Interestingly, we were able to detect
efficient splicing of exon 5 to 6 (fibroblast-type
splice) and exon 5 to 7 (skeletal-muscle-type splice),
using precursors in which exon 6 or 7 was first joined
to exon 8. The ability of HeLa cell nuclear extracts
to splice exon 5 to exon 7 was unexpected, since this
splice occurs exclusively in skeletal muscle in vivo.
Since HeLa cell nuclear extracts were able to utilize
the 3' splice sites of both exon 6 (fibroblast-type
splice) and exon 7 (skeletal-muscle-type splice), it
seems likely that 3' splice-site recognition of these
exons does not require cell-type-specific factors.
However, it is possible that 3' splice-site discrimina-
tion is lost using the in vitro system. This could be
due to the loss of a regulatory factor during the ex-
tract preparation. On the other hand, splicing of exon
5 to either exon 6 or exon 7 may not strictly be a
regulated event, but dependent solely on either of
the alternative exons being spliced to exon 8 (see be-
low).
The observation that both of the internal alterna-
tively spliced exons (exon 6 and exon 7) must first
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FIGURE 1 Schematic diagram of the tropomyosin gene and model for the generation of rat fibroblast TM-1 and skeletal-muscle
p-tropomyosin mRNAs by alternative RNA processing. Open boxes represent common exons, hatched boxes represent fibroblast
or smooth-muscle exons, closed boxes represent skeletal-muscle exons, and horizontal lines represent introns; they are not drawn
to scale. The amino acids encoded by each exon are indicated. The cap site and polyadenylation signal AATAAA are also indicated.
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be joined to the downstream constitutive exon be-
fore they can be spliced to the upstream constitutive
exon has important implications in understanding
the regulation of splice-site selection. The data are
consistent with a model in which the critical event
in alternative splicing occurs during the joining of
exon 6 to exon 8 (fibroblast-type splice) or exon 7
to exon 8 (skeletal-muscle-type splice). However, even
if this model is correct, we cannot conclude that splic-
ing exon 6 to exon 8 and exon 7 to exon 8 are both
regulated processes. For example, splicing of exon
6 to exon 8 may simply reflect the constitutive or de-
fault pathway, whereas splicing of exon 7 to exon
8 requires tissue-specific factors expressed in skele-
tal muscle. Experiments are in progress to determine
if splicing of exon 6 to exon 8 or exon 7 to exon 8
requires tissue-specific splicing factors.
In Vivo Analysis of Sequences
Involved in Internal Splice-site
Selection of the TM-1 Gene
D.M. Hellman, L.A. Finn
We are also studying the tissue-specific splicing of
the TM-1 gene by introducing into tissue-culture cells
DNA constructions (minigenes) containing defined
regions of DNA to determine which sequences are
required for alternative RNA processing. To study
the internal alternatively spliced region of the gene,
we have cloned genomic sequences from exons 5
through 9 into a eukaryotic expression vector con-
taining the SV40 early promoter and a functional
poly(A) site. Transient and stable expression of this
minigene in rat fibroblasts, He La cells, L6 myoblasts,
and C2 myoblasts resulted in splice products that
contain exon 5 + 6+ 8 + 9. No other products were de-
tected, and no RNAs were detected that contain exon
7. These results are consistent with the splice prod-
ucts expected if this minigene is being processed in
a tissue-specific mannner in these cells types. In ad-
dition, we have established a number of stable trans-
formants containing this minigene in mouse C2 my-
oblasts, a cell line that mimics myogenesis. Thus,
when the myoblasts fuse to form myotubes, there is
cessation of cell division, together with repression
of fibroblast TM-1 synthesis, followed by fusion of
the myoblasts with induction of skeletal-muscle 13-
tropomyosin. As described above, expression of this
minigene in the myoblasts results in the generation
of RNAs that contain only the fibroblast exon (exon
6). We are currently in the process of determining
if expression of this minigene in the differentiated
myotubes exhibits utilization of the skeletal-muscle-
specific exon (exon 7).
Studies of Alternative 3'-end
Processing of Tropomyosin
Pre-mRNA In Vivo
S. Erster, L.A. Finn, D.M. Heitman
The 3'-end processing events of the TM-1 gene re-
quires both alternative exon selection and utilization
of the appropriate poly(A) site (Fig. 1). To study the
alternative 3'-end processing events, we have gener-
ated a series of wild-type and mutant minigenes con-
taining genomic sequences from exon 9 to exon 11.
These minigenes have been introduced into cultured
cells by transfection, and the RNA processing prod-
ucts generated after transient expression have been
characterized by Sl- nuclease analysis and by a modi-
fied primer-extension assay (see below). Transient ex-
pression in COS cells results in splicing of exon 9
to both exon 10 (skeletal-muscle-type splice) and
exon 11 (fibroblast-type splice) and utilization of
both poly(A) sites, with a preference for the fibro-
blast-type pathway. In contrast, expression of wild-
type constructions in 3T3 fibroblasts results exclu-
sively in splicing of exon 9 to exon 11 (fibroblast-type
splice). We have generated several deletions within
intron 9 that result in an increase in the efficiency
of splicing of exon 9 to exon 10 in COS cells, as well
as utilization of exon 10 in 3T3 cells. We are cur-
rently determining whether the deletions in intron
9 that result in utilization of the skeletal-muscle exon
(exon 10) in 3T3 cells are simply the result of the de-
crease in intron length or the removal of specific se-
quences. In addition, we are characterizing the pro-
cessing products of the minigenes in the mouse
myogenic cell C2.
Development of a New Method to
Analyze Splice-site Selection
S. Erster, L.A. Finn, D.A. Frendewey, D.M. Hellman
To facilitate our studies of RNA splicing, we have
developed a procedure using a modification of stan-
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dard techniques to study RNA splice-site selection.
First, an oligodeoxynucleotide complementary to
exon sequences upstream of a 5' splice donor site of
interest is annealed to the RNA. The DNA-RNA hy-
brid is then digested with RNase H, resulting in RNA
molecules that are cleaved precisely at the same site.
The cleaved RNAs are then subjected to primer ex-
tension using a 32P labeled primer complementary
to sequences downstream from an appropriate 3'
splice site. Since the primer-extension products all
terminate at the site of RNase H cleavage, their
lengths are indicative of the splice sites utilized. The
method simplifies the study of splicing of complex
pre-mRNAs by allowing individual introns to be ana-
lyzed separately. We have used this method to char-
acterize successfully rat tropomyosin mRNAs ex-
pressed in different tissues and RNAs generated in
vivo by transient expression of tropomyosin minigene
constructions in cultured cells. In addition, we have
used this approach to study the differential splicing
at both the 3' end and at the internal region of the
TM-1 gene. One of the advantages of the technique
is the ability to detect exon skipping, which was un-
detected using available cDNA probes. Furthermore,
3' exon splicing can be studied with this procedure,
since there is no need to primer-extend a long RNA
from the 3' end all the way to the 5' end.
Identification of Novel Tropomyosin
Isoforms Expressed in Rat Brain via
Tissue-specific RNA Processing
J.P. Lees-Miller, D.M. Hellman
Using 32P- labeled probes prepared from a cDNA
clone that encode skeletal muscle a-tropomyosin (a-
TM), we have detected three mRNAs of approxi-
mately 3.0, 1.8, and 1.3 kb in rat brain. It has already
been shown that a single gene encodes skeletal-
muscle a-TM, smooth-muscle a-TM, and fibroblast
TM-2 by an alternative RNA-splicing mechanism.
To determine the structure of the brain mRNAs, and
to investigate a possible structural relationship with
other mRNAs, we have isolated and characterized
a number of cDNA clones from a rat brain library.
At present, we have isolated 20 cDNA clones that
contain sequences related to the a-TM. The longest
cDNA is approximately 2.8 kb; however, sequence
analysis indicates that it is not full length. This cDNA
starts at amino acid 83 and contains sequences
through the poly(A) tract. Comparison of the brain
cDNA indicates that it is identical to skeletal-muscle
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a-TM, smooth-muscle a-TM, and fibroblast TM-2
from the region encoding amino acids 83-257. These
data indicate that it is the product of the same gene
that encodes these three other isoforms. However,
the brain cDNA was found to contain a novel
carboxy-terminal region that would encode a
tropomyosin containing 281 amino acids. This is as-
suming that this message has the same 5'-coding se-
quences characteristic of other tropomyosin isoforms
expressed from this gene. At present, the structure
of the 5' end of this mRNA is unknown, and experi-
ments are under way to determine its structure. Fur-
ther sequence analysis of the 2.8-kb cDNA indicates
that it contains a long 3'-untranslated region, ter-
minating with the same sequences also found to en-
code the carboxy-terminal end and the 3'-untrans-
lated sequences through the poly(A) site used in
fibroblasts and smooth muscle. Analysis of genomic
clones has revealed that the 3-kb mRNA expressed
in the brain results from use of a brain-specific splice
located upstream of the exon used in fibroblasts and
smooth-muscle cells. In addition, we have deter-
mined that there are two additional poly(A) sites uti-
lized in the brain that are located downstream from
this brain-specific splice site that give rise to 1.3- and
1.8-kb mRNAs. We have also isolated a full-length
clone of approximately 1.3 kb from the brain cDNA
library that contains a portion of the 5'-untranslated
sequences through the poly(A) tract. This clone con-
tains coding sequences that are identical to those of
skeletal-muscle a-TM from amino acids 1 to 257 and
the novel brain-type carboxy-terminal end corre-
sponding to amino acids 258-281. The significance
of the three different poly(A) sites associated with
the same carboxy-terminal coding sequences is un-
clear at present. We are now determining if the differ-
ences in the 3'-untranslated regions of these mRNAs
correlate with distinct 5'-coding sequences. In addi-
tion, studies are under way to determine the expres-
sion of the brain tropomyosin isoforms with respect
to region, cell type, and developmental-stage speci-
ficity.
Structural Analysis of the Gene
Encoding Rat Fibroblast
Tropomyosin 4
J P Lees-Miller, D.M. Hellman
cDNA clones for TM-4 that we previously identi-
fied were used to isolate the gene that encodes this
isoform. Four overlapping X clones that contain the
entire transcription unit were isolated from a
genomic library. Restriction enzyme analysis indi-
cated that all sequences represented in the rat genome
are continuous at a single locus. The gene spans ap-
proximately 15 kb. For detailed mapping, genomic
DNA fragments were subcloned into plasmid vec-
tors pUC18/pUC19, and the intron/exon organiza-
tion of the gene was determined. The gene was found
to contain eight exons that encode the TM-4 mRNA.
At present, we do not know whether this gene con-
tains alternatively spliced exons used in different tis-
sues and cell types. Work from our laboratory has
already suggested that this gene may encode at least
two mRNAs: a 2.2-kb mRNA expressed in fibro-
blasts and smooth muscle and a 1.3-kb mRNA ex-
pressed in skeletal muscle (Yamawaki-Kataoka and
Helfman, J. Biol. Chem. 262: 10791 [1987]). Al-
though we detected two different mRNAs with
cDNAs encoding TM-4, it is not known if this gene
encodes two different RNAs via tissue-specific RNA
processing or if the two RNAs simply represent cross-
hybridization with the products of two different
genes. Work is currently under way to answer this
question.
Expression and Function of
Tropomyosin in Normal and
Transformed Cells
L. Goodwin, S. Cheley, D.M. Helfman
One of the major differences between normal and
transformed cells in tissue culture is their morpho-
logical appearance. Transformed cells are usually
more rounded or spindle-shaped, and their stress
fibers (microfilament bundles) are reduced or even
absent. The molecular and biochemical bases for
these changes in the cytoskeleton of transformed cells
are poorly understood. We have focused our atten-
tion on tropomyosin because recent studies have
demonstrated profound alterations in the pattern of
tropomyosin expression in cells transformed by on-
cogenic tumor viruses and carcinogens. This may,
in part, be reponsible for the reduction of microfila-
ment bundles (stress fibers) and the accompanying
alterations of cell shape characteristic of many trans-
formed cells. Neither the mechanism(s) responsible
for these altered patterns of tropomyosin synthesis
in transformed cells nor the functional significance
of the five different isoforms of tropomyosin in fi-
broblasts is known.
To study the function of tropomyosin in normal
and transformed cells, we want to introduce specific
tropomyosin isoforms into living cells by direct
microinjection of purified RNA or proteins. To syn-
thesize biologically active mRNAs encoding specific
tropomyosin isoforms, the full-length cDNAs encod-
ing TM-1, TM-2, and TM-4 were subcloned into SP6
plasmids. Direct purification of individual tropo-
myosin isoforms from rat fibroblasts has been dif-
ficult using conventional purification methods,
which is likely due to the fact that the different pro-
tein isoforms have such similar physicochemical
properties. To prepare large quantities of each of the
major fibroblast tropomyosin isoforms (TM-1,
TM-2, and TM-4), we have utilized a plasmid clon-
ing system that allows for the production of the pro-
tein in Escherichia coli. Using this system, we plan
to prepare homogeneous preparations of each iso-
form. In the future, we plan to label each of the
different isoforms with fluorescent probes in order
to determine the subcellular distribution of each pro-
tein species following microinjection into living cells.
In addition, we plan to express particular tropomyo-
sin isoforms in transformed cells where the cellular
gene product is repressed. Such studies may deter-
mine if expression of tropomyosin results in changes
in microfilament organization and cell shape. We
have already prepared large quantities of purified
TM-2 from E. coli for these studies.
Normal rat fibroblasts contain five tropomyosin
isoforms. To date, we have obtained full-length
cDNA clones of the three major fibroblast tropo-
myosin isoforms (TM-1, TM-2, and TM-4). To ob-
tain cDNA clones to the minor isoforms (TM-3 and
TM-5), we are preparing cDNA libraries from two
transformed cells lines: an adenovirus-transformed
cell line (Ad5D.4A) and a Kirsten-virus-transformed
cell line (NRK 1569). These cell lines exhibit increased
levels of TM-3 and TM-5, respectively. In addition,
previous work from our laboratory has demonstrated
that although the Kirsten virus NRK 1569 cell line
and the Rous sarcoma virus NRK 4/435 cell line do
not express TM-2, they still express a 1.8-kb mRNA
associated with this isoform (Yamawaki-Kataoka and
Helfman, J. Biol. Chem. 262: 10891 [1987]). Prelim-
inary experiments using RNA protection analysis in-
dicate that the mRNA expressed in transformed cells
is structurally different from the mRNA expressed
in normal cells. We are in the process of isolating
the corresponding cDNA clone from a cDNA library
prepared from the Kirsten-virus-transformed cells to
establish fully the structure of the RNA in these cells.
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CELL BIOLOGY OF THE NUCLEUS
D.L. Spector W.-K. Chan
M.R. Delannoy
J.P. Suhan
Our laboratory is divided into two sections, a re-
search group studying the structural and functional
organization of the cell nucleus and a core Electron
Microscopy Facility. Our core facility, through the
expert technical achievements of Mike Delannoy and
Joe Suhan, has provided a diverse range of services
to numerous scientists at Cold Spring Harbor Lab-
oratory, including standard transmission and scan-
ning electron microscopy, immunoperoxidase and
immunocolloidal gold electron microscopy, DNA
spreading, negative staining, and metal shadowing.
Descriptions of many of these projects can be found
in the individual research sections in this Annual
Report.
Our research program continues to proceed in two
related areas: (1) the elucidation of specific func-
tional regions within the cell nucleus and (2) the bi-
ochemical identification of the nuclear components
that interact with the myc oncoprotein.
Structural and Functional
Organization of the Cell Nucleus
D.L. Spector, M.R. Delannoy
In a previous series of immunocytochemical studies,
we examined the spatial organization of a group of
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nuclear proteins, some of which are associated with
small nuclear ribonucleoprotein particles (snRNP).
The proteins investigated colocalized within a dis-
crete nuclear domain that excludes the nucleolus and
parts of the nucleoplasm. We are now at the stage
of being able to examine the functions associated
with this nuclear region and to relate these findings
to the general organization of the interphase cell nu-
cleus. Our first series of experiments were designed
to localize the sites of DNA replication in situ by
using high-resolution autoradiography and to com-
pare these nuclear sites with the immunolocalization
of the myc oncoprotein. Quail cells (Q8) nonproduc-
tively transformed with the avian myelocytomatosis
virus MC29 were pulsed for 5 minutes with ['H]thy-
midine (sp. act. 74 Ci /mM) at 50 ytCi /ml. Short pulses
were used in order to be certain that we were look-
ing at the initial sites of label incorporation, rather
than label that has moved around the cell nucleus
subsequent to incorporation. After [31-1]thymidine
labeling, cells were fixed and immunolabeled with
an antibody raised against the human recombinant
c-myc protein followed by peroxidase-conjugated
secondary antibodies. Sections of cells (0.5 pm) em-
bedded in resin were affixed to slides and coated with
autoradiographic emulsion. After 20 days of ex-
posure, the sections were chemically developed and
examined microscopically. Panels A and B in Fig-
FIGURE 1 Quail 08 cells immunolabeled with antibodies against the myc oncoprotein
and radiolabeled with [3H]thymidine. Panels A and B are the same cell. Panel A is fo-
cused on the immunoperoxidase staining of v-myc, and panel B is focused on the au-
toradiographic grains. As shown, the localization of v-myc (arrowheads) is not coincident
with the sites of incorporation of [3H]thymidine (arrows). Panel C: Immunoelectron mi-
croscopic localization of v-myc showing that the bulk of autoradiographic grains due to
[3H]thymidine labeling (arrows) are not coincident with v-myc immunostaining (arrow-
heads).
ure 1 are the same 100-nm cell section; however, panel
A is focused on the immunolabel and panel B is fo-
cused on the autoradiographic grains that occur on
the section surface. Immunostaining of the myc on-
coprotein was restricted to a reticular network within
the cell nucleus (panels A and B, arrowheads). Au-
toradiographic grains resulting from [31-I]thymidine
incorporation were present in regions of the nucleo-
plasm, which were not coincident with the myc im-
munostaining (compare arrows in panel B, pointing
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FIGURE 2 Quail Q8 cells immunolabeled with antibodies against the myc oncoprotein
and radiolabeled with [3H]uridine. v-myc immunostaining (arrowheads) is not coincident
with [3H]uridine incorporation (arrows).
to autoradiographic grains, and arrows in panel A,
showing no immunolabeling in these regions). Two
other cells in panels A and B show immunolabel-
ing, but no autoradiographic grains, since they were
not in S phase during the 5-minute incorporation
of [31-1]thymidine. Although our light microscopic
data are quite convincing, we decided to evaluate
samples at the electron microscopic level so that we
could attain higher resolution. Improved resolution
was attained at three levels. Most obviously is the
inherent increase in resolution that the electron mi-
croscope has over the light microscope (2.04 A vs.
0.2 pm). In addition, the use of an electron micro-
scopic autoradiographic emulsion (L4) that is ap-
plied to the section in a monolayer provides a more
precise grain distribution. Finally, the use of physi-
cal development, rather than chemical development,
increases the sensitivity as well as the resolution by
virtue of the small and consistently round grain size,
so that underlying structures remain easily visible.
Combining all of these methods, we evaluated the
distribution of PHIthymidine, and we found that,
consistent with our light microscopic data, the sites
of myc immunostaining were distinct from the sites
of [3H]thymidine incorporation (Fig. 1C). In fact,
in some cases, the autoradiographic grains appeared
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to surround (rather than overlap with) the immuno-
stained regions. In all cases, little to no background
labeling was observed in the cytoplasm.
A second series of experiments evaluated the sites
of transcription using [31-I]uridine incorporation.
Cells were labeled with [31-I]uridine (sp. act. 18
Ci /mM) at 50 dCi/m1 for 5 minutes and processed
as above. Light microscopic autoradiography showed
the sites of incorporation of [3H]uridine to be dis-
tinct from the sites of immunoreactivity (Fig. 2A, B).
Similar results have been obtained in CHOC 400 cells
using the anti-Sm antibody that recognizes Ul, U2,
U4/U6, and U5 snRNPs (data not shown). Taken
together, these data suggest that the nuclear network
identified with myc and anti-Sm antibodies is dis-
tinct from those nuclear regions involved in DNA
replication and transcription. Our current hypothe-
sis is that the network-like staining observed with
these antibodies represents the sites of heterogeneous
nuclear RNA (hnRNA) processing. To address this
hypothesis, we are employing pulse-chase experi-
ments to determine whether the [31-1]uridine label
can be chased into the speckled-staining region. In
addition, we are preparing biotinylated SP6 probes
to specific cellular mRNAs and oligonucleotide
probes to splicing intermediates to determine if, in
fact, we can localize splicing intermediates to the
regions of the cell nucleus that are concentrated in
snRNPs.
Nuclear Associations of the
myc Oncoprotein
W.-K. Chan, M.R. Delannoy, D.L. Spector
Our laboratory has previously observed that the myc
oncoprotein is localized within distinct nuclear
clusters (speckles). Our current investigations are
aimed at identifying the polypeptides and/or nucleic
acids that are directly associated with the myc pro-
tein in the cell nucleus. Several approaches will be
used to achieve this goal. First, coimmunoprecipi-
tation experiments will be performed to examine
whether particular protein species will be coim-
munoprecipitated using myc-specific antibodies. To
facilitate the coimmunoprecipitation experiments, we
have recently gel-purified the human recombinant
c-myc oncoprotein expressed in E. coli (from M.
Rosenberg, Smith, Kline and Beckman Laboratories)
and have injected the purified protein into rabbits
to generate polyclonal antibodies against myc. Cross-
linking studies using bifunctional cross-linking rea-
gents will be used to confirm the coimmunoprecipi-
tation experiments. As myc may interact with par-
ticular species of nuclear RNA, such as snRNA,
which resides in the speckled region of the nucleus
in the form of snRNPs, we will perform UV-cross-
linking experiments that can covalently link the pro-
tein bound to the nucleic acid and allow us to inves-
tigate the possibility of direct interactions between
myc and RNA molecules.
Although the myc protein is readily available from
E. coli, the expressed protein aggregates to form
granular structures within the bacterium (Fig. 3A),
7 nm A
8 nm B
FIGURE 3 E. coli cells overexpressing the myc oncoprotein exhibit large granules within
the cells, which can be immunolabeled with myc antibodies coupled to colloidal-gold-
conjugated secondary antibodies (A). Control cells not expressing the myc oncoprotein
do not exhibit such granules (8).
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making it difficult to solubilize the protein. We have
used immunocolloidal gold-labeling techniques to
prove that the granule is composed of myc protein
(Fig. 3A). We are now attempting to optimize the
expression of myc in soluble form and subsequently
to purify this soluble form of myc protein. The pu-
rified protein will be used in in-vitro-binding studies
to investigate its nucleic-acid-binding capability and
specificity. The purified protein will also be used for
crystalization studies in collaboration with J. An-
derson (Structure Section) to determine its three-
dimensional structure. In addition, in collaboration
with D. Carroll in D. Marshak's laboratory (Tumor
Viruses Section), we will investigate the effect of
phosphorylation on the properties and function(s)
of the protein.
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QUEST LABORATORY/TWO-DIMENSIONAL GEL
BIOTECHNOLOGY RESOURCE
J.I. Garrels C. Chang M. Hannaford G. Mak
B.R. Franza H. Sacco P Myers A. Rudman
M.E. Lambert J. Kos J. Ross Salah-Ud-Din
The QUEST Laboratory has concentrated its efforts
on the analysis of the REF52 database and of the
yeast database, which is now growing rapidly through
collaborative work with Calvin McLaughlin and
Jonathan Warner.
Software tools for the construction and analysis
of databases have matured so that a thorough anal-
ysis of the REF52 data, including construction of
permanent spot sets and numerous spot annotations,
has been possible. Detailed reports on the methods
of database construction and on the REF52 data-
base itself have been accepted for publication. This
completed work now sets an example that can be fol-
lowed in the development of the yeast database and
in human databases yet to be constructed.
A new member of the laboratory, Salah-Ud-Din,
has begun to explore better ways to identify protein
spots in the two-dimensional gels. Having set up the
blotting techniques for antibody detection and
microsequencing of proteins from the gels, and for
enriching minor spots through prefractionation, he
will attempt to identify and characterize one or more
of the nuclear proteins with proliferating cell nuclear
antigen (PCNA)4ike regulation. This work is being
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done in collaboration with Bruce Stillman's labora-
tory (see Tumor Viruses Section).
Michael Lambert has moved on to the Scripps
Clinic in La Jolla, where he has received a staff po-
sition. He will continue to work on cellular responses
to DNA damage and plans to set up a facility for
two-dimensional gel analysis at the Scripps Clinic.
The REF52 Database
J.I. Garrels, B.R. Franza
As described in previous Annual Reports, the REF52
database is built on a family of ten normal and virus-
transformed rat fibroblast cell lines of the REF52
family. Cells from each line have been radiolabeled
and analyzed at four stages, during growth from low-
plating density to confluence and again after stimu-
lation of confluent cells with fresh serum. Three lines
(normal, SV40-transformed, and adenovirus-trans-
formed) have also been radiolabeled early (1-4 hr)
and late (21-24 hr) after addition of fresh serum to
serum-deprived cells.
The REF52 database also contains experiments
to identify cytoskeletal, nuclear, mitochondrial, and
mannose-labeled proteins. Permanent protein sets
have been created and stored in the database to iden-
tify the members of each group. Other sets have been
generated to indicate those proteins that are coregu-
lated during transformation, during growth to con-
fluence, and at early or late times after response to
serum stimulation. At the workstation, any set can
be recalled from the database, and its members can
be highlighted on the gel image being displayed. The
QUEST software allows us to characterize the be-
havior of each set quantitatively, as a whole and as
individual proteins. Names and other annotations
for each member of a set can be listed, based on the
annotations previously entered into the database.
CYTOSKELETAL PROTEINS
In transformed cells, the fraction of protein synthe-
sis represented by the cytoskeletal proteins is reduced
by as much as threefold. More highly transformed
REF52 derivatives have lower total cytoskeletal pro-
tein synthesis. Many individual cytoskeletal proteins
have marked virus-specific responses to transforma-
tion. Tropomyosin 3 is the most interesting of these
because it is highly elevated in adenovirus-trans-
formed cells (at low density, but not at high density),
yet it is suppressed in retrovirus-transformed cells
and in most SV40-transformed cells. Members of the
cytoskeletal group appear in other sets selected for
response to serum stimulation, progression to
anchorage-independence, and responses to viral mu-
tations (see below).
NUCLEAR PROTEINS
A set of 255 nuclear proteins was identified by com-
paring gels of purified nuclei to gels representing to-
tal cellular proteins. Nuclear proteins were defined
to be those that were enriched by twofold or more
during nuclear purification. The quantitative anal-
ysis of enrichment is necessary to screen out major
cytoplasmic and cytoskeletal proteins present in nu-
clear preparations as contaminants. About 20,10 of
the transformation-sensitive proteins are nuclear.
Only three nuclear proteins were detected among the
proteins induced early after serum stimulation, and
none of these have been identified. Ten nuclear pro-
teins are among the 40 major late responses to se-
rum stimulation, and these include PCNA and
lamin-B. The set of late-responding nuclear proteins
is regulated quite coordinately during growth, refeed-
ing, and serum stimulation. Furthermore, most are
elevated substantially in transformed cells. A set of
11 nuclear proteins has been selected for having regu-
lation similar to that of PCNA, and some of these,
like PCNA, might be involved in DNA replication.
MANNOSE-LABELED PROTEINS
A set of 50 glycoproteins was identified by labeling
with [3H]mannose and confirmed by tunicamycin
treatment (which blocks glycosylation of these pro-
teins). This set includes many secreted proteins: the
heat-shock protein (hsp100), glucose-stimulated pro-
tein, and the p45 group characterized by J.F. Santa-
ren and R. Bravo (EMBL, Heidelberg). The latter
family of proteins is prominent at early times after
serum stimulation but barely detectable at other
times. In transformed cells, mannose-labeled pro-
teins represent a two- to threefold lower fraction of
total protein synthesis, and the responses of
mannose-labeled proteins to serum stimulation are
absent.
SERUM-STIMULATED PROTEINS
The proteins induced early after serum stimulation
of normal cells include three families of glycopro-
teins (including the p45 family), one cytoskeletal pro-
tein (tropomyosin 3), and three unknown nuclear
proteins. The members of this set may overlap with
the products of genes identified in other laborato-
ries by differential screening of cDNA libraries made
from serum-stimulated cells. Most early-response
genes found by other investigators are transiently in-
duced. We find that nearly all members of the set
of early responses have returned to normal levels by
24 hours after stimulation. Proteins induced late
after serum stimulation include ten nuclear proteins,
but no members of the mannose-labeled or cyto-
skeletal sets. The induced proteins include PCNA,
lamin-B, and possibly other proteins involved in
DNA synthesis or cell-cycle-related events. In trans-
formed cells, most of the early responses to serum
do not occur at all, and most members of the late-
responding set are expressed at high levels regard-
less of the presence or absence of serum.
TRANSFORMATION-SENSITIVE PROTEINS
Proteins induced by SV40 transformation are gener-
ally also induced by adenovirus but are much less
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likely to be induced by Kirsten murine sarcoma virus
(Ki-MSV), a retrovirus. Proteins repressed by ade-
novirus transformation are usually repressed in all
other transformants. Of the induced proteins, about
20% are nuclear and only 1% or fewer are cytoskele-
tal. The repressed proteins contain nuclear, mannose-
labeled, and cytoskeletal proteins in about equal
proportions.
PROTEINS REPRESSED DURING PROGRESSION TO
ANCHORAGE INDEPENDENCE
SV40 transformants in different stages of progres-
sion to anchorage independence and tumorigenic-
ity were analyzed for proteins that might correlate
with progression. A set of nine proteins was selected
that are synthesized at lower rates in cells of higher
tumorigenicity. None of these proteins are nuclear.
One was identified as tropomyosin 4, and another
is a protein that responds early to serum stimula-
tion. Most of these nine proteins are synthesized at
very low rates in adenovirus-transformed cells, which
is significant because no adenovirus-transformed
cells were used in the selection of this set.
PROTEINS DIFFERENTIALLY REGULATED IN AN
ADENOVIRUS E113 MUTANT
Of the proteins normally repressed by adenovirus
transformation, 19 were much less repressed in cells
transformed by an adenovirus E1B mutant. Five of
these are known cytoskeletal proteins (a-sm-actin,
tropomyosin 2, an isoform of vinculin, nonmuscle
caldesmon, and calpactin-I). Adenovirus transfor-
mation usually represses these cytoskeletal proteins
much more than do the other transforming viruses,
but the mutant adenovirus seems to suppress them
only to the same level as the other viruses.
AN UNUSUAL SET OF PROTEINS IN NU2 CELLS
One tumorigenic SV40 transformant (NU2) was
found to contain more than 60 proteins never seen
in other rat cell lines. Most of these proteins were
found to comigrate with proteins in mouse 3T3 cells.
In particular, both rat and mouse forms of PCNA,
13-Fl-ATPase, calpactin-I, and calpactin-II, seem to
be present. Detailed chromosome analysis by W.
Nash (H&W Cytogenetic Services Inc.) has con-
firmed that NU2 contains both rat and mouse chro-
mosomes, apparently derived from a fusion event
that occurred when NU2 was grown as a tumor in
158
nude mice. Until database analysis was done, this
important property of NU2 cells had never been rec-
ognized.
A Protein Database for the Study of
Inducible Responses to DNA Damage
M.E. Lambert, J.I. Garrels
Studies of REF52 and human cells exposed to DNA-
damaging agents have continued with the analysis
of many more two-dimensional gel patterns of cells
exposed to chemical carcinogens and irradiation.
DNA damage is a form of cellular stress that, in nor-
mal cells, induces growth arrest, DNA-repair path-
ways, and yet undefined cellular responses mediated
by diffusible factors. The complex pattern of changes
induced by each agent in normal and transformed
rat cells requires the full utilization of the REF52
database to understand which responses are related
to growth arrest; which responses have to do with
DNA-replication; which responses are induced by
other forms of stress, such as heat shock; which re-
sponses are nuclear versus cytoplasmic or membrane-
associated; and which responses are specific to par-
ticular types of damage. With the REF52 database
fully assembled and analyzed with respect to our
studies of growth regulation and viral transforma-
tion, the analysis of our extensive data on DNA dam-
age can be completed. Already, it is clear that some
aspects of the DNA-damage response, in particular
the ability to arrest growth, are different in trans-
formed cells and that not all of the induced responses
are nuclear. Most of the induced proteins are yet un-
known, but one that is known, PCNA, is both a part
of the growth-arrest response and the DNA-repair
mechanism.
A particular aspect of these studies that has been
pursued in the last year is the induction of the ma-
jor histocompatibility complex (MHC) class I pro-
teins in human fibroblasts and keratinocytes by DNA
damage. The members of this family of cell-surface
proteins are induced severalfold in synthesis after
treatment of cells with UV light or BPDE, a meta-
bolically activated form of benzo[a]pyrene. Cyclo-
heximide or the DNA-synthesis inhibitor aphidico-
lin induces some members of the family to much
higher levels, but UV light of a nondamaging wave-
length and another DNA-synthesis inhibitor, hydrox-
yurea, had no effect. The induction of MHC class
I was not a secondary result of growth arrest because
it could be shown to occur in quiescent, nondivid-
ing cells. Cells defective in DNA repair (from pa-
tients with xeroderma pigmentosum) show even
higher levels of MHC class I induction. These find-
ings indicate that cells respond to some types of DNA
damage and to the abnormal arrest of DNA synthe-
sis in part through the altered expression of cell-
surface molecules.
The Yeast Database
J.I. Garrels [in collaboration with Calvin McLaughlin,
University of California, Irvine, and Jonathan Warner,
Albert Einstein College of Medicine]
The goal of the yeast database is to describe the pro-
tein metabolism of Saccharomyces cerevisiae under
conditions that are of major interest to the yeast
genetics and molecular biology communities. We are
constructing the database so that it will be a major
resource together with the genetic map and DNA and
protein sequence databases.
Our first problem was to determine how closely
related the common laboratory yeast strains are to
each other at the protein level. If the common strains
exhibit a large number of protein-level polymor-
phisms, the matching of protein patterns from one
strain to another strain could be very difficult. We
examined the protein patterns in strains S288c,
W303, A364A, D273, 10B, SKQ2N, and X2180. Al-
though a substantial number of polymorphisms ex-
ist, we have been able to match these patterns, provid-
ing the "linker" experiment that allows subsequent
data from different stains to be traced through the
database. Interestingly, on the basis of the number
of polymorphisms observed, we will be able to de-
termine how related the common laboratory strains
are to each other.
The identification of individual proteins in the pat-
tern is being pursued by several different approaches.
One of the most useful involves transformation by
high-copy-number plasmids based on 2-)tm vectors.
The coefficient of variation for most spots in repli-
cate gels is less than 25%, and thus a three- or four-
fold overproduction of a protein stands out very
clearly. We have used this technique to identify the
proteins encoded by URA3, LEU2, and TRP1. Pu-
rified proteins and immunoprecipitates are being
used for protein identification. We are labeling cells
with each of the 20 amino acids in turn to obtain
the amino acid composition of many of the proteins.
These data are being standardized to ten well-
resolved known spots to calibrate for pool and in-
terconversion problems. We also plan to pursue pro-
tein identification from the two-dimensional gels for
protein identification.
The synthesis, processing, and turnover of pro-
teins have been examined by pulse-labeling and
pulse-chase techniques. Although the majority of the
yeast proteins are stable and made at normal rates
in our shortest pulse of 30 seconds, a surprising num-
ber do show more complex kinetic behavior, indi-
cating that they are unstable or are involved in
precursor-product relationships. We are using the
rnal mutation to determine the effective mRNA half-
life for the proteins. We have initiated a systematic
study of protein modification. Our initial focus is
on phosphorylation, acetylation, and carbohydrate
modification of proteins. To determine the subcel-
lular localization of proteins, we have started a se-
ries of cell fractionations using labeled cells for
nuclei, mitochondria, ribosomes, and cytoplasmic
and membrane-bound proteins. We also anticipate
a general study of nucleic-acid-binding proteins.
To interface the database with the yeast field, we
are focusing our experiments on several traditional
areas of interest. To identify sex-specific proteins,
we have examined a, a, and diploid isogenic strains
of W303 growing in glucose. Under these conditions,
very few proteins are sex-specific. In contrast, we have
used rna2 mutants to determine the number of pro-
teins with introns or whose synthesis depends on a
protein with an intron, and we find that 5-10% of
the proteins in yeast have introns as defined by rna2.
In another experiment, over 50 proteins involved in
the heat-shock response have been detected. This is
the most complete description of the heat-shock re-
sponse yet carried out in yeast.
In the coming year, we propose to examine car-
bon, nitrogen, and sulfur starvation; growth on fer-
mentable and nonfermentable carbon sources to in-
terface with gene regulation studies, and entry into
and exit from Go. We will also examine a-factor ar-
rest, sporulation, and the meiotic and mitotic cell
cycles.
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CELLULAR TRANS-ACTIVATORS OF GENE EXPRESSION
B.R. Franza J.M. Ross
For the past 3 years, our effort has been focused on
developing a strategy for both qualitative and quan-
titative analyses of cellular proteins that interact with
genetically defined nucleic acid sequence elements.
The long terminal repeat (LTR) region of the human
immunodeficiency virus type 1 (HIV-l) was chosen
for initial investigation. This region has been shown
to mediate the inducible expression of either the vi-
ral genome itself or genetic recombinants consist-
ing of the LTR linked to different "reporter" genes.
From the outset, it was anticipated that more than
one protein would associate with specific sequence
elements. It was considered likely that proteins would
be found that interact with such elements by corn-
plexing with the proteins that directly contact the
nucleic acid. Therefore, the strategy had to permit
evaluation of both direct and indirect association of
proteins with specific control elements. The strategy
was designed not only to identify such proteins, but
also to allow the subsequent study of the regulation
of each protein throughout experimental simula-
tions of normal cellular growth and/or development.
Database analysis is the system that will be used to
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accomplish this task. Simply described, database
analysis provides the means to quantify and link ex-
perimental observations of any cellular protein re-
solved by two-dimensional gel electrophoresis. The
following is a simple description of the strategy and
a discussion of the results of its application to the
study of two control regions in the HIV-1 LTR.
MICROSCALE DNA-AFFINITY PRECIPITATION ASSAY
The basic principle of the strategy is to analyze
directly protein-nucleic acid interactions yielding
quantifiable information on the proteins involved.
To accomplish this task, an assay was developed that
utilizes fragments of nucleic acid that can be recov-
ered from a solution of proteins by virtue of the high
affinity that avidin has for any molecule containing
a biotin group. A biotin molecule is covalently at-
tached to the nucleic acid fragment. The fragment
is mixed with the proteins and recovered from the
solution by addition of avidin that is linked to an
insoluble matrix. The proteins are then eluted from
the matrix and separated on high-resolution, two-
dimensional (HR2D) gels. The two-dimensional ar-
ray of spots, each spot representing distinct proteins,
can be detected, quantified, and entered into the
database analysis environment for study. The assay
structure is highly flexible in that it permits con-
trolled alterations of the numerous cell-growth con-
ditions, extraction conditions, and reaction param-
eters required to dissect thoroughly the potential each
control element has for interacting with different cel-
lular proteins. Such flexibility is also required to char-
acterize the differential rates of synthesis, posttrans-
lational modification, and turnover of the proteins
associating with a specific sequence element. The as-
say is accomplished on a small scale (1 ml or less
reaction volumes) and is rapid (no more than 2 hr
from time of extracting the cellular proteins to hav-
ing them ready for gel separation). Either synthetic
oligonucleotides or restriction fragments containing
the control element(s) to be investigated have been
used successfully in the assay. The results discussed
below involved the study of control elements pres-
ent on double-stranded DNA; however, assays of
protein interactions with single-stranded DNA and
RNA have also been studied.
HIVEN86A IS AN INDUCIBLE CELLULAR
PROTEIN THAT INTERACTS SPECIFICALLY
WITH THE HIV ENHANCER
HIV, like other retroviruses, integrates into the ge-
nome of the cell it infects. It actually becomes part
of the cellular DNA, and it is capable of responding
to extracellular stimuli much like many cellular
genes. Elements, coded within the DNA in the LTR,
mediate this responsiveness. One of these elements
(see Fig. 1, -105 to - 80) is referred to as an enhancer
and confers inducible expression to the genes linked
to it. Enhancer activity of a sequence element means
that it contributes in a positive way to the promo-
tion of transcription of functionally linked genes.
Inducible expression means that the linked gene is
either wholly or partly dependent on certain signals
for transcription of new mRNA. We have identi-
fied several cellular proteins, produced in human
T-lymphoblast cells, that interact specifically with
the HIV enhancer. We have used synthetic oligonu-
cleotides representing either the "wild-type" en-
hancer or mutants thereof to detect these proteins.
Some of these proteins, expressed in the H9 cell line
(CD4+, supports replication of HIV), are shown in
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I +43 End TAR I4-- U3 R
TGCCTGTACT GGGTCTCTCT GGTTAGACCA GATCTGAGCC TGGGAGCTCT CTGGCTAACT 9165
+1
,-loo
AAGGAACCCA CTGCTTAAGC CTCAATAAAG CTTgcc t t ga g t gc t t ca 9213
FIGURE 1 A schematic of the HIV-1 LTR with various elements and sequence similarities noted.
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Figure 2A. We now know that the protein desig-
nated 86A in the figure (referred to as HIVEN86A
for HIV enhancer-binding protein of 86-kD ap-
parent molecular size) is an inducible protein. In
certain lymphoblast lines, grown under normal con-
ditions, HIVEN86A is virtually nondetectable. How-
ever, when these cells are stimulated by agents that
induce maturation of human T lymphoblasts,
HIVEN86A is expressed early-on, and associates
with the HIV enhancer probe. The expression of
HIVEN86A is rapid enough to be a transducer of
activating signals to responsive, normal cellular
genes, such as the interleukin-2 receptor (IL2R) gene,
as well as to control elements of the integrated HIV
provirus. Work is in progress to determine if
HIVEN86A functions to activate growth and/or
differentiation control genes. We do know that its
expression is positively correlated with early produc-
tion of both HIV mRNA and IL2R mRNA (in col-
laboration with W. Greene, Duke University Medi-
cal School, Durham, North Carolina).
More than one protein is found to interact specif-
ically with the HIV enhancer as shown in Figure 2A.
One of these proteins, 86B (HIVEN86B), is found
only in H9 cells. It is not inducible in the other hu-
man lymphoblasts studied thus far. The other pro-
teins shown in Figure 2A are variably detected in
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FIGURE 2 HIV-1 enhancer-associated proteins
isolated from human T- lymphoblast cells. (A) Pro-
teins isolated on the HIV enhancer (HIVEN) wild-
type probe; (8) proteins isolated on the HIV en-
hancer mutant probe (for details, see Franza et al.
Nature 330: 391 [1987]).
several different human lymphoblast cell lines and
appear to be responsive to certain extracellular stim-
uli. The specificity of the interaction of each of these
HIV enhancer proteins is indicated by the fact that
they do not associate with the mutant construct of
the enhancer element (compare panels A and B in
Fig. 2). One exception is that small amounts of
HIVEN86B still associate with the mutant construct.
Given the fact that only three of the ten bases in the
HIV enhancer core element were altered in the mu-
tant construct, it may be that HIVEN86B is less de-
pendent than the others on those bases for binding.
The surrounding proteins, seen in both panels,
nonspecifically associate with the matrix and are
therefore seen independent of whatever biotinylated
nucleic acid is added to the reaction. They are use-
ful in two respects: (1) They provide a means for nor-
malizing any set of DNAP assays and (2) they assist
in alignment of one HR2D gel image with any other
HR2D gel image.
ANOTHER SET OF INDUCIBLE CELLULAR
PROTEINS ASSOCIATES WITH HIV-1 LTR CONTROL
ELEMENTS DISTINCT FROM THE ENHANCER
A region in the HIV-1 LTR (-360 to - 278, see Fig. 1)
was noted to contain three sequence elements simi-
FIGURE 3 Human T-Iymphoblast proteins im-
munoprecipitated by an anti-Fos peptide antibody.
(A) Proteins immunoprecipitated from unstimulated
H9 cells; (8) proteins immunoprecipitated from cal-
cium ionophore (A23187)-stimulated cells (for de-
tails, see Franza et al., Science 239: 1150 [1988]).
H9 unstimulated
c-fos
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FRAI0v; FRA8
FRAI I
lar to the recently described He La cell transcriptional
activator protein 1 (AP-1) site. This region had been
partly characterized as a negative regulatory unit by
other investigators. It is not clear how many differ-
ent types of activities might be mediated by this re-
gion, since only one experimental setting has been
explored thus far. Specifically, these investigators
studied the expression of a linked reporter gene
several hours after its transfection into tissue-culture
cells. Our interest in this region resulted from the
observation that the product of the cellular proto-
oncogene, c-fos, was reported to associate with a con-
trol element from a differentiation-sensitive adipo-
cyte gene. I noticed that this element contained a site
similar to the AP-1 site in the human metallothionein
II gene, the SV40 enhancer, the gibbon ape leuke-
mia virus enhancer, the c-fos promoter, and the
HIV-1 LTR. T. Curran (Roche Institute, Nutley, New
Jersey) and I had successfully collaborated on the
HR2D gel analysis of the complex modifications of
the c-fos product (Fos), the numerous Fos-related
p39 FAP
`FRA 12
antigens, and the Fos-associated proteins, including
the different isoforms of p39. Along with F. Rauscher
III, a postdoctoral fellow in T. Curran's laboratory,
and S.F. Josephs at the National Cancer Institute,
we began a detailed DNAP analysis of those cellu-
lar proteins that interacted with AP-1 sites in several
different viral and cellular control regions. It quickly
became clear that Fos, several Fos-related antigens,
and the Fos-associated protein (FAP) p39 were re-
covered on probes containing intact AP -1 sites. None
of these inducible cellular proteins associated with
the HIV enhancer probes, confirming not only the
specificity of the assay, but also the fact that the same
agent could induce entirely different cellular proteins
that could be distinguished by their association with
distinct control elements.
An example of the proteins immunoprecipitated
with an antisera raised against a region of the Fos
protein is shown in Figure 3. In uninduced H9 cells,
some Fos, certain Fos-related antigens (FRA), and
barely detectable amounts of p39 were recovered and
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FIGURE 4 Human T- lymphoblast proteins that interact with AP-1 sites. (A) Proteins recovered from con-
trol reaction containing no biotinylated (b-) probe; (8) proteins recovered from a control reaction containing
b-HIV enhancer probe; (C) proteins recovered from a reaction containing b-H IV AP-1 probe; (D) proteins
recovered from a reaction containing a b-probe containing the AP-1 site in the fat-specific element from
the adipocyte aP2 gene. All extracts were obtained from H9 cells stimulated with calcium ionophore, A23187,
using conditions identical to those used in preparing extracts for immunoprecipitations as seen in Fig.
3. For details, see Franza et al. (Science 239: 1150 [1988]).
resolved on HR2D gels (Fig. 3A). On induction with
the calcium ionophore, A23187, considerable in-
creases in Fos, FRAs, and FAP p39, or the tumor
promoter, PMA, are easily detected (Fig. 3B). FRA
refers to the fact that the antibody can still immuno-
precipitate these proteins even after the extracts con-
taining them have been denatured by boiling them
in the presence of the detergent, SDS. FAP indicates
that p39 is immunoprecipitated only because it is
complexed with Fos or one of the FRAs. Figure 4
presents the results of four different DNAP assays
on similarly treated H9 cells. In Figure 4A, no bio-
tinylated probe was added, and in Figure 4B, bio-
tinylated HIV enhancer probe was added to the reac-
tion. In both cases, although nonspecific proteins
are detected on the HR2D gels, no Fos is detected.
In Figure 4, C and D, different probes containing
AP-1 sites were added to respective reactions, and it
is clear that the heterogeneous population of modi-
fied forms of Fos are recovered in each case. Figure
5, A and B, shows that not only was Fos recovered
by the probes containing AP-1 sites, but FAP p39
was also recovered. More extensive analysis revealed
that several FRAs also associated with the AP-1 sites.
Therefore, a set of inducible cellular genes encode
proteins that associate with the same nucleic acid
sequence element. This element has been shown to
confer inducibility to heterologous promoters. In
fact, this element resides in the promoter of the c-fos
gene itself and has been shown to interact with Fos
(the functional significance of which is being pur-
sued with M. Gilman [Molecular Genetics of Eu-
karyotic Cells Section]).
Activation of Fos occurs in response to diverse
stimuli. The process is typically very rapid and short-
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lived. However, the consequences, largely dependent
on cell type and growth state, are remarkably var-
ied. They include changes in growth status, differen-
tiation status, and nerve cell depolarization. The
demonstration of Fos association with a transcrip-
tional control element suggests that Fos may exert
effects on the regulation of different sets of cellular
and viral genes. The facts that Fos is associated with
other inducible cellular proteins, such as FAP p39,
and that antigenically related proteins are also in-
ducible and capable of recognizing AP-1 sites indi-
B
p39
4
FIGURE 5 Fos-associated protein (p39) associates with AP-1
sites. (A) Region from the HR2D gel in which p39 migrates; the
sample is the same as that presented in Fig. 4C. (8) Region from
the HR2D gel in which p39 migrates; the sample is the same
as that presented in Fig. 4D.
cate a very flexible although complex mechanism for
differential regulation of gene expression.
None of these observations would have been made
as directly and quantifiably as they have been with-
out the use of DNAP assays in conjunction with
HR2D gels. We suspect that this strategy will be use-
ful in the detailed examination of protein-protein and
nucleic acid interactions that is expected to lead to
an exposition of the mechanisms controlling gene
expression.
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STRUCTURE
This section includes three laboratories interested in the detailed structural proper-
ties of proteins. The Structure program is a new one that was organized when Drs.
Jim Pflugrath and John Anderson joined Cold Spring Harbor Laboratory to set up
a new X-ray crystallography laboratory. The other two groups that are associated
with this program are those of Dr. Mark Zoller, whose laboratory is interested in the
structure-function relationships of protein kinases, and Dr. Rich Roberts, whose
laboratory has had a long-standing interest in restriction enzymes and their asso-
ciated methylases.
The impetus to establish a Structure program came from a growing need for
more detailed structural information about many of the proteins that are being
studied by investigators at Cold Spring Harbor Laboratory. It has become appar-
ent, both here and elsewhere, that a full interpretation of the results of experiments
at the DNA and RNA levels requires the complementary information that can be
obtained from protein biochemistry, site-specific mutagenesis, and structural inves-
tigations. Increasingly, we find that promising lines of research are being hindered
by the absence of detailed structural information about proteins. At present, such
information can only be obtained by rigorous protein purification, crystallization,
and X-ray analysis.
Fortunately, advances in recombinant DNA technology now allow the ready
cloning and overexpression of proteins of interest. This combined with new
methods for purification offers the possibility that many proteins important for our
work can now be obtained in quantities sufficient to permit their crystallization. The
time is right to capitalize both on the new technology and on the possibilities for
analysis and understanding that can be afforded by X-ray analysis. Over the next
few years, we anticipate growing interactions between the members of the Struc-
ture program and all other members of the laboratory.
NUCLEIC ACID CHEMISTRY
R.J. Roberts A.S. Bhagwat J. Meyertons A. Sohail
C. Marcincuk B. Mollet M. Wallace
J. Mart ling J. Posfai K. Weule
Role of Dcm in Very Short Patch Repair
A.S. Bhagwat, A. Sohail [In Collaboration with M. Lieb,
University of Southern California Medical School]
Mismatches in DNA such as
-CTAGG-
-GGTCC- or
-CTTGG-
-GGACC-
are repaired in Escherichia coli in favor of the lower
strand creating CC(A /T)GG sites. This process is re-
ferred to as very short patch (VSP) repair. The se-
quence generated by the repair process is the site of
the only known DNA cytosine methylase inE. coli -
Dcm. This protein methylates the second cytosine
in the sequence at position 5. 5-Methyl-cytosines
created by Dcm deaminate to thymine at a signifi-
cant rate. This generates T/G mismatches that are
the normal substrates for VSP repair. In other words,
VSP repair is likely to prevent mutations that could
arise by the deamination of 5-methyl-cytosine.
We cloned the gene that codes for Dcm a few years
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ago and mapped it within the clones by BAL -31-
mediated deletions. The ability of various deletions
to complement a methylation-defective mutation in
the chromosomal dcm gene (dcm6) was tested for
this purpose. The information required for dcm ex-
pression was mapped within a 1.7-kb piece of DNA.
Recently, three groups showed that the dcm6 mu-
tation leads to a defect in the VSP repair ability of
the cell. The simplest explanation of this result is that
Dcm is required for VSP repair. It has been suggested
that Dcm could play a role in the recognition of T/G
mismatches that are the substrate for VSP repair.
Hence, we tested the BAL-31-generated deletions in
a dcm clone for their ability to complement the VSP
repair defect of dcm6.
Three classes of phenotypes were found for the
deletions (Fig. 1). All methylation-defective (M-)
Plasmid
Constructs
pDCM4
pDCM24
pDCM23
pDCM2I
pDCM8
pDCM 9
constructs were unable to complement the VSP re-
pair defect of dcm6: They were VSR-. This is con-
sistent with the suggestion that Dcm is required for
VSP repair. Most methylation-proficient (M.) con-
structs were repair-proficient (VSR*), but, unexpect-
edly, two 1%/1* constructs were found to be VSR-.
These contained the two smallest chromosomal in-
serts among the M* constructs (Fig. 1).
To understand the situation better, we sequenced
the smallest chromosomal insert that had the pheno-
type M+ VSR. (pDCM23). We also determined the
endpoints of various BAL-31 deletions for which the
methylation and repair phenotypes were already
known. Fragments from various BAL-31 deletion
constructs were cloned in bacteriophage M13 vec-
tors and sequenced using the dideoxy chain-
termination method.
Chromosomal
DNA
pBR322
Sequences
B S
V
B S
0 I
B
B
B
B
S
S
S
S
dcm
3 4 4.65 kb
Phenotype
M VSR
FIGURE 1 Phenotype of BAL-31 deletions in the dcm region. BAL 31 was used to generate
deletions from either the BamHl site or the Sall site in pDCM4. Chromosomal DNA (striped
lines) and a small segment of the vector, pBR322, are shown (heavy lines). Phenotypes
M and VSR refer to the ability of the plasmids to complement the dcm6 mutation for methy-
lation of CC(A/T)GG sites and for VSP repair, respectively. Open arrows represent the
ORFs in the insert within pDCM23, as deduced by DNA sequencing. (B) BamHl; (S) Sall.
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The largest open reading frame (ORF) in this se-
quence codes for a protein of 472 amino acids, and
nearly all the BAL-31 deletions that truncate this
ORF are M. The sequence of this ORF can be
aligned with the sequence of the EcoRII methylase,
which has the same sequence specificity as Dcm. On
the basis of these criteria, we believe that this ORF
is the dcm gene.
The plasmid pDCM21 contains all of the dcm
gene, but has the phenotype M* VSR-. Therefore,
dcm is not sufficient for complementing the VSP re-
pair defect of the dcm6 mutation. Within the se-
quenced DNA, there exists a second reading frame
partially overlapping with dcm and on the same
strand as dcm. The protein coded by this ORF
(named X temporarily) may also be required for VSP
repair (Fig. 1). All BAL-31-generated deletions from
the left that truncate or remove ORF X have the
phenotype VSR-. Deletions from the right presuma-
bly eliminate the common promoter of dcm and
ORF X and lead to the M- VSR- phenotype regard-
less of the length of the deletion. Finally, we have
made a construct that removes a restriction fragment
internal to dcm that has the phenotype M- VS12*.
This deletion does not affect the region 5' to dcm
or the ORF X. It is therefore possible that the pres-
ence of functional product X may be sufficient to
complement the defect in VSP repair in a dcm6 back-
ground. The dcm6 mutation may be pleiotropic, i.e..
affect both dcm and gene X.
We have apparently stumbled upon a new DNA
repair gene in E. coli. The product of this gene ap-
pears to be essential for VSP repair, and its expres-
sion may be from the same promoter as dcm. If so,
product X would be produced whenever Dcm is pro-
duced. Therefore, increased cytosine methylation in
the cell would go hand in hand with increased VSP
repair and C-.T transitions would be avoided.
Hybrid Cytosine Methylase Genes
J. Meyertons
DNA methylases that transfer a methyl group to po-
sition 5 in cytosine share long stretches of sequence
similarities. In addition, each methylase possesses
at least one segment of approximately 100 amino
acids that is unique. It is possible that the shared se-
quences among methylases represent common func-
tional domains for the methyl transfer reaction,
whereas the unique segment is involved in the rec-
ognition of the target DNA sequence. To identify
such protein domains, fusions are being made be-
tween the Hhal and HpaII methylases (recognition
sequences G*CGC and C*CGG respectively, where
*C is 5-methylcytosine). Over 40% of the residues
in the two enzymes are identical, and the regions of
amino acid sequence similarity between these two
methylases appear in the same order in each protein.
Hybrid methylases are being constructed by exchang-
ing the functionally equivalent segments of the Hhal
and HpaII methylase genes. The two genes are be-
ing placed next to each other, and nuclease BAL-
31-generated deletions will be used to fuse them.
Methylase activity expressed by the resulting hybrids
will be assayed by testing the resistance of plasmid
DNA to either Hhal or HpaII restriction endonu-
clease cleavage. The hybrid enzyme constructions
could potentially generate a novel methylase capa-
ble of recognizing a new sequence. These studies will
help to define the nature of DNA-cytosine methy-
lase recognition of DNA.
Studies of the Mspl Methylase
B. Mollet
The Mspl restriction-modification system recognizes
the sequence 5'-CCGG-3'. The complete system has
been previously cloned and sequenced (P.-M. Lin
and R.J. Roberts, in prep.). A fragment containing
the methylase gene was subcloned next to a fragment
containing the inducible pTac promoter, and this
derivative overproduced the methylase to high lev-
els. Our recent efforts have concentrated on develop-
ing a scheme for the purification of the Mspl methy-
lase to homogeneity. The first problems encountered
during purification resulted from the high levels of
expression. It was found that inclusion bodies were
present in E. coli cells expressing the methylase
(Fig. 2). As a result, the methylase was severely ag-
gregated and came out of solution very readily. For
instance, attempts to remove nucleic acids by strep-
tomycin sulfate precipitation resulted in the removal
of most of the Mspl methylase protein. However,
the methylase could be resolubilized by mild deter-
gent treatment and was in fact considerably purified
by this step. Further purification was achieved
by DEAE-cellulose chromatography, oligonucleo-
tide affinity chromatography, and FPLC on a Mono-
Q support. The oligonucleotide affinity column
was prepared from a polymerized oligonucleotide
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FIGURE 2 An electron micrograph of E. coil cells overproduc-
ing the Mspl methylase. The dark objects, indicated by arrows,
within many of the cells are well-formed inclusion bodies that are
believed to contain the bulk of the methylase protein. We thank
D. Spector (Cell Biology Section) for this figure.
(CCAGGCCGGCCTGGCCGG) containing the rec-
ognition sequence, which had been coupled to
cyanogen-bromide-activated Sepharose 4B. It proved
to be a very powerful step in the purification. This
is the first time that oligonucleotide affinity columns
have been used for the purification of methylases,
and our results suggest that it will prove to be an
extremely powerful method in other cases. We are
currently trying to solve the remaining problems of
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aggregation and to remove the final impurities so
that its crystallization might be attempted.
Computer Programs to Analyze DNA
and Protein Sequences
J. Posia
Many DNA sequences are available for the genes en-
coding restriction enzymes and their cognate methy-
lases. In addition, several sequences are available for
individual methylases. Among the restriction en-
zymes, comparisons reveal no obvious homologies
that can be related to function. However, compari-
sons of the primary sequences of 13 bacterial DNA
methyltransferases, which catalyze the formation of
5-methylcytosine, have been more rewarding. The
overall similarity of the 13 sequences is not sufficient
to allow any of the existing programs for multiple
sequence alignment to produce a satisfactory global
alignment. Consequently, pairwise dot-matrix com-
parisons were carried out, and individual alignments
were produced. These formed the basis for a global
alignment of all 13 sequences. Five regions of close
local similarity were used as initialization points for
this alignment, which was mainly carried out manu-
ally. Each of these conserved regions was also used
in the PROFILE method (Gribskov et al., Proc. Nati.
Acad. Sci. 84: 4355 [1987]) to build position-
dependent weight matrices (Profiles). This approach
could then produce a global alignment and allowed
the manual alignment to be improved. Using these
profiles as motifs of cytosine methylation, we have
found that they clearly differentiate the known cyto-
sine methylases from all other sequences in the PIR
library. This approach is being extended in several
ways. We have developed a set of new algorithms that
allow us to experiment with motif construction and
to use these motifs for predictive purposes. We have
also developed routines that use consensus sequences
to define relatedness and that will extract related se-
quences from protein databases. A database of pro-
tein sequence motifs is being set up that will facili-
tate the analysis of newly determined sequences. We
are presently searching for motifs that will uniquely
describe methylases that form N6- methyladenosine
and AM-methylcytosine. Further experiments are
aimed at defining motifs that may be of general use
in distinguishing proteins that interact with S-
adenosylmethionine.
Restriction Endonucleases
R.J. Roberts, J. Mart ling, K. Weule
The collection of restriction endonucleases continues
to grow, and more than 930 such enzymes have now
been isolated and characterized. 135 different speci-
ficities have been discovered among the type II en-
zymes. During the last year, more than 30 new en-
zymes have been isolated and characterized as part
of a collaborative program with I. Schildkraut and
D. Comb (New England Bio-Labs). Among these are
seven valuable new specificities, including two en-
zymes (MseI [TTAA] and Asel [AATTAAT]) that
recognize sequences containing only A or T within
the recognition sequence. Of the 16 possible
tetranucleotide palindromes, enzymes that recognize
13 of these sequences now exist (Table 1).
For many years, our group has been maintain-
ing databases of information about restriction en-
zymes and methylases. Some of this information has
been maintained in an electronic database manager,
INFORMIX, that has allowed easy access, update,
and dissemination of a small part of the informa-
tion. However, a great deal of information was main-
tained in unlinked files and could only be accessed
with difficulty. Recently, the Laboratory has acquired
a new electronic database system called ORACLE,
and a major effort has been under way for the last
few months to transfer all of the restriction enzyme
information into a single relational database
managed by the ORACLE software. Once the trans-
fer is complete and the appropriate user interfaces
are written, access to information about restriction
enzymes, their recognition sequences, commercial
availability, etc., will be very much simplified. Not
only will the information be available locally, but
its dissemination through BITNET and other dee-
TABLE 1 Simple Tetranucleotide Palindromes
AATT ACGT AGCT ATAT
TspEl Mae II Alul
CATG CCGG CGCG CTAG
NIalll Hpall FnuDll Mael
GATC GCGC GGCC GTAC
Mbol Hha I Haelll Rsal
TATA TCGA TGCA TTAA
Taql Msel
tronic networks can be automated. In particular, the
specific data that are required by computer programs
searching sequences for restriction enzyme recogni-
tion sites will be quickly available in electronic form.
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MACROMOLECULAR CRYSTALLOGRAPHY
J. W. Pflugrath R.M. Blumenthal A. Caleca J. Tropp
J. E. Anderson W. Brady T. Knapp J. Walter
J. Cairl J. Scuderi
A major objective of the Macromolecular Crystal-
lography Group is to determine the structures of a
number of biologically important proteins to atomic
resolution in order to better understand their func-
tions in cell processes such as growth control and
development. Our studies are designed to benefit
from and to complement the genetic and biochemi-
cal experiments performed by other groups at the
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Laboratory. Together with these biochemical data,
crystallographic models of protein kinases, oncogene
products, and trans-acting factors will help us com-
prehend the roles of these macromolecules in cell di-
vision, in cell transformation, and, ultimately, in dis-
eases such as cancer and acquired immunodeficiency
syndrome (AIDS).
Our crystallographic experiments require well-
formed crystals of the macromolecule being inves-
tigated. To grow crystals of a useful size (>0.3 mm
on a side), one must have available several milligrams
of the highly purified macromolecule. Although this
does not guarantee that crystals can be produced,
it is the minimal prerequisite before attempting to
crystallize the molecule. To this end, a major part
of our laboratory and time is devoted to producing
and purifying to crystallographic homogeneity the
proteins we are studying.
Once crystals are available, we are poised to col-
lect and evaluate diffraction data on our Enraf-
Nonius area detector. Installed this past year and
controlled by software developed in our laboratory,
it has yielded excellent data on test crystals of lyso-
zyme in a fraction of the time required by normal
diffractometer or film methods. Data are further
analyzed on one of our three MicroVAX computers,
and atomic models are built with the aid of our Evans
& Sutherland PS 350 interactive three-dimensional
computer graphics system.
Structure Determination of
Yeast RAS2
J.W. Pflugrath, J. Scuderi, J. Tropp [in collaboration with
J. Field and M. Wigler, Cold Spring Harbor Laboratory]
RAS2 from Saccharomyces cerevisiae is a structural
and functional homolog of the mammalian ras on-
cogene product (see M. Wig ler, Molecular Genetics
of Eukaryotic Cells Section). We wish to compare
the atomic structure of the yeast protein and the re-
cently determined structure of human c-Ha-ras p21
(de Vos et al., Science 239: 888 [1988]). Because of
amino acid sequence homology, we predict that the
structure of yeast RAS2 is very similar to that of hu-
man ras. We expect to see differences also, since the
mammalian protein contains only 189 amino acids,
whereas that of yeast has 322 amino acids. Of par-
ticular interest to us is the second half of the RAS2
molecule, which contains the "extra" 130-odd resi-
dues. From an Escherichia coli expression system de-
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veloped in M. Wigler's laboratory, we are currently
isolating RAS2 in sufficient quantity and purity to
begin crystallization experiments.
Yeast cAMP-dependent Protein Kinase
J.W. Pflugrath, J. Scuderi [in collaboration with J. Kuret
and M. Zoller, Cold Spring Harbor Laboratory]
We are investigating the structure of the yeast cAMP-
dependent protein kinase in a complementary col-
laboration with M. Zoller and colleagues. The
holoenzyme consists of a dimer of catalytic subunits
(TPKI) and a dimer of regulatory subunits (BCYI).
The results from X-ray crystallography will ideally
complement the genetic results of Zoller's group,
which highlight the nature of the protein-protein in-
teractions among the four polypeptide chains. Our
efforts are currently concentrated on obtaining the
amounts of BCYI needed for crystallization. We are
using the E. coil-expressed BCYI and a purification
procedure based on a cAMP-agarose affinity column
developed in the laboratory of M. Zoller (Johnson
et al., J. Biol. Chem. 262: 8636 [1987]). When purifi-
cation procedures for the holoenzyme or catalytic
out, we intend to crystallize them
also.
In closely related work with J. Kuret, we have ob-
tained crystals of a deletion mutant of the regula-
tory subunit, BCYI .6.1, that are unsuitable for X-
ray diffraction experiments. BCYI Al inhibits the
catalytic subunit with the same kinetics as the wild-
type regulatory subunit, yet cannot form dimers. We
are trying other methods of crystallization in order
to attain improved crystals.
Area Detector Software
J.W. Pflugrath [in collaboration with A. Messerschmidt,
Max-Planck-Institut fiir Biochemie]
Many laboratories including our own have developed
or purchased state-of-the-art area detectors in order
to collect and evaluate X-ray diffraction data from
macromolecules at a rate never before possible with
either film methods or automated diffractometers.
One impediment to the optimal use of these devices
has been the lack of adequate software to control
them. We have continued to develop our device-
independent software system to fulfill this need. We
have improved our MADNES area detector program
in a number of areas including searching, autoin-
dexing, prediction and evaluation of reflections, and
user-friendliness. Our success can be measured by
the growing list of users that now include, among
others, the MRC Laboratory of Molecular Biology,
Cambridge; the EMBL, Heidelberg; the Department
of Chemistry, Princeton University; the Department
of Chemistry, University of California, Berkeley; the
Rosenstiel Science Center, Brandeis University; the
Laboratory of Molecular Biology, Birkbeck College,
London; the Blackett Laboratory, Imperial College,
London; and the Laboratory of Chemical Physics,
University of Groningen, The Netherlands.
Purification of Bacterially Expressed
c-myc Protein
J. Anderson, J. Cairl [in collaboration with N. Sullivan,
Cold Spring Harbor Laboratory, and R. Watt,
Smith Kline & French]
Acquisition of the three-dimensional structure of the
c-myc protein will be a major advance in the study
of this proto-oncogene product. The structure will
be an invaluable aid to understanding c-myc func-
tion and perhaps to understanding the function of
other nuclear oncogenes. As a step toward our goal
of determining this structure, we purified overex-
pressed recombinant human c-myc protein from
Escherichia coli. The bacteria expressing the c-myc
protein were found by D. Spector (Cell Biology Sec-
tion) to contain intracellular inclusion bodies corre-
sponding to the c-myc protein. Accordingly, the
c-myc protein is recovered in the insoluble pellet when
the cell lysate is centrifuged. The purification in-
volves detergent extraction of the pellet to eliminate
some contaminants, urea solubilization of the c-myc
protein, and anion-exchange chromatography, fol-
lowed by removal of urea by dialysis. When this solu-
ble c-myc protein, which is about 90% pure, was
chromatographed on a Sephacryl S-200 column, it
eluted in the void volume, indicating that it has an
apparent molecular mass exceeding 250 kD, corre-
sponding to at least three or four c-myc molecules.
We analyzed samples of this aggregated c-myc pro-
tein by SDS-PAGE, using sample buffer with or
without dithiothreitol (DTT) as a reducing agent. The
sample containing DTT had as its main component
the 66-kD polypeptide corresponding to monomeric
c-myc protein. The sample without DTT, however,
had in addition to the 66-kD protein (which was pres-
ent at lower levels than in the + DTT sample) a very
high-molecular-weight polypeptide. Thus, the c-myc
protein purified as we have described exists predom-
inantly as a large aggregate that is at least partially
mediated by intermolecular disulfide bonds. It is un-
likely (although not impossible) that c-myc protein
normally has intermolecular disulfide linkages, es-
pecially since at least one other protein that forms
inclusion bodies when overexpressed in E. coli,
prochymosin, is also cross-linked by disulfides
(Schoemaker et al., EMBO J. 4: 775 [1985]). Some
of the cysteine residues involved in these cross-links
might participate in intramolecular disulfides in the
native c-myc protein, so there is a good chance that
the c-myc protein we have prepared is incorrectly
folded. For structural studies, we need homogeneous
native protein, and so we have decided to develop
an alternative purification procedure.
We are currently working to increase the propor-
tion of soluble c-myc protein produced in vivo, in
collaboration with K. Chan and D. Spector (Cell Bi-
ology Section). If disulfide cross-links form in in-
clusion bodies, as suggested by Schoemaker et al.
(EMBO J.4: 775 [1985]), then soluble protein that
does not form inclusion bodies should not be cross-
linked and would be more likely to be properly
folded. Increasing the amount of soluble protein may
require simply reducing the level of overexpression
from the existing vector, or it might require chang-
ing the expression system and possibly the host or-
ganism as well. Once we have accomplished this, we
will develop a protocol to purify the c-myc protein
to homogeneity for crystallization and structural
analysis.
Structural Studies of
Restriction-modification
Enzymes
J. Anderson, R.M. Blumenthal, J. Walter, A. Caieca
[in collaboration with F. Barany, Cornell University Medical
College, and I. Schildkraut, New England Bio-Labs]
Another aspect of our research concerns restriction
endonucleases and methylases. These enzymes recog-
nize specific DNA sequences and then cleave or
methylate the DNA, respectively. Methylation by a
particular methylase protects the site from cleavage
by the corresponding endonuclease. Our goal is to
solve the structures of several of these enzymes both
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FIGURE 1 (Top) Crystals of Hind III endonuclease, each about 0.5 mm across, grown from 2.4
M ammonium sulfate at pH 7.8 and room temperature. (Bottom) Cocrystals of HindlIl en-
donuclease and the oligonucleotide duplex
GTACAAGCTTCAT
ATGTTCGAAGTAC
grown from 1.75 M ammonium sulfate at pH 7.0 and room temperature. Rods are 0.6-0.7 mm
long.
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as free proteins and in complexes with oligonucleo-
tides carrying their recognition sites. These structures
will help us to understand how specific DNA se-
quences are recognized by these proteins and will also
help us to understand their enzymatic mechanisms.
HINDI!! ENDONUCLEASE
These studies were carried out by J. Anderson, A.
Caleca, J. Walter, and I. Schildkraut. The HindIll
endonuclease recognizes the site AAGCTT and
cleaves after the first adenine. Large, well-formed
crystals of the endonuclease (Fig. 1, top) grow from
ammonium sulfate at pH 7.8, but these crystals
diffract at best only to about 7-A resolution, which
would not provide adequate structural detail. We are
currently scanning for conditions that give crystals
that diffract to higher resolution.
We have also set up cocrystallizations of the
HindIll endonuclease with oligonucleotides carry-
ing its recognition site. We have obtained several crys-
tal forms, but none are yet large enough for X-ray
analysis. One of the crystal forms is shown in Fig-
ure 1 (bottom). We are searching for conditions that
will give larger cocrystals.
TAO! ENDONUCLEASE
These studies were carried out by J. Anderson,
A. Caleca, and E Barany. The Taql endonuclease,
from the thermophilic bacterium Therm us aquati-
cus, recognizes the DNA sequence TCGA and cleaves
after the thymine. We have obtained two crystal
forms for Taql endonuclease, neither of which is yet
large enough for X-ray analysis. Cocrystallization
attempts have yielded very tiny needle crystals. We
are continuing to search for conditions that will pro-
duce larger crystals both of the protein alone and
of the protein with DNA.
Both Taql and HindIll endonucleases are contami-
nated with small amounts of other polypeptides,
some of which may be breakdown products of the
intact molecules. Removal of these impurities might
improve our chances of growing quality crystals of
these proteins, and thus we are attempting to develop
purification protocols to accomplish this.
PVUII METHYLASE
These studies were carried out by R.M. Blumenthal
and J. Walter. The Pvull methylase recognizes the
sequence CAGCTG, and methylates the internal
cytosine at the N4 position. We have successfully
overexpressed the methylase in E. coli. The over-
producing strain expresses about 10% of the total
soluble protein as PvuII methylase. Most of the
methylase protein stays in the supernatant when a
whole-cell lysate is centrifuged. The methylase re-
mains soluble when up to 1% polyethyleneimine is
added as a precipitant to the supernatant of the cell
lysate. Subsequent ion-exchange chromatography on
DEAE-Sephacel yields protein that is about 75%
pure. We are devising further steps to purify the
methylase to homogeneity for crystallization studies.
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SITE-SPECIFIC MUTAGENESIS
M. Zoller K. Johnson L. Levin J. Kuret
M. lacovacci C. Nicollette
Structure/Function of Yeast
cAMP-dependent Protein Kinase
M. Zoller, K. Johnson, M. lacovacci, L. Levin,
C. Nicollette, J. Kuret
Protein kinases play an important role in regulating
cellular processes. Structural analysis of a number
of these enzymes has identified separate catalytic (C)
and regulatory (R) domains. The function of the R
domain is to inhibit kinase activity. These domains
can be on separate subunits, as in cAMP-dependent
protein kinase, or within the same polypeptide, as
in cGMP-dependent protein kinase, protein kinase
C, and myosin light-chain kinase. It has been postu-
lated that inhibition of phosphotransferase activity
is maintained by occupation of the active site of the
C domain by a pseudosubstrate sequence within the
R domain. The association between the R and C do-
mains has been shown to be extremely tight, with
binding constants in the subnanomolar range. Acti-
vation of these enzymes occurs by dissociation of
the R domain and is triggered by binding of small
effectors (cAMP, cGMP, Ca", phospholipid) or ac-
tivating proteins (calmodulin) to the R domain.
Comparisons have been made between the pri-
mary sequences of all known eukaryotic protein ki-
nases. This analysis has shown that the C subunits
(domains) belong to a family of proteins that stem
from a common primordial structure. The family can
be broken down into kinases that phosphorylate ser-
ine or threonine residues and proteins that phos-
phorylate tyrosine. The common structural features
are an ATP-binding site and a protein-substrate-
recognition site. However, only a few residues have
been mapped to these structural domains. New pro-
tein kinases are always compared with the primary
structure of cAMP-dependent protein kinase. The R
subunits (domains) from the different protein kinases
appear to be functionally similar, although unrelated
structurally.
Although the primary structures of many protein
kinases are known, many questions with respect to
the structure and function of these enzymes still ex-
ist regarding the interactions between the R and C
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domains as well as the recognition of specific sub-
strates. A three-dimensional structure of a protein
kinase does not yet exist. We are interested in apply-
ing recombinant DNA technology to the study of
protein kinases. cAMP-dependent protein kinase was
chosen for these studies because it is the best-
characterized protein kinase. Saccharomyces cere-
visiae is being utilized in order to exploit the advan-
tages of yeast molecular genetics for the isolation
and characterization of mutant proteins. We have
taken several approaches: (1) expression of the genes
encoding the subunits of cAMP-dependent protein
kinase, (2) genetic techniques to obtain interesting
mutants, and (3) site-directed mutagenesis to test the
role of specific amino acids.
In S. cerevisiae, as in higher eukaryotes, the
holoenzyme of cAMP-dependent protein kinase is
a tetrameric molecule composed of two C subunits
and two R subunits. In the absence of CAMP, the
R subunit binds tightly to the C subunit and inhibits
catalytic activity. The effector cAMP binds to the
R subunit, and the holoenzyme dissociates into two
active C subunits and an R-subunit dimer. The C
subunit phosphorylates specific protein substrates,
thereby altering the biochemical properties of these
proteins. As described by M. Wigler and co-workers
(Molecular Genetics of Eukaryotic Cells Section),
three genes in yeast, TPKI, TPK2, and TPK3, encode
distinct C subunits, C1, C2, and C3, respectively. All
three proteins are structurally and functionally ho-
mologous to their mammalian counterparts. A sin-
gle gene, BCYI, encodes the yeast R subunit. The
yeast R subunit is homologous to mammalian R sub-
units, and it resembles the mammalian type II R
subunit in its ability to act as a substrate for C. Syn-
thesis of cAMP in S. cerevisiae is catalyzed by
adenylate cyclase (CYRI) and is positively regulated
by the RASI and RAS2 gene products. At least one
of the RAS genes is normally required for viability,
but both can be deleted in strains that lack a func-
tional R subunit of cAMP-dependent protein kinase.
In addition, studies by T. Toda, S. Cameron, and
M. Wigler demonstrated that yeast cells require at
least one of the TPK genes for viability.
Purification and Characterization of
C1, the C Subunit of S. cerevisiae
cAMP-dependent Protein Kinase
Encoded by TPK1
M. Zoller, K. Johnson, J. Kuret
We have purified and characterized the C subunit,
C,, encoded by the TPKI gene. To purify C, com-
pletely free of C2 and C3, a strain was constructed
(in collaboration with T. Toda, S. Cameron, and
M. Wig ler [Molecular Genetics of Eukaryotic Cells
Section]) that contained only the TPKI gene and
genetic disruptions of the other two TPK genes. The
cellular level of C, was increased by expressing the
genes for C, (TPKI) and the yeast R subunit
(BCYI) on multiple-copy plasmids within this strain.
This resulted in increased expression of C, from
10 µg /liter to 400 µg /liter. Purification was accom-
plished by a two-column procedure in which cAMP-
dependent protein kinase holoenzyme was chro-
matographed on Sephacryl -200, and then bound to
an anti-R-subunit immunoaffinity column. Pure C,
was released from the antibody column by addition
of cAMP. The protein migrated on an SDS-poly-
acrylamide gel with a relative molecular weight of
52,000. Kinetic analysis showed that the apparent
K, values for ATP and Kemptide were 33 um and
101 pm, respectively. The /cc. was determined to be
640 min'. The protein weakly autophosphorylated,
incorporating less than 0.1 mole phosphate per mole
of C subunit. Amino-terminal sequencing revealed
that the protein was blocked. Recently, we have im-
proved the expression of C, by use of a heterolo-
gous promoter (ADHI) and coexpression with R
(Ala-241), a mutant form of BCYI that has a ten
times higher affinity for the C subunit, compared
with the wild-type R subunit. This resulted in a strain
that expresses cAMP-dependent protein kinase at a
level of approximately 5 mg/liter. This level should
provide sufficient protein to begin crystallographic
analysis of the yeast enzyme.
A Mutation in the C Subunit of
cAMP-dependent Protein Kinase
That Disrupts Regulation
L. Levin, J. Kuret, M. Zoller
A major question about protein kinases revolves
around the identification of the contacts between the
R and C domains that are important for regulation
of enzymatic activity. To approach this problem, we
have begun a project that maps these contacts by
analysis of genetically isolated mutants. Our first
mutant is an altered C subunit (TPKI) of yeast
cAMP-dependent protein kinase. This mutant C
subunit is no longer subject to regulation, yet it re-
tains its catalytic activity. As discussed above, at least
one of the RAS genes is normally required for via-
bility, but both can be deleted in strains that lack
a functional R subunit of cAMP-dependent protein
kinase. On the basis of these studies, we predicted
that mutations in the C subunit of cAMP-dependent
protein kinase that disrupt regulation of catalytic ac-
tivity would suppress a rasa defect. We isolated a
dominant suppressor of a temperature-sensitive al-
lele of RAS2 that mapped to the TPKI gene (in col-
laboration with S. Powers, T. Michaeli, S. Cameron,
and M. Wig ler). DNA sequencing of the coding re-
gion of the mutant gene identified a single adenine-
to-guanine transition in the TPKI- coding sequence,
resulting in a substitution of alanine for threonine
at amino acid 241 of C, (see Fig. 1A). This residue
is conserved between the yeast and mammalian C
subunits. Interestingly, this threonine is phos-
phorylated in both the yeast and mammalian pro-
teins. Affinity-labeling experiments on the mam-
malian C subunit suggest that a neighboring residue
is in close proximity to the protein-substrate-binding
site.
To characterize the properties of the mutant C
subunit, we purified the protein using the im-
munoaffinity procedure described above. Biochem-
ical analysis of the mutant subunit indicates at least
a 100-fold decreased affinity for the yeast R subunit.
The mutant C subunit exhibits an approximately
threefold increase in Km values for ATP and peptide
cosubstrates and is essentially unchanged in its cata-
lytic rate. These results identify this threonine as an
important contact between C and R subunits and
suggest that the phosphate plays a direct role in the
interaction. In addition, these studies suggest that
this residue is only a minor contact in substrate rec-
ognition. Thr-241 and a number of other amino acids
in the region from Asp-228 to Glu-252 are conserved
in mammalian cGMP- and cAMP-dependent protein
kinases and protein kinase C (see Fig. 1B). As dis-
cussed above, these protein kinases are composed of
separate R and C domains and may be regulated by
pseudosubstrate inhibition. The sequence conserva-
tion and apparent common regulatory mechanism
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B.
TPKI
CI
TPK 1-str6
Ci(Als241)
(709) GAC GTC ACA TAT ACA TTA TGC GGT ACT
(237) Asp Val Thr Tyr Thr Les Cys Gly Thr
GCA
Ala
4.
Yeast CI (228) 1:11MFAKYV-PD VNYO-CaTEDYLA11-E-
C 1 (A I a 241) (228) MBIFAKYV-PD V&A LCUMTLAP-E
C2 ( 21 1 ) EIMFAREV-QTVIVITLCBIEZMI AIM
C3 ( 229) anwAttyv-privratzwEorIPP-
Bovine C ( 184) INWAISRVK--GR-Vill.....AF-
Bovine cGdPK ( 501) D_F4FAIKK 1 G F-GK KTINTFCGIREMAEE-
Bovine PK-C ( 48 1) IIEGIACKEHMMDGVTERTICB1-21DYI APX-
FIGURE 1 (A) The nucleotide sequence of TPK1 and the predicted amino acid sequence
of Ci in the region surrounding the suppressor mutation. (8) Amino acid sequences of
the mutant, Ci (Ala-241), and wild-type yeast Ci subunits, and other serine-threonine pro-
tein kinases in the region of the putative substrate-binding domain. Shading indicates
absolutely conserved amino acids. The arrow points to the site of the substitution in Ci
(Ala-241). Numbers in parentheses indicate the first amino acid listed. Related protein
kinases are the other two isozymes of the yeast C subunit (C2 and 03), the Ca subunit
of the bovine cAMP-dependent protein kinase (bovine C), the bovine cGMP-dependent
protein kinase (cGdPK), and bovine protein kinase Ca (PK-C).
of these protein kinases suggest that the functional
role of this threonine is conserved. This mutant has
been extremely useful in developing strains to ob-
tain extragenic suppressors (e.g., mutant R subunits).
One of the phenotypes of a strain containing C,
(Ala-241) is that it is sensitive to heat shock, whereas
a strain carrying the wild-type C subunit is resistant
to heat shock. We have used this phenomenon to iso-
late and characterize R subunits that have a greater
affinity for the C subunit than for the wild-type R
subunit (discussed below).
A Yeast System to Express and
Analyze Mutants of the cAMP-dependent
Protein Kinase
L. Levin, M. Zoller
To purify mutant C subunits for biochemical analy-
sis, we use a "TPK swap procedure" that provides
a way to overexpress any mutant C subunit in the
absence of the wild-type protein. This procedure was
used by T. Toda and M. Wigler (Molecular Genetics
of Eukaryotic Cells Section) to assess plasmids car-
rying portions of the TPK1 gene. As depicted in Fig-
ure 2, the procedure involves introduction of a plas-
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mid containing the mutant C subunit (TPK1"') into
a strain in which all three chromosomal TPK genes
have been genetically destroyed. Since at least one
TPK gene is required for viability, the strain is kept
alive by a wild-type TPK1 carried on a plasmid. The
wild-type TPK1 plasmid is marked by the ADE8
gene (adenine auxotrophy); this strain requires leu-
cine for growth. The plasmid with the mutant
TPKI" gene contains the LEU2 gene (leucine aux-
otrophy). After selection for transformants that con-
tain both plasmids, plasmid loss is induced by growth
without selection for either plasmid. Individual colo-
nies are tested for leucine or adenine auxotrophy, in-
dicating which TPK gene has been maintained.
Strains that have successfully swapped plasmids will
now require adenine for growth, but not leucine.
Since viability requires an active C subunit, mutant
C subunits that cannot support growth will not swap.
Expression from plasmids, rather than chromoso-
mally integrated genes, improves the level of expres-
sion. Subsequently, an additional plasmid contain-
ing the BCY1 gene encoding the yeast R subunit can
be introduced in order to produce a strain that over-
expresses both the C and R subunits. This facilitates
purification of the mutant C subunit. Yeast offers
the advantage over heterologous expression systems
as being the natural environment for production of
these proteins. In addition, this system is superior
STRAIN LL8
leu2- ade
BCY1+
1A2L3*
TPKIwt
SELECT FOR
ADE+ LEU+
TRANSFORMANTS
TPK1 "SWAP" PROCEDURE
LEU2*
TPKI.
TRANSFORM LL8
WITH TPKI MUTANT
PLASMID
NON SELECTIVE
GROWTH IN YPD
leu2
tokl tpk2- tpk3- BCY1+
ADES*
TPK I wt
(WILD TYPE TPK1 I
W4c2- mk3 BCYI+
en+
TPK1.
MUTANT TPKI
FIGURE 2 The TPK swap procedure: A yeast system to express and analyze mutants
of the CAMP-dependent protein kinase. Strain LL8 (tpkl-, tpk2-, tpk3-, BCY1,
YEpADE8 /TPKI, leu2-) is transformed with YEpLEU2/TPK1T, a plasmid that contains
a mutant C-subunit gene. Transformants that have both plasmids are selected by growth
on media lacking both adenine (for selection of wild-type TPKI) and leucine (for selection
of mutant TPKI"'). Plasmid loss is induced by growth in media without selection and then
the surviving strains are tested for viability on selective media lacking either adenine or
leucine.
to other eukaryotic expression systems that rely on
the use of dominant mutants in order to accommo-
date the wild-type protein in the background.
The C Subunit of Mammalian
CAMP-dependent Protein Kinase Can
Replace the Yeast Protein In Vivo
K. Johnson, M. Zoller [in collaboration with L. Slice and
S. Taylor, University of California at San Diego]
To test the functional relationships between the yeast
and mammalian C subunits, we expressed the gene
encoding the mammalian C subunit in yeast. The
coding sequence of the yeast TPKI gene was replaced
by the coding sequence for the mammalian gene such
that the natural protein would be produced. This
gene was carried on a yeast expression vector and
introduced into yeast using the TPKI swap proce-
dure outlined above. Preliminary results indicate that
the mammalian C subunit can swap successfully with
the yeast C subunit and maintain viability. These ex-
periments indicate that the two proteins are struc-
turally and functionally similar and broaden the con-
clusions we will obtain from the study of the yeast
enzyme. Studies are in progress to determine whether
the genetic tricks that we use to isolate mutations
in the yeast cAMP-dependent protein kinase can be
used in the mammalian protein. In addition, this re-
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suit may provide a model system in which to reen-
gineer protein kinase activity.
Mutagenesis of the R Subunit of Yeast
cAMP-dependent Protein Kinase:
Isolation of Site-directed Mutants
with Altered Binding Affinity
for the C Subunit
J. Kuret, K. Johnson, C. Nicolette, M. Zoller
Biochemical experiments and amino acid sequence
comparisons on a number of different R subunits
have identified several structural domains. One of
these regions, termed the hinge, is a major deter-
minant involved in the specific inhibition of cata-
lytic activity in the inactive holoenzyme complex.
To dissect this region further and to characterize the
role of specific amino acids, oligonucleotide-directed
mutagenesis was used to produce mutants in the
hinge region of the yeast R subunit (see Fig. 3). Our
initial studies were focused on Ser-145, which is part
of the "pseudosubstrate" sequence in the hinge do-
main: ArgArgThrSerVal. The mutant proteins were
expressed in Escherichia coil, purified, and analyzed
in vitro for the ability to inhibit the activity of the
purified yeast C subunit in the presence and absence
A
B
C
N
of cAMP. When assayed in the absence of cAMP,
the wild-type R subunit inhibited C with an ICso
(inhibition constant) of 49 nm. Replacement of
amino acid residue Ser-145 with alanine or glycine
produced mutants that were two- to tenfold better
inhibitors of C, whereas replacement with glutamate,
aspartate, lysine, or threonine produced mutants that
were two- to fivefold worse inhibitors of C relative
to wild-type R. When assayed in the presence of
cAMP, all R subunits had a decreased affinity for
the C subunit. These results suggest that the amino
acid at position 145 of R contributes to R-C interac-
tion and therefore influences the equilibrium of yeast
protein kinase subunits in vitro. We have exploited
these findings by expressing the Ala-145 variant in
yeast in order to improve the level of expression of
wild-type and mutant C subunits and facilitate their
purification.
Crystallization of the
Yeast R Subunit
J. Kuret, M. Zoller [in collaboration with J. Pflugrath,
Cold Spring Harbor Laboratory]
To understand the structure of protein kinases on
a molecular level, we have initiated a collaborative
dimerization hinge" cAMP binding CAMP binding
RD
R11
BCY1
C
10 61 KATEKVEAQNNNN I TRKFURGA I SSEPE----GDKPATPLPN I RMVETQQ1MMIU
77-130 ISPP FMNRVVKGRRFSGA I E EDAASYVRKM-WDYKTMAAEAM
77-130 WOW) LDVRI RGRM-7RRVCIONYNRD E E E EDZDRRMIMMLIRC6MQEAC
125-171 TREK TSTMLRMHEMAQEST iGIM.QRNN FlIDWMRDHYK EKS EGOLGOMMSE
FIGURE 3 Structure of the hinge region of the wild-type R subunit and of the mutants. (A) Organization of functional domains
along the R-subunit polypeptide chain. (8) Sequence homology in the-hinge region of various R subunits including bovine
and Ril, D. discoideum R (RD), and yeast R (BCY1). (C) Ser-145 of yeast R is part of the pseudosubstrate sequence Arg-Arg-X-Ser
involved in inhibition of catalytic activity. To characterize the role of this serine in R-C interactions, it was changed to the amino
acids indicated by oligonucleotide-directed mutagenesis. Each of the mutated proteins was expressed, purified, and then tested
for the ability to inhibit C-subunit activity.
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project with J. Pfulgrath on the determination of
the three-dimensional structure of cAMP-dependent
protein kinase. Our efforts over the past year have
focused on the use of a relatively small (10-liter) fer-
mentor for the production of the yeast R subunit
(BCY1). Our experiments demonstrated that use of
the fermentor can improve yields significantly. A 10-
liter culture of E. coli expressing the yeast R subunit
yielded 100-200 mg of protein in crude extracts. This
represents a five times increase in yield of protein
expressed per liter over shaker-flask methods. Now
that we have optimized our expression system, our
efforts have turned to the problem of obtaining pro-
tein of sufficient purity to obtain usable crystals.
These studies are still in progress. We have recent evi-
dence that a form of the protein in which the amino-
terminal domain has been deleted can be obtained
with less heterogeneity than the full-length R sub-
unit. This form inhibits the C subunit with the same
kinetics as the wild-type R subunit but does not form
R-R dimers. An initial attempt to produce crystals
with this preparation yielded small crystals unusable
for X-ray analysis, yet provides an impetus that crys-
tallization will be possible with futher work.
A Genetic System to Study
Interactions between R and C Subunits:
Isolation and Characterization of R
Subunits with Increased Affinity
for the C Subunit
C. Nicolette, L. Levin, M. Zoller
This screen utilizes the sensitivity to heat shock of
a strain that contains C, (Ala-241) as the sole C
subunit. The strain is sensitive to heat shock because
the C subunit is not regulated. A strain that contains
a mutant R subunit that regulates the activity of C,
(Ala-241) will be heat-shock-resistant. We have al-
ready demonstrated that this screen can successfully
identify tight binding variants using R (Ala-145) con-
structed by in vitro site-directed mutagenesis.
The procedure involves the transformation of this
heat-shock-sensitive strain using a pool of plasmids
that contain the randomly mutagenized BCY1 gene.
Initially, we are using a mutD strain for mutagene-
sis, but we are investigating other procedures to di-
rect mutations randomly into the BCY1 gene. Trans-
formants are tested for resistance to heat shock, and
the BCY/-containing plasmids are isolated from
these heat-shock-resistant colonies. The mutation is
identified by sequencing with oligonucleotide
primers that span the BCYI -gene- coding sequence.
In the initial experiments, two strains of yeast were
constructed, both of which contain C, (Ala-241).
One strain contained the wild-type R subunit and
the other contained the mutant R (Ala-145). Each
strain was tested for sensitivity to heat shock. The
control strain containing the wild-type R subunit was
still heat-shock-sensitive, but the strain containing
R (Ala-145) was resistant.
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NEUROSCIENCE
The research conducted by the Neuroscience Program at Cold Spring Harbor
Laboratory continues to focus on the functional development of neurons. Our
interests lie in neurons of the central nervous system, particularly in the brain
where developmental disorders as well as degenerative neurological diseases can
lead to disabilities in learning and memory. To make progress in this field, we have
chosen a variety of cell-culture systems, both primary neurons and neural cell
lines, to examine their differentiation and proliferation. We use protein purification
and characterization to uncover factors that promote neuronal development.
Molecular biology has given us the tools to study the gene regulation of these
factors. Thus, the projects carried out in this context employ all the latest tech-
niques in molecular and cellular biology, biochemistry, and genetics to uncover
the mysteries of the brain.
NEURONAL GROWTH AND DIFFERENTIATION
D.R. Marshak J.C. Figueiredo
L.O. Goodwin
R. Tonner
We are interested in the mechanisms involved in the
development, organization, and maintenance of con-
nections within the central nervous system (CNS).
There is a great deal of evidence indicating that solu-
ble growth factors play a critical role in these
processes. Our goals are to isolate and characterize
these factors and to uncover experimentally their
mechanisms of action on neurons. To this end, we
have developed cell-culture systems for examining
neurotrophic growth factors, proteins that elicit the
outgrowth of projections, or neurites, from the cell.
It is these neurites that become the axon and den-
drites of the neuron that carry the signals from one
cell to another.
Cellular Models of Neurite
Outgrowth
J.C. Figueiredo, D.R. Marshak, R. Tonner, L.O. Goodwin
Neuronal cell cultures can be used to identify and
characterize soluble neurotrophic factors. A signifi-
cant problem with these cultures, however, is the dif-
ficulty in obtaining pure neuronal populations. We
are able to obtain cultures of pure CNS neurons in
the virtual absence of nonneuronal cells by utilizing
cells derived from 7-day-old chick embryo cerebral
cortex. As shown in Figure 1, the extension of neu-
ronal processes by these cells is highly dependent on
the presence of soluble growth factors, such as that
derived from bovine brain. At this stage of em-
bryonic development, the cerebral cortical cells are
postmitotic, having lost the ability to undergo cell
division. The cells are able to generate or regenerate
neurites under controlled conditions. In this neurite-
extension assay, the cells are maintained in a serum-
free, defined medium, which allows us to add known
samples with a high degree of reproducibility. Within
24 hours, neurite outgrowth is prominent, and the
cells are scored on the basis of their morphologies.
Survival of the cells is very high, which allows us to
distinguish neurite extension activity from survival
functions.
Cell lines have been very useful to us in studying
neurite outgrowth. The neuroblastoma cell line,
neuro-2a, is derived from a murine tumor line known
as C1300. The neuro-2a cells are an excellent paral-
lel to the primary cerebral cortical cells because they
respond to many of the same stimuli. The neuro-2a
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FIGURE 1 Chicken embryo cerebral cortical cells were maintained in defined media without
addition (A) or with bovine-brain-derived neurotrophic factor (8).
cells offer an important advantage over the primary
cells in that they can be manipulated to respond to
stimuli very rapidly, hours rather than days. Another
cell line, the C6 rat astrocytoma cell line, has been
helpful as a model of glial cells that produce solu-
ble neurotrophic substances. We prepare condi-
tioned, serum-free media from these cells, which con-
tain several strong neurite-promoting materials.
Thus, cell cultures provide significant models for the
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production and response to soluble neurotrophic
factors.
Soluble neurotrophic factors are likely to act
through specific cell-surface receptors. These recep-
tors would then activate selected second-messenger-
generating systems, thereby initiating an intracellu-
lar response. We have used the neuro-2a cell-culture
system to study the intracellular signals that medi-
ate neurite outgrowth and neuronal differentiation.
Figure 2 shows the various morphological changes
in neuro-2a cells caused by manipulation of com-
ponents of the cAMP and inositol phospholipid
second-messenger systems. The data indicate that
cAMP, calcium ions, and the activation of protein
kinase C may all be involved in the initiation of neu-
rite outgrowth. We are currently probing specific bi-
ochemical events that mediate the profound mor-
phological changes in neuro-2a cells caused by
various pharmacological probes.
Purification of a Neurotrophic
Factor
J.C. Figueiredo, D.R. Marshak
Using primary chick embryo cortical cultures, we
have identified a factor from bovine brain that causes
neurite outgrowth. We are currently purifying this
factor to chemical homogeneity for structural anal-
ysis. To date, the preparation consists of (1) homo-
genization in hypotonic, neutral buffer, (2) heat treat-
ment, (3) batch adsorption and elution on anion
exchange resins, (4) column chromatography on an-
ion exchange resin, (5) gel filtration, and (6) chro-
matography on heparin-Sepharose conjugates. The
specific activity appears to increase 50,000-fold dur-
ing this purification. This activity appears to be
different from that of the sloop protein described
below. Table 1 shows preliminary purification data
and the resulting specific activity of the factor.
Mechanism of Action of S10013
D.R. Marshak, R. Tonner, J.C. Figueiredo
During the past several years, we have been inves-
tigating the role of the protein sloop in neuronal
physiology. A disulfide form of the protein acts as
a neurotrophic factor in both the neuro-2a and pri-
mary chick cortical cells. We have recently observed
that S10013 dimerizes and polymerizes under certain
conditions in vitro (Fig. 3). Reduction and alkyla-
tion of cysteine residues obliterates the biological ac-
tivity, and a structural analog, S100a, lacking one
of the cysteine residues, also has no activity. We have
conducted studies of chemical reduction and reoxi-
dation with a variety of agents, including tetrathio-
nate, ferricyanide, glutathione, and benzofuroxan.
TABLE 1 Purification of Neurotrophic Activity from
Bovine Brain
Procedure
Homogenate
Heat-treated supernatant
DE-52 batch
DE-52 column
Ultrage
Heparin-Sepharose
Protein Specific activity
(mg) (units/mg protein)
200,000 not determined
3,000 not determined
640 not determined
150 666
8 1,100
0.16 50,000
In some instances, formation of dimers and higher
polymers occurs, but quantitative regeneration of
biological activity has not yet been accomplished.
To study further the mechanism of action of 510013
as a neurotrophic agent, we have developed a vari-
ety of reagents and methods. Antisera to the mono-
meric, oxidized protein and, alternatively, to the poly-
meric protein are being produced in rabbits to probe
the native state of the protein (Fig. 3). Synthetic pep-
tides comprising a large portion of the molecule have
been synthesized. These synthetic peptides will be
used to probe the functional domains of S10013 and
to prepare site-directed antisera. Using synthetic
oligonucleotides, J. Figueiredo has isolated cDNA
molecules for the protein from a rat brain library.
We are currently using all of these reagents to iden-
tify the active form of S10013 in cell culture, to char-
acterize the receptor for the protein, and to begin
to analyze the role of the protein in vivo. These
studies have taken on new importance since the re-
cent demonstration by another laboratory that the
gene for S100[3 resides on human chromosome 21
in the region that is duplicated in Down's syndrome
and in the vicinity of the gene for familial Alzhei-
mer's disease. The role of this protein in neurologi-
cal diseases and developmental disorders of the ner-
vous system is still unknown, and our goal is to
establish the function of this protein in the develop-
ing nervous system under normal and abnormal con-
ditions.
Proliferation and Differentiation of
Neurons
D.R. Marshak [in collaboration with D. Spector, Cold Spring
Harbor Laboratory]
One of the central questions in neuronal devlopment
is the relationship between the ability of a neuron
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FIGURE 2 Neuro-2A cells were treated with no addition (A), 1 mm dibutyryl cAMP (8), 100 nM phorbal ester (TPA) (C), 100 nm calcium ionophore (A23187) (D), and both
TPA and A23187 (E).
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FIGURE 3 (A) Polyacrylamide gel electrophoresis of S100)3
(lanes 2,3,4) showing dimer and monomer, S100)3 polymers (lanes
5,6,7), and molecular-weight standards (lanes 1,8). (B) Western
blot using antisera to S10013 showing polymers (lanes 1,2) and
monomer and dimer (lanes 3,4).
to undergo cell division and its ability to differenti-
ate into a functional, excitable neuron. We have be-
gun to study this in the neuro-2a neuroblastoma cell-
culture system. Under conditions of high density and
in the presence of serum, these cells proliferate,
whereas in serum-free media at low density, these
cells send out processes that are characteristic of the
developing neurons. We are using immunocytochem-
ical techniques to localize markers of neuronal matu-
ration and other proteins involved in proliferation.
Figure 4 shows neurons stained with fluorescent an-
tibody probes to tubulin (a marker of neurites) and
188
the proliferating cell nuclear antigen (PCNA), which
is involved in DNA replication. It is apparent from
these experiments that PCNA staining is still visible
even after prominent neurites have developed. How-
ever, we have not yet determined the extent of func-
tional DNA replication during neuronal differentia-
tion. It will be interesting to find out if differentiated
neurons retain the ability to divide, as a potential
therapy for degenerative neurological diseases.
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ON QUANTITATIVE BIOLOGY
The Evolution of Catalytic Function
May 27-June 3
167 participants
For all too long, RNA never had the essential simplicity we wanted from it. Unlike
DNA, the closer we got to it, the more complex it seemed. Initially, we focused on
its informational properties, postulating that it carried the genetic information from
DNA to the cytoplasmic sites of protein synthesis. It then seemed natural to believe
that the main RNA molecules within ribosomes were the templates for the ordering
of amino acids during protein synthesis. Quickly, however, this idea was overturned
with the discovery first of transfer RNA and then of the true templates, messenger
RNA itself. These seminal discoveries had the positive impact of permitting the
basic outlines of protein synthesis to be established, as well as permitting the
elucidation of the genetic code. At the same time, the dilemma arose of why RNA
played so many different roles. In some profound way, the explanation had to lie in
the molecular events that gave rise to the origin of life.
Rationally thinking about events so distant in the past, however, was then and
still is a major intellectual challenge. Francis Crick rose to the occasion by postulat-
ing that RNA had to have an enzymatic role, as well as template and structural
roles, functioning during the early stages of life as the enzyme for its own self-
replication. Under this scheme, the first genetic molecule was RNA, with DNA
coming later, after the essential outlines of the genetic code were established. But
logical as this idea was, it had little impact, and for almost 20 years, thinking
about the origin of life was regarded at best as a safe haven for minds unable to
keep up with the extraordinary rush of a recombinant-DNA-driven assault on the
nature of life as it exists today.
Then in 1982, the discovery of the first example RNA self-splicing suddenly led
to the realization that RNA molecules do have the capability to act as catalysts.
Over the past several years, many more examples of self-splicing have been
found, and the fact that the catalytic activity of RNase P resides in its RNA
component has been demonstrated. With Crick's conjecture now a fact and with
the recent rapid progress in understanding today's enzymes and ribosomes, the
time had thus arrived to bring together a diverse collection of pure chemists,
biochemists, molecular biologists, and evolutionary biologists to discuss the
evolutionary events that may have given rise to the living organisms that now exist
on earth. As a title, we chose the Evolution of Catalytic Function to help assure
that this Symposium would bring together minds that think in terms of chemistry,
as well as about genetic information. The final program comprised 110 speakers,
each speaking some 30 minutes. These presentations led to one of our intellectu-
ally most demanding meetings, since the talks were arranged to be longer than
customary in view of the very diverse nature of the audience, which this year
consisted of some 167 scientists. Helping to assure the success of the meeting
were the wide-ranging opening talks by Daniel Koshland, Leslie Orgel, and
Manfred Eigen as well as the gracefully lucid summary by Alan Weiner
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P. Grabowski, P.A. Sharp, N. Pace R. Gumport, R. Symons
This meeting was supported in part by the Alfred P. Sloan Foundation, National
Cancer Institute, a division of National Institutes of Health; National Science
Foundation; U.S. Department of Energy; and the Lucille P Mackey Charitable
Trust.
Welcoming Remarks: J.D. Watson
SESSION 1 OPENING REMARKS
Koshland, D., Dept. of Biochemistry, University of Califor-
nia, Berkeley: Evolution of function in enzymes.
Orgel, L., Salk Institute for Biological Studies, San Diego,
California: The earliest catalytic biopolymers-A specula-
tive review.
SESSION 2 PRIMORDIAL SOUP
Chairman: L. Orgel, Salk Institute for Biological Studies
Miller, S.L., Dept. of Chemistry, University of California, San
Diego, La Jolla: Which organic compounds could have
occurred on the prebiotic earth?
Ferris, J.P., Dept. of Chemistry, Rensselaer Polytechnic In-
stitute, Troy, New York: Prebiotic synthesis-Problems
and challenges.
Westheimer, F, Dept. of Chemistry, Harvard University,
Cambridge, Massachusetts: Why God chose phos-
phates.
Schwartz, A.W., Visscher, J., van der Woerd, R., Bakker,
C.G., Laboratory for Exobiology, Faculty of Science, Uni-
SESSION 3 ESSENTIALS OF CATALYSIS
Chairman: W.P. Jencks, Brandeis University
Jencks, W.P., Graduate Dept. of Biochemistry, Brandeis
University, Waltham, Massachusetts: Economics of en-
zyme catalysis.
Breslow, R., Dept. of Chemistry, Columbia University, New
York: Artificial enzymes.
Bartlett, PA., Marlowe, C.K., Giannousis, P.P., Hanson, J.E.,
Dept. of Chemistry, University of California, Berkeley:
Phosphorus-containing peptide analogs as peptidase in-
hibitors.
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Eigen, M., Max-Planck-Institut fur biophysikalische Chemie,
Gottingen, Federal Republic of Germany: New concepts
to deal with evolution of nucleic acids.
varsity of Nijmegen, The Netherlands: In search of RNA
ancestors.
Joyce, G.F., Salk Institute for Biological Studies, La Jolla,
California: Nonenzymatic template-directed synthesis of
informational macromolecules.
Benner, S.A., MacPherson, L.J., Piccirilli, J.A., Moroney,
S.E., Krauch, T., Laboratory for Organic Chemistry, Swiss
Federal Institute of Technology, Zurich, Switzerland: The
last riboorganism-Synthetic approaches to functional
RNA molecules.
Tramontano, A., Janda, K., Lerner, R., Dept. of Molecular
Biology, Research Institute of Scripps Clinic, La Jolla,
California: Catalytic antibodies.
Schultz, P., Pollack, S., Jacobs,. J., Dept. of Chemistry, Uni-
versity of California, Berkeley: Catalytic antibodies.
PlOckthun, A., Max-Planck-Institute for Biochemistry, Mar-
tinsried, Federal Republic of Germany: Engineering of
antibodies with known three-dimensional structure.
C.-I. Brandon, A. Klug
SESSION 4 RIBOSOMES
Picnic
Chairman: M. Nomura, University of California, Irvine
Nomura, M., Thomas, M., Sor, F, Bolotin-Fukuhara, M.,
Cole, J.R., Matthews, L., Yamagishi, M., Dept. of Biologi-
cal Chemistry, University of California, Irvine: Control of
the synthesis of ribosomes and ribosomal components in
bacteria-Translational regulation and feedback loops.
Nierhaus, K.H., Brimacombe, R., Gualerzi, C., Nowotny, V.,
Rheinberger, H.-J., StOffler, M., Wittmann-Liebold, B.,
Wittman, H.G., Max-Planck-Institut far Molekulare Gene-
tik, Berlin, Federal Republic of Germany: Studies on
structure, assembly, evolution, and function of ribo-
somes.
Oakes, M., Rivera, M., Soufer, D., Shankweiler, G., Schein-
man, A., Lake, J., Molecular Biology Institute, University
of California, Los Angeles: Evolving ribosome structure
and function-Mapping sequences with DNA hybridiza-
tion microscopy.
Weiss, R.B., Atkins, J.F., Smith, D.M., Gesteland, R.F., Dept.
of Human Genetics, University of Utah Medical Center,
Salt Lake City: Protein sequencing of frameshift junctions
resulting from abnormal ribosome translocations.
Noller, H.F., Stern S., Moazed, D., Powers, T, Svensson, P.,
Weiser, B., Thimann Laboratories, University of California,
Santa Cruz: rRNA-Architecture and active sites.
SESSION 5 PUTTING A PROTEIN TOGETHER
Chairman: M. Levitt, Weizmann Institute
Levitt, M., Weizmann Institute, Rehovot, Israel: Computer
simulation of protein dynamic in solution.
Karplus, M., Dept. of Chemistry, Harvard University, Cam-
bridge, Massachusetts: Dynamics of proteins-Applica-
tions.
Shoemaker, K.R.,' Marqusee, S.,' York, E.J.,2 Stewart,
J.M.,2 Baldwin, R.L.,"Dept. of Biochemistry, Stanford
University Medical Center, California; 2Dept. of Biochem-
istry, University of Colorado Medical School, Denver: a-
Helix formation by peptides in aqueous solution.
Gerbi, S.A.,' Jeppesen, C.,1 Stebbins-Boaz, B.,' Ares,
M.,2 Rothschild, L.J.,1 'Division of Biology and Medi-
cine, Brown University, Providence, Rhode Island;
2Dept. of Molecular Biophysics and Biochemistry, Yale
University, New Haven, Connecticut: Evolution of eukary-
otic rRNA.
Moore, P.B.,1,2,3 Capel, M.S.,. Kjeldgaard, M.,4 Engel-
man, D.M.,2.3 Depts. of 'Chemistry, 2Molecular Bio-
physics and Biochemistry, Yale University, New Haven,
Connecticut; 3Dept. of Biology, Brookhaven National
Laboratory, Upton, New York; 4Division of Biostructural
Chemistry, Dept. of Chemistry, Aarhus University, Den-
mark: Quaternary organization of the small ribosomal
subunit from E. coli.
Yonath, A.,2 Bartels, K.S.,2 Frolow, F.,' Hope, H.,3
Kratky, C.,4 Leonard, K.R.,5 Weinstein, S.,' Wittmann,
H.G.,6 'Weizmann Institute, Rehovot, Israel; 2Max-
Planck Research Unit, Hamburg, Federal Republic of
Germany; 3University of California, Davis; 4University of
Graz, Austria; 5EMBL, Heidelberg, Federal Republic of
Germany; Wax-Planck Institute, West Berlin, Federal Re-
public of Germany: Toward a molecular model for intact
ribosomal particles.
Chothia, Lesk, A.,13 'Laboratory of Molecular Biol-
ogy, Cambridge; 2Dept. of Chemistry, University College
London, England; 3Biocomputing Program, EMBL, Hei-
delberg, Federal Republic of Germany: Protein evolution
and protein structure.
McLachlan, A.D., MRC Laboratory of Molecular Biology,
Cambridge, England: Gene duplication and the building
up of protein structures.
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SESSION 6 RNA: CATALYSIS. I.
Chairman: T. Cech, University of Colorado, Boulder
Cech, T., Barford, L., Been, M., Price, J., Tanner, N.K.,
Zaug, A., Dept. of Chemistry and Biochemistry, Univer-
sity of Colorado, Boulder: The Tetrahymena intervening
sequence RNA as an enzyme.
Inoue, T., Salk Institute, La Jolla, California: Minimum re-
quirement for group] IVS RNA catalysis.
Waring, R.B.,' Towner, P.,' Davies, R.W.,12 'Dept. of Bio-
chemistry and Applied Molecular Biology, UMIST,
Manchester, England; 2Allelix, Inc., Mississauga, On-
tario, Canada: Role of exon-intron base pairing in splice-
site selection by the self-splicing intron of T. thermophila.
Michel, F, Jacquier, A., Centre de Genetique moleculaire
du CNRS, France: Long-range intron-intron and intron-
exon pairings implied in self-splicing of class II introns.
SESSION 7 PROTEINS: STRUCTURE, I.
Chairman: A. Jones, Uppsala University
Kaiser, E.T., Rockefeller University, New York, New York: To-
ward the rational design and construction of enzymes.
Schulz, G.E., Institut fur Organische Chemie and Bioch-
emie der Universitet, Freiburg, Federal Republic of Ger-
many: Structural and functional relationships in the aden-
ylate kinase family.
Achari, A.,' Scott, D.,' Barlow, P.,1 Vidal, J.C.,1 Brunie,
5.,2 Otwinowski, Z.,' Sigler, P.B.,"Dept. of Biochemis-
try and Molecular Biology, University of Chicago, Illinois;
2Ecole Polytechnique, Palaiseau, France: Facing up to
membranes-Structure/function relationships in phos-
pholipases.
Quiocho, FA., Vyas, N.K., Sack, J.S., Vyas,. M.N., Howard
Hughes Medical Institute, Depts. of Biochemistry and
Physiology and Molecular Biophysics, Baylor College of
Medicine, Houston, Texas: Atomic protein structures re-
veal basic features of binding of sugars, sulfate, leucine,
and calcium.
J. Knowles
Doudna, J.A., Cherry, J.M., Gerber, A.S., Szostak, J.W.,
Dept. of Molecular Biology, Massachusetts General Hos-
pital, Boston: Genetic dissection of a catalytic RNA.
Tabak, H.F.,' Arnberg, A.C.,2 Van der Horst, G.,' Kwak-
man, J.H.J.M.,1 Van der Veen, R.,' Winter, A.J.,' Gri-
veil, L.A.,' Laboratory of Biochemistry, 'University of
Amsterdam, 2University of Groningen, The Netherlands:
Yeast mitochondria! self-splicing RNAs.
Peebles, C.L.," Benaton, E.J.,1 Jarrell, K.A.,2 Dietrich,
R.C.,2 Uhl, TM.,2 Perlman, P.S.,2 'University of Pitts-
burgh, Pennsylvania; 2Ohio State University, Columbus:
cis and trans reactions of mutant and wild-type forms of a
group II intron.
Steitz, TA., Beese, L., Freemont, P, Friedman, J., Sander-
son, M., Derbyshire, V., Joyce, C., Dept. of Molecular
Biophysics and Biochemistry, Yale University, New Ha-
ven, Connecticut: Structural studies of Klenow frag-
ment-An enzyme with two active sites,
Klug, A., MRC Laboratory of Molecular Biology, University
Postgraduate Medical School, Cambridge, England:
"Zinc-fingers" -A novel protein fold.
Eisenberg, D., Almassy, R.J., Janson, C.A., Chapman, M.,
Suh, S.W., Smith, W.W., Cascio, D., Molecular Biology In-
stitute and Dept. of Chemistry and Biochemistry, Univer-
sity of California, Los Angeles: Glutamine synthetase and
RuBisCO D.
Branden, C., Uppsala Biomedical Center, Swedish Univer-
sity of Agricultural Sciences: Structure and formation of
RuBisCO.
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SESSION 8 RNA: TEMPLATES
Chairman: J. Darnell, Rockefeller University
Biebricher, C.K., Max-Planck Institut fOr Biophysikalische
Chemie, G6ttingen, Federal Republic of Germany: Repli-
cation and evolution of short-chained RNA species repli-
cated by Q/3 replicase.
Priano, C.,' Kramer, FR.,2 Mills, D.R.,"Institute of Can-
cer Research and Dept. of Genetics and Development,
Columbia University College of Physicians and Surgeons,
2Public Health Research Institute, New York, New York:
RNA bacteriophage replication-Requirement for sec-
ondary structure formation during RNA replication.
Hall, T.C.,1 Marsh, L.E.,' Rao, A.L.N.,' Dreher,
T.W.,2Griffing, L.R.,' 'Biology Dept., Texas A&M, College
Station; 2Dept. of Agricultural Chemistry, Oregon State
University, Corvallis: Promoter, aminoacylation, and nu-
cleotidyl transferase function of BMV RNA.
Wimmer, E., Dept. of Microbiology, State University of New
York, Stony Brook: Molecular events leading to poliovirus
genome replication.
Krug, R.M., St. Angelo, C., Broni, B., Meyers, L., Agris,
C.H., Shapiro, G., Memorial Sloan-Kettering Cancer Cen-
ter, New York, New York: Transcription and replication of
influenza virion RNA in the nucleus of infected cells.
Lai, M.M.C.,,2 Makino, S.,' Soe, L.,' Shieh, C.-K.,'
Chang, M.-F.," Stohlman, S.,1.2 Depts. of 'Microbiology,
2Neurology, University of Southern California School of
Medicine, Los Angeles: Leader RNA-primed transcription
of coronavirus.
Wertz, G.,' Howard, M.,' Patton, J.,2 Davis, N.,3 'Dept. of
Microbiology, University of Alabama, Birmingham;
2University of South Florida, Tampa; 3North Carolina
State University, Raleigh: Switch from transcription to rep-
lication on a viral RNA template.
Bellocq, C., Raju, R., Kolakofsky, D., Dept. of Microbiology,
University of Geneva Medical School, Switzerland: Trans-
lational requirement of LaCrosse virus mRNA synthesis.
SESSION 9 PROTEIN SYNTHESIS AND THE GENETIC CODE
Chairman: T. Cavalier-Smith, Kings College, London
Weiner, A.M., Maizels, N., Yale School of Medicine, New
Haven, Connecticut: The tRNA synthesome model -
Were tRNA synthetases the first step in the evolution of
protein synthesis?
Reanney, D., La Trobe University, Victoria, Australia: Ge-
netic error and genome design.
Cavalier-Smith, T., Dept. of Biophysics, Cell and Molecular
Biology, Kings College, London, England: Cellular basis
for molecular evolution.
Fitch, W.M., Dept. of Biological Sciences, University of
Southern California, Los Angeles: The phylogeny of tRNA
sequences provides evidence for ambiguity reduction in
the origin of the genetic code.
P.A. Sharp
Jukes, T.H.,' Osawa, S.,2 Muto, A.,2 Lehman, N.,"Space
Sciences Laboratory, University of California, Berkeley;
2Dept. of Biology, Nagoya University, Japan: Evolution of
anticodons-Variations in the genetic code.
Osawa, S.,' Jukes, T.H.,2 Muto, A.,' Yamao, F.,' Ohama,
T.,' Andachi, M.,' 'Dept. of Biology, Nagoya University,
Japan; 2Space Sciences Laboratory, University of Cali-
fornia, Berkeley: Role of GC/AT-biased mutation pressure
in evolution of eubacterial genetic code.
Ozeki, H.,' Umesono, K.,' Inokuchi, H.,' Kohchi, T.,2
Sano, T,2 Ohyama, K.,2 'Dept. of Biophysics, 2 Re-
search Center for Cell and Tissue Culture, Kyoto Univer-
sity, Japan: Genetic system of chloroplasts.
C. Chothia J.D. Watson
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SESSION 10 RNA: ANATOMY
Chairman: A. Klug, Medical Research Council, Cambridge
Moras, D., Institute de Biologie Moleculaire et Cellulaire du
CNRS, Strasbourg, France: Conformational changes and
dynamics of tRNA.
R. Basavappa,' Wagner, T.,' Schevitz, R.W.,' Podjarny,
A.D.,' Sussman, J.,2 Sigler, P.B.,"Dept. of Biochemis-
try, and Molecular Biology, University of Chicago, Illinois;
2Weizmann Institute of Science, Rehovot, Israel: Struc-
ture/function analysis of eukaryotic initiator tRNA.
Turner, D.H., Sugimoto, N., Jaeger, J.A., Longfellow, C.E.,
Freier, S.M., Kierzek, R., Dept. of Chemistry, University of
Rochester, New York: Improved parameters for predic-
tion of RNA structure.
Tinoco, I., Jr., Hardin, C.C., Walker, G.T., Davis, P., Dept. of
Chemistry and Laboratory of Chemical Biodynamics,
University of California, Berkeley: RNA conformation
from A to Z.
DORCAS CUMMINGS LECTURE
Ernest Mayr, Museum of Comparative Zoology, Harvard
University, Cambridge, Massachusetts: Evolutionary
Theory.
SESSION 11 RNA: CATALYSIS. II.
Chairman: S. Altman, Yale University
Altman, S., Baer, M., Bartkiewicz, M., Gold, H., Lawrence,
N., McCorkle, G., Vioque, A., Dept. of Biology, Yale Uni-
versity, New Haven, Connecticut: Properties of M1 RNA,
the catalytic RNA subunit of ribonuclease P from E. coli,
and its analogs from other organisms.
Pace, N.R., Reich, C., James, B.D., Waugh, D.S., Olsen,
G.J., Pace, B., Liu, J., Aprison, E.Z., Dept. of Biology and
Institute for Molecular and Cellular Biology, Indiana Uni-
versity, Bloomington: Structure and catalytic function in
B. subtilis RNase P RNA.
Forster, A.C., Jeffries, A.C., Sheldon, C.C., Symons, R.H.,
Dept. of Biochemistry, University of Adelaide, Australia:
Self-cleavage reactions of viroid and virusoid RNAs.
Epstein, L., Florida State University, Tallahassee: Tran-
scripts of newt satellite DNA self-cleave in vitro.
Uhlenbeck, 0.C., Sullivan, F.X., Sampson, J.R., Behlen,
L.S., DiRenzo, A.B., Dept. of Chemistry and Biochemis-
SESSION 12 PROTEINS: COFACTORS
Chairman: M. Perutz, Medical Research Council, Cambridge
Perutz, M.E,' Fermi, G.,' Luisi, B.,1 Shaanan, B.,2 Lid-
dington, R.C.,3 'MRC Laboratory of Molecular Biology,
Cambridge, England; 2Dept. of Structural Chemistry,
Weizmann Institute, Rehovot, Israel; 3Dept of Chemistry,
York University, England: Stereochemistry of cooperative
mechanisms in hemoglobin.
Bruice, T.C., Dept. of Chemistry, University of California,
Santa Barbara: Porphyrin iron (III) mixed function oxi-
dases. An evolutionary end point for transition metal (III)
reactions with oxygen donors.
Frey, P.A., Moss, M.L., Institute for Enzyme Research,
Graduate School, and Dept. of Biochemistry, College of
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M. Nomura, P.A. Sharp
ost
W. Gilbert, R. Lerner
try, University of Colorado, Boulder: Characterization of
RNA self-cleavage reactions.
Shvedova, T.A., Korneeva, G.A., Otroschenko, V.A., Venk-
stern, TV., USSR Academy of Sciences, Moscow: Cata-
lytic activity of the nucleic acid component of rabbit mus-
cle branching enzyme.
Sharp, P.A., Konarska, M.M., Grabowski, P.J., Lamond, A.,
Seiler, S., Center for Cancer Research and Dept. of Biol-
ogy, Massachusetts Institute of Technology, Cambridge:
Splicing of precursors to mRNAs.
Kramer, A., Frendewey, D., Lahr, G., Frick, M., Keller, W.,
Institute of Cell and Tumor Biology, German Cancer Re-
search Center, Heidelberg, Federal Republic of Ger-
many: Components involved in the assembly and the cat-
alytic activity of spliceosomes formed on nuclear mRNA
precursors in vitro.
Agricultural and Life Sciences, University of Wisconsin,
Madison: S-Adenosylmethionine and the mechanism of
hydrogen transfer in the lysine 2,3-aminomutase reac-
tion.
Berg, J.M., Dept. of Chemistry, Johns Hopkins University,
Baltimore, Maryland: Metal ions in proteins-Structural
and catalytic roles.
Lin, A.I., Ashley, G.W., Harris, G., Ator, M., Stubbe, J., Dept.
of Biochemistry, University of Wisconsin, Madison: Com-
parison between the L. leichmannii and E. coil ribonu-
cleotide reductases.
P. Carter, D. Helfman
SESSION 13 PROTEINS: STRUCTURE. II.
J. Ninio, L. Orgel
Chairman: F. Richards, Yale University
Richards, F., Yale University, New Haven, Connecticut: In-
ternal packing and protein structural classes.
Kretsinger, R.H., Dept. of Biology, University of Virginia,
Charlottesville: Calcium coordination and the calmodulin
fold divergent vs. convergent evolution.
Creighton, T.E., MRC Laboratory of Molecular Biology,
Cambridge, England: Biosynthesis, processing, and fold-
ing of bovine trypsin inhibitor.
DeGrado, W.,' Ho, S.,1 Eisenberg, D.,2 Regan, L.,"E.I.
du Pont de Nemours & Company, Wilmington, Delaware;
2Molecular Biology Institute, University of California, Los
Angeles: Design, synthesis, and chn'acterization of a
four-helix protein.
Carrell, R.W., Pemberton, P., Boswe J.R., Dept. of Hae-
matological Medicine, University Cambridge, England:
The serpins- Evolution and redesign of a family of pro-
tease inhibitors.
SESSION 14 EVOLUTIONARY TREES
Chairman: R. Doolittle, University of California, San Diego,
Olsen, G.J., Dept. of Biology, Indiana University, Blooming.
ton: The earliest phylogenetic branchings-Comparing
rRNA-based evolutionary trees inferred with various tech-
niques.
Lake, J.A., Molecular Biology Institute, University of Califor-
nia, Los Angeles: rRNA genes of the eukaryotic nucleus
evolved from those of sulfur-metabolizing prokaryotes.
Li, W.H., Sourdis, J., Wolfe, K.H., Sharp, PM., Center for
Demographic and Population Genetics, University of
Texas, Houston: Reconstruction of phylogenetic trees
and estimation of divergence times under nonconstant
rates of evolution.
Penny, D.,' Hendy, M.D.,2 Henderson, I.M.,' Depts. of
'Botany and Zoology, 2Mathematics and Statistics, Mas-
sey University, Palmerston North, New Zealand: Estimat-
ing rates and accuracy on evolutionary trees.
Miyata, T.,' Hayashida, H.,' Kuma, K.,' Mitsuyasu, K.,'
Yasunaga, T.,2 'Dept. of Biology, Faculty of Science,
Stackhouse, T.,' Onuffer, J.J.,' Matthews, C.R.,' Ahmed,
S.A.,2 Miles, E.W.,2 'Dept. of Chemistry, Pennsylvania
State University, University Park; 2NIADDKD, National In-
stitutes of Health, Bethesda, Maryland: Role of protein
folding in the evolution of protein sequences.
Wells, J.A.,' Carter, P.J.,' Cunningham, B.C.,' Graycar,
TP.,2 Estell, D.A.,2 'Dept. of Biocatalysis, Genentech,
Inc., 2Research Dept., Genecor, Inc., South San Fran-
cisco, California: Evolution of specificity and catalysis in
subtilisin.
Laskowski, M., Jr., Kato, I., Kohr, W.J., Park, S.J., Tashiro,
M., Whatley, H.E., Dept. of Chemistry, Purdue University,
West Lafayette, Indiana: Possible positive Darwinian se-
lection in evolution of protein inhibitors of swine protei-
nases.
La Jolla
Kyushu University, Fukuoka, 2lnstitute of Physical and
Chemical Research, Wako, Japan: Male-driven molecu-
lar evolution.
Doolittle, R.F., Dept. of Chemistry, University of California,
San Diego, La Jolla: Reconstructing the evolution of ver-
tebrate blood coagulation from a consideration of the
amino acid sequences of clotting proteins.
Goodman, M.,' Czelusniak, J.,' Koop, B.,' Tag le, D.,'
Slightom, J.,', 'Wayne State University, Detroit,
2Upjohn, Kalamazoo, Michigan: Globins-A case study
in molecular phylogeny.
Stewart, C.-B.,' Schilling, J.W.,3 Wilson, A.C.,14 'Dept.
of Biochemistry, University of California, Berkeley;
2Hormone Research Institute and Dept. of Biochemistry
and Biophysics, University of California, San Francisco;
3California Biotechnology, Mountain View; 4Dept. of Ge-
netics, Cambridge University, England: Convergent evo-
lution of lysozymes.
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SESSION 15 PROTEINS: FUNCTION
Chairman: J. Knowles, Harvard University
Hermes, J.D., Black low, S.C., Knowles, J.R., Dept. of
Chemistry, Harvard University, Cambridge, Massachu-
setts: Evolution of enzyme efficiency.
Alber, T.C., Davenport, R.C., Jr., Lolis, E.M., Ringe, D., Pet-
sko, G.A., Dept. of Chemistry, Massachusetts Institute of
Technology, Cambridge: Yeast triose phosphate isomer-
ase-Lessons on catalysis from crystallography and site-
directed mutagenesis.
Fersht, A.R., Dept. of Chemistry, Imperial College of Sci-
ence and Technology, London, England: Dissection of
the anatomy of an enzymatic reaction.
Higaki, J.,' Gibson, B.W.,' Craik, C.S.,1,2 Depts. of
'Pharmaceutical Chemistry, 2Biochemistry and Biophys-
ics, University of California, San Francisco: Genetic anal-
ysis of the active site of trypsin-Replacement of Ser-195
with Cys and Asp-102 with Asn.
Mowbray, S., Thorsness, P., Koshland, D.E., Jr., Dept. of
Biochemistry, University of California, Berkeley: Transmis-
sion of regulatory conformational changes through pro-
teins.
Benkovic, S.J., Fierke, C., Kuchta, R., Dept. of Chemistry,
Pennsylvania State University, University Park: Implica-
tions for protein function from kinetic analysis.
Ninio, J., Institute Jacques Monod, Paris, France: Kinetic
devices and enzyme accuracy.
SESSION 16 EXONS AND INTRONS
Chairman: W. Gilbert, Harvard University
Gilbert, W., Harvard University, Cambridge, Massachusetts:
Introns/exons in evolution.
Doolittle, W.F., Dept. of Biochemistry, Dalhousie University,
Halifax, Nova Scotia: What introns have to tell us.
Go, M., Nosaka, M., Dept. of Biology, Faculty of Science,
Kyushu University, Fukuoka, Japan: Protein architecture
and origin of introns.
Blake, C.C.F, Harlos, K., Holland, S.K., Laboratory of Mo-
lecular Biophysics, University of Oxford, England: Exon
and domain evolution in the proenzymes of blood coagu-
lation and fibrinolysis.
Belfort, M., Wadsworth Center for Laboratories and Re-
search and School of Public Health Sciences, State Uni-
versity of New York, New York State Department of
Health, Albany: Genetics and distribution of group I in-
trons in the T-even phages.
Shub, D.A., Dept. of Biological Sciences, State University of
New York, Albany: A family of self-splicing group I introns
in E. coli bacteriophage T4.
Summary: A. Weiner, Yale University School of Medicine
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MEETINGS
Regulation of Liver Gene Expression
April 29-May 3
ARRANGED BY
Georg Fey, Scripps Clinic and Research Foundation
Gerald Fuller, University of Alabama, Birmingham
229 participants
Attended by 250 scientists from the United States and abroad, the Regulation of
Liver Gene Expression meeting focused on mechanisms of tissue-specific gene
expression in the liver, on hormonal and developmental regulation of liver gene
expression, on conditions of maintaining differentiated hepatic cells in culture, and
on the expression of the liver acute-phase genes. Much attention has been
focused on the recent development of tissue-specific cell-free transcription systems
from rat liver nuclei (Schibler). Using this system, trans-acting control factors of the
albumin gene and of several other liver-specific genes have been identified and
partially purified. For several liver genes, tissue spe,cificity is achieved by coopera-
tive binding of a series of trans-acting factors in the promoter upstream regions
(Schibler, Yaniv, Klein-Hitpass, Wahli). Hepatocyte-stimulating factor (HSF), a
monokine responsible for the induction of liver acute-phase genes during acute
and chronic inflammation, was purified (Fuller). Gauldie reported that HSF is
identical to interferon /32. Impressive progress has been made with the genetic
characterization of trans-acting loci controlling liver gene expression (Fournier,
Weiss, Gluecksohn-Waelsch), and an extinguisher locus of the tyrosine amino
transferase gene has been mapped by somatic-cell genetics. Other genetic loci
controlling the expression of the a-feto protein gene (rif and raf; Camper and
Tilghman) have been characterized in detail. Retroviral vectors have been used
successfully to transfect primary hepatocyte cultures (Wolff, Wilson, Woo). Bennett
and collaborators reported on the successful establishment of a novel hepatoblast
culture system. These cultures, unlike other known hepatocyte cultures, undergo a
program of differentiation and tissue-specific gene expression that mimics events
during early embryogenesis in vivo. Gohda and collaborators reported the
discovery of a novel human hepatocyte growth factor in the plasma of patients
with fulminant hepatic failure. The hormone-binding and DNA-binding domains of
the glucocorticoid receptors were defined in a beautiful series of mutagenesis
experiments described by Ringold. Liao reported that the rat serum amyloid A
gene transcripts lack an exon, which is present in the rat gene and in the
equivalent mouse and human SAA gene transcripts. Mice and humans are
afflicted by serum amyloidosis due to the deposition of amyloid fibrils, whereas
rats do not suffer from this condition. Probably the alternative splicing pathway is
responsible for the absence of this disorder in rats. In the keynote presentation,
Tjian demonstrated the power and elegance of cell-free transcription systems and
biochemical purification procedures in defining transcriptional cofactors. Several
transcription factors have been purified, and the cloning and mutagenesis of SP1
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were reported. The next conference on the regulation of liver gene expression has
been scheduled for 1989 in Cold Spring Harbor.
This meeting was supported in part by American Hoechst Corporation, Inc.,
Bechman Instruments, Inc., Bethesda Research Laboratory, Bio-Rad (Chemical
Division), Calbiochem Biochemicals/Behring Diagnostics (division of Hoechst),
HaakeBuchler Instruments, Inc., The March of Dimes Birth Defects Foundation, the
following divisions of the National Institutes of Health: NIAID and NIDDK; Dr.
James Pittman, School of Medicine at University of Alabama, Birmingham,
Stratagene Cloning Systems, Whatman, Inc., Codon, and Behring.
SESSION 1 TISSUE-SPECIFIC EXPRESSION OF LIVER GENES
Chairman: U. Schibler, University of Geneva
Lichtsteiner, S., Gorski, K., Mueller, C., Wuarin, J., Schibler,
U., Dept. of Molecular Biology, University of Geneva,
Switzerland: Transcription factors and promoter elements
involved in the liver-specific expression of the albumin
gene.
Cereghini, S., Blumenfeld, M., Raymondjean, M., Carranca,
A.G., Yaniv, M., Dept. of Molecular Biology, CNRS, Insti-
tut Pasteur, Paris, France: Factors involved in control of
tissue-specific expression of the albumin gene.
Cortese, R., De Simone, E., Frain, M., Hardon, E., Morrone,
G., Oliviero, S., Paonessa, G., EMBL, Heidelberg, Fed-
eral Republic of Germany: Cell-specific expression of
genes coding for human plasma proteins.
Johnson, P., Landschulz, W., La Marco, K., Graves, B.,
McKnight, S., Dept. of Embryology, Carnegie Institution
of Washington, Baltimore, Maryland: Identification of a
DNA-binding protein from rat liver nuclei that activates
viral gene expression in vitro.
SESSION 2 MODULATION OF LIVER GENE EXPRESSION
Costa, R.H., Lai, E., Darnell, J.E., Jr., Rockefeller Univer-
sity, New York, New York: Regulatory sequences for the
mouse transthyretin (pre-albumin) gene include a cell-
specific enhancer.
Leff, T., Reue, K., Das, H.K., Breslow, J., Laboratory of Bio-
chemical Genetics and Metabolism, Rockefeller Univer-
sity, New York, New York: Negative control elements reg-
ulate cell-type-specific expression of the human
apoprotein-B and -CIII genes in vivo and in vitro.
Levy-Wilson, B., Blackhart, B.D., Mahley, R.W., McCarthy,
B.J., Gladstone Foundation Laboratories, University of
California, San Francisco: Structure and regulation of the
human apolipoprotein-B gene.
Schorpp, M., Wagner, U., Ryffel, G.U., Kernforschungszen-
trum Karlsruhe, Federal Republic of Germany: A DNA
element in the 5'-flanking region of the X. Iaevis albumin
genes confers tissue-specific expression in mouse hepa-
toma cells.
Chairman: G. Schutz, German Cancer Research Center, Heidelberg
Schutz, G., Jantzen, H.-M., Strahle, U., Klock, G., Gloss, B.,
Stewart, F., Becker, P. Schmid, W., German Cancer Re-
search Center, Heidelberg, Federal Republic of Ger-
many: Glucocorticoid regulation of expression of the ty-
rosine aminotransferase gene.
Granner, D., Dept. of Molecular Physiology and Biophysics,
Vanderbilt University School of Medicine, Nashville, Ten-
nessee: Mechanisms involved in the hormonal regulation
of transcription of the PEPCK gene.
Karin, M., Imagawa, M., Chiu, R., Bodner, M., Dana, S.,
Dept. of Pharmacology, University of California School of
Medicine, San Diego, La Jolla: Regulation of gene
expression by hormone-responsive and tissue-specific
trans-acting factors.
Klein-Hitpass, L., Cato, A.C.B., Ryffel, G.U., Kernfor-
schungszentrum Karlsruhe, Institut fur Genetik and Toxi-
kologie, Federal Republic of Germany: Estrogen-respon-
sive DNA element-Sequence requirements and
interaction with steroid hormone receptors.
Shapiro, D.J., Barton, M.C., Weiler, I.J., Lew, D., McKearin,
D.M., Keller, M.J., Blume, J., Nielsen, D., Dept. of Bio-
chemistry, University of Illinois, Urbana: Estrogen recep-
tor regulation in vitellogenin and retinol-binding protein
gene expression.
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Whitlock, J.P., Jr., Durrin, L.K., Jones, P.B.C., Dept. of Phar-
macology, Stanford University School of Medicine, Cali-
fornia: Regulation of gene expression by dioxin.
Duester, G., Knoll, D., Dept. of Biochemistry, Colorado
State University, Fort Collins: Regulation of human liver
ADH gene expression by glucocorticoids.
Wahli, W., Martinez, E., ten Heggeler-Bordier, B., Hipskind,
R., Seiler-Tuyns, A., Walker, P., Corthesy, B., Institut de
Biologie Anima le, Universite de Lausanne, Switzerland:
cis- and trans-Acting elements of the estrogen-regulated
Xenopus vitellogenin genes
J. Kushner, S. Macintyre
G. Fuller, L. Holland
SESSION 3 POSTER SESSION
Aiello, L.P., Shia, M.A., Pilch, PF., Farmer, S.R., Dept. of
Biochemistry, Boston University School of Medicine, Mas-
sachusetts: Characterization and hepatic expression of
rat a1-inhibitor III.
Amrani, D.L.,1.2 Nimmer, D.,2 Bergtrom, G.,2 'Dept. of
Medicine, University of Wisconsin Medical School,
2Dept. of Biology, University of Wisconsin, Milwaukee:
Glucocorticoids regulate production of plasma fibronec-
tin at the transcriptional and posttranscriptional levels.
Andus, T,' Bauer, J.,1 Ganter, U.,2 Northoff, H.,2 Mannel,
0.,3 Tran-Thi, T.-A.,1 Decker, K.,1 Heinrich, P.C.,'
'University of Freiburg; 2Blutspendezentrale des DRK,
Ulm; 3lnstitut fur Immunologie, Heidelberg, Federal Re-
public of Germany: Biosynthesis of HSF in human mono-
cytes.
Andus, T.,1 Geiger, T,' Bauer, J.,1 Kunz, D.,1 Heisig, M.,1
Northoff, H.,2 Tran-Thi, T-A.,1 Decker, K.,1 Gerok, W.,1
Heinrich, P.C.,' 'University of Freiburg; 2Blutspende-
zentrale des DRK, Ulm, Federal Republic of Germany: In-
duction of acute-phase protein synthesis-Studies on the
regulation of rat armacroglobulin in vivo and in hepato-
cyte primary cultures.
Aycock, R.S.,' Raghow, R.,2 Seyer, J.M.,3 Depts. of
'Medicine, 2Pharmacology, 3Biochemistry, University of
Tennessee, Memphis and Veterans Administration Medi-
cal Center: Enhanced expression of genes coding for in-
terstitial procollagen chains by a hepatic fibrogenic fac-
tor.
Bade, E.G., Feindler, S., Graf, H., Fakultat fur Biologie,
Universitat Konstanz, Federal Republic of Germany:
Modulation of liver epithelial cell gene expression by
EGF.
Baffet, G.,' Desvergne, B.,' Etienne, PL.,' Deugnier, Y.,'
Defer, N.,2 Guguen-Guillouzo, C.,' 'Hopital Pontchaillou,
Rennes, 2Institut de Pathologie et Biologie Cellulaires et
Moleculaires, Paris, France: Oncogene activation in hu-
man hepatocarcinomas.
Bauer, J., Ganter, U., Andus, T, Richter, I., Gebicke-
Haerter, P., Andreesen, R., L6hr, G., Heinrich, P.C.,
Gerok, W., University of Freiburg, Federal Republic of
Germany: Comparison of armacroglobulin synthesis in
rat hepatocytes, rat astrocytes, and human mononuclear
phagocytes.
Bauer, J.,' Gebicke-Haerter, F1,1 Andus, T,' Ganter, U.,,
Northoff, H.,2 Heinrich, P.C.,' Gerok, W.,"University of
Freiburg, 2DRK-Blutspendezentrale, Ulm, Federal Re-
public of Germany: Secretion of HSF by rat astrocyte pri-
mary cultures.
Bernuau, D., Pollard, A., Feldmann, G., Laboratoire de Biol-
ogie Cellulaire, INSERM, Paris, France: In situ hybridiza-
tion analysis of AFP mRNA expression in rat liver during
regeneration after partial hepatectomy.
Bertolotti, R., Lutfalla, G., Armbruster, L., Centre de Gene-
tique Moleculaire, CNRS, France: Liver-specific anti-on-
cogenes and extinguishers-Gene balance, shuttle vec-
tors, and expression libraries.
Bhat, N.K., Fujiwara, S., Fisher, R.J., Papas, T.S., NCI-Fred-
erick Cancer Research Facility, Frederick, Maryland:
Regulation of ets loci during early phase of murine he-
patic regeneration.
Bigot, Y.,' Ng, K.,2 Maigne, J.,2 Deschatrette, J.,2 Meu-
nier-Rotival, M.,2 'BEAS, Tours, 2H6pital de Bicetre,
France: Localization and sequence of interspersed re-
peats in the mouse serum albumin gene.
Buehler, W., Walter, U., Lohmann, S.M., Dept. of Medicine,
University of WOrzburg, Federal Republic of Germany:
Evidence for participation by the C subunit of cAMP-de-
pendent protein kinase in the mechanism of CAMP -regu-
lated gene expression in hepatocytes.
Chou, C.-K.,1.2 Tsai, T.-F.,2 Birnbaum, M.J.,3 Rosen,
0.M.,3 Su, TS.,'.2 'Dept. of Medical Research, Veterans
General Hospital, 2lnstitute of Microbiology and Immu-
nology, National Yang-Ming Medical College, Taipei, Tai-
wan, R.O.C.; 3Memorial Sloan-Kettering Cancer Center,
New York, New York: Expression of glucose transporter
mRNA in a human hepatoma cell line but not in normal
human liver.
Coe, J.E., Ross, M.J., Rocky Mountain Laboratories, Hamil-
ton, Montana: Paradoxical effect of steroid hormones on
hamster liver-Syrian vs. Armenian hamsters.
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Poster Session
Corcos, L.,' Rousset, J.-P.,' Wiebel, F.J.,2 Weiss, M.C.,2
'Dept. of Molecular Biology, Institut Pasteur, Paris,
France; 2lnstitute of Biochemistry and Toxicology, Dept.
of Toxicology, Munich, Federal Republic of Germany: Se-
lection of hepatoma cells deficient in some cytochrome
P450 molecular species.
Courtois, G., Morgan, J., Fourel, G., Crabtree, G., Dept. of
Pathology, Stanford University School of Medicine, Cali-
fornia: Tissue-specific expression of the /3-fibrinogen
gene requires the interaction of a liver-specific protein(s)
with the ft promoter.
Czaja, M., Weiner, F, Giambrone, M., Zern, M., Liver Re-
search Center, Albert Einstein College of Medicine,
Bronx, New York: Antifibrogenic effects of IFN-y in in vitro
and in vivo models.
Czaja, M., Weiner, F, Giambrone, M., Zern, M., Liver Re-
search Center, Albert Einstein College of Medicine,
Bronx, New York: Molecular studies of ceruloplasmin de-
ficiency in Wilson's disease.
Danan, J.L., Jose, M., Poliard, A., Tratner, I., Poiret, M., Na-
hon, J.L., Sala-Trepat, J.M., Laboratoire d'Enzymologie,
CNRS, France: Rat AFP gene regulation-Analysis of the
promoter region and its interaction with liver nuclear ex-
tracts.
Daniel, V.,' Sharon, R.,' Tichauer, Y,' Sand, S.,2 Depts.
of 'Biochemistry, 2Biophysics, Weizmann Institute of Sci-
ence, Rehovot, Israel: Mouse liver glutathione S-transfer-
ase Ya subunit-Gene structure and sequence.
Decaux, J.F.,' Levrat, F.,' Girard, J.,2 Kahn, A.,'
INSERM, Paris, 2CNRS, Meudon, France: Gene expres-
sion in primary culture of rat hepatocytes.
Delhaye, M.,' Gulbis, B.,2 Mairesse, N.,2 Galand, P., Free
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nochemistry Unit, Dept. of Biochemistry, Oxford Univer-
sity, England: Regulation of expression of the comple-
ment component genes encoded in the MHC.
Zakin, M.M., Schaeffer, E., Brunel, F, Boissier, F., Cohen,
G.N., Unite de Biochimie Cellulaire, Institut Pasteur, Paris,
France: Human transferrin gene-Organization, evolu-
tion, and specific transcriptional signals.
Tijian, R., Kadonaga, J., Briggs, M., Mitchell, P. Bohmann,
D., Heberlein, U., England, B., Biggin, M., Dept. of Bio-
chemistry, University of California, Berkeley: Regulation
of eukaryotic transcription by the interplay of promoter
and enhancer binding proteins in mammalian cells and
Drosophila.
SESSION 9 REQUIREMENTS FOR HEPATIC DIFFERENTIATION IN TISSUE CULTURE
Chairmen: J.E. Darnell, Jr., Rockefeller University
H. Leffert, University of California, San Diego, La Jolla
Bennett, A.L.,' Paulson, K.E.,' Miller, R.E.,2 Darnell, J.E.,'
'Dept. of Molecular Cell Biology, Rockefeller University,
New York, New York; 2Dept. of Medicine, Cleveland Vet-
erans Administration Medical Center and Case Western
Reserve University School of Medicine, Ohio: Phenotypic
heterogeneity in differentiating 13-day fetal hepatoblast
cultures that mimics in vivo differentiation.
Leffert, H.L.,1 Koch, K.S.,' Shapiro, Skelly, H.,'
Wolff, J.,2 Yee, J.-K.,2 Friedmann, T,2 Depts. of
'Medicine, 2Pediatrics, University of California, La Jolla,
San Diego: Growth control of rat hepatocytes in primary
culture.
Carr, B.I., Dept. of Medical Oncology, City of Hope Medical
Center, Duarte, California: Serum factor(s) control the
level of 1251-labeled TGF(3 binding in primary adult rat he-
patocytes.
Chou, J.Y., Wan, Y.-J.Y., NIC, National Institutes of Health,
Bethesda, Maryland: In vitro regulation of liver matura-
tion.
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Ichihara, A., Nakamura, T, Enzyme Science Center, Univer-
sity of Tokushima, Japan: Terminal differentiation of neo-
natal rat hepatocytes in primary cultures requires contact
with adult hepatocytes.
Isom, H.C., Woodworth, C.D., Georgoff, I., Dept. of Micro-
biology, Pennsylvania State University College of Medi-
cine, Hershey: Liver-specific gene expression in hepato-
cytes and immortalized hepatocyte cell lines.
Marceau, N., Neel, M., Germain, L., Hotel-Dieu de Quebec
Hospital and Laval University, Canada: Expression of he-
patocytic functions in cultured ductutar oval cells.
Gohda, E.,' Tsubouchi, H.,2 Nakayama, H.,1 Hirono, S.,'
Takahashi, K.,2 Sakiyama, 0.,2 Hashimoto, S.,2 Daiku-
hara, Y.,"Dept. of Biochemistry, Kagoshima University
Dental School, 2Second Dept. of Internal Medicine, Ka-
goshima University, Japan: Human hepatocyte growth
factor in plasma from patients with fulminant hepatic fail-
ure.
Liang, T.J., Plant, P.W., Diamond, L., Grieninger, G., L.D.
J. Gauldie, G. Fay, N. Northemann
Kimball Research Institute, New York Blood Center, New
York: Chicken embryo hepatocyte culture-A model for
dissecting the regulatory role of specific agents in the
expression of hemopexin and other liver-specific gene
products during hepatic development.
Dunsford, H.A., Karnasuta, C., Hunt, J.M., Sell, S., Univer-
sity of Texas Medical School, Houston: Monoclonal anti-
bodies define different lineages of chemically induced
hepatocellular carcinoma in rats.
Kelly, J.H., Dept. of Pathology, Baylor College of Medicine,
Houston, Texas: Transcriptional control of albumin and
AFP synthesis in the human hepatoblastoma line, Hep-
G2.
Lhadi, C., Corlu, A., Baffet, G., Bourel, D., Kneip, B., Gug-
uen-Guillouzo, C., Hopital Pontchaillou, Rennes, France:
SESSION 10 REGULATION OF LIVER ACUTE PHASE GENES
Chairmen: G. Fey, Institute of Scripps Clinic
G. Ringold, Stanford University
Ringold, G., Klein, E., Northrop, J., Danielsen, M., Dept. of
Pharmacology, Stanford University School of Medicine,
California: Transcriptional regulation of MMTV and al-
acid glycoprotein genes by the glucocorticoid receptor.
Schreiber, G., Dickson, P.W., Aldred, A.R., Fung, W.P.,
Thomas, T, Cole, T., Birch, H., de Jong, F., Dept. of Bio-
chemistry, University of Melbourne, Australia: Expression
and regulation of plasma protein genes in tissues associ-
ated with extracellular compartments.
Crabtree, G.R.,1 Courtois, G.,' Campbell, L.,' Chodosh,
L.,3 Carthew, R.,3 Fuller, G.,2 Sharp, P.,3 Morgan, J.,1
'Stanford University, California; 2University of Albama,
Birmingham; 3Massachusetts Institute of Technology,
Boston: Intracellular and extracellular factors controlling
the expression of the fibrinogen genes.
Woo, S.L.C., Shen, R.-F., Li, Y., Sifers, R.N., Clift, S., De-
Mayo, J., Wang, H., Tsai, S.Y., Dept. of Cell Biology,
Howard Hughes Medical Institute and Institute of Molecu-
lar Genetics, Baylor College of Medicine, Houston,
Texas: Tissue-specific expression and regulation of the
human a,- antitrypsin gene.
Ciliberto, G., Blither, U., Arcone, R., Wagner, E., EMBO,
Heidelberg, Federal Republic of Germany: Acute-phase
induction of the human CRP gene in transgenic mice.
E. Bade, M. Guille
Regulation of hepatocyte functions by cell-cell interac-
tions-Involvement of a plasma membrane protein.
Schuetz, E.,' Omiecinski, C.,2 Muller-Eberhard, U.,3 Klein-
man, H.,4 Guzelian, R,"Medical College of Virginia,
Richmond; 'University of Washington, Seattle; 3Cornell
Medical College, New York, New York; 4National Insti-
tutes of Health, Bethesda, Maryland: Regulation of gene
expression in adult rat hepatocytes cultured on a base-
ment-membrane matrix.
Carlin, C.R., Simon, D., Mattison, J., Knowles, B.B., Wistar
Institute of Anatomy and Virology, Philadelphia, Pennsyl-
vania: Expression and biosynthetic variation of the EGF
receptor in human hepatocellular carcinoma-derived cell
lines.
Rienhoff, H.,1.2 Groudine, M.,"Howard Hughes Medical
Institute, University of Washington, 2Fred Hutchinson
Cancer Research Center, Seattle, Washington: Control of
SAA gene expression.
Fowlkes, D.M.,' Lund, P.K.,2 Blake, M.,' Snouwaert, J.,1
'Dept. of Pathology, 'Program in Molecular Biology and
Biotechnology, University of North Carolina, Chapel Hill:
Regulation of fibrinogen production by steroids is indi-
rect.
Hu, S.-1.,1 Samols, D.,1 Schultz, D.,2 Macintyre, 5.,2 Kush-
ner, I.,2 Depts. of 'Biochemistry, 2Medicine, Case West-
ern Reserve University, Cleveland Metropolitan Hospital,
Ohio: Hepatocytes have a special intracellular mecha-
nism to regulate the secretion of CRP.
Liao, W.S.L., Li, X., Caldwell, C.K., Dept. of Biochemistry
and Molecular Biology, M.D. Anderson Hospital and Tu-
mor Institute, Houston, Texas: Expression and structural
analysis of rat SAA gene.
Fey, G.,' Northemann, W.,' Shiels, B.,' Gehring, M.,2 Bra-
ciak, T,' Hudson, G.,"Dept. of Immunology, Research
Institute of Scripps Clinic, 2Agouron Pharmaceuticals,
Inc., La Jolla, California: Structure and acute-phase regu-
lation of the rat liver a-macroglobulin gene family.
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C. elegans
May 6 -May 10
ARRANGED BY
Jonathan Hodgkin, MRC Laboratory of Molecular Biology
Robert Horvitz, Massachusetts Institute of Technology
Susan Strome, Indiana University
William Wood, University of Colorado, Boulder
299 participants
The growing number of nematode researchers attending this fifth Cold Spring
Harbor meeting on C elegans attests to its growing popularity as a developmental
system. Most of the topics covered were old favorites: embryogenesis,
postembryonic lineages, muscle organization, neuroanatomy, sex determination,
dosage compensation, and genome organization. In addition to the genetic
approaches to studying these topics described in past years, this year's meeting
included an impressive array of molecular analyses as well. First and foremost was
the ongoing cloning and mapping of the C elegans genome; as of the end of
1987, 90% of the genome has been mapped to 680 "contigs" (stretches of overlap-
ping, contiguous clones) of 100 kb average length. In addition, the identification of
a growing list of transposable elements and the availability of "mutator strains" in
which transposable elements hop at high frequency in the germ line have enabled
investigators to tag and clone specific genes of interest. Three laboratories
reported the generation of transgenic nematodes, enabling analysis of expression
of genes that have been manipulated prior to introduction into worms. An
unexpected finding was that many nematode RNAs undergo trans-splicing,
resulting in the addition of a common leader sequence; this occurs in addition to
cis-splicing. Most participants agreed that this was the best C. elegans meeting
yet.
This meeting was supported in part by The National Science Foundation and
the following divisions of the National Institutes of Health: Division of Research
Resources, National Institute of General Medical Sciences, National Institute on
Aging.
SESSION 1 EMBRYOGENESIS
Chairman: P. Sternberg, California Institute of Technology
Hyman, A., MRC Laboratory of Molecular Biology, Cam-
bridge, England: Centrosome movements in the early di-
visions of C. elegans.
Hill, D., Strome, S., Dept. of Biology, Indiana University,
Bloomington: Role of microfilaments in C. elegans zy-
gotes.
Morton, D., Kemphues, K., Section of Genetics and Devel-
opment, Cornell University, Ithaca, New York: New muta-
tions affecting cleavage pattern and cytoplasmic localiza-
tion.
Schierenberg, E., Max-Planck-Institute for Experimental
Medicine, GOttingen, Federal Republic of Germany: Early
cell-cell interaction in the embryo of C. elegans.
Ito, K., McGhee, J.D., Dept. of Medical Biochemistry, Uni-
versity of Calgary, Canada: Parental DNA strands segre-
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gate randomly during development.
Edgar, L., McGhee, J., Dept. of Medical Biochemistry, Uni-
versity of Calgary, Alberta, Canada: DNA synthesis and
control of gut-specific gene expression in early embryos.
Schnabel, R., Schnabel, H., MRC Laboratory of Molecular
Biology, Cambridge, England: Embryonic lethal muta-
tions of C. elegans.
Mains, R, Sulston, I., Wood, W.B., Dept. of Molecular, Cellu-
lar and Developmental Biology, University of Colorado,
Boulder: Dominant maternal-effect lethal mutations.
Levitan, D., Giambarella, H., Telfer, A., Stinchcomb, D.,
Dept. of Cellular and Developmental Biology, Harvard
University, Cambridge, Massachusetts: Molecular genet-
ics of maternal-effect lethal mutations.
Carter, P.W., Kemphues, K.J., Section of Genetics and De-
velopment, Cornell University, Ithaca, New York: Prog-
ress toward cloning zyg-9 and zyg-11.
Yuan, J., Horvitz, R., Dept. of Biology, Massachusetts Insti-
tute of Technology, Cambridge: Genetic and molecular
genetic studies of ced-3 and ced-4.
SESSION 2 GENOME ORGANIZATION AND TRANSCRIPTION
Chairman: T. Blumenthal, Indiana University
Coulson, A., Sulston, J., Albertson, D., Fishpool, R., MRC
Laboratory of Molecular Biology, Cambridge, England:
The thousand-island genome.
Huang, X.-Y., Barrios, L., Vonkhorporn, P., Hecht, R., Dept.
of Biochemical and Biophysical Sciences, University of
Houston, Texas: GAPDH gene family in C. elegans.
Ward, S.,' Burke, D.J.,' Hogan, E.,' Sulston, J.E.,2 Coul-
son, A.R.,2 Albertson, D.G.,2 Ammons, D.,3 Klass, M.,3
'Dept. of Embryology, Carnegie Institution of Washing-
ton, Baltimore, Maryland; 2MRC Laboratory of Molecular
Biology, Cambridge, England; 3Dept. of Biology, Univer-
sity of Houston, Texas: Genomic organization and se-
quence conservation of transcribed major sperm protein
genes.
Bird, D.M., Riddle, D.L., Division of Biological Sciences,
University of Missouri, Columbia: Molecular characteriza-
tion of arna-1 IV and environs.
Honda, S., Abruzzeze, R.V., Epstein, H.F., Dept. of Neurol-
ogy, Baylor College of Medicine, Houston, Texas: Tran-
scription of selected genes during development.
Nelson, D.W., Honda, B.M., Dept. of Biological Sciences,
Simon Fraser University, Burnaby, Canada: Structure, or-
ganization, and expression of the 5S rRNA genes of C.
elegans and C. briggsae.
SESSION 3 POSTER SESSION
Zetka, M.C., Rose, A.M., University of British Columbia,
Vancouver, Canada: Effect of rec-1 on the accumulation
of mutations and transposable elements.
Wojcik, A., Ozeran, D., Lanier, W., BIOSIS, Palo Alto, Cali-
fornia: Is migration of dauer larvae induced?
Wheaton, V.I.,' Hedgecock, E.M.,2 Otsuka, A.J.,"Dept.
of Genetics, University of California, Berkeley; 2Dept. of
Cell Biology, Roche Institute of Molecular Biology, Nutley,
New Jersey: Progress in cloning a novel dumpy gene.
Weston, K.,' Yochem, J.,2 Seydoux, G.,2 Greenwald, 1,2
'MRC Laboratory of Molecular Biology, Cambridge, Eng-
land; 2Dept. of Biology, Princeton University, New Jer-
sey: lin-12 update.
Waring, D., Kenyon, C., Dept. of Biochemistry and Bio-
physics, University of California, San Francisco: Genes
affecting the "ray vs. alae" decision.
Wadsworth, W.G., Riddle, D.L., Division of Biological Sci-
ences, University of Missouri, Columbia: Acidification of
intracellular pH accompanies the recovery of dauer lar-
vae.
Vahidi, H., Curran, J., Nelson, D.W., Webster, J.M., Honda,
B.M., Dept. of Biological Sciences, Simon Fraser Univer-
sity, Burnaby, Canada: 5S rRNA homologous sequences
in the rDNA of Meloidogyne species.
Turner, L.M., Rosenbluth, R.E., Bail lie, DI., Dept. of Bio-
logical Sciences, Simon Fraser University, Burnaby, Can-
ada: y-irradiation in C. elegans.
Dixon, D.K., Jones, D., Candido, E.P.M., Dept. of Biochem-
istry, Faculty of Medicine, University of British Columbia,
Vancouver, Canada: Alterations in the chromatin struc-
ture of the 16-kD heat-shock polypeptide (hsp16) genes
of C. elegans following heat induction.
Hartman, P.S.,' Marshall, A.,' Dwarakanath, V.,' Mitchell,
D.,2 'Dept. of Biology, Texas Christian University, Fort
Worth; 2University of Texas System Cancer Center,
Smithville: Biochemistry of DNA repair in C. elegans.
Mello, C., Dunaief, J., Stinchcomb, D., Dept. of Cellular and
Developmental Biology, Harvard University, Cambridge,
Massachusetts: C. elegans segregators-Sequence re-
quirements for the nucleation of a yeast spindle attach-
ment site.
Starr, T, Rose, A.M., Dept. of Medical Genetics, University
of British Columbia, Vancouver, Canada: Molecular stud-
ies in the region around dpy-14.
Rosenbluth, R., Rogalski, T, Johnsen, R., Heschl, M.,
McKim, K., Turner, L., Bail lie, D.L., Dept. of Biological
Sciences, Simon Fraser University, Burnaby, Canada:
Twenty major zones define LGV(left).
Tullis, G., Dailey, B., Golomb, M., Division of Biological Sci-
ences, University of Missouri, Columbia: RNA polymer-
ase II in mutant strains of C. elegans and in dauer larvae.
Trent, C., Wood, W.B., Dept. of Molecular, Cellular and De-
velopmental Biology, University of Colorado, Boulder:
Molecular cloning of the her-1 Vgene.
Thomas, J., Horvitz, R., Dept. of Biology, Massachusetts In-
stitute of Technology, Cambridge: Cell interactions be-
tween the somatic gonad and the vulval equivalence
group, the sex myoblasts, and the HSN neurons.
M. Stern, S. McIntire, E. Hedgecock
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Tabuse, Y., Miwa, J., NEC Fundamental Research Labora-
tories, Kawasaki, Japan: Phorbol ester TPA does not af-
fect early embryogenesis of C. elegans.
Tabuse, Y., Nishiwaki, K., Miwa, J., NEC Fundamental Re-
search Laboratories, Kawasaki, Japan: Molecular cloning
of the tpa -i gene.
Strome, S., Beanan, M., Dept. of Biology, Indiana Univer-
sity, Bloomington: Characterization of a temperature-sen-
sitive germ-line proliferation mutant.
Storfer, FA., Wood, W.B., Dept. of Molecular, Cellular and
Developmental Biology, University of Colorado, Boulder:
Characterization of nullo-X embryos.
Stewart, H.I., Bail lie, D.L., Dept. of Biological Sciences, Si-
mon Fraser University, Burnaby, Canada: Ultraviolet mu-
tagenesis in the nematode C. eiegans.Stern, B.D.,' Ishii,
N.,1 Culotti, J.G.,2 Hedgecock, E.M.,"Dept. of Cell Bi-
ology, Roche Institute of Molecular Biology, Nutley, New
Jersey; 2Dept. of Molecular Immunology and Neurobiol-
ogy, Mt. Sinai Hospital Research Institute, Toronto, Can-
ada: Progress in the molecular cloning of genes affecting
neural development.
Spence, A., Shen, M., Hodgkin, J., MRC Laboratory of Mo-
lecular Biology, Cambridge, England: Walking to sex-de-
termining genes fem-1, mab-3, and tra-1.
Sosnowski, B., Hogan, E., Ward, S., Dept. of Embryology,
Carnegie Institution of Washington, Baltimore, Maryland:
Developmental localization of a sperm-specific protein
and isolation of its gene.
Siddiqui, Culotti, J.,3 'Northwestern University, Ev-
anston, Illinois; 2Toyohashi University of Technology, Ja-
pan; 3Mt. Sinai Research Institute and Hospital, Toronto,
Canada: Antibodies against mouse neural cell adhesion
molecule, N-CAM, stain male-specific neurons in C. ele-
gans.
Shoemaker, J., Friedman, D., Fitzpatrick, P., Johnson, T.E.,
University of California, Irvine: Deficiency mapping of the
age-1 locus in C. elegans.
Shakes, D.C., L'Hernault, S.W., Ward, S., Dept. of Embryol-
. ogy, Carnegie Institution of Washington, Baltimore, Mary-
land: Analysis of spermiogenesis-defective mutants.
Sebastiano, M., Bazzicalupo, P., International Institute of
Genetics and Biophysics, CNR, Naples, Italy: Putative
gene for a vitelline membrane protein in C. elegans.
Schnabel, H., Schnabel, R., MRC Laboratory of Molecular
Biology, Cambridge, England: sot-/ ("sore-throat"), a
gene required for pharyngeal differentiation in the em-
bryo.
Schedin, P., Jonas, P., Wood, W.B., Dept. of Molecular, Cel-
lular and Developmental Biology, University of Colorado,
Boulder: Possible function for her-1 in maintaining differ-
entiated states of the intestine and germ line in adult
males.
Schauer, I.E., Wood, W.B., Dept. of Molecular, Cellular and
Developmental Biology, University of Colorado, Boulder:
Transcription in early embryos of C. elegans.
Sassa, T, Hosono, R., Kuno, S., Dept. of Biochemistry,
Kanazawa University, Japan: Enzymatic analysis of ChAT
from a temperature-sensitive mutant of C. elegans.
Sanicola, M., Roberts, S.B., Childs, G., Emmons, S., Albert
Einstein College of Medicine, Bronx, New York: Molecu-
lar characterization of the C. elegans histone gene family.
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T. Blumenthal, P. Sternberg
Rogalski, TM., Riddle, D.L., Dept. of Biological Sciences,
University of Missouri, Columbia: Lethal mutations and
chromosomal rearrangements affecting the ama-1 gene.
Reape, T, Burnell, A., Dept. of Biology, St. Patrick's Col-
lege, Kildare, Ireland: Investigation of enzyme activity in
the dauer larva of C. elegans on returning to food.
Ray, A., Riddle, D.L., Division of Biological Sciences, Uni-
versity of Missouri, Columbia: Changes in protein phos-
phorylation associated with dauer larva recovery.
Rand, J.B., Johnson, C.D., Dept. of Zoology, University of
' Wisconsin, Madison: Suppression of Ace-lethality by cha-
1 and unc-17 mutations.
Quarantillo, B., Donahue, L., Wood, W.B., Dept. of Molecu-
lar, Cellular and Developmental Biology, University of
Colorado, Boulder: Molecular analysis of X-chromosome
dosage compensation continued.
Prenger, J.,' Boettcher, J.,' Weinmann, R.,2 Golomb, M.,1
'Division of Biological Sciences, University of Missouri,
Columbia; 2Wistar Institute, Philadelphia, Pennsylvania:
Mapping epitopes and functional domains on RNA poly-
merase II from C. elegans.
Prasad, S., Baillie, D.L., Simon Fraser University, Burnaby,
Canada: Molecular analysis of the region around unc-22
on linkage group IV of C. elegans.
Plenefisch, J., Villeneuve, A., Hsu, D., Meyer, B., Dept. of
Biology, Massachusetts Institute of Technology, Cam-
bridge: Suppressin"n' enhancin' her-1(n695sd).
Dreyfus, D.H., Emmons, S.W., Dept. of Molecular Biology,
Albert Einstein College of Medicine, Bronx, New York:
Properties of a polymorphic foldback family in C. ele-
gans.
SESSION 4 SEX, GAMETES AND DOSAGE COMPENSATION
Chairman: C. Kenyon, University of California, San Francisco
Villeneuve, A., Meyer, B., Dept. of Biology, Massachusetts
Institute of Technology, Cambridge: sdc-1-A link be-
tween sex determination and dosage compensation.
Miller, L., Meyer, B., Dept. of Biology, Massachusetts Insti-
tute of Technology, Cambridge: y9-An XO-specific lethal
mutation that interacts with both dosage-compensation
and sex-determination mutations.
Meneely, P.M., Nordstrom, K.D., Fred Hutchinson Cancer
Research Center, Seattle, Washington: X-chromosome
duplications elevate X-linked gene expression.
Manser, J., Trent, C., Wood, W.B., Dept. of Molecular, Cellu-
lar and Developmental Biology, University of Colorado,
Boulder: sup-26111-A regulator of her-1?
Schedl, T, Barton, M.K., Kimble, J., University of Wiscon-
sin, Madison: Genetic analysis of germ-line sex determi-
nation.
Rosenquist, R., Lawson, D., Kimble, J., University of Wis-
SESSION 5 NEUROBIOLOGY
Chairman: J. Culotti, Mt. Sinai Research Institute, Toronto
Johnson, C.D., Dept. of Zoology, University of Wisconsin,
Madison: Inter- and intraspecies variance of the anatomy
of the nematode nervous system.
Durbin, R.M., Thomson, J.N., MRC Laboratory of Molecu-
lar Biology, Cambridge, England: Cell interactions in the
developing nervous system.
Hedgecock, E.,' Culotti, J.,2 Hall, D.,3 'Roche Institute of
Molecular Biology, Nutley, New Jersey; 2Mount Sinai
Hospital Research Institute, Toronto, Canada; 3Albert
Einstein College of Medicine, Bronx, New York: uncs-5, -
6, and -40 act in combination to guide migrating cells
and axons along the circumferential coordinate of the
body wall.
Desai, C.,' Garriga, G.,' McIntire, S.,' Thomson, N.,2
Horvitz, R.,' 'Dept. of Biology, Massachusetts Institute of
Technology, Cambridge; 2MRC Laboratory of Molecular
Biology, Cambridge, England: Genes involved in the de-
velopment of the HSN neurons.
Li, C., Chalfie, M., Dept. of Biological Sciences, Columbia
University, New York, New York: External cues necessary
for vulval innervation.
McIntire, S.,' White, J.,2 Horvitz, R.,"Massachusetts In-
stitute of Technology, Cambridge; 2MRC Laboratory of
Molecular Biology, Cambridge, England: Identified GA-
BAergic neurons and mutations affecting GABA expres-
sion and axonal outgrowth in C. elegans.
Way, J., Chalfie, M., Dept. of Biological Sciences, Columbia
University, New York, New York: Cloning the mec-3 gene.
Wolinsky, E.J., Chalfie, M., Dept. of Biological Sciences,
Columbia University, New York, New York: A TcI inser-
tion at the deg-1 locus.
Nawrocki, L.W., MRC Laboratory of Molecular Biology,
Cambridge, England: Molecular characterization of a
neural mutant, unc-24.
Siddiqui, Aamodt, E.,2 Rastinejad, F.,2 Culotti,
1Toyohashi University of Technblogy, Japan;
consin, Madison: Molecular analysis of the sex-determi-
nation gene, fem-3.
Okkema, P.G., Kimble, J., Dept. of Biochemistry, University
of Wisconsin, Madison: Molecular analysis of tra-2, a sex-
determination gene in C. elegans.
UHernault, S.W., Shakes, D.C., Hogan, E., Ward, S., Dept.
of Embryology, Carnegie Institution of Washington, Balti-
more, Maryland: Cloning, genetics, and phenotypic anal-
ysis of the spe-17 gene.
Blumenthal, T, Zucker, E., Dept. of Biology, Indiana Univer-
sity, Bloomington: Molecular analysis of the vitellogenin
genes. 68
Sharrock, W., Sutherlin, M., Dept. of Biochemistry, Univer-
sity of Minnesota, St. Paul: Supramolecular organization
of yolk proteins in C. elegans embryos.
Shen, M.M., MRC Laboratory of Molecular Biology, Cam-
bridge, England: mab-3, a gene controlling yolk produc-
tion and a sex-specific lineage.
2Northwestern University, Evanston, Illinois; 3Mt. Sinai
Research Institute and Hospital, Toronto, Canada: Differ-
ential expression of tubulin isotypes in C. elegans ner-
vous system.
Cowden, C.,' Sithigorngul, P.,' Guastella, J.,2 Stretton,
A.O.W.,"Dept. of Zoology, 2Neurosciences Training
Program, University of Wisconsin, Madison: Neuropep-
tide diversity in Ascaris.
Avery, L., Horvitz, H.R., Dept. of Biology, Massachusetts In-
stitute of Technology, Cambridge: Function of the phar-
ynx.
A. Rose
215
B Herman, J Rand, C. Johnson
SESSION 6 POSTER SESSION
Peters, K., Rose, A.M., University of British Columbia, Van-
couver, Canada: Genetic and molecular analysis of bli-4.
Papp, A., Ambros, V., Dept. of Cellular and Developmental
Biology, Harvard University, Cambridge, Massachusetts:
A genetic characterization of lin-29 - Isolation of extra-
genic suppressors.
Otsuka, A.J.,' Wheaton, V.I.,' Jeyaprakash, A.,' Hart-
shorne, T.,' Hedgecock, E.M.,2 'Dept. of Genetics, Uni-
versity of California, Berkeley; 2Dept. of Cell Biology,
Roche Institute, Nutley, New Jersey: Progress in cloning
unc-44.
Niebur, E., Erdes, P., Institut de physique theorique, Univer-
site de Lausanne, Switzerland: On the control of locomo-
tion of nematodes.
Nelson, G., Shubert, W., Marshall, T., Jet Propulsion Labo-
ratory, Caltech, Pasadena, California: Genetic and devel-
opmental effects of heavy-ion radiation in C. elegans.
Munakata, N., National Cancer Center Research Institute,
Tokyo, Japan: Mutations causing hypersensitivity to alkyl-
ating chemicals.
Morgan, P.G.,' Sedensky, M.M.,1 Meneely, P.M.,2 Cas-
corbi, H.F.,"Dept. of Anesthesiology, University Hospi-
tals of Cleveland, Case Western Reserve University
School of Medicine, Ohio; 2Fred Hutchinson Cancer Re-
search Center, Seattle, Washington: Response of C. ele-
gans to volatile anesthetics.
Moerman, D.G., Rioux, S., Waterston, R.H., Dept. of Genet-
ics, Washington University School of Medicine, St. Louis,
Missouri: Attempts to identify the unc-52 gene by Tc/ in-
sertional mutagenesis.
Miller, D.M., Dept. of Zoology, North Carolina State Univer-
sity, Raleigh: Transposon mutagenesis to isolate genes
regulating nematode neuromuscular development.
Milanick, M., Bennett, K., Dept. of Microbiology, University
of Missouri, Columbia: Monoclonal antibodies to Ascaris
recognize the P granules of Caenorhabditis.
Meheus, L., Vanfleteren, J., Laboratorium voor Morfologie
en Systematiek der Dieren, Rijksuniversiteit Gent, Bel-
gium: Age-related changes in the two-dimensional gel
pattern of the nuclear protein of C. elegans.
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J. Miwa, B. Horvitz
Mancillas, J.R., MRC Laboratory of Molecular Biology,
Cambridge, England: Spontaneous mutations affecting
backward movement in C. elegans.
Mancebo, R., Babity, J.M., Harris, L.J., Starr, T., Rose,
A.M., University of British Columbia, Vancouver, Canada:
Low-copy-number alterations in the Tcl pattern of the
Bristol strain, CB51 (unc-13).
Maine, E., Kimble, J., University of Wisconsin, Madison:
glp-1 suppressors.
McKim, K.S., Rose, A.M., Dept. of Medical Genetics, Uni-
versity of British Columbia, Vancouver, Canada: Analysis
of the left third of LGI using the reciprocal translocation
szT1 (I; X).
McKim, K.S.,1 Clark, D.V.,2 Johnsen, R.C.,2 Rose, A.M.,'
Baillie, D.L.,2 'Dept. of Medical Genetics, University of
British Columbia, Vancouver, 2Dept. of Biological Sci-
ences, Simon Fraser University, Burnaby, Canada: Tc1-
induced lethal mutations.
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Johnsen, R.C., Bail lie, D.L., Simon Fraser University, Bur-
naby, Canada: Analysis of EMS and formaldehyde-in-
duced lethals on LGV(Ieft).
Jeyaprakash, A.,' Wheaton, V.I.,' Hedgecock, E.M.,2 Ot-
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Simon Fraser University, Burnaby, Canada: Comparison
of some hsp70-related genes.
Herman, R.K., Dept. of Genetics and Cell Biology, Univer-
SESSION 7 POSTEMBRYONIC DEVELOPMENT AND AGING
Chairman: S. Emmons, Albert Einstein College of Medicine
Austin, J., Kimble, J., University of Wisconsin, Madison:
Genetic and developmental analysis of glp-1.
Kim, S., Horvitz, R., Dept. of Biology, Massachusetts Insti-
tute of Technology, Cambridge: Molecular genetics of
vulval cell lineages.
Thomas, J., Horvitz, R., Dept. of Biology, Massachusetts In-
stitute of Technology, Cambridge: Genes that interact
with lin-12 in specifying cell fates.
Kenyon, C., Costa, M., Lee, T., Waring, D., Dept. of Bio-
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Approaches to studying male tail morphogenesis.
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Friedman, D., Johnson, T, Dept. of Molecular Biology and
Biochemistry, University of California, Irvine: Genetic
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SESSION 8 TRANSFORMATION, TRANSPOSITION, AND SUPPRESSION
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vulval morphogenesis.
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California, San Francisco: Progress in molecular cloning
of mab-5.
Coohill, T., Schubert, W., Marshall, T., Nelson, G., Jet Pro-
pulsion Laboratory, Caltech, Pasadena, California: Re-
sponses of radiation-sensitive mutants to high and low
LET ionizing radiation,
Clark, S., Edwards, K., Horvitz, R., Dept. of Biology, Massa-
chusetts Institute of Technology, Cambridge: Suppres-
sors of lin-1.
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be unique to human lymphatic filarial nematodes.
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220
RNA Processing
May 13-May 17
ARRANGED BY
Thomas Cech, University of Colorado, Boulder
Christine Guthrie, University of California, San Francisco
Hugh D. Robertson, Rockefeller University
377 participants
The excitement generated during the 1987 RNA Processing meeting can be
gleaned from a list of the new advances announced at that meeting that were not
anticipated at the 1986 meeting.
1. Identification of the complete set of small nuclear RNAs (snRNAs) required for
nuclear mRNA splicing in yeast, their relationship to the mammalian snRNAs,
and in two cases their sites of binding to pre-mRNA. This is a major advance,
since only a few years ago it was not at all clear that there were yeast snRNAs
equivalent to mammalian Ul, U2, U4, U5, and U6 snRNAs. Now the powerful
genetic methods available in yeast can be applied to the dissection of mRNA
splicing in vivo and in vitro.
2. Evidence for trans-splicing (splicing together of RNA segments from different
primary transcripts) for a series of actin mRNAs from the nematode worm.
Combined with the earlier finding of trans-splicing in trypanosomes, it now
appears that trans-splicing might be a general phenomenon in eukaryotes.
3. Sequencing of the functionally essential RNA subunit of a primer endonuclease
involved in mammalian mitochondrial DNA replication and identification of RNA
in the terminal deoxyribonucleotidyltransferase involved in telomere generation
in Tetrahymena. These findings pave the way for studies designed to determine
the function of the RNA in these ribonucleoprotein enzymes.
4. Identification and genetic proof of two RNA tertiary interactions that hold the 5'
exon into place for group II mitochondrial mRNA self-splicing. These tertiary
interactions explain the molecular basis for group II RNA trans-splicing in vitro;
analogous interactions are likely to be involved in plant chloroplast mRNA
trans-splicing in vivo.
5. Determination of the RNA secondary structure of the RNA enzyme, RNase P,
and new information about the portion of the pre-tRNA substrate with which it
interacts. Both advances are necessary prerequisites for understanding
structure-function relationships for this RNA enzyme.
The rapid pace of development in the areas described above is of course
mainly due to the skill and ingenuity of individual research groups. Another key
ingredient has been the excellent communication and critical evaluation of ideas
and data provided by the annual RNA processing meetings.
This meeting was supported in part by the National Science Foundation
(National Institute of General Medical Sciences) and the National Institutes of
Health.
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SESSION 1 RNA STRUCTURE AND FUNCTION
Chairman: P. Moore, Yale University
Milligan, J.F., Groebe, D., Witherell, G., Uhlenbeck, 0.C.,
Dept. of Chemistry and Biochemistry, University of Colo-
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try, University of California, Berkeley: Structure of M-I
RNA as determined by psoralen cross-linking.
Zwieb, C., European Molecular Biology Laboratory, Heidel-
berg, Federal Republic of Germany: Determining the
three-dimensional folding of the 7SL RNA-Functional
implications.
Brow, D.A., Guthrie, C., Dept. of Biochemistry and Biophys-
SESSION 2 3' ENDS AND POLYADENYLATION
Chairman: M. Wickens, University of Wisconsin
Wickens, M., Bardwell, V., Conway, L., Fox, C., Sheets, M.,
Zarkower, D., Dept. of Biochemistry, University of Wis-
consin, Madison: Cleavage and polyadenylation of SV40
late pre-mRNAs in vitro.
Zhang, F, Cole, C.N., Molecular Genetics Center and Dept.
of Biochemistry, Dartmouth Medical School, Hanover,
New Hampshire: Identification of a complex involved in
processing of tk RNA 3' ends in vitro.
Moore, C.L,' Scolnik-David, H.,2 Sharp, PA., 2 'Dept. of
Molecular Biology, Tufts University Medical School, Bos-
ton, 2Dept. of Biology, Massachusetts Institute of Tech-
nology, Cambridge: Assembly of precursor RNA contain-
ing the L3 poly(A) site into RNA-protein complexes.
Green, T., Noll, G., Vattay, A., Hart, R., Dept. of Biological
Sciences, Rutgers University, Newark, New Jersey:
Poly(A) site sequence requirements for in vitro cleavage
activity and UV cross-linking to a protein factor.
Wilusz, J., Shenk, T., Dept. of Molecular Biology, Princeton
University, New Jersey: Identification of a 64-kD nuclear
protein that interacts specifically with the polyadenylation
signal.
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actions-The U4/U6 association is conserved in yeast.
Parker, K.A., Steitz, J.A., Dept. of Molecular Biophysics and
Biochemistry, Yale University Medical School, New Ha-
ven, Connecticut: Structural analyses of the U3 RNP re-
veal a conserved sequence available for base-pairing
with pre-rRNA.
Stroke, I., Weiner, A., Dept. of Molecular Biophysics and
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Arenas, J.,' Phillips, B.,2 Hurwitz, J.,2 'Albert Einstein Col-
lege of Medicine, Bronx, 2Memorial Sloan-Kettering Can-
cer Center, New York, New York: Isolation and character-
ization of an RNA helicase from HeLa cells.
Federal Republic of Germany: Is there an snRNP in-
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tial purification of the factors involved in mRNA 3'-end
cleavage and polyadenylation.
Gilmartin, G.M., McDevitt, M.A., Nevins, J.R., Rockefeller
University, New York, New York: Multiple factors are re-
quired for pre-mRNA 3' processing in vitro.
Proudfoot, N.J., Gil, A., Johnson, M.R., Whitelaw, E., Sir
William Dunn School of Pathology, University of Oxford,
England: Termination of transcription and 3'-end process-
ing in eukaryotic genes transcribed by RNA polymerase
II-The signals involved and their role in gene regulation.
Labhart, P., McStay, B., Reeder, R.H., Basic Sciences Divi-
sion, Fred Hutchinson Cancer Research Center, Seattle,
Washington: rRNA 3'-end formation requires sequences
at both 5' and 3' ends of the gene region.
Sarkar, N., Taljanidisz, J., Shen, P., Boston Biomedical Re-
search Institute and Dept. of Biological Chemistry, Har-
vard Medical School, Massachusetts: 3'-terminal poly-
adenylation of mRNA in prokaryotes.
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splicing of influenza virus NS1 mRNA occurs after spli-
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Aloni, Y., Kessler, M., Resnekov, 0., Seiberg, M., Regimov,
N., Ben-gal, E., Amster-Choder, 0., Dept. of Genetics,
Weizmann Institute of Science, Rehovot, Israel: Attenua-
tion in the regulation of gene expression in viruses and
animal cells.
Amero, S.A., Elgin, S.C.R., Dept. of Biology, Washington
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from Drosophila is associated with specific develop-
mentally regulated loci.
Andersen, J.,' Zhao, K.,' Inouye, M.,2 Delihas, N.,'
'Dept. of Microbiology, State University of New York
School of Medicine, Stony Brook; 2Dept. of Biochemis-
try, Robert Wood Johnson Medical School, UMDNJ, Pis-
cataway, New Jersey: Expression of the antisense RNA
gene, micF, is regulated in response to temperature and
osmolarity of the growth media.
Subbarao, M.N., Apirion, D., Dept. of Microbiology, Wash-
ington University, St. Louis, Missouri: 10Sa RNA-A small
stable RNA of E. coli; cloning and processing.
Ares, M., Giglio, L., Chung, J.-S., Weiner, A.M., Dept. of
Molecular Biophysics and Biochemistry, Yale University
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hancer.
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'Harvard-Division of Health Sciences and Technology,
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School, Boston, Massachusetts: Characterization of a
specific mRNA-protein interaction using the mobility
band-shift assay.
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University, New Haven, Connecticut: Differential effects
on tRNA suppressor function of mutations in RNase P
and selection of second-site revertants in the gene for
M1 RNA.
Ruohola, H.,1 Baker, S.M.,2 Hazen, J.,2 Parker, R.,3 Platt,
T.,2 'Dept. of Cell Biology, Yale University, New Haven,
Connecticut; 2Dept. of Biochemistry, University of Roch-
ester Medical Center, New York; 3Dept. of Biochemistry
and Biophysics, University of California, San Francisco:
Orientation-dependent 3'-end formation- CYC1 tran-
scription terminator fragments inserted in the actin intron
of yeast.
Bark, C., Weller, P., Zabielski, J., Janson, L., Pettersson, U.,
Dept. of Medical Genetics, Biomedical Center, University
of Uppsala, Sweden: Transcription of a mouse U6 RNA
gene by RNA polymerase III is enhancer-dependent.
Belasco, J.,' Beatty, J.T.,2 Cohen, S.ft,3 'Dept. of Micro-
biology and Molecular Genetics, Harvard Medical
School, Boston, Massachusetts; 2Dept. of Microbiology,
University of British Columbia, Vancouver, Canada;
3Dept. of Genetics, Stanford University, California: A de-
terminant of mRNA stability that governs differential
expression of R. capsulatus photosynthesis genes.
Bovenberg, R.A.L., Baas, P.D., Jansz, H.S., University of
Utrecht, The Netherlands: Processing of CALC-I RNA in
vitro.
Buck, G.A., McCarthy, C., Dept. of Microbiology and Immu-
nology, Virginia Commonwealth University, Richmond:
Small RNAs sharing sequence homology with the pri-
mary transcript of the trypanosome mRNA spliced
leader.
Carmichael, G., Marlor, C., Adami, G., Dept. of Microbiol-
ogy, University of Connecticut Health Center, Farming-
ton: Role of the polyoma late leader exon length in RNA
splicing and stability.
Rodrigues, M.L., Castano, J.G., University of Madrid,
Spain: 5' and 3' pre-tRNases from Ehrlich ascites cells.
Lavery, D., Chen-Kiang, S., Dept. of Microbiology, Mount
Sinai School of Medicine, New York, New York: Re-
pressed synthesis of adenovirus E1A mRNAs in human
lymphoid cells is regulated posttranscriptionally.
Christensen, M.,' Junio, M.,' Fuxa, K.,' Pierron, G.,2
'Dept. of Biology, Texas A & M UniverSity, College Sta-
tion; 2lnstitut de Recherches Scientifiques sur le Cancer,
Villejuif, France: Does the processing of mRNA and rRNA
involve related RNA-packaging proteins?
Chu, F.K., Maley, G.F., Maley, F, Wadsworth Center for Lab-
oratories and Research, New York State Dept. of Health,
Albany: Structural studies of a prokaryotic self-splicing
RNA.
Clark, M.W., Campbell, J., Abelson, J., California Institute of
Technology, Pasadena: The rnal mutation disrupts the lo-
cation of proteins found in the yeast nucleolus.
Collins, R.A., Dept. of Botany, University of Toronto, Can-
ada: Conservation of secondary structure outside of the
"core" in a large subclass of group I introns.
Connelly, S., Manley, J.L., Dept. of Biological Sciences, Co-
lumbia University, New York, New York: Sequences re-
quired for efficient cleavage and polyadenylation of the
SV40 early transcript also function as an RNA polymer-
ase II termination signal.
Craig, N.,1 Kass, 5.,2 Sollner -Webb, B.,2 'Dept. of Biologi-
cal Science, University of Maryland, Catonsville; 2Dept.
of Biological Chemistry, Johns Hopkins School of Medi-
cine, Baltimore, Maryland: Cell-free processing of mouse
rRNA-Analysis of nucleotide and biochemical determi-
nants.
Perea, J., Creusot, F, Banroques, J., Becam, A.M., Dela-
hodde, A., Goguel, V., Mendelzon, D., Jacq, C., Centre
de Genetique Moleculaire du CNRS, laboratoire associe
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The study of RNA tumor viruses continues to provide a focal interest for research-
ers working on retroviral replication and integration, retroviral vectors, mechanisms
of viral pathogenesis, and the activities of transduced viral oncogenes. The field
has already had a major impact on diverse arenas of investigation and, in particu-
lar, has fostered a rapid understanding of human immunodeficiency viruses,
cellular proto-oncogenes, mechanisms of insertional mutagenesis, and the function
of endogenous viral elements as model retrotransposons. The 1987 conference
brought together more than 400 scientists interested in the most recent develop-
ments in the field.
Studies of retroviral replication stressed the development of the first in vitro
systems to assay proviral integration, the activity of virus-coded endonucleases,
and the fidelity of reverse transcription. Progress in elucidating detailed require-
ments for ribosomal frameshifting during viral protein synthesis and for virion
assembly was also reported. Although the role of viral oncogenes and their
cellular proto-oncogene progenitors in cell transformation has become a subject of
major conferences elsewhere, several sessions remained dedicated to work in this
area. Highlights included functional studies of chimeric insulin/ros receptor
molecules, the demonstration of autocrine transformation in the c-fms/CSF-1 and
erb8/EGF systems, insertional mutagenesis of the CSF-1 receptor locus in Friend-
virus-induced myelogenous leukemia, activation of the transforming potential of the
c-fes gene product, and the description of revertants of v-fos-transformed cells
refractory to transformation by other oncogenes.
Another theme centered on the tissue-specific transcription of retroviruses, the
role of trans-activating factors in regulating viral gene expression, and the
importance of viral transcriptional control elements in pathogenesis. Continued
progress in the elucidation of the functions of the human immunodeficiency virus
tat and art gene products in regulating viral RNA expression, including the
elucidation of virus-coded positive and negative regulatory proteins and LTR target
sequences, was reported. A final session concerned the role of other HIV gene
products (sor) in viral replication, the mechanism of HIV cytopathicity, identification
of new HIV isolates, and the relationship of HIV to other recently characterized
primate retroviridae.
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Mbuntain Laboratories, Hamilton, Montana: Class II poly-
tropic MLVs of AKR/J mice-Possible role in the genera-
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Karolinska Institute, Stockholm, Sweden: Establishment
of stable cell lines expressing the EBV-EBNA-1 gene us-
ing a retroviral vector.
Paludan, K., Jorgensen, P., Kjeldgaard, N.O., Pedersen,
ES., Dept. of Molecular Biology, University of Aarhus,
Denmark: An Akv-neo transmission vector confers no
marker gene expression upon lymphoid cell clones, un-
less selected for G418 resistance.
SESSION 4 ONCOGENES: src, abl, int-1, sis, ras, raf
Chairmen: H. Hanafusa, Rockefeller University
J.T. Parsons, University of Virginia
Tanaka, A., Fujita, D.J., University of Western Ontario, Can-
ada: Chain termination, internal deletion, and point muta-
tion events involved in activated human c-src genes.
Potts, W., Reynolds, A., Lansing, T., Parsons, J.T., Dept. of
Microbiology, University of Virginia, Charlottesville: Fine-
structure analysis of domains of p605'° involved in onco-
genic transformation using oligonucleotide-directed mu-
tagenesis.
Fox, L., Frost, K., Brugge, J., Dept. of Microbiology, State
University of New York, Stony Brook: Generation of a
new class of pp60.-s'° mutants that display an intermedi-
ate level of pp60.-s. activation.
Sugano, S., Stoeckle, M.Y., Hanafusa, H., Rockefeller Uni-
versity, New York, New York: Transformation by RSV in-
duces a novel gene with homology to a mitogenic platelet
protein.
Hippenmeyer, P, Highkin, M., Dept. of Biological Sciences,
Monsanto Company, St. Louis, Missouri: Transfer and
expression of the bacterial NPT-II gene in chick embryos
using a retroviral vector.
Salmons, B., Gunzberg, W.H., Garcha, I., Legrand, S., Sar-
kar, N.H., Dept. of Cell and Molecular Biology, Medical
College of Georgia, Augusta: MMTV-based vector sys-
tem-Introduction of oncogenes into mammary epithelial
cells.
Winberg, G., Fuerstenberg, S., Klein, G., Dept. of Tumor Bi-
ology, Karolinska Institute, Stockholm, Sweden: A versa-
tile retrovirus vector allowing enhancer replacement and
multiple gene cloning.
Connors, R., Yokoyama, S., Deen, K., Rosenberg, M.,
Sweet, R., Smith Kline and French Laboratories, Swede-
land, Pennsylvania: Selection of overexpression of trans-
fected genes.
Bonnerot, C., Briand, P., Nicolas, J.F., Unite de Genetique
cellulaire du College de France et de l'Institut Pasteur,
Paris: Recombinant retroviruses encoding a nuclear-tar-
geted E. colt fl-galactosidase-A marker system for stud-
ies on control of gene expression on preimplantation
mouse embryos.
Menko, A.S., Boettiger, D., Dept. of Microbiology, Univer-
sity of Pennsylvania, Philadelphia: Integrin serves as a
critical target for phosphorylation by v-src in the suppres-
sion of myogenic differentiation.
Engelman, A., Rosenberg, N., Dept. of Molecular Biology
and Microbiology, Tufts University Medical School, Bos-
ton, Massachusetts: Construction of conditional Abelson
virus mutants by site-directed mutagenesis.
Brown, A.M.C., Papkoff, J., Varmus, H.E., Dept. of Microbi-
ology and Immunology, University of California Medical
Center, San Francisco: Studies of the mechanism of ac-
tion of the mammary oncogene int-1.
Sauer, M.K.,1 Donoghue, D.J.,2 Depts. of 'Biology,
2Chemistry, University of California, San Diego, La Jolla:
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Oligonucleotide site-directed mutagenesis of the eight
cysteine residues in the minimal transforming region of
v-sis.
Lee, B.A.,' Maher, D.W.,2 Hannink, M.,2 Donoghue, D.J.,2
Depts. of 'Biology, 'Chemistry, University of California,
San Diego, La Jolla: The v-sis protein contains a nuclear
targeting signal.
Shih, T.Y., Ulsh, L.S., Huang, K.-P., NCI, National Institutes
of Health, Bethesda, Maryland: Phosphorylation of p21
products of ras oncogenes by protein kinase C.
SESSION 5 ONCOGENES: ros, fms, met, erbB, erbA, fps/fes
Chairmen: G.S. Martin, University of California, Berkeley
L.-H. Wang, Rockefeller University
Wang, L.-H.,1 Lin, B.,' Jong, S.-M.,' Dixon, D.,' Ellis, L.,2
Rutter, W.J.,2 Roth, R.,3 'Rockefeller University, New
York, New York; 'University of California, San Francisco,
3Stanford University, Palo Alto, California: Activation of
the transforming potential of human insulin receptor
gene.
Wheeler, E.F.,1 Askew, D.,2 lh le, J.,2 Rettenmier, C.W.,'
Sherr, C.J.,"Dept. of Tumor Cell Biology, St. Jude Chil-
dren's Hospital, Memphis, Tennessee; 2NCI-Frederick
Cancer Research Facility, Frederick, Maryland: The v-fms
oncogene induces factor-independence and tumorigen-
icity in murine hematopoietic cell lines of the myeloid lin-
eage.
Heard, J.M.,' Roussel, M.F.,' Rettenmier, C.W.,' Ralph,
P.,2 Sherr, C.J.,"Dept. of Tumor Cell Biology, St. Jude
Children's Research Hospital, Memphis, Tennessee;
'Cetus Corporation, Emeryville, California: Cell transfor-
mation induced by retroviral vectors expressing the hu-
man CSF-1 and c-fms (CSF-1 receptor) genes.
Rogers, A.,'.2 Bishop, J.M.,1.3 'Hooper Foundation, and
Depts. of 'Biochemistry and Biophysics, 3Microbiology,
University of California, San Francisco: Mutational analy-
sis of c-fms transforming potential.
Bodescot, M., Park, M., Gonzatti-Haces, M., Dean, M.,
Vande Woude, G., NCI-Frederick Cancer Research Facil-
ity, Frederick, Maryland: Sequence of met proto-onco-
gene cDNA reveals features characteristic of the tyrosine
kinase family of growth-factor receptors.
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lyer, A., Sutrave, P, Park, M., Dean, M., Gonda, M., Vande
Woude, G.F., NCI-Frederick Cancer Research Facility,
Frederick, Maryland: Chromosomal location, tissue
expression, and characterization of cDNA of the mouse
met locus.
McMahon, M., Bruskin, A.M., Bishop, J.M., G.W. Hooper
Foundation, University of California, San Francisco: Anal-
ysis of transformation of established rodent fibroblasts by
recombinant murine retroviruses containing the v-erbB
oncogene.
Kaplan, J.M.,' Mardon, G.,2 Bishop, J.M.,3 Varmus, H.E.,2
Depts. of 'Biochemistry and Biophysics, 'Microbiology
and Immunology, 3G.W. Hooper Foundation, University
of California, San Francisco: The myristylation signal of
pp60v-s,2 is in the first seven amino acids, and codon 7
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Tsai, M.-H., Yu, C.-L., Stacey, D.W., Dept. of Cell Biology,
Roche Institute of Molecular Biology, Nutley, New Jersey:
c-ras proto-oncogene does not function to control phos-
pholipase-A2 or phospholipase-C activity.
Heidecker, G., Beck, T.W., Cleveland, J.L., Huleihel, M.,
Rapp, U.R., NCI-Frederick Cancer Research Facility,
Frederick, Maryland: Activation of the raf family proto-
oncogenes.
Velu, T.J.,' Beguinot, L.,2 Willingham, M.,2 Merlino, G.T.,2
Pastan, 1.,2 Vass, W.C.,' Lowy, D.R.,1 Laboratories of
'Cellular Oncology, 'Molecular Biology, NCI, Bethesda,
Maryland: EGF-dependent transformation by the human
EGF receptor proto-oncogene transmitted as a high-titer
retrovirus.
Bassiri, M.,' Boucher, P.,2 Koning, A.,' Judelson, C.,' Pri-
valsky, M.L.,' Depts. of 'Bacteriology, 'Biochemistry,
University of California, Davis: Genetic and biochemical
analysis of the v-erb A and v-erb B oncogenes of AEV.
Zenke, M.,' Sap, J.,' Munoz, A.,' Leutz, A.,2 Kahn, P.,'
Choi, H.-R.,3 Engel, D.,3 Vennstrom, B.,' Beug, H.,'
'EMBL, Heidelberg, Federal Republic of Germany;
'Dept. of Microbiology, State University of New York,
Stony Brook; 3Dept. of Biochemistry, Northwestern Uni-
versity, Evanston, Illinois: Effects of the v-erbA oncogene
on erythroid-specific gene expression.
Feldman, R.A., Vass, W.C., Tambourin, RE., NCI, National
Institutes of Health, Bethesda, Maryland: Human c-fps-
fes cDNA rescued via the retroviral shuttle vector en-
codes myeloid cell NCP92 and has transforming poten-
tial.
DeClue, J.,' Sadowski, 1.,2 Martin, G.S.,' Pawson, T,2
'Dept. of Zoology, University of California, Berkeley;
'Mount Sinai Hospital Research Institute, Toronto, Can-
ada: A site-directed mutant of the v-fps oncogene with
host-dependent transforming activity.
can be either lysine or arginine.
Ferrell, J.E., Jr., Martin, G.S., Dept. of Zoology, University
of California, Berkeley: Protein-tyrosine phosphorylation
in intact human platelets.
Howlett, A.R., Cullen, B., Hertle, M., Bissell, M.J., Labora-
tory of Cell Biology, University of California, Berkeley:
Temporal and tissue-specific expression of RSV in mi-
croinjected embryonic avian limb.
Sugano, S., Stoeckle, M.Y., Hanafusa, H., Rockefeller Uni-
versity, New York, New York: The 78-kD glucose-regu-
lated protein mRNA is elevated in RSV-transformed cells.
Simon, M., Arrigo, A.-P., Spahr, P. -F., Dept. of Molecular Bi-
ology, University of Geneva, Switzerland: Is the 34-kD tar-
get of RSV tyrosine kinase associated with a ribonucleo-
protein particle?
P. Tsichlis, P. Jolicoeur, N. Teich
Hopper, P., Coffin, J.M., Tufts University School of Medi-
cine, Boston, Massachusetts: Effect of antisense src RNA
on RSV replication and transformation.
Hevezi, P., Flees-Jones, R., Depts. of Microbiology and
Medicine, Columbia University College of Physicians and
Surgeons, New York, New York: A prominent phosphory-
lated glycoprotein present at high levels in cells trans-
formed by v-src and v -abl oncogenes.
Gebhardt, Al,' Col ledge, W.H.,1 Fry, M.J.,1 Foulkes,
J.G.,2 'National Institute for Medical Research, London,
England; 2Oncogene Science, Inc., Mineola, New York:
Characterization of nontumorigenic v-ab/-transformed fi-
broblast lines.
Singh, B., Arlinghaus, R., Dept. of Molecular Pathology,
University of Texas System Cancer Center, M.D. Ander-
son Hospital and Tumor Institute, Houston: Posttransla-
tional modification of vimentin in ts110 Mo-MSV-trans-
formed cells.
Ratner, L.,1 Thielan, B.J.,1 Collins, 1,2 'Depts. of Medicine
and Microbiology and Immunology, Washington Univer-
sity, St. Louis, Missouri; 2Dept. of Pathology, Harvard
Medical School, Boston, Massachusetts: Characterization
of the c-sis transcriptional promoter and regulation of
expression of the c-sis protein product.
Cleveland, J.,1 Dean, M.,2 lhle, J.,2 Rapp, U.,"BRI-Basic
Research Program, 2NCI-Frederick Cancer Research Fa-
cility, Frederick, Maryland: Role of myc in growth-factor
abrogation.
Bhat, G., Steffen, D.L., Worcester Foundation for Experi-
mental Biology, Shrewsbury, Massachusetts: Effect of
proviral insertion of c-myc expression in MLV-induced
thymomas.
Steffen, D.L., Donahue, J.L., Worcester Foundation for Ex-
perimental Biology, Shrewsbury, Massachusetts: Effect of
proviral insertion on methylation of the c-myc gene in
MLV-induced lymphomas.
Taparowsky, E.,' Farina, S.,2 Parsons, J.T.,2 'Dept. of Bio-
logical Sciences, Purdue University, West Lafayette, Indi-
ana; 2Dept. of Microbiology, University of Virginia School
of Medicine, Charlottesville: Cooperative transformation
of C3H/10T1/2 cells by the activated c-Ha-ras and MC29
gag-myc oncogenes- Identification of structural muta-
tions in myc that affect focus formation.
Konieczny, S., Taparowsky, E., Dept. of Biological Sciences,
Purdue University, West Lafayette, Indiana: Effect of nor-
mal and aberrant oncogene expression on the develop-
ment of muscle and adipocyte cell lineages in culture.
Bonham, L., Lobelle -Rich, F, Henderson, L.A., Levy, L.S.,
Dept. of Microbiology and Immunology, Tulane Medical
School, New Orleans, Louisiana: Biological activity of
myc-FeLV in early-passage feline cells in vitro.
Lamph, W.W., Raymond, V., Schweighofer, K., Verma, I.M.,
Molecular Biology and Virology Laboratory, Salk Institute,
San Diego, California: Human c-fos cDNA-Analysis of
its transforming potential or transformation by human
c-fos cDNA.
Teich, N.,M., Harrison, M.A., Rowe, J., Charles, G.S., Impe-
rial Cancer Research Fund, London, England: An onco-
gene interruption in a nonviral murine osteosarcoma.
Boettiger, D., Olsen, M., University of Pennsylvania, Phila-
delphia: Differentiation-dependent transformation of cells
in the monocyte lineage by v-myb.
Klempnauer, K.-H., Biedenkapp, H., Sippel, A.E., ZMBH,
University of Heidelberg, Federal Republic of Germany:
Specific DNA binding by the protein encoded by the ret-
roviral oncogene v-myb.
Peters, C.W.B., Sippel, A.E., Vingron, M., Klempnauer, K.-
H., ZMBH, University of Heidelberg, Federal Republic of
Germany: Drosophila and vertebrate myb proteins share
two conserved regions, one of which binds DNA.
Ibanez, C.E.,' Lipsick, J.S.,1.2 'Dept. of Pathology, Univer-
sity of California School of Medicine, 2Veteran's Adminis-
tration Medical Center, San Diego: Nuclear transport of
wild-type and mutant v-myb oncogene products.
Bordereaux, D., Fichelson, S., So la, B., Tambourin, P., Gis-
selbrecht, S., INSERM, HOpital Cochin, Paris, France:
fim-3-A third integration region of Fr-MLV in myeloblas-
tic leukemias.
Tainsky, M.A., Chiao, R, Yim, S.O., Dept. of Tumor Biology,
M.D. Anderson Hospital and Tumor Institute, University
of Texas System Cancer Center, Houston: A human cell
system for functional analysis of human oncogenes.
Niman, H.L.,' Liu, C.-H.,2 Ludwig, D.,2 Stuenkel, C.A.,2
Houghten, R.A.,1 Yen, S.S.C.,2 'Dept. of Molecular Biol-
ogy, Research Institute of Scripps Clinic, La Jolla, 2Dept.
of Reproductive Medicine, University of California, San
Diego: Sex-associated oncogene- and growth-factor-re-
lated proteins in newborn and maternal urine.
Niman, H.L., Dept. of Molecular Biology, Research Institute
of Scripps Clinic, La Jolla, California: Expression of onco-
gene-related proteins in human tumor extracts.
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Zarbi, H.,' Latreille, J.,2 Jolicoeur, P.,' 'Clinical Research
Institute of Montreal, 'Hotel Dieu Hospital, Quebec, Can-
ada: Isolation of revertants from v-fos-transformed fibro-
blasts.
Dang, C.,1 van Dam, H.,2 Lee, W.,"Cancer Research In-
stitute, Dept. of Medicine, University of California, San
Francisco; 2Sylvius Laboratory, University of Leiden, The
Netherlands: Regions of human c-myc protein specifying
its nuclear location, DNA binding, and transformation
ability.
Farina, S.F., Heaney, M.L., Huff, J.L., Parsons, J.T., Dept. of
Microbiology, University of Virginia School of Medicine,
Charlottesville: Analysis of structurally altered gag-myc
proteins.
Cleveland, J.,' Huleihel, M.,' Bressler, P,2 Sieben list, U.,2
Rapp, U.,' National Institutes of Health, 'LVC, NCI,
2LIR, Bethesda, Maryland: Role of myc in the expression
regulation of myc family proto-oncogenes.
Bender, TP.,' Thompson, C.B.,2 Kuehl, W.M.,"NCI, Be-
thesda, Maryland; 2Howard Hughes Institute, University
of Michigan, Ann Arbor: Differential expression of c-myb
mRNA is regulated by a block to transcription elongation
and is associated with different patterns of chromatin
DNase hypersensitivity in murine B lymphoid tumors.
SESSION 8 TRANS-ACTIVATION
Chairmen: I.S.Y. Chen, University of California, Los Angeles
C. Rosen, Dana-Farber Cancer Institute
Yoshida, M., Inoue, J., Fujisawa, J., Seiki, M., Cancer Insti-
tute, Tokyo, Japan: pX sequences of HTLV-I confer tran-
scriptional and posttranscriptional regulations for the viral
gene expression.
Cann, A.J., Wachsman, W., Chen, I.S.Y., Division of Hema-
tology-Oncology, University of California School of Medi-
cine, Los Angeles: Mechanism of trans-activation by the
HTLV x protein.
Rosenblatt, J.D., Cann, A.J., Shah, N.P., Wachsman, W.,
Smalberg, I., Chen, I.S.Y., Division of Hematology-Oncol-
ogy, University of California School of Medicine, Los An-
geles: The alternate open reading frame of HTLV-II pX
gene mRNA encodes an inhibitor of trans-activation.
Shimotohno, K., Takano, M., Ohta, M., Shima, H., Akagi, T,
Nyunoya, H., Okamoto, T, Sugimura, R., National Can-
cer Center Research Institute, Tokyo, Japan: Structure
and function of the x gene products of HTLV.
Wachsman, W.,' Nyborg, J.K.,2 Chen, I.S.Y.,' Dynan,
W.S.,2 'Division of Hematology-Oncology, University of
California School of Medicine, Los Angeles; 2Dept. of
Chemistry and Biochemistry, University of Colorado,
Boulder: Specific binding of nuclear factors to the HTLV-I
LTR-Implications for proviral trans-activation.
Boros, I., Jeang, K.-T, Giam, C.Z., Brady, J., Khoury, G.,
Laboratory of Molecular Virology, NCI, NIH, Bethesda,
Maryland: Identification of cellular proteins interacting
with specific regions of the HTLV-I LTR.
Yoshinaka, Y.,' Katoh, 1.,2 Ikawa, Y.,2 'Japan lmmunore-
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Kanter, M.R.," Smith, R.E.,2 Hayward, W.S.,' Memorial
Sloan-Kettering Cancer Center, New York, New York;
2Colorado State University, Fort Collins: Rapid tumor in-
duction by integration of EU-8 virus into the chicken c-
myb locus.
Fulton, R.,' Onions, D.,2 McFarlane, R.,' Tzavaris, T,'
Stewart, M.,' Neil, J.C.,"Beatson Institute for Cancer
Research, Bearsden, 2Dept. of Veterinary Pathology,
University of Glasgow, Scotland: Retroviral transduction
of T-cell antigen receptor (3-chain and myc genes.
Gisselbrecht, S., Fichelson, S., So la, B., Bordereaux, D.,
Tambourin, P., INSERM, HOpital Cochin, Paris, France:
Transcriptional activation of the fim-2 gene by retroviral
integration in murine myeloblastic leukemias.
Dickson, C., Smith, R., Moore, R., Thurlow, J., Peters, G.,
Imperial Cancer Research Fund, London, England: Tran-
scriptional complexity and differential expression of the
int-2 gene in embryonal carcinoma cells and MMTV-in-
duced mammary tumors.
Isfort, R., Lunsford, D., Schultz, A., Blair, D., !hie, J.N., NCI-
Frederick Cancer Research Facility, Frederick, Maryland:
Chromosomal rearrangement and Mo-MLV insertional
activation of the c-rasH locus in a T-cell lymphoma.
search Laboratories Co., Ltd., Takasaki, 2Laboratory of
Molecular Oncology, Tsukuba Life Science Center, Ja-
pan: trans-Activator and LTR-binding proteins of BLV-in-
fected cells.
Okamoto, Akagi, T.,' Shima, H.,' Josephs, S.F.,2
Arya, S.K.,2 Benter, T.,2 Shimotohno, K.,' Miwa, M.,'
Wong-Staal, F.,2 Sugimura, T.,"National Cancer Center
Research Institute, Tokyo, Japan; 2NCI, Bethesda, Mary-
land: Super-trans-activation of HTLV-III expression by a
transcription factor induced in HTLV-I-transformed cells.
Cullen, B.R., Hauber, J., Dept. of Molecular Genetics, Hoff-
mann-La Roche, Nutley, New Jersey: Mechanism of ac-
tion of the HIV trans-acting gene product tat.
Rosen, C.,' Terwilliger, E.,' Sodroski, J.,' Haseltine, W.,2
'Laboratory of Biochemical Pharmacology, Dana-Farber
Cancer Institute, 2Dept. of Cancer Biology, Harvard
School of Public Health, Boston, Massachusetts: Selec-
tive regulation of HIV/HTLV-III gene expression by the art
gene product is dependent on positive and negative in-
tragenic elements,
Wright, C.M., Felber, B.K., Tse, A., Pavlakis, G.N., NCI-
Frederick Cancer Research Facility, Frederick, Maryland:
cis- and trans-acting sequences involved in the trans-acti-
vation of HIV.
Viglianti, G.A., Mullins, J.I., Dept. of Cancer Biology, Har-
vard School of Public Health, Boston, Massachusetts:
Differential requirements for trans-activation by STLV-III/
HTLV-IV and HIV -I.
J. Coffin
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Rosen, C.,' Park, R.,' Sodroski, J.,' Haseltine, W.,2
'Dana-Farber Cancer Institute, Dept. of Pathology, Har-
vard Medical School, 2Dept. of Cancer Biology, Harvard
School of Public Health, Boston, Massachusetts: Nuclear
factors bind to HTLV-I LTR sequences responsive to the
HTLV-I tat gene product.
Giam, C.Z., NCI, National Institutes of Health, Bethesda,
Maryland: Purification and characterization of the HTLV-I
p4Ox protein overproduced in E. coli.
Derse, D., NCI-Frederick Cancer Research Facility, Freder-
ick, Maryland: Regulation of BLV gene expression by
p38(X-BL) and p18(X-BL).
Ferguson, B., Strehl, L., Bache ler, L., Hendrickson, E., Ray-
ner, M., Colberg-Poley, A., Whealy, M., Ruger, R., Enqu-
ist, L., Petteway, S., E.I. du Pont de Nemours & Co., Wil-
mington, Delaware: HIV tat/LTR-mediated control of gene
expression.
Felber, B.K., Cladaras, C., Cladaras, M.H., Pavlakis, EN.,
NCI-Frederick Cancer Research Facility, Frederick, Mary-
land: Splicing regulation of HIV.
Terwilliger, E.,1 Campbell, K.,' Sodroski, J.," Haseltine,
W.,2 Rosen, C.,' 'Dana-Farber Cancer Institute, Dept. of
Pathology, Harvard Medical School, 2Dept. of Cancer Bi-
ology, Harvard School of Public Health, Boston, Massa-
chusetts: Replication and cytopathic potential of HIV pro-
viruses with art gene mutations.
Bohan, C., York, D., Srinivasan, A., Division of Viral Dis-
eases, Centers for Disease Control, Atlanta, Georgia: Ac-
tivation of HIV-LTR-directed expression by tumor pro-
moter, corticosteroids, and sodium butyrate.
Bohan, C.,' Luciw, P.,2 Srinivasan, A.,"Division of Viral
Diseases, Centers for Disease Control, Atlanta, Georgia;
2University of California, Davis: trans-Activation of HIV by
herpesviruses-Mutational approach to identify the target
sequences.
Hess, J.L., Small, J.A., Clements, J.E., Depts. of Neurology
and Molecular Biology, Johns Hopkins University School
of Medicine, Baltimore, Maryland: Mutational analysis of
sequences controlling visna virus transcription and re-
sponse to viral trans-activation.
Mazarin, B., Gourdou, I., Querat, G., Sauze, N., Vigne, R.,
Faculte de Medicine, Marseille, France: Transcription of
visna virus during its lytic cycle-Evidence for a sequen-
tial early and late gene expression.
Dorn, P.L., Casey, J.W., Derse, D., NCI-Frederick Cancer
Research Facility, Frederick, Maryland: Identification of
EIAV LTR sequences that mediate virus-specific trans-ac-
tivation.
Thielan, B.J.,' Hunter, E.,2 Desrosiers, R.C.,3 Ratner, L.,'
"Depts. of Medicine and Microbiology and Immunology,
Washington University, St. Louis, Missouri; 2Dept. of Mi-
crobiology, University of Alabama, Birmingham; 3Dept.
of Microbiology, New England Primate Research Center,
Southborough, Massachusetts: trans-Activation of LTR-
sequence-mediated gene expression is not a property of
type-D retroviral replication.
Albert, J.,' Bredberg, U.,2 Chiodi, F.,' Bottiger, B.,2
Fenyo, E.M.,' Ljunggren, K.,' Norrby, E.,' Biberfeld,
G.,2 Dept. of Biology, Karolinska Institute, 2Dept. of Im-
munology, National Bacteriological Laboratory, Stock-
holm, Sweden: Immunological and biological characteris-
tics of four West African HIV isolates.
Jendis, J.B.,1 Bachi, T.,2 SchOpbach, J.,"Swiss Retrovi-
rus Reference Laboratory, 2lnstitute of Immunology and
Virology, University of Zurich, Switzerland: Characteriza-
tion of a novel human retrovirus isolated from a healthy
Swiss blood donor.
239
Chiodi, F, Feny6, EM., Albert, J., AsjO, B., Dept. of Virol-
ogy, Karolinska Institute, Stockholm, Sweden: HIV iso-
lates differ in replication potential in vitro.
Clouse, K.A.,1 Justement, J.,2 Weck, K.,2 Rabson, A.,2 Li-
nette, J.,' Fauci, A.S.,2 Folks, T.M.,2 'Georgetown Uni-
versity, Washington, D.C.; 2NCI, National Institutes of
Health, Bethesda, Maryland: Cytokine regulation of HIV
expression in a chronically infected promonocyte clone.
Rasheed, S.,' Norman, G.L.,' Su, S.,' Gill, P.S.,2 Levine,
A.,2 Depts. of 'Pathology, 2lnternal Medicine, University
of Southern California School of Medicine, Los Angeles:
High expression of HIV-p24 protein and lack of anti-p24
antibodies as predictors for the development of AIDS.
Pavlakis, G.N., Felber, B.K., NCI-Frederick Cancer Re-
search Facility, Frederick, Maryland: A simple quantita-
tive assay for the detection of infectious HIV.
Jacquemin, P., Dept. of Virology, Institut Pasteur du Bra-
bant, Brussels, Belgium: Enhanced membrane expres-
sion of an endogenous glycoprotein with reverse-tran-
scriptase-related antigenic determinants in HTLV- and
HIV-infected cells.
Hirsch, V., Riedel, N., Kornfeld, H., Mullins, J.I., Dept. of
Cancer Biology, Harvard School of Public Health, Bos-
ton, Massachusetts: Genome organization of STLV-IIIA,Gm.
Overbaugh, J.M.,' Hoover, E.A.,2 Quackenbush, S.L.,2
Donahue, P.R.,' Mullins, "Dept. of Cancer Biology,
Harvard School of Public Health, Boston, Massachusetts;
2Dept. of Pathology, Colorado State University, Fort Col-
SESSION 10 TISSUE-SPECIFIC EXPRESSION
Chairmen: A.M. Skalka, Roche Institute of Molecular Biology
J.M. Coffin, Tufts University School of Medicine
Embretson, J.E., Temin, H.M., McArdle Laboratory for Can-
cer Research, University of Wisconsin, Madison: The 5'
LTR of SNV-derived vectors is not transcribed in mouse
cells when a 3' SNV is present.
Arrigo, S., Carlberg, K., Ryden, T., Beemon, K., Dept. of Bi-
ology, Johns Hopkins University, Baltimore, Maryland:
Regulatory element(s) within the ASV genome.
S. Hughes, M. Federspiel
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lins: Feline AIDS viruses exhibit a spectrum of pathogenic
effects in vitro and in vivo.
Hoover, E.A.,' Mullins, J.I.,2 Quackenbush, S.L.,' Over-
baugh, J.M.,2 Donahue, P.R.,2 'Dept. of Pathology, Col-
orado State University, Fort Collins; 2Dept. of Cancer Bi-
ology, Harvard School of Public Health, Boston,
Massachusetts: Molecularly cloned FeLVs induce the fa-
tal immunodeficiency syndrome and are T-cell-cytopathic
in vitro.
Poss, M.L.,' Hoover, E.A.,' Mullins, J.i.,2 'Dept. of Pathol-
ogy, Colorado State University, Fort Collins; 2Dept. of
Cancer Biology, Harvard School of Public Health, Bos-
ton, Massachusetts: Analysis of feline AIDS virus glyco-
proteins.
Bile llo, J.A., Tracey, E., Benjers, B., Hoffman, P.M., VA Med-
ical Center and University of Maryland, Baltimore: Effects
of AZT on the replication of Cas-Br-M MLV in vitro and in
vivo.
Goudsmit, J.,' Smit, L.,' Gibbs, C.J., Jr.,2 Asher, D.M.,2
Gajdusek, D.C.,2 'Academic Medical Center, Amster-
dam, The Netherlands; 2NINCDS, National Institutes of
Health, Bethesda, Maryland: HIV induces antibodies in-
hibiting CD4-dependent cell fusion by HIV glycoprotein
in experimentally infected chimpanzees.
Lower, J., L6wer, R., Kurth, R., Paul-Ehrlich-Institut, Frank-
furt, Federal Republic of Germany: Correlation between
expression of HTDV and state of differentiation in cell
lines established from human germ-cell tumors.
Lenz, J., Okenquist, S., Short, M., Boral, A., Cupelli, L.,
Morrison, H., Dept. of Genetics, Albert Einstein College
of Medicine, Bronx, New York: Cell-type-specific tran-
scription from MLV LTRs in leukemogenesis.
Golemis, E.,' Li, Y.,' Hartley, J.W.,2 Hopkins, N.,"Center
for Cancer Research, Massachusetts Institute of Technol-
ogy, Cambridge; 2National Institutes of Health, Be-
thesda, Maryland: Disease specificity of MLVs.
Gorska-Flipot, I.,' Rassart, E.,2 Jolicoeur, P.,1 'Clinical Re-
search Institute of Montreal, 2Universite du Quebec,
Canada: Nuclear factors interacting with the LTR of lym-
photropic and fibrotropic MLV.
Buetti, E., KOhnel, B., Sossi, T, Diggelmann, H., Swiss Insti-
tute for Experimental Cancer Research, Epalinges, Swit-
zerland: Regulation of transcription in MMTV and func-
tional relationships between control elements.
Ball, J.K.,' Diggelmann, H.,2 Grossi, G.F.,2 'Dept. of Bio-
chemistry, University of Western Ontario, London, Can-
ada; 2Swiss Institute for Experimental Cancer Research,
Lausanne, Switzerland: Type-B retroviruses associated
with nonmammary gland tumors have alterations in the
U3 region of the LTR.
Hsu, C.-L.L., Fabritius, C., Dudley, J., Dept. of Microbiol-
ogy, University of Texas, Austin: Structure and function of
MMTV LTR variants in T-cell lymphomas.
Grez, M., Hilberg, F., Ostertag, W., Heinrich-Pette-Institut,
Abteilung Zellbiologie, Hamburg, Federal Republic of
Germany: Retroviral gene expression in embryonal carci-
noma cells.
Valerio, D., Li, C.L, Wamsley, P.M., Verma, I.M., Salk Insti-
tute, San Diego, California: Retroviral vectors with recom-
binant LTRs.
SESSION 11 PATHOGENESIS
Anklesaria, P., Sakakeeny, M., Greenberger, J., Holland, C.,
Dept. of Radiation Oncology, University of Massachusetts
Medical School, Worcester: Enhancer sequences of a ret-
roviral vector augment gene transfer to multipotent he-
matopoietic progenitors.
Chairmen: S. Ruscetti, National Cancer Institute
P. Jolicoeur, Clinical Research Institute of Montreal
Crittenden, L.B., Salter, D.W., USDA-ARS Regional Poultry
Research Laboratory, East Lansing, Michigan: Artificial
insertion of avian leukosis proviruses into the chicken
germ line.
Brown, D.W., Robinson, H.L., Worcestor Foundation for Ex-
perimental Biology, Shrewsbury, Massachusetts: Analysis
of recombinants of RAV-0 and RAV-1 for associated pa-
thology and tissue tropism.
Brightman, B.K.,' Chandy, K.G.,2 Gupta, S.,2 Pattengale,
P.K.,3 Fan, H.,' Depts. of 'Molecular Biology and Bio-
chemistry, 2Medicine, University of California School of
Medicine, Irvine; 3Dept. of Pathology, University of
Southern California School of Medicine, Los Angeles:
Characterization of lymphoid tumors induced by a re-
combinant murine retrovirus carrying the avian v-myc on-
cogene- Identification of a novel lymphoid cell type.
Green, PL., Kaehler, D.A., Risser, R., McArdle Laboratory
for Cancer Research, University of Wisconsin, Madison:
Cell transformation and tumor induction by helper-virus-
free A-MuLV.
Poirier, Y., Savard, P., Jolicoeur, P., Clinical Research Insti-
tute, Montreal, Canada: Abelson lymphomas-Role of
the helper virus and identification of a common proviral
integration site in these tumors.
Chung, S.-W., Wong, P.M.C., Ruscetti, S., NCI, National In-
stitutes of Health, Bethesda, Maryland: Murine embry-
onic multipotent hematopoietic progenitors are targets for
Abelson virus.
Wolff, L., Ruscetti, S., NCI, National Institutes of Health, Be-
thesda, Maryland: The envelope gene of the SFFV, when
introduoed into mice in the absence of other SFFV genes,
induces an acute erythroleukemia.
Sitbon, M.,' d'Auriol, L.,2 Perryman, 5.,3 Nishio, J.,3
Wehrly, K.,3 Galibert, F.,2 Chesebro, B.,3 'INSERM,
HOpital Cochin, 2Centre Hayem, H6pital Saint-Louis,
Paris, France; 3National Institutes of Health, Rocky
Mountain Laboratories, Hamilton, Montana: A single
base-pair change in the leader sequence of the env gene
is responsible for the lower level of hemolytic anemia in-
duced by some strains of Fr-MLV.
Bovenhoff, M.E., de Groene, E.M., Visser, T.P., Dorssers, L.
Wagemaker, G., Radiobiological Institute TNO, Rijswijk,
The Netherlands: Effect of replication-defective Friend vi-
rus on hematopoietic cell differentiation in genetically de-
fective W/WY mice.
Holland, C.A.,' Chattopadhyah, S.,2 Thomas, C.,3
Koehne, C.,. O'Donnell, PV.,4 'Dept. of Radiation Oncol-
ogy, University of Massachusetts Medical School,
Worcester; 2NIAID, National Institutes of Health, Be-
thesda, Maryland; 3University of Virginia, Charlottesville;
4Memorial Sloan-Kettering Cancer Center, New York,
New York: Localization of the lesion that blocks the accel-
eration of leukemia in AKR mice by an MCF virus.
Fan, H., Davis, B.R., Brightman, B.K., Dept. of Molecular
Biology and Biochemistry, University of California, Irvine:
Evidence for two infection events in leukemogenesis by
Mo-MLV.
Tsichlis, P.N., Shinton, S., Fox Chase Cancer Center, Phila-
delphia, Pennsylvania: Provirus integration and clonal
cell growth in the early and late states of Mo-MLV-in-
duced lymphomagenesis in the rat.
SESSION 12 POSTER SESSION: TISSUE-SPECIFIC EXPRESSION, PATHOGENESIS
Manley, N.,' Mbangkollo, D.,' Hartley, J.W.,2 Hopkins,
N.,' 'Center for Cancer Research, Massachusetts Insti-
tute of Technology, Cambridge; 2NCI, National Institutes
of Health, Bethesda, Maryland: Disease specificity of
MLVs- Differences in cellular protein-binding sites in the
region responsible for targeting.
Runnels, J., Rosenberg, N., Dept. of Pathology, Tufts Uni-
versity Medical School, Boston, Massachusetts: M-MuLV
immortalizes B cells in vitro.
Rassart, E.,' Bergeron, R.,' Paquette, Y,2 Jolicoeur, P.,2
'Dept. Sciences Biologiques, Universite du Quebec,
2lnstitut de Recherches Cliniques de Montreal, Canada:
Mapping the viral determinant blocking the replication of
the BL /VL3 RadLV on fibroblasts.
White, J.H., McCune, J.M., Weissman, I.L., Kaneshima, H.,
Sen Majumdar, A., Lieberman, M., Stanford University
School of Medicine, California: Tissue-specific expression
driven by the RadLV LTR.
Sen Majumdar, A., Kaneshima, H., White, J.H., Weissman,
I.L., Leiberman, M., Stanford University School of Medi-
cine, California: Monoclonal antibodies against radiation-
induced lymphomas of C57BL/Ka mice.
Kaneshima, H., Sen Majumdar, A., Heimfeld, S., Okada,
C.Y., Weissman, I.L., Leiberman, M., Stanford University
School of Medicine, California: Establishment of culture
conditions to study preleukemic thymocytes from irradi-
ated C57BL/Ka mice.
King,S.R.,"Berson,B.J.,2Risser, R.,2 'Dept. of Immunology
and Microbiology,Wayne State University,Detroit, Michigan;
2McArdle Laboratory for Cancer Research,University of
Wisconsin, Madison: Functional analysis of the germ-line
ecotropic murine leukemia provirus of C57BL/6 mice.
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Chung, S.-W., Wolff, L., Ruscetti, S., NCI, National Institutes
of Health, Bethesda, Maryland: Sequences responsible
for the altered Epo responsiveness of SFFVp-infected
cells are localized to a 120-bp transmembrane portion at
the carboxyl terminus of the envelope gene.
Nagasu, N., Amanuma, H., Ikawa, Y., Institute of Physical
and Chemical Research, Ibaraki, Japan: Reconstructed,
nonleukemogenic Fr-SFFV recovers its leukemogenicity
in 2 months when injected into newborn mice.
Pinter, A., Honnen, W., Sarafoglue, V., Laboratory of Retro-
viral Biology, Public Health Research Institute, New York,
New York: Characterization of secreted gene products of
Fr-SFFV involved in leukemogenesis.
Friedrich, R.W., Koch, W., von Maydell, U., Schrewe, H., In-
stitute of Medical Virology, University of Giessen, and In-
stitute of Immunobiology, University of Freiburg, Federal
Republic of Germany: Nucleotide sequence of the Fr-
MLV genome.
Geib, R.W., Seaward, M.B., Stevens, M.L., Dept. of Microbi-
ology, Terre Haute Center for Medical Education, Indiana
University School of Medicine: Studies on EY10/B6-A
strain of Friend virus adapted to replicate in resistant
mice.
Stoye, J.P., Coffin, J.M., Tufts University School of Medi-
cine, Boston, Massachusetts: Genetics of endogenous
MLVs.
Morrey, J.D., Evans, L.H., National Institutes of Health,
Rocky Mountain Laboratories, Hamilton, Montana: Analy-
sis of different populations of polytropic viruses induced
by Friend and Moloney MLVs.
Kahn, A.S., Theodore, TS., NIAID, National Institutes of
Health, Bethesda, Maryland: The mouse genome con-
tains at least two distinct LTR progenitors to MCF MLVs.
Ch'ang, L. -Y.,1 Myer, FE.,2 Yang, D.M.,2 Koh, C.K.,2 Yang,
W.K.,2 'Dept. of Microbiology, University of Tennessee,
Knoxville; 2Biology Division, Oak Ridge National Labora-
tory, Tennessee: Promoter and enhancer elements in the
LTRs of endogenous MLV-related proviral genes.
Nikbakht, K.N., Yang, D.M., Ch'ang, L.-Y., Yang, W.K., Biol-
ogy Division, Oak Ridge National Laboratories, Dept. of
Microbiology, University of Tennessee, Knoxville: Func-
tional characterization of a mouse endogenous MLV-re-
lated proviral DNA clone stably transfected into a human
fibrosarcoma cell line.
Policastro, P.F., Fredholm, M., Wilson, M.C., Dept. of Molec-
ular Biology, Research Institute of Scripps Clinic, La Jolla,
California: Structure and dispersion of replication-defec-
tive, but transcribed, endogenous retroviral loci.
Kiessling, A.A.,' Crowell, R.C.,' Connell, R.S.,2 "Dept. of
Obstetrics and Gynecology, Harvard Medical School,
Boston, Massachusetts; 2Dept. of Anatomy, Oregon
Health Sciences University, Portland: Retroviral particles
in the male reproductive tract of mice are sperm-associ-
ated.
Voytek, P., Kozak, C., NCI, National Institutes of Health, Be-
thesda, Maryland: Isolation and partial characterization
of a novel MLV from the wild-mouse species M. hortu-
lanus.
Riedel, N.,1 Hoover, E.A.,2 Dornsife, R.E.,2 Overbaugh,
J.M.,1 Mullings, J.I.,"Dept. of Cancer Biology, Harvard
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School of Public Health, Boston, Massachusetts; 2Dept.
of Pathology, Colorado State University, Fort Collins:
Pathogenic and host-range determinants of the feline
aplastic anemia retrovirus.
Spodick, D.A.,' Ghosh, A.K.,2 Parimoo, S.,2 Roy-Burman,
P.,1,2 Depts. of 'Biochemistry, 2Pathology, University of
Southern California School of Medicine, Los Angeles:
Variability within U3 sequences of endogenous feline
RD114 LTRs.
Berry, B.T.,1 Spodick, D.A.,2 Roy-Burman, P.,1,2 Depts. of
'Pathology, 2Biochemistry, University of Southern Califor-
nia School of Medicine, Los Angeles: Structural and func-
tional characterization of endogenous FeLV LTRs.
Rhoads, D.,1,2 Kiessling, A.,2 Kirsch, K.,1'2 Isselbacher,
Gattoni-Celli, S.,1 2 'Harvard Medical School,
2G1 Unit, Massachusetts General Hospital, Boston: Hu-
man endogenous retroviral sequences-Expression in
human colon tumors and characterization of a cDNA
clone.
Boyce-Jacino, M., Resnick, R., Faras, A., Institute of Hu-
man Genetics and Dept. of Microbiology, University of
Minnesota, Minneapolis: Analysis of the LTRs and other
regulatory elements of the avian endogenous retrovirus
family identified in EV -O line chickens.
Vaidya, A.B., Morrisey, J.M., Connors, R.W., Long, C.A.,
Hahnemann University, Philadelphia, Pennsylvania: Neg-
ative regulation of MMTV LTR-linked genes in a mam-
mary epithelial cell line from the C57BL strain.
Heeney, J.L.,1 Valli, V.E.O.,2 1NCI-Frederick Cancer Re-
search Facility, Frederick, Maryland; 2Dept. of Pathology,
University of Guelph, Canada: Genotypic and phenotypic
characteristics of BLV lymphomas reflect alterations in
humoral immunity.
Lagarias, D., Grossman, D., Adamson, L., Radke, K., Dept.
of Avian Sciences, University of California, Davis: Early
responses of sheep to infection by BLV.
Steiner, B., Johnson, K., Aronoff, R., Linial, M., Fred Hutch-
inson Cancer Center, Seattle, Washington: Characteriza-
tion of retrovirus-generated processed pseudogenes.
C. Holland, R. Risser
SESSION 13 IMMUNODEFICIENCY VIRUSES
Chairmen: J.I. Mullins, Harvard School of Public Health
P.J. Kanki, Harvard School of Public Health
Strebel, K.,' Daugherty, D.F.,2 Folks, TM.,3 Clouse, K.A.,4
Martin, M.A.,' Laboratories of 'Molecular Microbiology,
2Immunoregulation, NIAID, National Institutes of Health,
Bethesda, Maryland; 'University of Michigan, Ann Ar-
bor; 4Georgetown University, Washington, D.C.: Func-
tional analysis of the HIV A (sor) gene product.
Dayton, A.I.,' Potz, J.,1 Dorfman, T.,1 Walker, B.,2 Hasel-
tine, W.A.,' Dana-Farber Cancer Institute,
'Massachusetts General Hospital, Boston: HIV requires
the integrase gene for normal viral replication.
Kowalski, M.,' Potz, J.,' Rosen, C.,' Terwilliger, E.,' Basi-
ripour, L.,' Goh, W.C.,1 Dayton, A.,' Haseltine, W.,2
Sodroski, J.,"Dept. of Pathology, Dana-Farber Cancer
Institute, Harvard Medical School, 'Dept. of Cancer Biol-
ogy, Harvard School of Public Health, Boston, Massachu-
setts: Structural and functional studies of the HIV enve-
lope glycoprotein.
Somasundaran, M., Robinson, H.L., Worcester Foundation
for Experimental Biology, Shrewsbury, Massachusetts:
Cytopathic effects of HIV do not correlate necessarily
with cell fusion.
Koyanagi, Y.,1 Miles, S.,' Mitsuyasu, R.T.,' Merrill, J.E.,2
Vinters, H.V.,3 Chen, I.S.Y.,1 Depts. of 'Medicine,
'Neurology, 'Neuropathology, University of California
School of Medicine, Los Angeles: Dual infection of the
CNS by HIV with distinct cellular tropisms.
Emerman, M., Guyader, M., Sonigo, P., Clavel, F, Montag-
Yeast Cell Biology
nier, L., Alizon, M., Institut Pasteur, Paris, France: Analy-
sis of HIV-2.
Kanki, FJ.,' M'Boup, 5.,2 Barin, F.,' Denis, F.,4 Essex,
M.,"Harvard School of Public Health, Boston, Massa-
chusetts; 'University of Dakar, Senegal; 'University of
Tours, 4University of Limoges, France: HTLV-IV and
HTLV-III/HIV in West Africa.
Kong, L.,' Lee, S.-W.,' Hahn, B.H.,' Kanki, P.J.,2 Essex,
M.,2 Shaw, G.M.,"University of Alabama, Birmingham;
'Dept. of Cancer Biology, Harvard School of Public
Health, Boston, Massachusetts: Isolation and molecular
characterization of a new human retrovirus from West Af-
rica.
Kornfeld, H., Riedel, N., Viglianti, G., Hirsch, V., Mullins,
J.I., Dept. of Cancer Biology, Harvard School of Public
Health, Boston, Massachusetts: HTLV-IV and its relation-
ship to STLVs and HIVs.
Kanki, P.J.,' Eichberg, J.,2 Dreesman, G.,2 Essex, M.,'
'Harvard School of Public Health, Boston, Massachu-
setts; 'Southwest Foundation of Biomedical Research,
San Antonio, Texas: STLV- IIIAGM- induced immuno-
suppression in macaques and baboons.
Donahue, PR.,' Hoover, E.A.,2 Overbaugh, J.M.,' Quack-
enbush, S.L.,2 de Noronha, C.M.C.,' Mullins, J.I.,'
'Harvard School of Public Health, Boston, Massachu-
setts; 'Colorado State University, Fort Collins: Patho-
genic determinants of the feline AIDS virus.
August 11-August 16
ARRANGED BY
Amer Klar, Cold Spring Harbor Laboratory
Paul Nurse, Imperial Cancer Research Fund
Randy W. Schekman, University of California, Berkeley
268 participants
The main meeting of Yeast Genetics and Molecular Biology was previously held
every other year at Cold Spring Harbor Laboratory. The success of these meetings
contributed to the speed with which this field has progressed. However, there was
a price to pay for this success. The Cold Spring Harbor facilities could no longer
accommodate all of the applicants who wished to attend the proceedings, and so
the main meeting will now be held elsewhere. Nevertheless, it was decided that a
meeting on a yeast subtopic would be appropriate for the laboratory to continue
with in the future in alternate years. This year's topic was Yeast Cell Biology. The
areas of cell-cycle controls, developmental choices, cytoskeleton and cell structure,
protein secretion and targeting were emphasized. The meeting was very success-
ful; it was a universal consensus of the participants that such a meeting should be
continued at Cold Spring Harbor Laboratory.
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This meeting was supported in part by the Anheuser-Busch Companies;
Gist-Brocades NV; Labatt Brewing Company Ltd.; Miller Brewing Company; Stroh
Brewery Company; and ZymoGenetics, Inc.
SESSION 1 CYTOSKELETON
Chairman: J. Pringle, University of Michigan
Adams, A., Botstein, D., Dept. of Biology, Massachusetts
Institute of Technology, Cambridge: Genetic analysis of
the actin-based cytoskeleton of yeast.
Drubin, D., Botstein, D., Dept. of Biology, Massachusetts
Institute of Technology, Cambridge: Identification of yeast
actin-binding proteins-Evidence for in vivo interactions.Liu, H., Bretscher, A., Section of Biochemistry, Molecular
and Cell Biology, Cornell University, Ithaca, New York:
Purification and characterization of a tropomyosin-like
protein from S. cerevisiae and cloning of its gene.
Wertman, K.F., Drubin, D., Botstein, D., Dept. of Biology,
Massachusetts Institute of Technology, Cambridge:
Myosin-like molecules in S. cerevisiae.
Katz, W., Solomon, F., Massachusetts Institute of Technol-
ogy, Cambridge: Molecular analysis of tubulin function.
Schroeder-Lorenz, A.,' Marks, J.,2 Hyams, J.,2 Fantes,P.,1 'Dept. of Zoology, University of Edinburgh, Scotland;2Dept. of Botany and Microbiology, University College,
London, England: Ben4 mutations of S. pombe interact
with the actin and p-tubulin genes.
Uno, I., Ishikawa, T., Institute of Applied Microbiology, Uni-
versity of Tokyo, Japan: Regulation of cytoskeletal struc-ture by cAMP cascade.
Schmitt, H.D., Wagner, P., Haubruck, H., Gallwitz, D., Dept.
of Molecular Genetics, Max-Planck Institute for Biophysi-
cal Chemistry, Gottingen, Federal Republic of Germany:
The ras-related YPT protein in yeast-Mutations affect the
regulation of intracellular Ca* + and cause cytoskeletallesions.
SESSION 2 ORGANELLE STRUCTURE, INTERACTIONS, AND DYNAMICS
Chairman: E. Jones, Carnegie Mellon University
Shio, H., Small, G.M., Lazarow, P.B., Rockefeller University,New York, New York: Immunofluorescence detection of
one or a few tiny peroxisomes in all glucose-repressed
Candida tropicalis cells.
Wright, R.M., Poyton, R.O., Dept. of Molecular, Cellular and
Developmental Biology, University of Colorado, Boulder:
Intergenomic signaling in yeast.
Segev, N., Botstein, D., Dept. of Biology, Massachusetts In-
stitute of Technology, Cambridge: The yeast RAS-related
gene, YPT1, is involved in bud growth and secretion.
Franzusoff, A.J., Schekman, R., Dept. of Biochemistry, Uni-
versity of California, Berkeley: Phosphorylation of an es-
sential component of the yeast secretory pathway.
Chappell, T.G., Warren, G., Dept. of Biochemistry, Univer-
sity of Dundee, Scotland: Biogenesis and partitioning of
the Golgi apparatus in S. pombe.
Preston, R.A., Kirkpatrick, D., Jones, E.W., Dept. of Biologi-
SESSION 3 POSTER SESSION
Cytoskeleton
Huffaker, T., Thomas, J., Botstein, D., Dept. of Biology, Mas-
sachusetts Institute of Technology, Cambridge: Role of mi-
crotubules in yeast.
Kim, J.,' Fink, G.,' -2 'Dept. of Biology, Massachusetts Insti-
tute of Technology, 2Whitehead Institute, Cambridge:
Kar -enhancing mutations (kern) in yeast.
Lillie, S.H., Brown, S.S., Dept. of Anatomy and Cell Biology,
University of Michigan, Ann Arbor: Characterization of pu-
tative actin-binding proteins from the yeast S. cerevisiae.
Stearns, T., Botstein, D., Dept. of Biology, Massachusetts In-
stitute of Technology, Cambridge: Visualizing yeast mito-
chondria in vivo-The role of actin and tubulin in organiza-tion and movement.
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cal Sciences, Carnegie Mellon University, Pittsburgh,
Pennsylvania: Characterization of PEPS, an essential
gene required for vacuole biogenesis.
Weisman, L.S., Bacallao, R., Guthrie, B., Wickner, W., Mo-
lecular Biology Institute, University of California, Los An-
geles: Vacuole dynamics in the yeast S. cerevisiae.
Novick, P., Salminen, A., Goud, B., Walworth, N., Yale Uni-
versity School of Medicine, New Haven, Connecticut: A
ras-like GTP-binding protein is required for a post-Golgi
event of the yeast secretory pathway.
Kambouris, N.G.,' Martin, W.H.,' Fromer, E.S.,1 Snyder,
. S.,' Hamman, H.C.,1 Creutz, C.E.,1 Smith, M.M.,2
Depts. of 'Pharmacology, 2Microbiology, University of
Virginia, Charlottesville: Ca* *- dependent membrane-binding proteins from yeast-Possible mediators of exo-
cytosis.
Mating
Chant, J., Herskowitz, I., Dept. of Biochemistry and Biophys-ics, University of California, San Francisco: Mutants with al-tered spatial control of bud initiation.
Cross, F., Fred Hutchinson CancerResearch Center, Seattle,
Washington: Dominant a-factor resistance mutations.Jahng, K.-Y, Ferguson, J., Reed, S., Dept. of Molecular Biol-
ogy, Research Institute of Scripps Clinic, La Jolla, Califor-
nia: Isolation and characterization
of mutations capable of
allowing an ste2-deletion mutant strain to conjugate.
Morgan, B.A., Mittman, B.A., Smith, M.M., Dept. of Microbi-
ology, University of Virginia School of Medicine, Charlottes-
ville: Identification of a histone H4 mutation that affects
mating-type expression.
Whiteway, M., Hougan, L., Thomas, D.Y., NRC Biotechnology
Research Institute, Montreal, Canada: Expression of MFa1
in MATa cells supersensitive to a-factor.
Courchesne, W.E., Kunisawa, R., Thorner, J., Dept. of Bio-
chemistry, University of California, Berkeley: Two genes
(SST2 and SSS1) involved in recovery from pheromone-in-
duced growth arrest in S. cerevisiae.
Cell Cycle
Singer, R.A., Hanic-Joyce, P.J., Johnston, G.C., Faculty of
Medicine, Dalhousie University, Halifax, Nova Scotia, Can-
ada: Distinct effects of prtl mutations on translation and on
control of cell proliferation.
Levin, L., Kuret, J., Powers, S., Michaeli, T, Cameron, S.,
Wig ler, M., Zoller, M., Cold Spring Harbor Laboratory, New
York: Suppression of rase by disruption of subunit interac-
tions of cAMP-dependent protein kinase.
Lisziewicz, J.,' Agoston, D.,2 FOrster, H.H.,' Kuntzel, H.,'
lAbteilung Chemie, Max-Planck-Institut kir experimentelle
Medizin, 2Abteilung Neurochemie, Max-Planck-Institut fur
Biophysikalische Chemie, GOttingen, German Federated
Republic: Overexpression of cAMP-dependent protein ki-
nase in a cdc25 mutant containing a plasmid-amplified
suppressor gene.
Powers, S., Wig ler, M., Cold Spring Harbor Laboratory, New
York: Dominant conditionally lethal RAS2 alleles that inter-
fere with the function of RAS and CDC25 genes.
Kim, W.-J., Jong, A.Y.-S., Dept. of Pediatrics and Microbiol-
ogy, University of Southern California, Davis: Yeast SOC8-1
gene that suppresses cdc8 mutation possesses deoxypyr-
imidine monosphosphate kinase activity.
Baum, P., Goetsch, L., Byers, B., Dept. of Genetics, Univer-
sity of Washington, Seattle: Integration of spindle-pole-
body duplication with cell division by ESP1.
Crouzet, M., Du lau, L., Aigle, M., Laboratoire de Genetique,
University de Bordeaux, Talence, France: Yeast mutants
impaired in stationary-phase entry.
Brizuela, L., Draetta, G., Beach, D., Cold Spring Harbor Lab-
oratory, New York: Physical association between the
cdc2 and the sucl gene products in fission yeast.
Colasanti, J., Bruschi, C.V., Dept. of Microbiology, East Caro-
lina University, Greenville, North Carolina: Molecular analy-
sis of cdc6 gene function in S. cerevisiae.
Draetta, G., Brizuela, L., Beach, D., Cold Spring Harbor Lab-
oratory, New York: Human p34-p13 complex-Structural
homology with p34°.2 and p13...1 cell-cycle regulators of
yeast.
Drebot, M.A., Veinot-Drebot, L.M., Johnston, G.C., Singer,
R.A., Faculty of Medicine, Dalhousie University, Halifax,
Nova Scotia, Canada: Stationary phase is a distinct devel-
opmental state.
Hagan, Riddle, P.,2 Nurse, P.,2 Hyams, J.S.,' University
College London, 2lmperial Cancer Research Fund, Lon-
don, England: The mitotic period of the fission yeast S.
pombe is extended in cells dividing at an increased size
but maintained in cells dividing at a reduced size.
Nagel, A., Muller, I., Institut fOr Entwicklungsphysiologie,
KOIn, Federal Republic of Germany: Inheritance of life
span during the vegetative reproduction of S. cerevisiae.
Martegani, E., Baroni, M.D., Vanoni, M., Frascotti, G., Monti,
P., Alberghina, L., Dipt. di Fisiologie a Biochimica Genera li,
University di Milano, Italy: Characterization of the CDC25
start gene of budding yeast-Functional interrelationship
with the RAS2 gene and modulation of the cell size.
Booher, R., Beach, D., Cold Spring Harbor Laboratory, New
York: Isolation of a temperature-sensitive cdc13 mutation
that supresses a cold-sensitive allele of the cdc2 protein ki-
nase in S. pombe.
Prendergast, J.A., Murray, L.E., Rowley, A., Carruthers, D.R.,
Singer, R.A., Johnston, G.C., Faculty of Medicine, Dalhou-
sie University, Nova Scotia, Canada: New mutations show
that many genes are involved in the regulation of yeast cell
proliferation.
Shalitin, C., Levy, M., Kenoshi, E., Dept. of Biology, Technion-
Israel Institute of Technology, Haifa: Stable binding of yeast
ras-related proteins to DNA as revealed by immunological
cross-reactivities.
Smith, S., Rosamond, J., Dept. of Biochemistry and Molecu-
lar Biology, University of Manchester, England: Character-
ization of a gene whose product is required at two stages
of the yeast cell cycle.
Sporulation and Life Cycle
Fukui, Y., Miyake, S., Yamamoto, M., Institute of Medical Sci-
ence, University of Tokyo, Japan: Genes closely related to
real either functionally or structurally in S. pombe.
Nadin-Davis, S.A., Nasim, A., Division of Biological Sciences,
National Research Council, Ontario, Canada: A putative
protein kinase encoded by the Byrl gene bypasses the
sporulation defect of rasl - fission yeast.
Jakubowski, H., Dept. of Microbiology, UMDNJ-New Jersey
Medical School, Newark: Cell-density-dependent interac-
tions in yeast sporulation.
Watanabe, Y., lino, Y., Furuhata, K., Yamamoto, M., Institute
of Medical Science, University of Tokyo, Japan: mei2 gene
expression and control of meiosis in S. pombe.
245
Secretion and Localization
Jigami, Y.,' lwakura, M.,2 Muraki, M.,' Kioke, T.,3 'National
Chemical Laboratory for Industry, Tsukuba, 2Research In-
stitute for Polymers and Textiles, Tsukuba, 3Rohto Phar-
maceutical Co., Ltd., Osaka, Japan: Participation of the
vacuole-associated process in the secretion of human lyso-
zyme and bacterial DHFR fusion protein in yeast.
Tipper, D.J., Kane, J., Zhu, Y.S., Zang, X.Y., Kang, Y.S., Dept.
of Molecular Genetics and Microbiology, University of Mas-
sachusetts Medical School, Worcester: Use of fl-lactamase
fusions to study processing of killer preprotoxin in S. cere-
visiae.
Silver, P., Chiang, A., Yang, X., Salder, I., Dept. of Biology,
Princeton University, New Jersey: Mutations affecting
GAL4 nuclear localization.
Silveira, L.A., Schekman, R., Dept. of Biochemistry, Univer-
sity of California, Berkeley: Molecular analysis of clathrin
light chain from S. cerevisiae.
Nero, D., Farrell, L.B., Gearing, DR, Braidotti, G., Meltzer,
S., Devenish, R.J., Nag ley, P., Dept. of Biochemistry, Mon-
ash University, Clayton, Victoria, Australia: An imported
version of a hydrophobic protein normally made inside mi-
tochondria correctly assembles into the mitochondrial AT-
Pase complex.
Sutherland, M., Bozzato, R., Allelix, Inc, Biochemicals Divi-
sion, Ontario, Canada: Effects of signal-sequence altera-
tions on the level of protein secretion in yeast.
Sidhu, R.S., Bolton, A.R, Wadley Institutes of Molecular Medi
cine, Dallas, Texas: GAL1-PHO5 gene fusions-An internal
signal sequence can be functional for protein secretion.
Cohen, G., Hartig, A., Ruis, H., Institut WI' Allgemeine Bioch-
emie der Universitat Wien and Ludwig Boltzmann-For-
schungsstelle fur Biochemie, Vienna, Austria: Comparison
of structures of peroxisomal and nonperoxisomal catalases
of S. cerevisiae.
Matoba, S., Fukayama, J., Ogrydziak, D., Institute of Marine
Resources, University of California, Davis: Precursors and
processing of the alkaline extracellular protease of Yar-
rowia lipolytica.
Preuss, D., Botstein, D., Massachusetts Institute of Technol-
ogy, Cambridge: Suppression of mutations in the invertase
signal sequence.
Newman, A., Ferro-Novick, S., Dept. of Cell Biology, Yale
University, New Haven, Connecticut: Characterization of
new mutants in the early part of the yeast secretory path-
way isolated by a [3H]mannose suicide selection.
Li, Y.Y., Qin, N., Zhao, Z.G., Institute of Genetics, Fudan Uni-
versity, Shanghai, People's Republic of China: Expression
of heterologous genes directed by SUC2 promoter-signal
sequence in yeast.
Lehman, D.J., Das, R.C., Kaumeyer, J.F., Biotechnology
Group R&D, Miles Laboratories, Inc., Elkhart, Indiana:
Expression and secretion of human inter-a-trypsin inhibitor-
related polypeptides in S. cerevisiae.
Legrain, M., Portetelle, D., Dumont, J., Burny, A., Hilger, F,
Chaire de Microbiologie, Faculte des Sciences Agrono-
miques de l'Etat, Gembloux, Belgium: Expression of the
gene coding for the BLV envelope glycoprotein gp51 in S.
cerevisiae.
Bielefeld, M., Reipen, G., Hollenberg, C.P., Institut fOr Mikro-
biologie, Universitat Dusseldorf, Federal Republic of Ger-
246
J. Thorner, B. Stillman, J.D. Watson
many: Analysis of the secretory pathway in S. cerevisiae
by SUC2 mutations and fusions.
Dihanich, M.,1 Benz, R.,2 Suda, K.,1 Oppliger, W.,1
'Biocenter, University of Basel, Switzerland; 2University of
WOrzburg, Federal Republic of Germany: A yeast mutant
lacking mitochondrial porin accumulates an 86-kD protein.
Processing
Atkinson, PH.,' Trimble, R.B., 2 'Albert Einstein College of
Medicine, Bronx, 2Wadsworth Center, New York State De-
partment of Health, Albany: Structure of yeast N-linked oli-
gosaccharide processing intermediates by high-field one-
and two-dimensional 'H NMR spectroscopy.
Bourbonnais, Y., Shields, D., Depts. of Anatomy and Struc-
tural Biology and Developmental Biology and Cancer, Al-
bert Einstein College of Medicine, Bronx, New York: Pro a-
factor -peptide hormone chimeras are proteolytically
cleaved by the enzymes encoded by the STE13 and KEX2
genes.
Butt, TR., Khan, M.I., Marsh, J., Ecker, D.J., Crooke, S.T.,
Smith Kline and French Laboratories, Dept. of Molecular
Pharmacology, King of Prussia, Pennsylvania: Ubiquitin-
mettallothionein gene fusion-A genetic system for protein-
turnover studies.
Chen, J.L., Padmanabha, R., Glover, C.V.C., Dept. of Bio-
chemistry, University of Georgia, Athens: Isolation and se-
quencing of genomic clones encoding the a-subunit of
yeast casein kinase II.
Davis, T.N., Thorner, J., Dept. of Biochemistry, University of
California, Berkeley: Vertebrate calmodulin can substitute
for yeast calmodulin in vivo.
Alberghina, L., Vai, M., Grandori, R., Popo lo, L., Dipt. de Fi-
siologia e Biochimica Genera li, Universita di Milani, Italy:
Detection of phosphotyrosine-containing protein modu-
lated by growth conditions in S. cerevisiae.
Haselbeck, A., Tanner, W., Institut fOr Botanik, Universitat Re-
gensbur, Federal Republic of Germany: Purification of a
GDP-Man-Dol-P mannosyltranferase from yeast and clon-
ing of the corresponding gene.
Jackson, B.J.,' Warren, C.D.,2 Bugge, B.,2 Robbins, P.W.,'
'Center for Cancer Research, Massachusetts Institute of
Technology, Cambridge; 2Laboratory for Carbohydrate
Research, Massachusetts General Hospital and Harvard
SESSION 4 CELL SURFACE AND MORPHOGENESIS
Chairman: K. Nasmyth, MRC, England
Ford, S.K., Ketcham, S., Haarer, B., Ashcroft, D., Pringle,
J.R., Dept. of Biology, University of Michigan, Ann Arbor:
On the roles of CDC3, CDC10, CDC11, and CDC12 gene
products in cellular morphogenesis during the S. cerevis-
iae cell cycle.
Johnson, D.I., Pringle, J.R., Dept. of Biology, University of
Michigan, Ann Arbor: Molecular characterization of the S.
cerevisiae CDC42 gene and its product.
Conklin, D.S., Gustin, M.C., Culbertson, M.R., Kung, C.,
Laboratory of Molecular Biology, University of Wisconsin,
Madison: Toward a mutational study of ion channels in
yeast.
Gustin, M.C., Zhou, X.L., Martinac, B., Culbertson, M.R.,
Kung, C., Laboratory of Molecular Biology, University of
Wisconsin, Madison: Ion channels opened by membrane
stretch in the yeast S. cerevisiae.
SESSION 5 MATING
Chairman: A. Klar, Cold Spring Harbor Laboratory
Berlin, V.,' Fink, G.R.,''2 'Whitehead Institute, 2Dept. of
Biology, Massachusetts Institute of Technology, Cam-
bridge: A genetic selection for mutants defective in zy-
gote formation in S. cerevisiae.
Ner, S.S., Johnson, J.A., Smith, M., Dept. of Biochemistry,
University of British Columbia, Vancouver, Canada: Muta-
tional analysis of operator sequences that bind MAT reg-
ulatory protein al and a2.
Blinder, D., Bouvier, S., Jenness, D., Dept. of Molecular Ge-
netics and Microbiology, University of Massachusetts
Medical School, Worcester: Mutant a cells that show
pheromone-independent arrest of cell division.
Klar, A., Cafferkey, R., Flynn, K., Cold Spring Harbor Labo-
ratory, New York: Determination of the yeast cell lineages.
SESSION 6 CELL CYCLE AND SPORULATION
Chairman: P. Nurse, Imperial Can.cer Research Fund
Broek, D., Lee, M., Nurse, P., Imperial Cancer Research
Fund, London, England: Role of fission yeast cdc2 in cell
cycle control.
Mendenhall, M.D.' Jones, C.A.,2 Reed, S.I."Dept. of
Molecular Biology, Research Institute of Scripps Clinic,
Medical School, Boston: Synthesis of lipid-linked oligosac-
charides in S. cerevisiae-Man(1,3)ManGIcNAc2 and
ManiGlcNAc2 are transferred to protein.
Or lean, P., Robbins, P.W., Massachusetts Institute of Technol-
ogy, Cambridge: Yeast dol-P-man synthase-Selection of
mutants defective in this enzyme and cloning of the gene.
Roitsch, T., Leh le, L., Faculty for Biology and Pre-clinical
Medicine, University of Regensburg, Federal Republic of
Germany: Post-transcriptional translocation of truncated
yeast invertase across the endoplasmic reticulum mem-
brane.
Shih, C.-K., Wagner, R., Feinstein, S., Ennulat, C., Neff, N.,
Memorial Sloan-Kettering Cancer Center, New York, New
York: Dominant trifluoperazine-resistant gene TFP-1 has
homology with PP ATP synthetase.
Perlin, D.S.,1 McCusker, J.H.,2 Haber, J.E.,2 'Dept. of Bio-
chemistry, Public Health Research Institute, New York,
New York; 2Dept. of Biology, Brandeis University, Wal-
tham, Massachusetts: Mutations affecting the plasma
membrane-ATPase from S. cerevisiae.
Teem, J., Fink, G., Whitehead Institute, Cambridge, Massa-
chusetts: Mutations in the yeast plasma membrane AT-
Pase.
Chvatchko, Y., van Tuinen, E., Riezman, H., Swiss Institute
for Experimental Cancer Research, Epalinges, Switzer-
land: Pheromone endocytosis and action in yeast.
Nasmyth, K., Seddon, A., MRC Laboratory of Molecular Bi-
ology, Cambridge, England: Mother-cell-specific HO
expression.
Jarvis, E., Hagen, D., Bender, A., Sprague, G., Jr., Institute
of Molecular Biology, University of Oregon, Eugene: a-
specific gene expression-Binding of a MATa1 to up-
stream activation site elements.
Blumer, K.J., Reneke, J.E., Thorner, J., Dept. of Biochemis-
try, University of California, Berkeley: Chemical evidence
that the STE2 gene encodes the pheromone-binding
component of the a-factor receptor of S. cerevisiae.
Chaleff, D.T., Focht, R.J., Rizzo, C.J., E.I. du Pont de Nem-
ours and Co., Experimental Station, Wilmington, Dela-
ware: The STE7 gene encodes a protein kinase.
La Jolla, California; 2Leicester Biocentre, University of
Leicester, England: Dual regulation of the yeast CDC28
protein kinase: Cell cycle, pheromone, and nutrient limi-
tation effects.
Booher, R., Molz, L., Beach, D., Cold Spring Harbor Labo-
247
ratory, New York: Characterization of mcs mutants, extra-
genic suppressors of "mitotic catastrophe" in fission
yeast.
Nash, R., Tokiwa, G., Futcher, B., McMaster University,
Hamilton, Canada: Characterization of a new Whi mutant
of S. cerevisiae.
Bahman, M., Rosamond, J., Dept. of Biochemistry and Mo-
lecular Biology, University of Manchester, England: Char-
acterization of the CDC7 gene product as a protein ki-
nase.
SESSION 7A GROWTH CONTROL
Chairman: P. Nurse, Imperial Cancer Research Fund
Cameron, S., Toda, T., Levin, L., Zoller, M., Wig ler, M., Cold
Spring Harbor Laboratory, New York: Characterization of
the cAMP effector system of S. cerevisiae.
Field, J.,' Nikawa, Broek, D.,' Rodgers, L,' Mac-
Donald, B.,' Kataoka, T,' Wilson, I.A.,2 Lerner, R.A.,2
Wig ler, M.,1 'Cold Spring Harbor Laboratory, New York;
2Research Institute of Scripps Clinic, La Jolla, California:
Interactions between yeast RAS proteins and adenylate
cyclase.
SESSION 7B POSTTRANSCRIPTIONAL TRANSPORT
Chairman: R. Schekman, University of California, Berkeley
Herman, P.K., Emr, S.C., Division of Biology, California Insti-
tute of Technology, Pasadena: Localization of the KEX2
protein.
Raymond, C.K., Rothman, J.H., Stevens, T.H., Institute of
Molecular Biology, University of Oregon, Eugene: Molec-
ular analysis of yeast vacuolar protein localization genes.
Du lid, V., Riezman, H., Swiss Institute for Experimental Can-
SESSION 8 PROTEIN LOCALIZATION
Chairman: R. Schekman, University of California, Berkeley
Li, J.-M.' Ellis, S.R.,1 Hooper, A.K.,2 Martin, N.C.,"Dept.
of Biochemistry, University of Texas Health Science Cen-
ter, Dallas; 2Dept. of Biological Chemistry, M.S. Hershey
Medical Center, Hershey, Pennsylvania: Characterization
of mitochondria' and nuclear targeting signals of the
TRM1 gene product.
Heidi, M., Guarente, L., Dept. of Biology, Massachusetts In-
stitute of Technology, Cambridge: Molecular genetic
analysis of mitochondria' protein import.
Small, G.M., Szabo, L.J., Lazarow, P.B., Rockefeller Univer-
sity, New York, New York: Targeting of acyl-CoA oxidase
to peroxisomes in Candida tropicalis.
Hansen, H., Roggenkamp, R., Institut fur Mikrobiologie,
Universitat Dusseldorf, Federal Republic of Germany:
Heterologous gene expression in yeast peroxisomes.
Kaiser, C., Botstein, D., Dept. of Biology, Massachusetts In-
stitute of Technology, Cambridge: Amino-terminal pep-
tide sequences with low information content can direct
cytoplasmic proteins to the ER.
Brennwald, P., Liao, X., Holm, K., Porter, G., Wise, J.A.,
Dept. of Biochemistry, University of Ilinois, Urbana: Iden-
tification of a S. pombe RNA homologous to the 7SL
248
Goebl, M.G., Byers, B., Dept. of Genetics, University of
Washington, Seattle: The gene products of CDC4 and
RAD6 are interrelated.
Icho, T., Wickner, R.B., NIDDK, National Institutes of
Health, Bethesda, Maryland: The CDC16 protein has
three potential metal-binding nucleic-acid-binding do-
mains.
McLeod, M., Beach, D., Cold Spring Harbor Laboratory,
New York: Control of meiosis in fission yeast by the inter-
action of p21mei3 with the p52'."' protein kinase.
Jacquet, M., Boy-Marcotte, E., Camonis, J., Damak, F., Ver-
dier, J.M., Garreau, H., Groupe Information Genetique et
Developpement, Universite Paris, France: Suppressors of
the CDC25 mutation in S. cerevisiae-Cloning of a new
gene SCD25 and isolation of a new mutation ICY1.
Fields, FO., Flanagan, C.A., Gimble, F.S., Thorner, J., Dept.
of Biochemistry, University of California, Berkeley: Bio-
chemical evidence for components of the phosphatidyl-
inositol pathway in S. cerevisiae.
cer Research, Epalinges, Switzerland: Characterization of
two genes important in endocytosis by budding yeast.
Sturley, S.L., Palmer, J.D., Bostian, K.A., Division of Biome-
dicine, Brown University, Providence, Rhode Island: Mu-
tagenic analysis of trans-acting factors that determine the
expression of specific immunity to the type-1 killer toxin
of S. cerevisiae.
P. Nurse, D. Gallwitz
component of signal-recognition particle.
Deshaies, R., Schekman R., Dept. of Biochemistry, Univer-
sity of California, Berkeley: Characterization of S. cerevis-
iae mutants defective in protein translocation.
Ferro-Novick, S., Ruohola, H., Bangs, J., Dept. of Cell Biol-
SESSION 9 POSTER SESSION
Proteins
Das, G.,' Mann, K.,' Fingar, S.,' Sherman, F.,2 Depts. of
'Biochemistry, 2Biophysics, University of Rochester
Medical Center, New York: Structure and function of
yeast iso-l-cytochrome c studied using alterations in the
structural gene CYCI.
Karwan, R., Wintersberger, U., Institute for Tumorbiology
and Cancer Research, University of Vienna, Austria: In
addition to RNase H (70), two other proteins of S. cerevis-
iae exhibit ribonuclease-H activity.
Moore, C.,1,2 Jones, C.,1 Wall, L.,' "University of Roches-
ter, 2City University of New York Medical Schools, New
York: Deoxyribonuclease-like activities of structurally re-
lated, low-molecular-weight (M'= -1500) glycopeptides
exhibited preferential internucleosomal chromatin cleav-
age.
Marguet, D., Lauquin, G.J.-M., Labortorie Physiologie Cel-
lulaire Faculte des Sciences de Luminy, University Aix-
Marseille, France: The SRP gene-Cloning and charac-
terization of a new family of repetitive elements homolo-
gous to the SRP gene.
Karwan, R., Wintersberger, U., Institute for Tumorbiology
and Cancer Research, University of Vienna, Austria: In
addition to RNAse H(70) two other proteins of S. cerevis-
iae exhibit ribonuclease H Activity.
Gra Ila, E.B., Bermingham-McDonogh, 0 Valentine, J.S.,
Dept. of Chemistry and Biochemistry, University of Cali-
fornia, Los Angeles: The Cu, Zn superoxide dismutase
gene of S. cerevisiae-Cloning, sequencing, and initial
characterization.
Fraundorfer, F-J., Kuehne, C., Wintersberger, U., Institute
of Tumorbiology-Cancer Research, Dept. of Molecular Bi-
ology, Vienna, Austria: Cloning of a single gene coding
for both ribonuclease, H 55 and ribonuclease H 42 in S.
cerevisiae (RNH 55).
Minasi, L.-A.E., Willsky, G.R., Dept. of Biochemistry, State
University of New York, Buffalo: Vanadate-stimulated
NADH oxidation activity associated with S. cerevisiae
plasma membranes.
Mortitz, M., Rotenberg, M., Woolford, J., Dept. of Biological
Sciences, Carnegie Mellon University, Pittsburgh, Penn-
sylvania: Formation of "halfmer" polyribosomes upon de-
pletion of ribosomal protein 39.
Chromosomes
Haggren, W., Burgum, A., Kolodrubetz, D., Dept. of Micro-
biology, University of Texas Health Science Center, San
Antonio: A gene encoding an HMG1-like protein has an
essential function in yeast.
Thoma, F, Institut fOr Zellbiologie, ETH-HOnggerberg, Zu-
rich, Switzerland: Regulation of nucleosome positioning
in yeast plasmid chromatin.
ogy, Yale University, New Haven, Connecticut: A protein
on the cytoplasmic surface of the ER membrane func-
tions at a late stage of protein transport into the ER lu-
men.
Cottarel, G., Funk, M., Jiang, W., Wenick, P., Jager, D., Ge-
gemann, J.H., Philippsen, P., Institut fur Mikrobiologie
and Molekularbiologie, Giessen, Federal Republic of Ger-
many: Functional analysis of mutated centromeres.
Allshire, R.,' Fantes, P.,2 'MAC CAPCU, Western General
Hospital, 2Dept. of Zoology, Edinburgh, Scotland: Main-
tenance of a fission yeast chromosome in mouse cells.
Resnick, M.,' Westmoreland, J.,' Harwell, E.,2 Bloom, K.,2
'Cellular and Genetic Toxicology Branch, National Insti-
tutes of Environmental Health Science, Research Triangle
Park, 2Dept. of Biology, University of North Carolina,
Chapel Hill: Heterogeneity in copy number of centromere
plasmids in yeast.
Bonaduce, M.J., Mittman, B.A., Dept. of Biology, University
of Richmond, Virginia: Analysis of a sodium-bisulfite-gen-
erated mutation of histone H4 in yeast.
Chan, C., Botstein, D., Dept. of Biology, Massachusetts In-
stitute of Technology, Cambridge: New screens for genes
and mutations that affect chromosome segregation in
yeast.
Hadfield, C., Leicester Biocentre, University of Leicester,
England: Probes for determining chromosome ploidy in
yeast.
Pifer, M.L., Karpov, V.L., Institute of Molecular Biology,
USSR Academy Sciences, Moscow: Investigation of S.
cerevisiae centromere structure by protein-DNA cross-
linking.
Steensma, H.Y.,1 de Jonge, P.,' Linnekamp, M.,' Kaback,
D.B.,2 Dept. of Microbiology and Enzymology, Delft Uni-
versity of Technology, The Netherlands; 2Dept. of Micro-
biology and Molecular Genetics, UMDNJ-New Jersey
Medical School, Newark: Molecular organization of chro-
mosome I from S. cerevisiae - Physical map of the DNA
molecule.
Villadsen, I.S., Riis, P, Dept. of Microbiology, Technical Uni-
versity of Denmark: Characterization and cloning of a
new nuclear division cycle mutant of the yeast S. cerevis-
iae.
Wakem, L.P.,' Bulgac, E.,2 Hicks, J.,2 Sherman, F.,'
'University of Rochester, New York; 2Scripps Clinic, La
Jolla, California: A new method for the chromosomal as-
signment of mutations in yeast.
Gene Structure and Expression
Ye, Z.H., Bhattacharjee, J.K., Dept. of Microbiology, Miami
University, Oxford, Ohio: Gene, enzyme relationship, and
heterologous expression of lysine genes in S. pombe.
Messenguy, F., Dubois, E., Research Institute of the CERIA,
Brussels, Belgium: The yeast ARGRII regulatory protein
has homology with various RNases and DNA-binding
proteins.
249
Freeman, K., Karns, L., Smith, M.M., Dept. of Microbiology,
University of Virginia Medical School, Charlottesville:
Transcriptional regulation of the cell-cycle-expressed his-
tone genes, H3 and H4.
Goyer, C., Altmann, M., Sonenberg, N., Dept. of Biochemis-
try, McGill University, Quebec, Canada: Characterization
of S. cerevisiae cap-binding proteins.
Schultz, J., Carlson, M., Columbia University College of
Physicians & Surgeons, New York, New York: SSN6, a
gene functionally related to the SNF1 protein kinase.
Herrick, D., Jacobson, A., Dept. of Molecular Genetics and
Microbiology, University of Massachusetts Medical
School, Worcester: Structural determinants of mRNA sta-
bility in S. cerevisiae.
Jacobs, E.,' Laloux, 1.,2 Dubois, E.,3 'Smith Kline-RIT,
Dept. of Molecular and Celluar Biology, Rixensart,
'University Libre de Bruxelles, Laboratory de Microbiolo-
gie, 3Research Institute CERIA, Bruxelles, Belgium: Mo-
lecular cloning and characterization of the S. cerevisiae
ROC1 gene.
Jaehning, J.A., Wilcoxen, S.E., Peterson, C.R., Schultz,
P.W., Marczynski, G.T., Dept. of Biology, Indiana Univer-
sity, Bloomington: Transcription by the yeast mitochondr-
ial RNA polymerase.
Khan, N., Dept. of Biology, Brooklyn College, New York:
The gal3 mutation and maltose utilization in yeast.
Mehta, K.D., Smith, M., Dept. of Biochemistry, University of
British Columbia, Vancouver, Canada: Identification of
cis-acting DNA sequence(s) involved in the negative reg-
ulation of ANBt gene by oxygen in yeast by in vitro muta-
genesis using a synthetic oligonucleotide with a low level
of misincorporated nucleotides.
Macreadie, I.G., Vaughan, P.R., Jagadish, M.N., CSIRO, Di-
vision of Protein Chemistry, Victoria, Australia: Controlled,
heterologous gene expression in yeast-Use of a highly
versatile, modified CUP1 gene.
Os ley, M.A., Program in Molecular Biology, Memorial
Sloan-Kettering Cancer Center, New York, New York:
Trans-acting mutations that abolish periodic transcription
of the histone genes.
Witte, M.M., Dickson, R.C., Dept. of Biochemistry, Univer-
sity of Kentucky, Lexington: Characterization of the DNA-
binding domain of a eukaryotic-positive regulatory gene.
Thompson, J.R., Tsay, YE, Woolford, J.L., Dept. of Biologi-
cal Sciences, Carnegie Mellon University, Pittsburgh,
Pennsylvania: Posttranscriptional regulation of ribosomal
protein synthesis.
Trueblood, C.E., Poyton, R.O., Dept. of Molecular, Cellular
and Developmental Biology, University of Colorado,
Boulder: Differential regulation of COX5a and COX5b by
HAP1 , HAP2, and a newly identified gene, REO1.
Uemura, H., Wickner, R.B., NIDDKD, National Institutes of
Health, Bethesda, Maryland: Cytoplasmic suppression of
some mak mutations is a property of a variant of L-A.
Camilloni, G., Caserta, M., Della Seta, F., Di Mauro, E.,
Ficca, A.C., Negri, R., Venditti, S., Dipt. di Genetica e
Biologia Molecolare, Universita "La Sapienza," Roma, It-
aly: S. cerevisiae RNA polymerase II promoters-Intrinsic
topological information and interaction with purified RNA
pol II.
Morgan, B.A., Mittman, B.A., Smith, M.M., Dept. of Microbi-
250
ology, University of Virginia School of Medicine, Char-
lottesville: Identification of a histone H4 mutation that af-
fects mating-type expression.
de Larminat, M.A., Lee, G.S.-E, von Borstel, R.C., Dept. of
Genetics, University of Alberta, Edmonton, Canada: An
A-T transversion in the initiation codon results in a leaky
phenotype.
Crabeel, M., Seneca, S., Devos, K., Heimberg, H., Glans-
dorff, N., Dept. of Microbiology, University of Brussels,
Belgium: Role of conserved sequences in the control re-
gion of the arginine regulon of S. cerevisiae.
Linder, R, Slonimski, P.P., Centre de Genetique Moleculaire
du CNRS. Gif-sur-Yvette, France: Cloning and character-
ization of two iso-functional nuclear genes essential for
growth and involved in nucleo-mitochondrial interactions.
Capsey, L.,' Yotsuyanagi, Y.,2 Banks, G.,' Williamson,
D.H.,"National Institute for Medical Research, London,
England; 'Centre Genetique Moleculaire due CNRS,
France: Frequent virus-like particles in the S. uvarum
strain NCYC74 may be intermediates in Ty element trans-
position.
Casey, G.P.,1 Xiao, W.,2 Rank, G.H.,2 Depts of 'Applied
Microbiology and Food Science, 'Biology, University of
Saskatchewan, Saskatoon, Canada: SMR1-410-encoded
resistance to the herbicide sulfometuron methyl as a
dominant selection marker in industrial strains of Saccha-
romyces yeast.
Fahrig, R., Fraunhofer-lnstitut fur Toxikologie and Aerosol-
forschung, Dept. of Genetics, Hannover, Federal Repub-
lic of Germany: Adaptive response of S. cerevisiae to
chronic treatment with alkylating and nonalkylating muta-
gens.
Hill, J.E., Henry, S.A., Depts of Genetics and Molecular Bi-
ology, Albert Einstein College of Medicine, Bronx, New
York: S. pombe mutants blocked in phosphatidylcholine
biosynthesis.
Gangloff, S., Marguet, D., Lauquin, G.J.-M., Laboratory of
Physiologie Cellulaire, Universito d'Aix-Marseille, France:
Aconitase-Cloning, disruption, and regulation of the
ACO gene.
Hoffmann, A.,12 Swida, U.,' Kaufer, N.F.,2 'Institut far
Biochemie and Molekularbiologie, Freie Universitat Ber-
lin, Federal Republic of Germany; 'Dept. of Bioscience
and Biotechnology, Drexel University, Philadelphia, Penn-
sylvania: Studies with artificial introns in the ura4 gene of
S. pombe.
Ming, M., Thomas, W., Holm, C., Dept. of Cellular and De-
velopmental Biology, Harvard University, Cambridge,
Massachusetts: Fine-structure mapping of the structural
gene for DNA topoisomerase II.
Balzi, E., Weining, C., Ulaszewski, S., Capieaux, E., Gof-
feau, A., Laboratoire d'Enzymologie, Universite de Lou-
vain, Belgium: A regulatory gene for yeast multiple-drug
resistance.
KOhrer, K., Domdey, H., Genzentrum der Ludwig-Maximili-
ans-Universitat Munchen, Martinsried, Federal Republic
of Germany: The S. cerevisiae MA Tat transcript is differ-
entially spliced in vitro and in vivo.
Kuang, D.R., Xuan, J.W., Fan, J.B., Jiang, W.D., Zhus, Y.W.,
Zhang, X.G., Shanghai Institute of Cell Biology, Academia
Sinica, People's Republic of China: Studies on yeast
genes encoding proline-synthesizing enzymes.
Zang, G., Kuang, D.-R., Shanghai Institute of Cell Biology,
Academia Sinica, Peoples Republic of China: Sequence
analysis of the pro3 gene and the revolutionary signifi-
cance of pro3 and proC proteins.
Hanes, S.D., Bostian, K.A., Division of Biology and Medi-
cine, Brown University, Providence, Rhode Island: Ge-
netic mapping of ESS1 and use of a regulated promoter
to investigate its function.
Lemmon, S., Freund, C., Conley, K., Jones, E., Dept. of Bi-
ological Sciences, Carnegie Mellon University, Pitts-
burgh, Pennsylvania: Mutants bearing a deletion of the
clathrin heavy-chain gene (CHC1) become polyploid at
high frequency.
Porter, G., Brennwald, P., Jermone, J., Wise, J.A., Dept. of
Biochemistry, University of Illinois, Urbana: S. pombe an-
alogs of mammalian snRNAs.
Roof, L.L., Klein, R.D., Molecular Biology Research, Up-
john Company, Kalamazoo, Michigan: Cloning and char-
acterization of the gene encoding orotidine 5'-phosphate
decarboxylase of Schwanniomyces occidentalls.
Wilkinson, B.M., Walmsley, R.M., Dept. of Biochemistry and
Applied Molecular Biology, UMIST, Manchester, England:
Deletion of potential Z DNA sequences from the yeast
genome.
Cafferkey, R., Klar, A., Cold Spring Harbor Laboratory, New
York: Cloning of the swi3 * gene of S. pombe.
Racher, A.J.,' Kinghorn, J.R.,' Wright, D.M.,2 'Molecular
Genetics Unit, University of St. Andrews, 2Research and
Development Dept., Distillers Company (Yeast) Ltd.,
Clackmannanshire, Scotland: Isolation and characteriza-
tion of glutamate synthase mutants of S. cerevisiae.
Barbhaiya, H., Dept. of Microbiology, University of Baroda,
India: Functional qualities of yeast.
SESSION 10 COVALENT MODIFICATION
Chairman: J. Thorner, University of California, Berkeley
Ennulat, C., Neff, N., Molecular Biology Program, Memorial
Sloan-Kettering Cancer Center, New York, New York:
Characterization of sodium-orthovanadate-resistant mu-
tants of S. cerevisiae and comparison with cells express-
ing v-src.
Levin, D.E., Bishop, J.M., G.W. Hooper Foundation and
Dept. of Microbiology and Immunology, University of Cal-
ifornia, San Francisco: Mutants in the KIN gene of S.
pombe display multiple phenotypic defects.
Deschenes, R.J., Broach, J.R., Dept. of Molecular Biology,
Princeton University, New Jersey: Characterization of
RAS2 fatty acylation mutations and second-site suppres-
sors that allow growth of mutant strains.
Bohni, P.C., Schekman, R.W., Dept. of Biochemistry, Uni-
versity of California, Berkeley: SEC11 is required for sig-
nal peptide processing and yeast cell growth.
Fuller, B.S.,' Brake, A.,2 Thorner, J.,3 'Dept. of Biochemis-
try, Stanford University School of Medicine, 2Chiron Cor-
poration, Emeryville, 3Dept. of Biochemistry, University
of California, Berkeley: KEX2 endopeptidase, despite its
sensitivity to thiol reagents, is a serine protease with ho-
mology to the bacterial subtilisins.
Sturley, S.L.,' LeVitre, J.,' Tipper, D.J.,2 Bostian, K.A.,1
'Division of Biomedicine, Brown University, Providence,
Rhode Island; 2Dept. of Molecular Genetics and Microbi-
ology, University of Massachusetts Medical School,
Worcester: Processing of the S. cerevisiae type-1 killer
toxin precursor and its relationship to the expression of
immunity.
Bachmair, A., Finley, D., Wunning, I., Varshaysky, A., Dept.
of Biology, Massachusetts Institute of Technology, Cam-
bridge: Amino-terminal targeting in selective protein deg-
radation.
Jentsch, S., McGrath, J.P., Varshaysky, A., Dept. of Biology,
Massachusetts Institute of Technology, Cambridge: Ubi-
quitin-ligation system of S. cerevisiae.
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SESSION 11 CHROMOSOMES
Chairman: B.K. Tye, Cornell University
Hoyt, M.A., Stearns, T., Botstein, D., Dept. of Biology, Mas-
sachusetts Institute of Technology, Cambridge: Genetic
analysis of chromosome segregation in S. cerevisiae.
Surosky, R.T., Tye, B.K., Section of Biochemistry, Molecular
and Cell Biology, Cornell University, Ithaca: Homologous
pairing of the chromosome arms, but not the centro-
meres, determines the orientation of kinetochores in the
meiotic disjunction of homologs.
Niwa, 0., Matsumoto, T, Chikashige, Y., Nakaseko, Y., Yan-
agida, M., Dept. of Biophysics, Faculty of Science, Kyoto
University, Japan: Construction of minichromosomes in
S. pombe- Relation of structure to meiotic behavior.
Kenna, M., Amaya, E., Bloom, K., Dept. of Biology, Univer-
sity of North Carolina, Chapel Hill: Isolation of the centro-
mere chromatin complex from yeast.
Rose, D., Thomas, W., Holm, C., Dept. of Cellular and De-
velopmental Biology, Harvard University, Cambridge,
Massachusetts: DNA topoisomerase II is required for nu-
clear division in meiosis.
Jazwinski, S.M., Cosgrove, K.L., Dept. of Biochemistry and
Molecular Biology, Louisiana State University Medical
Center, New Orleans: Protein kinase activity in prepara-
tions of yeast replicative complex is CDC7-dependent.
Diffley, J.F.X., Stillman, B., Cold Spring Harbor Laboratory,
New York: DNA-protein interactions at the chromosomal
replicator, ARS1, and their effect on DNA bending.
Gasser, S., Swiss Institute for Experimental Cancer Re-
search (SREC), Epalinges, Switzerland: Specific associa-
tion of yeast sequences with a yeast nuclear scaffold.
Lowary, P.T., Widom, J., Depts. of Chemistry and Biochem-
istry, University of Illinois, Urbana: Structure of, yeast
chromosomes.
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SESSION 12 NUCLEAR STRUCTURE AND TRANSPORT
Chairman: M. Douglas, University of Texas Health
Science Center
Allen, J., Douglas, M., Dept. of Biochemistry, University of
Texas Health Science Center, Dallas: Nuclear pore com-
plex.
Wright, R., Rine, J., Dept. of Biochemistry, University of Cal-
ifornia, Berkeley: Karmellae formation-Overproduction
of HMG-CoA reductase induces nuclear-associated
membrane proliferation.
Armstrong, K.,' Talty, J.,2 Broach, J.,"Dept. of Molecular
Biology, Princeton University, New Jersey; 2Dept. of Bio-
chemistry, University College, Cork, Ireland: Interaction
of the REP1 and REP2 partitioning proteins encoded by
the 2-1.4m circle plasmid.
Rose, M.D., Roberts, T., Lister, K., Princeton University,
New Jersey: KAR1-lacZ gene fusions localize 13-galactosi-
dase to the vicinity of the spindle plaque.
Clark, M.W., Jong, A., Abelson, J., Campbell, J.L., Divi-
sions of Chemistry and Biology, California Institute of
Technology, Pasadena: Use of SSB-1, a nucleolar pro-
tein, and rnal mutants to probe nuclear structure. The
rnal mutation disrupts the location of proteins found in
the yeast nucleolus.
Sadler, I., Goodson, H., Silver, P., Dept. of Biology, Prince-
ton University, New Jersey: Genetic analysis of nuclear
protein localization.
Benton, B.,' Eng, W.-K.,2 Fisher, P.A.,' Studier, F.W.,3
Dunn, J.,3 Sternglanz, R.,2 Depts. of 'Pharmacology,
2Biochemistry, State University of New York, Stony Brook,
3Biology Division, Brookhaven National Laboratory, Up-
ton, New York: Regulated import of bacteriophage T7
RNA polymerase into the yeast nucleus and transcription
of target genes.
McLaughlin, C.,1 Garrels, J.,2 Johnson, S.P.,3 Warner,
J.R.3 'Dept. of Biological Chemistry, University of Califor-
nia, Irvine; 2Co Id Spring Harbor Laboratory, New York;
3Dept. of Cell Biology, Albert Einstein College of Medi-
cine, Bronx, New York: A database for the proteins of S.
cerevisiae.
Racher, A.J.,1 Kinghorn, J.R.,1 Wright, D.M.,2 'Molecular
Genetics Unit, University of St. Andrews; 2Distillers Co.
(Yeast) Ltd., Menstrie, Scotland: Isolation and character-
ization of glutamate synthase mutants of S. cerevisiae.
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The 1987 meeting on Molecular Genetics of Bacteria and Phages was one of the
most successful "phage" meetings in the past several years. More than 360 people
attended; approximately 120 talks and 135 posters were presented. A major
strength of the phage meeting is that it brings together scientists working on
virtually every aspect of prokaryotic molecular genetics. This year's topics included
DNA replication, recombination, and transposition; transcription initiation and
termination; developmental regulation of gene expression; RNA processing and
translation; phage morphogenesis; membrane proteins; and recombinant DNA
technology.
Among the exciting new results presented, perhaps the most surprising was
the finding of Huang and Fang that a region of T4 gene 60 is a functional intron
which is not spliced. Apparently, secondary structure of the mRNA permits
ribosomes to "jump" from one "exon" to the next without translating the intervening
50 nucleotides. Several other papers documented the unusual transcriptional and
translational properties of T4 genes. These include genes with genuine introns,
and other genes that code for more than one polypeptide, depending on the
choice of transcription and/or translation startpoint at different stages of phage
development.
Several groups (Gardella and Susskind; Siege le et al.; Healy et al.) have now
isolated mutations in genes encoding sigma subunits of RNA polymerases. These
mutations alter the promoter recognition specificity of RNA polymerase; the nature
of the amino acid changes strongly suggests that the wild-type amino acids make
contacts with specific nucleotides in promoter DNA. These results were part of a
common thread: the mechanisms by which specific protein-DNA interactions
influence DNA replication, site-specific recombination, transposition, regulation of
gene expression, and phage DNA packaging.
The quality of the presentations throughout the meeting was exceptional.
SESSION 1 DNA REPLICATION
Baker, T., Bramhill, D., Kornberg, A., Dept. of Biochemistry,
Stanford University School of Medicine, California: Tran-
scriptional activation of initiation of replication at the ori-
gin of the E. coli chromosome.
Polaczek, P., Wright, A., Dept. of Molecular Biology and Mi-
crobiology, Tufts University School of Medicine, Boston,
Massachusetts: Effect of dnaA box mutations on dnaA
gene expression in E. coli.
Russell, D.W., Zinder, N.D., Rockefeller University, New
York, New York: Hemimethylation prevents DNA replica-
tion in E. coli.
Traxler, B., Mink ley, E.G., Jr., Dept. of Biological Sciences
and Mellon Institute, Carnegie Mellon University, Pitts-
burgh, Pennsylvania: Studies of the tra/ gene and oriT
nicking of F plasmid.
Greenstein, D., Roth, A., Horiuchi, K., Rockefeller Univer-
sity, New York, New York: Double-strand cleavage and
strand joining by the replication initiator protein of bacte-
riophage f1.
Gennaro, MI., Novick, R.P., Dept. of Plasmid Biology, Pub-
lic Health Research Institute, New York, New York: Struc-
tural and functional analysis of cmp, an enhancer of plas-
mid replication.
Wahle, E., Kornberg, A., Dept. of Biochemistry, Stanford
University School of Medicine, California: The par se-
quence of pSC101 is a gyrase-binding site.
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Ohmori, H., Murakami, Y., Nagata, T., Institute for Virus Re-
search, Kyoto University, Japan: Nucleotide sequence
required for replication of the ColE1-type plasmid in E.
coli cells with or without RNase H.
Cohen, G., Sternberg, N., E.I. du Pont de Nemours and
Co., Experimental Station, Wilmington, Delaware: Locali-
zation and characterization of the bacteriophage P1 lytic
replicon.
Pelletier, A.J., Hill, T.M., Kuempel, P.L., Dept. of Molecular,
Cellular, and Developmental Biology, University of Colo-
SESSION 2 RECOMBINATION AND REPAIR
Segall, A., Roth, J., Dept. of Biology, University of Utah,
Salt Lake City: Half-tetrad analysis in bacteria.
Mosig, G., Powell, D., Dept. of Molecular Biology, Vander-
bilt University, Nashville, Tennessee: Complex regulation
of two proteins from bacteriophage T4 gene 49 (recombi-
nation endonuclease VII).
Panayotatos, N.,1 Fontaine, A.,2 Biogen SA, Geneva, Swit-
zerland, 'Michigan Biotechnology Institute, Lansing;
2lnstitut Pasteur, Paris, France: Native cruciforms in bac-
teria.
Abremski, K., Frommer, B., Wierzbicki, A., Hoess, R., E.I.
du Pont de Nemours and Co., Inc., Central Research and
Development Dept., Wilmington, Delaware: Properties of
a mutant Cre protein that alters the topological linkage of
recombination products.
Glasgow, A.C., Simon, M.I., Dept. of Biology, California In-
stitute of Technology, Pasadena: Interactions between fis
and the recombinational enhancer of the hin inversion
system of Salmonella.
SESSION 3 POSTER SESSION
Abe les, A.L., Austin, S.J., NCI-Frederick Cancer Research
Facility, Frederick, Maryland: Role of E. coli dam methy-
lase in P1 replication.
Andersson, D., Roth, J., Dept. of Biology, University of
Utah, Salt Lake City: Transcriptional regulation of coba-
lamin biosynthetic genes.
Alifano, P., Nappo, A.G., Bruni, C.B., Carlomagno, M.S.,
Dept. of Molecular and Cellular Pathobiology, University
of Naples, Italy: Strong transcriptional polarity in a mis-
sense mutant of S. typhimurium.
Angov, E., Solomon, K., Brusilow, W., Dept. of Chemistry
and Biochemistry, University of Maryland, College Park:
Autoregulation of E. coif ATPase gene expression.
Armengod, M.E., Garcia-Sago, M., Lambies, E., Institute
de Investigaciones Citologicas, Valencia, Spain: The recF
and dnaN genes of E. coli constitute an operon.
Arraiano, C.M., Yancey, S.D., Kushner, S.R., Dept. of Ge-
netics, University of Georgia, Athens: Analysis of specfic
cleavage sites in mRNA decay in E. coll.
Baracchini, E., Bremer, H., Biology Programs, University of
Texas of Dallas, Richardson: Control of stable RNA syn-
thesis in bacteria by ppGpp.
Benedik, M., Ball, T., Saurugger, P., Dept. of Biology, Texas
A & M University, College Station: Extracellular nuclease
of S. marcescens.
Berg, C.M.,' Liu, L.,' Whalen, W.A.,2 Das, A.,2 'Dept. of
254
rado, Boulder: Identification of the sites that inhibit DNA
replication in the terminus region of the E. coli chromo-
some.
Funnell, B.E., Yarmolinsky, M.B., NCI, National Institutes of
Health, Bethesda, Maryland: Overproduction of the P1
ParB protein inhibits proper partitioning of P1-derived
plasmids.
Davis, M.A., Martin, K.A., Austin, S.J., NCI-Frederick Can-
cer Research Facility, Frederick, Maryland: Partition pro-
teins of the P1 plasmid.
Heitman, J., Model, P., Rockefeller University, New York,
New York: Mutagenesis of the EcoRl endonuclease-Al-
leles with altered or reduced cleavage-site specificity.
Gann, A.A.F., Fuller-Pace, F.V., Murray, N.E., Dept. of Mo-
lecular Biology, Edinburgh, Scotland: Reassortment of
DNA recognition domains by recombination leads to the
generation of new specificities.
Semerjian, A.V., Poteete, A.R., Dept. of Molecular Genetics
and Microbiology, University of Massachusetts Medical
School, Worcester: Bacteriophage P22 PL operon
genes-Roles in growth and recombination and compari-
son with A.
Sassanfar, M., Roberts, J., Section of Biochemistry, Molecu-
lar and Cell Biology, Cornell University, Ithaca, New York:
Effects of the recF mutation on SOS induction.
Phillips, G.J., Kushner, S.R., Dept. of Genetics, University
of Georgia, Athens: Analysis of the role of exonuclease I
in DNA repair, genetic recombination, and the SOS re-
sponse.
Molecular and Cell Biology, University of Connecticut,
Storrs; 2Dept. of Microbiology, University of Connecticut
Health Center, Farmington: Position-effect mutations in-
duced by y-d insertions adjacent to the E. coli avtA gene.
Berg, C.M., Liu, L., Wang, B., Dept. of Molecular and Cell
Biology, University of Connecticut, Storrs: Rapid identifi-
cation of lethal genes.
Brissette, J.L., Russel, M., Rockefeller University, New York,
New York: Expression of fl gene IV induces a cellular
protein.
Brooks, J.E.,' Nwankwo, D.,2 Sznyter, L.,' Jager, T.,' Wil-
son, G.,1 Heiter, D.,3 Slatko, B.,' Moran, L.,' Benner,
J.,1 'New England Biolabs, Beverly Massachusetts;
2Dept. of Biological Sciences, University of Calabar, Ni-
geria; 3Dept. of Molecular Biology, Princeton University,
New Jersey; Cloning of the BamHl restriction-modifica-
tion system.
Bukau, B., Walker, G.C., Dept. of Biology, Massachusetts
Institute of Technology, Cambridge: New phenotypes of a
AdnaK mutant of E. coli suggest an essential role for
DnaK at low temperature.
Burckhardt, S., Woodgate, R., Scheuermann, R., Echols,
H., Dept. of Molecular Biology, University of California,
Berkeley: The UmuD mutagenesis protein of E. coli -Ov-
erproduction, purification, and cleavage by RecA.
Campbell, J.L., Kleckner, N., Dept. of Biochemistry and
Molecular Biology, Harvard University, Cambridge, Mas-
sachusetts: Methylation control of IS/O's transposase
promoter involves a second competing promoter, pC.
Champness, W.C., Dept. of Microbiology, Michigan State
University, East Lansing: New loci required for S. coelico-
lor morphological and physiological differentiation.
Clyman, J., Cunningham, R.P., Dept. of Biological Sci-
ences, State University of New York, Albany: E. coli mu-
tants dependent on recA function for viability.
Condemine, G., Smith, C., Dept. of Genetics and Develop-
ment, College of Physicians & Surgeons, Columbia Uni-
versity, New York, New York: Site-specific cleavage of E.
coli chromosome by DNA gyrase.
Conley, P.B., Lemaux, P.G., Grossman, A., Dept. of Plant Bi-
ology, Carnegie Institution of Washington, Stanford, Cali-
fornia: Transcriptional regulation by specific wavelengths
of light of a photosynthetic antenna complex gene family.
Connell, N., Siekhaus, D., Kolter, R., Dept. of Microbiology
and Molecular Genetics, Harvard Medical School, Bos-
ton, Massachusetts: Regulation of a stationary-phase-in-
duced promoter.
Costantino, N.,' Zuber, M.,2 Court, D.L.,3 'Program Re-
sources, Inc., Frederick, Maryland; 2Oregon State Uni-
versity, Corvallis; 3NCI-Frederick Cancer Research Facil-
ity, Frederick, Maryland: The bypl mutation of
bacteriophage A.
Cotter, T., McClung, C.R., Chelm, B., DOE-Plant Research
Laboratory and Dept. of Microbiology, Michigan State
University, East Lansing: Genetic locus essential for for-
mate-dependent growth by B. japonicum.
Coulby, J.N., Sternberg, N.L., E.I. du Pont de Nemours and
Co., Experimental Station, Wilmington, Delaware: Locali-
zation of the bacteriophage P1 dam gene.
Craig, N.L., Chen, T, Gringuaz, E., McKown, R., Orle, K.,
Waddell, C., Dept. of Microbiology and Immunology, Uni-
versity of California, San Francisco: att-Tn7-A specific
site for transposon Tn7 insertion.
Dila, D., Trimarchi, R., Raleigh, E.A., New England Biolabs,
Beverly, Massachusetts: Dissection of the mcrB region of
E. coli K12.
Dodd, I.B., Egan, J.B., Dept. of Biochemistry, University of
Adelaide, Australia: Control of lysis and lysogeny in coli-
phage 186.
Dodson, K.W., Berg, D.E., Dept. of Microbiology and Im-
munology, Washington University, St. Louis, Missouri:
Factors controlling the use of IS50 ends during transposi-
tion.
Drivdahl, R., D'Acci, K., Guttman, B., Kutter, E., Evergreen
State College, Olympia, Washington: Inhibition of tran-
scription elongation by the bacteriophage T4 alc gene
product.
Ehrenman, K.,1 2 Belfort, M.,' Povinelli, C.M.,3 Hall, D.H.,3
'Wadsworth Center for Laboratories and Research, New
York State Dept. of Health, 2Dept. of Microbiology and
Immunology, Albany Medical College, New York;
3School of Applied Biology, Georgia Tech, Atlanta: Clus-
tering of mutations in the group I td intron of bacterio-
phage T4.
Eisenstein, B.I., Sweet, D., Vaugh, V., Friedman, D.I., Uni-
versity of Michigan, Ann Arbor: Integration host factor is
J. Roth
required for the DNA inversion controlling phase varia-
tion in E. coli.
Elliott, T., Roth, J., Dept. of Biology, University of Utah, Salt
Lake City: Genetic analysis of heme synthesis in S. typhi-
murium.
Erickson, B.D., Lesley, S.A., Burgess, R.R., McArdle Labo-
ratory for Cancer Research, University of Wisconsin,
Madison: Transcription of the rpsU-dnaG-rpoD operon of
E. coli under different growth conditions.
Fane, B., King, J., Dept. of Biology, Massachusetts Institute
of Technology, Cambridge: Second-site suppressors that
correct missense defects in the folding and chain associ-
ation of the P22 tailspike.
Fornwald, J.,' Schimdt, F.,1.2 Adams, C.,' Rosenberg,
M.,' Brawner, M.,"Smith, Kline and French Laborato-
ries, Dept. of Molecular Genetics, King of Prussia, Penn-
sylvania; 2Dept. of Biochemistry, University of Missouri,
Columbia: Two independently regulated promoters con-
trol transcription of the S. lividans galactose operon.
Forsman, K., GOransson, M., Uhlin, B.E., Dept. of Microbi-
ology, University of Umea, Sweden: Regulatory genes
activating transcription of a pilus operon in E. coli.
French, S.,' Miller, 01., Jr.,' Gourse, R.,2 'Dept. of Biol-
ogy, University of Virginia, Charlottesville; 2Dept. of Ge-
netics, University of Georgia, Athens: Distribution of RNA
polymerases along rrnB and the regulation of rRNA syn-
thesis in E. colt.
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Friedman, S.A., Austin, S.J., NCI-Frederick Cancer Re-
search Facility, Frederick, Maryland: Regulation of the P1
partition operon.
Gary, T.,' Lukas, T.,2 Trupin, M.,' Mosig, G.,"Dept. of
Molecular Biology, 'Howard Hughes Medical Institute,
Vanderbilt University, Nashville, Tennessee: Bacterio-
phage T4 dCTPase is one of three proteins encoded in
the same reading frame by a gene overlapping an origin
of DNA replication.
Gentry, D., Burgess, R., McArdle Laboratory for Cancer Re-
search, University of Wisconsin, Madison: Operon struc-
ture and mutational analysis of the gene encoding the co
subunit of E. coli RNA polymerase.
Glaser, P,' Sezer, O.,' Danchin, A.,' Ladant, D.,2 Pichot,
F.,2 Ullmann, A.,2 'Regulation de ('Expression Gene-
tique, 2Biochimie des Regulations Cellulaires, Institut
Pasteur, Paris, France: Cloning of B. pertussis adenylate
cyclase gene and expression in E. coll.
Goliger, J.A., Roberts, J.W., Dept. of Biochemistry, Cornell
University, Ithaca, New York: Phage 82 0-dependent and
Q-independent antitermination in vitro.
SESSION 4 TRANSPOSONS AND MU
Falvey, E., Grindley, N.D.F., Dept. of Molecular Biophysics
and Biochemistry, Yale University, New Haven, Connecti-
cut: Protein-DNA interactions at the res site of y-d - Analy-
sis of site mutations.
Prentki, R,' Zerbib, D.,2 Jakowec, M.,' Gamas, P.,2 Chan-
dler, M.,2 Galas, D.J.,"Dept. of Molecular Biology, Uni-
versity of California, Los Angeles; 2CNRS, Toulouse,
France: Sequence-specific DNA-protein interactions at
the ends of 1St.
Fuchs, K., Schnetz, K., Rak, B., Institut kir Biologie, Univer-
sitat, Freiburg, Federal Republic of Germany: The mobile
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Gbransson, M., Baga, M., Forsman, K., Normark, S., Uhlin,
D.E., Dept. of Microbiology, University of Umea, Sweden:
Transcriptional organization of a temperature-regulated
pilus gene cluster in E. coli.
Greenberg, J.T., Demple, B., Dept. of Biochemistry and
Molecular Biology, Harvard University, Cambridge, Mas-
sachusetts: Regulation of resistance to oxidative damage
in E. coil-Mutations that suppress the oxyR phenotype.
Griffo, G.,' Gottesman, M.E.,' Oppenheim, A.,2
'Columbia University, New York, New York; 'Hebrew
University, Jerusalem, Israel: Why A.cin-1 mutants fail to
grow on an IHF host.
Gustafsson, C.E.D., LindstrOrn, P.H.R., Hagervall, TG.,
Bjork, G.R., Dept. of Microbiology, University of Lima
Sweden: The promoter of the gene coding for tRNA
(m5U54)-methyltransferase has a nucleotide sequence
similar to that of the P1 promoter of stable RNA.
Guzman-Verduzco, L.M., Kupersztoch, Y.M., Dept. of Mi-
crobiology, University of Texas Health Science Center,
Dallas: Fusion of the heat-stable and the B subunit of the
heat-labile enterotoxins.
DNA element IS5 of E. colt can function as an enhancer
activating gene expression.
DeLong, A., Syvanen, M., Dept. of Microbiology and Mo-
lecular Genetics, Harvard Medical School, Boston, Mas-
sachusetts: Transposon Tn5 mutants with trans-dominant
defects in the regulation of transposition.
Makris, J.C., Nordmann, P., Krebs, M., Reznikoff, W.S.,
Dept. of Biochemistry, University of Wisconsin, Madison:
IS50 outside and inside end mutations.
Kubo, K., Waddell, C., Craig, N.L., Dept. of Microbiology
and Immunology and the Hooper Foundation, University
of California, San Francisco: Tn7 transposition-Choos-
ing the target site.
Darzins, A., Kent, N.E., Buckwalter, M.S., Casadaban, M.J.,
Dept. of Molecular Genetics and Cell Biology, University
of Chicago, Illinois: Mu cis-transposition immunity.
Higgins, P.,' McGovern, V.,' Hillyard, D.,2 'Dept. of Bio-
chemistry, University of Alabama, Birmingham; 2Howard
Hughes Medical Institute, University of Utah Medical
Center, Salt Lake City: Roles of histone-like DNA-binding
proteins in bacteriophage Mu.
Alazard, R.,' Betermier, M.,' Chandler, M.,' Desmet, L.,2
Gama, M.J.,2 Toussaint, A.,2 1Centre de Recherche de
Biochimie et Genetique Cellulaire du CNRS, France;
'Dept. de Biologie Moleculaire, University libre de Brux-
elles, Belgium: Transposase mutants of bacteriophage
Mu.
Craigie, R., Mizuuchi, K., NIDDK, National Institutes of
Health, Bethesda, Maryland: Cleavage of the 3' ends of
Mu is an early step in the Mu DNA strand-transfer reac-
tion.
Adzuma, K., Mizuuchi, K., NIDDK, National Institutes of
Health, Bethesda, Maryland: Involvement of the Mu B AT-
Pase activity in target immunity in the Mu DNA strand-
transfer reaction.
van de Putte, P., Vollering, M., University of Leiden, The
Netherlands: Regulation of Mom expression in bacterio-
phage Mu.
Nagaraja, V., Hattman, S., Dept. of Biology, University of
Rochester, New York: Bacteriophage Mu "late" gene tran-
scription activator, C, is a site-specific DNA-binding pro-
tein.
SESSION 5 TRANSCRIPTION. I. REGULATION BY REPRESSORS AND ACTIVATORS
Haber, R., Adhya, S., NCI, National Institutes of Health, Be-
thesda, Maryland: Mechanism of repression of the gal
operon.
Lee, D.-H., Schleif, R., Dept. of Biochemistry, Brandeis Uni-
versity, Waltham, Massachusetts: Lower limits to the
spacing of two operators for repression in the ara BAD
promoter.
Vogel, J.,' Toussaint, A.,2 Higgins, P,"Dept. of Biochem-
istry, University of Alabama, Birmingham; 2Laboratory of
Genetics, Free University of Brussels, Belgium: Changes
of the Mu repressor protein near its normal carboxyl ter-
minus can confer a super repressor or a temperature-
sensitive repressor phenotype.
Dallmann, G., Papp, P., Orosz, L., Dept. of Genetics, Attila
Jozsef University, Szeged, Hungary: Related repressor
specificity of unrelated phages and autonomy of the
DNA-binding region.
Eliason, J.L., Conley, M.A., Gabriel, G., Sternberg, N., E.I.
du Pont de Nemours and Co., Inc., Wilmington, Dela-
ware: Studies on the specific binding of the C1 repressor
of bacteriophage P1 to DNA.
SESSION 6 POSTER SESSION
Hailing, C., Calendar, R., Dept. of Molecular Biology, Uni-
versity of California, Berkeley: Activation of P2 and P4
late gene transcription by the P4 6 gene product.
Hardy, L.W., Rennell, D., Poteete, A.R., Dept. of Molecular
Genetics and Microbiology, University of Massachusetts
Medical Center, Worcester: Mutational studies of bacte-
riophage T4 lysozyme structure.
Hayes, S., Hayes, C., Dept. of Microbiology, College of
Medicine, University of Saskatchewan, Saskatoon, Can-
ada: Elevated IS2 transposition in RK* strains with defec-
tive A prophage.
Heitman, J., Model, P, Rockefeller University, New York,
New York: Mutagenesis of the EcoRl endonuclease-Al-
leles with altered or reduced cleavage-site specificity,
Highlander, S.K., Engler, M.J., Weinstock, G.M., University
of Texas Medical School, Houston: Expression of the
cloned P. haemolytica leukotoxin in E. coli.
Hoess, R., Wierzbicki, A., Abremski, K., E.I. du Pont de
Nemours and Co., Inc., Central Research and Develop-
Gussin, G.N., Hwang, J.-J., Dept. of Biology, University of
Iowa, Iowa City: Interactions between I repressor and
RNA polymerise- Mutations in pRM quantitatively affect
repression of /DR.
Kim, J., Garges, S., Adhya, S., NCI, National Institutes of
Health, Bethesda, Maryland: Analysis of CRP* mutants-
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Hasan, N. G., Posfai, G., Szybalski, W., McArdle Labora-
tory, University of Wisconsin, Madison: N and nut-depen-
dent stimulation of transcription in the absence of antiter-
mination.
P. Model
A. Toussaint, P. van de Putte
bosome-binding-site activity and antisense RNA control
of the bacteriophage P22 ant gene.
Young, R.,' Raab, R.,2 Depts. of 'Biochemistry and Bio-
physics, 21Bio logy, Texas A & M University, College Sta-
tion: x sdi mutations-Evidence for RNA structure con-
trolling the choice of initiation codons of the S lysis gene.
Olins, P.O., Rangwala, S.H., Monsanto Co., Chesterfield,
Missouri: A bacteriophage ribosome-binding site reveals
a novel mechanism for translation initiation.
Hattman, S., Ives, J., Wall, L., Marie, S., Dept. of Biology,
University of Rochester, New York: The bacteriophage
Mu corn gene appears to specify a translation factor re-
quired for morn gene expression.
O'Connor, M.,4 Falahee, B.,4 Hughes, D.,2 O'Mahony, D.,2
Mims, B.,3 Murgola, E.,3 Tuohy, T,2 Weiss, B.,' Geste-
land, R.,' Thompson, 5.,2 Atkins, J.,''4 'Howard
Hughes Medical Institute and Dept. of Human Genetics,
SESSION 12 PHAGE ASSEMBLY AND DEVELOPMENT
Sternberg, N., Coulby, J., E.I. du Pont de Nemours and
Co., Inc., Experimental Station, Wilmington, Delaware:
Cleavage of the bacteriophage P1 packaging site (pac)
is regulated by adenine methylation and DNA replication.
Randall, S., Eppler, K., Casjens, S., Dept. of Cellular, Viral
and Molecular Biology, University of Utah Medical Cen-
ter, Salt Lake City: Molecular analysis of mutants that af-
fect the frequency of generalized transduction by bacte-
riophage P22.
Xin, W., Feiss, M., Dept. of Microbiology and Genetics
Ph.D. Program, University of Iowa, Iowa City: Interaction
of E. coli integration host factor at the bacteriophage A
cos site.
Kosturko, L.D., Dept. of Molecular Biology and Biochemis-
try, Wesleyan University, Middletown, Connecticut: Inte-
gration host factor binds to A DNA near cos.
University of Utah, Salt Lake City; 2Dept. of Genetics,
Trinity College, Dublin, Ireland; .Dept. of Genetics, Uni-
versity of Texas, M.D. Anderson Hospital, Houston;
4Dept. of Biochemistry, University College, Cork, Ireland:
External suppressors for a -1 frameshift mutant.
Levin, M., Ripepi, L., Hendrix, R., Dept. of Biological Sci-
University of Pittsburgh, Pennsylvania: Transla-
tional frameshifting in bacteriophage A tail genes G and
T.
Ivey, M.R., Steege, D.A., Dept. of Biochemistry, Duke Uni-
versity Medical Center, Durham, North Carolina: Expres-
sion of phage f1 gene VII occurs from an inherently inac-
tive initiation site made functional by translational
coupling.
Lindahl, L., Zengel, J.M., Dept. of Biology, University of
Rochester, New York: Expression of the S10 ribosomal
protein operon of E. coli.
Smith, G.P., Bauer, M., Division of Biological Sciences, Uni-
versity of Missouri, Columbia: Morphogenetic signal se-
quence mos and the orientation of DNA in filamentous
phage.
Russel, M., Rockefeller University, New York, New York:
Filamentous phage assembly.
Gottlieb, P.,' Strassman, J.,' Bamford, D.,2 Mindich, L.'
'Public Health Research Institute, New York, New York;
2University of Helsinki, Finland: Production of polyhedral
particles in E. coif from a cDNA copy of the large ge-
nomic segment of bacteriophage +6.
Villafane, R., King, J., Dept. of Biology, Massachusetts Insti-
tute of Technology, Cambridge: Sites of temperature-sen-
sitive folding (tat) mutations in the P22 tailspike polypep-
tide chain.
Cheng, H.,' Muhlrad, P.J.,' Hoyt, M.A.,' Crowl, R.M.,2
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Echols, H.,"Dept. of Molecular Biology, University of
California, Berkeley; 2Dept. of Molecular Genetics, Hoff-
man-La Roche, Inc., Nutley, New Jersey: Characteriza-
tion of the HfIA protease, a key element in the choice of
lysis or lysogeny by bacteriophage A.
Minnich, S.A., Newton, A., Dept. of Molecular Biology,
Princeton University, New Jersey: Flagellin gene regula-
tion in C. crescentus.
Grossman, A.D., Losick, R., Dept. of Cellular and Develop-
mental Biology, Harvard University, Cambridge, Massa-
chusetts: Mutations affecting extracellular control of spor-
ulation in B. subtilis.
Weinberg, R.A., Zusman, D.R., Dept. of Microbiology and
Immunology, University of California, Berkeley: Charac-
terization of the frizzy mutants of M. xanthus.
Monneron, A.,1 Ladant, D.,2 d'Alayer, J.,1 Ballalou, J.,2
Barzu, 0.,2 Ullmann, A.,2 'Dept. de Biologie Molecu-
laire, 2Dept. de Genetique Moleculaire, Institut Pasteur,
Paris: Is Bordetella pertussis adenylate cyclase of eukary-
otic origin?
SESSION 13 PROTEIN LOCALIZATION AND GENETIC TRICKS
Myers, R., Maloy, S., Dept. of Microbiology, University of Illi-
nois, Urbana: Genetic analysis of protein structure and
function-Mutations that alter the active site of proline
permease in S. typhimurium.
Bergs land, K., Snyder, L., Dept. of Microbiology, Michigan
State University, East Lansing: The go/ site of bacterio-
phage T4-A new type of signal sequence?
Boyd, D., Manoil, C., Beckwith, J., Dept. of Microbiology
and Molecular Genetics, Harvard Medical School, Bos-
ton, Massachusetts: Genetic analysis of the topological
structure of a complex membrane protein, E. coli MaIF
protein.
Garrido, M.C.,' Moreno, F,' Kolter, R.,2 'Hospital Ramon
y Cajal, Madrid, Spain; 2Harvard Medical School, Bos-
ton, Massachusetts: Immunity to the DNA replication in-
hibitor microcin B-17 involves its export from the cell.
Sun, T.-R,' Levengood, 5.,1 Russel, M.,2 Webster, R.E.,1
'Dept. of Biochemistry, Duke University Medical Center,
Durham; 2Rockefeller University, New York, New York:
The products of tol Q, R, and A genes are required for
infection of the filamentous phage and the entry of the E
colicins into E. coll.
Schnaitman, C., Catron, K., Click, E.M., Dept. of Microbiol-
ogy, University of Virginia Medical School, Charlottesville:
Regulation of outer membrane protein expression cou-
pled to protein translocation.
Strauch, K.L., Beckwith, J., Dept. of Microbiology and Mo-
lecular Genetics, Harvard Medical School, Boston, Mas-
sachusetts: Mutations that reduce proteolysis in the peri-
plasm of E. coll.
Groisman, E.A., Pagratis, N., Richard, B.H., Casadaban,
M., Dept. of Molecular Genetics and Cell Biology, Univer-
sity of Chicago, Illinois: In vivo DNA cloning and protein
identification in enteric bacteria with mini-Mu trans-
posons.
Hasan, N., Szybalski, W., McArdle Laboratory, University of
Wisconsin, Madison: Multistep method utilizing Mboll-
and Fok I-mediated precise deletions with removal of up
to 12 base pairs per step.
Sauer, B., Henderson, N., E.I. du Pont de Nemours and
Co., Experimental Station, Wilmington, Delaware: Cycli-
zation of linear transforming DNA in E. coli by Cre-me-
diated site-specific recombination.
Sznyter, L.A.,' Howard, K.A.,2 Slatko, B.E.,1 Moran, L.S.,1
Brooks, J.E.,1 'New England Biolabs, Beverly, 2Dept. of
Biochemistry, Brandeis University, Waltham, Massachu-
setts: Sequence and characterization of the Ddel restric-
tion- modification system.
Molecular Biology of Mitochondria and Chloroplasts
August 25-August 30
ARRANGED BY
John E. Boynton, Duke University
Ronald A. Butow, University of Texas Health Sciences Center
David A. Clayton, Stanford University
Nicholas W. Giliham, Duke University
286 participants
The Molecular Biology of Mitochondria and Chloroplasts meeting, held in August,
1987, was the first such international conference on the molecular aspects of the
biogenesis of both organelles since a similar meeting was held in Munich,
Germany in 1976. Approximately 250 presentations were given, of which about
30% were platform talks and the remaining were poster presentations. The major
topics, which covered a wide range of organisms, included the organization,
expression, and replication of organelle genomes; the targeting and assembly of
nuclear-encoded organelle macromolecules; interactions between organelle and
nuclear genomes; and the evolution of organelle genomes. The meeting provided
a unique opportunity to compare and contrast the remarkably diverse ways in
which chloroplasts and mitochondria solve the fundamental problems of
arranging, expressing, and replicating their genomes and assembling their various
constitutents encoded both by the organelle and nuclear genomes. A major thrust
of current research seeks to understand the controls that operate to coordinate
organelle biogenesis with nuclear and organelle gene expression.
This meeting was supported in part by Amoco Corporation; Ciba-Geigy
Corporation, Del Monte, Inc.; E.I. du Pont De Nemours & Company; Monsanto
Company; Smith Kline & French Laboratories; U.S. Department of Energy; U.S.
Department of Agriculture; Zoecon Research Institute/Sandoz Crop Protection
Corporation; National Science Foundation; Phillips Petroleum Company; Pioneer
Hi-Bred International, Inc.; and the following divisions of the National Institutes of
Health: National Institute of Diabetes and Digestive and Kidney Diseases; National
Institute of General Medical Sciences.
SESSION 1A OPENING LECTURES
Chairman: D. von Wettstein, Carlsberg Laboratory
P. Slonimski, Centre de Genetique Moleculaire du CNRS: Mitochondria
L. Bogorad, Biological Laboratories Harvard University: Chloroplasts
SESSION 1B REPLICATION OF ORGANELLE GENOMES
Chairman: M. Simpson, State University of New York, Stony Brook
Ryan, K.A., Englund, P.T Dept. of Biological Chemistry,
Johns Hopkins School of Medicine, Baltimore, Maryland:
Replication of kinetoplast DNA in trypanosomes.
Wu, M., Lou, J.K., Nie, Z.Q., Wang, Z.F., Dept. of Biological
Sciences, University of Maryland, Baltimore: Initiation of
chloroplast DNA replication in C. reinhardtii.
Chang, D.D., Topper, J.N., Clayton, D.A., Dept. of Pathol-
ogy, Stanford University School of Medicine, California:
Sequence analysis of a nuclear gene that encodes the
RNA component of an mtRNA processing enzyme.
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SESSION 2 GENES AND GENOMES
Chairman: E. Stutz, Universite de Neuchatel
Ohyama, K.,1 Kohchi, T.,' Umesono, K.,2 Ozeki, H.,2
'Research Center for Tissue and Cell Culture, Faculty of
Agriculture, 2Dept. of Biophysics, Faculty of Science,
Kyoto University, Japan: Entire gene organization of the
M. polymorpha chloroplast genome and gene expression
(trans-splicing).
Shinozaki, K., Sugiura, M., Center for Gene Research, Na-
goya University, Japan: Organization and expression of
tobacco chloroplast genes.
Fromm, H., Galun, E., Edelman, M., Dept. of Plant Genet-
ics, Weizmann Institute of Science, Rehovot, Israel: Mo-
lecular genetics of rRNA-dependent spectonomycin re-
sistance in Nicotiana chloroplasts.
Clark-Walker, G.D., Research School of Biological Sci-
ences, Australian National University, Canberra, Aus-
tralia: Creation of rearranged mtDNA in S. cerevisiae-
Consequences for gene expression and genome evolu-
tion.
Wolstenholme, D.R., Okimoto, R., Macfarlane, J.L., Clary,
D.O., Garey, J.R., Wahleithner, J.A., Dept. of Biology,
SESSION 3 POSTER SESSION
Replication
Barat-Gueride, M.,' Mignotte, B..' Delain, E.,2 Mounolou,
J.C.,' Laboratoire de Biologie Generale, University
Paris-Sud, 2Laboratoire de Microscopie Cellulaire et Mo-
leculaire, Institut Gustave Roussy, France: A mitochondr-
ial protein with a high affinity for supercoiled DNA.
Bendixen, B., Flatmark, T, Dept. of Biochemistry, University
of Bergen, Norway: Mitochondrial thymidine kinase, a
regulator of mtDNA replication?
Cairns, S.S., Bogenhagen, D.E., Dept. of Pharmacology,
State University of New York, Stony Brook: Detection and
analysis of DNA-binding activities in lysates of X. laevis
mitochondria.
de Haas, J.M., Kors, F., Kool, A., Hille, J., Nijkamp, H.J.J.,
Dept. of Genetics, Free University, Amsterdam, The Neth-
erlands: Analysis of putative P. hybrids chloroplast and
mitochondrial replication origins.
Dunon-Bluteau, D.,' Cordonnier, A.,' Brun, G.,2 'Section
de Biologie, Institut Curie, Paris, 2Laboratoire de Bioch-
imie, Ecole Normale Superieure de Saint-Cloud, France:
In vitro replication of Xenopus mtDNA- Initiation and
elongation of the H strand.
Ragnini. A., Fukuhara, H., Institut Curie Section de Biolo-
gie, Centre universitaire, Orsay, France: Amplification of
mtDNA segments in the petite-negative yeast K. lactis.
Kaguni, L.S., Wernette, C.M., Conway, M.C., Dept. of Bio-
chemistry, Michigan State University, East Lansing: Struc-
tural and catalytic features of the mtDNA polymerase
from D. melanogaster embryos.
Cummings, 0.W.,' King, TC.,' Holden, J.A.,' Buzan, J.,'
Low, R.L.,1 .2 Depts. of 'Pathology, 2Biological Chemis-
try, Washington University School of Medicine, St. Louis,
Missouri: The bovine mitochondrial endonuclease prefers
a conserved sequence tract in the D-loop region.
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University of Utah, Salt Lake City: Mitochondrial ge-
nomes of lower invertebrates.
Lonsdale, D.M., Rottmann, W., Dept. of Molecular Genet-
ics, Plant Breeding Institute, Cambridge, England: T-
URF13-A gene uniquely associated with the mitochon-
drial genome and male sterility in the T cytoplasm of
maize.
Pring, D.R.,' Gengenbach, B.G.,2 Kennell, J.C.,' Wise,
R.R,"USDA-ARS, Dept. of Plant Pathology, University
of Florida, Gainesville; 2Dept. of Agronomy and Plant
Genetics, University of Minnesota, St. Paul: Mitochondria!
mutants of T (Texas) cytoplasm maize.
Levings, C.S., Dept. of Genetics, North Carolina State Uni-
versity, Raleigh: Cytoplasmic male sterility in maize.
Hanson, M.R.,' Young, E.G.,3 Rothenberg, M.,2 Nivison,
H.T.,1 Pruitt, K.D.,' Sections of 'Genetics and Develop-
ment, 2Biochemistry, Cellular and Molecular Biology,
Cornell University, Ithaca, New York; 3Dept. of Biology,
University of Virginia, Charlottesville: An abnormal fused
mitochondrial gene is associated with cytoplasmic male
sterility in Petunia.
Michaels, G.S.,' Laipis, P.J.,2 Hauswirth, W.W.,3
'Laboratory of Molecular Genetics, National Institute of
Child Health and Human Development, Bethesda, Mary-
land; Depts. of 2Biochemistry and Molecular Biology,
3lmmunology and Medical Microbiology, University of
Florida, Gainesville: Developmental accumulation of mito-
chondria and mtDNA in mammalian oocytes.
Solignac, M.,' Genermont, J.,2 Monnerot, M.,2 Mounolou,
J.C., 2 Laboratoire de Biologie et Genetique Evolutives,
CNRS, 2Universite de Paris, Orsay, France: How do Dro-
sophila maintain repeated sequences in the noncoding
region of their mtDNA?
Nass, M.M.K., Dept. of Radiation Therapy, University of
Pennsylvania School of Medicine, Philadelphia: Mammal-
ian mtDNA replication and protein synthesis patterns in
response to heat shock.
Nielsen, B., Meeker, R., Tewari, K.K., Dept. of Molecular Bi-
ology and Biochemistry, University of California, Irvine: In
vitro replication of pea chloroplast DNA recombinants
confirms location of the replication origins in pea chloro-
plast DNA.
Sbisa, E.,' Loguercio Polosa, P.,2 Cantatore, P.,2 Saccone,
C.,2 'CSMME CNR, Bari, 2Dept. of Biochemistry/Molec-
ular Biology, University of Bari, Italy: Characterization of
H-strand transcripts in the replication origin of rat mtDNA.
Silliker, M.E., Cummings, D.J., Dept. of Microbiology and
Immunology, University of Colorado Health Sciences
Center, Denver: Analysis of reverse transcriptase activity
in wild-type strains and a temperature-sensitive mutant of
P. anserina.
Keilbaugh, S.A.,' De Giorgi, C.,2 Simpson, M.V.,"Dept.
of Biochemistry, State University of New York, Stony
Brook; 2Dept. of Biochemistry and Molecular Biology,
E. Stutz, R. Hal lick, C. Price, D. von Wettstein
University of Bari, Italy: Studies of DNA polymerase y us-
ing a supercoiled template.
Surzycki, S.J., Fong, S., Hong, T.-H., Opperman, T., Dept.
of Biology, Indiana University, Bloomington: Identification
and analysis of expression of chloroplast genes involved
in transcription, DNA replication, and repair in C. rein-
hardtii.
Hoke, G.D., Ledwith, B.J., Van Tuyle, G.C., Dept. of Bio-
chemistry and Molecular Biophysics, Virginia Common-
wealth University, Richmond: Binding parameters and
functional characteristics of the rat mtDNA-binding pro-
tein P16.
Genes and Genomes
Boer, PH., Gray, M.W., Dept. of Biochemistry, Dalhousie
University, Halifax, Canada: Scrambled rRNA gene
pieces in algal mitochondria.
Bryant, D.A., Annarella, M.B., Stirewalt, V.L., Dept. of Mo-
lecular and Cell Biology, Pennsylvania State University,
University Park: The atpD gene of C. paradoxa is en-
coded by cyanellar DNA and there is no intron in its atpF
gene.
Cantatore, P., Roberti, M., Loguercio Po losa, P., Rainaldi,
G., Saccone, C., Gadaleta, M.N., Dept. of Biochemistry
and Molecular Biology, University of Bari, Italy: Organiza-
tion and expression of P. lividus mtDNA.
Csaikl, F,' Horvath, S.,1 Csaikl, Institutes of
'Tumorbiology, 2Applied and Experimental Oncology, Vi-
enna, Austria: Mitochondria! genome of the guinea pig
(C. porcellus).
Fauron, C., Howard Hughes Medical Institute, University of
Utah, Salt Lake City: Maize mtDNA-A comparison of re-
striction maps in various types.
Howell, N., Nalty, N.S., Gilbert, K., Dept. of Radiation Ther-
apy, University of Texas Medical Branch, Galveston: Mu-
tational analysis of the mitochondria! cytochrome b gene.
Jacobs, H.T., Elliott, D.J., Math, V.R., Farquharson, A.,
Dept. of Genetics, University of Glasgow, Scotland: Se-
quence and gene organization of sea urchin mtDNA.
Joyce, P.B.M.,' Spencer, D.F.,' Bonen, L.,2 Gray, M.W.,'
'Dept. of Biochemistry, Dalhousie University, Halifax,
2Dept. of Biology, University of Ottawa, Canada: Wheat
mitochondria! tRNA genes.
Kipp, D.V., Kuhl, S.A., Birky, C.W., Dept. of Molecular Ge-
netics, Ohio State University, Columbus: Isolation and
characterization of leukoplast DNA from P. uvella.
KOck, U., Lehrstuhl fOr Allgemeine Botanik, Ruhr Universi-
tat Bochum, Federal Republic of Germany: mtDNA from
a chlorella-like alga- Isolation and characterization of or-
ganelle genes.
Lee, R.W.,1 Dumas, C.,2 Lemieux, C.,2 Turmel, M.,2
'Dept. of Biology, Dalhousie University, Halifax, 2Dept.
de biochimie, Faculte des sciences et genie, University
Laval, Qu6bec, Canada: Physical and gene mapping of
the C. moewusii mitochondrial genome.
Leon-Mejia, P, Bedinger, P., Walbot, V., Dept. of Biological
Sciences, Stanford University, California: Molecular char-
acterization of the 2.3-kb linear plasmid of maize mito-
chondria.
LOffelhardt, W.,' Mucke, H.,1 Janssen, I.,1 Pfanzagl, B.,'
Berenguer, J.,2 de Pedro, M.A.,2 Michalowski, C.,3 Boh-
nert, H.J.,3 'Institut fOr Allgemeine Biochemie der Univ-
ersitat Wien and Ludwig Boltzmann-Forschungsstelle fur
Biochemie, Vienna, Austria; 2Centro de Biologic Molecu-
lar, Universidad Autonoma de Madrid, Spain; 3Dept. of
Biochemistry, University of Arizona, Tucson: Molecular bi-
ology of the cyanelles from C. paradoxa.
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Masters, B.S., Stohl, L.L., Clayton, D.A., Dept. of Pathology,
Stanford University School of Medicine, California: Yeast
mtRNA polymerase is homologous to those encoded by
bacteriophages T3 and T7.
Morin, G.B., Cech, T.R., Dept. of Chemistry and Biochemis-
try, University of Colorado, Boulder: The mitochondrial te-
lomeres of six species of Tetrahymena form four groups
possessing unusual features.
Okimoto, R., Wostenholme, D.R., Dept. of Biology, Univer-
sity of Utah, Salt Lake City: C. elegans mtDNA.
Rasmussen, J.L., Hanson, M.R., Section of Genetics and
Development, Cornell University, Ithaca, New York: An
ORF in the 3' flank of a Petunia CMS-associated gene.
Robertson, D.,' Woessner, J.P.,' Gil lham, N.W,' Boynton,
J.E.,2 Depts. of 'Zoology, 2Botany, Duke University,
Durham, North Carolina: Molecular analysis of C. rein-
hardtii point mutants mapping in the chloroplast-encoded
atpB gene encoding the (3-subunit of the ATP synthase.
Cattolico, R.A., Shivji, M.S., Dept. of Botany, University of
Washington, Seattle: Chloroplast DNA analysis of chrom-
ophytic and rhodophytic algae.
Siculella, L., Palmer, J.D., Dept. of Biology, University of
Michigan, Ann Arbor: Physical and gene organization of
the sunflower mitochondrial genome.
Suyama, Y., Ziaie, Z., Jenney, F., Dept. of Biology, Univer-
sity of Pennsylvania, Philadelphia: Tetrahymena mito-
chondrial genome-tRNA genes, protein-coding se-
quences, genome organization, and the genetic code.
Turmel, M., Bergeron, A., Boulanger, J., Lemieux, C., Dept.
de biochimie, Faculty de sciences et genie, Universite
Laval, Quebec, Canada: Sequence analysis of two re-
gions of major deletion/addition differences in the chloro-
plast genomes of C. eugametos and C. moewusii.
Wahleithner, J.A., Wolstenholme, D.R., Dept. of Biology,
University of Utah, Salt Lake City: Ribosomal protein S14
genes in broad bean mtDNA.
Yamada, T., Mitsubishi-Kasei Institute of Life Sciences, To-
kyo, Japan: Rearrangements of the chloroplast ge-
nome-Unusual organization of the Ch/ore//a chloroplast
rRNA operons.
Transmission, Segregation, and Recombination
Aviv, D., Galun, E., Dept. of Plant Genetics, Weizmann Insti-
tute of Science, Rehovot, Israel: Can mitochondria) com-
position of cybrid plants be controlled?
Chiu, W.-L.,' Stubbe, W.,2 Sears, B.B.,' 'Dept. of Botany
and Plant Pathology, Michigan State University, East Lan-
sing: Institute of Botany, University of Dusseldorf, Fed-
eral Republic of Germany: The organelle genome deter-
mines the extent of biparental plastid inheritance in
Oenothera.
Foury, F., Genga, A., Lahaye, A., Van Dyck, E., Laboratory
of Enzymology, Belgium: Characterization of nuclear
genes involved in recombination and/or replication of
yeast mtDNA.
Gross, S.R., Mary, A., Levine, RH., Dept. of Biochemistry,
Duke University, Durham, North Carolina: Amplification
of short DNA sequences in circular derivatives of the mi-
tochondria] chromosome of Neurospora.
Haring, M.A., Hille, J., Nijkamp, H.J.J., Dept. of Genetics,
Free University, Amsterdam, The Netherlands: Chloro-
plast transformation-Development of integrating and
replicating vectors.
Harris, E.H., Boynton, J.E., Gillham, N.W,, Depts. of Botany
and Zoology, Duke University, Durham, North Carolina:
Genetic and physical mapping of antibiotic resistance
mutations in C. reinhardtii.
Hurko, 0.,' Reynafarje, B.,2 Kuncl, R.,' McKee, L.,' Feld-
man, E.,2 Depts. of 'Neurology, 2Biological Chemistry,
Johns Hopkins University School of Medicine, Baltimore,
Maryland: Defective cytochrome oxidase activity in sib-
lings from a pedigree suggestive of matroclinal inheri-
tance and heteroplasmy.
King, M.P., Attardi, G., Division of Biology, California Insti-
tute of Technology, Pasadena: Transmitochondrial human
cell lines-A new approach to mitochondrion-mediated
transformation.
Kuroiwa, T.,' Nakamura, S.,2 'Dept. of Biology, Faculty of
Science, University of Tokyo, 2Dept. of Cell Biology, Na-
tional Institute for Basic Biology, Okazaki, Japan: Poly-
peptides responsible for maternal inheritance of chloro-
plast DNA in C. reinhardtii.
Matagne, R.F., Bovie, C., Loppes, R., Dept. of Botany, Uni-
versity of Liege, Belgium: Transmission of chloroplast
genes and mtDNA in diploids resulting from artificial fu-
sion or sexual crosses between C. reinhardtii and
C. smithii.
Morawiec, A., Gerber, D., Perlman, F, Dept. of Molecular
Genetics, Ohio State University, Columbus: Studies of pe-
tite formation in yeast mitochondria.
Kaplan, S.A., Blasko, K., Johnson, E.M., Lim, P. -O., Wolf-
son, R., Sears, B.B., Dept. of Botany and Plant Pathol-
ogy, Michigan State University, East Lansing: The Oen-
othera plastome mutator line is heteroplasmic for
chloroplast DNA restriction-fragment-length polymor-
phisms.
VanWinkle-Swift, K.P., Salinger, A.P., Dept. of Biology, Texas
A & M University, College Station: Loss of mte-derived
chloroplast DNA is associated with a lethal allele in C.
monoica.
Wenzlau, J.,' Pohlman, J.,2 Morawiec, A.,' Dietrich, R.,'
Butow, R.,2 Perlman, R,' 'Dept. of Molecular Genetics,
Ohio State University, Columbus; 2Dept. of Biochemistry,
University of Texas Health Science Center, Dallas: Con-
version of optional sequences in mitochondrial crosses.
Uthayashanker, R., Zassenhaus, H.P., Dept. of Microbiol-
ogy, St. Louis University, Missouri: Effect of nuclease defi-
ciency on mitochondria] recombination and gene conver-
sion.
SESSION 4 TRANSMISSION, SEGREGATION, AND RECOMBINATION OF ORGANELLE GENOMES
Chairman: R. Sager, Sidney Farber Cancer Institute
Coleman A W , Brown University, Providence, Rhode Is-
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land: Thoughts on how/why cells control plastid genome
number.
Boynton, J.E., Harris, E.H., Gil lham, N.W., Depts. of Botany
and Zoology, Duke University, Durham, North Carolina:
Mating type and organelle genome transmission in C.
reinhardtii.
Lemieux, C., Gauthier, A.,' Lee, R.W.,2 Lemieux, B.,' Tur-
mel, M.,' 'Dept. de biochimie, Faculte des sciences et
genie, Universite Laval, Quebec, 2Dept. of Biology, Dal-
housie University, Halifax, Canada: Intron-mediated gene
conversion in the chloroplast of Chlamydomonas.
Spreitzer, R.J., Zhang, D., Chastain, C.J., Dept. of Agricul-
ture and Biochemistry, University of Nebraska, Lincoln:
Heteroplasmicity mediates informational suppression of
chloroplast nonsense mutations in Chlamydomonas.
Perrin, A., Monteilhet, C., Colleaux, L., Dujon, B., Center for
Molecular Genetics, University Pierre et Marie Curie, Gif-
sur-Yvette, France: Biochemical activity of an intron-en-
coded transposase of S. cerevisiae.
Maliga, R, Fejes, E., Engler, D., Advanced Genetic Sci-
ences, Inc., Oakland, California: Extensive homologous
chloroplast DNA recombination in a Nicotiana somatic
hybrid.
Laipis, P.J., Hauswirth, W.W., Depts. of Biochemistry and
Molecular Biology and Immunology and Medical Microbi-
ology, University of Florida, Gainesville: Transmission ge-
netics of mtDNA in heteroplasmic animals.
Perlman, RS.," Butow, R.A.,2 'Dept. of Molecular Genet-
ics, Ohio State University, Columbus; 2Dept. of Biochem-
istry, University of Texas Health Science Center, Dallas:
Recombination processes in yeast mitochondria.
SESSION 5 EXPRESSION OF ORGANELLE GENES. I. INTRON SPLICING
Chairman: P. Perlman, Ohio State University
Benne, R.,' Sloof, P.,' de Vries, B.F.," Hakvoort, T.,2 Mu-
ijsers, A.O.,2 'Laboratory of Biochemistry, 2Section for
Molecular Biology and Enzymology, University of Amster-
dam, The Netherlands: Unusual features of kinetoplast
DNA from trypanosomes-Novel mechanism of gene
expression (RNA-editing), the absence of tRNA genes,
and the variable presence of a cytochrome oxidase sub-
unit gene.
Wolf, K., Merlos-Lange, A.M., Ahne, A., Zimmer, M., Institut
fur Genetik und Mikrobiologie der Universitat Munchen,
Federal Republic of Germany: Introns as mobile genetic
elements-DNA splicing and horizontal gene transfer.
Akins, R.A., Cherniack, A., Lambowitz, A.M., Depts. of Mo-
lecular Genetics and Biochemistry, Ohio State University,
Columbus: A protein component required for splicing
group I introns in Neurospora mitochondria is mitochon-
dria? tyrosyl-tRNA synthetase or some derivative thereof.
Muller, Schmelzer, C.,' Augustin, S.,1.2
Schweyen, R.J.,2 Institut fur Genetik und Mikrobiologie,
Universitat MOnchen, Federal Republic of Germany: In-
SESSION 6 POSTER SESSION
Expression I. Introns and Splicing
Bordonne, R., Ame, J.C., Schwob, E., Dirheimer, G., Mar-
tin, R.R, Laboratory of Biochemistry, CNRS, Strasbourg,
France: Expression of yeast mitochondrial genes and
characterization of RNA processing activities.
Hildebrand, M.,' Hallick, R.B.,' Passavant, C.W.,2 Bo-
urque, D.P.,' Depts. of Biochemistry, Molecular and Cel-
lular Biology, and Nutrition and Food Sciences,
'University of Arizona, Tucson; 2Dept. of Microbiology,
Oregon State University, Corvallis: Trans-splicing in chlo-
roplasts-The rps12 loci of N. tabacum.
Carignani, G.,' Bergantino, E.,' Netter, P.,2 'Istituto di
Chimica Biologic deltUniversita, Padova, Italy: 2Centre
de Genetique Moleculaire du CNRS, Gif-sur-Yvette,
France: Analysis of cis- and trans-acting mutations affect-
ing the splicing of two class II introns.
Collins, R.A., Dept. of Botany, University of Toronto, Can-
ada: Conserved secondary structures outside the "core"
stitut fur Mikrobiologie und Genetik, Universitat Wien,
Austria: Catalytic activities of group II introns in vitro.
Jacq, C., Banroques, J., Becam, A., Creusot, F, Goguel, V.,
Mendelzon, J., Perea, J., Center for Molecular Genetics,
CNRS, Gif-sur-Yvette, France: Intron- encoded RNA matu-
rases of yeast mitochondria. In vivo and in vitro proper-
ties of the bI4 RNA maturase.
Peebles, C.L.,' Benatan, E.J.,' Jarrell, K.A.,2 Dietrich,
R.C.,2 Uhl, TM.,2 Perlman, RS.,2 'University of Pitts-
burgh, Pennsylvania; 2Ohio State University, Columbus:
Cis and trans reactions of mutant and wild-type forms of
a group II intron.
Montandon, RE., Stutz, E., Laboratoire de Biochimie, Univ-
ersite de Neuchatel, Switzerland: E. gracilis chloroplast
DNA-Analysis of the spliced tutA-ORF206 mRNA.
Kuck, U., Lehrstuhl fur Allgemeine Botanik, Ruhr Universi-
tat Bochum, Federal Republic of Germany: The discon-
tinuous chloroplast gene for the P700 chlorophyll a-apo-
protein from C. reinhardtii- Evidence for trans-splicing of
pre-mRNAs.
in a large subclass of group I introns.
Serizawa, N., Dobinson, K.F., Lambowitz, A.M., Dept. of
Molecular Genetics and Biochemistry, Ohio State Univer-
sity, Columbus: Characterization of cyt-4, a Neurospora
nuclear gene required for processing of mitochondrial
rRNA.
Seraphin, B., Simon, M., Faye, G., Institut Curie-Biologie,
Centre Universitaire, Orsay, France: MSS18, a yeast nu-
clear gene involved in the splicing of intron al5fl of the
mitochondrial COX1 transcript.
Gampel, A., Tzagoloff, A., Dept. of Biological Sciences, Co-
lumbia University, New York, New York: A nuclear gene
product promotes splicing of the terminal intervening se-
quence of mitochondrial cytochrome b pre-mRNA.
Altamura, N., Ben-Asher, E., Dujardin, G., Groudinsky, 0.,
Herbert, C.J., Kermorgant, M., Labouesse, M., Slonimski,
RR, Center for Molecular Genetics, CNRS, Gif-sur-Yvette,
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France: NAM1 and NAM2-Nuclear genes involved in
mtRNA splicing and translation.
Kreike, J.,1.2 Schmidt, N.,' S011ner, T.,' Schweyen, R.J.,2
'Institute for Genetics and Microbiology, University of Mu-
nich, Federal Republic of Germany, 2Institute for Microbi-
ology and Genetics, University of Vienna, Austria: In-
volvement of nuclear genes in mtRNA splicing in yeast.
Morales, M.J., Hollingsworth, M.J., Chen, J.-Y., Martin,
N.C., Dept. of Biochemistry, University of Texas Health
Science Center, Dallas: Nuclear and mitochondrial gene
products necessary for endonucleolytic cleavages that
liberate mitochondria' tRNAs from their primary tran-
scripts.
Kohchi, T.,' Ogura, Y.,' Ohyama, K.,' Umesono, K.,2 Na-
kahigashi, K.,2 Ozeki, H.,2 'Research Center for Cell
and Tissue Culture, Faculty of Agriculture, 2Dept. of Bio-
physics, Faculty of Science, Kyoto University, Japan: Bio-
genesis of chloroplast ribosomes- In vivo expression of a
trans-split gene, rps12, for chloroplast ribosomal protein
S12.
Osiewacz, H.D., Kuck, U., Esser, K., Lehrstuhl fur Allge-
meine Botanik, Ruhr Universitat, Bochum, Federal Re-
public of Germany: Expression of an ORF encoded by
the first intron (p1DNA) of the gene coding for cyto-
chrome c oxidase subunit I of P. anserina.
Cushman, J.C., Price, C.A., Waksman Institut of Microbiol-
ogy, Rutgers University, Piscataway, New Jersey: Devel-
opment-specific splicing of plastid genes in Euglena.
Shaw, J.M., Simpson, L., Dept. of Biology and Molecular
Biology Institute, University of California, Los Angeles:
RNA editing of maxicircle ORF 3/4 and C011 mRNAs in L.
tarentolae- Evidence for translation of C011 mRNA
through the frameshift region.
Hofmann, T.J., Dake, E., Zassenhaus, H.P., Dept. of Micro-
biology, St. Louis University, Missouri: RNA processing
catalyzed by mitochondrial extracts prepared from a
nucl yeast strain.
Expression II and Ill. Transcriptional and
Translational Regulation
Akada, S., Xu, Y.Q., Machii, H., Kung, S.D., Agricultural
Biotechnology Center and Dept. of Botany, University of
Maryland, College Park: Studies of rbcL transcription ter-
mination in heterologous and homologous systems.
Bai, U., Brody, M., Dept. of Biological Sciences, Hunter
College, City University of New York, New York, New
York: II. Ricinus chloroplasts-Source of a lectin/f3-galac-
tosidase; in vitro translation studies.
Balaji, K.S.K., Rajamanickam, C., Dept. of Biochemistry,
School of Biological Sciences, Madurai Kamaraj Univer-
sity, India: Transcriptional stimulation of CYC1 gene
expression by hemin in cells of S. cerevisiae-Possible
mediation by a hemoprotein.
Bendich, A.J., Dept. of Botany, University of Washington,
Seattle: Constitutive transcription in mitochondria and
chloroplasts.
Berends, T., Gamble, P.E., Muilet, J.E., Dept. of Biochemis-
try and Biophysics, Texas A & M University, College Sta-
tion: Characterization of the barley chloroplast transcrip-
tion units containing psaB-psaB and psbD-psbC.
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Bonen, L., Bird, S., Dept. of Biology, University of Ottawa,
Canada: Transcript analysis of wheat mitochondrial pro-
tein-coding genes.
Brody, M., Bai, U., Dept. of Biological Sciences, Hunter
College, City University of New York, New York, New
York: I. Ricinus chloroplasts-Source of a lectin/f3-galac-
tosidase; in vitro translation studies.
Brown, T.A., Dyson, N.J., Waring, R.B., Davies, R.W., Dept.
of Biochemistry and Applied Molecular Biology, UMIST,
Manchester, England: The Mitochondria' ribosomal RNA
molecules of A. nidulans.
Auchincloss, A.H., Manolson-Kuhl, P., Brown, C.G., Dept.
of Biology, McGill University, Montreal, Canada: Tran-
scription initiation sites on the soybean mitochondria' ge-
nome.
ErdOs, G.,' Chen, H.-Q.,' Buetow, D.E.,'2 Depts. of
'Physiology and Biophysics, 2Plant Biology, University of
Illinois, Urbana: Developmental-stage-specific controls
regulate LHCII nuclear gene expression during light-in-
duced chloroplast development in cultured soybean
cells.
Castora, F.J., Brothers, P.N., Dept. of Chemistry, University
of Maryland Baltimore County, Catonsville: A transcrip-
tion promoter of rat mtDNA found using prokaryotic pro-
moter identification vector pK01.
P. Slonimski
Chanut, F., Grabau, E.A., Geste land, R.F., Howard Hughes
Medical Institute, University of Utah Medical Center, Salt
Lake City: Organization and transcription of the aATPase
gene of soybean mitochondria.
Chiu, I., Fink, G.R., MIT/Whitehead Institute, Cambridge,
Massachusetts: The cytoplasmic and mitochondrial histi-
dine-tRNA synthetases can functionally replace each
other in vivo.
Chomyn, A., Tar le, I., Strathman, M., Attardi, G., Division of
Biology, California Institute of Technology, Pasadena:
Translational regulation of mitochondrial gene expression
in human cells.
Dens low, N.D.,' LiCata, V.J.,2 Gualerzi, C.,3 O'Brien,
T.W.,"University of Florida, Gainesville; 'Johns Hopkins
University, Baltimore, Maryland; 3Max-Planck-Institute for
Molecular Genetics, Berlin, Federal Republic of Ger-
many: Interaction of E. coli IF3 with bovine mitochondrial
ribosomes.
Feagin, J.E.,1 Shaw, J.,2 Simpson, L.,2 Stuart, K.,'
'Seattle Biomedical Research Institute, Washington;
'Dept. of Biology, University of California, Los Angeles:
Addition of nucleotides within cytochrome b transcripts of
kinetoplastids.
Fisher, R.R, Topper, J.N., Clayton, D.A., Dept. of Pathology,
Stanford University School of Medicine, California: Pro-
moter selection of human mitochondria involves binding
of a transcription factor to orientation-independent up-
stream regulatory elements.
Gamble, PE., Berends, T, Mullet, J.E., Dept. of Biochemis-
try and Biophysics, Texas A & M University, College Sta-
tion: Illumination of dark-grown barley causes the accu-
mulation of two RNAs that hybridize to the psbD-psbC
transcription unit.
Gounaris, I., Price, C.A., Waksman Institute of Microbiology,
Rutgers University, Piscataway, New Jersey: Plastid
genes and gene transcripts in chromoplasts and chloro-
plasts of C. annuum.
Hadjeb, N., Price, C.A., Waksman Institute of Microbiology,
Rutgers University, Piscataway, New Jersey: Chromo-
plast-specific proteins in C. annuum.
Herrin, D.L., Battey, J.F., Greer, K.L., Schmidt, G.W., Bot-
any Dept., University of Georgia, Athens: Pigment control
of LHCII expression in Chlamydomonas.
Hos ler, J.P., Boynton, J.E., Gillham, N.W., Depts. of Botany
and Zoology, Duke University, Durham, North Carolina:
Posttranscriptional regulation of protein synthesis in the
chloroplast of the green alga C. reinhardtii.
Kobayashi, H.,' Ngernprasirtsiri, J.,2 Macherel, D.,2 Aka-
zawa, T.,2 'Radioisotope Center, 'Research Institute for
Biochemical Regulation, Nagoya University, Japan: Tran-
scriptional regulation of genes for photosynthesis in non-
photosynthetic plastids.
Kobayashi, H.,' Via le, A.M.,' Valle, E.,2 Akazawa, T.,2
'Radioisotope Center, 'Research Institute for Biochemi-
cal Regulation, Nagoya University, Japan: Gene expres-
sion and subunit assembly of RuBisCO.
Liu, X-Q., Hosier, J.P., Boynton, J.E., Gillham, N.W., Depts
of Botany and Zoology, Duke University, Durham, North
Carolina: Preferential translation of chloroplast ribosomal
proteins in C. reinhardtii.
Neuhaus, H., Hughes, J.E., Link, G. University of Bochum,
Plant Cell Physiology, Federal Republic of Germany:
Structure, transcription, and expression in E. colt and in
vivo of the split trnK gene from mustard (S. a /ba) chloro-
plasts.
Thomas, F., Briat, J.F., Massenet, 0., Seyer, P, Mache, R.,
Laboratoire de Biologie Moleculaire Vegeta le, CNRS,
Universite de Grenoble, France: Expression of the chlo-
roplastic St 0-like operon in spinach.
Mannan, M.R., Krishnan, M., Gnanam, A., School of Bio-
logical Science, Madurai Kamaraj University, India: Syn-
thesis of polypeptides associated with PSI by the isolated
S. vulgare chloroplast.
Thompson, R.J., Mosig, G., Dept. of Molecular Biology,
Vanderbilt University, Nashville, Tennessee: Repression
of a Chlamydomonas chloroplast promoter in E. coli by
torsional stress involves integration host factor.
Mulligan, R.M., Walbot, V., Dept. of Biological Sciences,
Stanford University, California: Transcription initiation and
RNA processing in maize mitochondria.
Narasimhan, N., Attardi, G., Division of Biology, California
Institute of Technology, Pasadena: Specific requirement
for ATP at an early step of in vitro transcription of human
mtDNA.
Hu, M.-C.,' Orozco, E.M., Jr:2.3 'Depts. of Plant Biology,
'Agronomy, University of Illinois, Urbana; 3USDA Agri-
cultural Research Service, Urbana, Illinois: In vitro tran-
scription start sites of the spinach chloroplast atpB gene.
Ragnini, A.,' Francisci, S.,' Zennaro, E.,' Palleschi, C.,1
Frontali, L.,1 Bolotin Fukuhara, M., 'Dept. of Cell and
Developmental Biology, University of Rome, Italy;
2Laboratoire de Genetique Moleculaire, Universite Paris
Sud, France: Expression of the mitochondrial tRNA
genes in S. cerevisiae.
SchOn, A.,1 Kannangara, C.G.,2 Gough, S.,2 Soli, D.,'
'Dept. of Molecular Biochemistry and Biophysics, Yale
University, New Haven, Connecticut; 'Dept. of Physiol-
ogy, Carlsberg Research Laboratories, Copenhagen,
Denmark: tRNA mischarging and a transamidase reac-
tion are required for normal protein biosynthesis in or-
ganelles-A tRNA-dependent amidotransferase synthes-
izes Gln-tRNAGln from Giu-tRNA.1..
Silk, G.W., Wu, M.C., Dept. of Biological Sciences, Univer-
sity of Maryland, Baltimore County, Catonsville: Rapid
light regulation of chloroplast transcript levels in C. rein-
hardtii.
Feagin, J.E., Stuart, K., Seattle Biomedical Research Insti-
tute, Washington: Developmental regulation of U addition
within mitochondrial transcripts of T. brucei.
van Grinsven, M.Q.J.M., Kneppers, T.J.A., Hille, J., Nijk-
amp, H.J.J., Kool, A.J., Dept. of Genetics Vrije Universi-
teit de Boelelaan, Amsterdam, The Netherlands: Regula-
tion of chloroplast gene expression during plastid
biogenesis.
White, D., Michaels, A., Dept. of Biology, University of
South Florida, Tampa: Constant and variable chloroplast
mRNA abundance during the cell cycle of C. reinhardtii.
Zhu, H., Macreadie, I.G., Butow, R.A., Dept. of Biochemis-
try, University of Texas Health Science Center, Dallas:
RNA processing and expression of an intron-encoded
protein in yeast mitochondria-Role of a conserved do-
decamer sequence.
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SESSION 7 EXPRESSION OF ORGANELLE GENES. II. TRANSCRIPTIONAL AND TRANSLATIONAL REGULATION
Chairman: R. Herrmann, Botanisches Institut de Ludwig-Maximilians-Universitat
Mullet, J.E., Klein, R.R., Gamble, RE., Berends, T, Baum- Westhoff, P.,' Herrmann, R.G.,' Eskins, K.,2 Grune, H.,'
gartner, B.J., Dept. of Biochemistry and Biophysics, Muller, M.,3 Oswald, A.,' Schrubar, H.,' Streubel, M.,'
Texas A & M University, College Station: Transcriptional Institutes of 'Botany and 3Genetics, University of Mu-
and posttranscriptional regulation of chloroplast gene nich, Federal Republic of Germany, 2USDA Northern Re-
expression during barley leaf biogenesis. gional Research Laboratory, Peoria, Illinois: Gene
Rochaix, J.-D.,1 Day, A.,' Mayfield, S.,' Goldschmidt-Cler- expression during thylakoid membrane biogenesis.
mont, M.,' Choquet, Y.,' Erickson, J.,' Kuchka, M.,' Schmidt, G.W., Botany Dept., University of Georgia, Ath-
KOck, U.,' Girard-Bascou, J.,3 Bennoun, P.,3 'Dept. of ens: Chloroplast transcription and translation-Depend-
Molecular Biology, University of Geneva, Switzerland; ence on nuclear gene products.
2Ruhr Universitat Bochum, Federal Republic of Germany; Grienenberger, J.M., Wintz, H., Runeberg-Roos, F, Mare-
3Institut de Biologie Physico-Chimique, Paris, France: chal, L., Jeannin, G., Weil, J.H., Institut de Biologie Mole-
Structure and expression of genes involved in photosyn- culaire et Cellulaire, Universite L. Pasteur, Strasbourg,
thesis in C. reinhardtii. France: Localization of tRNA genes present in the mito-
Gruissem, W., Deng, X.W., Jones, H., Stern, D., Tonkyn, J., chondrial genomes of maize and wheat.
Dept. of Botany, University of California, Berkeley: Tran- Hal lick, R., Dept. of Biochemistry, University of Arizona,
scriptional and posttranscriptional control of chloroplast Tucson: Chloroplast rpoA, rpoB, and rpoC genes encode
gene expression. subunits of chloroplast DNA-dependent RNA polymer-
Whitfield, P.R., Hudson, G.S., Holton, T.A., Bottom ley, W., ases.
CSIRO, Division of Plant Industry, Canberra, Australia:
Are there two f' -type subunits in chloroplast RNA poly-
merases?
SESSION 8A EXPRESSION OF ORGANELLE GENES. III. TRANSCRIPTIONAL AND TRANSLATIONAL REGULATION
Chairman: N. Martin, University of Texas Health Science Center
Simpson, L., Simpson, A.M., Shaw, J., Dewes, H., Dept. of Bogenhagen, D.F., Romanelli, M., Insdorf, N.F., Dept. of
Biology and Molecular Biology Institute, University of Cal- Pharmacology, State University of New York, Stony
ifornia, Los Angeles: Transcription of mitochondrial maxi- Brook: Nucleotide sequence and protein requirements
circle and minicircle DNAs in L. tarentolae. for in vitro transcription of X. laevis mtDNA.
Hauswirth, W.W., McCarty, D.M., Muise, R.C., Dickel, C.D., Getz, G.S.,' 2.3 Biswas, T.K.,2 Ticho, B.,3 Mueller, D.,2
Dept. of Immunology and Medical Microbiology, Univer- Wettstein-Edwards, J.,2 Backer, J.,2 Edwards, J.,2 San-
sity of Florida, Gainesville: Maize mitochondrial transcrip- yal, A.,2 Rabinowitz, M.,2 Depts. of 'Pathology,
tion initiation in vivo and in vitro. 2Medicine, 3Biochemistry/Molecular Biology, University
Jaehning, J.A., Wilcoxen, S.E., Peterson, C.R., Schultz, of Chicago, Illinois: Regulation of transcription in yeast
P.W., Marczynski, G.T., Dept. of Biology, Indiana Univer- mitochondria.
sity, Bloomington: Transcription by the yeast mtRNA poly-
merase.
SESSION 8B IMPORT AND ASSEMBLY OF PROTEINS BY ORGANELLES. I.
Chairman: J.-D. Rochaix, Universite de Geneve
Erickson, J.M.,' Rochaix, J.-D.,2 'Dept. of Biology, Univer-
sity of California, Los Angeles; 2Depts. of Molecular and
Plant Biology, University of Geneva, Switzerland: PSII
core proteins-Structure, function, assembly, and gene
regulation.
Smeekens, S.,'3 Hageman, J.,' de Boer, D.,' Cremers,
F.,' Bauerle, C. 2 Keegstra, K.,2 Weisbeek, P.,"Dept. of
Molecular Cell Biology, University of Utrecht, The Nether-
lands, 2Dept. of Botany, University of Wisconsin, Madi-
son, 3Division of Molecular Plant Biology, University of
California, Berkeley: Protein transport toward different
SESSION 9 POSTER SESSION
Import and Assembly
Archer, E.K., Hanson, M.R., Section of Genetics and Devel-
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chloroplast compartments-In vitro and in vivo analysis.
Kohorn, BD.,' Tobin, E.M., 2 D e pt . of Botany, Duke Uni-
versity, Durham, North Carolina; 2Dept. of Biology, Uni-
versity of California, Los Angeles: Import and assembly
of a nucleus-encoded LHCP into chloroplast membranes.
Herrmann, R.G., Westhoff, R, Bartling, D., Reilander, H.,
Botanical Institute, Ludwig-Maximilians-Universitat, Mu-
nich, Federal Republic of Germany: Structure and modifi-
cation of genes for thylakoid membranes from spinach
and Oenothera.
zymes in tomato as a system for studying protein target-
ing.
Bedwell, D.M., Emr, S.D., California Institute of Technology,
Pasadena: Redundant mitochondrial import information
is present at the amino terminus of the F,-ATPase ft-sub-
unit in yeast.
Berthier, F, Sebald, W., Physiologisch-Chemisches Institut
der Universitet Koellikerstr., Warzburg, Federal Republic
of Germany: Retargeting of human IL-2 into mitochondria
depends on the type of targeting sequence.
Buvinger, W.E., Michel, H.P., Bennett, J., Dept. of Biology,
Brookhaven National Laboratories, Upton, New York: A
functional analysis of transit peptide sequences from an
LHCP.
Glaser, S.M., Miller, B.R., Foreman, J.E., Cumsky, M.G.,
Dept. of Molecular Biology and Biochemistry, University
of California, Irvine: The amino-terminal five residues of
the COX4 precursor constitutes a fully functional mito-
chondrial import signal.
Dumont, M.E., Das, G., Sherman, F, Dept. of Biochemistry,
University of Rochester Medical Center, New York: Heme
attachment is required for import of cytochrome c into
yeast mitochondria.
Hendrick, J., Sztul, E., Kraus, J., Kalousek, F., Rosenberg,
L.E., Yale School of Medicine, New Haven, Connecticut:
Two cleavage steps are required for removal of the orni-
thine transcarbamylase leader peptide.
Kraus, J.P.,1 Novotny, J.,2 Kalousek, F.,' Swaroop, M.,'
Rosenberg, L.E.,' Yale University School of Medicine,
New Haven, Connecticut; 'Massachusetts General Hos-
pital, Harvard Medical School, Boston: The amino-termi-
nal domain of ornithine transcarbamylase leader is in-
volved in both mitochondrial import and carboxy-terminal
cleavage.
Lampoa, G., Abad, M., Dept. of Molecular Genetics and
Cell Biology, University of Chicago, Illinois: Cleavage of
the LHCP precursor in vitro.
Leu, S., Michaels, A., Dept. of Biology, University of South
Florida, Tampa: Reconstitution of in-vitro-synthesized
ps1A2 into CPI.
Linnane, A.W., Willson, T., Marzuki, S., Lukins, H.B.,
Meltzer, S., Dept. of Biochemistry, Monash University,
Clayton, Victoria, Australia: Subunit composition and as-
sembly of yeast mitochondrial ATP synthase.
Liu, X.,' Freeman, K.,2 Shore, G.,' 'Dept. of Biochemistry,
McGill University, Montreal, 'Dept. of Biochemistry,
McMaster University, Hamilton, Canada: Topogenesis of
mitochondrial inner membrane uncoupling protein.
Toukifimapa, R.,' Romby, P.,2 Rozier, C.,1 Ehresmann, C.,2
Westhof, E.,2 Ebel, J.P.,2 Ehresmann, B.,2 Mache, R.,'
' Laboratoire de Biologie Moleculaire Vegetate, Universite
de Grenoble, 2Laboratoire de Biochimie, Institut de Biol-
ogie Moleculaire et Cellulaire du CNRS, Strasbourg,
France: High-order structure of chloroplastic 5S rRNA
and binding to two homologous ribosomal proteins.
Skerjanc, I., Silvius, J., Shore, G., Dept. of Biochemistry,
McGill University, Montreal, Canada: The interaction of a
synthetic mitochondrial signal peptide with lipid mem-
branes is independent of transbilayer potential.
Sutton, A., Michel, H.P., Buvinger, W.E., Bennett, J., Dept.
of Biology, Brookhaven National Laboratory, Upton, New
York: Organization and assembly of PSII.
Vainstein, A.,' Ferreira, R,' Morishige, D.,' Verbeke, J.,2
Peterson, C.C.,' Thornber, J.P.,"Dept. of Biology, Uni-
versity of California, Los Angeles; 'Dept. of Biological
Sciences, University of Illinois, Chicago: Expression and
import of the PSII LHCII/3 into maize mesophyll and bun-
dle sheath cells.
Viitanen, Bacot, K.O.,' Dunsmuir, P.,2 'Central Re-
search and Development Dept., Du Pont Experimental
Station, Wilmington, Delaware; 'Advanced Genetic Sci-
ences, Oakland, California: What is the role of the transit
peptide in thylakoid integration of the LHCP?
Nuclear-Organelle Interactions
Barkan, A.,' Rock, C.,2 Martienssen, R.,' Taylor, W.,'
'Dept. of Genetics, University of California, Berkeley;
200E-Plant Research Laboratory, Michigan State Univer-
sity, East Lansing: Influence of nuclear mutations and cel-
lular differentiation of plastid gene expression in maize.
Daignan-Fornier, B., Su, I., Contamine, V., Bolotin-Fuku-
hara, M., Laboratoire de Genetique Moleculaire, Univer-
site de Paris-Sud, France: Cloning and expression of a
yeast mitochondrial ribosomal protein.
Breen, G.A.M., Garnett, K.E., Holmans, RL., Biology Pro-
grams, University of Texas at Dallas, Richardson: Isola-
tion of cDNAs for the a and p subunits of the bovine mito-
chondrial ATP synthase complex.
Chow, C.M.,' Benarous, R.,2 RajBhandary, U.L.,"Dept.
of Biology, Massaschusetts Institute of Technology, Cam-
bridge; 'Institut de Pathologie Moleculaire, Faculte de
Medecine Cochin Port Royal, Paris, France: Nuclear
genes for the cytoplasmic and mitochondrial forms of
cyl-tRNA synthetase in N. crassa map to two different
linking groups.
di Rago, J.-R, Meunier, B., Colson, A.-M., Laboratoire de
Genetique Microbienne, University of Louvain, Belgium:
Molecular basis for resistance to antimycin and diuron in-
hibitors of the mitochondrial ubiquinol-cytochrome c re-
ductase in S. cerevisiae.
Crivellone, M.D., Wu., M., Txagoloff, A., Columbia Univer-
sity, New York, New York: Mechanism of assembly of
coenzyme 01-12-cytochrome c reductase in yeast mito-
chondria.
Kuiper, M.T.R., ' Holtrop, M.,' Vennema, H.,' Lambowitz,
A.R. , 2 de Vries, H.,"Laboratory of Physiological Chem-
istry, State University Groningen, The Netherlands;
'Dept. of Genetics, Ohio State University, Columbus:
Characterization of the nuclear gene for mito-ribosomal
protein S24 of N. crassa -Analysis of its function and its
regulation.
Dieckmann, C.L., Cavenagh, M., Gandy, B.J., Dept. of Bio-
chemistry, University of Arizona, Tucson: Deletion of a
gene adjacent to CBP1 results in overproduction of an
86-kD cytoplasmic protein in yeast.
Ellis, S.R.,' Hopper, A.K.,2 Martin, N.C.,3 'Dept. of Bio-
chemistry, University of Louisville, Kentucky; 2Dept. of
Biological Chemistry, Hershey Medical Center, Pennsyl-
vania; 3Dept. of Biochemistry, University of Texas Health
Science Center, Dallas: Characterization of the mitochon-
drial targeting signals of the trml gene product of S.
cerevisiae.
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Evans, C.T., Srere, P.A., Veterans Administration Medical
Center and University of Texas Health Science Center,
Dallas: Isolation and nucleotide sequence of a cDNA en-
coding pig citrate synthase.
Gantt, J.S., Botany Dept., University of Minnesota, St. Paul:
Nucleus-encoded plastid ribosomal proteins-Transit se-
quences and homology with E. coll.
Heckmann, J., Langer, C., Weaver, W., Kreader, C., Dept.
of Chemistry, Indiana University, Bloomington: Analysis
of cDNA clones for two mitochondrial ribosomal proteins
of N. crassa.
Kispal, G.,' Rosenkrantz, M.,2 Guarente, L.,2 Srere, P.A.,'
'Veterans Administration Medical Center and University
of Texas Health Science Center, Dallas; 2Massachusetts
Institute of Technology, Cambridge: Metabolic effects of
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The 1987 Cancer Cells meeting was the sixth meeting in this series and focused
on eukaryotic DNA replication. Nearly 300 scientists were brought together for the
first international meeting on this subject. The choice of this topic reflected the fact
that this expanding area of research is an integral part of efforts to understand the
abnormal proliferation found in cancer cells. The timing was apparently just right
as many avenues of investigation have recently yielded exciting new results. Many
areas were covered at this meeting, including studies on eukaryotic DNA viruses,
which continue to provide valuable insight on the mechanism of DNA replication
and the function of both virus-encoded and cellular proteins. The program also
included sessions on the replication of stable, extrachromosomal elements such as
papillomavirus and Epstein-Barr virus episomes, mitochondrial chromosomes, and
the yeast autonomously replicating plasmids. Other sessions focused on the
replication and amplification of cellular DNA and on the structures and functions
of centromeres, telomeres, and origins within eukaryotic chromosomes. The
structure and functions of the four eukaryotic cell DNA polymerases were also
discussed in detail. Control of the cell-cycle progression and S-phase-specific
regulatory events were also presented. A special session on prokaryotic DNA
replication opened the meeting and provided an excellent summary of some of
the best-characterized replication systems. In addition, two poster sessions
contained a wealth of interesting information from many laboratories.
This meeting was supported in part by grants from the National Institute on
Aging, the National Institute of General Medical Sciences and the National
Science Foundation.
This meeting was supported in part by the National Science Foundation and
the following divisions of the National Institutes of Health: National Institute of
Aging; National Institute of General Medical Sciences.
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Modern Approaches to New Vaccines Including
Prevention of AIDS
September 9-September 13
ARRANGED BY
Robert M. Chanock, NIAID, National Institutes of Health
Richard A. Lerner, Research Institute of Scripps Clinic
Fred Brown, Wellcome Biotechnology Ltd.
Harold Ginsberg, Columbia University
329 participants
The annual meeting on Modern Approaches to New Vaccines goes from strength
to strength. More than 350 people attended the meeting held in September, 1987.
About one half of those attending were from commercial organizations, an
indication that the concept of vaccines based on the new technology is regarded
as a realistic practical possibility.
More than 150 papers were submitted for oral presentation. Even with the
packed sessions for which Cold Spring Harbor meetings are famous or notorious,
it was impossible to accept more than 60 papers. Disappointment was ameliorated
somewhat by allowing a few 5-minute talks, but this meant that the sessions
became sprints as well as marathons. The program included a poster session
(more than 90 posters were on display) and sessions on Immunology, Parasitol-
ogy, Bacteria and Bacterial Diseases, three sessions on Virology, and three
sessions on AIDS.
This Rockefeller Foundation.
SESSION 1 IMMUNOLOGY
Chairman: R. Lerner, Research Institute of Scripps Clinic
Satterthwait, A., Hogotian, R., Zavala, F, Nussenzweig, V.,
Lerner, R., Medical Research Institute of Scripps Clinic,
La Jolla, California; 2Dept. of Medical and Molecular Par-
asitology, New York University Medical Center, New York:
Building synthetic peptides shaped in three-dimension
by covalent replacements for hydrogen bonds.
Francis, M.J., Hastings, G.Z., Syred, A.D., McGinn, B.,
Brown, F., Rowlands, D.J., Wellcome Biotechnology Ltd.,
Pirbright, England: Peptides with added T-cell epitopes
can overcome genetic restriction of the immune re-
sponse.
Houghten, R.A., Research Institute of Scripps Clinic, La
Jolla, California: Determination of the precise amino
acids involved, and their relative importance, in peptide
antigen/monoclonal antibody interactions.
Milich, D.R.,' McLachlan, A.,' Thornton, G.B.,2 Hughes,
J.,1 'Dept. of Basic and Clinical Research, Research In-
stitute of Scripps Clinic, La Jolla, 2Johnson and Johnson
Biotechnology Center, Sorrento Valley, California: Cellular
mechanisms of the enhanced immunogenicity of the nu-
cleocapsid of HBV.
Bernards, R., Destree, A., McKenzie, S., Gordon, E., Wein-
berg, R., Panicali, D., Whitehead Institute for Biomedical
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D. Brown, R. Chanock, N. Letvin
Research, Applied bioTechnology, Inc., Dept. of Biology,
Massachusetts Institute of Technology, Cambridge: Effec-
tive tumor immunotherapy directed against an onco-
gene-encoded product using a vaccinia virus vector.
Williams, W.V.,' Rubin, D.H.,' Robey, F.,' Greene, M.I.,'
'University of Pennsylvania School of Medicine and Vet-
erans Administration Medical Center, Philadelphia; 'NCI,
National Institutes of Health, Bethesda, Maryland: Use of
shared primary structure to predict the oligopeptide-neu-
SESSION 2 PARASITOLOGY
Chairman: M. Good, National Institutes of Health
Capron, A., Institute Pasteur, Lille, France: Newly recog-
nized schistosomiasis antigen and its role in resistance.
Scott, P., Pearce, E., Natovitz, P., Sher, A., NIAID, National
Institutes of Health, Bethesda, Maryland: Identification of
T-cell-reactive antigens in a partially defined vaccine
against L. major.
Zavala, F.,' Tam, J.P.,2 Nussenzweig, V.,' Nussenzweig,
R.S.,' New York University Medical Center, 'Rockefeller
University, New York, New York: Synthetic vaccine in-
duces protective immunity against P. berghei sporo-
zoites.
Lal, A.A., de la Cruz, V.F., Good, M.F., Weiss, W.J., Maloy,
W.L., Welsh, J.A., Lunde, M., McCutchan, T.F., NIAID,
National Institutes of Health, Bethesda, Maryland: Anti-
bodies against the repeat region of circumsporozoite pro-
tein are not protective against challenge of sporozoites-
A rodent model study.
Schofield, L., Nussenzweig, V., Nussenzweig, R.S., Dept. of
Medical and Molecular Parasitology, New York University
Medical Center, New York, New York: Antimalarial activity
of Lyt2+ (suppressor/cytotoxic) T cells required for im-
munity to sporozoite challenge.
SESSION 3 AIDS I
Chairman: E. Norrby, Karolinska lnstitutet
Schiller, P.,' Geffin, R.,2 Parks, W.,2 Voellmy, R.,' Depts. of
'Biochemistry, 'Pediatrics, University of Miami School of
Medicine, Florida: Inducible expression of HIV envelope
glycoproteins in a mammalian cell-culture system.
Rice, A.P., Mathews, M.B., Cold Spring Harbor Laboratory,
Cold Spring Harbor, New York: Use of a recombinant ad-
enovirus vector to analyze the mechanism of tatll trans-
activation of HIV LTR gene expression.
Kowalski, M.,' Potz, J.,' Basiripour, L.,' Dorfman, T.,'
Goh, W.C.,' Dayton, A.,' Terwilliger, E.,' Rosen, C.,'
Haseltine, W.,2 Sodroski, J.,' 'Dana-Farber Cancer Insti-
tute, Dept. of Pathology, Harvard Medical School, 'Dept.
of Cancer Biology, Harvard School of Public Health, Bos-
ton, Massachusetts: Structure-function relationships of
the HIV envelope glycoproteins.
Clavel, F, Alizon, M., Guyader, M., Emerman, M., Sonigo,
P., Montagnier, L., Unite d'oncologie virale, Institute Pas-
teur, Paris, France: Molecular and biological character-
ization of HIV-2.
Miyazawa, M., Nishio, J., Chesebro, B., NIAID, National In-
tralizing epitope on the type-3 reovirus hemagglutinin.
Field, H.,' Yarranton, G.,2 Rees, A.R.,' Laboratory of Mo-
lecular Biophysics, University of Oxford, 2Celltech Ltd.,
Slough, England: Production of mini-antibodies in E. colt.
Meloen, R.H., Puyk, W.C., Schaaper, W.M.M., Lankhof, H.,
Meijer, D.J.A., Posthumus, W.P.A., Central Veterinary In-
stitute, Lelystad, The Netherlands: Use of peptides to lo-
cate and characterize epitopes.
Good, M.F.,1 Pombo, D.,' Quakyi, LA.,' Riley, E.M.,4
Menon, A.,4 Maloy, W.L.,2 Houghten, R.,5 de la Cruz,
Berzofsky, J.A.,3 Miller, L.H.,"Laboratory of Para-
sitic Diseases, NIAID, 'Laboratory of Immunogenetics,
3Metabolism Branch, NCI, National Institutes of Health,
Bethesda, Maryland; 4Medical Research Council Labo-
ratories, The Gambia; 5Scripps Clinic and Research
Foundation, La Jolla, California: Identification of the poly-
morphic regions of circumsporozoite protein as the im-
munodominant domains recognized by human and mu-
rine T cells.
Brake, D., Burns, J.M., Vidaya, A., Weidenz, W.P., Malaria
Research Group, Dept. of Microbial and Immunology,
Hahnemann University, Philadelphia, Pennsylvania:
Adoptive protection in nude mice against a murine ma-
laria parasite by a cloned T-cell line.
Langford, C.,' Edwards, Ss,' Corcoran, L.,' Peterson, G.,'
Mclntrye, F,' Kemp, D.,' Anders, R.,"Walter and Eliza
Hall Institute of Medical Research, 'Commonwealth
Serum Laboratories, Victoria, Australia: Recombinant
protein, synthetic peptide, recombinant virus, and hybrid
"cocktail" antigen vaccines against falciparum malaria.
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stitutes of Health, Rocky Mountain Laboratories, Hamil-
ton, Montana: Antigen-presenting cells control T-cell re-
sponsiveness to Friend viral antigens.
Cheng-Mayer, C., Levy, J.A., Cancer Research Institute,
University of California School of Medicine, San Fran-
SESSION 4 VIROLOGY. I.
Chairman: A. Kapikian, NIAID, National Institutes of Health
Clarke, B.E., Newton, S.E., Carroll, A.R., Francis, M.J., Ap-
pleyard, G., Syred, A.D., Highfield, P.E., Rowlands, D.J.,
Brown, F., Wellcome Biotechnology Ltd., Pirbright, Eng-
land: Chimeric proteins based on HBcAg form highly im-
munogenic particles.
Cohen, J., Rosenblum, B., Feinstone, S., Ticehurst, J., Pur-
cell, R., NIAID, National Institutes of Health, Bethesda,
Maryland: Use of infectious HAV cDNA to study viral at-
tenuation.
Mason, B., Molnar-Kimber, K.L., Morin, J.E., Lubeck, M.D.,
Conley, A.J., Davis, A.R., Hung, PR, Wyeth Laboratories,
Inc., Division of Microbiology, Philadelphia, Pennsylvania:
Adenovirus type 4 and type 7 as viral vectors.
Cox, N.J.,' Kitame, F.,2 Naeve, C.,. Kendal, A.P.,'
'Influenza Branch, Center for Infectious Diseases, Cen-
ters for Disease Control, Atlanta, Georgia; 2Dept. of Bac-
teriology, Yamagata University School of Medicine, Ja-
pan; .Division of Virology and Molecular Biology, St.
Jude Children's Research Hospital, Memphis, Tennessee:
Sequence changes in genes of the attenuated influenza-
A vaccine donor strain, A/Ann Arbor/6/60.
Snyder, M.H.,' Betts, R.F.,2 Clements, M.L.,3 Herrington,
D.,' Sears, S.D.,. Maassab, H.F.,. Murphy, B.R.,'
'NIAID, National Institutes of Health, Bethesda, Mary-
land; 2University of Rochester School of Medicine, New
York; .Center for Immunization Research, Johns Hopkins
University School of Public Health, "University of Mary-
land School of Medicine, Baltimore; °University of Michi-
gan School of Public Health, Ann Arbor: identification of
SESSION 5 AIDS
Chairman: H. Ginsberg, Columbia University
Fultz, P.N.,' Switzer, W.,' McClure, H.,2 Reed, C.,' Mon-
tagnier, L.,. 'AIDS Program, Centers for Disease Con-
trol, 2Yerkes Primate Research Center, Emory University,
Atlanta, Georgia; .Institut Pasteur, Paris, France: Simian
models for AIDS-SIV/SMM and HIV-2 infection of rhesus
macaques.
Arthur, L., Robey, W., Pyle, S., Bess, J., Jr., Nara, P., Kel-
liher, J., Gilden, R., Fischinger, P., NCI-Frederick Cancer
Research Facilities, Frederick, Maryland: Preparation
and evaluation of an HIV outer envelope glycoprotein
prototype vaccine.
Estin, C.D., Hu, S.-L., Stevenson, U.S., Plowman, G.D.,
HellstrOrn, I., HellstrOrn, K.-E., ONCOGEN, Seattle, Wash-
ington: Recombinant vaccinia virus expressing the hu-
man melanoma-associated antigen p97 as a therapeutic
tumor vaccine.
Luciw, Tong-Starksen, S.,2 Peterlin, B.M.,2 'University
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cisco: Biologic and serologic properties of neurotropic
HIV.
Letvin, N.L., Kannagi, M., Harvard Medical School, New
England Regional Primate Research Center, Southbor-
ough, Massachusetts: Functional role of DC8+ lympho-
cytes in SIV infection of rhesus monkeys.
four genes that attenuate influenza A/Ann Arbor/6/60
(H2N2) cold-adapted reassortant viruses.
Kapikian, A.,' Flores, J' Midthun, K.,' Hoshino, Y.,'
Green, K.,' Gorziglia, M.,' Taniguchi, K.,' Nishikawa,
K.,' Chanock, R.,' Potash, L.,2 Perez-Schael, 1.,3 Dolin,
R.,' Christy, C.,' Santosham, M.,5 Halsey, N.,6 Clem-
ents, M.,6 Sears, S.,. Black, R.,. Levine, M.,' Losonsky,
G.,' Rennels, M.,' Gothefors, L.,8 Wadell, G.,5 Glass,
R.,5 Vesikari, T.,"") Anderson, E., Belshe, R.," Wright,
P.,12 Urasawa, S.,'. 'National Institutes of Health, Be-
thesda, Maryland; 2Flow Labs, Virginia; .Central Univer-
sity of Venezuela, Caracas; 'University of Rochester,
New York; .Johns Hopkins University, Arizona or
6Baltimore, Maryland; 'University of Maryland,
.University of Umea, Sweden; °Center for Disease Con-
trol, Atlanta, Georgia; '°University of Tampere, Finland;
"Marshall University, Huntington, West Virginia;
12Vanderbilt University, Nashville, Tennessee; '3Sapporo
Medical College, Japan: Development of a rotavirus vac-
cine by a "Jennerian" and a modified "Jennerian" ap-
proach.
Markoff, L.J.,' Bray, M.,' Gordon, S.W.,' Lai, C.J.,' Gen-
try, M.K.,2 Echols, K.,2 Summers, P.,2 Houghton, R.,3
Lerner, R.,3 Chanock, R.M.,' 'NIAID, National Institute
of Health, Bethesda, Maryland; 2Walter Reed Army Re-
search Institute, Washington, D.C.; .Research Institute of
the Scripps Clinic, La Jolla, California: Antigenic analysis
of the dengue envelope glycoprotein using synthetic
peptides.
of California, Davis; 2Howard Hughes Medical Institute,
University of California, San Francisco: The HIV LTR re-
sponds to T-cell-activation signals.
Linnette, G.,' Pierce, P,' Wagner, K.,2 Wong, D.,' Folks,
T.,. Hartzman, R.,2 'Georgetown University, Washington,
D.C.; 2Naval Medical Command and Naval Medical Re-
search Institute, .NIAID, National Institutes of Health, Be-
thesda, Maryland: Evidence for HIV-specific cellular im-
munity in seropositive asymptomatic individuals.
Payne, S.,' Ball, J.,' Issel, C.,2.3 Montelaro, R.,2.3 Depts.
of 'Biochemistry, 2Veterinary Science, Louisiana State
University and Louisiana Agricultural Experiment Station,
'Dept. of Veterinary Microbiology and Parasitology, Loui-
siana State University School of Medicine, Baton Rouge:
Envelope gene variation in EIAV- Implications for vac-
cine development.
Sadaie, M.R., Benter, T., Wong-Staal, F., NCI, National Insti-
S. Grant, S. Alpert, E. Wetzel
tutes of Health, Bethesda, Maryland: Direct mutagenesis
analysis of conserved domains of tat in a cloned HIV-1
provirus.
Guy, B.,' Kieny, M.P.,' Riviere, Y,2 Girard, M.,3 Montag-
nier, L.,2 Lecocq, J.P.,' 1Transgene S.A., Strasbourg,
2lnstitut Pasteur, Paris, 3Pasteur-Vaccins, France: Phos-
phorylation of the F protein (3' orf) of HIV by protein ki-
nase C and down-regulation of the lymphocyte T4 anti-
Smith, T.F,' Myers, G.,2 'Harvard Medical School, Boston,
Massachusetts; 2Theoretical Division, Los Alamos Na-
SESSION 6 POSTER SESSION
Adams, S.E.," Malim, M.H.,2 Senior, J.M.,' Kingsman,
Kingsman, A.J.,1.2 'Depts. of Molecular Biology
and Immunology, British Bio-technology Ltd., 2Dept. of
Biochemistry, University of Oxford, England: Induction of
influenza HA antibodies by Ty-HA hybrid virus-like parti-
cles.
Bertonis, J.,' Costopoulos, D.,' Liu, T.,' Meier, W.,' Ko-
walski, M.,2 Fisher, R.,' 1Biogen Research Corp., Cam-
bridge, 2Dana Farber Cancer Institute, Boston, Massa-
chusetts: Development of recombinant soluble T4 as a
novel AIDS therapeutic.
Broekhuijsen, M.P.,' Blom, A.J.M.,' van Rijn, J.M. M.,,
Pouwels, P.H.,' Francis, M.J.,2 Brown, F.,2 Enger-Valk,
B.E.,' 1TNO Medical Biological Laboratory, Rijswijk, The
Netherlands; 2Wellcome Biotechnology Ltd., Pirbright,
England: Neutralization and protection induced by fusion
proteins containing FMDV epitopes synthesized in E. colt.
Burnette, W.N.,' Mar, V.L.,' Morris, C.F.,' Cieplak,
Kaljot, K.,2 Sato, H.,3 Keith, J.M., 2 Amgen, Thousand
Oaks, California; 2NIAID, Rocky Mountain Laboratory,
Hamilton, Montana; 3National Institute of Health, Tokyo,
Japan: Recombinant strategy for development of pertus-
sis vaccine components.
Campbell, J.I.A., Binns, M., Boursnell, M., Tomley, F.M.,
tional Laboratory, New Mexico: Phylogenetic analysis of
HIV-1 and HIV-2.
Plata, F.,' Hoffenbach, A.,1 Pedroza-Martins, L.,' Lang-
lade-Demoyen, P.,' Autran, B.,2 Garcia-Pons, F.,'
Debit, R,2 Wain-Hobson, 5.,"Laboratoire de Biologie
et d'Immunologie Moleculaires des Retrovitus, Institut
Pasteur, 2Laboratoire d'Immunologie Cellulaire et Tissu-
laire, Hopital Pitie-Salpe-triere, Paris, France: Quantitative
analysis of AIDS'virus-specific cytotoxic T lymphocytes in
human and murine experimental systems,
Dept. of Microbiology, Institute for Animal Disease Re-
search, Huntington, England: Nucleotide sequence of
the terminal region of the fowl poxvirus genome-Ar-
rangement of repeated and unique sequences.
Cieplak, W., Locht, C., Lobet, Y., Kaljot, K.T., Keith, J.M.,
NIAID, Rocky Mountain Laboratories, Hamilton, Mon-
tana: Structure-function relationships of the S1 subunit of
pertussis toxin,
Dale, J.B., Bronze, M.S., Beachey, E.H., Veterans Adminis-
tration Medical Center and University of Tennessee,
Memphis: Protective and heart-cross-reactive epitopes of
type-19 streptococcal M protein.
de la Cruz, V., Lal, A.A., McCutchan, T.F., NIAID, National
Institutes of Health, Bethesda, Maryland: Sequence var-
iation in putative functional domains of the circumsporo-
zoite protein of P. falciparum.
Delaporte, E.,' Dazza, M.C.,' Wain-Hobson, 5.,2 Brun-Ve-
zinet, F.,3 Larouze, B.,' Saimot, A.G.,' Dupont, A.,4
Roelants, G.E.,4 1INSERM, HOpital Claude Bernard,
2Unite de Biologie Moleculaire et d'Immunologie des Ret-
rovirus, Institut Pasteur, 3Laboratoire de Virologie, HOpi-
tal Claude Bernard, Paris, 4lnternational Centre for Medi-
cal Research, Gabon, France: HIV-related viruses in
Gabon.
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Dietzschold, B., Wang, H., Rupprecht, C.E., Koprowski, H.,
Wistar Institute, Philadelphia, Pennsylvania: Immunization
with rabies nucleocapsid protein and synthetic nucleo-
capsid-protein fragments-A novel approach to vaccina-
tion against rabies.
Duchene, M.,' Schweizer, A.,' Mertz, R.,' von Specht,
B.U.,2 Lottspeich, F.,3 Domdey, H.,"Laboratorium kir
molekulare Biologie-Genzentrum-der Universitat
MOnchen, Martinsried, 2Chirurgische Universitatsklinik,
Freiburg, 3Gentechnologische Arbeitsgruppe am Max
Planck Institut, Martinsried, Federal Republic of Ger-
many: Immunization against P. aeruginosa with peptides
derived from outer-membrane porin protein F.
Edelman, R., NIAID, National Institutes of Health, Be-
thesda, Maryland: A perspective on the development
and deployment of rotavirus vaccines.
Elder, J.,' Nicolaisen-Strouss, K.,' Kumar, H.,' Fitting, T.,'
Grant, C.,2 'Scripps Clinic and Research Foundation, La
Jolla, California; 'Pacific Northwest Research Founda-
tion, Seattle, Washington: Natural FeLV escapes neutrali-
zation by a monoclonal antibody via an amino acid
change outside the antibody-binding epitope.
Emini, E.,' Silberklang, M.,' Kieff, E.,2 Lehman, D.,' Ellis,
R.,"Merck, Sharp and Dohme Research Laboratories,
West Point, Pennsylvania; 'University of Chicago, Illinois:
Protection of susceptible S. labiatus marmosets from EBV
infection-Positive efficacy of a VERO-cell-expressed
EBV2gp350/220 vaccine.
Flexner, C., Murphy, B., Rooney, J., Wohlenberg, C., Yu-
ferov, V., Notkins, A., Moss, B., NCI, National Institutes of
Health, Bethesda, Maryland: Disease protection by a
vaccinia double recombinant expressing HSV and influ-
enza proteins is comparable to single recombinants and
is not adversely affected by prior exposure to HSV or in-
fluenza.
Fung, M.S.C.,' Sun, C.,2 Sun, N.C.,' Chang, N.T.,2
Chang, T.W.,' 'Dept. of Virology and Epidomiology, Bay-
lor College of Medicine, 2Tanox Biosystems, Inc., Hous-
ton, Texas: Monoclonal antibodies that neutralize the in-
fectivity of HIV-1 virions and inhibit syncytium formation
by infected cells.
Gardner, M.,' Salk, J.,2 'Dept. of Medical Pathology, Uni-
versity of California School of Medicine, Davis, 'Salk In-
stitute, La Jolla: Postexposure immunization-A new
strategy for control of AIDS.
Goodman-Snitkoff, G.,' Heimer, E.P.,2 Danho, W.,2 Felix,
A.M.,' Mannino, R.J.,' 'Dept. of Microbiology and Im-
munology, Albany Medical College, New York; 'Peptide
Research Dept., Hoffmann-LaRoche Inc., Nutley, New
Jersey: Induction of antibody production to synthetic
peptides via peptide phospholipid complexes.
Gras-Masse, H.,' Jolivet, M.,2 Drobeco, H.,' Aubert, J.P.,3
Beachey, E.,4 Audibert, F.,2 Chedid, L.,2 Tartar, A.,'
'Service de Chimie des Biomolecules, Institute Pasteur,
Lille, France; 'Dept. of Pharmacology and Therapeutics,
College of Medicine, University of South Florida Medical
Center, Tampa; 3Institut de Recherce sur le Cancer, IN-
SERM, Lille, France; 'Veterans Administration Center,
Memphis, Tennessee: Influence of helical organization of
immunogenicity and antigenicity of synthetic peptides.
Greenspan, N.S., Institute of Pathology, Case Western Re-
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serve University, Cleveland, Ohio: Temperature-depen-
dent constant domain modulation of IgG3 anti-strepto-
coccal group-A carbohydrate antibody functional affinity.
Gritz, L., McKenzie, S., Destree, A., Panicali, D., Applied
bioTechnology, inc., Cambridge, Massachusetts: Animal
studies with vaccinia recombinants expressing multiple
pseudorabies glycoproteins.
Gruters, R.A.,' Neefjes, J.J.,2 Tersmette, M.,' de Goede,
R.E.Y,' Huisman, H.G.,' Tulp, A.,2 Miedema, F.,'
Ploegh, H.L.,2 'Central Laboratory of the Netherlands
Red Cross Blood Transfusion Service, incorporating the
Laboratory of Experimental and Clinical Immunology,
University of Amsterdam, 'The Netherlands Cancer Insti-
tute, Amsterdam: Inhibitors of trimming glucosidase inter-
fere with HIV cytopathogenicity.
Heber-Katz, E., Yamashita, K., Wistar Institute, Philadelphia,
Pennsylvania: Peptide-lipid conjugates as antiviral T-cell
vaccines-Parameters of protection.
Hellstreim, U.B., Sylvan, S.P.E., Elias Bengtsson Research
Unit, Dept. of Infectious Diseases, Karolinska Institute,
Roslagstull Hospital, Stockholm, Sweden: HBV-induced
autoimmune reactions in man.
Hu, S.-L.,' Fultz, P.N.,2,3 McClure, H.M.,3 Eichberg, J.,4
Kinney-Thomas, E.,' Zarling, J.M.,' Swenson, R.B.,3
Anderson, D.C.,3 Kosowski, S.G.,' Singhal, M.,' To-
daro, G.,"ONCOGEN, Seattle, Washington; 'Centers
for Disease Control, 3Yerkes Regional Primate Center, At-
lanta, Georgia; "Southwest Foundation for Biomedical
Research, San Antonio, Texas: Immunization of chimpan-
zees with recombinant vaccinia-virus-expressing HIV en-
velope glycoproteins.
Hu, S.-L., Travis, B., Sridhar, F, Chinn, J., Oncogen, Seat-
tle, Washington: Immunogenicity of recombinant vaccinia
viruses expressing core antigens of HIV.
Hudson, D., Wellems, T.E., Miller, L.H., NIAID, National In-
stitutes of Health, Bethesda, Maryland: Genetic basis for
variation in a surface protein expressed in malaria.
Jansen, R., Newbold, J., Lemon, S., University of North
Carolina, Chapel Hill: Characterization of mutations pres-
ent in a cell-culture-adapted HAV variant-An approach
to understanding the molecular basis of cell culture adap-
tation and attenuation of virulence.
Jessup, J.M., Campbell, D.E., Qi, K., University of Texas,
M.D. Anderson Hospital, Houston: A molecular approach
to a generic vaccine for human colorectal carcinoma-
Identification of altered cytokeratin as autoantigen.
Johnson, J.M.,' Harmon, S.A.,' Richards, C.C.,' Ehren-
feld, E.,2 Summers, D.F.,2 'Dept. of Medicine, University
of Texas Health Science Center, San Antonio; 'Dept. of
Cellular, Viral and Molecular Biology, University of Utah
School of Medicine, Salt Lake City: Expression of the
HAV VP1 gene in prokaryotic and eukaryotic vectors.
Judd, A.K.,' Winters, M.A.,' Humphres, R.C.,2 Sharma,
I.K.,3 Bhatia, G.,3 Smith, S.,3 Robinson, W.S.,3 'Bic-Or-
ganic Chemistry Laboratory, 2lmmunobiology Section,
Biomedical Research Laboratory, Life Sciences Division,
SRI International, Menlo Park, 3Dept. of Medicine, Divi-
sion of Infectious Diseases, Stanford University School of
Medicine, California: Studies on synthetic peptides from
any glycoprotein of HIV.
Kalyanaraman, V.S.,' Pal, R.,' De Vico, A.,' Gallo, R.C.,2
N. Greenspan, E. Norrby
Sarngadharan, M.G.,' Bionetics Research, Inc., Rock-
ville, 2NCI, National Institutes of Health, Bethesda, Mary-
land: A novel method for the isolation of native gp120
and gp160 of HIV and an evaluation of their immunologi-
cal properties.
Kensil, C.R., Patel, U., Marciani, D.J., Cambridge Bio-
Science Corp., Worcester, Massachusetts: Purification
and characterization of adjuvants from Quillaja saponaria
Molina.
Kingsman, Adams, S.E.,' Dawson, K.,1 Kingsman,
S.M.,1.2 'University of Oxford, 2Dept. of Molecular Biol-
ogy and Immunology, British Biotechnology, Ltd., Oxford,
England: Expression of hybrid HIV-Ty virus-like particles
in yeast.
Lal, A.A.,' de la Cruz, V.F.,1 Collins, W.E.,2 Campbell, G.,2
McGutchan, T.F.,"NIAID, National Institutes of Health,
Bethesda, Maryland; 2Centers for Disease Control, At-
lanta, Georgia: Circumsporozoite gene from P. brasi-
lianum.
Langsley, G.,1 Guerin-Marchand, C.,2 Galey, B.,2 Lon-
dono, A.,2 Patarapotikul, J.,2 Beaudoin, R.1_,3 Du-
beaux, C.,4 Tartar, A.,4 Mercereau-Puijalon, O.,4 Mazier,
D.,2 Druilhe, P.,2 'Experimental Parasitology, Institut Pas-
teur, 2Dept. of Parasitology, Paris, France; .Malaria
Branch, Naval Medical Research Institute, Washington,
D.C.; 4Service of Chemistry of Biomolecules, Institut Pas-
teur, Lille, France: Identification, cloning, and immunoge-
nicity of a liver stage-specific antigen of P. falciparum.
Lehner, T.,' Childerstone, A.,' Haron, J.,2 'Dept. of Immu-
nology, United Medical and Dental Schools of Guy's and
St. Thomas' Hospitals, London, England; 2Biotechnology
Center, Inc., Johnson and Johnson, La Jolla, California:
Human CD4 cell responses and serum antibodies to syn-
thetic peptides derived from a streptococcal cell-surface
antigen.
Levrero, M.,' Bailey, A.,' Schellenkens, H.,' Tiollais, P.,2
Perricaudet, M.,1 Institut de Recherches Scientifiques,
Villejuif,2 Institut Pasteur, Paris, France: Live recombinant
adenovirus can protect chimpanzees against hepatitis B.
LOwenadler, B.,' Jansson, B.,2 Paleus, S.,1 Nilsson, B.,2
Holmgren, E.,1 Moks, T,2 Palm, G.,' Uhlen, M.,2 Jo-
sephson, S.,1 1Kabigen AB, 2Dept. of Biochemistry,
Royal Institute of Technology, Stockholm, Sweden: A
novel gene fusion system for raising antibodies against a
defined peptide sequence.
Lue, C., Tarkowski, A.I., Mestecky, J., Dept. of Microbiol-
ogy, University of Alabama, Birmingham: Predominant
IgA response after systemic immunization with a polyva-
lent pneumococcal vaccine.
Mach, M.,' Utz, U.,' Britt, W.,2 Fleckenstein, B.,"Institut
far Klinische and Molekulare Virologie der Universitat Er-
langen-Nurnberg, Federal Republic of Germany; 2Dept.
of Pedicatrics, University of Alabama, Birmingham: The
major glycoprotein of human cytomegalovirus is a candi-
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ARRANGED BY
Michael Mathews, Cold Spring Harbor Laboratory
John Hershey, University of California, Davis
Brian Safer, National Institutes of Health
277 participants
It has been more than ten years since a meeting on the topic of protein synthesis
was last held at Cold Spring Harbor. That this year's meeting could concentrate on
the regulatory aspects of the process, rather than on its mechanism, is a token of
how far the field has advanced over the years. Of course, it is impossible to
consider regulation without a knowledge of mechanism, and so an afternoon
Workshop was included in the program to discuss recent ideas on the action of
the protein synthesis factors. These enzymes mediate the initiation, elongation,
and termination phases of messenger RNA decoding on the ribosome: Their
activities are subject to controls of several different kinds, in organisms from the
unicellular to the most complex, and under a large variety of circumstances.
The meeting was distinguished by the beginnings of the molecular genetic
approach to problems that were previously amenable only to biochemical
techniques, often of the most demanding sort. The genes or cDNAs for some of
the protein synthesis factors themselves have been cloned and sequenced, and
more are on the way. The first results to stem from a mutational analysis were
presented, and we can now confidently look forward to answers to hitherto
inaccessible questions from the application of reverse genetics strategies. Directed
mutagenesis of messenger RNA genes, carried out over the last several years, has
already disclosed numerous features of RNA sequence and structure that govern
its efficiency as a template for protein synthesis in both prokaryotic and eukaryotic
cells. A broad-ranging survey of this topic did as much to show how much we
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need to know as how much we already know. As in so many other fields, viral
systems were very much in evidence, lending themselves to both genetic and
biochemical analyses. These systems offer insights into the range of regulatory
processes open to the cell, serving as models for the more complex systems that
participate in the developmental and growth regulatory programs which were also
the subject of lively debate.
At its conclusion, both the participants and the Laboratory agreed that we
should not wait another decade for the next meeting on this subject at Cold
Spring Harbor. A second Translational Control meeting has been scheduled for
1989, and we will then see whether the rate of advance continues to accelerate.
This year's meeting was the fortunate beneficiary of a generous grant from ICN
Biomedicals, Inc., which covered all the costs of the conference.
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Hepatitis B Viruses
September 28-October 1
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William Mason, Fox Chase Cancer Center
Hans Will, Max-Planck Institut fur Biochemie, Munich
203 participants
The Molecular Biology of Hepatitis-B Virus meeting covered a broad range of
topics, from regulation of RNA and protein biosynthesis to vaccine development, to
the molecular basis of liver damage, to hepatocellular carcinoma. Results were
presented on the characterization of all four members of the hepatitis-B virus
(hepadnavirus) family, as well as the related delta agent, and on cauliflower
mosaic virus. Since last year's meeting, considerable progress has been made in
defining viral gene products and functions. The role of signal sequences and
posttranslational processing in virus maturation is now better understood, as are
the host-range determinants of the viral envelope gene and the trans-acting
regulatory potential of the viral x gene. The purification and characterization of the
hepadnavirus reverse transcriptase also appear to be imminent and, along with
genetic approaches made possible by the successful cultivation of hepadnaviruses
in mammalian cells, should lead to a complete description of viral DNA synthesis
from pregenomic RNA.
Progress has also been made in understanding the role of viral gene products
and the immune response in progression to a chronic infection and associated
liver disease. Along with the characterization of factors associated with the
immune response to viral infection in man, a number of reports described mouse
models as paradigms of the role of immunity and antigen expression in infection
and disease. These studies led to the conclusion that both the immune response
of the host and aberrant viral gene expression within individual cells may serve as
major sources of liver damage during chronic infection.
The final session of the meeting focused on the role of chronic infection in
hepatocellular carcinoma. Work presented at previous meetings had indicated that
viral DNA integration was common in tumors; however, analysis of the structure
and site of integration of viral DNA in tumors did not support the existence of a
viral oncogene or of insertional activation of a cellular proto-oncogene. Several
groups have now obtained evidence that insertional activation of oncogenes may
play a role in some tumors and that trans-activation of cellular genes by a viral
product may also have a role in tumor outgrowth.
This meeting was supported in part by the National Science Foundation and
the following divisions of the National Institutes of Health: National Institute of
Allergy and Infectious Diseases and the National Cancer Institute.
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to HBsAg.
Milich, D.R.,1 McLachlan, A.,' Thornton, G.B.,2 Moriarty,
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A. O'Connell, P. Marionst
A.,2 Hughes, J.,"Dept. of Molecular Biology, Research
Institute of Scripps Clinic, La Jolla, 2Johnson and John-
son Biotechnology Center, Sorrento Valley, California: Lo-
calization of multiple T-cell recognition sites confirms the
cross-reactivity of HBcAg and HBeAg at the T-cell level.
Cote, P.J.,1 Pohl, C.,' Gerin, J.L.,1 Tennant, B.C.,2 1DMVI,
Georgetown University, Rockville, Maryland; 2Cornell
University School of Veterinary Medicine, Ithaca, New
York: Serum AFP and y-glutamyl transferase as markers
for hepatocellular carcinoma in woodchucks.
Motte, P.,' Takahashi, H.,' Ozturk, M.,1 Wilson, B.E.,1
Frohlich, M.W.,1 Kew, M.C.,2 Wands, J.R.,"GI Unit,
SESSION 9 MECHANISMS OF ONCOGENESIS
Chairman: P. Marion, Stanford University
Marion, Pl.,' Salazar, F.H.,2 Robinson, W.S.,1 Will, H.,3
Steevens, C.,"Division of Infectious Diseases, Dept. of
Medicine, Stanford University, 2Syntex Inc., Palo Alto,
California; 3Max-Planck-Institut fur Biochemie, Martins-
ried/Munchen, Federal Republic of Germany: Determina-
tion of the inversion-deletion sites in a GSHV novel DNA
form cloned from chronically infected ground squirrel
liver.
Wang, H., Rog ler, C.E., Albert Einstein College of Medicine,
Bronx, New York: Evidence for topoisomerase I cleavage
of WHV virion DNA in the cohesive overlap region.
Imazeki, F.,' Omata, M.,1 Koike, K.,2 'First Dept. of Medi-
cine, Chiba University School of Medicine, 2Dept. of
Gene Research, Cancer Institute, Tokyo, Japan: Cloning
and structural analysis of integrated DHBV DNA in
chronic hepatitis.
Zhou, Y.-z.," Donehower, L.A.,' Slagle, B.L.,1 vanTuinen,
P.,2 Ledbetter, D.H.,2 Butel, J.S.,"Dept. of Virology,
2lnstitute for Molecular Genetics, Baylor College of Medi-
cine, Houston, Texas: HBV DNA integration in chromo-
some 17p near the human p53 gene in a hepatocellular
carcinoma.
Hsu, T.Y.,1 Mitirby, T.,' Etiemble, J.,1 Trepo, C.,2 Tiollais,
P.,1 Buendia, M.A.,"Unite de Recombinaison et
Expression Genetique, INSERM, CNRS, Institut Pasteur,
Paris, 2Unite de Recherches sur les Hepatites, UER Alex
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Massachusetts General Hospital, Boston; 'University of
Witwatersrand, Johanesberg, South Africa: Characteriza-
tion of human hepatoma-associated antigens using
monoclonal antibodies.
Colucci, G.,1 Tackney, C.,2 Waksal, S.D.,2 'Dept. of Biol-
ogy and Genetics, University of Milan, Italy; 2lmClone
Systems Inc., New York, New York: Identification of a ma-
jor HBcAg epitope using synthetic peptides.
Liu, Y.-F., Hou, Y., Yang, x.-Y., Dept. of Pathology, Fourth
Military Medical College, Beijing, Peoples Republic of
China: Presence of HBsAg in proliferating bile ductules.
Carrel, Lyon, France: Insertional activation of c-myc by
WHV by woodchuck hepatocellular carcinoma.
Lee, H.S., Rajagopalan, M.S., Vyas, G.N., Dept. of Labora-
tory Medicine, University of California, San Francisco:
Lack of direct role of HBV in the activation of c-myclras
oncogenes but a possible role of aflatoxin-DNA adducts
in human hepatocellular carcinoma.
Dejean, A., de The, H., Marchio, A., Tiollais, P., INSERM,
CNRS, Institut Pasteur, Paris, France: A novel steroid/thy-
roid hormone-receptor-related gene inappropriately ex-
pressed in human hepatocellular carcinoma.
Lasserre, C., Carlon', E., Hamelin, B., Brechot, C., IN-
SERM, Paris, France: Reexpression of insulin-like growth
factor II fetal transcripts in human primary liver tumors.
Su, T.,1,2 Tsai, T.,3 'Dept. of Medical Research, Veterans
General Hospital, 2Graduate Institute of Microbiology
and Immunology, National Yang-Ming Medical College,
Taiwan, Republic of China: Structure and expression of
oncogenes (proto-oncogene) in human hepatoma cell
lines.
Shirakata-Takasaki, Y.,' Yaginuma, K.,' Sano, H.,2 Oda,
M.,2 Kobayashi, M.,' Koike, K.,"Dept. of Gene Re-
search, Cancer Institute, Tokyo, 2Meiji Institute of Health
Science, Odawara, Japan: Introduction of the X gene
and enhancer sequence of HBV-stimulated growth and
c-myc expression of mouse NIH-3T3 cells.
Molecular Neurobiology of Drosophila
October 4-October 8
ARRANGED BY
Barry Ganetzky, University of Wisconsin
Jeffrey Hall, Brandeis University
144 participants
The subject of this conference was genetic and molecular analysis of the develop-
ment and function of the nervous system in Drosophila. The six sessions on the
program proceeded from embryonic development, through aspects of later neural
development, and then on to neural/functional topics, including sensory
phenomena, membrane physiology, neurochemistry (neurotransmitters plus
putative neuropeptides), and finally "higher" behaviors.
There were two 2-day poster sessions, involving about 90 presentations: These
paralleled the oral parts of the program in that the posters covered development
and then function of the fruit fly's nervous system.
Some of the substantive highlights of the conference involved efforts of
participants not only to update well-known genetic and/or molecular "systems" that
have come to the fore in the recent literature, but also to bring out new
approaches and efforts that have begun to be developed in the last year or so.
The first, more salient category included presentations on "neurogenic" genes;
factors controlling the development of the visual system; manipulation of genes
encoding opsin molecules; the definitive identification and characterization of a
locus that encodes components of potassium channels; manipulation and
expression studies revolving around genes involved in the biosynthesis or
reception of nonpeptide neurotransmitters; and genes involved in learning and
memory or in biological rhythms.
The second, newer category included presentations on one of the many genes
in Drosophila known to disrupt muscle development (when mutated), which-
unlike other "muscle genes"- has turned out to be molecularly expressed solely in
the central nervous system; on the patterns of "births" plus later proliferations of
definitively identified postembryonic neurons; on the first case of "reverse genetics"
having been achieved in this organism (whereby the investigators moved from
monoclonal antibody, to antigen, to gene isolation, and finally to the induction of
interesting mutations at the locus, which influences photoreceptor cells); on the
cloning of a gene encoding an apparent sodium/potassium ATPase; on the
isolation of what seems to be a "G-protein" gene in this invertebrate; on the first
cases of gene isolations for factors that produce what seem to be neuropeptides
in Drosophila (starting with the relevant biochemical information from other
organisms); and finally on some fascinating aspects of acoustical communication
in species of Hawaiian Drosophila (which have long been studied evolutionarily,
but now for the first time with regard to auditory signals that accompany reproduc-
tive behavior).
The conference seemed to be successful both in terms of revealing the
frighteningly rapid progress that is occurring in studies of now-famous cloned
"neural genes" in this organism and because the several new systems were
announced not only by investigators who have been studying Drosophila
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neurogenetics for some time (although they might have only recently begun to do
so at the faculty level), but also by some neurobiologists who have moved portions
of their research programs into genetic plus molecular analysis of excitable cells
and tissues in the fruit fly.
SESSION 1 EMBRYONIC DEVELOPMENT
Chairman: R.J. Greenspan, Roche Institute of Molecular Biology
Hoppe, P.E.,' Greenspan, R.J.,2 'Dept. of Biology, Prince-
ton University, 2Dept. of Neurosciences, Roche Institute
of Molecular Biology, Nutley, New Jersey: Analysis of
Notch gene action in neural-epidermal determination.
Yedvobnick, B., Smoller, D., Young, P, Mills, D., Dept. of Bi-
ology, Emory University, Atlanta, Georgia: Molecular
analysis of mastermind, a locus essential for proper neu-
rogenesis.
Modolell, J., Centro de Biologia Molecular, CSIC and Univ-
ersidad Autonoma de Madrid, Spain: Involvement of the
achaete-scute complex in neurogenesis.
SESSION 2 POSTEMBRYONIC DEVELOPMENT
Chairman: K.-F. Fischbach, Universitat Freiburg
Fischbach, K.-F.,, Boschert, U.,' Tix, S.,2 Technau, G.M.,2
'Institute fur Biologie, Universitat Freiburg, 2lnstitut far
Entwicklungsphysiologie, KO In, Federal Republic of Ger-
many: Mutant analysis of optic lobe development and lar-
val visual neurons.
Posakony, J., Ellis, H., Hartenstein, V., Leviten, M., Spann,
D., Dept. of Biology, University of San Diego, La Jolla:
Genetic and developmental studies of the patterning and
differentiation of epidermal sensilla.
Truman, J.W.,' Bate, M.,2 Irish, V.,2 'Dept. of Zoology, Uni-
versity of Washington, Seattle; 2Dept. of Zoology, Univer-
C.-W. Wu, B. Ganetzky, S. Benzer, A. Ferris
Holmgren, R.,1 Schafer, B.,' Patel, N.,2 Goodman, C.,2
'Dept. of Biochemistry, Molecular Biology and Cell Biol-
ogy, Northwestern University, Evanston, Illinois; 2Dept. of
Biology, Stanford University, California:.Function of the
segment polarity genes in the formation of the nervous
system.
Fleming, R.J., De Simone, S., White, K., Dept. of Biology,
Brandeis University, Waltham, Massachusetts: Molecular
analysis of the erect wing locus.
sity of Cambridge, England: Neurogenesis and its rela-
tionship to Ubx expression in the larval CNS.
Zipursky, L., Reinke, R., Van Vactor, D., Krantz, D., Dept. of
Biological Chemistry, University of California School of
Medicine, Los Angeles: A molecular and genetic analysis
of chaoptin-A photoreceptor-cell-specific glycoprotein
required for cellular morphogenesis.
Katz, F.,' Moats, W.,' Jan, Y.M.,2 'University of Texas
Health Science Center, Dallas; 2University of California,
San Francisco: Biochemical and genetic studies of a neu-
ronal cell-surface antigen.
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SESSION 3 SENSORY SYSTEMS
Chairman: G.M. Rubin, University of California, Berkeley
Zuker, C.,' Cowman, A.,2 Montell, C.,2 Rubin, G.2 'Dept.
of Biology, University of California, San Diego, La Jolla;
2Dept. of Biochemistry, University of California, Berkeley:
Opsins and the phototransduction cascade in the visual
system.
Feiler, R.,' Harris, W.,2 Kirschfeld, K.,' Mismer, D.,3 Wehr-
hahn, C.,' Rubin, G.,3 Zuker, C.,2 Max Planck Institut
fur Biologische Kybernetik, Tubingen, Federal Republic
of Germany; 2Dept. of Biology, University of California,
San Diego; 3Dept. of Biochemistry, University of Califor-
nia, Berkeley: Genetically engineered cell-specific mis-
expression of a rhodopsin gene.
SESSION 4 MEMBRANE PHYSIOLOGY
Chairman: C.-F. Wu, University of Iowa
O'Dowd, D.K., Germeraad, S., Aldrich, R.W., Dept. of Neu-
robiology, Stanford University, California: Electrophysio-
logical analysis of genes involved in sodium channel
function.
Lebovitz, R.M., Fambrough, D.M., Dept. of Biology, Johns
Hopkins University, Baltimore, Maryland: Molecular clon-
ing of gene and cDNA encoding the a-subunit of the
Na*/K+ ATPase.
Wadsworth, S.C.,' Rosenthal, L.S.,2 Kammermeyer, K.L.,'
Potter, M.B." Nelson, D.J.,2 'Cell Biology Group,
Worcester Foundation for Experimental Biology, Shrews-
bury, 2Dept. of Chemistry, Clark University, Worcester,
Massachusetts: CNS expression of an acetylcholine-re-
ceptor-related gene.
Stark, W.S., Sapp, R., Division of Biological Sciences, Uni-
versity of Missouri, Columbia: Turnover of photoreceptor
membrane.
Tanimura, T., Dept. of Biology, Faculty of Science, Fukuoka
University, Japan: Genetic dissection of the trehalose
taste receptor.
Jallon, J.M., Boukella, H., Ferveur, J.F., Biologie et Gene-
tique Evolutives du CNRS, Paris, France: Biosynthetic
and genetic studies of pheromone production.
Pongs, 0., Baumann, A., Krah, I., Muller, R., Kecskemethy,
M011er-Holtkamp, F., Institut fur Biochemie, Fakultat fOr
Chemie, Ruhr-Universitat Bochum, Federal Republic of
Germany: Molecular analysis of the Shaker gene com-
plex.
Schwarz, TL., Papazian, D.M., Tempel, B.L., Jan, Y.N., Jan,
L.Y., Howard Hughes Medical Institute and Dept. of
Physiology, University of California, San Francisco: Clon-
ing and sequences of cDNA from three probable potas-
sium-channel components from the Shaker locus.
Iverson, L., Kamb, A., Ramaswami, M., Tseng-Crank, J.,
Tanouye, M., Division of Biology, Caltech, Pasadena: Ion
channel genes.
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SESSION 5 NEUROCHEMISTRY
Chairman: J. Hirsh, Harvard University Medical School
Morgan, B.A.,' Bray, S.J.,' Johnson, W.A.,' Beall, C.J.,1
McCormick, C.A.,' Tully, T.,2 Hirsh, J.,"Dept. of Biolog-
ical Chemistry, Harvard Medical School, Boston, 'Dept.
of Biology, Brandeis University, Waltham, Massachusetts:
Neural expression of the D. melanogaster DOPA decar-
boxylase gene-Mechanisms and manipulation of gene
expression.
Wolfgang, W.J., Gnagey, A., Forte, M., Vollum Institute for
Advanced Biomedical Research, Oregon Health Sci-
ences University, Portland: Monoclonal antibodies reveal
the presence of acetylcholinesterase very early in the de-
veloping optic system of Drosophila.
Thambi, N.,' Northup, J.,2 Forte, M.,"Vollum Institute for
Advanced Biomedical Research, Oregon Health Sci-
ences University, Portland; 'Dept. of Pharmacology, Yale
University School of Medicine, New Haven, Connecticut:
Characterization and purification of GTP-binding proteins
SESSION 6 BEHAVIOR
Chairman: C.P. Kyriacou, University of Leicester
Yun, Y., Davis, R., Dept. of Biochemistry, Michigan State
University, East Lansing: Abnormal expression of RNAs
from copia transposable elements and serine protease
genes in dunce mutants.
Ackerman, S.L., Siegel, R.W., Dept. of Biology, University of
California, Los Angeles: Memory deficit in constitutive
and conditional protein synthesis mutants.
Dowse, H., Kass, L., Ringo, J., Dept. of Zoology, University
of Maine, Orono: Close parallels between puparial heart
POSTERS
Artavanis-Tsakonas, S., Bryant, R., Fehon, R., Fleming, R.,
Flach, J., Herndon, V., Johansen, K.M., Ramos, R., Scott,
N., Xu, T., Dept. of Biology, Yale University, New Haven,
Connecticut: Molecular biology of neurogenesis.
Baker, N., Moses, K., Rubin, G.M., Dept. of Biochemistry,
University of California, Berkeley: Autosomal mutations
affecting the Drosophila eye.
Banerjee, U., Renfranz, P.J., Hinton, D.R., Rabin, B., Ben-
zer, S., Division of Biology, California Institute of Technol-
ogy, Pasadena: Localization of expression of the seven-
less gene protein product.
Bernstein, L., Teng, D., Blake, A., Kolodkin, A., Venkatesh,
T, Institutes of Molecular Biology and Neuroscience, Uni-
versity of Oregon, Eugene: Characterization of hybrid
dysgenesis-induced mutations that perturb photorecep-
tor cell structure and function.
Bier, E., Ackerman, L.A., Barbel, S,, Jan, L., Jan, Y.M.,
Howard Hughes Medical Institute and Dept. of Physiol-
ogy, University of California, San Francisco: Identification
and characterization of a neuronal-specific nuclear anti-
gen.
Bloomquist, B.,' Shortridge, R.,' Montell, C.,' Steller, H.,2
Rubin, G.,2 Pak, W.L.,"Dept. of Biological Sciences,
Purdue University, West Lafayette, Indiana; 'Dept. of
Biochemistry, University of California, Berkeley: Isolation
318
from Drosophila neuronal membranes.
Yarfitz, S., Provost, N., Hurley, J.B., Dept. of Biochemistry
and Howard Hughes Medical Institute, University of
Washington, Seattle: Isolation and characterization of a
Drosophila G protein /3-subunit gene.
Nichols, R., Dept. of Biochemistry, Purdue University, West
Lafayette, Indiana: Isolation of a vertebrate neuropeptide
homolog present in D. melanogaster.
Nambu, J.R.,' Murphy-Erdosh, C.,' Andrews, P.C.,' Feist-
ner, G.J.,3 Scheller, R.N.,' 'Dept. of Biological Sciences,
Stanford University, California; 'Dept. of Biochemistry,
Purdue University, West Lafayette, Indiana; 3Dept. of
Psychiatry and Behavioral Sciences, Stanford Medical
Center, California, Isolation and characterization of an
FMRF amide-related neuropeptide gene from Drosoph-
ila.
rate and circadian rhythms in clock mutants.
Thackeray, J., Greenacre, M., Hill, M., Kyriacou, C.P., Dept.
of Genetics, Leicester University, England: Analysis of bi-
ological timers.
Hoy, R.R.,' Hoikkala, A.,2 Kaneshiro, K.,' 'Section of Neu-
robiology and Behavior, Cornell University, Ithaca, New
York; 'Hawaiian Evolutionary Biology Program, Univer-
sity of Hawaii, Honolulu: Auditory signals in the courtship
of Hawaiian Drosophila.
and characterization of the norpA gene.
Boschert, U., Fischback, K.7F., Institut far Biologie, Univer-
sitat Freiburg, Federal Republic of Germany: Disorders of
the optic chiasms in D. melanogaster.
Cagan, R.L., Ready, D.F., Dept. of Biology, Princeton Uni-
versity, New Jersey: Primary pigment cells are lost in
facet-glossy.
H. Steller, G. Rubin
Campos, A.R., Rosen, D., Robinow, S., White, K., Dept. of
Biology, Brandeis University, Waltham, Massachusetts:
Molecular genetic analysis of the e/av locus in D. melano-
gaster.
Campos-Ortega, J.A., Bremer, K.A., de la Concha, A., Die-
trich, U., Knust, E., Technau, G.M., Tietze, K., Vassin, H.,
Ziemer, A., Institut fur Entwicklungsphysiologie, Universi-
tat KO In, Federal Republic of Germany: Genetics of early
neurogenesis in D. melanogaster.
Canal, Ferrus, A.,2 'Universidad Autonoma; 2Instituto
Cajal, CSIC, Madrid, Spain: Genetic basis of metamerism
in the CNS of Drosophila.
Crews, S., Thomas, J., Goodman, C., Dept. of Biological
Sciences, Stanford University, California: The Drosophila
S8 gene encodes a nuclear protein with homology to the
per gene product.
Dambly-Chaudiere, C.,1 Ghysen, A.,' Leyns, L.,' Jan,
L.Y,2 Jan, Y.N.,2 'Laboratory of Genetics, University
Libre de Bruxelles, Belgium; 2Howard Hughes Medical
Institute, San Francisco, California: Genetics of peripheral
neurogenesis in Drosophila.
de Couet, H.G.,1 Yamamoto, M.,' Davies, J.,' Pirrotta, V.,2
Miklos, G.L.G.,"Developmental Neurobiology Group,
Research School of Biological Sciences, Canberra, Aus-
tralia; 2Dept. of Cell Biology, Baylor College of Medicine,
Houston, Texas: Genetic characterization and molecular
cloning of a flightless locus at the base of the X chromo-
some of D. melanogaster.
Egger, M.D." Harris, S.,1 Peng, B.,' Schneiderman, A.M.,2
Wyman, R.J.,2 'Dept. of Anatomy, UMDNJ, Robert
Wood Johnson Medical School, Piscataway, New Jersey;
2Dept. of Biology, Yale University, New Haven, Connecti-
cut: Morphometric analysis of thoracic muscles in wild
type and in bithorax complex mutants.
Elkins, T., Patel, N., Jacobs, R., Goodman, C., Dept. of Bio-
logical Sciences, Stanford University, California: Deletion
studies of the Fasciclin Ill gene.
Hackett, R.W., Benzer, S., Division of Biology, California In-
stitute of Technology, Pasadena: Characterization of eyes
B. Ganetzky, C.-F. Wu, M. Stern
absent, a mutation that eliminates the compound eyes.
Harrelson, A., Zinn, K., Snow, P., Bastiani, M., Goodman,
C., Dept. of Biological Sciences, Stanford University, Cali-
fornia: Molecular characterization of the Fasciclin II cell-
surface glycoprotein.
Hartenstein, V., Posakony, J.W., Dept. of Biology, University
of California, San Diego, La Jolla: Sensory.neuron devel-
opment in string, a mutant that inhibits postblastoderm
cell proliferation.
Reinke, R., Hess, R., Hart, A., Zipursky, L., Dept. of Biologi-
cal Chemistry, University of California School of Medi-
cine, Los Angeles: bride of sevenless-An autosomal lo-
cus required for the development of photoreceptor cell
seven.
Hyde, D.R., Palazzolo, M.J., Mecklenburg, K.L., Raghavan,
K.V., Meyerowitz, E.M., Benzer, S., Division of Biology,
California Institute of Technology, Pasadena: Identifica-
tion and characterization of 60 optic-pathway-specific
cDNAs from a pool of 500 "head"-specific clones.
Palazzolo, M.J., Hyde, D.R., Raghavan, K.V., Mecklenburg,
K., Benzer, S., Meyerowitz, E.M., Division of Biology, Cali-
fornia Institute of Technology, Pasadena: Isolation and
preliminary characterization of 500 noncross-hybridizing
Drosophila "head-specific" cDNA clones by sorting a
subtracted ASWAJ cDNA library.
Isono, K.,' Tanimura, T,2 Tsukahara, Y.,"Research Cen-
ter for Applied Information Sciences, Tohoku University,
Sendai, 2Dept. of Biology, Fukuoka University, Japan:
Biogenesis of 3-hydroxyretinal and visual pigment in the
compound eyes of D. melanogaster.
Jones, S., Fitzgerald, G., Tan, L., Kankel, D.R., Dept. of Bi-
ology, Yale University, New Haven, Connecticut: Genetic
and biochemical analysis of the role of glycoproteins in
the development of Drosophila.
Kiger, J.A., Jr., Be Ilen, H.J., Dept. of Genetics, University of
California, Davis: cAMP phosphodiesterase coded by the
dunce gene is essential for normal embryogenesis.
Kimura, K.-I.,1 Tanimura, T.,2 'Zoological Institute, Faculty
of Science, Hokkaido University, Sapporo, 2Dept. of Biol-
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ogy, Faculty of Science, Fukuoka University, Japan: Mu-
tations affecting programmed cell death of head muscles
in Drosophila.
Knust, E., Tietze, K., Ziemer, A., Campos-Ortega, J.A., Insti-
tut fur Entwicklungsphysiologie, KOln, Federal Republic
of Germany: A genetic and molecular analysis of En-
hancer of split, a complex of gene functions involved in
neurogenesis in D. melanogaster.
LaBonne, S.,' Mahowald, A.P.,2 'Dept. of Biochemistry,
University of Mississippi Medical Center, Jackson; 2Dept.
Reserve University, Cleveland, Ohio: Molecular genetics
of the maternal-effect neurogenic locus pecanex.
Meinertzhagen, I.A., O'Neil, S.D., Life Sciences Centre, Dal-
housi University, Halifax, Nova Scotia, Canada: Synaptic
organization of the lamina cartridge in Drosophila.
Muskavitch, M.A.T., Alton, A.K., Fechtel, K., Kopczynski,
C.C., Shepard, S.B., Kooh, P.J., Peterson, K.R., Parks,
C.G., Institute for Molecular and Cellular Biology and
Dept. of Biology, Indiana University, Bloomington: Molec-
ular genetics of neurogenesis in Drosophila.
Nakao, K.' Hotta, Y.,1 Asahara, H.,1 Mogami, K.,' Mi-
yake, T.," Dept. of Physics, University of Tokyo,
2Mitubishi-Kasei Institute of Life Sciences, Tokyo, Japan:
Immunohistological screenings of the second chromo-
somal embryonic lethals having neural defects.
O'Tousa, J.E., Washburn, T., Dept. of Biological Sciences,
University of Notre Dame, Indiana: Molecular defects in
Drosophila rhodopsin mutants.
Palka, J., Schwaninger, H., Dept. of Zoology, University of
Washington, Seattle: Phenotypic interactions between
hairy and several venation mutations.
Perkins, L.,' Zhang, K.,' Perrimon, N.,' Mahowald, T.,2
'Dept. of Genetics, Harvard Medical School, Boston,
Massachusetts; 2Dept. of Developmental Genetics and
Anatomy, Case Western Reserve University, Cleveland,
Ohio: Genes expressed in cultured neuroblasts.
Pollock, J.A., Benzer, S., Division of Biology, California Insti-
tute of Technology, Pasadena: Expression of the seven-
less gene.
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Preiss, A., Harley, D., Artavanis-Tsakonas, S., Dept. of Biol-
ogy, Yale University, New Haven, Connecticut: Molecular
analysis of Enhancer of split.
Raghavan, K.V., Celniker, S.E., Lewis, E.B., Meyerowitz,
E.M., Division of Biology, California Institute of Technol-
ogy, Pasadena: Role of the nervous system and epider-
mis in muscle development-Genetic and molecular
analysis of the Drosophila locus stripe.
Robinow, S., Campos, A.R., White, K., Dept. of Biology,
Brandeis University, Waltham, Massachusetts: In situ lo-
locus elay.
Rothberg, J., Hartley, D., Artavanis-Tsakonas, S., Dept. of
Biology, Yale University, New Haven, Connecticut: Molec-
ular genetics of a growth-factor-like gene exhibiting a
specific neural pattern of expression.
Rubin, G.M., Baker, N., Bowtell, D., Fortini, M., Heilig, J.,
Kimmel, B., Mismer, D., Moses, K., Simon, M., Steller, H.,
Tomlinson, A., Dept. of Biochemistry and Howard
Hughes Medical Institute, University of California, Berke-
ley: Development of the Drosophila visual system.
Smouse, D.,'.2 Goodman, C.,' Perrimon, N.,2 Dept. of Bi-
ological Sciences, Stanford University, California; 2Dept.
of Genetics, Harvard Medical School, Boston, Massachu-
setts: Polyhomeotic and Posterior sex combs are re-
quired for axonal guidance in the embryonic CNS.
Steller, H.,' Heilig, J.S.,' Fischback, K.-F.2 Rubin, G.M.,1
'Howard Hughes Medical Institute and Dept. of Biochem-
istry, University of California, Berkeley; 2lnstitut kir Biolo-
gie, Universitat Freiburg, Federal Republic of Germany:
Developmental and molecular genetic analyses of dis-
connected, a locus involved in neuronal cell recognition.
Tomlinson, A., Bowtell, D., Hafen, E., Rubin, G., Howard
Hughes Medical Institute and Dept. of Biochemistry, Uni-
versity of California, Berkeley: Localization of sevenless
protein in the eye imaginal disk of Drosophila.
Uemura, T., Barbel, S., Jan, L., Jan, Y.N., Howard Hughes
Medical Institute and Dept. of Physiology, University of
California, San Francisco: A mutation that causes reduc-
tion of sensory neurons and duplication of sensory struc-
tures.
Vassin, H., Bremer, K.A., Knust, E., Campos-Ortega, J.A.,
Institut fOr Entwicklungsphysiologie, Universitat KOln,
Federal Republic of Germany: The neurogenic gene
Delta of D. melanogaster is expressed in neurogenic ter-
ritories and encodes a putative transmembrane protein
with EGF-like repeats.
Watanabe, T., Kankel, D.R., Dept. of Biology, Yale Univer-
sity, New Haven, Connecticut: Molecular genetics studies
on the 1(1) ogre locus.
Weinzierl, R.,' Axton, M.,' Ghysen, A.,2 Akam, M.,'
'Dept. of Genetics, University of Oxford, Cambridge,
England; 2Laboratoire de Genetique, Universite de Brux-
ells, Belgium: An Ultrabithorax microexon mutation sug-
gests a CNS-specific RNA processing pathway for Ubx
transcripts.
Wong, F.,1.2 Yuh, X.-T.,' Schafer, E.L.' Roop, B.C.,'
Depts. of 'Ophthalmology, 2Anatomy and Cell Biology,
University of Illinois, Chicago: Overlapping transcription
units in the transient receptor potential locus of D. melan-
ogaster.
Woodard, C., Sun, H., Helfand, S., Carlson, J., Dept. of Bi-
ology, Yale University, New Haven, Connecticut: Genetic
and molecular analysis of olfaction.
Zinn, K., McAllister, L., Snow, P., Elkins, T., Goodman, C.,
Dept. of Biological Sciences, Stanford University, Califor-
nia: Molecular genetics of grasshopper and Drosophila
Fasciclin I.
Aldrich, R.W., Zagotta, W.N., Brainard, M.S., Dept. of Neu-
robiology, Stanford University, California: Single potas-
sium channels in wild-type and Shaker Drosophila my-
otubes.
Atkinson, N., Robertson, G., Ganetzky, B., Laboratory of
Genetics, University of Wisconsin, Madison: Isolation and
analysis of new mutations at the slowpoke locus.
Bargiello, TA.,' Saez, L.,' Bay lies, M.K.,' Young, M.W.1
Spray, D.C.,2 'Howard Hughes Medical Institute, Rocke-
feller University, New York, 2Albert Einstein College of
Medicine, Bronx, New York: A biological clock mutation
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Rosbash, M., Dept. of Biology, Brandeis University, Wal-
tham, Massachusetts: Interspecific comparisons of the
period gene.
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sity of Wisconsin, Madison: Molecular analysis of eag -A
gene affecting two potassium channels in Drosophila.
Ewer, J., Rosbash, M., Hall, J.C., Dept. of Biology, Brandeis
University, Waltham, Massachusetts: Requirement of per
gene expression during development for the expression
of an adult circadian locomotor activity rhythm.
Folkers, E., Quinn, W.G., Dept. of Brain and Cognitive Sci-
ence, Massachusetts Institute of Technology, Cambridge,
Massachusetts: Behavioral and genetic analysis of the
Drosophila mutant radish.
Gailey, D.A., Hall, J.C., Dept. of Biology, Brandeis Univer-
sity, Waltham, Massachusetts: Behavioral and cytoge-
netic analysis of the fruitless phenotype.
Loughney, K., Gantezky, B., Laboratory of Genetics, Uni-
versity of Wisconsin, Madison: Homology between para
and the rat sodium channel.
Germeraad, S., O'Dowd, D.K., Aldrich, R.W., Dept. of Neu-
robiology, Stanford University, California: A "zero-dose"
screen for genes affecting ion channel function.
Gundelfinger, E.D., Hermans-Borgmeyer, I., Schlob, P., Sa-
wruk, E., Betz, H., ZMBH, Heidelberg, Federal Republic
of Germany: The neuronal nicotinic acetylcholine recep-
tor of Drosophila.
Hall, L.M., Gil, D.W., Kasbekar, D.P., Dept. of Genetics, Al-
bert Einstein College of Medicine , Bronx, New York: The
tip-E locus affects a subset of sodium channels.
Jackson, F.R., Elliott, K., Worcester Foundation for Experi-
mental Biology, ShrewsburV;iMassachusetts: Chromo-
somal walking through the Andante clock locus.
Kasbekar, D.P., Hall, L.M., Dept. of Genetics, Albert Ein-
stein College of Medicine, Bronx, New York: Novel phe-
notypes associated with the enhancer of seizure, a mem-
brane excitability mutation.
Komatsu, A., Rathe, P., Gorczyca, M., Wu, C. -F, Dept. of
R. Greenspan, J. Pollack
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Biology, University of Iowa, Iowa City: Single-channel re-
cording of Ca"-dependent potassium currents in nor-
mal and mutant Drosophila muscles.
Kulkarni, S.J., Vargo, M.A., Steinlauf, A.D., Hall, J.C., Dept.
of Biology, Brandeis University, Waltham, Massachusetts:
Neurogenetic connections between the control of court-
ship singing and visual system functions in D. melano-
gaster.
Liu, X., Lorenz, L., Yu, Q., Hall, J.C., Rosbash, M., Dept. of
Biology, Brandeis University, Waltham, Massachusetts:
Temporal and spatial expression of the per gene assayed
with fl-galactosidase fusions and in situ hybridization.
Lorenz, L., Hall, J.C., Rosbash, M., Dept. of Biology, Bran-
deis University, Waltham, Massachusetts: Studies on the
cycling 0.9-kb transcript neighboring the period gene.
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Jersey: Mutant analysis of D. melanogaster for geo-
taxis-A preliminary report.
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Technology, Cambridge: Characterization of tyrosine hy-
droxylase in Drosophila.
Okamoto, H., Takasu-Ishikawa, E., Sakai, K., Goto, S., Na-
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Science, University of Tokyo, Japan: Isolation of the Dro-
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and Howard Hughes Medical Institute, University of
Washington, Seattle: Isolation and characterization of a
Drosophila G protein gene.
Quan, F., Liston, D., Forte, M., Vollum Institute for Ad-
vanced Biomedical Research, Oregon Health Sciences
University, Portland: Isolation of Drosophila sequences
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Sun, Y.A., Wyman, R.J., Dept. of Biology, Yale University,
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Tompkins, L., Dept. of Biology, Temple University, Philadel-
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Whitaker, J., Nash, H., NIMH, National Institutes of Health,
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BANBURY CENTER
DIRECTOR'S REPORT
Banbury Center's tenth year was overshadowed by the tragic death of Steve
Prentis in February of 1987. That his program went ahead just as he had planned
was due to Terri Grodzicker who became the acting director, and Bea To liver, the
Center's administrative assistant, who took on all responsibility for the day-to-day
running of the Center. A total of 14 meetings were held on a wider variety of topics
than has been usual in the Banbury program. In addition, we conducted a
workshop for science journalists and the second in a series of special meetings
arranged in conjunction with Shearson Lehman Brothers. Banbury Center was
also host to four advanced lecture courses.
Risk Assessment Program
Three meetings in the risk assessment program were held in 1987, two dealing
with the problems of mutations. In the early part of the year, the meeting on
Mammalian Cell Mutagenesis reviewed the latest data on the molecular
mechanisms of mutational events in mammalian cells, and a session of particular
importance dealt with recent advances in methods for detecting mutations. It was
agreed that there had been interesting developments in understanding the roles of
recombination and repair processes in modulating mutational processes in
mammalian cells.
The meeting on Eukaryotic Transposable Elements as Mutagenic Agents
brought together investigators in the areas of eukaryotic retroviruses and transpos-
able elements, cancer biology, DNA damage and repair, and human risk
assessment. An area of particular interest concerned the mechanisms of retroviral
latency and the factors that might influence this state.
In October, there was a meeting that exemplified the nature of Banbury Center
conferences, where a group including academic and industrial scientists and
representatives of the regulatory agencies came together to review New Directions
in the Qualitative and Quantitative Aspects of Carcinogen Risk Assessment. It
was clear that risk assessment per se is an extremely complicated and difficult
subject, and the Banbury Center will continue to provide a forum for exploring the
consequences of the interaction between science and public policy.
Meetings in the Corporate Sponsor Series
The Corporate Sponsor Program has become the core support of the Banbury
Center's activities, providing funds that support meetings concerned with a variety
of topics that are of great intrinsic interest and also of importance to those
companies that generously contribute to the program.
Two of the meetings dealt with basic techniques in molecular biology. One
meeting was concerned with the Development of the Human Lymphocyte Protein
Database, a system for analyzing and classifying lymphocytes on the basis of their
specific proteins detected by two-dimensional polyacrylamide gel electrophoresis.
Antisense RNA has been promoted as a general method for manipulating gene
expression, and a meeting was held in December to review the use of antisense
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RNA techniques in a variety of systems. The results have been rather variable,
depending on the organism and genes being studied, and this was a particularly
timely meeting to examine factors that might account for this variation.
The application of molecular techniques to the analysis of the strategies by
which parasites thwart the defenses of their hosts promises to yield tremendous
benefits, and a meeting to review advances in the Molecular Genetics of Parasitic
Protozoa was held at Banbury in November. Another meeting dealing with a topic
of great practical importance was that on the Transformation of Agriculturally
Important Crops. Genetic engineering of plant crops has progressed well beyond
the laboratory stage, and much of the meeting was concerned with the practicali-
ties and consequences of developing large-scale field testing. The meeting
continued the Banbury theme of dealing with scientific issues of great public
interest.
A very popular meeting was that on Nuclear Oncogenes, and it was notable
for bringing together research workers who perhaps spend less time talking with
each other than they should. Among the topics covered were ras, fos, myc, and
myb, and adenovirus E1A, and although much new information was presented, it
is not yet clear what relationship, if any, there is between the mechanisms by
which these various oncogenes act.
The question of how extracellular signals are transmitted across the plasma
membrane was the subject of a meeting on the Role of Inositol Lipids in
Signaling. The importance of this mechanism of signal transduction has been
recognized increasingly, and as well as dealing with the biochemical pathway
involved, the meeting also examined the ways in which increases in free cytoplas-
mic Ca" concentration come about and how the system is involved in the
regulation of cell growth.
Program Meetings
Two other major meetings were held during 1987 at the Banbury Center. In April, a
meeting entitled Therapeutic Peptides and Proteins: Assessing the New Technol-
ogies was organized with support from the James S. McDonnell Foundation and
a number of biotechnology companies. The meeting encompassed a wide range
of subjects, from reviews of new methods of producing peptides and proteins
using recombinant DNA techniques or chemical or enzymatic syntheses, through
their characterization and clinical testing, to the ways in which regulatory agencies
in the United States and in other countries are dealing with these new
developments.
The largest meeting of the year was that on the Role of the Heat-shock
Response in Biology and Disease, supported by the Samuel Freeman Trust, The
meeting considered the function of the so-called heat-shock proteins produced in
response to noxious stimuli or disease. It was also one of the most wide-ranging of
our meetings, bringing together scientists working on the physiological and
behavioral responses of desert animals to heat, with scientists cloning genes and
analyzing proteins!
Congressional Staff and Science Journalist Workshops
A growing interest of the Laboratory is the education of the general public in the
area of biotechnology, and molecular biology and genetics in particular. In 1980,
the Banbury Center, with support from the Alfred P Sloan Foundation, instituted a
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series of small workshops for science journalists and for congressional staffers.
The workshops are intended to provide an opportunity for these two groups, who
play significant roles in shaping and enacting science policy, to learn in depth
about topics of current public concern. In March, a journalists workshop was held
on the Cellular and Molecular Basis of Normal and Abnormal Development. An
interesting feature of this meeting was that it dealt with development in widely
differing animal groups, including Drosophila, nematodes, amphibia,and
mammals, and with the increasing evidence for the involvement of oncogenes in
developmental processes.
Joint Meeting with Shearson Lehman Brothers
Another part of the Banbury Center program for making the scientific basis of
biotechnology better understood is a series of meetings for chief executive officers
and other senior staff members of companies with an interest in biotechnology.
Organized in conjunction with Shearson Lehman Brothers, the meetings are
intended to give the executives who attend an opportunity to learn, at first hand,
from scientists who are world authorities in particular topics. The first meeting, The
Genetic Knowledge of Man, was held in 1986, and the second meeting, entitled
The Human Brain, was held in October of 1987 The topics covered ranged from
the gross anatomy of the brain, through cloning the genes for color vision
pigments, to the impact of neurobiology on philosophical problems such as mind-
body dualism and free will. An outstanding group of.scientists presented talks,and
the meeting was a tremendous success.
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housing and dining
accommodations at
Banbury Center.
Other Meetings
The Banbury Center was also used as a venue to promote the activities of groups
concerned with topics of biological or medical importance. A meeting on CCK
Antagonists was organized under the auspices of the National Institute of Mental
Health. We were pleased to welcome again the Esther A. and Joseph Klingenstein
Fund that used the Center to bring together the young neuroscientists supported
by the Fund and the Fund's trustees and scientific advisors. The contemplative
ambience of Banbury Center meetings was exploited for weekend meetings both
by the deans of the Associated Medical Schools of New York and by the
Psychiatric Department of Mt. Sinai Hospital Medical School.
Meetings of quite a different kind began in 1987, when the facilities of the
Center were used by our neighbors in Lloyd Harbor for a seminar series.
Appropriately, the first of these seminars was given by members of the Laboratory:
Doug Hanahan spoke on the use of transgenic mice in studying cancer and I
spoke on the molecular genetics of Duchenne muscular dystrophy.
Publication of Banbury Center Meetings
Meetings on risk assessment are published as Banbury Reports, and as reviews
of volumes in the series show, the Banbury Reports are established as authorita-
tive and timely studies. In 1987, Banbury Report 25, Nongenotoxic Mechanisms
in Carcinogenesis, was published. Meetings in the Corporate Sponsor Program
held at the Banbury Center are published as Current Communications in
Molecular Biology. In 1987, four titles were published in this series: Gene Transfer
Vectors for Mammalian Cells; Angiogenesis: Mechanisms and Pathobiology;
Inositol Lipids in Cellular Signaling; and Nuclear Oncogenes. These publications
are records of the meetings held here at Banbury, but if the subject of the meeting
justifies it, then a book based on the meeting, but dealing with the subject in
greater detail, may be considered.
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The Future
The Banbury Center is firmly established as a unique contributor to the processes
of disseminating and promoting knowledge in the international scientific
community. As can be seen from this report, Steve Prentis had begun.to diversify
the topics covered by Banbury Center meetings, and this is a trend that I intend to
continue. The Corporate Sponsor Program and generous long-term funding from
sources such as the Alfred P Sloan Foundation and the James S. McDonnell
Foundation have helped support the program, but funding is a continuing
concern. I should like to establish series of meetings that would have funds
assured over three-year periods, giving us long-term stability for planning exciting
and topical meetings. For example, we would hold two meetings each on risk
assessment, human genetics, neurobiology, cancer, plant molecular biology, AIDS,
and biotechnology each year. These are topics that are scientifically challenging
and exciting, and they are areas in which there will be increasing interaction
between science and society. The consequences of such interactions must be
examined if we are to promote the advancement of scientific knowledge and the
well being of society. The Banbury Center will continue to contribute to this
process by examining important issues involving the biological sciences and
public policy.
Jan Witkowski
Publications
Caskey, C.T., R.E. Gibbs, J.A. Witkowski, and J.F. Hejtmancik. 1988. Human inheritable
diseases. Philos. Trans. R. Soc. Lond. B (in press).
Hejtmancik, J.A. Witkowski, S. Gunnel, S. Davis, L. Baumbach, and C.T. Caskey. 1988.
Prenatal and carrier detection of Duchenne muscular dystrophy using recombinant DNA
technology. In Nucleic acid probes in diagnosis of human genetic diseases (ed. A.M.
Willey). Alan R. Liss Inc., New York. (In press.)
McCabe, E.R.B., J. Towbin, J. Chamberlain, L. Baumbach, J.A. Witkowski, G.J.B. van
Ommen, M. Koenig, L.M. Kunkel, and W.K. Seltzer cDNA for the Duchenne muscular
dystrophy locus demonstrate a previously undetectable deletion in a patient with
dystrophic myopathy, glycerol kinase deficiency and congenital adrenal hypoplasia.
Lancet (Submitted.)
Pizzey, J.A., J.A. Witkowski, and G.E. Jones. 1987. Spreading behaviour of cultured
fibroblasts from carriers of Duchenne muscular dystrophy. J. Cell Sci. 87: 163-169.
Witkowski, J.A. 1987. Optimistic analysis-Chemical embryology in Cambridge, 1920-1942.
Med Hist. 31: 247-268.
. 1987. Cell aging in vitro: A historical perspective. Exp. Gerontol. 22: 231-248.
1988. The molecular genetics of Duchenne muscular dystrophy: The beginning of
the end? Trends Genet. (in press).
1988. RNA splicing-A scientific revolution. Trends Biochem. Sci. (in press).
. 1988. Huxley in the laboratory: Embracing inquisitiveness and widespread curiosity.
In Julian Huxley-Biologist and statesman of science (ed. A. van Heiden). (In press.)
Witkowski, J.A. and C.T. Caskey. 1988. Duchenne muscular dystrophy-DNA diagnosis in
practice. In Current neurology (ed. S.H. Appel). Medical Year Books, Chicago. (In press.)
329

MEETINGS
Nuclear Oncogenes
March 3-March 6
ARRANGED BY
E. Harlow, Cold Spring Harbor Laboratory, New York
F. Alt, Columbia University, New York, New York
E.B. Ziff, New York University Medical Center, New York
SESSION 1
Chairperson: E.B. Ziff, New York University Medical Center, New York
C. Stiles, Dana-Farber Cancer Institute, Boston,
Massachusetts: Do inducible nuclear proto-oncogenes
play a functional role in growth factor action?
E.B. Ziff, New York University Medical Center, New York:
Transcriptional regulation of the c-fos gene.
M. Gilman, Cold Spring Harbor Laboratory, New York:
Intracellular mediators of c-fos induction.
R. Treisman, MRC Laboratory of Molecular Biology,
Cambridge, England: Regulation of c-fos transcription.
B.H. Cochran, Massachusetts Institute of Technology,
Cambridge: Activation of transcription by growth factors.
P Sassone-Corsi, The Salk Institute, San Diego, California:
c-fos regulation is mediated by positive and negative
cellular factors.
R.G. Roeder, Rockefeller University, New York, New York:
Identification and functional analysis of common and
gene-specific transcription factors for regulated eukaryotic
genes.
SESSION 2
Chairperson: A.J. Levine, Princeton University, New Jersey
B. Vennstrom, European Molecular Biology Laboratory,
Heidelberg, Federal Republic of Germany: Biochemical
and biological functions of the cellular and viral erbA
oncogenes.
T. Curran, Roche Institute of Molecular Biology, Nutley, New
Jersey: Possible role of c-fos in signal transduction.
T Jenuwein, European Molecular Biology Laboratory,
Heidelberg, Federal Republic of Germany: Analysis of the
molecular and biological function of fos.
E. Premkumar Reddy, The Wistar Institute of Anatomy and
Biology, Philadelphia, Pennsylvania: Structure,
mechanisms of activation, and function of myb
oncogene.
A.J. Levine, Princeton University, New Jersey: Interaction of
p53 with viral and cellular proteins.
D. Beach, Cold Spring Harbor Laboratory, New York:
Interaction between products of cdc2 and sucl genes of
fission yeast and between the homologs in human cells.
B. Stillman, J. Adams
N. Kohl
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SESSION 3
Chairperson: E. Harlow, Cold Spring Harbor Laboratory, New York
N.C. Jones, Imperial Cancer Research Fund Laboratories,
London, England: Functional and structural characteriza-
tion of the adenovirus E1A proteins.
E. Moran, Cold Spring Harbor Laboratory, New York:
Functional domains in the adenovirus E1A proteins.
M.R. Green, Harvard University, Cambridge, Massachusetts:
A mutational analysis of the adenovirus type 5 E1A
protein.
B. Wasylyk, Faculte de Medecine, Strasbourg, France; The
ras oncogene and a tumor promoter stimulate the
polyomavirus enhancer.
E. Harlow, Cold Spring Harbor Laboratory, New York:
Regions of the adenovirus E1A proteins required for
transformation are binding sites for cellular proteins.
J.R. Nevins, The Rockefeller University, New York, New York:
Cellular factors involved in EtA gene control.
J. Brady, National Cancer Institute, Bethesda, Maryland:
Transcriptional regulatory sequences in the human T-
lymphotropic virus type I long terminal repeat.
SESSION 4
E. Harlow, B. Vennstrom
Chairperson: R. Eisenman, Fred Hutchinson Cancer Research Center, Seattle, Washington
F. Alt, Columbia University, New York, New York: Structure
and expression of myc-family genes.
R. Dalla-Favera, New York University Medical Center, New
York: Mechanisms and biological role of c-myc oncogene
activation in B-cell tumors.
R. Eisenman, Fred Hutchinson Cancer Research Center,
Seattle, Washington: Proteins encoded by the c-myc
oncogene.
W. Lee, University of California, San Francisco: Definition of
regions in human c-myc involved in transformation and
nuclear localization.
R.A. Watt, Smith Kline & French Laboratories, Swede land,
Pennsylvania: Functional characterization of the c-myc
protein.
K.B. Marcu, State University of New York, Stony Brook:
Regulation and biological properties of the c-myc
proto-oncogene.
M. Groudine, Fred Hutchinson Cancer Research Center,
Seattle, Washington: Control of c-myc transcription by
blocking elongation.
M. Keuhl
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SESSION 5
Chairperson: F. Alt, Columbia University, New York, New York
M. Cole, Princeton University, New Jersey: c-myc and the
control of cellular gene expression.
U.R. Rapp, N.C.I.-Frederick Cancer Research Facility,
Maryland: Role of myc in tumor induction, growth factor
abrogation, and control of c-myc expression.
N. Kohl, Massachusetts Institute of Technology, Cambridge:
Mechanisms of oncogene collaboration.
J.M. Adams, Walter & Eliza Hall Institute of Medical
Research, Melbourne, Australia: Consequences of
enforced myc expression within the B-cell lineage of E,-
myc transgenic mice.
W.M. Kuehl, National Naval Medical Center, Bethesda,
Maryland: Structure, expression, and regulation of murine
c-myb.
T Roberts, Dana-Farber Cancer Institute, Boston,
Massachusetts: Analysis of the effects of polyoma and
SV40 large T antigens on differentiation.
D. Hanahan, Cold Spring Harbor Laboratory, New York:
Expression of the murine p53 protein in 13 cells of
insulin-SV40 T antigen transgenic mice.
Journalists' Workshop on the Cellular and Molecular Basis of
Normal and Abnormal Development
March 11-March 13
ARRANGED BY
S. Prentis, Cold Spring Harbor Laboratory, New York
SESSION 1
R. Pedersen, University of California, San Francisco: Early
development of the mammalian embryo.
I.B. Dawid, National Institutes of Health, Bethesda,
Maryland: Development of amphibians.
SESSION 2
M.P. Scott, University of Colorado at Boulder: The develop-
ment of Drosophila and the role of homeotic genes.
R. Weinberg, Whitehead Institute for Biomedical Research,
Cambridge, Massachusetts: Oncogenes.
SESSION 3
J. Kimble, University of Wisconsin, Madison: Nematodes and
sex determination.
E.J. Lammer, Massachusetts General Hospital, Boston:
Developmental toxicity-The case of accutana
B. Patrusky
R. W. Cooke D. Zimmerman
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Mammalian Cell Mutagenesis
March 22-March 25
ARRANGED BY
M.M. Moore, U.S. Environmental Protection Agency, Research Triangle Park, North Carolina
F.J. de Serres, Research Triangle Institute, Research Triangle Park, North Carolina
D.M. De Marini, U.S. Environmental Protection Agency, Research Triangle Park, North
Carolina
K.R. Tindall, National Institute of Environmental Health Sciences, Research Triangle Park,
North Carolina
SESSION 1: A REVIEW OF GENETIC MARKERS FOR THE STUDY OF MUTATION IN MAMMALIAN CELLS
Chairperson: R.J. Albertini, University of Vermont College of Medicine, Burlington
G.M. Adair, University of Texas System Cancer Center,
Smithville: The Chinese hamster aprt locus.
J.A. Nickles, University of Vermont, Burlington: Mutation at
the human major histocompatibility complex (HLA) as a
genotoxicity assay.
D. Clive, Burroughs Wellcome Company, Research Triangle
Park, North Carolina: Historical overview of the mouse
lymphoma TK*I- mutagenesis assay.
A.W. Hsie, University of Texas Medical Branch, Galveston:
The hyprt locus as as ideal and cautious choice for
studying quantitative mammalian cell mutagenesis.
Panel Discussion (G.M. Adair, R.J. Albertini, D.Clive, A.W.
Hsie, J.A. Nickles)
SESSION 2: DIFFERENTIAL RECOVERY OF MUTANTS AT DIFFERENT LOCI
Chairperson: D.M. De Marini, U.S. Environmental Protection Agency, Research Triangle Park, North Carolina
D.M. De Marini, U.S. Environmental Protection Agency,
Research Triangle Park, North Carolina: Differential
recovery of mutants at hemizygous vs. heterozygous loci
in mammmalian cell specific locus assays.
F.J. de Serres, Research Triangle Institute, Research Triangle
Park, North Carolina: Specific-locus studies in
Neurospora crassa predict differential recovery of
mutants in mammalian cells.
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L.F. Stankowski, Jr, Pharmakon Research International, Inc.,
Waverly, Pennsylvania: Detection of clastogens vs. point
mutagens at the gpt or hgprt locus.
H.H. Evans, Case Western Reserve University, Cleveland,
Ohio: Differential recovery of mutants in cells heterozy-
gous vs. hemizygous for the tk locus.
M.M. Moore, U.S. Environmental Protection Agency,
Research Triangle Park, North Carolina: Factors that
J. Hozier, K. Dixon P. O'Neil, R. Jensen, L. Stankowski
affect the recovery of all classes of induced mutations in
mammalian cells.
L.B. Russell, Oak Ridge National Laboratory, Tennessee:
Genetic and molecular characterization of chromosomal
regions surrounding specific loci of the mouse.
Panel Discussion (H.M. Brockman, D.M. DeMarini, F.J. de
Serres, H.H. Evans, M.M. Moore, L.B. Russell, L.F.
Stankowski, Jr, K.R. Tindall)
SESSION 3: DIFFERENTIAL RECOVERY OF MUTANTS IN VIVO
Chairperson: M.M. Moore, U.S. Environmental Protection Agency, Research Triangle Park, North Carolina
R.J. Albertini, University of Vermont College of Medicine, California: Use of MN markers in human erythrocytes to
Burlington: Quantitative considerations in in vivo studies. quantitate mutation.
R.H. Jensen, Lawrence Livermore National Laboratory, Panel Discussion (R.J. Albertini, R.H. Jensen)
SESSION 4: THE MOLECULAR ANALYSIS OF MUTATION
Chairpersons: F. Hutchinson, Yale University, New Haven, Connecticut
K.R. Tindall, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina
A. Analysis of Chromosomal Loci
The aprt locus
B.W. Glickman, York University, Downsville, Toronto, Ontario,
Canada: Studies on mutational specificity in the aprt
gene of CHO cells.
M. Meuth, Imperial Cancer Research Fund, Herts, England:
Molecular basis of genome rearrangements at the
hamster aprt locus.
Panel Discussion (G.M. Adair, R.J. de Jong, B.W. Glickman,
M. Meuth)
SESSION 5: THE MOLECULAR ANALYSIS OF MUTATION
The tk and hgprt loci
J.C. Hozier, Florida State University, Tallahassee: Cytogenetic
and molecular studies of tk mutagenesis in mouse
L51787 cells.
J.B. Little, Harvard School of Public Health, Boston,
Massachusetts: Molecular analyses of tk and hgprt
mutations in human cells.
R.A. Gibbs, Baylor College of Medicine, Houston, Texas:
Molecular analysis of HPRT mutations.
J.P. O'Neill, University of Vermont, Burlington: DNA
alterations in spontaneous in-vivo- and y-irradiation-
induced in vitro hgprt mutants of human T lymphocytes.
Other loci
L.A. Chasin, Columbia University, New York, New York:
Mutation at the dhfr locus in CHO cells.
E.H.Y. Chu, University of Michigan Medical School, Ann
Arbor: Analysis of multilocus mutations in human somatic
cells based on protein variants detected by two-
dimensional polyacrylamide electrophoresis.
Panel Discussion (L.A. Chasin, E.H.Y. Chu)
(cont'd)
Panel Discussion (M. Applegate, R.A. Gibbs, J.C. Hozier,
J.B. Little, J.A. Nicklas, J.P. O'Neill)
The gpt gene as a chromosomally integrated structure
K.R. Tindall, National Institute of Environmental Health
Sciences, Research Triangle Park, North Carolina:
Molecular analysis of mutation in the AS 52 cell line.
C.R. Ashman, University of Chicago Medical Center, Illinois:
Recovery and analysis of spontaneous and induced
mutations from mammalian chromosomal DNA.
Panel Discussion (C.R. Ashman, T.G. Rossman, L.F.
Stankowski, Jr, K.R. Tindall)
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SESSION 6: THE MOLECULAR ANALYSIS OF MUTATION (cont'd)
B. Shuttle Vectors and SV40
Chairperson: A. Sarasin, Institut de Recherches Scientifiques sur le Cancer, Villejuif, France
M.P. Ca los, Stanford University School of Medicine, Califor-
nia: Use of shuttle vectors in human cells.
K. Dixon, National Institute of Child Health and Human
Development, Bethesda, Maryland: Analysis of mutation
induction in mammalian cells with an SV40-based shuttle
vector.
A. Sarasin, Institut de Recherches Scientifiques sur le
Cancer, Villejuif, France: Use of SV40 to analyze point
mutations induced by UV-light or chemical carcinogens.
Panel Discussion (M.P. Ca los, K. Dixon, A. Sarasin)
SESSION 7: RECOMBINATION AND REPAIR AS MODULATORS OF MUTATIONAL PROCESSES IN MAMMALIAN CELLS
Chairperson: F.J. de Serres, Research Triangle Institute, Research Triangle Park, North Carolina
L.H. Thompson, Lawrence Livermore National Laboratory,
Livermore, California: Cloning of human DNA repair
genes by functional complementation.
V.M. Maher, Michigan State University, East Lansing:
Summary
E.H.Y. Chu, University of Michigan Medical School, Ann Arbor
Molecular analysis of recombination and gene conversion
in carcinogen-treated mouse cells.
Panel Discussion (V.M. Maher, L.H. Thompson)
J. Little, M. Meu h B. Glickman
Inositol Lipids in Cellular Signalling
April 5-April
ARRANGED BY
R.H. Michell, University of Birmingham, England
J.W. Putney, Jr., National Institute of Environmental Health Sciences, Research Triangle
Park, North Carolina
SESSION 1: BIOCHEMISTRY OF INOSITOL LIPIDS AND INOSITOL PHOSPHATES
Chairperson: R.J. Haslam, McMaster University, Hamilton, Ontario, Canada
R.H. Michell, University of Birmingham, England: Metabolic C.P. Downes, Smith Kline and French Research Ltd.,
pooling of inositol lipids. Welwyn, Herts, England: Specificity of agonist-stimulated
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phospholipase C and metabolism of inositol phosphates.
Gershengorn, Cornell University Medical College, New
York, New York: TRH stimulating of inositol lipid
metabolism-Evidence for direct hydrolysis of PI as well
as PIP2.
W.R. Sherman, Washington University School of Medicine,
St. Louis, Missouri: Evidence that Ptdlns and Ptdlns-
(4,5)P2 respond independently to stimulation.
S.B. Shears, University of Birmingham, England: Hepatic
metabolism of inositol polyphosphates.
SESSION 2: RECEPTOR COUPLING TO PHOSPHOLIPASE C
Chairperson: T.F.J. Martin, University of Wisconsin, Madison
M. Ui, University of Tokyo, Japan: Differential roles of G, and
Go in coupling to multiple receptors in brain.
S. Cockcroft, UniversitY College London Medical School,
England: Regulation of polyphosphoinositide
phosphodiesterase by a G-protein.
R.J. Has lam, McMaster University, Hamilton, Ontario,
Canada: Activation of platelet phospholipase C by a
guanine-nucleotide-binding protein.
T.K. Harden, University of North Carolina, Chapel Hill:
Guanine-nucleotide-binding-protein-mediated regulation of
phospholipase C.
C.O. Rock, St. Jude Children's Research Hospital, Memphis,
Tennessee: Regulation of phosphatidylinositol 4,5-
bisphosphate phospholipase C.
J.N. Fain, Unviersity of Tennessee Center for the Health
Sciences, Memphis: Regulation of phosphoinositide-
specific phospholipase C in cell-free systems by ligands
and guanine nucleotides.
J.C. Gambier, National Jewish Center for Immunology and
Respiratory Medicine, Denver, Colorado: Antigen receptor
coupling to inositol lipid hydrolysis in isolated B-
lymphocyte membranes: Is GTP required?
C. Rock, M. Feinstein
S. Cockcroft, L. Cant ley
337
SESSION 3: ACTION OF INOSITOL LIPID-DERIVED MEDIATORS
Chairperson: I. Schulz, Max-Planck-Institut fur Biophysik, Frankfurt, Federal Republic of Germany
T.J. Rink, Smith Kline and French Research Ltd., Welwyn,
Herts, England: Receptor-mediated calcium mobilization.
P.H. Cobbold, University of Liverpool, England: The
generation of repetitive free-calcium transients in
hormone-stimulated cells.
D.L. Gill, University of Maryland School of Medicine,
Baltimore: Calcium release mediated by guanine
nucleotides and inositol 1,4,5-trisphosphate.
A.P. Thomas, Thomas Jefferson University, Philadelphia,
SESSION 4: GROWTH FACTOR AND ONCOGENES
Chairperson: M.D. Houslay, University of Glasgow, Scotland
B.C. Tilly, Netherlands Institute for Developmental Biology,
Utrecht, The Netherlands: Signal transduction by growth
factors.
L.C. Cant ley, Tufts University School of Medicine, Boston,
Massachusetts: PI kinases.
I.G. Macara, University of Rochester Medical Center, New
York: Down-regulation of protein kinase C by oncogenic
transformation.
Pennsylvania: GTP-dependent regulation of the InsP,-
activated Ca" channel.
M.B. Feinstein, University of Connecticut Health Center,
Farmington: Monoclonal antibodies that block response
to IP,.
A.R. Saltiel, Rockefeller University, New York, New York: A
role for novel glycosylated phosphoinositides in insulin
action.
B. Agranoff, A. Saliel
SESSION 5: PHOSPHOINOSITIDE-LINKED RECEPTORS IN MODEL SYSTEMS
Chairperson: C.P. Downes, Smith Kline and French Research Ltd., Welwyn, Herts, England
J.W. Putney, Jr, National Institute of Environmental Health
Sciences, Research Triangle Park, North Carolina:
Receptor regulation of phospholipase C in parotid acinar
cells.
I. Schulz, Max-Planck-Institut fur Biophysik, Frankfurt,
Federal Republic. of Germany: Effects of inosito1-1,4,5-
triphosphate and guanosine nucleotides in stimulus-
secretion coupling of exocrine pancreas cells.
B.W. Agranoff, University of Michigan, Ann Arbor: Inositol
lipids in CNS.
S.E. Rittenhouse, University of Vermont College of Medicine,
Burlington: Regulation of platelet phospholipase C
activation.
T.F.J. Martin, University of Wisconsin, Madison: Mechanisms
underlying stimulus-secretion coupling in GH3 pituitary
cells.
A.H. Drummond, University of London, England: Perturba-
tion by lithium ions of inositol phosphate metabolism in
GH3 pituitary cells.
M.D. Houslay, University of Glasgow, Scotland: Desensitiza-
tion of glucagon-stimulated adenylate cyclase exposes
interactions between the signal transduction mechanism
that produces cAMP and that stimulating inositol
phospholipid metabolism.
J. Putney, R. Mitchell
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I. Schultz
Therapeutic Peptides and Proteins: Assessing the New
Technologies
April 12-April 15
ARRANGED BY
D.R. Marshak, Cold Spring Harbor Laboratory, New York
A.N. Schechter, National Institutes of Health, Bethesda, Maryland
D.R. Bangham, National Institute for Biological Standards and Control, London, England
SESSION 1: NEW PRODUCTION TECHNOLOGIES
Chairperson: D.R. Marshak, Cold Spring Harbor Laboratory, New York
R.A. Flavell, Biogen Research Corporation, Cambridge, S.B.H. Kent, California Institute of Technology, Pasadena:
Massachusetts: Recombinant DNA products from The chemical synthesis of therapeutic peptides and
prokaryotes. proteins.
J. Obijeski, Genentech, Inc., South San Francisco, California: J.T. Johansen, Carlsberg Biotechnology Ltd., Copenhagen,
Recombinant DNA products from eukaryotes. Denmark: Enzymatic synthesis of peptides.
SESSION 2: CHEMICAL AND BIOLOGICAL EVALUATION OF PRODUCTS
Chairperson: D.T. Liu, Food and Drug Administration, Bethesda, Maryland
R.L. Heinrikson, The Upjohn Company, Kalamazoo,
Michigan: Purification and chemical characterization of
recombinant proteins-The example of human renin.
D.R. Marshak, Cold Spring Harbor Laboratory, New York:
Physiochemical characterization of proteins produced by
chemical synthesis.
P.W. Robbins, Massachusetts Institute of Technology,
Cambridge: Glycosylations.
J.A. Smith, Massachusetts General Hospital, Boston:
Acylation and removal of acetylated amino acids.
A.N. Schechter, National Institutes of Health, Bethesda,
Maryland: Disulfide bonds.
W. Hancock, Genentech, Inc., South San Francisco, Califor-
nia: Oxidation and degradation.
M. Wig ler, Cold Spring Harbor Laboratory, New York:
Possible contaminants, DNA-containing oncogenes.
P.L. Storring, National Institute for Biological Standards and
Control, London, England: The role of biological methods
in evaluating highly purified peptide and protein
products.
SESSION 3: CLINICAL EVALUATION
E. Esber, D. Bangham
Chairperson: A.N. Schechter, National Institutes of Health, Bethesda, Maryland
J.E. Osborn, University of Michigan: Possible contaminants,
viruses.
R.A. Houghten, Scripps Clinic and Research Foundation, La
Jolla, California: Immunogenicity.
A.M. Breckenridge, University of Liverpool, England: Clinical
toxicity.
B.J. Marafino, Jr, Cetus Corporation, Emeryville, California:
The appropriate toxicologic testing of recombinant
proteins.
N. Stebbing, I.C.I. Pharmaceutical Division, Cheshire,
England: Risk assessment.
D. Hanahan, Cold Spring Harbor Laboratory, New York:
Transgenic animal models of disease.
G.W.H. Jay, National Cancer Institute, Bethesda, Maryland:
Transgenic animal models for the study of human
retroviruses.
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D. Liu, L. Sjodin A. Schecter, D. Marshak
P. Storring
Y. Y. Chiu, W. Hancock D. Vapnek
P. Robbins, R. Blacher
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J. Johanson, L. Frycklund
SESSION 4: CASE STUDIES
Chairperson: David L. Aronson, Food and Drug Administration, Bethesda, Maryland
Y. Chiu, Food and Drug Administration, Rockville, Maryland:
Scientific review on the safety of the peptide hormones:
insulin, hGH, LHRH.
G. Poste, Smith Kline and French Laboratories, Philadelphia,
Pennsylvania: Characterization and testing of
lymphokines and cytokines.
SESSION 5: REGULATORY CONCEPTS
E. Grossbard, Genentech, Inc., South San Francisco, Califor-
nia: TPA.
D. Vapnek, AMGen, Thousand Oaks, California: Character-
ization of human erythropoietin produced in CHO cells.
L. Fryklund, KabiVitrum Peptide Hormones AB, Stockholm,
Sweden: Recombinant IGF-1 produced in yeast.
Chairperson: D.T. Liu, Food and Drug Administration, Bethesda, Maryland
E.C. Esber, Food and Drug Administration, Bethesda,
Maryland: U.S. perspective.
D.R. Bangham, National Institute for Biological Standards
and Control, London, England: U.K. perspective.
T. Hayakawa, National Institute of Hygienic Sciences, Tokyo,
Japan: Control of the quality of biotechnological
therapeutic agents intended for human use in Japan.
L. Sjodin, Socialstyrelsen, Lakemedelsavdelningen, Uppsala,
Sweden: Swedish perspective.
J. Hsieh, Development Center for Biotechnology, Taipei,
Taiwan, Republic of China: Development of HBsAg
vaccine processes in Taiwan, Republic of China.
Eukaryotic Transposable Elements as Mutagenic Agents
April 21-April 24
ARRANGED BY
I.B. Weinstein, Columbia University College of Physicians & Surgeons, New York, New York
M.E. Lambert, Cold Spring Harbor Laboratory, New York
J.F. McDonald, University of Athens, Georgia
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SESSION 1: INTRODUCTION OVERVIEW OF PROKARYOTIC TRANSPOSABLE ELEMENTS
J.A. Shapiro, University of Chicago, Illinois: What transpo- E.M. Witkin, Rutgers-The State University of New Jersey,
sons do in the bacterial genome. Piscataway: Prokaryotic models: SOS functions and
D. Roberts, Massachusetts Institute of Technology, mutation.
Cambridge: Communication between a bacterial
transposable element and its host.
SESSION 2: MUTATIONAL EFFECTS OF TRANSPOSABLE ELEMENT INSERTIONS-1
M.M. Green, University of California, Davis: Overview.
M. Strobel, N.C.I,Frederick Cancer Research Facility,
Maryland: Molecular genetic analysis of the murine dilute
locus.
N. Fedoroff, Carnegie Institution of Washington, Baltimore,
Maryland: Regulation of the expression of the maize
suppressor-mutator transposable element.
SESSION 3: MUTATIONAL EFFECTS OF TRANSPOSABLE ELEMENT INSERTIONS-2
M.F. Singer, National Institutes of Health, Bethesda, Intracisternal A-particle elements as insertional mutagens.
Maryland: Line-1 sequences in primates. R. Callahan, National Cancer Institute, Bethesda, Maryland:
E.L. Kuff, National Cancer Institute, Bethesda, Maryland: Endogenous human retrovirus-like elements.
SESSION 4: INDUCERS/REGULATORS OF TRANSPOSABLE ELEMENT EXPRESSION AND TRANSPOSITION
Part 1: Host Effects Retroviral elements and suppressor genes in Drosophila.
P.M. Bingham, State University of New York, Stony Brook: M.C. Wilson, Research Institute of the Scripps Clinic, La
Evidence that suppressor-of-white-apricot is a regulatory Jolla, California: Expression of endogenous replication-
gene acting at the level of RNA processing. defective retroviral elements as regulated by trans-acting
V.G. Corces, Johns Hopkins University, Baltimore, Maryland: genes.
SESSION 5: INDUCERS/REGULATORS OF TRANSPOSABLE ELEMENT EXPRESSION
Part 2: Host Effects Surgeons, New York, New York: Genetic control of
F. Winston, Harvard University School of Medicine, Boston, recombination between retrotransposon elements in
Massachusetts: Host genes required for Ty-mediated yeast.
gene expression in yeast. J.D. Boeke, Johns Hopkins University, Baltimore, Maryland:
R. Rothstein, Columbia University College of Physicians & Ty element transposition and the yeast genome.
SESSION 6: INDUCERS/REGULATORS OF TRANSPOSABLE ELEMENT EXPRESSION
Part 3: Genetic Mutator Systems
M.G. Kidwell, University of Arizona, Tucson: Regulatory
aspects of expression of P-M hybrid dysgenesis in
Drosophila.
F.H. Sobels, State University of Leiden, The Netherlands:
Mutation induction by MR(P) and its modification by
various conditions.
D.J. Finnegan, University of Edinburgh, Scotland: Mutation
and chromosome rearrangements stimulated by I-R
hybrid dysgenesis in D. melanogaster.
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SESSION 7: INDUCERS/REGULATORS OF TRANSPOSABLE ELEMENT EXPRESSION
Part 4: Genomic Stress and Environmental Effects
J.F. McDonald, University of Georgia, Athens: Stress
response and other host-mediated effects on retroviral
element expression in Drosophila.
C. Paquin, University of Cincinnati, Ohio: Effect of tempera.
ture on Ty transposition.
V.L. Chandler, University of Oregon, Eugene: Regulation of
mutator transposable elements in maize.
SESSION 8: INDUCERS/REGULATORS OF TRANSPOSABLE ELEMENT EXPRESSION
Part 5: Genomic Stress and Environmental Effects
G.R. Anderson, Roswell Park Memorial Institute, Buffalo,
New York: Induction of VL30 and endogenous
retroviruses in rat by anoxic stress and cyanide.
M.E. Lambert, Cold Spring Harbor Laboratory, New York:
SESSION 9:
Inducible cellular responses to DNA damage.
H. zur Hausen, Deutsches Krebforschungszentrum,
Heidelberg, Federal Republic of Germany: Mutations and
DNA amplifications induced by DNA viruses.
INDUCERS/REGULATORS OF RETROVIRAL ELEMENT EXPRESSION
R. Rothstein, M. Lambert
I.B. Weinstein, Columbia University College of Physicians &
Surgeons, New York, New York: Constitutive expression
of endogenous retrovirus-related sequences during
chemical carcinogenesis.
E. Gateff, Johannes Gutenberg-Universitat Mainz, Federal
Republic of Germany: c-src expression, retrovirus-like
particles, and reoviruses in tumors of D. melanogaster.
W.C. Greene, Duke University, Durham, North Carolina:
HTLV-I, HIV, and human T-cell growth.
SESSION 10: SUMMARY: OVERVIEW
K. Sankaranarayanan, State University of Leiden, The
Netherlands: Transposable genetic elements, spontane-
ous mutations, and the assessment of genetic radiation
hazards in man.
J. Cairns, Harvard School of Public Health, Boston,
Massachusetts: Implications for cancer.
The Development of the Human Lymphocyte Protein Database
May 10-May 12
ARRANGED BY
R. Franza, Cold Spring Harbor Laboratory, New York
L. Hood, California Institute of Technology, Pasadena
SESSION 1
J.D. Watson, Cold Spring Harbor Laboratory, New York:
Introduction.
J. Garrets and R. Franza, Cold Spring Harbor Laboratory,
New York: The REF52 cellular protein database: A model
for database analysis of mammalian cells.
F.C. Neidhardt, University of Michigan Medical School, Ann
SESSION 2
Arbor: The E. coli protein database.
J.R. Warner, Albert Einstein College of Medicine, Bronx, New
York: The yeast protein database.
I. Weissman, Stanford University, California: Systems for the
study of lymphoblast differentiation.
P Jones, Stanford University, California: Potential of database analysis on studies of T and B lymphoblasts.
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C.R. Merril, National Institute of Mental Health, Bethesda,
Maryland: Strategies for the use of protein databases to
examine disease processes.
E.P. Lester, University of Tennessee, Memphis: GELLAB.
S.M. Hanash, University of Michigan Medical School, Ann
Arbor: Application of two-dimensional gels to genetic
analyses.
W.R. Parker, Bio Image, Ann Arbor, Michigan:
Electrophoretic analysis and data management with
machine vision instruments.
N.L. Anderson, Large Scale Biology Corporation, Rockville,
Maryland: Studies of gene expression in human
lymphoid cells.
I. Lefkovits, Basel Institute for Immunology, Switzerland:
Toward an objective classification of the cells in the
immune system.
K.E. Willard-Gallo, Catholic University of Louvain, Brussels,
Belgium: Two-dimensional gel studies of subpopulations
of T lymphoblasts.
S. Blose, Protein Databases, Inc., Huntington Station, New
York: The PDQUEST system: Development and construc-
tion of protein databases for access and distribution.
Banbury Meeting House
SESSION 3
L. Hood and R. Aebersold, California Institute of Technology,
Pasadena: Use of database-directed, two-dimensional gel
technology in the purification and biochemical character-
ization of proteins leading to the isolation of the encoding
genes.
L.A. Herzenberg, Stanford University School of Medicine,
California: Sorting technologies and gene transfection
studies: Impact on the study of lymphoblasts.
SESSION 4:
Moderators:
R. De Mars, University of Wisconsin, Madison: Two-
dimensional gel analysis of MHC-encoded proteins.
D. Goldman, National Institutes of Health, Bethesda,
Maryland: Structuring a lymphoblast database to study
protein polymorphisms.
R. Franza, Cold Spring Harbor Laboratory, New York: An
approach to the study of lymphoblast proteins that
interact with control regions in the HIV-LTR.
DISCUSSION OF POSSIBLE MECHANISMS FOR THE ASSEMBLY OF SPECIFIC LYMPHOCYTE DATABASES
J.D. Watson, Cold Spring Harbor Laboratory, New York
L. Hood, California Institute of Technology, Pasadena
Discussion of the establishment of a resource to interconnect
and distribute such databases.
Discussion of the establishment of a group responsible for
the identification of human cellular proteins in specific B-
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and T- lymphocyte lines for dissemination to all builders
and users of lymphocyte databases.
Formation of an internationally recognized coordinating
committee to monitor the progress of such an effort.
New Directions in the Qualitative and Quantitative Aspects of
Carcinogen Risk Assessment
October 11-October 14
ARRANGED BY
F.D. Hoerger, The Dow Chemical Company, Midland, Michigan
R.W. Hart, National Center for Toxicological Research, Jefferson, Arkansas
J.D. Wilson, Monsanto Company, St. Louis, Missouri
SESSION 1: STRUCTURE ACTIVITY RELATIONSHIP DATA
Chairperson: E.K. Weisburger, National Cancer Institute, Bethesda, Maryland
D. Thakker, National Institutes of Health, Bethesda,
Maryland: High-molecular-weight structure.
W. Lijinsky, NCI-Frederick Cancer Research Facility,
Maryland: Nitrogen-containing alkylating carcinogens.
Discussants-C.J. Michejda, NCI-Frederick Cancer
Research Facility; D.E. Stevenson, Shell Oil Company;
H.S. Rosenkranz, Case Western Reserve University;
K. Enslein, Health Designs, Inc.
SESSION 2: PHARMACOKINETIC AND METABOLIC ACTIVITY DATA
Chairperson: R.W. Estabrook, University of Texas, Dallas
F.P. Guengerich, Vanderbilt University, Nashville, Tennessee:
Interindividual metabolic variation in humans-
Mechanisms, methods of assessment, and
consequences.
W. Weber, University of Michigan, Ann Arbor: Acetylation
pharmacogenetics; acetylator phenotype and assessing
susceptibility to aromatic amine carcinogenesis.
SESSION 3: MOLECULAR BIOLOGICAL DATA
W. Far land, U.S. Environmental Protection Agency, Washing.
ton, D.C.: Use of pharmacokinetic and metabolism data
in quantitative risk assessment.
Discussants: C.C. Travis, Oak Ridge National Laboratory;
D.B. Clayson, Health and Welfare Canada; P Fu, National
Center for Toxicological Research; M.C. Poirier, National
Cancer Institute
Chairperson: R.B. Set low, Brookhaven National Laboratory, Upton, New York
B. Singer, University of California, Berkeley: Molecular
distortions in DNA.
J.E. Trosko, Michigan State University, East Lansing,
Michigan: Nongenotoxic mechanisms in carcinogenesis:
Role of inhibited intercellular communication.
W.G. Flamm, U.S. Food and Drug Administration, Washing-
SESSION 4: APPROACHES TOWARD INTEGRATION
ton, D.C.: How molecular data is presently used.
Discussants-M.S. Cohn, U.S. Consumer Product Safety
Commission; F.A. Be land, National Center for Toxicologi-
cal Research; K. Kraemer, National Cancer Institute; R.W.
Tennant, National Institute of Environmental Health
Sciences
Chairperson: E.A. Pfitzer, Hoffmann-La Roche Inc., Nutley, New Jersey
K.S. Crump, Clement Associates, Inc., Ruston, Louisiana:
Comparison of estimates from animal and human data.
I.C. Munro, Canadian Centre for Toxicology, Guelph, Ontario,
Canada: Qualitative factors in classification.
J.D. Graham, Harvard University, Boston, Massachusetts:
Judgmental considerations.
Thorslund, Clement Associates, Inc., Washington, D.C.:
Framework for a biological model.
D. Krewksi, Environmental Health and Welfare, Vanier,
Ontario, Canada: Recent developments in carcinogenic
risk assessment.
SESSION 5: IMPLICATIONS FOR POLICY AND RESEARCH
Chairperson: F.D. Hoerger, The Dow Chemical Company, Midland, Michigan
E. Anderson, Clement Associates, Inc., Washington, D.C.: C. St. Hilaire, ILSI Risk Science Institute, Washington, D.C.:
Perspective on risk assessment of carcinogens. Research needs to improve the basis of risk assessment.
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Subsession A: Implications for Research Directors
Panel discussion: F.P. Perera, Columbia University School of
Public Health; R.W. Hart, National Center for Toxicological
Research; R.A. Neal, Chemical Industry Institute of
Toxicology
Subsession B: Recommendations for Improving Regulatory
Policy for Dealing with Carcinogens
Panel discussion: P.F. Deis ler, Jr, University of Houston;
A.K. Ahmed, Natural Resources Defense Council
Transformation of Agriculturally Important Crops
October 25-October 28
ARRANGED BY
N.M. Frey, Pioneer Hi-Bred International, Inc., Johnston, Iowa
R.T. Fraley, Monsanto Company, St. Louis, Missouri
J. Schell, Max-Planck-Institut, Koln, Federal Republic of Germany
SESSION 1: PLANT TRANSFORMATION SYSTEMS
J. Schell, Max-Planck-Institut, Koln, Federal Republic of A. Weissinger, Pioneer Hi-Bred International, Inc., Johnston,
Germany: Plant transformation using Agrobacterium and Iowa: Maize transformation via microprojectile
direct DNA uptake methods. bombardment.
R.B. Horsch, Monsanto Agricultural Company, St. Louis, D.M. Stalker, Calgene Inc., Davis, California: Development of
Missouri: Strategies for practical gene transfer into herbicide resistance in transgenic plants.
agriculturally important crops.
SESSION 2: TRANSFORMATION TO IMPROVE TRAITS OF AGRONOMIC IMPORTANCE
C.J. Lamb, The Salk Institute, San Diego, California: Transfer
of defense genes.
J.J. Leemans, Plant Genetic Systems NV., Gent, Belgium:
Engineering insect and herbicide resistance in crops.
R.N. Beachy, Washingon University, St. Louis, Missouri:
Transformation to produce virus-resistant plants.
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C.J. Arntzen, Du Pont Experimental Station, Wilmington,
Delaware: Agronomically useful genes for crop plants,
J.B. Mudd, The Plant Cell Research Institute, Inc., Dublin,
California: Altering protein and oil quality traits in seeds.
J. Bedbrook, Advanced Genetic Sciences, Oakland, Califor-
nia: Chitinase as a suppressor of fungal diseases.
SESSION 3: FIELD TESTING AND THE DEVELOPMENT OF
N.M. Frey, Pioneer Hi-Bred International, Inc., Johnston,
Iowa: Developing seed products before genetic
engineering.
P Dale, IPSR Cambridge Laboratory, England: Progress
toward cereal transformation and field trials of genetically
engineered potatoes.
T Helentjaris, Native Plants, Inc., Salt Lake City, Utah:
SESSION 4: REGULATORY REQUIREMENTS FOR TESTING
ENGINEERED PLANTS
S. Poe, U.S. Department of Agriculture, Hyattsville, Maryland:
U.S.D.A. regulation of genetically engineered plants and
microorganisms.
P Roberts, U.S. Environmental Protection Agency, Washing-
ton, D.C.: E.P.A. regulation of genetically engineered
plants and microorganisms.
SESSION 5: THE ISSUES OF SCIENCE, ECONOMICS AND
R.T. Fraley, Monsanto Company, St. Louis, Missouri-
Discussion Leader
V.W. Ruttan, Department of Economics, University of
Minnesota, St. Paul
SEED PRODUCTS
Identification of agronomically useful genes through
RFLP analysis.
S. Rothstein, CIBA-Geigy Corporation, Research Triangle
Park, North Carolina: Field testing genetically engineered
plants.
RT Fraley, Monsanto Company, St. Louis, Missouri: Field
testing transgenic plants.
AND COMMERCIALLY DEVELOPING GENETICALLY
J.H. Maryanski, U.S. Food and Drug Administration,
Washington, D.C.: Genetically modified agricultural
crops-An F.D.A. perspective.
P.B. Moses, National Research Council, Washington, D.C.:
The N.A.S. policy process-Examples in biological
control and organism introductions.
PRODUCT DEVELOPMENT FOR AGRONOMIC CROPS
N. Federoff, Carnegie Institution of Washington, Baltimore,
Maryland
M.M. Simpson, Congressional Research Service, Washing-
ton, D.C.
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Recent Advances in the Molecular Genetics of the Parasitic
Protozoa
November 3-November 6
ARRANGED BY
M.J. Turner, Merck Sharp & Dohme Research Laboratories, Rahway, New Jersey
D. Arnot, New York University Medical Center, New York
SESSION 1: MALARIA
V. Enea and D. Arnot, New York University Medical Center,
New York: The circumsporozdite gene of Plasmodia.
M. Walgren, University of Stockholm, Sweden: Asparagine-
rich molecules of P falciparum.
J.V. Ravetch, Sloan-Kettering Institute, New York, New York:
Molecular biology of parasite/host interactions.
SESSION 2: MALARIA, THEILERIA AND LEISHMANIA
T.E. Wellems, National Institutes of Health, Bethesda,
Maryland: Structural analysis of chromosome-length
polymorphisms in P falciparum.
T.F. McCutchan, National Institute of Allergy and Infectious
Diseases, Bethesda, Maryland: Stage-specific ribosomes
in Plasmodium.
A. Tait, Wellcome Unit of Molecular Parisitology, Glasgow,
Scotland: Sporozoite and infection-specific antigen genes
in Theileria.
R. Williams, University of Karlsruhe, Federal Republic of
D. Walliker, University of Edinburgh, Scotland: Genetic
recombination in P falciparum.
M. Lockyer, Wellcome Research Laboratories, Beckenham,
Kent, England: Variation in P falciparum gene structure.
Germany: Autocrine loop immortalization of lymphocytes
by T parva.
S.M. Beverley, Harvard Medical School, Boston,
Massachusetts: Chromosomal basis of gene amplification
in Leishmania.
J.M. Kooter, The Netherlands Cancer Institute, Amsterdam:
H. Circler in Leishmania.
B. Ullman, Oregon Health Sciences University, Portland:
Genetic analysis of purine metabolism in L. donoyani.
SESSION 3: TRYPANOSOMES
A. Tait, Wellcome Unit of Molecular Parisitology, Glasgow,
Scotland: Genetic exchange in T brucei: Allelic segrega-
tion and reassortment.
J.M. Wells, University of Cambridge, England: Genetic
analysis of hybrid T brucei clones.
B. Sollner-Webb, Johns Hopkins University School of
Medicine, Baltimore, Maryland: Expression of DNA
transfected in T brucei.
G.A.M. Cross, Rockefeller University, New York, New York:
Mapping the 117 VSG gene-expression site.
SESSION 4: TRYPANOSOMES
J. Boothroyd, Stanford University School of Medicine, Califor-
nia: trans-Splicing and polycistronic transcripts-in
trypanosomes.
R. Nelson, University of California, San Francisco: RNA
processing and trypanosome gene expression.
S.L. Hajduk, University of Alabama, Birmingham: Structure
and transcription of k-DNA of trypanosomes.
R. Benne, University of Amsterdam, The Netherlands:
Mitrochondrial genes in trypanosomes.
SESSION 5: GIARDIA AND OTHERS
T.E. Nash, National Institutes of Health, Bethesda, Maryland:
Antigenic variation in Giardia.
D. Wirth, Harvard School of Public Health, Boston,
Massachusetts: Divergence of k-DNA minicircle
mexicana.
L. Van der Ploeg, Columbia University College of Physicians
& Surgeons, New York, New York: Role of chromosomal
rearrangements in antigenic variation.
J.M. Kooter, The Netherlands Cancer Institute, Amsterdam:
Structure and expression of a telomeric VSG gene
expression site in T brucei.
E. Pays, Free University of Brussels, Belgium: Transcription
in T brucei.
K. Stuart, Seattle Biomedical Research Institute, Washington:
Regulation of gene expression in trypanosomes by
mRNA editing.
R. Layden, Fred Hutchinson Cancer Research Center,
Seattle, Washington: Ubiquitin in trypanosomatids.
J. Manning, University of California at Irvine: Characterization
of the 85-kD surface antigen gene of T cruzi.
K. Stuart, Seattle Biomedical Research Institute, Washington:
Multicopy virus-like nucleic acids in Leishmania.
The Role of the Heat-Shock (Stress) Response in Biology and
Human Disease
November 9-November 13
ARRANGED BY
R. Morimoto, Northwestern University, Evanston, Illinois
W. Welch, Cold Spring Harbor Laboratory, New York
A. Tissieres, University of Geneva, Switzerland: History and
perspective of heat shock.
SESSION 1: THERMOBIOLOGY
Chairperson: M.J. Schlesinger, Washington University, St. Louis, Missouri
A.F. Bennett, University of California, Irvine: Thermal
dependence of physiological function.
R.B. Huey, University of Washington, Seattle: Physiological
adjustments to fluctuating environments: An ecological
perspective.
W.P. Porter. University of Wisconsin, Madison: Multiple low-
level stressors affecting growth and reproduction potential
in small mammals.
M.J. Kluger, University of Michigan, Ann Arbor: Effects of
febrile temperatures on host defense responses.
H.C. Heller, Stanford University, California: Central nervous
control of body temperature in health and disease.
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SESSION 2: CELLULAR AND MOLECULAR ASPECTS OF THE HEAT-SHOCK RESPONSE. I
Chairperson: C. Georgopoulos, University of Utah School of Medicine, Salt Lake City
S. Lindquist, University of Chicago, Illinois: Expression and
function.
J.J. Bonner, Indiana University, Bloomington: Regulation of
the heat-shock response.
J. Lis, Cornell University, Ithaca, New York: Engaged RNA
polymerase II at the start of uninduced heat-shock
genes.
C. Wu, National Cancer Institute, Bethesda, Maryland:
Purification and properties of heat-shock activator
proteins.
SESSION 3: THERMOTOLERANCE
M.L. Pardue, Massachusetts Institute of Technology,
Cambridge: 93D-, a different sort of heat-shock locus.
E. Craig, University of Wisconsin, Madison: Genetics and
regulation of hsp70 genes in yeast.
R. Voellmy, University of Miami, Florida: Studies of heat-
shock promoters; abnormal protein induction of heat-
shock genes.
Evening Informal Session, "Nomenclature of Stress Proteins"
Chairperson: F. C. Neidhardt, University of Michigan, Ann Arbor
G.M. Hahn, Stanford University, California: RIF-1 and RIFTR
cells: A novel system for investigation of heat resistance,
adaptation to heat, and thermotolerance.
E.W. Gerner, University of Arizona, Tucson: Factors affecting
thermotolerance expression in mammalian cells.
W.C. Dewey, University of California, San Francisco:
Thermotolerance for heat killing and heat radiosensitiza-
tion of CHO cells.
G.C. Li, University of California, San Francisco: hsp70 as an
indicator of thermotolerance: Clinical relevance.
R. Hallberg, Iowa State University, Ames: The eukaryotic
homolog of the product of the E. coli heat-shock gene,
groEL, is a mitochondrial protein.
K.N. Prasad, University of Colorado, Denver: Modification of
heat sensitivity in neural tumors by cAMP and prosta-
glandin A,.
SESSION 4: CELLULAR AND MOLECULAR ASPECTS OF THE HEAT SHOCK RESPONSE. II
Chairperson: S. Lindquist, University of Chicago, Illinois
W. Welch, Cold Spring Harbor Laboratory, New York:
Properties and possible functions of mammalian stress
proteins.
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P Arrigo, Cold Spring Harbor Laboratory, New York:
Characterization of the low-molecular-weight heat-shock
proteins.
P.K. Sorger and Hugh R. B. Pelham, M.R.C. Laboratory of
Molecular Biology, Cambridge, England: Regulation of
the yeast heat-shock transcription factor.
J.R. Subjeck, Roswell Park Memorial Institute, Buffalo, New
York: Glucose-regulated response and resistance to
chemotherapeutic agents.
M.J. Schlesinger, Washington University, St. Louis, Missouri:
Events in heat-shocked chicken fibroblasts.
R. Morimoto, Northwestern University, Evanston, Illinois: Cell
cycle and viral oncogene activation of human heat-shock
gene expression.
B. Wu, Genetics Institute, Cambridge, Massachusetts:
SESSION 5: CLINICAL APPLICATIONS OF HYPERTHERMIA
Transcriptional regulation of the human hsp70 gene.
L. Nover, Institute of Plant Biochemistry, Academy of
Sciences of German Democratic Republic: Cytoplasmic
heat-shock granules.
Evening Informal Session, "Are Stress Proteins Involved in
Thermotolerance?"
Chairperson: W.C. Dewey, University of California, San Francisco
T Herman, Dana Farber Cancer Institute, Boston,
Massachusetts: Systemic cisplatin (CDDP), local
hyperthermia, and radiation for treatment of locally
advanced human malignancies.
C. Vernon, Hammersmith Hospital, London, England:
Thermal dose.
M.W. Dewhirst, Duke University, Durham, North Carolina:
Feasibility of incorporation of spatially varying modifiers of
hyperthermic effect in the clinical setting.
J.R. Oleson, Duke University, Durham, North Carolina: Is
there evidence of thermal tolerance in clinical hyperther-
mic results?
J.M.C. Bull, University of Texas, Houston: Systematic
hyperthermia combined with chemotherapy.
M. Abe, Kyoto University, Japan: RF capacitive hyperthermia
for deep-seated tumors.
SESSION 6: STRESS PROTEIN EXPRESSION DURING DEVELOPMENT
Chairperson: M.L. Pardue, Massachusetts Institute of Technology, Cambridge
N.S. Petersen, University of Wyoming, Laramie: Phenocopy
induction and thermotolerance.
L. Hightower, University of Connecticut, Storrs: Expression of
mammalian heat-shock genes in early embryos, cultured
rat cells, and E. coli.
D.J. Wolgemuth, Columbia University College of Physicians
& Surgeons, New York, New York: Expression of hsp70
gene family members in the male mammalian germ cell.
E. Baulieu, INSERM, Bicetre, France: Antisteroid hormones,
receptor structure, and heat-shock protein MW 90,000
(hsp90).
D. Pauli and C. H. Tonka, University of Geneva, Switzerland:
Structure and expression during development of heat-
shock genes 2 and 3 from Drosophila locus 67B.
M. Tytell, Wake Forest University, Winston-Salem, North
Carolina: Significance of heat-shock protein production in
nervous system trauma.
I.R. Brown, University of Toronto, Canada: Analysis of heat-
shock gene expression in the mammalian brain using in
situ hybridization.
T.S. Nowak, Jr, National Institute of Neurological,
Communicative Disorders and Stroke, Bethesda,
Maryland: Stress response in brain following transient
cerebral ischemia.
D. Young, Hammersmith Hospital, London, England: Stress
proteins are antigens in leprosy and tuberculosis.
SESSION 7: CONTROL AND FUNCTION OF STRESS REGULONS
Chairperson: E. Craig, University of Wisconsin, Madison
F.C. Neidhardt, University of Michigan, Ann Arbor: Functions
of bacterial heat-shock response.
C. Georgopoulos, University of Utah, Salt Lake City: Role of
E. coli heat-shock proteins in bacteriophage X. growth.
T. Yura, Kyoto University, Japan: On the roles of o32 and
heat-shock proteins in E. coll.
C. Gross, University of Wisconsin, Madison: Regulation of
the heat-shock response in E. coll.
K. McEntee, University of California, Los Angeles: Stress
responsive genes in yeast; transcription regulation of
DDR genes by heat shock and DNA damage.
A. Varshaysky, Massachusetts Institute of Technology,
Cambridge: Ubiquitin system, selective protein turnover,
and the stress response.
A.L. Goldberg, Harvard Medical School, Boston,
Massachusetts: Protein breakdown and the heat-shock
response.
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Antisense RNA
December 1-December 3
ARRANGED BY
D.A. Melton, Harvard University, Cambridge, Massachusetts
SESSION 1: NATURAL EXAMPLES OF ANTISENSE REGULATION
R.W. Simons, University of California, Los Angeles: Antisense
RNA control of IS10 gene expression.
N. Kleckner, Harvard University, Cambridge, Massachusetts:
Mechanism of IS/O's antisense RNA regulation in vitro.
W.R. McClure, Carnegie Mellon University, Pittsburgh,
Pennsylvania: Roles for antisense RNA in bacteriophage
gene regulation.
SESSION 2: ANTISENSE OLIGONUCLEOTIDES
J. Walder, University of Iowa, Iowa City: Mechanism of
hybrid-arrested translation and applications of antisense
oligonucleotides.
A. Weiner, Yale University School of Medicine, New Haven,
Connecticut: Inhibition of mRNA splicing by Ul snRNPs
with altered specificity.
P.S. Miller, Johns Hopkins University, Baltimore, Maryland:
M.M. Susskind, University of Southern California, Los
Angeles: Control of the phage P22 antirepressor gene by
a small antisense RNA.
M. Inouye, UMDNJ-Robert Wood Johnson Medical School,
Piscataway, New Jersey: Antisense RNA as a tool in viral
immune systems.
"Antisense oligonucleotide methylphosphonates.
C. Helene, Museum National d'Histoire Naturelle, INSERM,
Paris, France: Regulation of gene expression by oligo-
deoxynucleotides covalently linked to intercalating agents.
J.J. Toulme, Museum National d'Histoire Naturelle, INSERM,
Paris, France: Antisense oligodeoxynucleotides as
regulatory agents for parasitic genes.
SESSION 3: ANTISENSE RNAs REGULATING GENE FUNCTION IN VIVO. I
R.A. Firtel, University of California, San Diego, La Jolla: Use
of antisense to examine gene function in Dictyostelium.
S. Cohen, Max-Planck-Institut, Tubingen, Federal Republic of
Germany: Phenocopies produced by antisense RNA in
Drosophila embryos.
S. Lundquist, University of Chicago, Illinois: Use of antisense
RNA in investigating the function and regulation of heat-
shock proteins.
M. Jacobs-Lorena, Case Western Reserve University,
Cleveland, Ohio: Disruption of ribosomal protein gene
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expression in Drosophila by the conditional expression of
an integrated antisense gene.
R.G. Oshima, La Jolla Cancer Research Foundation, Califor-
SESSION 4:
nia: Suppressive effects of antisense Endo B cytokeratin
RNA on embryonal carcinoma differentiation.
ANTISENSE RNAs REGULATING GENE FUNCTION IN VIVO. II
H. Weintraub, Fred Hutchinson Cancer Research Center,
Seattle, Washington: Teflon RNA.
R. Moon, University of Washington School of Medicine,
Seattle: Antisense RNA inhibits expression of membrane
skeleton protein 4.1 during Xenopus development.
S. Strickland, State University of New York at Stony Brook:
Antisense injections into the mouse oocyte.
C.T. Caskey, Baylor College of Medicine, Houston, Texas:
Antisense inhibition of HPRT in cultured cells and
transgenic mice.
R.W. Wagner, The Wistar Institute of Anatomy and Biology,
Philadelphia, Pennsylvania: Expression of an RNA duplex
unwindase activity in mammalian cells.
SESSION 5: ANTiSENSE RNAs REGULATING GENE FUNCTION IN VIVO. III
P.E. Neiman, Fred Hutchinson Cancer Research Center,
Seattle, Washington: Antisense RNA effects in avian
retroviral vector systems: Viral replication and target gene
expression.
M. Kindy, The Salk Institute, San Diego, California: Inhibition
of c-fos gene expression does not alter the differentiation
pattern of PC12 cells.
J.G. Izant, Yale University School of Medicine, New Haven,
Connecticut: Enhancement of antisense RNA activity:
Antisense RNA to study cell organization.
J. Goodchild, Worcester Foundation for Experimental
Biology, Shrewsbury, Massachusetts: Antisense
oligodeoxynucleotides as potential inhibitors of HIV
replication in tissue culture.
E.W. Holmes, Duke University Medical Center, Durham,
North Carolina: Inhibition of translation by antisense RNA
complementary to 3'-coding and 3'-noncoding
sequences.
D.A. Melton, Harvard University, Cambridge, Massachusetts:
Summary.
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Postgraduate Courses
The summer program of Postgraduate Courses at Cold Spring Harbor Laboratory
is aimed at meeting the special need for training in interdisciplinary subjects that
are either so new or so specialized that they are not adequately treated by
universities. Our aim is to provide intensive study in the most recent developments
and techniques in these subjects and to prepare students to enter directly into
research in a particular area. To ensure up-to-date coverage of current research
work, we bring together a workshop staff from many laboratories around the world
and supplement this staff with a series of seminar speakers.
Molecular Approaches to Ion Channel Function and Expression
June 5-June 25
INSTRUCTORS
Dionne, Vincent E., Ph.D., University of California, San Diego
Snutch, Terry, Ph.D., California Institute of Technology, Pasadena
White, Michael, Ph.D., University of Pennsylvania, Philadelphia
Margiota, Joseph, Ph.D., University of California, San Diego
Beam, Kurt, Ph.D., Colorado State University, Fort Collins
Corey, David, Ph.D., Harvard University, Cambridge, Massachusetts
ASSISTANT
Stevens, Meg, RA., Harvard University, Cambridge, Massachusetts
The technologies of molecular biology and patch-clamping promise major
revisions and novel approaches for the examination of many neurobiological
problems. Applications of these methods to the study of ion channels are taught in
this intensive laboratory/lecture course. Students concentrate initially on the basic
aspects of these two methods and then proceed to more integrated studies.
Single Channel Recording: cell-attached, excised patch and whole cell recording;
design and implementation of recording equipment; theory and analysis of single-
channel currents. /on channel expression: mRNA isolation and handling; the use
of Xenopus oocytes as an expression system; characterization of newly expressed
ion-channels in oocytes using voltage- and patch-clamp methods; monitoring
changes in ion channel expression during differentiation using northern blot
analysis. There are opportunities during the final week for students to undertake
special projects of their own design which utilize the methods taught in the course.
PARTICIPANTS
Avery, Leon, Ph.D., Massachusetts Institute of Technology,
Cambridge
Boland, Linda M., M.S., University of North Carolina,
Durham
Chalmers, Alison E., Ph.D., American Cyanamid, Princeton,
New Jersey
Dixon, Donald B., M.S., University of Toronto, Canada
Enyeart, John J., Ph.D., Ohio State University, Columbus
Getchell, Thomas V., Ph.D., Wayne State University, Detroit,
Michigan
Karpen, Jeffrey W., Ph.D., Stanford University, California
Nedergaard, Maiken, M.D., Cornell Medical Center,
New York, New York
Surmeier, D. James, Ph.D., University of Tennessee,
Memphis
Wong, Linda, B.S. University of Texas, Galveston
SEMINARS
Sahley, C., Yale University. Membrane properties in learning
and memory.
Kinnamon, S. C., Colorado State University. Mechanisms of
taste transduction.
Belardetti, F., University of Texas. Modulation of ion channels
in Aplysia.
Stevens, C. F., Yale University. Glutamate receptors.
Brehm, P. Tufts University. Electrophysiology of sodium and
acetylcholine receptor channels.
Mandel, G. Tufts University. Molecular biology of the sodium
channel.
Molecular Embryology of the Mouse
June 5-June 25
INSTRUCTORS
Beddington, Rosa, Ph.D., ICRF, Oxford, England
Robetson, Liz, Ph.D., Cambridge University, England
Rossant, Janet, Ph.D., Mount Sinai Hospital, Toronto, Canada
Pedersen, Roger, Ph.D., University of California, San Francisco
ASSISTANTS
Ca lof, Anne, Ph.D., Tufts University, Medford, Massachusetts
Fox, Niles, Ph.D., Wistar Institute, Philadelphia, Pennsylvania
Mahon, Kathy, Ph.D., National Institutes of Health, Bethesda, Maryland
This course is designed for molecular biologists, biochemists and cell biologists
interested in applying their expertise to the study of mouse embryonic develop-
ment. Lecture and laboratory components of the course emphasize both the
practical aspects of working with mouse embryos and the conceptual basis of
current embryonic research. The following procedures and their potential applica-
tions are described: isolation and culture of germ cells and preimplantation and
postimplantation embryos, embryo transfer, establishment of embryo-derived stem
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cell lines, germ layer separation, chimera formation, nuclear transplantation,
microinjection of DNA into eggs, retroviral infection of embryos, microinjection of
cell lineage tracers, in situ hybridization using immunofluorescence and
immunoperoxidase techniques.
PARTICIPANTS
Avraham, Karen B., B.S., Weizmann Institute, Rehovot, Israel
Barker, Douglas D., Ph.D., University of California,
Los Angeles
Boisseau, Sylvie, M.S., C.N.R.S., Gif- sur- Yvette, France
Ciejek, Elena M., Ph.D., University of Rochester, New York
Dodd, Jane, Ph.D., Columbia University, New York,
New York
Harvey, Richard, Ph.D., Harvard University, Cambridge,
Massachusetts
Karlsson, Stefan, Ph.D., National Institutes of Health,
Bethesda, Maryland
Narasimhan, Nalini, Ph.D., California Institute of Technology,
Pasadena
Nguyen-Huu, Chi, Ph.D., Columbia University, New York,
New York
Overbeek, Paul A., Ph.D., Baylor College of Medicine, Waco,
Texas
Parvari, Ruti, M.S., Weizmann Institute, Rehovot, Israel
Poirier, Francoise, Ph.D., National Institute for Medical
Research, London, England
Weaver, Steven, Ph.D., University of Illinois, Urbana
Williams, David A., M.D., Childrens Hospital, Boston,
Massachusetts
SEMINARS
Chalfie, M., Columbia University. Cell lineages in C. elegans.
Chapman, V., Roswell Park Memorial Institute. Mouse
genetic resources.
Copeland, N., Frederick Cancer Research Institute.
Ecotropic viruses and insertional mutagenesis.
Costantinz, F, Columbia University. Analysis of B. globin
expression in transgenic mice.
Darling, S., Mount Sinai Hospital. Sex determination in
mammals.
Gardner, R., ICRF. Analysis of extraembryonic lineages.
Hanahan, D., Cold Spring Harbor Laboratory. Expression of
oncogene constructs in transgenic mice.
Hastie, N., MRC Clinical and Population Cytogenetics Unit.
Organization of the mouse genome.
Herrup, K., Yale University. Retrospective analysis of cell
lineages in the central nervous system.
Jaenisch, R., Whitehead Institute. Retroviruses and
insertional antigenesis.
Jenkins, N., Frederick Cancer Research Institute. Genetics of
mouse coat colors.
Lacy, E., Memorial-Sloan Kettering Cancer Center. Insertional
mutations in transgenic mice.
Papaoannou, G., Tufts University. Developmental mutants.
Petersen, A., Ludwig Institute, Montreal. Development of the
nervous system and neurological mutants.
Rudd le, F., Yale University. Mouse homeobox genes.
Sargent T, National Institutes of Health. Induction and
determination in the early Xenopus embryo.
Silver, L., Princeton University. Developmental genetics of the
T-complex.
Solter, D., Wistar Institute. Nuclear transfer and genomic
imprinting.
Struhl, G., Columbia University. Developmental genetics of
Drosophila.
Wasserman, P., Roche Institute of Molecular Biology.
Gametogenesis and fertilization.
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Advanced Bacterial Genetics
June 5-June 25
INSTRUCTORS
Berget, Peter, Ph.D., Carnegie Mellon University, Pittsburgh, Pennsylvania
Maurer, Russell, Ph.D., Case Western Reserve University, Cleveland, Ohio
Weinstock, George, Ph.D., University of Texas, Houston
ASSISTANTS
Eraso, Jesus, B.S., University of Texas, Houston
Mjoumdar, Mona Lisa, Ph.D., Carnegie Mellon University, Pittsburgh, Pennsylvania
Shrimankar, Paresh, M.S., Case Western Reserve University, Pittsburgh, Pennsylvania
This laboratory course demonstrates genetic approaches that can be used to
analyze biological processes and their regulation as well as detailed
structure/function relationships of genes. Techniques that are covered include:
isolation, complementation and mapping of mutations, use of transposable genetic
elements, construction of gene fusions, cloning and manipulation of DNA, and
DNA sequencing. The course consists of a set of experiments incorporating
most of these techniques supplemented with lectures and discussions. The aim is
to develop in students the ability to design a successful genetic approach to any
biological problem.
PARTICIPANTS
Butler, Charles A., M.S., University of Tennessee, Nashville
Dunlap, Paul V., Ph.D., New Mexico State University,
Las Cruces
Giroux, Sylvie, B.S., University of Montreal, Canada
Harriman, Philip D., Ph.D., National Science Foundation,
Washington, D.C.
Kalpana, Ganjam V., M.S., Albert Einstein College, Bronx,
New York
Kobiashi, Ichizo, Ph.D., National Medical Research Center,
Tokyo, Japan
Lin-Chao, Sue D., Ph.D., University of Texas, Dallas
McCarty, Shawn C., B.A., University of Louisville, Kentucky
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Michiels, Christiaan W., M.S., Catholic University of Leuven,
Belgium
Reilly, Pamela M., M.S., University of Minnesota, Duluth
Richter, Agneta A., B.S. University of Uppsala, Sweden
Rohlman, Christopher E., MS., University of Michigan,
Ann Arbor
Stoltzfus, Arlin B., B.A., University of Iowa, Iowa City
Thaler, David S., Ph.D., University of Oregon, Eugene
Vezina, Guy, M.S., Laval University, Quebec, Canada
Willey, Joanne M., B.S., Woods Hole Oceanographic,
Massachusetts
SEMINARS
Sauer, R., Massachusetts Institute of Technology. Genetic
dissection of protein structure.
Taylor, R., University of Tennessee. The use of phoA fusions
to study secreted virulence determinants.
Hillyard, R., Howard Hughes Medical Institute. Macrorestric-
tion of the salmonella chromosome.
Figurski, D., Columbia University College of Physicians &
Surgeons. Replication control in promiscuous plasmid
RK2.
Craig, N., University of California, San Francisco. Transposi-
tion of Tn7
Smith, G., University of Missouri. Using felamentous phages
in bacterial genetics.
Silhavey, T., Princeton University. Genetic analysis of protein
export.
Molecular Biology of the Nervous System
June 5-June 19
INSTRUCTORS
Evans, Ronald, Ph.D., Salk Institute, San Diego, California
McKay, Ronald, Ph.D., Massachusetts Institute of Technology, Cambridge
Reichardt, Louis, Ph.D., University of California, San Francisco
Zipursky, Larry, Ph.D., University of California, Los Angeles
This lecture course is designed for neuroscientists who wish to understand the
concepts and methods of molecular biology and their application to problems in
neuroscience. The participants are drawn from a wide range of backgrounds. The
methods of recombinant DNA technology are introduced in a series of lectures.
These are followed by lectures from visiting faculty. The lectures cover a variety of
topics to give an overview of the molecular mechanisms underlying the develop-
ment and function of the nervous system.
361
PARTICIPANTS
Augenbraun, Eliene, B.A., Columbia University, New York,
New York
Condic, Maureen L., B.A., University of California, Berkeley
Giza, Christopher C., B.A., West Virginia University,
Morgantown
Hall, Garth F., Ph.D., University of California, Berkeley
Khrestchatisky, Michel, Ph.D., University of California,
Los Angeles
Lagrutta, Armando A., B.S., University of Connecticut, Storrs
Martin, Kathleen, M.S., Yale University Medical School,
New Haven, Connecticut
Ottiger, Hans Peter, M.D., Scripps Clinic and Research
Institute, La Jolla, California
Padgett, Janet L., B.S., Johns Hopkins University, Baltimore,
Maryland
Penn, Anna A., B.S., Harvard University, Cambridge,
Massachusetts
SEMINARS
Struhl, K., Harvard University. Controlling gene expression in
bacteria and yeast.
Green, M., Harvard University. RNA splicing mechanisms.
Myers, R., University of California, San Francisco. Long
range structure of the human genome.
Zuker, C., University of California, San Diego. Structure and
function of Drosophila opsins.
Mitchison, T, University of California, San Francisco. Micro-
tubule function.
Reese, T, Woods Hole Oceanographic Institute. The
structure and function of axons.
Kelly, R., University of California, San Francisco. Cellular
mechanisms of secretion and uptake.
Jessel, T, Columbia University. Cell adhesion systems in
early CNS development.
Phillips, D., University of California, San Francisco. The cell
and molecular biology of platelets.
Petrucci, Tamara C., Ph.D., Yale University, New Haven,
Connecticut
Redies, Christoph, M.D., Montreal Neurological Institute,
Canada
Saccomano, Nicholas A., Ph.D., Pfizer Central Research,
Groton, Connecticut
Szigethy, Eva M., B.A., Montreal Neurological Institute,
Canada
Thormodsson, Finnbogi R., B.S., Cornell University, Ithaca,
New York
Valtorta, Flavia, M.D., Rockefeller University, New York,
New York
Wang, Samuel, B.S., Stanford University, California
Wolswijk, Guus, MS., Institute of Neurology, London,
England
Wigler, M., Cold Spring Harbor Laboratory. Oncogenesis.
Hall, J., Brandeis University. Drosophila behavioral
neurogenetics.
Sternberg, P, University of California, San Francisco.
Nematode development.
Levine, M., Columbia University. Genetic control of Drosoph-
ila development.
Anderson, D., California Institute of Technology. The differen-
tiation of chromafin cells.
Bronner-Fraser, Marianne, University of California, Irvine. The
development of the peripheral nervous system.
Aldrich, R., Stanford University. The biophysics of ion flux.
Makowski, L., Columbia University. The structure and
function of gap junctions.
Partick, J., Salk Institute. The molecular analysis of
acetylcholine receptors.
Molecular Neurobiology of Human Disease
June 21-July 1
INSTRUCTORS
Black, Ira B., M.D., Cornell University Medical College, New York, New York
Breakefield, Xandra, Ph.D., E.K. Shriver Center, Harvard Medical School, Boston
Gusella, James, Ph.D., Massachusetts General Hospital, Boston
This intensive seminar course explores the molecular and cellular basis of
abnormal neural function. It focuses on basic scientific studies that have provided
insight into the etiology and pathogenesis of neurologic and psychiatric diseases.
Emphasis is also placed on new techniques in neuroscience and molecular
genetics that should provide additional insights. Topics include: Molecular
pathology of neurotransmitter derangement; Developmental plasticity and choice
of neurotransmitter phenotype; Synthesis and regulation of neuropeptides; Cellular
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events in neural regeneration and brain transplantation; Neural pathways involved
in pain syndromes; Genetic linkage analysis using DNA polymorphisms; Defects in
DNA repair; Activation of one genes and genetic homozygosity in neural tumors;
Mutations causing the Lesch-Nyhan syndrome and possible means of gene
therapy; Biochemistry of the lipidoses; Autoimmune diseases; Brain imaging and
metabolism; Epilepsy and seizure disorders; Cell death in degenerative disorders;
Viral infections of the nervous system; Experimental models of learning and
memory.
PARTICIPANTS
Acsay, Vilmos, M.S., Hoffmann-La Roche, Basel, Switzerland
Amano, Takehlko, M.D., Mitsubishi-Kasei Institute, Tokyo,
Japan
Bahro, Marcel, M.D., University of Zurich, Switzerland
Baron, Miron, M.D., New York State Psychiatric Institute,
New York
Boni, Claudette, Ph.D., CNRS, Gif-Sur ,(vette, France
Campos, Ana R., M.A., Brandeis University, Waltham,
Massachusetts
Chneiweiss, Herve, Ph.D., INSERM, Paris, France
Dorkins, Huw R., B.A., University of Oxford, England
Eshhar, Nomi, M.S., Weizmann Institute, Rehovot, Israel
Gheuens, Jan, M.D., Universitair Hospitaal, Antwerpen,
Belgium
Gottlieb, Jacqueline, B.S., Yale University, New Haven,
Connecticut
Jacob, William F, Ph.D., National Institutes of Health,
Bethesda, Maryland
Kaufman, Charles, M.D., Columbia University, New York,
New York
Lieman-Hurwitz, Judy, Ph.D., Hebrew University of
Jerusalem, Israel
Lombroso, Paul, M.D., St. Vincents Hospital, New York,
New York
Lynch, Sue A., M.D., North Carolina Memorial Hospital,
Chapel Hill
Nance, Martha, M.D., University of Minnesota, Minneapolis
Naujoks, K., Ph.D., Boehringer Mannheim GmbH, Tutzing,
Federal Republic of Germany
Pandolfo, Massimo, M.D., University of California, Irvine
Schlaug, Gottfried, M.D., Louisiana State Medical Center,
New Orleans
Spigelman, Igor, M.S., University of British Columbia,
Vancouver
Tashayyod, Dara, B.A., Medical College of Pennsylvania,
Philadelphia
Turetsky, Dorothy, B.S., University of California,
San Francisco
SEMINARS
Gravel, R., Hospital for Sick Children. Cloning of lysosomal
enzymes.
Davies, P, Albert Einstein College of Medicine. Neuropatho-
logical and neurochemical features of Alzheimer disease.
Caskey, T, Baylor College of Medicine. Molecular defects of
HPRT in the Lesch-Nyhan syndrome.
Dingledine, R., University of North Carolina Medical School.
Epilepsy, kinddomg and ion channels.
McNamara, J.0., Durham VA Hospital-Duke University
Medical Center. Epilepsy, kindling and ion channels.
Fields, H., University of California School of Medicine. Pain
and neuropeptides.
Jessell, T.J., Harvard Medical School. Pain and
neuropeptides.
Aguayo, A., Montreal General Hospital. Nerve regeneration.
Ray. P, Hospital for Sick Children. Duchennbs muscular
dystrophy gene locus.
Milner, R., Research Institute of Scripps Clinic.
Proteolipoprotein gene defect in jimpy mice.
Hood, L., California Institute of Technology. Correction of
cyelin basic protein defect in transgenic shiverer mice
and sequencing the human genome.
Neurobiology of Drosophila
Sly, W., St. Louis University School of Medicine. Processing
of lysosomal enzymes and role in lipidoses.
Cavenee, W., University of Cincinnati Medical School.
Retinoblastoma.
Gallie, B., Hospital for Sick Children. Retinoblastoma.
Clements, J., Johns Hopkins University. Visna virus.
Gage, F., University of California, San Diego. Brain
transplantation.
Schwarcz, R., Maryland Psychiatric Research Center.
Huntington disease: Molecular and human aspects.
Wexler, N., Hereditary Disease Foundation. Huntington
disease: Molecular and human aspects.
Gurney, M., University of Chicago. Motor neuron growth
factor.
Caviness, V., Massachusetts General Hospital. Nuclear
magnetic resonance.
Sejnowski, T, Johns Hopkins University. Speech.
Mishkin, M., National Institute of Mental Health. Memory.
June 28-July 18
INSTRUCTORS
Bate, Michael, Ph.D., University of Cambridge, England
Jan, Lily Yeh, Ph.D., University of California, San Francisco
Jan, Yuh Nung, Ph.D., University of California, San Francisco
ASSISTANT
Hay, Bruce, University of California, San Francisco
Genetics has been used to approach questions in neurobiology that are otherwise
difficult to address. Drosophila is an ideal organism for such studies. This
laboratory/lecture course provides an introduction to current research in neuronal
function and development in Drosophila. It is intended for researchers at all levels
who may want to use Drosophila as an experimental system for studying
neurobiology.
The course begins with a crash course on Drosophila genetics and other
techniques which make Drosophila research distinctive, such as cytogenetics and
DNA transformation. The main emphasis, however, is on studies of the nervous
system.
The course covers basic electrophysiological techniques, as applied to mutants
with altered ion channels or sensory physiology. It also includes mutant analysis of
complex behaviors, such as courtship, circadian rhythm, learning and memory.
In the developmental section, processes of neurogenesis including determina-
tion and pathway formation are examined. The course familiarizes students with
various preparations, including the embryonic nervous system, imaginal discs, and
adult nervous system. It also reviews the different approaches being used in
attempts to unravel the molecular basis of neural development.
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PARTICIPANTS
Bastia, Deepak, Ph.D., Duke University, Durham, North
Carolina
Drain, Peter F., B.A., Massachusetts Institute of Technology,
Cambridge
Heberlein, Ulrike A., M.S., University of California, Berkeley
Hortsch, Michael, M.S., European Molecular Biology
Laboratory, Heidelberg, Federal Republic of Germany
SEMINARS
Ganetzky, B., University of Wisconsin. Drosophila genetics.
Wu, C.-F., University of Iowa. Ionic channels in Drosophila.
Rubin, G., University of California, Berkeley. Molecular
studies of neural development.
Heisenberg, M., Institut fur Genetik and Mikrobiologie.
Structural brain mutants and behavior.
Weischaus, E., Princeton University. Genes involved in
cellularization and gastrulation in Drosophila.
Ready, D., Princeton University. Eye development and
mutants of eye development.
Campos-Ortega, J., Universitat Koln. Early neurogenesis in
Drosophila.
Krantz, David E., B.S., University of California School of
Medicine, Los Angeles
Nedivi, El ly, B.S., Stanford University, California
O'Kane, Cahir, Ph.D., University of Basel, Switzerland
Siegler, Melody, Ph.D., Emory University, Atlanta, Georgia
Singh, Satpal, Ph.D., University of Iowa, Iowa City
Yovell, Yoram, B.S., Weizmann Institute, Rehovot, Israel
Technau, G., Universitat Koln. Lineage analysis of
transplanted individual cells in Drosophila embryos.
Quinn, W., Massachusetts Institute of Technology. Learning
mutants.
Goodman, C., Stanford University. Cellular and molecular
studies of axon guidance.
Hall, J., Brandeis University. Circadian rhythm and courtship
mutants.
Murphy, R.K., State University of New York, Albany. Sensory
neuron projections in Drosophila.
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Advanced Techniques in Molecular Cloning
June 28-July 17
INSTRUCTORS
Zoller, Mark, Ph.D., Cold Spring Harbor Laboratory, New York
Brosius, Jurgen, Ph.D., Columbia University, New York
Cate, Richard, Ph.D., Biogen, Cambridge, Massachusetts
Gubler, Ueil, Ph.D., Hoffmann La-Roche, Nutley, New Jersey
Henikoff, Steve, Ph.D., Fred Hutchinson Cancer Center, Seattle, Washington
MacGillivry, Ross, Ph.D., University of British Columbia, Vancouver
Schatzman, Allan, Ph.D., Smith, Kline & Beckman, King of Prussia, Pennsylvania
Urdea, Micky, Ph.D., Chiron Corp., Emoryville, California
Wallner, Barbara, Ph.D., Biogen, Cambridge, Massachusetts
This is a laboratory and lecture course on important aspects of molecular cloning.
The primary focus is aimed at the use of oligonucleotides and antibodies to isolate
the gene coding for a specific protein and the subsequent characterization and
manipulation of the cloned gene. The experiments consist of construction of cDNA
libraries, screening of libraries with oligonucleotides and antibodies, DNA
sequencing, probing Northern and Southern blots with oligonucleotides,
expression of foreign genes in E. coli, gene synthesis, oligonucleotide directed
mutagenesis using phagemid vectors, and the use of computers for DNA and
protein sequence analysis. Instructors present the application of these techniques
to the analysis of cloned genes and discuss alternative approaches not covered in
the laboratory section.
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PARTICIPANTS
Carmack, Condie E., Ph.D., Institute for Cancer Research,
Philadelphia, Pennsylvania
Dinsmore, Jonathan H., B.S., Dartmouth College, Hanover
New Hampshire
Eng, John, M.D., Veterans Hospital, Bronx, New York
Ennulat, David J., Ph.D., New York University Medical
Center, New York
Hasemann, Charles, B.S., University of Texas Health Science
Center Dallas
Hogarth, P. Mark, Ph.D., University of Melbourne, Australia
Jahn, Reinhard, Ph.D., Max-Planck-Institute, Martinsried,
Federal Republic of Germany
SEMINARS
Helfman, D., Cold Spring Harbor Laboratory. Molecular
aspects of muscle and non-muscle tropmyosins.
Pielak, G., University of Oxford. Analysis of mutated proteins
by two-dimensional NMR.
Summers, M., Texas A&M University. Baculovirus cloning
system.
Schatzman, A., Smith, Kline & Beckman. Cloning and
expression of human alpha-1 antitrypsin in E. coli.
Lannigan, Deborah A., Ph.D., University of Rochester
New York
Larsson, Gunilla K., MS., Chemical Center, Sweden
Lauerman, Tod W., RA., Johns Hopkins University,
Baltimore, Maryland
Parnell, Laurence D., B.S., University of Wisconsin, Madison
Pouyssegur, Jacques, Ph.D., CNRS, Nice, France
Qian, Su Wen, B.S., Shanghai Institute, Republic of China
Schwander, Juerg C., M.D., Kantonsspital, Basel, Switzerland
Yellen, Gary I., Ph.D., Johns Hopkins University, Baltimore,
Maryland
Yonamoto, Wes, Ph.D., University of California, San Diego
Cate, R., Biogen. Mullerian inhibiting substance
Henikoff, S., Fred Hutchinson Cancer Research Center.
Peculiar organization of Drosophila genes.
Arasu, P., New England Biolabs. Lymphatic filariasis:
Molecular cloning and characterization of antigen.
Molecular and Developmental Biology of Plants
June 28-July 17
INSTRUCTORS
Sussex, Ian, Ph.D., Yale University, New Haven, Connecticut
Messing, Joachim, Ph.D., Waksman Institute, Rutgers University, Piscataway, New Jersey
Horsch, Robert, Ph.D., Monsanto Company, St. Louis, Missouri
ASSISTANTS
Chereskin, Barbara, Ph.D., Rutgers University, Piscataway, New Jersey
Das, Prem, Rutgers University, Piscataway, New Jersey
Hinchee, Maud, Monsanto Company, St. Louis, Missouri
Kerk, Nancy, B.S., Yale University, New Haven, Connecticut
Solberg, Lorraine, Yale University, New Haven, Connecticut
Syzmkowaik, Eugene, Yale University, New Haven, Connecticut
This course provides an intensive overview of current topics and techniques in
plant biology, with emphasis on molecular and developmental biology and
genetics. It is designed for scientists with working knowledge of molecular
techniques who are either working with plant systems or wish to. The course
consists of a rigorous lecture series, a hands-on laboratory, and informal
discussions. Different guest speakers provide both an in-depth discussion of their
work and an overview of their specialty as well as informal discussions after their
seminars. The laboratory covers established and novel techniques in plant biology,
including plant structure and development, nucleic acid manipulations, gene
transfer techniques, tissue and cell culture techniques, photosynthesis, and
genetics and cytogenetics of maize.
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PARTICIPANTS
Bachmair, Andreas, Ph.D., Massachusetts Institute of
Technology, Cambridge
Caelles, M. Carme, B.A., University of Barcelona, Spain
Cardarelli, Maura, Ph.D., University "La Sapienza," Rome,
Italy
De Moor, Janice M., M.S., Agriculture Canada, Ottawa
Foley, Kevin P, B.A., Wallenberg Traditional High School,
San Francisco, California
Gousseau, Helene D. M., Ph.D., University of Calgary,
Canada
Holwerda, Barry C., M.S., University of Saskatchewan,
Canada
Hsu, Francis, Ph.D., E. I. DuPont de Nemours & Co.,
Wilmington, Delaware
SEMINARS
Horsch, R., Monsanto Company. The leaf disk transformation
system.
Sommerville, C., Michigan State University. Biochemical
mutants of Arabidopsis.
Nasrallah, J., Cornell University. Self incompatibility in
Brassica.
Beachy, R., Washington University. Studies of TMV coat
protein in transgenic plants.
Lamb, C., Salk Institute. Pathways in plant pathogens
interaction.
Rogers: J., Washington University. Differential gene
expression in barley aleurone tissue.
Ho, D., Washington University. Plant hormones and growth
regulators.
Staskawizc, B., University of California, Berkeley. Microbial
genes involved in plant pathogenesis.
Wessler, S., University of Georgia. Transposable elements in
maize.
368
Keierleber, Carolyn, B.S., University of California, Irvine
Luehrsen, Kenneth R., Ph.D., Stanford University, California
Nib lett, Charles L., Ph.D., University of Florida, Tallahassee
San Francisco, Michael J., Ph.D., University of Maryland,
College Park
Schalk, Joachim, B.S., Max-Planck-Institut, Koln, Federal
Republic of Germany
Stout, Richard G., Ph.D., Montana State University, Bozeman
Weigel, Detlef, B.S., Max-Planck-Institut, Tubingen, Federal
Republic of Germany
Wright, Rhonda L., M.S., University of Missouri, Columbia
Tanks ley, S., Cornell University. Mapping plant genomes with
RFLP.
Bevan, M., Plant Breeding Institute. Potatin gene expression
using glucoronidase gene fusions.
Gronenborn, B., Max-Planck Institute. Wheat dwarf virus
replication.
Ahlquist, P., University of Wisconsin. In vitro genetics of
brome mosaic virus.
Messing, J., Rutgers University. High methionine corn.
Fink, G., Whitehead Institute. Mutants in amine acid
biosynthesis.
Bogorad, L., Harvard University. Structure and function of
the chloroplast genome.
Hanson, M., Cornell University. Mitochondrial genes in
plants.
Cell and Molecular Biology of Learning and Memory
July 10-July 24
INSTRUCTORS
Byrne, Jack, Ph.D., University of Texas Medical School, Houston
Kandel, Eric, M.D., Columbia University, New York, New York
Nottebohm, Fernando, Ph.D., Rockefeller University, New York, New York
Pearson, Keir, Ph.D., University of Alberta, Canada
This lecture course provides an introduction to cell and molecular biological
approaches to learning and memory. It is suited for graduate students in
molecular biology, neurobiology and psychology as well as research workers who
are interested in an introduction to this new field. The course covers topics ranging
from behavioral considerations of learning and memory to gene regulation in the
nervous system. Rather than an extensive survey, the lectures provide an.intensive
coverage of four selected areas: 1) an introduction to modern behavioral studies
of learning and memory; 2) the cell biology of neuronal plasticity and the regula-
tion of gene expression by experience; 3) cellular and molecular mechanisms of
simple forms of learning and memory in invertebrates and vertebrates; and
4) neural approaches to cognition as evident in studies of communication and
language. To put the cellular work on learning into perspective, selected examples
are taken from human behavior and its abnormalities.
PARTICIPANTS
Amano, Takehiko, Ph.D., Mitsubishi-Kasei Institute, Tokyo,
Japan
Aztely, F., University of Goteborg, Sweden
Beers, David Robert, B.S., University of Utah, Salt Lake City
Bonhoeffer, Tobias, M.S., Max-Planck-Institute, Tuebingen,
Federal Republic of Germany
Brown, Glen D., B.A., University of Iowa, Iowa City
Burrous, Mary R., B.A., Rockefeller University, New York,
New York
Christenson, Johan, B.A., Karolinska Institute, Stockholm,
Sweden
Cooper, Lee D., Ph.D., New York State Psychiatric Institute,
New York
Eliot, Lise S., B.A., New York State Psychiatric Institute,
New York
Gomez, Hortensia Gonzalez, M.S., CILVESTAV-IPN, Mexico
City
Hanse, Eric L., B.S., University of Goteborg, Sweden
Jacobs, Kimberle M., B.A., Brown University, Providence,
Rhode Island
SEMINARS
Rescorla, R., University of Pennsylvania. Introduction to
learning theory.
Gould, J., Princeton University. Ethological approaches to
learning.
Wyman, R., Yale University. Introduction to the study of
genes and behavior.
Knapp, M., Columbia University. Cloning of genes important
for learning.
Kano, Masanobu, Ph.D., Jichi Medical School, Tochigi-Ken,
Japan
Keller, Hansjorg, B.S., University of Zurich, Switzerland
Lockery, Shawn R., B.A., University of California, San Diego
Marcus, Emilie A., B.A., Yale University, New Haven,
Connecticut
Middleton, Pamela, M.A., Columbia University, New York,
New York
Nilsson, Ola G., B.S., University of Lund, Sweden
O'Malley, Edward K., B.S., Cornell University, New York,
New York
Sato, Thomas, B.S., Georgetown University, Washington, D.C.
Sinclair, Alison, Ph.D., Children's Hospital, Boston,
Massachusetts
Taylor, Anne J., B.S., Boston University, Massachusetts
Terlau, Heinrich, M.S., Max-Planck-Institute, Gottingen,
Federal Republic of Germany
Yun, Yungdae, B.S., Michigan State University, East Lansing
Schwartz, J., Columbia University. Overview of second
messenger systems and their role in learning and
memory.
Adler, J., University of Wisconsin. Genes and the behavior of
bacteria.
Kung, C., University of Wisconsin. Genes, ion channels, and
behavior of paramecium, yeast, and E. coli.
Quinn, J., Massachusetts Institute of Technology. Genetic
approaches to study associative learning in Drosophila.
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Thompson, R., Stanford University. Cellular locus and
correlates of the classical conditioning of the nictitating
membrane response.
Lisberger, S., University of California, San Francisco. Plastic-
ity in the vestibulo-occular reflex.
Thach, T., Washington University. Neuronal correlates of
motor learning.
Bliss, T., National Institute for Medical Research. Presynaptic
mechanisms in long-term potentiation.
Stevens, C., Yale University. Postsynaptic mechanisms in
long-term potentiation.
Berger, T, University of Pittsburgh. Role of long-term potenti-
ation in learning.
Black, I., Cornell University. Modulation of gene expression
in the vertebrate nervous system.
Squire, L., University of California, San Diego. Memory in
humans and non-human primates.
Price, D., Johns Hopkins University. Alzheimer's diseases.
Immunoglobulins: Molecular Probes of the Nervous System
July 20-August 9
INSTRUCTORS
Levitt, Pat, Ph.D., Medical College of Pennsylvania, Philadelphia
Evans, Christopher, Ph.D., Stanford University, California
PARTTIME INSTRUCTORS
Lafenaur, Carl, Ph.D., University of Pittsburgh School of Medicine, Pennsylvania
Pintar, John, Ph.D., Columbia University College of Physicians & Surgeons, New York,
New York
Carlson, Steve, Ph.D., University of Washington, Seattle
Hockfield, Susan, Ph.D., Yale University School of Medicine, New Haven, Connecticut
ASSISTANT
Barbe, Mary, Ph.D., Medical College of Pennsylvania, Philadelphia
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Antibodies are invaluable probes used extensively in neurobiological research.
This course is designed to provide an advanced understanding of the power and
pitfalls of immunoglobulins as biochemical and anatomical reagents. Through
laboratory work participants explore many immunotechniques including generation
of monoclonals, preparation and characterization of antibodies to synthetic
peptides and complex antigens, immunohistochemistry, immunoassays, affinity
purification, western blotting, antibody conjugation interfacing immunoassays with
HPLC, In Vitro education and in situ hybridization.
PARTICIPANTS
Benfenati, Fabio, M.D., Rockefeller University, New York,
New York
Born, Donald E., Ph.D., University of Washington, Seattle
Cisse, Soriba, M.S., INRS-Sante, Montreal, Canada
Cserr, Helen F, Ph.D., Brown University, Providence,
Rhode Island
Hevner, Robert F., B.S., Medical College of Wisconsin,
Milwaukee
Hsu, Hsiao-Lan, B.A., Johns Hopkins University, Baltimore,
Maryland
SEMINARS
Steiner, L., Massachusetts Institute of Technology. Introduc-
tion to Immunoglobulins.
Woodland, R., University of Massachusetts Medical Center.
B cells and cellular immunology.
Janeway, C., Yale University School of Medicine. T-cells and
the immune response.
Scharff, M., Albert Einstein College of somatic mutation and
the generation of better hybridomas.
Alt, F, Columbia University College of Physicianu &
Surgeons. Ig gene rearrangements.
Koroshetz, Walter J., M.D., Massachusetts General Hospital,
Boston, Massachusetts
Rizzo, Joseph, M.D., Massachusetts Eye and Ear Infirmary,
Boston, Massachusetts
Taylor, Marianne, B.S., University of Calgary, Canada
Teixeira, Geriinda, B.S., Universidade Federal, Niterio, Brazil
Tiffany Tsui, Ho-Ching, Ph.D., Washington University Medical
School, Seattle
Volpe, Bruce T, M.D., New York Hospital-Cornell Medical
Center, New York
Levitt, D., Hoffman-La Roche. Interleukins and the immune
response.
Lindstrom, J., Salk Institute. Monoclonal antibodies as
probes of the acetylcholine receptor.
Lagenaur, C., University of Pittsburgh School of Medicine
Cell surface molecules and nerve cell development.
Barald, K., University of Michigan Medical School. No-flow
cytometry as a tool to study neural crest development.
Milner, T, Cornell University Medical College. EM immuno-
cytochemistry.
Molecular Cloning of Eukaryotic Genes
July 20-August 9
INSTRUCTORS
Alt, Fred, Ph.D., Columbia University, New York, New York
Bothwell, AI, Ph.D., Yale University, New Haven, Connecticut
Roberts, Thomas, Ph.D., Harvard University, Cambridge, Massachusetts
ASSISTANTS
Okada, Ami, B.S., Columbia University, New York, New York
Callum, Robert, B.S., Columbia University, New York, New York
Carbleg, Michael, B.S., Harvard University, Cambridge, Massachusetts
This laboratory and lecture course covers the principles of recombinant DNA
technology and the application of these procedures to the study of eukaryotic
genes. The isolation and characterization of lymphocyte specific genes are
emphasized. Among the topics covered are: construction of cDNA libraries in
plasmid or bacteriophage ? vectors, construction of bacteriophage 7 and cosmid
libraries of high-molecular-weight eukaryotic DNA, screening DNA libraries with
gene-specific hybridization probes, purification and characterization of recombinant
clones using restriction endonuclease and blot hybridization analyses, and
reintroduction and expression of cloned genes in heterologous systems. Strategies
for isolating genes that encode rare mRNA sequences are discussed. Guest
lecturers discuss the application of molecular cloning procedures to the study of
specific eukaryotic gene systems.
PARTICIPANTS
Cass, Carol E., Ph.D., University of Alberta, Canada
Cavanaugh, Colleen M., Ph.D., Harvard University,
Cambridge, Massachusetts
Cerni, Christa M., M.D., University of Vienna, Austria
Chaganti, Raju S., Ph.D., Memorial Sloan Kettering Cancer
Center, New York, New York
372
D'Amore, Patricia A., Ph.D., The Childrens Hospital, Boston,
Massachusetts
Dennert, Gunther, Ph.D., University of Southern California,
Los Angeles
Ernberg, Ingmar T, Ph.D., Karolinska Institutet, Stockholm,
Sweden
Fu, Shu Man, Ph.D., Oklahoma Medical Research
Foundation
Glukhova, Marina, Ph.D., Institute of Cardiology, Moscow,
USSR
Kaplan, Jerry, Ph.D., University of Utah, Salt Lake City
Kincade, Paul W., Ph.D., Oklahoma Medical Research
Foundation, Oklahoma City
Latt, Samuel A., Ph.D., Harvard Medical School, Boston,
Massachusetts
SEMINARS
Hood, L., California Institute of Technology. Structure and
function of antigen receptor genes.
. Biotechnology
Lutzker, S., and P. Ferrier, Columbia University. Gene transfer
into mammalian cells.
Mulligan, R., Whitehead Institute Use of retrovirus vectors to
analyze Hematopoietic differentiation.
Cantor, C., Columbia University. New techniques for human
molecular genetics.
Hanahan, D., Cold Spring Harbor Laboratory. Oncogene
function in transgenic mice.
Moss, B., National Institutes of Health. Vaccinia virus:
Regulation of transcription and use as an expression
vector.
Alt, F., and G. Yancopoulos, Columbia University. Hybridiza-
tion techniques.
Goff, S., Columbia University. Definition of retrovirus genes
by in vitro mutagenesis.
Schimke, R., Stanford University. Gene amplification, Part 1.
. Gene amplification, Part 2.
Yeast Genetics
Pratt, Melanie M., Ph.D., University of Miami, Florida
Seaman, William E., M.D., VA Medical Center, San Francisco,
California
Smith, Frances I., Ph.D., Mt. Sinai School of Medicine,
New York, New York
Thompson, Linda F., Ph.D., Scripps Clinic & Research
Foundation, La Jolla, California
Snider, M., Yale University. Use of gt11 to clone and study
yeast gene products: Centromere binding proteins.
Wig ler, M., Cold Spring Harbor Laboratory. Structure and
function of cellular oncogenes.
Davis, M., Stanford University. T-cell receptor and XLR gene
families.
Tucker, P., Southwestern Medical School. Regulation of Ig
isotype expression.
Mc Night, S., Carnegie Institute. Regulation of transcription.
Pintar, J., Columbia University. Use of in situ hybridization to
study mammalian development.
Kellems, R., Baylor University. The adenosine deaminase
gene and gene therapy.
Kaufman, R., Genetics Institute. Molecular genetics of Factor
VIII.
Rosenberg, M., Smith, Kline and French. Expression of
proteins in E. coil.
July 20-August 9
INSTRUCTORS
Sherman, Fred, Ph.D., University of Rochester, New York
Winston, Fred, Ph.D., Harvard Medical School, Boston, Massachusetts
Rose, Mark, Ph.D., Princeton University, New Jersey
Fink, Gerald, Ph.D., Whitehead Institute, Cambridge, Massachusetts
PARTTIME INSTRUCTOR
Hicks, James, Ph.D., Research Institute of Scripps Clinic, La Jolla, California
ASSISTANTS
Rose, Alan, M.S., Princeton University, New Jersey
Swanson, Michele, B.A., Harvard Medical School, Boston, Massachusetts
The major laboratory techniques used in the genetic analysis of yeast are studied,
including the isolation and characterization of chromosomal and mitochondria!
mutants, tetrad analysis, chromosomal mapping, mitotic recombination, and test of
allelism and complementation. Micromanipulation used in tetrad analysis is carried
out by all students. Recombinant DNA techniques, including yeast transformation,
filter hybridization, and gel electrophoresis are applied to cloning and genetic
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analysis of yeast DNA. Lectures on fundamental aspects of yeast genetics are
presented along with seminars given by outside speakers on topics of current
interest.
PARTICIPANTS
Adair, W. Lee, Ph.D., University of South Florida, Tampa
Alfano, Christine L., B.S., Johns Hopkins University,
Baltimore, Maryland
Cellini, Allessandra, Ph.D., Cell Biology Institute, Rome, Italy
Dranginis, Anne M., Ph.D., NIDDK, National Institutes of
Health, Bethesda, Maryland
Goyer, Charles, M.S., McGill University, Montreal, Canada
Jakubowski, Heironim, Ph.D., UMDNJ-New Jersey Medical
School, Piscataway
Kallal, Lorena A., B.S., University of Notre Dame, Indiana
Kambouris, Nicholas G., B.A., University of Virginia,
Charlottesville
Kosman, Daniel J., Ph.D., State University of New York,
Buffalo
SEMINARS
Petes, T, University of Chicago. Meiotic recombination in
yeast: The rules of the game.
Warner, J., Albert Einstein College of Medicine. Ribosomal
genes: Structure and regulation.
Guarente, L. Massachusetts Institute of Technology. DNA
binding and transcriptional activation.
Hinnebusch, A., National Institutes of Health. Translational
control of GCN4.
Wig ler, M., Cold Spring Harbor Laboratory. Controlof cell
proliferation in yeast.
Carlson, M., Columbia University. Glucose repression
involves a protein kinase.
Sternglanz, R., State University of New York, Stony Brook.
DNA topoisomerase and histone acetyltransferase.
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Lieberman, Howard B., Ph.D., Columbia University College
of Physicians & Surgeons, New York, New York
Morgan, Edward A., Ph.D., Roswell Park Memorial Institute,
Buffalo, New York
Perfect, John R., M.D., Duke University, Durham, North
Carolina
Picks ley, Steven, Ph.D., Potters Bar, Imperial Cancer
Research Fund, England
Ruggieri, Rosamaria, MS., Weizmann Institute of Science,
Rehovot, Israel
Thoma, Fritz, Ph.D., Institut for Zellbiologie, Zurich,
Switzerland
Tien, Ming, Ph.D., Pennsylvania State University, University
Park
Klar, A., Cold Spring Harbor Laboratory. The yeast sex.
Pringle, J., University of Michigan. Cellular morphogenesis in
yeast.
Broach, J., Princeton University. Plasmid propagation in
yeast.
Fox, T., Cornell University. Nuclear control of translation of
mitochondrial mRNAs.
Herskowitz, I., University of California, San Francisco. Cell
specialization in yeast.
Douglas, M., University of Texas Health Science Center.
Mitochondrial import in yeast.
Schekman, R., University of California, Berkeley. Protein
localization in yeast.
Computational Neurosciences: Vision
July 26-August 9
INSTRUCTORS
Movshon, J. Anthony, Ph.D., New York University, New York
Hildreth, Ellen C. Ph.D., Massachusetts Institute of Technology, Cambridge
ASSISTANTS
Clemens, David, M.S. Massachusetts Institute of Technology, Cambridge
Horswill, Ian, B.S., Massachusetts Institute of Technology, Cambridge
Computational approaches to problems in neuroscience have produced important
advances in our understanding of neural processing. The most prominent
successes have come in areas where strong inputs from neurobiological,
behavioral and computational approaches can interact. Through a combination of
lectures and hands-on experience with a computer laboratory, this intensive
course examines several areas of vision including motion analysis, binocular
stereo and color. The theme is that an understanding of the computational
problems, the constraints on solutions to these problems, and the range of
possible solutions can help guide research in neuroscience. Students should have
experience in neurobiological or computational approaches to visual processing. A
strong background in mathematics will be beneficial.
PARTICIPANTS
Bornstein, Yael, MS., Weizmann Institute, Rehovot, Israel
Bracewell, Robert M., B.A., University of California,
San Diego
Brainard, David H., B.A., Stanford University, California
Britten, Kenneth H., Ph.D., State University of New York,
Stony Brook
Deno, Curtis D., M.D., Smith Kettlewell Eye Research
Foundation, San Francisco, California
Downing, Cathryn J., Ph.D., New York University, New York
Edelman, Shimon, M.S., Weizmann Institute, Rehovot, Israel
Ferrera, Vincent P, B.A., University of Chicago, Illinois
Gallant, Jack, M.S., Yale University, New Haven, Connecticut
Johnston, Elizabeth, M.A., Oxford University, England
Ka ley, Ainat, MS., Hebrew University Givat-Ram, Jerusalem,
Israel
Kiorpes, Lynne, Ph.D., New York University, New York
Krauzlis, Richard J., A.B., University of California,
San Francisco
McLean, Judith, B.A., University of Pennsylvania,
Philadelphia
Mowafy, Lyn K., M.A., University of Arizona, Tucson
Noble, Alison J., B.A., Robotics Research Group, Oxford,
England
Poirson, Allen B., B.A., Stanford University, California
Rensink, Ron A., M.S., University of British Columbia,
Vancouver
Royden, Constance S., B.S., University of California,
San Francisco
Snowden, Robert J., B.S., University of Cambridge, England
Thoreson, Wallace B., B.A., University of Minnesota,
Minneapolis
SEMINARS
Andersen, R., Massachusetts Institute of Technology.
Physiological studies of motion analysis.
Lennie, P, University of Rochester. Psychophysical and
physiological studies of color vision.
Maunsell, John, University of Rochester. Task dependent
neural behavior. Neural correlates of visual attention and
recognition.
Medioni, G. University of Southern California. Computational
models of binocular stereo.
Morgan, M., University College London. The psychophysical
study of early visual processing.
Nakayama, K., Smith-Kettlewell Eye Research Foundation.
The measurement of motion in human vision.
. Integrating multiple visual cues and the role of visual
attention.
Van Hateren, Hans J. H., M.D., Groningen University,
Federal Republic of Germany
Zimmerman, George L., B.S., University of Minnesota,
Minneapolis
Zohary, Ehud, B.S., Hebrew University, Jerusalem, Israel
Poggio, T., Massachusetts Institute of Technology. The neural
implementation of visual computations.
. A unified theoretical framework for early vision and the
integration of multiple visual processes.
Sejnowski, T, Johns Hopkins University. Neural networks for
visual computation.
Thompson, W., University of Minnesota. Computational
models of motion measurement.
Ullman, S., Massachusetts Institute of Technology and
Weizmann Institute of Science. Higher-lever vision:
Computing spatial relation, visual routine and object
recognition.
Wandell, B., Stanford University. The analysis of color
Molecular Cloning of Neural Genes
August 11-August 30
INSTRUCTORS
Eberwine, James, Ph.D., Stanford University, California
Evinger, Marian, Ph.D., Cornell University Medical College, New York, New York
PART -TIME INSTRUCTORS
Margolskee, Robert, Ph.D., Roche Institute of Molecular Biology, Nutley, New Jersey
Schachter, Beth, Ph.D., Mt. Sinai Medical School, New York, New York
ASSISTANTS
Fox, Susan, Ph.D., Rockefeller University, New York, New York
Inman, Irene, B.S., Stanford Medical Center, California
This intensive laboratory/lecture course is intended to provide scientists with a
basic knowledge of the use of the techniques of molecular biology in examining
questions of neurobiological significance. Particular emphasis is placed on using
and discussing methods for circumventing the special problems posed in the
study of the nervous system, for example, examination of low abundance mRNAs
in extremely heterogeneous cell populations.
The laboratory work includes mRNA quantitation techniques, preparation of
hybridization probes, cloning techniques (plasmid, kgt11 and Okayama-Berg),
colony screening techniques (probe hybridization, antibody interaction and activity
assays), DNA sequencing, eukaryotic cell transfection and in situ hybridization.
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The lecture series, by invited speakers, focuses on how molecular biology
techniques can be used to supplement more standard neurobiological tools in
examining the nervous system. Topics include: use of transgenic mice in neurobio-
logical studies, cloning of neurotransmitter receptors and use of simple model
systems in the study of the mammalian nervous system.
PARTICIPANTS
Bendotti, Caterina, Ph.D., Johns Hopkins University,
Baltimore, Maryland
Boyle, Mary B., Ph.D., Yale University, New Haven,
Connecticut
Coleman, Paul D., Ph.D., University of Rochester, New York
D'Ambrosio, Steven M., Ph.D., Ohio State University,
Columbus
Douville, Philippe, B.S., Montreal General Hospital, Canada
Elzinga, Marshall, Ph.D., Brookhaven National Laboratory,
Upton, New York
Erdos, Joseph J., Ph.D., Connecticut Mental Health Center,
New Haven
Girault, Jean-Antoine, Ph.D., Rockefeller University,
New York, New York
SEMINARS
Chao, M., Cornell University Medical College. Gene transfer
and molecular cloning of mammalian cell receptors.
Hahn, W., University of Colorado Medical Center. Perspec-
tives and targets useful in developing strategies for the
establishment of the structure and function of brain
specific proteins.
Knapp, M., Columbia University College of Physicians &
Surgeons. Approaches to the cloning of genes important
for the establishment or maintenance of brain specific
proteins.
Helfman, D., Cold Spring Harbor Laboratory. Immunological
screening methods for expression libraries.
Comb, M., Massachusetts General Hospital. Mechanisms of
transsynaptic regulation of gene expression.
Chikaraishi, D., Tufts University School of Medicine.
Expression of catecholamine genes.
Watson, S., University of Michigan School of Medicine.
Applications of in situ hybridization in the study of the
CNS.
Horton, Heather L., B.S., Medical College of Pennsylvania,
Philadelphia
Jones, Kathryn J., Ph.D., Chicago Medical School, Illinois
McKinney, Michael, Ph.D., Abbott Laboratories, Abbott Park,
Illinois
Melrose, Patricia A., Ph.D., University of Rochester,
New York, New York
Schafer, Martin K-H., M.D., Mental Health Research Institute,
Ann Arbor, Michigan
Scotting, Paul J., Ph.D., University of Cambridge, England
Soumoff, Cynthia, Ph.D., University of Tennessee, Oak Ridge
Weber, Michel J., Ph.D., CNRS, Toulouse, France
Tobin, A., University of California, Los Angeles. Structural
and developmental regulation of brain glutamate
decarboxylase.
Draft, C., VA Medical Center, Dallas. Isolation and character-
ization of retinal/pineal cDNA encoding S antigen.
Higgins, G., Scripps Clinic and Research Foundation. In situ
hybridization shows regulated expression of amyloid beta
protein mRNA in Alzheimer's Disease.
Carroll, J., Cornell University Medical College. DNA
sequencing methodologies.
Claudia, T, Yale University. Gene transfer techniques.
Hanahan, D., Cold Spring Harbor Laboratory. Use of
transgenic mice in neurobiological studies.
Hoffman, A., Stanford University School of Medicine.
Hormonal control of pituitary peptide hormone gene
expression.

Seminars
Cold Spring Harbor Seminars were initiated to provide a semiformal avenue for
communication between the various research groups at the Laboratory. They are
particularly useful for research personnel who have joined the Laboratory during
the summer. The seminars also afford a necessary opportunity for the graduate
students and postgraduate staff to develop their skills in defending, organizing,
and presenting their research. In addition to those listed below, seminars were
given by many others involved in research at this Laboratory.
1987
January
Richard Selinfreund, Los Alamos National Laboratories, New
Mexico: A possible role for calmodulin in the transduction
of the mitogenic signal.
Wai-Kit Chan, Baylor College of Medicine, Waco, Texas:
Membrane insertion and topography of the nonstructural
glycoprotein of simian rotavirus
Robert Eisenman, Fred Hutchinson Research Center, Seattle,
Washington: Proteins encoded by the c-myc oncogene.
Nigel Crawford, Stanford University Medical Center, Califor-
nia: Molecular biology of plant nitrate reductase.
Carol St. Angelo, Memorial Sloan-Kettering Cancer Center,
New York, New York: Influenza virus polymerase protein
complexes in baculovirus expression vectors and in
influenza-virus-infected cells.
February
David Thaler, University of Oregon, Eugene: Red recombina-
tion pathway in bacteriophage X.
Susan Rosenberg, University of Oregon, Eugene: Chi
recombination hot spots: New thoughts on old sequence.
Brian Cullen, Hoffman-La Roche, Nutley, New Jersey: Trans-
activation of HIV LTR is mediated by nuclear events.
Morris Birnbaum, Memorial Sloan-Kettering Cancer Center,
New York, New York: Molecular regulation of glucose
transport.
Michael David Marks, Zoecon Research Institute, Palo Alto,
California: Development of a novel transformation
procedure for Arabidopsis phaliana: A model plant for
the study of plant molecular biology.
Ed Ziff, New York University Medical Center, New York: Gene
regulation by nerve growth factor.
Ursula Vogel, University of Cambridge, England: Molecular
cloning of CNPase: A myelin-specific protein.
Maynard Olson, Washington University School of Medicine,
St. Louis, Missouri: Physical mapping of yeast
chromosomes.
Darryl Rideout, Research Institute of Scripps Clinic, La Jolla,
California: Self-assembling cytotoxins.
March
Joyce Fox, Long Island Jewish Medical Center, New Hyde
Park, New York: Molecular diagnosis of ornithine
transcarbamylase deficiency.
Jean-Francois Brunet, Centre de Immunologie, Marseille,
France: Cytotoxic T- lymphocyte- associated transcripts.
Charles Cantor Columbia University College of Physicians &
Surgeons, New York, New York: Determining the structure
of the human genome.
Gary Struhl, Columbia University College of Physicians &
Surgeons, New York, New York: Genes controlling
segment determination in Drosophila.
Cori Bargmann, Whitehead Institute, Cambridge,
Massachusetts: Activation of the NEU oncogene.
Jenine LeBlanc, Wesleyan University, Middletown, Connecti-
cut: Characterization and localization of the 7SL RNA and
signal recognition particle in the developing sea urchin.
Joan Brugge, State University of New York, Stony Brook:
Expression of the cellular src proto-oncogene in normal
cells.
Tom Schneider University of Colorado, Boulder: The informa-
tion content of binding sites on nucleotide sequences.
April
Cecile Butor, EMBL, Heidelberg, Federal Republic of
Germany: Glycolipid polarity in MDCK cells.
Moshe Shani, Weizmann Institute, Rehovot, Israel:
Expression of rat muscle specific genes introduced into
pluripotent stem cells and mouse germ cells.
Nikki Harter, New Jersey Medical School, Piscataway:
Purification and biological characterization of an adenovi-
rus type-2 DA protein expressed in E. coli.
Fred Goldberg, Harvard Medical School, Boston,
Massachusetts: Selective degradation of abnormal
proteins in animal and bacterial cells.
Keith Joho, State University of New York Downstate Medical
School, New York: Identification of a region in the T3 and
T7 RNA polymerases that is required for specific
promoter recognition.
Carlo Tacchetti, National Institute for Cancer Research,
Genova, Italy: In vitro morphogenesis of chick embryo
cartilage.
Mark Ptashne, Harvard University, Cambridge,
Massachusetts: Gene control in bacteria and yeast.
Manuel Ares, Yale University, New Haven, Connecticut: U2
genes of man and yeast.
Don Rio, Whitehead Institute, Cambridge, Massachusetts:
Regulation of Drosophila P-element transposition
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May
Dan Di Maio, Yale University, New Haven, Connecticut:
Genetic analysis of bovine papilloma virus transforming
genes.
Benjamin Rich, Yale University, New Haven, Connecticut:
Characterization of genes encoding human ribosomal
phosphoproteins.
Florence Tsui, Toronto Western Hospital, Canada: Molecular
studies on the gene for mammalian histidyl tRNA
synthetase.
Fritz Melchers, Basel Institute, Switzerland: B-cell-cycle
control.
Greg Conway, Vanderbilt University, Nashville, Tennessee: In
vitro RNP assembly suggests a ribonucleosomal
architecture for pre-mRNA.
June
Seth Stern, University of California, Santa Cruz: Protein-RNA
interactions in the 30S subunit form a basis for the three-
dimensional structure of 16S RNA.
Jean Thierry, NCI, Bethesda, Maryland: Control of cytoplas-
mic Ca** concentration by inositol phosphates and
guanine nucleotides in eukaryotic cells.
July
Ulrike Heberlein, University of California, Berkeley: In vitro
transcription of developmentally regulated genes in
Drosophila.
Jergen Behreus, Max-Planck Institut, Tubingern, Federal
Republic of Germany: Epithelial cells acquire invasive
properties following disturbance of cell-cell adhesion.
September
Paul Lambert, NCI, Bethesda, Maryland: Negative regulation
of BPV I transcription.
Frank McCormick, Cetus Corporation, Emoryville, California:
Structure and function of RAS proteins.
Mike McClelland, University of Chicago: Restriction
endonucleases for pulsed-field gel electrophoresis.
October
Mike Fried, ICRF, London, England: The use of expression-
selection for the study of gene regulation in mammalian
cells.
Arne Stenlund, University of California, Berkeley: The role of
transcriptional elements in the replication of BPV I.
Dominique Be lin, University of Geneva, Switzerland:
Molecular control of proteolytic activity in mouse male
and female genetics.
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Julian Downward, Whitehead Institute, Cambridge,
Massachusetts: G proteins, p21f. and signal transduction
mechanism.
November
Mario Rebecchi, Memorial Sloan-Kettering Cancer Center,
New York, New York: Phosphoinositide-specific
phospholipase C: Regulation and mechanism.
Peter Sorger, MRC Laboratory of Molecular Biology,
Cambridge, England: Regulation of the heat-shock
transcription factor by stress.
Michael Greenberg, Harvard Medical School, Boston,
Massachusetts: Regulation of the c-fos proto-oncogene
during cell growth and differentiation.
Joe Nadeau, Jackson Laboratory, Bar Harbor, Maine: Gene
mapping and genome organization in mammals.
Pierpaolo Di Fiore, NCI, Bethesda, Maryland: Transforming
potential of growth factor receptors: EGF and erbB-2.
Michael Mendenhall, Scripps Clinic and Research
Laboratory, La Jolla, California: Control of the yeast
mitotic cell cycle: Regulation of the cdc28 protein kinase.
Steinunn Baekkeskov, Hagedorn Research Laboratory,
Copenhagen, Denmark: Characterization of a target for
autoimmunity in diabetes: A 64K 0-cell membrane
protein.
December
Earl Ruley, Massachusetts Institute of Technology,
Cambridge: Oncogene-induced lipogenesis: In vitro
atherosclerosis.
Alan Smith, Monsanto Corporation, St. Louis, Missouri:
Isolation and characterization of genes having preferential
expression in tomato flowers.
Fred Cross, Fred Hutchinson Cancer Research Facility,
Seattle, Washington: A dominant mutation affecting
pheromone arrest cell size and cell-cycle control in
S. cerevisiae.
George Scangos, Molecular Therapeutics, Inc., West Haven,
Connecticut: Dysmyelination in transgenic mice express-
ing the early region of JC virus.
Nancy Reich, Rockefeller Unviersity, New York, New York:
Transcriptional regulation of interferon-induced genes.
Joseph Schlessinger, Rorer Biotechnology, Inc., Rockville,
Maryland and Weizmann Institute, Rehovot, Israel: The
EGF receptor proto-oncogene: Structure, evolution, and
role in oncogenesis.
David Levin, University of California, San Francisco: The Kin
protein kinase genes of yeast.
Frans deBruijn, Max-Planck Institut, Cologne, Federal
Republic of Germany: Structure and regulation of
Leghemoglobin genes: Conserved cis-acting elements
and trans-acting factors.
Undergraduate Research
An important aspect of the summer program at the Laboratory is the participation
of college undergraduate students in active research projects under the super-
vision of full-time laboratory staff members. The program was initiated in 1959.
Since that year, 310 students have completed the course, and many have gone on
to creative careers in biological science.
The objectives of the program are to provide (1) a greater understanding of the
fundamental principles of biology, (2) an increased awareness of major problem
areas under investigation, (3) better understanding of the physical and intellectual
tools for modern research and the pertinence of this information to future training,
and (4) a personal acquaintance with research, research workers, and centers for
study.
The following students, selected from well over 100 applicants, took part in the
program, which was supported by Alfred P. Sloan Foundation, Burroughs
Wellcome Fund, Pfizer Inc., and Robertson Research Fund
Struan Coleman, Harvard University
Research Advisor: Daniel Marshak
Phosphorylation by casein kinase II.
Michelle Dziejman, University of Rochester
Research Advisor: William Welch
The mammalian heat shock response.
Malek Faham, University of Maryland
Research Advisor: Fevzi Daldal
Genetic analysis of the structure of the quinol oxidization site
of the cytochrome bc1 complex.
Lisa M. Gloss, Michigan State University
Research Advisor: Winship Herr
Transcriptional control in SV40.
Joshua Gordon, Washington University
Research Advisor: Loren Field
Construction of an albumin-ANF fusion gene.
Diane Harvey, Cornell University
Research Advisor: Eileen White
Expression of the adenovirus E1B gene products.
Adam Kap lin, Yale University
Research Advisor: David Spector
Preliminary investigations into the functional significance of
the Sm antigen distribution pattern in situ.
Elena Levine, Yale University
Research Advisors: Terri Grodzicker, and Margaret
Quinlan
The effect of adenovirus E1A on the SV40 enhancer in CV-1
cells.
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Rong Li, Yale University
Research Advisor: David Frendewey
Pre-mRNA splicing in S. pombe.
John M. Logsdon, Jr., Iowa State University
Research Advisor: Steve Briggs
Gene expression in response to a fungal toxin in maize.
Tobe Mel !man, Cornell University
Research Advisor: David Beach
Isolating suppressors of a cdc13 mutation in S. pombe.
Andrew Millar, University of Cambridge
Research Advisor: Bruce Stillman
In vitro mutagenesis of the ARS1 replication element of
yeast.
Alice Paquette, Massachusetts Institute of Technology
Research Advisor: Mike Gilman
Investigation of c-fos regulation.
Pam Reinagal, Carnegie Mellon University
Research Advisor Nouria Hernandez
Small nuclear RNA U1 3' end formation
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Barbara A. Sampson, Princeton University
Research Advisor: Amar Klar
Mating type switching in S. pombe.
Elizabeth Sowell, College of Charleston
Research Advisor: VenKatesan Sundaresan
Mapping of the Mu transposon in the bronze Gene.
Fiona Stewart, University of Glasgow
Research Advisor: Betty Moran
Characterization of conserved regions of adenovirus E1A
gene.
Jonathan Tropp, Harvard College
Research Advisor: James Pflugrath
Purification of yeast Ras2.
Johannes Walter, University of California, Berkeley
Research Advisor: John Anderson
DNA-protein interactions at the molecular level.
DNA Literacy Program
David A. Mick los, Director
Mark V. Bloom, Assistant Director
The techniques of "gene splicing" have revolutionized biology over the last 15 years
and have spawned the new biotechnology industry. The manifold economic and
social implications of the increasing ability to manipulate the DNA blueprint of life
appear regularly on the front pages of the nations newspapers. Even so, there is
abundant evidence that we are a nation of biotechnological illiterates. Recent
studies show that a majority of Americans have little understanding of DNA and
claim not to have heard of biotechnology!
The DNA Literacy Program was founded in 1985 to improve this situation by
retraining science teachers nationwide so that they can better prepare students for
the biotechnological world they will inherit. We see our mission as threefold:
1. To serve as a direct interface between science and society by translating
current research into learning experiences for the general public.
2. To directly adapt research protocols so that they can be safely performed by
students at the college and advanced high school levels.
3. To serve as a national clearinghouse for distribution of information about
genetics and biotechnology to the general public.
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A Japanese exchange stu-
dent (left) and his lab part-
ner from East Hampton
High School participate in a
student laboratory on bac-
terial transformation at the
DNA Learning Center
DNA Literacy Program
Director David Mick los (left),
summer intern Jeff Dia-
mond, and Dr. Greg Freyer
of Columbia University Col-
lege of Physicians & Sur-
geons with the Vector Mo-
bile DNA Laboratories in
front of Jones Laboratory.
DNA Science Workshops
The most visible aspect of our education program has been the Vector DNA
Science Workshop, which has now been taken by more than 600 high school and
college educators from New York to California, and from Wisconsin to Alabama.
The week-long course gives teachers practical experience with recombinant-DNA
techniques, bolstering confidence to integrate more discussion of biotechnology
into their classrooms and addressing the practical aspects of implementing DNA
labs. All equipment and supplies needed to teach the course are carried in a
specially designed Vector Van, which was provided through a 1986 grant from
Citibank, N.A. In summers 1985 and 1986, a total of 250 educators attended eight
workshops. Demand for courses in summer 1987 was great enough to justify the
purchase of a second Vector Van that enables us to teach two workshops
simultaneously in different parts of the country. In summer 1987, 370 educators
attended 14 Vector Workshops around the country. Two additional workshops were
conducted for technicians and researchers at the Cleveland Clinic. In summer
1988, the Vector Vans will visit 12 new venues, including a Navajo Indian reserva-
tion at Tuba City, Arizona.
Major Three-Year Support
Receipt in 1987 of major three-year grants from the Josiah Macy, Jr. Foundation
($490,850) and the National Science Foundation ($451,928) has lent legitimacy to
the proposition that it is possible to "backpack" a DNA laboratory to essentially
anywhere in the nation. These grants provide key support for our teaching staff, as
well as stipend and travel expenses for workshop participants. They also provide
funds to hold weekend follow-ups during the fall and winter to introduce new
innovations that make it easier and more cost-effective to teach biotechnology in
the high school classroom. More than 225 teachers attended the 12 follow-up
workshops, and the response of participants was overwhelmingly favorable.
Participants who successfully complete both a summer workshop and a
weekend follow-up receive an intense 50 hours of instruction. Through a collabora-
tion with the State University of New York at Stony Brook, these individuals are
eligible to receive three hours of graduate credit from the Continuing Education
Department.
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Collaboration with Carolina Biological Supply Company
As our teaching program grew and teachers in many areas began to adopt our
laboratory methods, it became clear that we needed to identify a company with
the capability to distribute equipment and reagents to teachers who wished to
implement lab-teaching programs. Thus, in late 1986, we signed a cooperative
agreement with Carolina Biological Supply Company, one of the nation's oldest
and most respected science suppliers. In 1987, we collaborated with their biotech-
nology department to develop reagents and kits that articulate fully with our
laboratory text, DNA Science: A First Laboratory Course in Recombinant-DNA
Technology. We also assisted in the design and evaluation of an inexpensive
power supply and an electrophoresis chamber. These apparatuses, which are
used to produce DNA "fingerprints," are key to introducing DNA science in the
classroom.
DNA Learning Center
The Macy and NSF support, along with continuing grants from a consortium of
private foundations and biotechnology companies, emboldened us to put into
action our dreams for a "museum" devoted entirely to helping the general public
understand the DNA blueprint that determines the life and health of all living
things. Thus, we concluded negotiations with the Cold Spring Harbor Central
School District for the long-term lease, with purchase option, of the former grade
school building at 334 Main Street in Cold Spring Harbor Village.
Considering the magnitude of the Laboratory's commitment, a trustee advisory
committee was formed to assume fiduciary responsibility for the Learning Center.
Chaired by William Everdell, the committee includes Mrs. Henry U. Harris, Jr,
Mrs. George N. Lindsay, Dr. David Botstein, Dr. David D. Sabatini, Byam K.
Stevens, Jr, and Mrs. George G. Montgomery, Jr.
The trustees of the Laboratory showed strong support for the Center by
approving a capital budget of $158,000 for Phase I renovations. Offices were
prepared for a permanent staff of four, and computer, telephone, and fire/security
systems were installed. We are most pleased with the teaching laboratory, which
we consider the heart of our institution. Designed to accommodate 24-27
participants, the laboratory provides an environment where young people and the
lay public can learn science in the same way as scientists, by asking questions
and performing experiments.
Dr. Mark Bloom instructs
high school students at the
DNA Learning Center.
Raymond Fleischmann
(right) from Walt Whitman
High School separates DNA
fragments using electropho-
resis at a week-long teacher
workshop at SUNY, Stony
Brook. Dr. Jan Witkowski
(below) of Cold Spring Har-
bor Laboratory explains the
use of gene probes in diag-
nosing muscular dystrophy
at an honors lecture for
local students.
Student Laboratory Field Trips
With the completion of the teaching laboratory, we initiated a schedule of six
hands-on laboratories per week for high school students from the Metropolitan
New York area. Two laboratory experiences introduce the key techniques of gene
manipulation:
1. Bacterial Transformation. This experiment illustrates the direct link between an
organism's genetic complement (genotype) and its observable characteristics
(phenotype). Students introduce a new gene into the bacterium Escherichia
coli, giving it the ability to grow in the presence of the antibiotic ampicillin.
2. DNA Fingerprinting. This experiment demonstrates that DNA can be precisely
manipulated and that it behaves as predicted by the structure determined by
James Watson and Francis Crick in 1953. Students use restriction enzymes to
cut purified DNA, and the resulting DNA fragments are analyzed by gel
electrophoresis. Students take home Polaroid snapshots of their results.
Response to this new program has been overwhelming. Within three weeks
following the announcement of the opening of the teaching lab, our entire spring
schedule was booked with 50 class visits.
Local Curriculum Study Grows
The DNA Literacy Program arose out of an initial collaboration with science
educators in eight neighboring school districts. Using Long Island schools as a
proving ground, we developed and tested our lab-teaching programs and
workshop methods. The program has now grown to include 20 school districts,
which benefit from enhancement activities that include teacher in-service training,
honors lectures for students, student research symposia, free and reduced-rate
student visits to the Learning Center, and lab-teaching consultation.
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The Search for Life Exhibit
During the past year, the Laboratory cooperated with The National Museum of
American History of the Smithsonian Institution and the Maryland Agricultural
Experiment Station in the development of their new exhibit, The Search for Life,
by supplying historical artifacts, photographs, and video footage. The largest and
most up-to-date museum exhibit on modern biology in the United States, The
Search for Life traces the quest to understand the genetic and molecular basis of
life, which culminated in the recombinant-DNA revolution. The exhibit also
confronts the visitor with the promise and the controversy of our increasing ability
to manipulate the genetic code. Key discoveries of four Cold Spring Harbor staff
members are specifically highlighted.
We were thus delighted when, in early 1988, we concluded an agreement to
have the DNA Learning Center as the first site of a national tour of the exhibit. The
Search for Life will open at Cold Spring Harbor in September 1988 and run
through September 1989. The Smithsonian exhibit represents a rare opportunity to
accelerate the development of the DNA Learning Center, allowing it to burst into
existence with a powerful education program. The prospect of learning the
museum business from the nation's preeminent museum is most exciting.
The 2500-square-foot exhibit was developed in collaboration with New York City
theater designers, who utilized historical artifacts, video monitors, interactive
displays, and a three-screen slide show within a futuristic "set" composed of
aluminum girders whose latticework suggests the DNA helix. The entire program,
including narration and theatrical lighting used to guide the visitor through the
exhibit, is computer-controlled.
The exhibit will be situated adjacent to the teaching laboratory, where visitors
can perform hands-on experiments or view daily demonstrations. Since Smith-
sonian curators had originally hoped to include live demonstrations in the exhibit,
the Learning Center staff has agreed to train subsequent exhibit hosts in appropri-
ate hands-on lab activities. In addition, our staff has committed to develop
educational materials to expand and interpret the information in The Search for
Life exhibit. Pre- and post-trip packages and interpretive materials will be shared
with subsequent exhibit hosts.
The exhibit will be seen by a significant number of research biologists who
attend meetings and workshops at Cold Spring Harbor Laboratory. Their
suggestions and help will be incorporated into a renovation of the exhibit prior to
its shipment to subsequent tour sites. Input from visiting scientists will also be of
help in developing our own exhibit, DNA at Work, to follow on the heels of the
Smithsonian exhibit.
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The Smithsonian Institution's
Search for Life exhibit high-
lights the accomplishments
of four Cold Spring Harbor
scientists, including Labora-
tory Director James D. Wat-
son (far left) and Dr Barbara
McClintock (below).
The DNA Literacy Program
staff (from the left) Henri
Dold, David Mick los, Nancy
Baldwin, Mark Bloom, Cort-
ney Armstrong, and John
Kruper; (below) summer in-
tern Jeff Mondshein.
Staff Members and Interns
We were most lucky to coax Dr. Mark Bloom to take on responsibility for the lab-
training aspects of the DNA Literacy Program. With graduate training in biology
and experience as a research molecular biologist at the Roche Institute and
Michigian State University, he provides authority to our advice to teachers and
insurance that our programs will continue to focus on real science. Joining us in
June, he was thrown into the fray of summer activity, teaching 8 of 14 workshops.
Dr. Greg Freyer, who helped found the program and who worked on develop-
ment of our protocols while a postdoctoral fellow at Cold Spring Harbor
Laboratory, is currently an assistant professor at Columbia University College of
Physicians and Surgeons. Greg continues to provide research support to our
program and has just completed development of plasmid vectors used in our
workshop program. To our knowledge, these are the first DNA molecules specifi-
cally developed for teaching purposes.
Our summer interns, who lead the life of DNA gypsies traveling trom worksnop
to workshop, continued to provide critical support for our teaching staff. Two were
students from the neighboring high schools of Jericho and Sachem: Jeff
Mondschein, now in his first year of pre-medical training at New York University,
completed his second summer with the program, and Thomas Hyland, now a
freshman at Rensselaer Polytechnic Institute. Undergraduate intern Jeff Diamond
is now completing his junior year in biomedical engineering at Duke University.
Since we consider ourselves an academic unit, we were especially pleased to
take on graduate student John Kruper, now working on a D.A. in molecular
biology at the University of Illinois at Chicago. With previous training in virology,
John is basing his thesis on evaluative data on teachers who have participated in
our training workshops. During the winter, one Vector Van was stationed in
Chicago with John, who taught four weekend follow-ups in the midwest.
Joining the permanent staff of the Learning Center in 1988, from other
positions at the Laboratory, were Nancy Baldwin and Cortney Armstrong. Program
Associate Henri Dold, who was among the first teachers in the nation to introduce
DNA analysis at the high school level, assumed major responsibility for organizing
our summer 1988 schedule of 12 Vector Workshops.
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Recalling our Heritage as a Teaching Center
The DNA Literacy Program recalls the founding of the Biological Laboratory at
Cold Spring Harbor in 1890 as a summer field station where high school teachers
could experience experimental aspects of biology that could not be learned from
a textbook. With the opening of the DNA Learning Center, we are now well into
the lead of DNA education, but there are few road maps to follow.
As keepers of the nation's first exploratorium of DNA, we are sometimes
daunted by the operating costs of our rapidly expanding programs-approximately
$50,000 per month, including capital development of the Center. Facing similar
needs when he assumed directorship of the Laboratory in 1968, Jim Watson said,
"The Lab badly needs a real benefactor, but with much love it will probably
survive without one. Of course, I dream an angel will appear soon and make me
free of any serious worries for at least a month"
There is no time to tarry in working toward our goal to foster public understand-
ing of the DNA revolution. As a small institution, we are prepared to accept a
disproportionate share of the cost of educating the first generation of Americans
who already dwell in a brave new world. It is a huge task, but the stakes of
biotechnological illiteracy are too high.
Vector Workshop Sites, 1985-88
Alabama
Arizona
California
Connecticut
Illinois
Indiana
Iowa
Kentucky
Maryland
Massachusetts
New Hampshire
New York
North Carolina
Ohio
Pennsylvania
South Carolina
Virginia
Wisconsin
University of Alabama, Tuscaloosa
Tuba City High School, Tuba City
University of California, Davis
Choate Rosemary Hall, Wallingford
Argonne National Laboratory, Argonne
Butler University, Indianapolis
Drake University, Des Moines
Murray State University, Murray
McDonough School, Baltimore
Beverly High School, Beverly
Randolph High School, Boston
Winsor School, Boston
St. Paul's School, Concord
Albany High School, Albany
Bronx High School of Science, The Bronx
Cold Spring Harbor High School, Cold Spring Harbor
DNA Learning Center, Cold Spring Harbor
Huntington High School, Huntington
Irvington High School, Irvington
S.U.N.Y., Stony Brook
Wheatley School, Old Westbury
North Carolina School of Science and Math, Durham
Cleveland Clinic, Cleveland
Dusquesne University, Pittsburgh
Germantown Academy, Philadelphia
Medical University of South Carolina, Charleston
University of South Carolina, Columbia
Jefferson High School for Science, Alexandria
Marquette University, Milwaukee
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Graduate intern John Kruper
(left) interprets a DNA finger-
print for teachers at a local
Curriculum Study workshop
at Cold Spring Harbor High
School.
1987, 1988
1988
1986
1987
1986, 1987
1987
1987
1988
1988
1986
1988
1987
1986, 1987
1987
1987
1985, 1987
1988
1986
1986
1987, 1988
1985
1987
1987
1988
1988
1988
1988
1987
1986, 1987
Teachers at a week-long
workshop at SUNY, Stony
Brook prepare a reaction to
cut DNA with restriction
enzymes.
Dr. Greg Freyer (left) with
workshop participants at
the Bronx High School
of Science.
Curriculum Study Membership
*Cold Spring Harbor Central School District
Commack Union Free School District
*East Williston Union Free School District
*Great Neck Public Schools
Half Hollow Hills Central School District
Harborfields Central School District
*Herricks Union Free School District
Huntington Union Free School District
*Jericho Union Free School District
Lawrence Public Schools
Locust Valley Central School District
Manhasset Public Schools
*Northport-East Northport Union Free School District
North Shore Central School District
*Oyster Bay-East Norwich Central School District
Plainview-Old Bethpage Central School District
Port ledge School
Port Washington Union Free School District
Sachem Central School District at Holbrook
*Syosset Central School District
*Founding Member
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Nature Study Program
The Nature Study Program gives elementary and secondary school students the
opportunity to acquire a greater knowledge and understanding of their environ-
ment. Through a series of specialized field courses, students can engage in such
introductory programs as Nature Detectives, Seashore Life, and Pebble Pups, as
well as more advanced programs such as Marine Biology and Nature
Photography.
During the summer of 1987 a total of 490 students participated in the Nature
Study Program. Most classes were held outdoors, when weather permitted, or at
the Uplands Farm Nature Preserve, the headquarters of the Long Island Chapter
of the Nature Conservancy. The Laboratory has equipped and maintains
classrooms/laboratories as well as a darkroom at Uplands Farm. This facility is
used as a base for the student's exploration of the local environment. Field classes
are held on Laboratory grounds, St. John's Preserve, Fire Island National
Seashore, Caumsett State Park, the Cold Spring Harbor Fish Hatchery, and the
Muttontown Preserve, as well as other local preserves and sanctuaries. Students in
Marine Biology participated in a whale watch aboard the Finback II, operated by
the Okeanos Ocean Research Foundation Inc. Hampton Bays, New York.
In addition to the four-week courses, a series of one-day marine biology
workshops was offered to students. Studies on the marine ecology of L.I. Sound
were conducted aboard the 66 foot Ketch J.N. Carter chartered from Schooner
Inc. of New Haven, Connecticut. Students were able to study the Sound
chemically, physically, and biologically using the ship's instrumentation. The three-
day Adventure Education class took students on an 18 mile bike hike to Caumsett
State Park, a 12-mile canoe trip on the Nissequogue River, and a day of sailing on
the Ketch J.N. Carter.
PROGRAM DIRECTOR
William M. Payoski, M.A., Adjunct Professor,
Nassau Community College
INSTRUCTORS
Ruth Burgess, B.A., teacher, Cold Spring Harbor Nurse
Terry Crowley, B.A., science teacher candidate, Longwood School District
Steven Lander, M.S., science teacher, Port Washington School District
Fred Maasch, M.S., science teacher, Islip High School
Linda Payoski, B.A., science teacher, Uniondale High School
Marjorie Pizza, B.A., science teacher, Glen Cove School District
COURSES
Nature Bugs
Nature Detectives
Advanced Nature Study
Introduction to Ecology
Frogs, Flippers, and Fins
Pebble Pups
Bird Study
Fresh Water Life
Seashore Life
Marine Biology
Nature Photography
Adventure Education
Marine Biology Workshops
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FINANCIAL STATEMENT
CONSOLIDATED BALANCE SHEET
year ended December 31, 1987
with comparative figures for year ended December 31, 1986
ASSETS
1987 1986
Cash and Cash Equivalents:
Unrestricted Funds $2,010,250 $1,882,075
Precollections of Restricted Grants $400,217 $1,574,992
Restricted for Neuroscience Center Project $3,333,394 $0
Restricted for Loan Interest and Principal Payments $6,885,065 $8,263,233
Total Cash and Cash Equivalents $12,628,926 $11,720,300
Investments and Marketable Securities-Restricted
for Capital Projects $179,000 $98,750
Accounts Receivable and Other Assets $921,522 $1,104,065
Grants Receivable $6,568,125 $3,651,596
Inventory of Publications $425,832 $309,058
Endowment Funds-(at lower of Cost or Market Value)
Robertson Research Fund (quoted Market
1987-$25,522,567; 1986-$25,757,275) $24,103,554 $21,603,638
Robertson Maintenance Fund (quoted Market
1987-$4,148,900; 1986-$4,163,713) $3,939,978 $3,526,426
Other Endowment Funds (quoted Market
1987-$1,937,311; 1986-51,615,309) $1,937,311 $332,042
Total Endowment Funds $29,980,843 $25,462,106
Land, Buildings and Equipment, net of
accumulated Depreciation $21,810,816 $20,038,249
Total Assets $72,515,064 $62,384,124
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LIABILITIES AND FUND BALANCES
1987 1986
Accounts Payable and Accrued Expenses $1,884,836 $1,028,268
Deferred Income $312,553 $228,211
Loan Payable ($2,500,000 due 8/1/88,
$4,000,000 due 8/1/89) $6,500,000 $8,000,000
Unexpended Portion of Restricted Grants $6,558,028 $5,036,887
Fund Balances:
Unrestricted Funds $4,415,391 $4,376,243
Endowment Funds $29,959,234 $25,422,968
Land, Building and Equipment Funds $22,885,022 $18,291,547
Total Fund Balances $57,259,647 $48,090,758
Total Liabilities and Fund Balances $72,515,064 $62,384,124
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CONSOLIDATED STATEMENT OF OPERATING REVENUES AND EXPENSES
year ended December 31, 1987
with comparative figures for year ended December 31, 1986
1987 1986
REVENUES
Restricted Grant Income $ 9,566,026 $ 9,111,010
Indirect Cost Allowances 4,544,846 4,491,480
Contributions & Gifts
Annual Giving 294,108 323,591
Corporate Sponsors 435,000 300,000
Endowment Funds Distributions 995,500 770,000
Royalty & Licensing Fees 41,297 72,334
Summer Programs Fees 793,476 721,951
Marina Rental Income 65,769 63,423
Carnegie Institute of Washington Rental Income 20,732 20,732
Publications 1,646,913 1,499,228
Dining Hall 990,389 855,510
Housing Rentals (Net) 420,387 426,104
Investment Income 340,967 280,187
Miscellaneous 40,062 19,716
Total Revenues 20,195,472 18,955,266
EXPENSES
Research, Conferences & Educational Programs 10,437,633 9,845,407
Direct Research Overhead 504,153 359,542
Summer Programs Administration 420,930 320,292
Nature Study 27,032 24,202
Publications 1,449,178 1,193,741
Library Services 287,905 285,024
Operation & Maintenance of Plant 2,945,532 2,602,993
General & Administrative 2,184,763 2,135,621
Information Services 221,367 142,478
Dining Hall 1,034,927 919,497
Total Expenses, Before Depreciation 19,513,420 17,828,797
Excess, Before Depreciation 682,052 1,126,469
Depreciation Expense 1,126,349 1,093,084
Net Excess (Deficit) of Revenues over Expenses $ (444,297) $ 33,385
NOTE: Copies of our complete, audited financial statements, certified by the independent auditing firm
of Peat, Marwick, Main & Co., are available upon request from the Comptroller, Cold Spring Harbor
Laboratory.
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COLD SPRING HARBOR LABORATORY
SOURCES OF REVENUE
YEAR ENDED DECEMBER 31, 1987
Endowments Auxiliary Activities3.9% 14.7%
Foundation Grants
22.8%
Interest and
Private Contributions
3.9%
Corporate Contributions
Miscellaneous 1.1% and Grants 6.7%
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GRANTS AND
*NTRI

FINANCIAL SUPPORT OF THE LABORATORY
Cold Spring Harbor Laboratory is a nonprofit research and educational institution
chartered by the University of the State of New York. Contributions are tax exempt
under the provisions of Section 501(c)(3) of the Internal Revenue Code. In addition,
the Laboratory has been designated a "public charity" and, therefore, may receive
funds resulting from the termination of "private" foundations.
Because its endowment is limited and the uses of research grants are formally
restricted, the Laboratory depends on generous contributions from private
foundations, sponsors, and friends for central institutional needs and capital
improvements.
Over the years, the Laboratory has won a reputation for innovative research
and high-level science education. By training young scientists in the latest
experimental techniques, it has helped spur the development of many research
fields, including tumor virology, cancer genes, gene regulation, moveable genetic
elements, yeast genetics, and molecular neurobiology. However, the continued
development of new research programs and training courses requires substantial
support from private sources.
METHODS OF CONTRIBUTING TO COLD SPRING HARBOR LABORATORY
Gifts of money can be made directly to Cold Spring Harbor Laboratory.
Securities You can generally deduct the full amount of the gift on your income tax return,
and, of course, you need pay no capital gains tax on the stock's appreciation.
We recommend any of the following methods:
(1) Have your broker sell the stock and remit the proceeds to Cold Spring Harbor
Laboratory.
(2) Deliver the stock certificates to your broker with instructions to him to open an account
for Cold Spring Harbor Laboratory and hold the securities in that account pending
instructions from Cold Spring Harbor Laboratory.
(3) Send the unendorsed stock certificates directly to the Laboratory: Comptroller, Cold
Spring Harbor Laboratory, Cold Spring Harbor New York 11724. In a separate
envelope send an executed stock power.
Bequests Probably most wills need to be updated. Designating Cold Spring Harbor
Laboratory as beneficiary ensures that a bequest will be utilized as specified for continuing
good.
Appreciated real estate or personal property Sizable tax benefits can result from such
donations; the Laboratory can use some in its program and can sell others.
Life insurance and charitable remainder trusts can be structured to suit the donor's
specific desires as to extent, timing, and tax needs.
Conversion of private foundation to "public" status on termination This may be done
by creating a separate fund within Cold Spring Harbor Laboratory whereby the assets of
the private foundation are accounted for as a separate fund and used for the purposes
specified by the donor. Alternatively, the private foundation can be established as a
"supporting organization of Cold Spring Harbor Laboratory"
For additional information, please contact the Director of Development, Cold Spring Harbor
Laboratory, Box 100, Cold Spring Harbor, N.Y. 11724, or call 516-367-8455.
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GRANTS
January 1, 1987-December 31, 1987
COLD SPRING HARBOR LABORATORY
Grantor Program/Principal Investigator Duration of Grant Total Award
FEDERAL GRANTS
NATIONAL INSTITUTES OF HEALTH
Program Projects
Research Support
Cancer Research Center, Dr. Mathews
Cancer Center Support, Dr. Watson
Dr. Beach
Dr. Beach
Dr. Blose
Dr. Daldal
Dr. Feramisco
Dr. L. Field
Dr. Franza
Dr. Frendewey
1/87-12/91
7/87- 6/90
12/84-11/87
9/86- 8/89
12/78-11/87
3/87-11/87
4/85- 3/88
4/87- 3/92
9/85- 7/88
4/87- 3/92
$16,787,416*
5,346,907*
361,511
578,929
1,094,594
172,385"
535,534
568,521 *
478,689
775,814*
Dr. Garrels 1/85-12/89 2,028,833
Dr. Gilman 9/87- 8/92 608,291 *
Dr. Hanahan 8/87- 7/92 1,587,267*
Dr, Heitman 9/85- 8/88 572,760
Dr. Hernandez 7/87- 6/92 1,293,754*
Dr. Klar 7/81- 6/92 3,302,677
Dr. Rice 9/87- 8/90 528,037*
Dr. Roberts 6/87- 5/88 38,991 *
Dr. Roberts 9/86- 8/88 216,446
Dr. Spector 2/87- 2/88 165,000*
Dr. Stillman 7/83- 6/92 1,869,678
Dr. Watson 4/87- 3/88 117,413*
Dr. Welch 4/84- 3/92 1,575,365
Dr. Wig ler 7/85- 6/92 8,426,929
Dr. Zoller 9/85- 8/88 545,752
Fellowships Dr. Bar-Sagi 9/85- 8/87 47,000
Dr. Cheley 10/86- 3/88 37,494
Dr. J. Field 10/86- 9/89 63,996
Dr. McLeod 2/85- 1/88 63,996
Dr. Morris 11/86-10/89 82,008
Dr. Munroe 10/87- 4/88 28,000*
Dr. Potashkin 10/85- 9/88 64,886
Dr. Quinlan 6/84- 5/87 57,244
Training Institutional, Dr. Grodzicker 7/78- 8/89 1,291,646
Course Support Advanced Bacterial Genetics, Dr. Klar 5/80- 4/88 302,523
Cancer Research Center Workshops,
Dr. Grodzicker 1/83- 3/92 1,010,057
Neurobiology Short Term Training, Dr. Hockfield 5/82- 4/90 723,939
Neurobiology Short Term Training, Dr. Hockfield 6/79- 3/89 922,087
New grants awarded in 1987
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Grantor Program/Principal Investigator Duration of Grant Total Award
Meeting Support C. elegans 1987 & 1989 61,874*
Eukaryotic DNA Replication 1987 4,600*
Hepatitis B 1987 4,500*
Regulation of Liver Gene Expression 1987 16,000*
Molecular Biology of Mitochondria and
Chloroplasts 1987 8,000*
RNA Processing 1986-1987 3,500
52nd Symposium: Evolution of Catalytic
Function 1987 26,202*
NATIONAL SCIENCE FOUNDATION
Research Support Dr. Hiatt 4/87- 6/87 20,000*
Dr. Klar 8/86- 7/89 330,000
Dr. Marshak 7/87-12/90 190,000*
Dr. Roberts 1/83- 5/90 640,000
Dr. Roberts 2/87- 1/89 359,262*
Dr. Roberts 8/87- 1/90 20,925*
Dr. Spector 3/87- 2/89 95,000*
Dr. Sundaresan 5/87-10/90 270,000*
Course Support Plant Molecular Biology, Dr. Klar 8/86- 1/90 137,490
Meeting Support C. elegans 1987-1989 17,819*
Eukaryotic DNA Replication 1987 2,500*
Hepatitis B 1987 3,000*
Molecular Biology of Mitochondria and
Chloroplasts 1987 8,000*
RNA Processing 1986-1987 12,400
52nd Symposium: Evolution of
Catalytic Function 1987 3,000*
Undergraduate Research Program, Dr. Herr 6/87-11/88 32,000*
DEPARTMENT OF AGRICULTURE
Research Support Dr. Hiatt 8/86- 6/87 53,347
Meeting Support Molecular Biology of Mitochondria and
Chloroplasts 1987 12,000*
DEPARTMENT OF ENERGY
Meeting Support 52nd Symposium: Evolution of
Catalytic Function 1987 9,000*
Molecular Biology of Mitochondria and
Chloroplasts 1987 3,000*
NONFEDERAL GRANTS
Research Support
A.B.C. Foundation Dr. Wig ler 5/82- 4/87 600,000
* New grants awarded in 1987
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Grantor Program/Principal Investigator Duration of Grant Total Award
American Cancer Society Dr. Hanahan 7/87- 6/89 160,000*
Dr. Spector 7/87- 6/89 162,000*
Drs. Stillman, Gluzman, Welch-Institute Award 7/82- 6/88 220,000
Dr. Wigler 4/87- 3/88 10,000*
Dr. Wigler, Professorship 1986-2012 1,333,333
American Foundation for
AIDS Research Dr Franza 12/87-11/88 60,000*
Amersham International plc Dr Welch 10/85- 9/87 50,000
Dr Harlow 11/86-10/87 148,780
Anonymous Dr Mathews 1987 10,000*
Cancer Research Institute Dr Franza 4/86- 3/87 25,000
Diabetes Research & Education
Foundation Dr. Hanahan 5/86- 4/87 19,960
Fannie E. Rippe) Foundation Dr. Watson 3/87-12/88 125,000"
Juvenile Diabetes Foundation Dr. Hanahan 9/86- 9/88 66,000
LIBA Dr. Hernandez 7/87- 6/88 20,000*
LIBA Dr. Spector 4/87- 3/88 27,000*
Muscular Dystrophy Association Dr. Feramisco 1/87-12/88 83,742*
Dr. Heitman 7/86- 6/89 94,500
Dr. Mathews 1/87-12/89 100,718*
Monsanto Company Cooperative Research 10/84- 9/90 2,089,200
Pfizer, Inc. Dr. Wigler 1985-1990 500,000
Pioneer Hi-Bred International, Inc. Cooperative Research 8/85- 4/91 2,500,000
Rita Allen Foundation Dr. Herr 9/85- 8/90 150,000
Dr. Stillman 1/83-12/87 150,000
Scripps Clinic Dr. Hanahan (subcontract) 1/86- 3/88 377,029
Fellowships
Albert Heritage Foundation
for Medical Research Dr. Mizzen 7/86- 6/87 19,730
American Heart Association Dr. Lamb 7/87-11/87 6,750*
Bristol-Myers Company Fellowship Support 6/86- 5/91 500,000
Cancer Research Institute Dr. Cone 10/85- 9/87 48,000
Dr. Young 8/85- 8/87 46,000
Dr. Sturm 9/86- 8/88 51,000
Dr. Efrat 9/86- 8/88 51,000
Damon Runyon-Walter Winchell
Cancer Fund Dr. Michaeli 3/87- 2/90 69,000*
Esther and Joseph A. Klingenstein
Fund, Inc. Dr. Marshak 7/87- 6/90 100,000*
J.N. Pew, Jr. Charitable Trust Dr. Watson 4/87- 4/90 260,000*
Juvenile Diabetes Foundation
International Dr. Grant 7/87- 6/88 25,000*
LIBA Four Fellowships 1987 100,000"
Life Science Research Foundation Dr. Colicelli 9/86- 8/89 105,000
Medical Research Council
of Canada Dr. Mizzen 6/87- 5/88 38,052*
NYS Health Research Council Dr. Bautch 9/86- 8/88 39,000
Oncogene Science Fellowship Dr. Watson 1987 12,500"
Fund
Training
Alfred P. Sloan Foundation Undergraduate Research Program 1985-1988 74,000
Burroughs Wellcome Fund Undergraduate Research Program 1987 16,560*
Grass Foundation Neurobiology Scholarship Support 1980-1987 126,670
Lucille P. Markey Charitable Trust Scholarship Support 1985-1988 150,000
Robert H.P. Olney Memorial Fund Undergraduate Research Program 1987 3,854*
New grants awarded in 1987
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Grantor Program/Principal Investigator Duration of Grant Total Award
Pfizer, Inc.
Samuel Freeman Charitable Trust
Course Support
Alfred P. Sloan Foundation
The Esther A. and Joseph
Klingenstein Fund
Meeting Support
American Hoechst Corp.
Amoco Corporation
Anheuser Busch Co.
Beckman Instruments
Bethesda Research Laboratories
Bio-Rad, Chemical Division
Ciba-Geigy Corp.
Codon
DelMonte, Inc.
E.I. du Pont de Nemours,
& Company
Gist Brocades
Haake Buchler Instruments, Inc.
ICN Biomedicals
Labatts Brewing Co.
Lucille P. Markey Charitable Trust
March of Dimes Birth Defects
Foundation
Merck & Co., Inc.
Miller Brewing Co.
Monsanto Company
Nestle S.A.
Phillips Petroleum
Pioneer Hi Bred International, Inc.
Promega Biotech
Rockefeller Foundation
Alfred P. Sloan Foundation
SmithKline Beckman Corporation
Stratagene Cloning System
Stroh Brewing Co.
University of Alabama,
Birmingham
Whatman Inc.
Zymo Genetics, Inc.
Zoecon Research Institute/
Sandoz Crop Protection Corp.
* New grants awarded in 1987
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Undergraduate Research Program
Undergraduate Research Program
Computational Neuroscience Course
Neurobiology Support
Regulation of Liver Gene Expression
Molecular Biology of Mitochondria and
Chloroplasts
Yeast Cell Biology
Regulation of Liver Gene Expression
Regulation of Liver Gene Expression
Regulation of Liver Gene Expression
Molecular Biology of Mitochondria and
Chloroplasts
Regulation of Liver Gene Expression
Molecular Biology of Mitochondria and
Chloroplasts
Molecular Biology of Mitochondria and
Chloroplasts
Yeast Cell Biology
Regulation of Liver Gene Expression
Translational Control
Yeast Cell Biology
52nd Symposium: Evolution of Catalytic
Function
Regulation of Liver Gene Expression
Regulation of Liver Gene Expression
Yeast Cell Biology
Molecular Biology of Mitochondria and
Chloroplasts
Regulation of Liver Gene Expression
Molecular Biology of Mitochondria and
Chloroplasts
Molecular Biology of Mitochondria and
Chloroplasts
Regulation of Liver Gene Expression
Vaccines
52nd Symposium: Evolution of Catalytic
Function
Molecular Biology of Mitochondria and
Chloroplasts
Regulation of Liver Gene Expression
Yeast Cell Biology
Regulation of Liver Gene Expression
Regulation of Liver Gene Expression
Yeast Cell Biology
Molecular Biology of Mitochondria and
Chloroplasts
1987 8,280*
1987 2,500*
1986-1989 140,000
1982-1988 300,000
1987 100*
1987 1,000*
1987 500*
1987 300*
1987 300*
1987 500*
1987 500*
1987 500*
1987 2,000*
1987 1,000*
1987 500*
1987 100*
1987 20,000*
1987 500*
1987 15,000*
1987 2,000*
1987 500*
1987 500*
1987 2,000*
1987 1,000*
1987 1,000*
1987 1,000*
1987 500*
1986-1988 45,000
1987 25,000*
1987 500*
1987 500*
1987 500*
1987 2,500*
1987 100*
1987 500*
1987 1,000*
Grantor Program/Principal Investigator Duration of Grant Total Award
DNA Literacy Program
GIBCO/BRL Research Products
division of Life Technologies
Inc. Core Program Support 1987 $10,000*
J.M. Foundation Core Program Support 1986-1987 60,000
Richard Lounsbery Foundation Core Program Support 1987 15,000*
Josiah Macy, Jr. Foundation Core Program Support 7/87- 6/90 490,850*
National Science Foundation Core Program Support 6/87-11/90 451,928*
Brinkmann Instruments, Inc. DNA Learning Center 1987 10,000*
Argonne National Laboratory Vector Workshop Program 1987 1,421 *
Center for Biotechnology,
SUNY Stony Brook Vector Workshop Program 1987 11,130*
Cleveland Clinic Foundation Vector Workshop Program 1987 16,784*
Fotodyne Incorporated Vector Workshop Program 1987 9,000*
Eli Lilly and Company Vector Workshop Program 1987 10,000*
Miller Brewing Company Vector Workshop Program 1987 1,000*
North Carolina Biotechnology
Center Vector Workshop Program 1987 500*
Pioneer Hi-Bred International, Inc. Vector Workshop Program 1987 9,038*
Cold Spring Harbor School
District Curriculum Study 1987 500*
Commack School District Curriculum Study 1987 1,500*
East Williston School District Curriculum Study 1987 500*
Great Neck School District Curriculum Study 1987 500*
Half Hollow Hills School District Curriculum Study 1987 3,000*
Harborfields School District Curriculum Study 1987 4,000*
Herricks School District Curriculum Study 1987 1,000*
Huntington School District Curriculum Study 1987 1,500*
Jericho School District Curriculum Study 1987 2,250"
Lawrence School District Curriculum Study 1987 1,500*
Locust Valley School District Curriculum Study 1987 2,000*
Manhasset School District Curriculum Study 1987 1,500*
Northport-East Northport
School District Curriculum Study 1987 500*
North Shore School District Curriculum Study 1987 1,500*
Oyster Bay-East Norwich
School District Curriculum Study 1987 500*
Plainview-Old Bethpage
School District Curriculum Study 1987 1,500*
Port ledge School Curriculum Study 1987 1,500*
Port Washington School District Curriculum Study 1987 1,500*
Sachem School District Curriculum Study 1987 1,500*
Syosset School District Curriculum Study 1987 500*
New grants awarded in 1987
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BANBURY CENTER
Grantor Program/Principal Investigator Duration of Grant Total Award
FEDERAL GRANTS
Meeting Support
Department of Energy Transposable Elements as Mutagenic Agents 1987 5,000"
Environmental Protection Agency Transposable Elements as Mutagenic Agents 1987 5,000*
Mammalian Cell Mutagenesis 1987 46,600*
Food and Drug Administration Approaches to Carcinogenesis 1987 40,000"
National Institutes of Health Transposable Elements as Mutagenic Agents 1987 10,000*
NONFEDERAL GRANTS
Meeting Support
ABI Biotechnology, Inc. Therapeutic Peptides and Proteins 1987 2,500*
Alfred P. Sloan Foundation Journalists and Congressional Workshops 1985-1987 162,000
American Industrial Health Council New Directions in the Qualitative and
Quantitative Aspects of Carcinogen
Risk Assessment 1987 10,000*
AMGEN Therapeutic Peptides and Proteins 1987 1,000*
Applied Biosystems Therapeutic Peptides and Proteins 1987 1,000*
Development Center for
Biotechnology, Republic of
China Therapeutic Peptides and Proteins 1987 2,500*
Dow Chemical New Directions in the Qualitative and
Quantitative Aspects of Carcinogen
Risk Assessment 1987.. 5,000*
International Commission for
Protection Against Environmental
Mutagens and Carcinogens Transposable Elements as Mutagenic Agents 1987 6,000*
James C. McDonnell Foundation Conference Support 1985-1987 300,000
Kabivitrum Therapeutic Peptides and Proteins 1987 2,000*
Molecular Devices Corp. Therapeutic Peptides and Proteins 1987 1,000*
Samuel Freeman Charitable Trust Stress Response in Biology and Disease 1987 30,000*
* New grants awarded in 1987
408
ENDOWMENTS AND GIFTS FOR FACILITIES
AND EQUIPMENT
ENDOWMENTS
Cold Spring Harbor Laboratory
Cold Spring Harbor Laboratory Unrestricted Endowment Fund
1987 Contributors: Anonymous
Dr. Bayard Clarkson
Mr. and Mrs. Miner D. Crary, Jr.
Mr. Robert L. Cummings
Mr. and Mrs. George W. Cutting, Jr.
Mr. and Mrs. Norris Darrell
Mr. William Everdell
Mr. David L. Luke III
Dr. David B. Pall
William and Maude Pritchard Charitable Trust
The Doubleday Professorship for Advanced Cancer Research
Robert H.P. Olney Memorial Fund
1987 Contributors: The Rev. Linda Peyton Hancock
Mr. Peter B. Olney, Jr.
Mrs. Pamela Peyton Post
Mrs. Robert W. Tilney, Jr.
Robertson Research Fund
Robertson Maintenance Fund
Posy White Memorial Fund
1987 Contributor: Mrs. George G. Montgomery, Jr.
Total Cold Spring Harbor
Long Island Biological Association (LIBA)
Dorcas Cummings Memorial Lecture Fund
1987 Contributor: Mr. Robert L. Cummings
Other Endowments
Total LIBA
Market Value"
$ 402,353
1,359,388
45,961
25,435,105
4,134,407
26,1731
$31,403,387
47,499
35,618
$83,117
FACILITIES AND EQUIPMENT
Arthur and Walter Page Laboratory of Plant Genetics
Charles E. Culpepper Foundation Construction 1985-1987 $ 75,000
Ira W. DeCamp Foundation Construction 1985-1987 200,000
Morgan Guaranty Trust Company of New York Construction 1987-1988 200,000t
National Science Foundation Construction 1983-1988 690,715
William and Maude Pritchard Charitable Trust Construction 1985-1987 220,000
Individual Contributors Construction 1987 50,471t
Neuroscience Education and Research Facility
Samuel S. Freeman Charitable Trust Construction 1987-1988 200,0001
Lita Annenberg Hazen Charitable Trust Construction 1987 25,0001
Howard Hughes Medical Institute Construction/ 1987-1990 5,000,000t.
Equipment
Esther A. and Joseph Klingenstein Fund, Inc. Construction 1987-1990 1,000,0001
James S. McDonnell Foundation Construction 1987 1,000,000
Individual Contributors Construction 1987 3,0471
X-ray Crystallography Laboratory
Lucille P. Markey Charitable Trust Equipment 1986-1988 863,500
* As of December 31, 1987
t New grants awarded in 1987
# Also see research and course support in the non-Federal grants listing
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ANNUAL GIVING PROGRAMS
Corporate Sponsor Program
Cold Spring Harbor Laboratory has become the "schoolhouse for modern biology:'
offering the most comprehensive series of biological conferences available
anywhere in the United States. Access to current research presented at these
high-level professional meetings is an important resource for the biotechnology
industry.
The annual $15,000 membership commitment from each Corporate Sponsor
has enabled the Laboratory to significantly expand this role as a clearinghouse for
biotechnical information. In 1987, more than 3,700 scientists from around the world
attended 26 conferences and 14 advanced training courses at Cold Spring Harbor
and Banbury Center.
As the meetings program has expanded, so too has the Laboratory's
commitment to create an atmosphere at Cold Spring Harbor that encourages
increased interaction between academic and industrial scientists. Since establish-
ment of the Corporate Sponsor program in 1984, corporate attendance has risen
73 percent, while overall attendance has increased 46 percent. Among those
attending 1987 meetings were 360 scientists representing more than 100
companies.
Proceeds from the Corporate Sponsor Program allowed initiation of an ongoing
series of Special Banbury Conferences that focus on emerging areas of research
especially germane to industrial biotechnology. These high-level meetings are the
basis for the Laboratory's popular book series Current Communications in
Molecular Biology. Topics of 1987 conferences were "Nuclear Oncogenes:' "Inositol
Lipids in Signalling:' "Molecular Biology and Genetic Engineering of Crops:'
"Molecular Genetics of Protozoa': and 'Antisense RNA:'
Benefits to Sponsor companies include waiver of all fees for six representatives
at Cold Spring Harbor meetings and Special Banbury Conferences; gratis Cold
Spring Harbor and Banbury publications, including the journal Genes & Develop-
ment; and recognition in meeting abstracts and publications.
Since 1984, more than 30 companies have participated in the Corporate
Sponsor Program. The membership renewal rate is 90 percent. 1987 members of
the Corporate Sponsor Program-world leaders in the application of biotechnology
to health care, agriculture, and manufacturing-were:
Abbott Laboratories
American Cyanamid Company
Amersham International plc
AMGen
Becton Dickinson and Company
Boehringer Mannheim GmbH
Bristol-Myers Company
Cetus Corporation
Ciba-Geigy Corporation
Diagnostic Products Corporation
E.I. du Pont de Nemours
& Company
Eastman Kodak Company
Genentech, Inc.
Genetics Institute
Hoffmann-La Roche Inc.
Johnson & Johnson
Eli Lilly and Company
Millipore Corporation
Monsanto Company
Oncogene Science, Inc.
Pall Corporation
Pfizer Inc.
The Procter & Gamble Company
Schering-Plough Corporation
Smith Kline & French Laboratories
Tambrands Inc.
The Upjohn Company
The Wellcome Research Laboratories,
Burroughs Wellcome Co.
Wyeth Laboratories
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Alumni Cabin Campaign
Since the first Symposium on Quantitative Biology in 1933, Cold Spring Harbor
has been a major site for discussion of serious science. Many scientists from
around the world who attend Cold Spring Harbor meetings each year remember
a time when the whole molecular biology community could be comfortably seated
in Vannevar Bush Hall. The spectacular growth of molecular biology research
worldwide is reflected in attendance at Cold Spring Harbor meetings. Over the last
five years, the number of meetings participants has increased 46 percent, to a
record 3,700 scientists in 1987.
The caliber of science discussed at Cold Spring Harbor has remained
consistently excellent, but facilities once considered rustic are now just plain
inadequate. Last year, as part of a major program to update visitor facilities prior
to the Laboratory's centennial year in 1990, meetings attendees, course instructors,
and former staff were asked to recall how their careers had benefited from the
Cold Spring Harbor experience by contributing to "Alumni Cabin" one of six four-
bedroom cabins planned to replace existing, dilapidated structures.
By the end of 1986, nearly 200 biologists from around the world had donated
almost $34,000. In late 1987, as ground was broken for construction of the cabins,
the fund for 'Alumni Cabin" had reached nearly $42,000. In response to a new
appeal in early 1988, Cold Spring Harbor alumni continue to make donations, and
it is hoped the goal of $100,000 can be reached by the time the cabins come into
service later in 1988.
Donations were received prior to December 31, 1987, from:
Dr. Judy Abraham Gesellschaft zur FOrderung der Dr. Ronald McKay
Dr. and Mrs. Sankar Adhya molekularbiologischen Dr. Daniel Nathans
Dr. Bruce N. Ames Forschung in Heidelberg e.V. Dr. Mary Osborn
Dr. Carl Anderson Dr. Philip Harriman Dr. Barry Polisky
Anonymous Dr James Hicks Dr. Keith R. Porter
Dr. E.G. Bade Dr Bernhard Hirt Dr. Jeffrey W. Roberts
Dr. Jonathan Beckwith Dr. Mahlon Hoagland Dr. Keith Roberts
Dr. and Mrs. Seymour Benzer Dr. P.H. Hofschneider Dr. Gerald M. Rubin
Dr Robert M. Blumentahl Dr. H. Robert Horvitz Dr. Earl Ruley
Dr Herbert Boyer Dr. Judith Jaehning Dr. A.J. Shatkin
Dr Fred Brown Dr. Rudolf Jaenisch Dr. David Stacy
Dr Janet S. Butel Dr. Tohru Kataoka Dr. and Mrs. A.R. Srinivasan
Ms. Edith Calzolari Dr. Yuriko Kataoka Dr Rolf Sternglanz
Dr. John M. Coffin Dr. Yoshiki Katoh Dr. Elizabeth J. Taparowsky
Dr. Donald M. Crothers Dr. Daniel E. Koshland Dr A.J. Van der Eb
Ms. Katya Davey Dr. Charles Laird Dr. Volker M. Vogt
Dr. Norman Davidson Dr. Michael J. Lenardo Dr. James D. Watson
Dr. Henry Drexler Dr. Andrew Lewis Dr. Klaus Weber
Dr. Harrison Echols Dr. David M. Livingston Dr. Robin A. Weiss
Dr. Robert Eisenman Dr. Elisabeth Ljungquist Dr. James F. Williams
Dr. Ellen Fanning Dr. John Mapoles Dr. Moshe Yaniv
Dr C.R. Fuerst Dr. Kenichi Matsubara Dr. Sayeeda Zain
Dr. William M. Gelbart Dr. Shigeko Matsumura
Dr. GOnter Gerisch Dr. William McClure
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Individual Contributions and Memorial Gifts
American Institute of Architects,
Long Island Chapter
Mrs. Donald Arthur
Miss Christine Bartels
Dr. and Mrs. Paul Berg
Dr. Jonathan M. Borkum
Dr. Thomas Broker
Mr. G. Morgan Browne, Jr
Dr. C. Thomas Caskey
Dr. Louise Chow
Mr. and Mrs. John P Cleary
Mr. and Mrs. Miner D. Crary, Jr
Mr and Mrs. Henry B. Cross
Mr. and Mrs. George W. Cutting, Jr.
Dr. and Mrs. F.E. Donoghue
Mr and Mrs. James Eisenman
Elsevier Science Publishers
Elsevier Science Publishing Co., Inc.
Mr. Alan Fortunoff
Dr Don Ganem
Ms. Helena Gaviola
GEICO
Dr. and Mrs. Martin Gellert
Dr. and Mrs. H. Bentley Glass
Dr. and Mrs. Richard L. Golden
Mr. Oliver P Grace
Miss Maxine Harrison
Dr. Stanley Hattman
Dr and Mrs. Alfred D. Hershey
Dr. Ira Herskowitz
Mrs. Elsie Herzog
Dr. Bernhard Hirt
Mrs. Warren C. Hutchins
Mr and Mrs. Reginald L. Jones
Mrs. Robert J. Jones
Dr Walter Keller
Mr. Arthur Landy
Mr and Mrs. Richard E Leckerling
Mr. William Lehrfeld
Dr and Mrs. Monroe L. Levin
Mr. Henry Luce III
Drs. Fumio and Shigeko Matsumura
Ms. Leila Laughlin McKnight
Mrs. Florence L. Meader and Family
Dr. Jeffrey H. Miller
Mrs. Martha M. Osterhus
Mr. and Mrs. Richard Neuendorffer
Pederson-Krag Center
Mr. J. Gardiner Pieper
Mrs. Andrew R. Povill
Mr. Richardson Pratt, Jr
Mrs. Sherman Pratt
Dr and Mrs. John R. Ray III
Ms. Joan R. Read
The Sanibel Writers Group
Ms. Marilyn Louise Schmitt
Dr. and Mrs. Walter Shropshire
Lt.Col. and Mrs. Jesse S. Skaggs III
Dr. David Stacy
Mr Colton P Wagner
Dr and Mrs. James D. Watson
Dr. Robert A. Weisberg
Mr. James F. Wellington
Dr. and Mrs. Heiner Westphal
Mr. and Mrs. Duane N. Williams
In memory of . . .
Jean Bardsley
Frederich Barnes
Dudley R. Barr
Donald Braid
Grace Eisenberg
R.B. Hintenach
Helen H. Leckerling
Jeanne R. Leckerling
Laurie Lowman
Margaret M. McCarthy
Patricia McDonald
David C. Noyes III
Robert H.P. Olney
Sigourney B. Olney
Mother of Mr Irving Paeff
Dr and Mrs. R. Townley Paton
Elizabeth Pieper
Stephen James Prentis
Richard Taylor
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"Nothing But Steel"
Two sculptures by Michael Malpass, "Nuts and Bolts" (right) and "Midnight Fair,"
have been donated to the Laboratory by Richardson Pratt, Jr., president of the
Pratt Institute in Brooklyn. The public was invited to view these pieces and 22
other works on display throughout the Laboratory grounds from June 1987
through March 1988. The exhibition, "Nothing But Steer comprised the work of 19
artists, including Lloyd Harbor resident Christopher Solbert, who conceived the
exhibition, selected the artists, and supervised installation of the works.
Contributions totalling $5400 were made to the "Nothing But Steel" fund by:
Mrs. Donald Arthur
Mr and Mrs. William Braden
Mr. and Mrs. G. Morgan Browne, Jr
Mr. George W. Cutting, Jr.
Mrs. John P Campbell
Mr and Mrs. Miner D. Crary, Jr
Mr and Mrs. Norris Darrell
Mr and Mrs. Charles Dolan
Mr and Mrs. James A. Eisenman
Mr and Mrs. Duncan Elder
ME and Mrs. Joseph G. Fogg
Mr. and Mrs. Oliver R. Grace
Mr. and Mrs. Henry U. Harris, Jr
Mrs. Sinclair Hatch
Mr. and Mrs. Robert D. Jay
Mr. and Mrs. Gordon Lamb
Mr. Edward M. Lamont
Mr and Mrs. George N. Lindsay
Mrs. Charles P. Noyes
Mr. and Mrs. Randall P. McIntyre
Mr and Mrs. Robert J. Osterhus
Mr and Mrs. Donald R. Peirce
Mrs. Richardson Pratt
Mr and Mrs. John R. Reese
Mr and Mrs. Peter O.A. Solbert
Dr. and Mrs. James D. Watson
Mr. and Mrs. Taggart Whipple
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The LONG ISLAND BIOLOGICAL ASSOCIATION (LIBA)
and Its Relation to the Cold Spring Harbor Laboratory
Biological research at Cold Spring Harbor began in 1890 when the Brooklyn
Institute of Arts and Sciences established a summer laboratory here as the field
station for its Department of Zoology. Representatives of the Institute were invited
by Eugene G. Blackford, at that time the Fish Commissioner of the State of New
York, to inspect a site on Bungtown Road across Northern Boulevard from the
Fish Hatchery. The site was found to be ideal, and so the original laboratory was
organized with Mr. Blackford as president of the Board of Trustees. The land was
leased from Mr. John D. Jones, whose family since 1819 had operated various
industries, including shipbuilding, coopering, whaling, and textile manufacture at
the head of Cold Spring Harbor. Bungtown Road, which runs through the
Laboratory property, got its name from the factory that specialized in making
bungs-or stoppers-for barrels.
In 1892, the Laboratory's land was leased for a dollar a year from the Wawepex
Society, which Mr. Jones had organized as a corporation for holding real estate
and for investing funds for the propagation of fishes and for scientific research. In
1904, the Wawepex Society leased additional land to the Carnegie Institution of
Washington to locate a Station for Experimental Evolution at Cold Spring Harbor.
Charles B. Davenport, who had been directing the Laboratory since 1896,
assumed additional duties as director of the Carnegie Institution's facility. It is
interesting to note that Mr. Davenport lived in the Victorian house on Route 25A
which was built on the site of the Jones family homestead before the turn of the
century. Formerly known as "Carnegie Dormitory:' it is now repainted in its original
colors and called "Davenport House."
During the early years, scientists at the Laboratory worked out the genetics of
eye and hair color in humans. In 1908, they developed the first hybrid corn. Many
consider this discovery one of the most significant achievements of this century.
Another discovery with far-reaching importance to molecular biology was made by
Alfred Hershey in 1952, when he provided key evidence that DNA is the molecule
of heredity-work for which he shared the Nobel Prize.
The Long Island Biological Association (LIBA) was founded by a small group of
community leaders in 1924 when the Brooklyn Institute decided to discontinue its
research at Cold Spring Harbor. For the next 38 years, this association operated
the laboratory in conjunction with the Carnegie Institution.
In 1962, the Carnegie and LIBA facilities were merged to form the Cold Spring
Harbor Laboratory of Quantitative Biology, and the property owned by LIBA was
conveyed to the Laboratory, with LIBA retaining reversionary rights. In addition to
its representation on the Board of Trustees of the Laboratory, LIBA became an
important source of capital for the funding of specific projects at Cold Spring
Harbor, including the building of the James Laboratory Annex, the renovation of
Blackford Hall, the rebuilding of Williams House, and the acquisition of the land
formerly owned by the Carnegie Institution, culminating with a $600,000 donation
toward the cost of the Oliver and Lorraine Grace Auditorium.
LIBA's membership has grown from the small band of residents who saw the
importance of maintaining an independent laboratory at Cold Spring Harbor in
Membership in LIBA requires a minimum annual contribution (tax deductible) of $25 per family. Further information can be
obtained from the Long Island Biological Association, Post Office Box 100, Cold Spring Harbor, N.Y. 11724 or by telephoning
the Laboratory at 516/367-8319.
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1924 to an association of more than 500 interested supporters today. Its affairs are
handled by a board of 29 directors who are elected to office by the membership
at an annual meeting. LIBA members and their friends are encouraged to attend
lectures and other events designed to increase their understanding of molecular
biology.
In the fall of 1986, the Trustees of the Laboratory recognized the need to
establish an annual giving program at Cold Spring Harbor to give the Laboratory
the ability to continue to attract the best new Ph.D. scientists. The LIBA Directors
responded and established an annual giving program to initially fund four
incoming postdoctoral scientists and to augment laboratory support for young staff
investigators. Additionally, the Cold Spring Harbor Laboratory Associate Program
was conceived to give special recognition to those who contribute $1000 or more
to annual giving. This program offers special educational opportunities through
"Associates only" lectures, briefings, and workshops.
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Officers
Mr. George W. Cutting, Jr., Chairman
Mrs. George N. Lindsay, Vice-Chairman
Mr. James A. Eisenman, Treasurer
Mrs. John P. Campbell, Secretary
Mr. G. Morgan Browne, Asst. Secretary/Treasurer
Directors
Mrs. Donald Arthur
Mrs. Allen L. Boorstein
Mr. Lionel Chaikin
Mr. Arthur M. Crocker
Mr. Lawrence L. Davis
Mr. Joseph P Downer
Dr. Lester Dubnick
Mrs. Duncan Elder
Mrs. Henry U. Harris, Jr.
Mrs. Sinclair Hatch
Mr. Gordon E. Lamb
Mrs. Walter C. Meier
Mr. Arthur C. Merrill
Mr. F. Warren Moore
Dr. Larry Nathanson
Mr. William F. Payson
Mr. Edward Pulling
Mr. John R. Reese
Mr. Douglas E. Rogers
Mr. Byam K. Stevens, Jr.
Mrs. Stanley S. Trotman, Jr.
Mrs. Philip R. von Stade
Dr. James D. Watson
Mrs. Bradford Weekes, Ill
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Cold Spring Harbor Laboratory Associates
Mr. Amyas Ames Mr. & Mrs. Edward Greenberg Mr. & Mrs. George D. O'Neill
Mrs. Donald Arthur Rey Linda Peyton Hancock Mr. & Mrs. Walter H. Page
Mr. & Mrs. Allen L. Boorstein Mr. & Mrs. Henry U. Harris, Jr Dr. David B. Pall
Dr. David Botstein Miss Maxine Harrison Mr & Mrs. Nicholas R. Parks
Mrs. Harry Brooks Harweb Foundation Mr & Mrs. William Parsons, Jr.
Mr. & Mrs. G. Morgan Browne Mr. & Mrs. Sinclair Hatch Mr & Mrs. Fremont C. Peck
Mr. & Mrs. John P. Campbell Dr. & Mrs. Alfred D. Hershey Mrs. Claire Platkin
Centerbrook Architects Mrs. Thomas L. Higginson Mrs. Francis T P Plimpton
Mr. & Mrs. Lionel Chaikin Mr. & Mrs. Charles J. Hubbard Mr. & Mrs. Martin Pollak
Mr. David C. Clark Mr. Waldo Hutchins Mrs. H. Irving Pratt
Dr. & Mrs. Bayard D. Clarkson Mrs. Warren C. Hutchins Mr. & Mrs. Richardson Pratt, Jr.
Mrs. Robert L. Clarkson Mr. & Mrs. Nicholas L. lhasz Mr. Edward Pulling
Mr. James W. Cleary Mr. & Mrs. Francis S. Kinney Mrs. Seena H. Purdy
Mr. & Mrs. John P Cleary Mr. Townsend J. Knight Mr. & Mrs. John R. Reese
Mr. & Mrs. Gregory S. Coleman Mr. & Mrs. Gordon E. Lamb Mr. & Mrs. Willis L. M. Reese
Mrs. John K. Colgate Dr. Laurie J. Landau Miss Elizabeth Roosevelt
Mr. & Mrs. Arthur Crocker Mr. & Mrs. Henry C. Lee Mr. Robert Sabin
Mr. Robert L. Cummings Dr. Robert V. Lewis Mr. & Mrs. Harvey E. Sampson
Mr. Roderick H. Cushman Mr. & Mrs. George N. Lindsay Schiff Foundation
Ms. Lucy Cutting Mr. & Mrs. Robert V Lindsay Mr. & Mrs. Franz Schneider
Mr. & Mrs. George W. Cutting, Jr. Mr. & Mrs. V S. Littauer Mr. Douglas A. Shepardson
Mr. Norris Darrell, Jr Mr. & Mrs. John H. Livingston Smith-Richardson Foundation
Mr & Mrs. Donald L. Deming Mr. & Mrs. David L. Luke, Ill Mr & Mrs. James F. Stebbins
Mr & Mrs. Charles F. Dolan Ms. Martha Makanna Mr & Mrs. Byam K. Stevens, Jr.
Dr & Mrs. Lester Dubnick Mr. Robert R. Maxfield ME Donald J. Sutherland
Mr. & Mrs. James A. Eisenman Mr Gerald M. Mayer, Jr Mr & Mrs. Richard M. Sykes
Mr & Mrs. William Everdell Miss Diana Mcllvaine Mr & Mrs. Daniel G. Tenney Jr.
Mr. John R. Fell, Jr Dr & Mrs. Walter C. Meier Mr & Mrs. Charles R. Thompson
Mr Alan Fortunoff Mr Arthur C. Merrill Mrs. Robert W. Tilney, Jr
Mr & Mrs. Robert S. Gardner, Jr Miller-Richard, Inc. Mrs. Helene P Victor
Mr & Mrs. Charles S. Gay Dr. Peter Model Mrs. George G. Walker
Mr & Mrs. Robert A. Gay Mr & Mrs. George G. Montgomery, Jr Dr & Mrs. James D. Watson
Mr & Mrs. Daniel W. Gerrity Mr & Mrs. F. Warren Moore Webster Foundation
Mr & Mrs. Joseph Gerrity Dr & Mrs. Larry Nathanson Mr & Mrs. Bradford G. Weekes, Ill
Mr & Mrs. Oliver R. Grace National Westminster Bank Mr & Mrs. Richard J. Weghorn
Mr & Mrs. Oliver R. Grace, Jr Mr & Mrs. John Nields Mr & Mrs. Taggart Whipple
(Contributors of $1000 or more to Annual Giving at the Laboratory)
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CHAIRMAN'S REPORT
1987 was an especially exciting year for the Long Island Biological Association. As
the pace of discovery in molecular biology quickened, LIBAs initial efforts to raise
annual funds for the Cold Spring Harbor Laboratory met with considerable
success.
Membership swelled to 519, and total contributions reached $182,550. A
principal reason for this success was support from 94 Cold Spring Harbor
Laboratory Associates during our fiscal year ending September 30, 1987.
Dr. David Botstein, Laboratory Trustee from MIT, addressed the Annual Meeting
with an interesting speech on "Genetic Fingerprints:' and Dr. Ernst Mayr from the
Museum of Comparative Zoology in Cambridge gave the Dorcas Cummings
Lecture on "What Is Evolution All About?" These programs were augmented by a
series of open houses to familiarize members and guests with the exciting
developments at the Laboratory. In addition, the Associates were invited to attend
"hands-on" laboratory workshops. At one workshop, they cut DNA with several
restriction enzymes, each of which cleaved at specific nucleotide sequences within
the DNA molecule. The resulting DNA restriction fragments were then separated
according to size using gel electrophoresis. At a second workshop, Associates
added a plasmid DNA to bacterial cells and demonstrated that the transformed
cells thrived in a medium containing the antibiotic ampicillin, which killed the
normal bacterial cells.
These two experiments were highly effective in giving the participants a real
understanding of laboratory procedures and some of the exciting possibilities
brought about through genetic engineering. To further their understanding of
molecular biology, Associates were invited to interesting lectures and scientific
briefings during the year.
DNA Literacy Program Director David Mick los (left) explains use of micropipet to Mrs.
Nicholas Parks and her son Nicholas at a special Associatds workshop on DNA finger-
printing.
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E. Mayr, G.W. Cutting, Jr., and
B.D. Clarkson at the Dorcus
Cummings lecture.
As part of the allocation of the contributions received, fellowships were awarded
to Toshiki Tsurimoto, Paul Walton, Roymarie Ballester, and Gokul Das. Moreover,
staff scientists Nouns Hernandez and David Spector were awarded grants from
the New Investigator Start-up Fund, which was established through LIBA contribu-
tions. Funds were also applied to the Science Meetings Program, including an
important meeting in September, "Modern Approaches to Vaccines:' at which the
problem of AIDS was a major topic.
LIBA is taking an increasing responsibility for expanding the community's
knowledge and understanding of basic molecular biology. Through the continued
interest and strong support of its membership, LIBA is sharing in the excitement
and progress of this fast-growing science.
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George W. Cutting, Jr., Chairman
Members
of the Long Island Biological Association
Mr & Mrs. Thomas H. Ackerman
Mr. & Mrs. James F Adams
Mrs. Stirling S. Adams
Mrs. Charles E. Ames
Mr. & Mrs. Hoyt Ammidon
Mrs. Barbara Amott
Dr Harold Anderson
Mr & Mrs. Robert W. Anthony
Mr. & Mrs. Silas Reed Anthony
Mr. & Mrs. Martin S. Arbonies
Mr. & Mrs. J. S. Armentrout, Jr
Mrs. Robert W. Ayer
Dr. & Mrs. Alfred A. Azzoni
Mr. & Mrs. Henry D. Babcock, Jr
Mr. Benjamin H. Balkind
Mrs. Gilbert A. Ball
Mrs. William N. Bannard
Mr. & Mrs. George Barclay
Dr. & Mrs. Henry H. Bard
Mr. & Mrs. John S. Barker
Mr. & Mrs. Edmund Bartlett
Mr. & Mrs. Sherburn M. Becker
Mr. Walter E. Beer, Jr
Dr. & Mrs. John Bell - Thomson
Mr. Paul Berg
Mr. & Mrs. Loren C. Berry
Mr. & Mrs. Robert P Beuerlein
Mr. & Mrs. Nicholas Biddle, Jr.
Mrs. William Binnian
Mr. F Roberts Blair
Ms. Mary Lenore Blair
Ms. Margery Blumenthal
Mr. & Mrs. Elito J. Bongarzone
Mr. & Mrs. Murray Borson
Mr. & Mrs. James C. Bostwick
Mr. & Mrs. William Braden
Mr. Thomas A. Bradley, Jr.
Mrs. Leonie T Brigham
Dr. & Mrs. Arik Brissenden
Dr. Thomas Broker
Mr. F Sedgwick Browne
Mr. & Mrs. Franklin Bruder
Mr & Mrs. James T Bryan, Jr.
Mr. Julian G. Buckley
Mr. Robert M. Bunnell
Mrs. Elizabeth T Busby
Mr. & Mrs. Clarence M. Buxton
Ms. Grace T Caidin
Mr. & Mrs. Samuel R. Callaway
Mr. & Mrs. Ward C. Campbell
Ms. Bernadette Castro
Mr. & Mrs. Thomas C. Cattrall
Mr. & Mrs. Gilbert W. Chapman, Jr.
Mr. & Mrs. Harry G. Charlston
Mr. & Mrs. Paul J. Chase
Mrs. Helen B. Chenery
Dr. Eleanor Chernick
Mr. & Mrs. Anwar Chitayat
Dr. Louise Chow
Drs. Peter & Joan Cohn
Mrs. C. Payson Coleman
Mr. & Mrs. John H. Coleman
Mr. & Mrs. Francis X. Coleman, Jr.
Mr. & Mrs. Emilio G. Collado
Mr. Bradley Collins
Mr. & Mrs. Patrick Collins
Mr. & Mrs. Kingsley Colton
Mrs. Ralph C. Colyer
Dr. & Mrs. Joseph B. Conolly, Jr.
Mrs. Crispin Cooke
Mr. & Mrs. Robert Cooper
Mrs. Ann B. Copeland
Mrs. Howard Corning, Jr.
Mr. Henry Cragg
Mr & Mrs. Charles Craig
Mr & Mrs. Miner D. Crary, Jr
Mrs. Ralph Crews
Mr. & Mrs. Henry B. Cross
CSS Pederson Krag Center
Mr. & Mrs. Robert Cuddeback
Mr. Robert L. Cummings Ill
Mr. Richard T Cunniff
Dr. & Mrs. Paul Cushman, Jr.
Mr. & Mrs. A. Neville Cutting
Mrs. Howard H. Dana
Mr. Bryan N. Danforth
Mr. Theodore N. Danforth
Mr. & Mrs. A. George Dartt
Mrs. Katya Davey
Mr. Lawrence L. Davis
Mrs. F. Trubee Davison
Mr. & Mrs. Donald C. Death
Mr. & Mrs. Raymond deClairville
Mr. & Mrs. Louis D. Delalio
Mrs. Douglas C. Despard, Jr
Mr. & Mrs. Joseph C. Dey
Mr. & Mrs. Joseph P. Downer
Mr. E. Richard Droesch
Mrs. Eugene Dubois
Dr. & Mrs. John L. Duffy
Mr. & Mrs. Edgar P Dunlaevy
Mr. & Mrs. William T Dunn, Jr.
Dr. & Mrs. Gerard L. Eastman
Dr. & Mrs. James D. Ebert
Mrs. Fred J. Eissler
Mr. & Mrs. Duncan Elder
Mr & Mrs. Ashton G. Eldredge
Mr. Martin Elias
Mr. & Mrs. John J. Evans
Mr. & Mrs. Raymond Z. Fahs
Mr. & Mrs. Joel M. Fairman
Mr. & Mrs. Harold L. Fates
(Contributors of $25 or more to Annual Giving at the Laboratory)
Mr. George S. Franklin, Jr
Mr. Jack B. Friedman
Mr Stephen D. Fuller
Mr. & Mrs. H. Gaiss
Mr. & Mrs. D. Kent Gale
Mr. & Mrs. Clarence E. Galston
Mr. & Mrs. John W. Galston
Dr. & Mrs. Aaron Ganz
Mrs. James E. Gardner Jr
Mrs. Louis F Geissler
Mr. & Mrs. Martin Gellert
Mr. & Mrs. David George
Mr. Elbridge T Gerry, Jr.
Mrs. Vera C. Gibbons
Mr. Harry Giffords
Mr. & Mrs. Stephen E. Gilhuley
Mr. & Mrs. Robert Gilmor, Jr.
Dr. & Mrs. H. Bentley Glass
Mrs. J. Wooderson Glenn
Mr. Bernard J. Gloisten
Mr. & Mrs. Edward R. Godfrey, Jr
Mr. Stanley F. Gordon
Mr. & Mrs. Kilbourn Gordon, Jr.
Mrs. Henry W. Grabowski
Mr. & Mrs. William R. Grant
Mr. Austen T Gray
Mr. & Mrs. Craig P Greason
Mrs. Lewis S. Greenleaf, Jr
Mr. & Mrs. Alfred T Gregory
Mr. & Mrs. George J. Haberer
Mr. & Mrs. John W. B. Hadley
Mr. & Mrs. Lawrence J. Hahn
Dr. Seymour Halpern
Mrs. Beverly Fite Hanson
Mr. & Mrs. Gordon Hargraves
Mr. & Mrs. Gerald W. Hart
Dr. & Mrs. Chester Hartenstein
Mr. & Mrs. Rolf D. Hartmann
Mr. & Mrs. Stanley Hattman
Mr. & Mrs. Horace Havemeyer, Jr
Mr. Ralph F Hayden
Mr. & Mrs. Thomas M. Hearn
Mrs. R. Graham Heiner
Mr. Huy ler C. Held
Mr. Michael R. Held
Mr. & Mrs. James E. Hellier
Dr. & Mrs. William Heroy
Mrs. Charles L. Hewitt
Mr. & Mrs. Charles A. Hickmann
Mr. Albert P Hildebrandt
Mrs. Albert L. Hoffman
Mr. Robert L. Hoguet
Mr & Mrs. Charles R. Holcomb
Mr & Mrs. George J. Hossfeld
Mr. & Mrs. George J. Hossfeld, Jr.
Mr. George H. Howard
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Mr. & Mrs. George H. Howard III
Mr. & Mrs. Philip G. Hull
Mrs. John S. Humes
Mr. & Mrs. James W. Husted, Jr
Mr. & Mrs. Robert Hutchings
Mr. & Mrs. J. A. V. Hyatt
Mrs. David Ingraham
Mr. & Mrs. Frederic B. Ingraham
Mr. & Mrs. Fred Irwin
Mrs. Richard M. Jackson
Mr. & Mrs. Valdemar F Jacobsen
Mrs. Margaret K. Jadwin
Irving D. Jakobson
Jakobson Shipyard Inc.
Mr. & Mrs. Alfred A. Jarnow, Jr.
Mr & Mrs. Robert D. Jay
Mrs. B. Brewster Jennings
Mr. Hugh G. Johnson
Mr. & Mrs. Laurence S. Johnson
Mr. E. William Jones
Dr. Gail Jones
Mrs. Ruth B. Jordan
Mr. & Mrs. John Juda, Jr.
Mr. & Mrs. Howard L. Kane
Mr. Daniel Karpen
Mr. & Mrs. Morris I. Karpen
Dr. & Mrs. Francis C. Keil
Mr. Francis E. Kelly, Jr.
Mrs. Walter A. Kernan
Mrs. Louise M. King
Mr. & Mrs. Jeffrey Klein
Mrs. Robert Koenig
Mr. & Mrs. Jack Kolodny
Mr. Edward W. Kozlik
Mr. & Mrs. Paul Kramer
Dr. Rakesh Kumar
Mr. & Mrs. Mort Kunst ler
Mrs. Carol Hill Lamb
Mr. Edward M. Lamont
Dr. & Mrs. Ralph Landau
Mr. Charles L. Lassen
Mrs. Ward Law
Mrs. Orin T. Leach
Mr. & Mrs. Leslie S. Learned
Mrs. Randall J. LeBoeuf
Mr & Mrs. Richard E. Leckerling
Rev. & Mrs. T. Carleton Lee
Mr. & Mrs. Thomas Leon
Dr. & Mrs. Monroe L. Levin
Mrs. Elizabeth A. Lindsay
Mr. & Mrs. George Lindsay, Jr.
Dr & Mrs. Lawrence Lippert
Mr. & Mrs. Robert F. Little
Mr. Angus C. Littlejohn
Mr & Mrs. Candido V. Llovera
Mr. & Mrs. Alan J. Long
Mrs. Wladimir Z. Lotowycz
Mr. Henry Luce III
Mr. Richard H. MacDougall
Mr. & Mrs. John F. MacKay
Mr & Mrs. Malcolm MacKay
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Mr. Sayre MacLeod III
Dr & Mrs. James N. Macri
Mrs. Henry R. Macy
& Mrs. William E. Mahoney
Mr & Mrs. John Mariani
Mr & Mrs. John Maroney
Mrs. John B. Marsh
Dr Daniel R. Marshak
Mr. Milward W. Martin II
Mr & Mrs. William H. Mathers
Dr. Ernst Mayr
Mr & Mrs. Edward F. McCann II
Dr. & Mrs. Robert L. McCollom
Mr & Mrs. Victor C. McCuaig, Jr
Mr. & Mrs. James A. McCurdy II
Mr. Richard McDaniel
Mr & Mrs. Victor King McElheny
Mr. James McEnerney, Jr
ME & Mrs. Angus P McIntyre
Mr. & Mrs. Randall P. McIntyre
Ms. Leila Laughlin McKnight
Mr. & Mrs. Robert M. McLane
Mr & Mrs. Lawrence M. Mead, Jr.
Mr & Mrs. Robert G. Merrill
Mrs. Nancy Metz
Mrs. Frances Meurer
Mrs. Charles G. Meyer
Mr & Mrs. George S. Meyer
Dr. & Mrs. Leo M. Meyer
Mr. Richard W. Meyer
Mr & Mrs. Kennedy B. Middendorf
Mr & Mrs. William H. Miller
Millham
Mr. & Mrs. Keith M. Moffat
Mrs. F. Franklin Moon
Mr. & Mrs. James D. Mooney, Jr
Mr & Mrs. Richard K. Moore
Mr. George Morgese
Mrs. Dorothy C. Morrell
Mr. & Mrs. Duncan C. Morrell
Mr. & Mrs. Grinnell Morris
ME & Mrs. Charles Morton
Mr. Frederick R. Moseley, Jr
Mr & Mrs. Brent M. Mowery, Jr
Mrs. Robert C. Muhlhausen
Mr. Gardner M. Mundy
Mr. & Mrs. George Murnane, Jr
Mr & Mrs. Francis W. Murray III
Mr. Rem V. Myers
Mr & Mrs. F Barry Nelson
Mr & Mrs. Richard Neuendorffer
New York Community Trust
Mr & Mrs. John S. Nichols
Mr & Mrs. Adams H. Nickerson
Mrs. Jeanne S. Niven
Mr & Mrs. Albert C. Nolte, Jr
North Shore Garden Club
Mr. Lawrence W. Northam
Mr & Mrs. Charles P. Noyes
Mr & Mrs. David C. Noyes
Mr & Mrs. Richard B. Opsahl
Mr. Thomas W. Orme
Mrs. William H. Osborn
Mr & Mrs. Robert J. Osterhus
Dr. David A. Page
Mr & Mrs. John H. Page
Mr. & Mrs. Arthur W. Page, Jr
Mr & Mrs. Fred W. Pain
Mr & Mrs. Samuel D. Parkinson
Mr. & Mrs. Joseph M. Parriott
Mr. William Parsons, Sr
Mr & Mrs. William H. Peck, Jr
Mr. & Mrs. Donald R. Peirce
Mr. & Mrs. Peter J. Pell
Mr. Paul G. Pennoyer, Jr
Mr & Mrs. John M. Perkins
Ms. Joan M. Pesek
Mr. & Mrs. Stanley Pesinkowski
Ms. Susan R. Peterson
Mr & Mrs. Howard Phipps, Jr
Mrs. Elena M. Phleger
Mr. Whitney D. Pidot
Mr & Mrs. John A. Pieper
Mrs. Richard N. Pierson
Mr & Mrs. Robert A. Pilkington
Mrs. James J. Pirtle, Jr
Mr & Mrs. Collier Platt
Mr & Mrs. Graham L. Platt
Mr. Henry Platt
Hon. & Mrs. Thomas Platt
Mr & Mrs. Joseph D. Posillico, Jr.
Mr & Mrs. Edward Everett Post
Mrs. William S. Post
Mrs. Helen W. Powers
Mr. & Mrs. Richard M. Powers
Mrs. Sherman Pratt
Mr. & Mrs. Tom Pratt
Mr. & Mrs. William M. Preston
Mr. Thomas L. Pulling
Mr & Mrs. Preston V. Pumphrey
Mr & Mrs. Tarrant Putnam
Mr & Mrs. James T. Pyle
Mr. William Rand
Mrs. Joan R. Read
Mr Arthur G. Reid
Dr & Mrs. Robert M. Reiss
Mr. Bernard J. Reverdin
Mr. & Mrs. Harold Van B. Richard
Dr. Frederic M. Richards
Mr & Mrs. John T. Ricks
Mr & Mrs. George H. Roberts
Mr & Mrs. Douglas E. Rogers
Mr & Mrs. Samuel B. Rogers
Mr. P. James Roosevelt
Mrs. Quentin Roosevelt
Mrs. Donald W. Rose
Mrs. Sarane Hickox Ross
Mr & Mrs. Arthur W. Rossiter, Jr.
Mr & Mrs. Walter N. Rothschild, Jr
Mr & Mrs. Francis J. Rue, Jr
Mrs. Francis E. Ruland
Dr. Claire A. Ryan
Mrs. Harold P Salembier
Mr. & Mrs. Bernard Salzberg
Mr. & Mrs. John K. Sands
Mr. Carl Schlanger
Dr. Carl J. Schmidlapp
Dr. & Mrs. Irving M. Schneider
Mr. & Mrs. Henry Schniewind
Mr. & Mrs. Hermann G. Schwab
Mr & Mrs. David R. Schwarz
Mr. & Mrs. Enrique F. Senior
Mr & Mrs. Frederick E. Seymour
ME & Mrs. Marvin J. Sharfin
Mr. Ralph Z. Sharp
Ms. Louise H. Sharretts
Dr & Mrs. Edward M. Shepard
Col. & Mrs. Robert E. Sheridan
Mr Alan Shestack
Dr & Mrs. Walter Shropshire, Jr.
Mr. & Mrs. Robert P Sibert
Mr. & Mrs. Paul W. Siegert
Dr & Mrs. Paul Siminoff
Mr. William C. Simpson
Mr & Mrs. James C. Skiff
Mr. & Mrs. Rowland G. Skinner
Mr. Richard Slade
Mr. Alexander B. Slater
Mr & Mrs. H. Turner Slocum
Dr. & Mrs. Robert Smirnow
Mr. & Mrs. Brant R. Smith
Mr. Herbert L. Smith III
Mr. & Mrs. William S. Smoot
Mr. & Mrs. Sedgwick Snedeker
Mr & Mrs. James Sommermeyer
Dr. Keld Sorensen
Mr. & Mrs. Gerhard G. Spielmann
Mrs. Julian C. Stanley
Mr. & Mrs. David H. Stein
Dr Kingsley M. Stevens
Mr. & Mrs. John C. Stevenson
Mr. & Mrs. Norman W. Stewart
Mr Dudley W. Stoddard
Mr & Mrs. F. Page Storment
Mr & Mrs. Richard Storrs
Mr & Mrs. Joseph S. Stout
Mr & Mrs. Joseph S. Stout, Jr
Mr & Mrs. James E. Swiggett
Mr & Mrs. Robert L. Swiggett
Dr & Mrs. Basil Tangredi
Mr & Mrs. Benjamin N. Taylor
Mr John W. Taylor
Mr Dudley B. Tenney
Mr & Mrs. Roderick P Thaler
Mr & Mrs. Seth A. Thayer
Mr & Mrs. Fred Theilking
Mr & Mrs. Edward M. Thomas
Mr & Mrs. Evan W. Thomas II
Mr. & Mrs. William J. Thompson
Mr & Mrs. Warren I. Titus, Jr
Mr & Mrs. Alexander C. Tomlinson
Mr & Mrs. George I. Toumanoff
Mr & Mrs. David B. Townsend
Mr & Mrs. Martin B. Travis, Jr
Mr & Mrs. Bronson Trevor, Jr
Mr & Mrs. Stanley S. Trotman
Mr & Mrs. Anthony M. Trotter
Mr Godfrey G. Truslow
Mrs. Ernest T Turner
Mr & Mrs. Wilfred 0. Uhl
Mr & Mrs. Cornelius M. Ulman
Mr & Mrs. Stephen Van R. Ulman
Dr & Mrs. Thornton Vandersall
Mr & Mrs. Lawrence B. VanIngen
Ms. Elizabeth R. Van Norden
Mr & Mrs. Joseph C. Viviani
Mr. Eric A. Von Raits
Mrs. Marjorie M. von Staade
Mr & Mrs. Eugene D. Wadsworth
Mr & Mrs. Colton P. Wagner
Mr Sherwood Waldron
Mr & Mrs. R. W. Walker
Mr & Mrs. Robert P. Walton
Mr & Mrs. Charles W. B. Wardell, Jr
Mr & Mrs. David E. Warden
Mrs. Ethelbert Warfield
Mr & Mrs. Bradford A. Warner
Dr. Jonathan R. Warner
Mr & Mrs. Harold L. Warner Jr
Mr & Mrs. Morris Wasser
Mrs. Bradford G. Weekes
Mr & Mrs. R. Ray Weekes
Mr Townsend U. Weekes
Mr John C. Weghorn
Mr & Mrs. L. B. Wehle, Jr
Mr & Mrs. Hugh J. Weidinger
Mr & Mrs. H. L. Christian Wenk
Dr & Mrs. Charles A. Werner
Mr & Mrs. Heiner Westphal
Mr & Mrs. Edward C. R. Whitcraft
Mr & Mrs. Hendricks H. Whitman
Mr Theodore S. Wickersham
Mr Malcolm D. Widenor
Mr & Mrs. Marvin S. Wiggins
Ms. Judy Wilbur
Mr & Mrs. Douglas Williams
Mr & Mrs. Duane N. Williams
William Wilson & Associates
Mrs. John C. Wilmerding
Mrs. Charles A. Wilson
Mrs. T Scudder Winslow
Mr & Mrs. Frederick C. Witsell, Jr
Women's Outreach Network, Inc.
Mrs. Helen C. Woodbridge
Mr & Mrs. William A. Woodcock
Mr & Mrs. James A. Woods
Mrs. Ethel M. Woolverton
Mr William H. Woolverton, Jr
Mr & Mrs. George Wulfing
Mr & Mrs. Warren D. Wylie
Mr Woodhull B. Young
Mr & Mrs. Robert W. Young, Jr
Mr. Robert F. Zakary

LABORATORY
STAFF

Laboratory Staff
James D. Watson, Director
G. Morgan Browne, Administrative Director
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